FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Daltro, RT
   Leony, LM
   Freitas, NEM
   Silva, AAO
   Santos, EF
   Del-Rei, RP
   Brito, MEF
   Brandao, SP
   Gomes, YM
   Silva, MS
   Donato, ST
   Jeronimo, SMB
   Monteiro, GRD
   Carvalho, LP
   Magalhaes, AS
   Zanchin, NIT
   Celedon, PAF
   Santos, FLN
AF Daltro, Ramona Tavares
   Leony, Leonardo Maia
   Maron Freitas, Natalia Erdens
   Oliveira Silva, Angelo Antonio
   Santos, Emily Ferreira
   Del-Rei, Rodrigo Pimenta
   Felinto Brito, Maria Edileuza
   Brandao-Filho, Sinval Pinto
   Gomes, Yara Miranda
   Silva, Marcelo Sousa
   Donato, Silvia Tavares
   Bezerra Jeronimo, Selma Maria
   de Gois Monteiro, Gloria Regina
   Carvalho, Lucas Pedreira
   Magalhaes, Andrea Santos
   Tonin Zanchin, Nilson Ivo
   Fiorani Celedon, Paola Alejandra
   Neves Santos, Fred Luciano
TI Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic
   Performance in Settings Where Chagas Disease and American Cutaneous or
   Visceral Leishmaniasis Are Coendemic
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE American cutaneous leishmaniasis; Chagas disease; cross-reactivity;
   recombinant chimeric antigens; visceral leishmaniasis
ID UNITED-STATES; INFECTION; STANDARDIZATION; IMMUNOASSAY; ANTIBODIES;
   PEPTIDE; ELISA; ASSAY; SPP.
AB Chimeric T. cruzi antigens have been proposed as a diagnostic tool for chronic Chagas disease (CD) in both settings where Chagas disease is endemic and those where it is not endemic. Antibody response varies in accordance to each T. cruzi strain, presenting challenges to the use of antigens lacking demonstrated cross-reactivity with Leishmania spp. Our group expressed four chimeric proteins (IBMP-8.1, IBMP-8.2, IBMP-8.3, and IBMP-8.4) and previously assessed their diagnostic performance to determine cross-reactivity with Leishmania spp. Here, we validated our findings using serum samples from different Brazilian geographic areas reporting endemic Chagas disease, endemic visceral or American cutaneous leishmaniasis (ACL), or both. Overall, 829 serum samples were evaluated using commercial and IBMP enzyme-linked immunosorbent assays. Due to the absence of a reference assay to diagnosis CD, latent class analysis (LCA) was performed through the use of a statistical model. The incidence of cross-reactivity for ACL-positive samples varied from 0.35% (IBMP-8.3) to 0.70% (IBMP-8.1 and IBMP-8.2). Regarding visceral leishmaniasis (VL)-positive samples, the IBMP-8.2 and IBMP-8.3 antigens cross-reacted with six (3.49%) and with only one sample (0.58%), respectively. No cross-reactivity with either ACL or VL was observed for the IBMP-8.4 antigen. Similarly, no cross-reactions were found when VL-positive samples were assayed with IBMP-8.1. The agreement among the results obtained using IBMP antigens ranged from 97.3% for IBMP-8.2 and 99% for IBMP-8.1 and IBMP-8.3 to 100% for IBMP-8.4, demonstrating almost perfect agreement with LCA. Accordingly, in light of the negligible cross-reactivity with both ACL and VL, we suggest the use of IBMP antigens in regions where T. cruzi and Leishmania spp. are coendemic.
C1 [Daltro, Ramona Tavares; Leony, Leonardo Maia; Maron Freitas, Natalia Erdens; Oliveira Silva, Angelo Antonio; Santos, Emily Ferreira; Carvalho, Lucas Pedreira; Neves Santos, Fred Luciano] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Del-Rei, Rodrigo Pimenta] Fac Technol & Sci Bahia, Salvador, BA, Brazil.
   [Felinto Brito, Maria Edileuza; Brandao-Filho, Sinval Pinto; Gomes, Yara Miranda] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Silva, Marcelo Sousa; Donato, Silvia Tavares; Bezerra Jeronimo, Selma Maria; de Gois Monteiro, Gloria Regina] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Silva, Marcelo Sousa] Inst Hyg & Trop Med, Lisbon, Portugal.
   [Carvalho, Lucas Pedreira; Magalhaes, Andrea Santos] Univ Fed Bahia, Salvador, BA, Brazil.
   [Tonin Zanchin, Nilson Ivo] Fundacao Oswaldo Cruz, Carlos Chagas Inst, Curitiba, Parana, Brazil.
   [Fiorani Celedon, Paola Alejandra] Mol Biol Inst Parana, Curitiba, Parana, Brazil.
RP Santos, FLN (corresponding author), Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
EM fred.santos@bahia.fiocruz.br
RI Brandao-Filho, Sinval Pinto/AAP-4792-2020; Zanchin, Nilson Ivo
   Tonin/AAB-4907-2019; Carvalho, Lucas/AAP-1844-2020; SANTOS,
   Fred/S-2954-2019; Jeronimo, Selma/AAY-4033-2020
OI Brandao-Filho, Sinval Pinto/0000-0003-3768-2810; Zanchin, Nilson Ivo
   Tonin/0000-0002-1153-0694; SANTOS, Fred/0000-0002-3944-0818; Jeronimo,
   Selma/0000-0002-4784-9904; Leony, Leonardo/0000-0003-0681-8332; Freitas,
   Natalia/0000-0001-6286-1883
FU Internal Research Support Program-PIAP Jovem + [PIAP-001/2017];
   Coordination of Superior Level Staff Improvement-CAPES [PROEX
   0720/2018]; National Council for Scientific and Technological
   Development-CNPqNational Council for Scientific and Technological
   Development (CNPq) [479046/2011-5, 400331/2012-8]; Araucaria
   FoundationFundacao Araucaria [05/2016]; Research Support Foundation of
   the State of Bahia (FAPESB)
FX This work was supported by the Internal Research Support Program-PIAP
   Jovem + (grant PIAP-001/2017); the Coordination of Superior Level Staff
   Improvement-CAPES (grant PROEX 0720/2018), the National Council for
   Scientific and Technological Development-CNPq (grants 479046/2011-5 and
   400331/2012-8), Araucaria Foundation (grant 05/2016), and Research
   Support Foundation of the State of Bahia (FAPESB). Nilson I. T. Zanchin,
   Sinval P. Brandao-Filho, and Selma M. B. Jeronimo are research fellows
   of CNPq (process no. 312195/2015-0, 305549/2017-0, and 311699/2016-2,
   respectively).
CR Abras A, 2016, J CLIN MICROBIOL, V54, P1566, DOI 10.1128/JCM.00142-16
   Alviarez Y, 2014, BIOMEDICA, V34, P308, DOI [10.1590/S0120-41572014000200017, 10.7705/biomedica.v34i2.2078]
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   Basile L., 2011, Eurosurveillance, V16, P19972
   Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07
   Camargo M E, 1986, Bull Pan Am Health Organ, V20, P233
   Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09
   Chin-Hong PV, 2011, AM J TRANSPLANT, V11, P672, DOI 10.1111/j.1600-6143.2011.03444.x
   Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799
   Conners EE, 2016, ACTA TROP, V156, P68, DOI 10.1016/j.actatropica.2016.01.002
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   de Andrade JP, 2011, ARQ BRAS CARDIOL, V96, DOI 10.1590/S0066-782X2011000600002
   De Marchi CR, 2011, CLIN VACCINE IMMUNOL, V18, P1850, DOI 10.1128/CVI.05289-11
   Flores-Chavez MD, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01446-17, 10.1128/jcm.01446-17]
   Frank FM, 2003, PARASITOLOGY, V126, P31, DOI 10.1017/S0031182002002585
   Gadelha AAM, 2003, VOX SANG, V85, P165, DOI 10.1046/j.1423-0410.2003.00340.x
   Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017
   Granjon E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004596
   Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   MALCHIODI EL, 1994, CLIN EXP IMMUNOL, V97, P417, DOI 10.1111/j.1365-2249.1994.tb06104.x
   Manne-Goehler J, 2015, AM J TROP MED HYG, V93, P108, DOI 10.4269/ajtmh.14-0826
   Peverengo LM, 2018, PARASITOLOGY, V145, P1594, DOI [10.1017/S0031182018000458, 10.1017/s0031182018000458]
   Santos FLN, 2018, AM J TROP MED HYG, V99, P1174, DOI 10.4269/ajtmh.17-0727
   Santos FLN, 2017, J CLIN MICROBIOL, V55, P2934, DOI 10.1128/JCM.00851-17
   Santos FLN, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005433
   Santos FLN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161100
   Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820
   Pedral-Sampaio G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162793
   Dias JCP, 2016, REV SOC BRAS MED TRO, V49, P3, DOI 10.1590/0037-8682-0505-2016
   Reis LD, 2008, REV SOC BRAS MED TRO, V41, P439, DOI 10.1590/S0037-86822008000500001
   Sanchez B, 2001, ARCH MED RES, V32, P382, DOI 10.1016/S0188-4409(01)00303-4
   Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003
   Telles S, 2003, FEMS IMMUNOL MED MIC, V37, P23, DOI 10.1016/S0928-8244(03)00086-5
   Umezawa ES, 2003, TRANSFUSION, V43, P91, DOI 10.1046/j.1537-2995.2003.00279.x
   Benedetti AFV, 2013, TROP MED INT HEALTH, V18, P1103, DOI 10.1111/tmi.12144
   Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11
   World Health Organization, 2007, 2 WHO CONS DEV WHO R
NR 39
TC 3
Z9 3
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD AUG
PY 2019
VL 57
IS 8
AR e00762-19
DI 10.1128/JCM.00762-19
PG 10
WC Microbiology
SC Microbiology
GA IM1HD
UT WOS:000477738500027
PM 31189586
OA Green Published, Other Gold
DA 2020-11-26
ER

PT J
AU Mody, RM
   Lakhal-Naouar, I
   Sherwood, JE
   Koles, NL
   Shaw, D
   Bigley, DP
   Co, EMA
   Copeland, NK
   Jagodzinski, LL
   Mukbel, RM
   Smiley, RA
   Duncan, RC
   Kamhawi, S
   Jeronimo, SMB
   DeFraites, RF
   Aronson, NE
AF Mody, Rupal M.
   Lakhal-Naouar, Ines
   Sherwood, Jeffrey E.
   Koles, Nancy L.
   Shaw, Dutchabong
   Bigley, Daniel P.
   Co, Edgie-Mark A.
   Copeland, Nathanial K.
   Jagodzinski, Linda L.
   Mukbel, Rami M.
   Smiley, Rebecca A.
   Duncan, Robert C.
   Kamhawi, Shaden
   Jeronimo, Selma M. B.
   DeFraites, Robert F.
   Aronson, Naomi E.
TI Asymptomatic Visceral Leishmania infantum Infection in US Soldiers
   Deployed to Iraq
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE visceral leishmaniasis; asymptomatic; US soldiers; deployed; Iraq
ID ENDEMIC AREA; RISK-FACTORS; CHAGASI; DIAGNOSIS; MILITARY; CARRIERS;
   EPIDEMIOLOGY; SURVEILLANCE; PARASITES; DISEASE
AB Background. Visceral leishmaniasis (VL), due to Leishmania infantum, is a persistent intracellular parasitic infection transmitted by the bite of infected sand flies. Symptomatic VL has been reported in U.S. soldiers with Iraq deployment. Untreated symptomatic VL can be fatal; asymptomatic VL (AVL) may establish a lifelong risk of reactivation. We report prevalence and AVL risk factors in Operation Iraqi Freedom (OIF) deployers during 2002-11.
   Methods. Healthy soldiers exposed to VL endemic areas in Iraq and 50 controls who never traveled to endemic regions were recruited through military healthcare facilities (2015-17). Responses to a risk factor survey and blood samples were obtained. Leishmania research diagnostics utilized included enzyme-linked immunosorbent assay (ELISA), rk39 test strips, quantitative polymerase chain reaction (PCR), and interferon gamma release (IGRA) assays. Statistical analyses included Fisher exact test, Pearson chi(2) test, Mann-Whitney U test, and logistic regression.
   Results. 200 deployed subjects were enrolled, mostly males (84.0%), of white ethnicity (79.0%), and median age 41 (range 24-61) years. 64% were seropositive for Phlebotomus alexandri saliva antibodies. Prevalence of AVL (any positive test result) was 39/200 (19.5%, 95% confidence interval 14.4%-25.8%). Two (1.0%) PCR, 10 (5%) ELISA, and 28 (14%) IGRA samples were positive. Travel to Ninewa governorate increased risk for AVL (P = .01).
   Conclusion. AVL was identified in 19.5% of OIF deployers; travel to northwest Iraq correlated with infection. Further studies are needed to inform risk for reactivation VL in US veterans and to target additional blood safety and surveillance measures.
C1 [Mody, Rupal M.; Sherwood, Jeffrey E.] William Beaumont Army Med Ctr, Infect Dis Dept, El Paso, TX 79920 USA.
   [Lakhal-Naouar, Ines; Koles, Nancy L.; Aronson, Naomi E.] Uniformed Serv Univ Hlth Sci, Infect Dis Div, Bethesda, MD 20814 USA.
   [Shaw, Dutchabong] Uniformed Serv Univ Hlth Sci, Clin Res Unit, Bethesda, MD 20814 USA.
   [Bigley, Daniel P.] DiLorenzo TRICARE Hlth Clin Pentagon, Washington, DC USA.
   [Co, Edgie-Mark A.] William Beaumont Army Med Ctr, Internal Med Dept, El Paso, TX 79920 USA.
   [Copeland, Nathanial K.; Jagodzinski, Linda L.] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Mukbel, Rami M.] Jordan Univ Sci & Technol, Dept Basic Vet Sci, Irbid, Jordan.
   [Smiley, Rebecca A.] William Beaumont Army Med Ctr, Dept Clin Invest, El Paso, TX 79920 USA.
   [Duncan, Robert C.] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Silver Spring, MD USA.
   [Kamhawi, Shaden] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, Rockville, MD USA.
   [Jeronimo, Selma M. B.] Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
   [DeFraites, Robert F.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA.
RP Mody, RM (corresponding author), William Beaumont Army Med Ctr, 5005 North Piedras St, El Paso, TX 79920 USA.
EM rupal.m.mody.civ@mail.mil
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
FU Global Emerging Infections Surveillance Section, Armed Forces Health
   Surveillance Branch, Department of DefenseUnited States Department of
   Defense [P0024_17_HS]
FX Funding support for this project PRoMIS ID P0024_17_HS was received from
   the Global Emerging Infections Surveillance Section, Armed Forces Health
   Surveillance Branch, Department of Defense.
CR Al-Nahhas S, 2003, East Mediterr Health J, V9, P856
   Armed Forces Press Services, 2011, IR NUMB
   Aronson N, 2016, CLIN INFECT DIS, V63, pE202, DOI 10.1093/cid/ciw670
   Aronson NE, 2007, EMERG INFECT, V7, P325
   Aronson NE, 2006, CLIN INFECT DIS, V43, P1045, DOI 10.1086/507539
   Asfaram S, 2017, TRANSFUS APHER SCI, V56, P474, DOI 10.1016/j.transci.2017.06.001
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142
   Cardo LJ, 2006, TRANSFUSION, V46, P1641, DOI 10.1111/j.1537-2995.2006.00941.x
   Clemente W, 2015, CLIN MICROBIOL INFEC, V21, P89, DOI 10.1016/j.cmi.2014.09.002
   Coleman RE, 2009, J MED ENTOMOL, V46, P649, DOI 10.1603/033.046.0333
   Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716
   Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680
   de Oliveira JM, 2010, REV SOC BRAS MED TRO, V43, P188, DOI 10.1590/S0037-86822010000200016
   Marques LHD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001955
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Fletcher K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121418
   Gambel JM, 1998, J TRAVEL MED, V5, P217, DOI 10.1111/j.1708-8305.1998.tb00511.x
   Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001042
   HANTOSH HA, 2013, J INFECT DIS THER, V1, P122, DOI DOI 10.4172/2332-0877.1000122
   Herrador Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003594
   Hirve S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004896
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Kakarsulemankhel Juma Khan, 2010, Pakistan Entomologist, V32, P125
   Kaushal H, 2017, AM J TROP MED HYG, V96, P1448, DOI 10.4269/ajtmh.16-0592
   Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608
   Kopterides P, 2007, T ROY SOC TROP MED H, V101, P1181, DOI 10.1016/j.trstmh.2007.08.003
   Kubar J, 1998, AIDS, V12, P2147, DOI 10.1097/00002030-199816000-00009
   Lane RP, 1986, B BR MUS NAT HIST, V52, P35
   Maalej IA, 2003, AM J TROP MED HYG, V68, P312, DOI 10.4269/ajtmh.2003.68.312
   MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904
   Maia Z, 2016, VECTOR-BORNE ZOONOT, V16, P368, DOI 10.1089/vbz.2015.1880
   Majeed B, 2013, EPIDEMIOL INFECT, V141, P443, DOI 10.1017/S0950268812000556
   MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491
   Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004
   Meyerhoff A, 1999, CLIN INFECT DIS, V28, P42, DOI 10.1086/515085
   Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012
   Moral L, 2002, T ROY SOC TROP MED H, V96, P129, DOI 10.1016/S0035-9203(02)90278-6
   Myles O, 2007, ARCH INTERN MED, V167, P1899, DOI 10.1001/archinte.167.17.1899
   Oliveira F, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3043
   Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284
   Poeppl W, 2013, CLIN MICROBIOL INFEC, V19, P572, DOI 10.1111/j.1469-0691.2012.03960.x
   Prina E, 2007, MICROBES INFECT, V9, P1307, DOI 10.1016/j.micinf.2007.06.005
   Ramer-Tait AE, 2012, J PARASITOL, V98, P1109, DOI 10.1645/GE-3130.1
   Rodrigues V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1412-x
   Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900
   Saha P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005391
   Sakkas H, 2016, J VECTOR DIS, V53, P8
   Schnorr D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001947
   SCOTT P, 1987, J IMMUNOL, V139, P3118
   Silva LA, 2013, REV INST MED TROP SP, V55, P101, DOI 10.1590/S0036-46652013000200006
   Silva LA, 2011, AM J TROP MED HYG, V84, P261, DOI 10.4269/ajtmh.2011.10-0092
   Singh Om Prakash, 2015, J Parasitol Res, V2015, P239469, DOI 10.1155/2015/239469
   Singh OP, 2014, CLIN INFECT DIS, V58, P1424, DOI 10.1093/cid/ciu102
   Stahlman Shauna, 2017, MSMR, V24, P2
   Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345
   Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421
   van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556
   Viana LD, 2008, T ROY SOC TROP MED H, V102, P548, DOI 10.1016/j.trstmh.2008.02.007
   Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747
   Weisser M, 2007, CLIN MICROBIOL INFEC, V13, P751, DOI 10.1111/j.1469-0691.2007.01755.x
   Xynos ID, 2009, EMERG INFECT DIS, V15, P956, DOI 10.3201/eid1506.090101
   Zanger P, 2013, EUROSURVEILLANCE, V18, P49, DOI 10.2807/1560-7917.ES2013.18.30.20542
NR 63
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUN 15
PY 2019
VL 68
IS 12
BP 2036
EP 2044
DI 10.1093/cid/ciy811
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA IW7JF
UT WOS:000485163700012
PM 30239631
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Ozanne, MV
   Brown, GD
   Oleson, JJ
   Lima, ID
   Queiroz, JW
   Jeronimo, SMB
   Petersen, CA
   Wilson, ME
AF Ozanne, Marie V.
   Brown, Grant D.
   Oleson, Jacob J.
   Lima, Iraci D.
   Queiroz, Jose W.
   Jeronimo, Selma M. B.
   Petersen, Christine A.
   Wilson, Mary E.
TI Bayesian compartmental model for an infectious disease with dynamic
   states of infection
SO JOURNAL OF APPLIED STATISTICS
LA English
DT Article
DE Multinomial; seasonality; SIR; visceral leishmaniasis; Bayes factor;
   empirically-adjusted reproductive number
ID VISCERAL LEISHMANIASIS; COMPUTATION; CHAGASI; BRAZIL; POPULATION;
   INFERENCE; EPIDEMIC; NUMBER; TRENDS; DENGUE
AB Population-level proportions of individuals that fall at different points in the spectrum [of disease severity], from asymptomatic infection to severe disease, are often difficult to observe, but estimating these quantities can provide information about the nature and severity of the disease in a particular population. Logistic and multinomial regression techniques are often applied to infectious disease modeling of large populations and are suited to identifying variables associated with a particular disease or disease state. However, they are less appropriate for estimating infection state prevalence over time because they do not naturally accommodate known disease dynamics like duration of time an individual is infectious, heterogeneity in the risk of acquiring infection, and patterns of seasonality. We propose a Bayesian compartmental model to estimate latent infection state prevalence over time that easily incorporates known disease dynamics. We demonstrate how and why a stochastic compartmental model is a better approach for determining infection state proportions than multinomial regression is by using a novel method for estimating Bayes factors for models with high-dimensional parameter spaces. We provide an example using visceral leishmaniasis in Brazil and present an empirically-adjusted reproductive number for the infection.
C1 [Ozanne, Marie V.; Brown, Grant D.; Oleson, Jacob J.] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA.
   [Lima, Iraci D.; Queiroz, Jose W.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
   [Petersen, Christine A.; Wilson, Mary E.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA.
   [Petersen, Christine A.] Univ Iowa, Ctr Emerging Infect Dis, Coll Publ Hlth, Iowa City, IA USA.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Iowa City VA Med Ctr, Iowa City, IA USA.
RP Ozanne, MV (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA.
EM marie-ozanne@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; Petersen, Christine/M-1881-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275;
   Petersen, Christine/0000-0002-7285-4254
FU Fogarty International Center of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R01TW010500];
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50 AI30639]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R01TW010500, R01TW010500,
   R01TW010500, R01TW010500] Funding Source: NIH RePORTER
FX Research reported in this publication was supported by the Fogarty
   International Center of the National Institutes of Health under Award
   Number R01TW010500 and by the National Institute of Allergy and
   Infectious Diseases under Award Number P50 AI30639. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Agyingi EO, 2011, J BIOL SYST, V19, P237, DOI 10.1142/S0218339011003841
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Andersson H., 2000, STOCHASTIC EPIDEMIC
   Beaumont MA, 2002, GENETICS, V162, P2025
   Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621
   Bonsu BK, 2004, PEDIATR INFECT DIS J, V23, P511, DOI 10.1097/01.inf.0000129689.58211.9e
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Brown GD, 2016, BIOMETRICS, V72, P335, DOI 10.1111/biom.12432
   Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122
   Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   Geweke J, 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.1371/J0URNAL.P0NE.0059328
   HASIBEDER G, 1992, PARASITOLOGY, V105, P43, DOI 10.1017/S0031182000073674
   Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x
   LEVY MD, 1948, JAMA-J AM MED ASSOC, V136, P81, DOI 10.1001/jama.1948.02890190009003
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Martin Andrew D., 2011, J STAT SOFTW, V42, P22, DOI DOI 10.18637/JSS.V042.I09
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   Moral L, 2002, T ROY SOC TROP MED H, V96, P129, DOI 10.1016/S0035-9203(02)90278-6
   MORRISON AC, 1995, J MED ENTOMOL, V32, P538, DOI 10.1093/jmedent/32.4.538
   MOTT KE, 1990, B WORLD HEALTH ORGAN, V68, P691
   Neal RM, 2011, CH CRC HANDB MOD STA, P113
   PIESMAN J, 1987, AM J EPIDEMIOL, V126, P1187, DOI 10.1093/oxfordjournals.aje.a114757
   Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281
   Plummer M, 2008, BIOSTATISTICS, V9, P523, DOI 10.1093/biostatistics/kxm049
   Raftery AL, 1992, BAYESIAN STATISTICS, V4, P763
   Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412
   Shimozako Helio Junji, 2017, Infect Dis Model, V2, P143, DOI 10.1016/j.idm.2017.03.002
   Singh OP, 2014, CLIN INFECT DIS, V58, P1424, DOI 10.1093/cid/ciu102
   Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405
   Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172
   Venables WN, 2002, MODERN APPL STAT S
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 44
TC 1
Z9 1
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0266-4763
EI 1360-0532
J9 J APPL STAT
JI J. Appl. Stat.
PD APR 26
PY 2019
VL 46
IS 6
BP 1043
EP 1065
DI 10.1080/02664763.2018.1531979
PG 23
WC Statistics & Probability
SC Mathematics
GA HM2HW
UT WOS:000459281100005
PM 31537954
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Toepp, AJ
   Monteiro, GRG
   Coutinho, JFV
   Lima, AL
   Larson, M
   Wilson, G
   Grinnage-Pulley, T
   Bennett, C
   Mahachi, K
   Anderson, B
   Ozanne, MV
   Anderson, M
   Fowler, H
   Parrish, M
   Willardson, K
   Saucier, J
   Tyrell, P
   Palmer, Z
   Buch, J
   Chandrashekar, R
   Brown, GD
   Oleson, JJ
   Jeronimo, SMB
   Petersen, CA
AF Toepp, Angela J.
   Monteiro, Gloria R. G.
   Coutinho, Jose F. V.
   Lima, Adam Leal
   Larson, Mandy
   Wilson, Geneva
   Grinnage-Pulley, Tara
   Bennett, Carolyne
   Mahachi, Kurayi
   Anderson, Bryan
   Ozanne, Marie V.
   Anderson, Michael
   Fowler, Hailie
   Parrish, Molly
   Willardson, Kelsey
   Saucier, Jill
   Tyrell, Phyllis
   Palmer, Zachary
   Buch, Jesse
   Chandrashekar, Ramaswamy
   Brown, Grant D.
   Oleson, Jacob J.
   Jeronimo, Selma M. B.
   Petersen, Christine A.
TI Comorbid infections induce progression of visceral leishmaniasis
SO PARASITES & VECTORS
LA English
DT Article
DE Tick-borne diseases; Canine leishmaniosis; Risk-factor; Progression
ID CANINE LEISHMANIASIS; EHRLICHIA-CANIS; NORTHEASTERN BRAZIL; INFANTUM
   INFECTION; LYME-DISEASE; RISK-FACTORS; DOGS; COINFECTION; URBAN;
   DIAGNOSIS
AB BackgroundVisceral leishmaniasis (VL) is a vector borne zoonotic disease endemic in humans and dogs in Brazil. Due to the increased risk of human infection secondary to the presence of infected dogs, public health measures in Brazil mandate testing and culling of infected dogs. Despite this important relationship between human and canine infection, little is known about what makes the dog reservoir progress to clinical illness, significantly tied to infectiousness to sand flies. Dogs in endemic areas of Brazil are exposed to many tick-borne pathogens, which are likely to alter the immune environment and thus control of L. infantum.ResultsA cross-sectional study of 223 dogs from an area of Natal, in the Rio Grande do Norte, Brazil, were studied to determine the association between comorbid tick-borne disease and Leishmania infection in this endemic area. The risk of Leishmania seropositivity was 1.68x greater in dogs with tick-borne disease seropositivity compared to those without (Adjusted RR: 1.68, 95% CI: 1.09-2.61, P = 0.019). A longitudinal study of 214 hunting dogs in the USA was conducted to determine the causal relationship between infection with tick-borne diseases and progression of VL. Hunting dogs were evaluated three times across a full tick season to detect incident infection with tick-borne diseases. A logistic regression model with generalized estimating equations to estimate the parameters was used to determine how exposure to tick-borne disease altered VL progression over these three time points when controlling for other variables. Dogs infected with three or more tick-borne diseases were 11x more likely to be associated with progression to clinical VL than dogs with no tick-borne disease (Adjusted RR: 11.64, 95% CI: 1.22-110.99, P = 0.03). Dogs with exposure to both Leishmania spp. and tick-borne diseases were five times more likely to die during the study period (RR: 4.85, 95% CI: 1.65-14.24, P = 0.0051).ConclusionsComorbid tick-borne diseases dramatically increased the likelihood that a dog had clinical L. infantum infection, making them more likely to transmit infection to sand flies and people. As an important consequence, reduction of tick-borne disease exposure through topical or oral insecticides may be an important way to reduce progression and transmissibility of Leishmania infection from the canine reservoir to people.
C1 [Toepp, Angela J.; Lima, Adam Leal; Larson, Mandy; Wilson, Geneva; Grinnage-Pulley, Tara; Bennett, Carolyne; Mahachi, Kurayi; Anderson, Bryan; Anderson, Michael; Fowler, Hailie; Parrish, Molly; Willardson, Kelsey; Petersen, Christine A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA.
   [Toepp, Angela J.; Lima, Adam Leal; Larson, Mandy; Wilson, Geneva; Grinnage-Pulley, Tara; Bennett, Carolyne; Mahachi, Kurayi; Anderson, Bryan; Anderson, Michael; Parrish, Molly; Willardson, Kelsey; Petersen, Christine A.] Univ Iowa Res Pk, Ctr Emerging Infect Dis, Coralville, IA 52241 USA.
   [Monteiro, Gloria R. G.; Coutinho, Jose F. V.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59078970 Natal, RN, Brazil.
   [Ozanne, Marie V.; Brown, Grant D.; Oleson, Jacob J.] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA 52242 USA.
   [Fowler, Hailie; Petersen, Christine A.] Univ Iowa, Carver Coll Med, Program Immunol, Iowa City, IA 52242 USA.
   [Saucier, Jill; Tyrell, Phyllis; Buch, Jesse; Chandrashekar, Ramaswamy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME 04092 USA.
   [Palmer, Zachary] Univ Iowa, Coll Liberal Arts & Sci, Dept Geog & Sustainabil Sci, Iowa City, IA 52242 USA.
RP Petersen, CA (corresponding author), Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52242 USA.; Petersen, CA (corresponding author), Univ Iowa Res Pk, Ctr Emerging Infect Dis, Coralville, IA 52241 USA.; Petersen, CA (corresponding author), Univ Iowa, Carver Coll Med, Program Immunol, Iowa City, IA 52242 USA.
EM ajschneider3@uwalumni.com; christine-petersen@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; Petersen, Christine/M-1881-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Petersen,
   Christine/0000-0002-7285-4254; Grinnage-Pulley, Tara/0000-0002-7797-4642
FU Morris Animal Foundation [D16CA-517]; Fogarty International Center of
   the US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R01 TW 010500]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R01TW010500, R01TW010500, R01TW010500, R01TW010500, R01TW010500]
   Funding Source: NIH RePORTER
FX This work was funded by grant D16CA-517 from the Morris Animal
   Foundation with support from the Masters of Foxhounds Association
   Foundation and by R01 TW 010500 through the Fogarty International Center
   of the US National Institutes of Health. Neither of the funding agencies
   had a role in the study design or manuscript preparation.
CR ALVAR J, 1992, LANCET, V339, P1427, DOI 10.1016/0140-6736(92)91255-7
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Andrade GB, 2014, REV BRAS PARASITOL V, V23, P509, DOI 10.1590/S1984-29612014081
   Aoun O, 2009, VET PARASITOL, V166, P27, DOI 10.1016/j.vetpar.2009.08.006
   APPEL MJG, 1993, J INFECT DIS, V167, P651, DOI 10.1093/infdis/167.3.651
   Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   Aslan H, 2016, J INFECT DIS, V213, P1752, DOI 10.1093/infdis/jiw022
   Attipa C, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2717-8
   Azeredo-Coutinho RBG, 2016, ACTA TROP, V154, P42, DOI 10.1016/j.actatropica.2015.10.015
   Baneth G, 2015, VET PARASITOL, V208, P30, DOI 10.1016/j.vetpar.2014.12.013
   Baxarias M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2724-9
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851
   Bhadesiya CM, 2015, VET WORLD, V8, P713, DOI 10.14202/vetworld.2015.713-717
   Biglino A, 2010, J CLIN MICROBIOL, V48, P131, DOI 10.1128/JCM.00416-09
   Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019
   Cardoso L, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-27
   Cortes S, 2012, VET PARASITOL, V189, P189, DOI 10.1016/j.vetpar.2012.04.028
   Cota GF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002816
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31
   da Silva DA, 2013, VET J, V195, P252, DOI 10.1016/j.tvjl.2012.06.010
   de Melo EC, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/319234
   Duthie MS, 2018, TRENDS PARASITOL, V34, P881, DOI 10.1016/j.pt.2018.07.012
   Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810
   Gaunt SD, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-33
   Grinnage-Pulley T, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005302
   Hajjaran H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/789326
   Ismail N, 2007, INFECT IMMUN, V75, P4608, DOI 10.1128/IAI.00198-07
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Kader M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006644
   Kocoglu ME, 2014, TURK J MED SCI, V44, P914, DOI 10.3906/sag-1308-38
   Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657
   Larson M, 2017, APPL MICROBIOL BIOT, V101, P381, DOI 10.1007/s00253-016-7925-6
   Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002
   Lima ALM, 2017, T ROY SOC TROP MED H, V111, P440, DOI 10.1093/trstmh/trx080
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Lima ID, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006164
   Lima WG, 2004, ACTA TROP, V92, P43, DOI 10.1016/j.actatropica.2004.04.007
   Magalhaes JT, 2016, VET PARASITOL, V223, P120, DOI 10.1016/j.vetpar.2016.04.031
   Maia Z, 2016, VECTOR-BORNE ZOONOT, V16, P368, DOI 10.1089/vbz.2015.1880
   McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148229
   McMahan CS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1431-7
   Mekuzas Y, 2009, CLIN MICROBIOL INFEC, V15, P30, DOI 10.1111/j.1469-0691.2008.02150.x
   Miro G, 2017, TRENDS PARASITOL, V33, P718, DOI 10.1016/j.pt.2017.05.005
   Monno R, 2009, FUTURE MICROBIOL, V4, P159, DOI 10.2217/17460913.4.2.159
   Nair ADS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148239
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   Petersen CA, 2009, VET CLIN N AM-SMALL, V39, P1065, DOI 10.1016/j.cvsm.2009.06.008
   Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014
   Rudoler N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0798-1
   Schaut RG, 2015, EMERG INFECT DIS, V21, P2209, DOI 10.3201/eid2112.141167
   Scorza BM, 2017, J INVEST DERMATOL, V137, P2149, DOI 10.1016/j.jid.2017.05.028
   Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86
   Toepp A, 2018, VACCINE, V36, P6433, DOI 10.1016/j.vaccine.2018.08.087
   Toepp A, 2018, AM J TROP MED HYG, V98, P1332, DOI 10.4269/ajtmh.17-0888
   Toepp Angela J, 2017, Vet Parasitol Reg Stud Reports, V10, P75, DOI 10.1016/j.vprsr.2017.08.011
   Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119
   Vida B, 2016, VET IMMUNOL IMMUNOP, V169, P34, DOI 10.1016/j.vetimm.2015.11.008
   Vorou RM, 2007, EPIDEMIOL INFECT, V135, P1231, DOI 10.1017/S0950268807008527
   Vrhovec MG, 2017, PARASITOL RES, V116, pS131, DOI 10.1007/s00436-017-5499-6
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
NR 62
TC 3
Z9 3
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 23
PY 2019
VL 12
AR 54
DI 10.1186/s13071-019-3312-3
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HI7DG
UT WOS:000456615000001
PM 30674329
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU de Pinho, FA
   Vendrame, CMV
   Maciel, BLL
   Silva, LD
   Miyashiro, SI
   Jeronimo, SMB
   Goto, H
AF de Pinho, Flaviane Alves
   Vieira Vendrame, Celia Maria
   Lima Maciel, Bruna Leal
   Silva, Lucilene dos Santos
   Miyashiro, Samantha Ive
   Bezerra Jeronimo, Selma Maria
   Goto, Hiro
TI Association between Insulin-Like Growth Factor-I Levels and the Disease
   Progression and Anemia in Visceral Leishmaniasis
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; INTERFERON-GAMMA; IGF-I; HEMATOPOIETIC ACTIVITY;
   BONE-MARROW; MOUSE MODEL; ERYTHROPOIESIS; EXPRESSION; CYTOKINES
AB We analyzed the association between insulin-like growth factor-I (IGF-I) and the pathogenesis of anemia during active visceral leishmaniasis (VL). Serum levels of IGF-I, IGF-binding protein 3 (IGFBP3), and cytokines were measured in samples from individuals with active VL and cured VL, asymptomatic Leishmania-infected, and noninfected individuals. Then, we extended our analysis to VL dogs to evaluate hematimetric parameters, bone marrow alterations, and cytokine and IGF-I expression. We identified a positive correlation between lower IGF-I and IGFBP3 levels in active VL patients and lower hemoglobin levels. In infected dogs, there was a positive correlation between lower IGF-I expression in the bone marrow and lower peripheral blood hematocrit and hemoglobin levels. There was no correlation between decreased IGF-I level/expression and any measured cytokine serum levels in either host. The data suggest that low IGF-I expression is associated with pathogenesis of anemia in active VL, primarily in severe cases, by mechanisms other than alterations in cytokine production.
C1 [de Pinho, Flaviane Alves; Vieira Vendrame, Celia Maria; Goto, Hiro] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [de Pinho, Flaviane Alves] Univ Fed Bahia, Dept Anat Patol & Clin, Escola Med Vet & Zootecnia, Salvador, BA, Brazil.
   [Lima Maciel, Bruna Leal] Univ Fed Rio Grande do Norte, Dept Nutricao, Ctr Ciencias Saude, Natal, RN, Brazil.
   [Silva, Lucilene dos Santos] Univ Fed Piaui, Setor Patol Anim, Ctr Ciencias Agr, Teresina, Brazil.
   [Miyashiro, Samantha Ive] Univ Sao Paulo, Dept Clin Med, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
   [Goto, Hiro] Univ Sao Paulo, Dept Med Prevent, Fac Med, Sao Paulo, Brazil.
RP de Pinho, FA (corresponding author), Univ Fed Bahia, Av Adhemar Barros 500, BR-40170110 Salvador, BA, Brazil.
EM flaviane.alves@ufba.br; vendramecelia@yahoo.com;
   brunalimamaciel@gmail.com; vetluc@hotmail.com; samanthaive@yahoo.com;
   smbj@cb.ufm.br; hgoto@usp.br
RI Jeronimo, Selma/AAY-4033-2020; Goto, Hiro/B-5745-2009
OI Jeronimo, Selma/0000-0002-4784-9904; Goto, Hiro/0000-0001-7048-562X
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2010/16257-2]; Fundacao de
   Amparo a Pesquisa do Estado da Bahia [1780-2007]; Conselho Nacional de
   Pesquisa [484499/2006]; Seropidemiology and Immunobiology Laboratory
   [LIM/38]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [AI
   030639]
FX This study was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (fellowship 2010/16257-2 to F. A. P.), Fundacao de Amparo a
   Pesquisa do Estado da Bahia (fellowship 1780-2007 to C. M. V. V.),
   Conselho Nacional de Pesquisa (research fellowship to S. M. B. J. and H.
   G. and research grant 484499/2006), the Seropidemiology and
   Immunobiology Laboratory LIM/38 (HC-FMUSP), and National Institutes of
   Health (AI 030639).
CR ARKINS S, 1995, MOL ENDOCRINOL, V9, P350, DOI 10.1210/me.9.3.350
   Askenasy N, 2015, BLOOD REV, V29, P11, DOI 10.1016/j.blre.2014.09.002
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Choi I, 2000, BLOOD, V95, P3742
   Choi JW, 2004, ANN CLIN LAB SCI, V34, P324
   Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000
   Daneshbod Y, 2010, ACTA CYTOL, V54, P12, DOI 10.1159/000324961
   de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451
   dos Santos PL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004375
   Elmlinger MW, 2004, CLIN CHEM LAB MED, V42, P654, DOI 10.1515/CCLM.2004.112
   FAN J, 1995, AM J PHYSIOL-REG I, V269, pR1204
   Goto Y, 2017, PARASITOL RES, V116, P457, DOI 10.1007/s00436-016-5313-x
   Grigorakaki C, 2011, BIOCHEM PHARMACOL, V82, P156, DOI 10.1016/j.bcp.2011.03.030
   Harvey J.W., 2012, VET HEMATOLOGY
   Hasegawa MY, 2005, VET CLIN PATH, V34, P213, DOI 10.1111/j.1939-165X.2005.tb00043.x
   Koury MJ, 2014, BLOOD REV, V28, P49, DOI 10.1016/j.blre.2014.01.002
   Lafuse WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059509
   Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopes AC, 2006, TRATADO CLIN MED, V3
   Marini MA, 2017, ONCOTARGET, V8, P32398, DOI 10.18632/oncotarget.16132
   Messick J, 2010, SCHALMS VET HEMATOLO
   Miljus G, 2013, METALLOMICS, V5, P251, DOI 10.1039/c3mt20210k
   Miniero R, 2012, J PEDIAT HEMATOL ONC, V34, P407, DOI 10.1097/MPH.0b013e318253f082
   Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
   Nicolato RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082947
   O'Connor JC, 2008, CELL IMMUNOL, V252, P91, DOI 10.1016/j.cellimm.2007.09.010
   Pinho FA, 2013, VET IMMUNOL IMMUNOP, V151, P163, DOI 10.1016/j.vetimm.2012.10.008
   Pinto AI, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006465
   Preham O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02958
   Ratajczak J, 1998, LEUKEMIA, V12, P371, DOI 10.1038/sj.leu.2400927
   Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198
   Saporito L, 2013, INT J INFECT DIS, V 17, pE572, DOI 10.1016/j.ijid.2012.12.024
   Savino W, 2005, ADV EXPT MED BIOL, V567
   Schubert T, 2003, LAB INVEST, V83, P1743, DOI 10.1097/01.LAB.0000101693.12149.2C
   Schubert TEO, 2005, INT J MOL MED, V16, P753
   Succurro E, 2011, THROMB HAEMOSTASIS, V105, P365, DOI 10.1160/TH10-06-0379
   Carvalho MDT, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/230129
   Varma N, 2010, INDIAN J HEMATOL BLO, V26, P78, DOI 10.1007/s12288-010-0027-1
   Welniak LA, 2004, BIOL BLOOD MARROW TR, V10, P32, DOI 10.1016/j.bbmt.2003.09.008
   Zumkeller W, 2002, LEUKEMIA LYMPHOMA, V43, P487, DOI 10.1080/10428190290011958
   2014, REV INST MED TROP SP, V56, P1, DOI DOI 10.1590/S0036-46652014000100001
NR 42
TC 1
Z9 1
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 4
BP 808
EP 815
DI 10.4269/ajtmh.17-0982
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HW9UV
UT WOS:000467037100011
PM 30761980
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU dos Santos, ARR
   Serufo, AV
   Figueiredo, MM
   Godoi, LC
   Vitorio, JG
   Marcelino, AP
   de Avelar, DM
   Rodrigues, FTC
   Machado-Coelhos, GLL
   Medeiros, FAC
   Jeronimo, SMB
   de Oliveira, EJ
   Nascimento, FC
   Teixeira, SMR
   Gazzinelli, RT
   Nagem, RAP
   Fernandes, AP
AF dos Santos, Anna Raquel Ribeiro
   Serufo, Angela Vieira
   Figueiredo, Maria Marta
   Godoi, Lara Carvalho
   Vitorio, Jessica Gardone
   Marcelino, Andreza Pain
   de Avelar, Daniel Moreira
   Comes Rodrigues, Fernandes Tenerio
   Lins Machado-Coelhos, George Luiz
   Cardoso Medeiros, Fernanda Alvarenga
   Bezerra Jeronimo, Selma Maria
   de Oliveira, Edward Jose
   Nascimento, Frederico Crepaldi
   Ribeiro Teixeira, Santuza Maria
   Gazzinelli, Ricardo Tostes
   Pinto Nagem, Ronaldo Alves
   Fernandes, Ana Paula
TI Evaluation of three recombinant proteins for the development of ELISA
   and immunochromatographic tests for visceral leishmaniasis serodiagnosis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE visceral leishmaniasis; recombinant proteins; diagnosis; ELISA;
   immunochromatographic test
ID LINKED IMMUNOSORBENT ASSAYS; CVL RAPID TEST; CHROMATOGRAPHIC
   IMMUNOASSAY; DIAGNOSIS; INFANTUM; DIPSTICK; DOGS; LEISH-TEC(R);
   PERFORMANCE; INFECTIONS
AB BACKGROUND Visceral Leishmaniasis (VL) is an infectious disease that is a significant cause of death among infants aged under 1 year and the elderly in Brazil. Serodiagnosis is a mainstay of VL elimination programs; however, it has significant limitations due to low accuracy.
   OBJECTIVE This study aimed to evaluate three recombinant Leishmania infantum proteins (rFc, rC9, and rA2) selected from previous proteomics and genomics analyses to develop enzyme-linked immunosorbent assay (ELISA) and immunochromatographic tests (ICT) for the serodiagnosis of human VL (HVL) and canine VL (CVL).
   METHODS A total of 186 human (70 L. infantum-infected symptomatic, 20 other disease-infected, and 96 healthy) and 185 canine (82 L. infantum-infected symptomatic, 27 L. infantum-infected asymptomatic, and 76 healthy) sera samples were used for antibody detection.
   FINDINGS Of the three proteins, rA2 (91.5% sensitivity and 87% specificity) and rC9 (95.7% sensitivity and 87.5% specificity) displayed the best performance in ELISA-HVL and ELISA-CVL, respectively. ICT-rA2 also displayed the best performance for HVL diagnosis (92.3% sensitivity and 88.0% specificity) and had high concordance with immunofluorescence antibody tests (IFAT), ELISA-rK 39, IT-LEISH (R), and ELISA(EXT). ICT-rFc, ICT-rC9, and ICT-rA2 had sensitivities of 88.6%, 86.5%, and 87.0%, respectively, with specificity values of 84.0%, 92.0%, and 100%, respectively for CVL diagnosis.
   MAIN CONCLUSIONS The three antigens selected by us are promising candidates for VL diagnosis regardless of the test format, although the antigen combinations and test parameters may warrant further optimisation.
C1 [dos Santos, Anna Raquel Ribeiro; Serufo, Angela Vieira; Vitorio, Jessica Gardone; Nascimento, Frederico Crepaldi; Fernandes, Ana Paula] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [de Avelar, Daniel Moreira; de Oliveira, Edward Jose; Gazzinelli, Ricardo Tostes] Fundacao Oswaldo Cruz, Fiocruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [Figueiredo, Maria Marta; Godoi, Lara Carvalho; Ribeiro Teixeira, Santuza Maria; Gazzinelli, Ricardo Tostes; Fernandes, Ana Paula] Univ Fed Minas Gerais, Ctr Tecnol Vacinas, Belo Horizonte, MG, Brazil.
   [Comes Rodrigues, Fernandes Tenerio; Ribeiro Teixeira, Santuza Maria; Gazzinelli, Ricardo Tostes; Pinto Nagem, Ronaldo Alves] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
   [Lins Machado-Coelhos, George Luiz] Univ Fed Ouro Preto, Dept Med Familia Saude Mental & Colet, Ouro Preto, MG, Brazil.
   [Marcelino, Andreza Pain; Cardoso Medeiros, Fernanda Alvarenga] Fundacao Ezequiel Dias, Inst Octavio Magalhaes, Belo Horizonte, MG, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Natal, RN, Brazil.
RP Fernandes, AP (corresponding author), Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.; Fernandes, AP (corresponding author), Univ Fed Minas Gerais, Ctr Tecnol Vacinas, Belo Horizonte, MG, Brazil.
EM apfernandes.ufmg@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; Coelho, George Luiz Lins
   Machado/S-3411-2019
OI Jeronimo, Selma/0000-0002-4784-9904; Coelho, George Luiz Lins
   Machado/0000-0002-9806-9721; Vitorio, Jessica/0000-0002-5009-6675;
   Avelar, Daniel/0000-0001-7907-7913; Oliveira,
   Edward/0000-0002-0042-5178; Nagem, Ronaldo/0000-0001-7219-1625
CR Akhoundi B, 2013, EXP PARASITOL, V133, P307, DOI 10.1016/j.exppara.2012.12.002
   Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349
   Almeida APMM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00465
   Carvalho FAA, 2002, DIAGN MICR INFEC DIS, V43, P289, DOI 10.1016/S0732-8893(02)00410-8
   Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y
   Coura-Vital W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091009
   de Souza JA, 2016, VET PARASITOL, V225, P114, DOI 10.1016/j.vetpar.2016.06.011
   Testasicca MCDS, 2014, VET PARASITOL, V204, P169, DOI 10.1016/j.vetpar.2014.04.025
   Farahmand M, 2015, REV SOC BRAS MED TRO, V48, P188, DOI 10.1590/0037-8682-0285-2014
   Faria AR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001310
   Fonseca AM, 2014, ACTA TROP, V137, P25, DOI 10.1016/j.actatropica.2014.04.028
   Ghedin E, 1997, CLIN DIAGN LAB IMMUN, V4, P530, DOI 10.1128/CDLI.4.5.530-535.1997
   Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
   Kohanteb J, 2005, MED PRIN PRACT, V14, P79, DOI 10.1159/000083915
   Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002
   MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X
   Martins-Melo FR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006559
   Matlashewski G, 2014, LANCET GLOB HEALTH, V2, pE683, DOI 10.1016/S2214-109X(14)70318-3
   Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005
   Fraga DBM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004333
   de Carvalho FLN, 2018, EPIDEMIOL INFECT, V146, P571, DOI 10.1017/S0950268818000225
   Pastorino Antonio C., 2002, J. Pediatr. (Rio J.), V78, P120, DOI 10.1590/S0021-75572002000200010
   Pattabhi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000822
   Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06
   Quinnell RJ, 2001, PARASITOLOGY, V122, P253, DOI 10.1017/S0031182001007363
   Regina-Silva S, 2016, VACCINE, V34, P2233, DOI 10.1016/j.vaccine.2016.03.019
   Reithinger R, 2002, J CLIN MICROBIOL, V40, P2352, DOI 10.1128/JCM.40.7.2352-2356.2002
   Schubach EYP, 2014, T ROY SOC TROP MED H, V108, P568, DOI 10.1093/trstmh/tru109
   Zanette MF, 2014, REV SOC BRAS MED TRO, V47, P105, DOI 10.1590/0037-8682-1723-2013
   Zhang WW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000248
NR 30
TC 2
Z9 2
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PY 2019
VL 114
AR e180405
DI 10.1590/0074-02760180405
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA HK4BJ
UT WOS:000457864200001
PM 30726344
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Amorim, FM
   Nobre, ML
   Nascimento, LS
   Miranda, AM
   Monteiro, GRG
   Freire-Neto, FP
   Queiroz, MDP
   Queiroz, JW
   Duthie, MS
   Costa, MR
   Reed, SG
   Johnson, WD
   Dupnik, KM
   Jeronimo, SMB
AF Amorim, Francianne M.
   Nobre, Mauricio L.
   Nascimento, Larissa S.
   Miranda, Alesson M.
   Monteiro, Gloria R. G.
   Freire-Neto, Francisco P.
   Palmeira Queiroz, Maria do Carmo
   Queiroz, Jose W.
   Duthie, Malcolm S.
   Costa, Marcos R.
   Reed, Steven G.
   Johnson, Warren D., Jr.
   Dupnik, Kathryn M.
   Jeronimo, Selma M. B.
TI Differential immunoglobulin and complement levels in leprosy prior to
   development of reversal reaction and erythema nodosum leprosum
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID B-CELLS; FC-GAMMA; IGG SUBCLASSES; ANTIBODIES; RECEPTORS
AB Background Leprosy is a treatable infectious disease caused by Mycobacterium leprae. However, there is additional morbidity from leprosy-associated pathologic immune reactions, reversal reaction (RR) and erythema nodosum leprosum (ENL), which occur in 1 in 3 people with leprosy, even with effective treatment of M. leprae. There is currently no predictive marker in use to indicate which people with leprosy will develop these debilitating immune reactions. Our peripheral blood mononuclear cell (PBMC) transcriptome analysis revealed that activation of the classical complement pathway is common to both RR and ENL. Additionally, differential expression of immunoglobulin receptors and B cell receptors during RR and ENL support a role for the antibody-mediated immune response during both RR and ENL. In this study, we investigated B-cell immunophenotypes, total and M. leprae-specific antibodies, and complement levels in leprosy patients with and without RR or ENL. The objective was to determine the role of these immune mediators in pathogenesis and assess their potential as biomarkers of risk for immune reactions in people with leprosy.
   Methodology/findings We followed newly diagnosed multibacillary leprosy cases (n = 96) for two years for development of RR or ENL. They were compared with active RR (n = 35), active ENL (n = 29), and healthy household contacts (n = 14). People with leprosy who subsequently developed ENL had increased IgM, IgG1, and C3d-associated immune complexes with decreased complement 4 (C4) at leprosy diagnosis. People who developed RR also had decreased C4 at leprosy diagnosis. Additionally, elevated anti-M. leprae antibody levels were associated with subsequent RR or ENL.
   Conclusions Differential co-receptor expression and immunoglobulin levels before and during immune reactions intimate a central role for humoral immunity in RR and ENL. Decreased C4 and elevated anti-M. leprae antibodies in people with new diagnosis of leprosy may be risk factors for subsequent development of leprosy immune reactions.
   Author summary One in three people with leprosy develop an immune reaction, which worsen quality of life. Reactions occur despite effective treatment of the causative bacteria of leprosy, Mycobacterium leprae, with antibiotics. These reactions cause worsening skin lesions and additional nerve damage. Reactions can be chronic and recurrent, and may necessitate years of treatment with high dose corticosteroids. Our research focuses on why certain people develop these reactions while others do not. We found that people who have higher antibodies to M. leprae when they are diagnosed with leprosy are more likely to develop immune reactions in the two years after diagnosis. Also, we identify that C4 levels in the blood may be useful for monitoring the development and progression of leprosy reactions. These may be ways to identify who is at highest risk for leprosy immune reactions before they occur.
C1 [Amorim, Francianne M.; Freire-Neto, Francisco P.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
   [Amorim, Francianne M.; Nobre, Mauricio L.; Nascimento, Larissa S.; Miranda, Alesson M.; Monteiro, Gloria R. G.; Freire-Neto, Francisco P.; Queiroz, Jose W.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Nobre, Mauricio L.; Monteiro, Gloria R. G.] State Hlth Secretariat, Giselda Trigueiro Hosp, Natal, RN, Brazil.
   [Palmeira Queiroz, Maria do Carmo] Univ Fed Rio Grande do Norte, Dept Internal Med, Hlth Sci Ctr, Natal, RN, Brazil.
   [Palmeira Queiroz, Maria do Carmo] Univ Fed Rio Grande do Norte, Onofre Lopes Univ Hosp, Natal, RN, Brazil.
   [Duthie, Malcolm S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA.
   [Costa, Marcos R.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil.
   [Johnson, Warren D., Jr.; Dupnik, Kathryn M.] Weill Cornell Med, Ctr Global Hlth, Dept Med, New York, NY USA.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil.
RP Dupnik, KM (corresponding author), Weill Cornell Med, Ctr Global Hlth, Dept Med, New York, NY USA.
EM kad9040@med.cornell.edu
RI Jeronimo, Selma/AAY-4033-2020; Costa, Marcos R/F-8071-2012
OI Jeronimo, Selma/0000-0002-4784-9904; Costa, Marcos
   R/0000-0002-4928-2163; Duthie, Malcolm/0000-0002-8515-5516
FU Brazil National Institute of Science and Technology Tropical Diseases
   [CNPq: 465229/2014-0]; Heiser Foundation for Leprosy Research; Burroughs
   Wellcome FundBurroughs Wellcome Fund; American Society of Tropical
   Medicine and Hygiene postdoctoral fellowship; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)CAPES [001]
FX This work was supported by the Brazil National Institute of Science and
   Technology Tropical Diseases [grant CNPq: 465229/2014-0]; the Heiser
   Foundation for Leprosy Research; and the Burroughs Wellcome Fund and the
   American Society of Tropical Medicine and Hygiene postdoctoral
   fellowship to K. M. D. This study was financed in part by the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES) - Finance Code 001. The funding agencies had no role in the
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amorim FM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004934
   [Anonymous], 2018, LEPROSY ELIMINATION
   AUGENER W, 1971, IMMUNOCHEMISTRY, V8, P1011, DOI 10.1016/0019-2791(71)90489-7
   Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785
   BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2010, GUIA PROC TECN BAC H
   Brito MDD, 2008, REV SOC BRAS MED TRO, V41, P67, DOI 10.1590/S0037-86822008000700014
   Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139
   Dupnik KM, 2015, J INFECT DIS, V211, P1658, DOI 10.1093/infdis/jiu612
   Duthie MS, 2014, DIAGN MICR INFEC DIS, V79, P233, DOI 10.1016/j.diagmicrobio.2014.02.006
   Gergely P, 2007, ANN NY ACAD SCI, V1108, P183, DOI 10.1196/annals.1422.020
   Hungria EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005396
   Hungria EM, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0203-0
   (ILEP) TIFoA-LA, 2002, REC MAN LEPR REACT L
   Irani V, 2015, MOL IMMUNOL, V67, P171, DOI 10.1016/j.molimm.2015.03.255
   Isaak A, 2008, INT IMMUNOL, V20, P185, DOI 10.1093/intimm/dxm132
   Iyer AM, 2007, HUM PATHOL, V38, P1065, DOI 10.1016/j.humpath.2006.12.017
   Kahawita IP, 2008, T ROY SOC TROP MED H, V102, P329, DOI 10.1016/j.trstmh.2008.01.004
   Karnell JL, 2014, J IMMUNOL, V192, P1480, DOI 10.4049/jimmunol.1301361
   Kifayet A, 1996, INT J LEPROSY, V64, P105
   Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158
   Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477
   Moura DF, 2012, EUR J IMMUNOL, V42, P2925, DOI 10.1002/eji.201142198
   MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0
   Negera E, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006321
   Negera E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006121
   Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206
   Nothelfer K, 2015, NAT REV MICROBIOL, V13, P173, DOI 10.1038/nrmicro3415
   Ochoa MT, 2010, IMMUNOLOGY, V131, P405, DOI 10.1111/j.1365-2567.2010.03314.x
   Penna MLF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004703
   Polycarpou A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00233
   Prokopec KE, 2010, CLIN IMMUNOL, V137, P322, DOI 10.1016/j.clim.2010.08.006
   Reed NK, 1997, INT J LEPROSY, V65, P328
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Saigawa K, 1974, Repura, V43, P254
   Sales AM, 2017, LEPROSY REV, V88, P499
   Serrano-Coll H, 2017, T ROY SOC TROP MED H, V111, P125, DOI 10.1093/trstmh/trx026
   Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520
   Walker SL, 2015, LEPROSY REV, V86, P304
   Walker SL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000351
   Walker SL, 2008, LEPROSY REV, V79, P372
   WHO, 1982, CHEM LEPR CONTR PROG
   YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582
NR 42
TC 3
Z9 3
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JAN
PY 2019
VL 13
IS 1
AR e0007089
DI 10.1371/journal.pntd.0007089
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HJ7SX
UT WOS:000457398700051
PM 30689631
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Dourado, MET
   Fernandes, UT
   Ramos, ES
   Vital, ALF
   Urbano, JCC
   Queiroz, JW
   Jeronimo, SMB
AF Dourado Junior, Mario E. T.
   Fernandes, Ugor T.
   Ramos, Eugenio S.
   Vital, Ana L. F.
   Urbano, Joao C. C.
   Queiroz, Jose W.
   Jeronimo, Selma M. B.
TI Egos has a reduced capacity to predicts GBS prognosis in Northeast
   Brazil
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Editorial Material
DE Guillain-Barre syndrome; Nerve Conduction Study; neuropathies;
   peripheral neuropathies; prognosis
ID GUILLAIN-BARRE-SYNDROME; PATHOGENESIS; INFECTIONS
AB ObjectiveThe Erasmus Guillain Barre Outcome Score (EGOS) is a prognostic model that predicts the chance of being able to walk independently at 6months after Guillain Barre syndrome (GBS). This study was conducted aiming to determine the validity of EGOS in a Brazilian population.
   Material and MethodsData collected from GBS patients in Rio Grande do Norte, Brazil, were used to determine the validity of EGOS. GBS disability score was assessed in the second week of disease and at 6months.
   ResultsA total of 206 subjects were studied. The Brazilian patients were younger, with a more severe clinical presentation, with higher percentage of cranial nerve involvement and upper respiratory infection. There was no difference relative to sex or presence of anti-gangliosides antibodies. The demyelinating variant was more common (73.9%). However, only 24% of the Brazilians with EGOS 5.5-7 were not able to walk after 6months, compared to 52% to European Group. Nine patients (3.8%) presented nodopathies, of these four had an EGOS >5, but only one of the latter group was unable to walk after 6months of GBS.
   ConclusionsErasmus Guillain Barre Outcome Score was not a good predictor for the ability to walk after 6months of GBS in Rio Grande do Norte, Brazil. Differences could be that the Brazilian GBS were younger, or alternatively, it could be due to a different infection profile or in the incidence of nodopathies.
C1 [Dourado Junior, Mario E. T.] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, Natal, RN, Brazil.
   [Dourado Junior, Mario E. T.] Univ Fed Rio Grande do Norte, Dept Integrat Med, Av Nilo Pecanha, BR-59012300 Natal, RN, Brazil.
   [Dourado Junior, Mario E. T.; Fernandes, Ugor T.; Ramos, Eugenio S.; Vital, Ana L. F.; Urbano, Joao C. C.; Queiroz, Jose W.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
RP Dourado, MET (corresponding author), Univ Fed Rio Grande do Norte, Dept Integrat Med, Av Nilo Pecanha, BR-59012300 Natal, RN, Brazil.
EM medourado@ufrnet.br
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [CNPQ-440893/2016-0]
FX This work was supported in part with funds from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPQ-440893/2016-0). The
   funder had no role in the study design.
CR ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Draak THP, 2016, J PERIPHER NERV SYST, V21, P74, DOI 10.1111/jns.12167
   FEASBY TE, 1993, J NEUROL SCI, V116, P185, DOI 10.1016/0022-510X(93)90324-R
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Peitersen E, 2002, ACTA OTO-LARYNGOL, V122, P4, DOI 10.1080/000164802320401694
   Rivera-Lillo G, 2016, J PERIPHER NERV SYST, V21, P339, DOI 10.1111/jns.12182
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Uncini A, 2015, J NEUROL NEUROSUR PS, V86, P1186, DOI 10.1136/jnnp-2014-310097
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   Willison H.J., 2016, LANCET, V6736, P1, DOI DOI 10.1016/S0140-6736(16)00339-1.ELSEVIER
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
NR 20
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD NOV
PY 2018
VL 138
IS 5
BP 459
EP 462
DI 10.1111/ane.12995
PG 4
WC Clinical Neurology
SC Neurosciences & Neurology
GA GW0JK
UT WOS:000446549700011
PM 30003535
DA 2020-11-26
ER

PT J
AU Lima, JG
   Nobrega, LHC
   Lima, NN
   dos Santos, MCF
   Silva, PHD
   Baracho, MDP
   Lima, DN
   Campos, JTAD
   Ferreira, LC
   Neto, FPF
   Mendes-Aguiar, CD
   Jeronimo, SMB
AF Lima, Josivan Gomes
   Nobrega, Lucia Helena C.
   Lima, Natalia Nobrega
   Ferreira dos Santos, Marcel Catao
   Dantas Silva, Pedro Henrique
   Baracho, Maria de Fatima P.
   Lima, Debora Nobrega
   Araujo de Melo Campos, Julliane Tamara
   Ferreira, Leonardo Capistrano
   Freire Neto, Francisco Paulo
   Mendes-Aguiar, Carolina de O.
   Jeronimo, Selma Maria B.
TI Causes of death in patients with Berardinelli-Seip congenital
   generalized lipodystrophy
SO PLOS ONE
LA English
DT Article
ID CARDIOMYOPATHY
AB Introduction
   Berardinelli-Seip Congenital Lipodystrophy (BSCL) is a rare autosomal recessive disease that affects the development of adipocytes and leads to an inability to store fat in adipocytes. This study aimed to evaluate the life expectancy and the causes of death of patients with BSCL.
   Method
   We analyzed death certificates, and medical records of BSCL patients who died between 1997 and 2017. If the death certificate was incomplete or unavailable, we reviewed the medical records, and if they were not available too, we collected information from the patient's relatives to understand how the death happened. We calculated the potential years of life lost as a result of premature death.
   Results
   Twenty patients (12 female and 8 male) died between 1997 and 2017. The mean age at the time of death was 27.1 +/- 12.4 years (women 25.2 +/- 12.5 vs. men 29.9 +/- 12.6 years, p = 0.41). Life expectancy for the study population was 62.9 +/- 4.8 years. The potential number of years of life lost was 35.6 +/- 16.6 years. The causes of deaths were divided into three major groups: infections (7 patients, 35%), liver disease (7 patients, 35%), and other causes (acute pancreatitis, one patient; renal failure, three patients; sudden death/myocardial infarction, two patients). Three patients had pulmonary fibrosis.
   Conclusion
   BSCL led to premature death, cutting the patients' lifespan by 30 or more years. The majority of these young patients died of liver disease or infection. Other studies are needed to understand better the mechanisms that predispose to infections, as well as to assess whether new therapies can alter the natural history of this disease.
C1 [Lima, Josivan Gomes; Nobrega, Lucia Helena C.; Lima, Natalia Nobrega; Ferreira dos Santos, Marcel Catao; Dantas Silva, Pedro Henrique; Baracho, Maria de Fatima P.] Hosp Univ Onofre Lopes HUOL UFRN, Dept Med Clin, Natal, RN, Brazil.
   [Lima, Debora Nobrega] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Araujo de Melo Campos, Julliane Tamara] Fac Ciencias Saude Trairi UFRN, Santa Cruz, RN, Brazil.
   [Ferreira, Leonardo Capistrano; Freire Neto, Francisco Paulo; Mendes-Aguiar, Carolina de O.; Jeronimo, Selma Maria B.] Inst Med Trop Rio Grande Norte UFRN, Natal, RN, Brazil.
RP Lima, JG (corresponding author), Hosp Univ Onofre Lopes HUOL UFRN, Dept Med Clin, Natal, RN, Brazil.
EM josivanlima@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; de Melo Campos, Julliane Tamara JTAMC
   Araujo/I-2528-2018; Ferreira, Leonardo Capistrano/D-7097-2019; Lima,
   Josivan/I-6362-2013
OI Jeronimo, Selma/0000-0002-4784-9904; de Melo Campos, Julliane Tamara
   JTAMC Araujo/0000-0002-8501-5521; Ferreira, Leonardo
   Capistrano/0000-0001-9268-4881; Lima, Josivan/0000-0002-1627-7018
CR Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880
   Akinci B, 2016, J CLIN ENDOCR METAB, V101, P2759, DOI 10.1210/jc.2016-1005
   Berardinelli W, 1954, J CLIN ENDOCR METAB, P14
   Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213
   Chiquette Elaine, 2017, Diabetes Metab Syndr Obes, V10, P375, DOI 10.2147/DMSO.S130810
   Dayakar A, 2016, EXP PARASITOL, V160, P54, DOI 10.1016/j.exppara.2015.12.002
   Medeiros LBD, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0280-7
   Debray FG, 2013, MOL GENET METAB, V109, P227, DOI 10.1016/j.ymgme.2013.04.011
   Drummond MB, 2010, COPD, V7, P179, DOI 10.3109/15412555.2010.481695
   Fu M, 2004, J CLIN ENDOCR METAB, P89
   Ghosh J, 2014, INFECT IMMUN, V82, P607, DOI 10.1128/IAI.00583-13
   Gupta N, 2017, J CLIN ENDOCR METAB, V102, P363, DOI 10.1210/jc.2016-2271
   Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660
   Hsu RH, 2018, J FORMOS MED ASS
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Lima JG, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0140-x
   Madsen CM, 2017, EUR HEART J
   Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   RHEUBAN KS, 1986, J PEDIATR-US, V109, P301, DOI 10.1016/S0022-3476(86)80389-4
   Seip M, 1959, ACTA PAEDIATR, P48
   Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722
   WorldBank, 2017, LIF EXP BIRTH TOT YE
NR 23
TC 15
Z9 17
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 8
PY 2018
VL 13
IS 6
AR e0199052
DI 10.1371/journal.pone.0199052
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI7ZT
UT WOS:000434728100046
PM 29883474
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Medeiros, AS
   Costa, DMP
   Branco, MSD
   Sousa, DMC
   Monteiro, JD
   Galvao, SPM
   Azevedo, PRM
   Fernandes, JAV
   Jeronimo, SMB
   Araujo, JMG
AF Medeiros, Arlinete S.
   Costa, Diego M. P.
   Branco, Mario S. D.
   Sousa, Daise M. C.
   Monteiro, Joelma D.
   Galvao, Silvio P. M.
   Azevedo, Paulo Roberto M.
   Fernandes, Jose A. V.
   Jeronimo, Selma M. B.
   Araujo, Joselio M. G.
TI Dengue virus in Aedes aegypti and Aedes albopictus in urban areas in the
   state of Rio Grande do Norte, Brazil: Importance of virological and
   entomological surveillance
SO PLOS ONE
LA English
DT Article
ID TRANS-OVARIAL TRANSMISSION; CHIKUNGUNYA VIRUS; POPULATIONS; MOSQUITOS;
   OUTBREAK
AB Background
   Vector control remains the sole effective method to prevent dengue virus (DENV) transmission, although a vaccine for dengue has recently become available and testing of its efficacy and coverage is being performed in multiple places. Entomological surveillance is a key factor in alerting authorities to possible outbreaks, but until now natural DENV infection of mosquito populations has been scarcely used as an early warning system to monitor fluctuating prevalence of infected mosquitoes. The purpose of this study was to determine the burden of adult and larval/pupae of Aedes aegypti and Aedes albopictus with DENV in urban areas in the state of Rio Grande do Norte, Brazil.
   Methodology/Principal findings
   Immature insect forms (larvae and pupae) were collected from April 2011 to March 2012, whereas the collection of adults was conducted along 3 years: May 2011 to April 2014. Total RNAs of the samples were extracted and the nested reverse transcriptase PCR assay for detecting and typing DENV was performed. Of the 1333 immature insects collected during the study period, 1186 (89%) were A. aegypti and 147 (11%) A. albopictus. DENV-4 was identified in pools of A. aegypti larvae. The rate of DENV infection in immature A. aegypti was expressed as MIR = 3.37. DENV wasnot detected in immature A. albopictus. A total of 1360 adult female mosquitoes of the Aedes genus were captured from May 2011 to April 2014. Of this total, 1293 were A. aegypti (95%) and 67 were A. albopictus (5%). From the 130 pools studied, 27 (20.7%) were positive for DENV. DENV-1 was identified in 2/27 (7.4%) pools; 1of A. albopictus and 1 of A. aegypti. DENV-2 was identified in only 1/27 (3.7%) A. aegypti pools. DENV-4 was the most prevalent, identified in 24/27 (88.8%) of the positive pools, with 19 being of A. aegypti and 5 of A. albopictus pools. The minimum infection rate for adults of the Aedes genus was 19.8, considering both A. aegypti and A. albopictus.
   Conclusions/Significance
   This work represents the most complete study to date on the interaction between dengue viruses and Aedes mosquitoes in the State of Rio Grande do Norte, and raises important questions about a possible role of A. albopictus in the transmission of dengue virus in Brazil.
C1 [Medeiros, Arlinete S.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, PostGraduateHlth Program, Hlth Sci Ctr, Natal, RN, Brazil.
   [Medeiros, Arlinete S.; Costa, Diego M. P.; Branco, Mario S. D.; Sousa, Daise M. C.; Monteiro, Joelma D.; Galvao, Silvio P. M.; Fernandes, Jose A. V.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Biosci Ctr, Lab Mol Biol Infect Dis & Canc, Natal, RN, Brazil.
   [Medeiros, Arlinete S.; Araujo, Joselio M. G.] Univ Fed Rio Grande do Norte, Inst Trop Med, Lab Virol, Natal, RN, Brazil.
   [Azevedo, Paulo Roberto M.] Univ Fed Rio Grande do Norte, Dept Stat, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Immunogenet Lab, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Lab Complex Dis, Inst Trop Med, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis, Brasilia, DF, Brazil.
RP Araujo, JMG (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Biosci Ctr, Lab Mol Biol Infect Dis & Canc, Natal, RN, Brazil.; Araujo, JMG (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med, Lab Virol, Natal, RN, Brazil.
EM joselio@cb.ufrn.br
RI Araujo, Joselio M G/B-5502-2013; Jeronimo, Selma/AAY-4033-2020
OI Araujo, Joselio M G/0000-0003-3548-2786; Jeronimo,
   Selma/0000-0002-4784-9904; Fernandes, Jose Verissimo/0000-0002-5169-6496
FU Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico-CNPqNational Council for Scientific and Technological
   Development (CNPq) [479828/2013-0, PVE 400328/2014-3]
FX This investigation received financial support from the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico-CNPq (grants Universal
   479828/2013-0 and PVE 400328/2014-3). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Branco MSD, 2015, TROP MED INT HEALTH, V20, P1707, DOI 10.1111/tmi.12612
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Dalla Bona AC, 2011, B MALARIOL SALUD AMB, V51, P107
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Freire M.S.B., 1990, ACTA BOT BRAS, V4, P41, DOI DOI 10.1590/S0102-33061990000300006
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Guedes DRD, 2010, J VECTOR DIS, V47, P67
   Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2017, NAT
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   KHIN MM, 1983, AM J TROP MED HYG, V32, P590, DOI 10.4269/ajtmh.1983.32.590
   Kumar NP, 2012, VECTOR-BORNE ZOONOT, V12, P907, DOI 10.1089/vbz.2012.0969
   Kumari R, 2011, TROP MED INT HEALTH, V16, P949, DOI 10.1111/j.1365-3156.2011.02789.x
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Pierson TC, 2013, FIELDSVIROLOGY
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000935
   Rohani A., 2007, Dengue Bulletin, V31, P47
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   Sivan A, 2016, ACTA TROP, V156, P122, DOI 10.1016/j.actatropica.2016.01.015
   Sousa DM, 2015, THESIS
   Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x
   Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004
   WHO, 2012, GLOB STRAT DENG PREV
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 32
TC 14
Z9 16
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 13
PY 2018
VL 13
IS 3
AR e0194108
DI 10.1371/journal.pone.0194108
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FZ0JA
UT WOS:000427253500025
PM 29534105
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Lima, ID
   Lima, ALM
   Mendes-Aguiar, CD
   Coutinho, JFV
   Mary, EW
   Pearson, RD
   Queiroz, JW
   Jeronimo, SMB
AF Lima, Iraci Duarte
   Lima, Adila L. M.
   Mendes-Aguiar, Carolina de Oliveira
   Coutinho, Jose F. V.
   Wilson, Mary E.
   Pearson, Richard D.
   Queiroz, Jose Wilton
   Jeronimo, Selma M. B.
TI Changing demographics of visceral leishmaniasis in northeast Brazil:
   Lessons for the future
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; CANINE LEISHMANIASIS; CHAGASI; INFECTION; INFANTUM; HIV;
   MEASLES; DISEASE; STATE; ASSOCIATION
AB Background
   Visceral leishmaniasis (VL) caused by Leishmania infantum became a disease of urban areas in Brazil in the last 30 years and there has been an increase in asymptomatic L. infantum infection with these areas.
   Methodology/Principal findings
   A retrospective study of human VL was performed in the state of Rio Grande do Norte, Brazil, for the period of 1990-2014. The data were divided into five-time periods. For all VL cases, data on sex, age, nutritional status and childhood vaccination were collected. Geographic information system tools and statistical models were used to analyze the dispersion of human VL. The mean annual incidence of VL was 4.6 cases/100,000 inhabitants, with total 3,252 cases reported. The lethality rate was 6.4%. Over time the annual incidence of VL decreased in the 0-4 years (p<0.0001) and 5-9 (p <0.0001) age groups, but increased in ages 20-39 (p< 0.001) and >40 years (p<0.0001). VL occurred more often in males (beta(2) = 2.5; p<0.0001). The decreased incidence of VL in children was associated with improved nutritional status and childhood immunizations including measles, poliomyelitis, BCG, and hepatitis B. Human VL correlated temporally and geographically with canine L. infantum infection (p = 0.002, R-2 = 0.438), with rainfall and with Lutzomyia longipalpis density (r = 0.762). Overall, the incidence of VL decreased, while VL-AIDS increased, especially between 2010-2014. VL was more frequently found in areas that lacked urban infrastructure, detected by lack of garbage collection and sewers, whereas HIV infection was associated with higher levels of schooling and evidence of higher socioeconomic status.
   Conclusion/Significance
   The demographics of VL in northeastern Brazil have changed. Disease incidence has decreased in children and increased in adults. They were associated with improvements in nutrition, socioeconomic status and immunization rates. Concurrent VL-AIDS poses a serious challenge for the future.
C1 [Lima, Iraci Duarte; Lima, Adila L. M.; Coutinho, Jose F. V.; Queiroz, Jose Wilton; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Grad Program, Natal, RN, Brazil.
   [Lima, Iraci Duarte; Lima, Adila L. M.; Mendes-Aguiar, Carolina de Oliveira; Coutinho, Jose F. V.; Queiroz, Jose Wilton; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.
   [Lima, Iraci Duarte; Lima, Adila L. M.] State Rio Grande do Norte Hlth Secretariat, Natal, RN, Brazil.
   [Lima, Adila L. M.; Coutinho, Jose F. V.] Natal Hlth Secretariat, Ctr Zoonosis Control, Natal, RN, Brazil.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol & Epidemiol, Iowa City, IA USA.
   [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   [Pearson, Richard D.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [Queiroz, Jose Wilton; Jeronimo, Selma M. B.] INCT DT, Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Grad Program, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), INCT DT, Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-030639]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI045540, R01AI045540, R01AI045540, R01AI045540, R01AI045540,
   R01AI045540, R01AI045540, R01AI045540, R01AI045540] Funding Source: NIH
   RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX001983, I01BX001983, I01BX001983, I01BX001983, I01BX001983,
   I01BX001983] Funding Source: NIH RePORTER
FX This work was supported in part by a grant from National Institutes of
   Health (AI-030639). The funder had no role in study design, data
   collection and analysis, decision to publish or preparation of this
   manuscript.
CR Agostoni C, 1998, INFECTION, V26, P93, DOI 10.1007/BF02767767
   ALVAR J, 1992, LANCET, V339, P1427, DOI 10.1016/0140-6736(92)91255-7
   ALVAR J, 1989, J INFECT DIS, V160, P560, DOI 10.1093/infdis/160.3.560
   ALVAR J, 1987, EUR J CLIN MICROBIOL, V6, P604, DOI 10.1007/BF02014266
   Alvar J, 1996, CLIN DERMATOL, V14, P541, DOI 10.1016/0738-081X(96)00046-6
   Andrade IG, 2009, T ROY SOC TROP MED H, V103, P506, DOI 10.1016/j.trstmh.2008.12.017
   ANURADHA, 1990, INDIAN J EXP BIOL, V28, P876
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Brasil Ministerio da Saude Secretaria de Atencao a Saude Departamento de Atencao Basica, 2013, MAN COND GER PROGR N
   Cavalcante Ítalo José Mesquita, 2014, Rev. bras. epidemiol., V17, P911, DOI 10.1590/1809-4503201400040010
   Cencini E, 2015, EUR J HAEMATOL, V94, P186, DOI 10.1111/ejh.12312
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   Chagas E, 1936, SCIENCE, V84, P397, DOI 10.1126/science.84.2183.397-a
   Coelho L, 2016, LANCET HIV, V3, pE490, DOI 10.1016/S2352-3018(16)30052-2
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DE AJ, 1961, REV INST MED TROP SP, P175
   Viana GMD, 2011, REV SOC BRAS MED TRO, V44, P722, DOI 10.1590/S0037-86822011000600013
   de Oliveira EF, 2017, AM J TROP MED HYG, V96, P178, DOI 10.4269/ajtmh.16-0191
   DEANE LM, 1962, REV INST MED TROP SP, P198
   Dey A, 2006, Indian J Med Microbiol, V24, P165
   Duarte EC, 2014, REV SOC BRAS MED TRO, V47, P763, DOI 10.1590/0037-8682-0274-2014
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Genaro O, 1990, Rev Soc Bras Med Trop, V23, P121, DOI 10.1590/S0037-86821990000200011
   Gramiccia M, 2003, ANN TROP MED PARASIT, V97, P65, DOI 10.1179/000349803225002543
   Guerrant RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158772
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Leite RD, 2015, EMERG INFECT DIS, V21, P1681, DOI 10.3201/eid2109.150391
   LIMA AA, 2017, PEDIAT INFECT DIS J, P33779
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Maciel BLL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107564
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   MARQUES LHD, 2016, PARASITOLOGY, P1
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   Mengesha Bewketu, 2014, BMC Res Notes, V7, P75, DOI 10.1186/1756-0500-7-75
   Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012
   Mina MJ, 2017, J INFECTION, V74, pS10, DOI 10.1016/S0163-4453(17)30185-8
   Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662
   Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4
   Moreno J, 2000, T ROY SOC TROP MED H, V94, P328, DOI 10.1016/S0035-9203(00)90345-6
   Mukhopadhyay D, 2016, INT J DERMATOL, V55, pE250, DOI 10.1111/ijd.13048
   Nackers F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004187
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   Nieto P, 2006, GEOSPATIAL HEALTH, V1, P115, DOI 10.4081/gh.2006.286
   Pagano M, 2000, PRINCIPLES BIOSTATIS
   ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39
   Lemos DRQ, 2017, VACCINE, V35, P1721, DOI 10.1016/j.vaccine.2017.02.023
   Rabello A, 2003, ANN TROP MED PARASIT, V97, P17, DOI 10.1179/000349803225002507
   Scarlata Francesco, 2008, Infez Med, V16, P21
   Thompson RA, 2002, AM J TROP MED HYG, V67, P648, DOI 10.4269/ajtmh.2002.67.648
   Tielemans SMAJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3862
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Zoghami Z, 2014, ACTA TROP, V139, P32, DOI 10.1016/j.actatropica.2014.06.012
NR 60
TC 19
Z9 19
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2018
VL 12
IS 3
AR e0006164
DI 10.1371/journal.pntd.0006164
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GE5NI
UT WOS:000431268900004
PM 29509765
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Basilio, ILD
   Catao, MDC
   Carvalho, JDD
   Freire-Neto, FP
   Ferreira, LC
   Jeronimo, SMB
AF Diniz Basilio, Irigracin Lima
   Celino Catao, Maria de Fatima
   de Sousa Carvalho, Janilson Dantas
   Freire-Neto, Francisco Paulo
   Ferreira, Leonardo Capristano
   Bezerra Jeronimo, Selma Maria
TI Risk factors of Helicobacter pylori infection in an urban community in
   Northeast Brazil and the relationship between the infection and gastric
   diseases
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Epidemiology; Helicobacter pylori; Risk factors; Brazil
ID PYLORI INFECTION; DUODENAL-ULCER; PREVALENCE; CHILDREN; SMOKING; CANCER;
   WATER; ASSOCIATION; CONSUMPTION; PAKISTAN
AB Introduction: Helicobacter pylori, a water contaminant. is the primary pathogenic agent associated with gastric diseases in humans. Exposure to H. pylori is more likely higher in developing countries. This study aimed to evaluate the risk factors associated with H. pylori infection in patients undergoing endoscopy to validate the cause of dyspeptic symptoms in an urban population in northeast Brazil and to compare the urease test and polymerase chain reaction assay results with the histopathological findings. Methods: We evaluated 200 of 759 individuals with dyspeptic complaints from Campina Grande, State of Paraiba, northeast Brazil. Patients underwent endoscopy, followed by gastric biopsies. Logistic regression analysis was performed to adjust for confounders and to determine significant risk factors of dyspeptic disorders. Results: Women accounted for 72.5% (145/200) of the participants. Approximately 59.8% (120/200) of the samples tested positive for li. pylori based on histological examinations. The specificity of polymerase chain reaction assay was higher than that of the urease test (77% vs. 64%, p=0.034). City drinking water [odds ratio (OR): 2.6; 95% confidence interval (CI): 1.3-5.21; p=0.004] and smoking (OR: 4.0; 95% CI: 1.13-14.5; p=0.031) were the risk factors of H. pylori infection. Belching was the most common symptom associated with H. pylori infection (p=0.05). Conclusions: The increased risk of H. pylori infection associated with non-treated water consumption indicates the need for improvements in public water treatment and better sanitary conditions because these can be a source of not only H. pylori infections but also other water-borne pathogen infections.
C1 [Diniz Basilio, Irigracin Lima; Celino Catao, Maria de Fatima; de Sousa Carvalho, Janilson Dantas] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Diniz Basilio, Irigracin Lima; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Saude, Natal, RN, Brazil.
   [Freire-Neto, Francisco Paulo; Ferreira, Leonardo Capristano; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Natal, RN, Brazil.
   [Freire-Neto, Francisco Paulo; Ferreira, Leonardo Capristano; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.
   [Freire-Neto, Francisco Paulo; Ferreira, Leonardo Capristano; Bezerra Jeronimo, Selma Maria] Inst Nacl Ciencia & Tecnol Doencas Trop, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Programa Posgrad Saude, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Inst Nacl Ciencia & Tecnol Doencas Trop, Natal, RN, Brazil.
EM selma.b.jeronimo@gmail.com
RI Ferreira, Leonardo Capistrano/D-7097-2019; Jeronimo, Selma/AAY-4033-2020
OI Ferreira, Leonardo Capistrano/0000-0001-9268-4881; Jeronimo,
   Selma/0000-0002-4784-9904
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX This work was supported in part from a grant from the Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Alazmi WM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-14
   Ben Mansour K, 2016, INFECT GENET EVOL, V37, P43, DOI 10.1016/j.meegid.2015.10.028
   Braga LLBC, 2014, MEM I OSWALDO CRUZ, V109, P1045, DOI 10.1590/0074-0276140279
   Brown LM, 2002, INT J EPIDEMIOL, V31, P638, DOI 10.1093/ije/31.3.638
   Chen TS, 2005, J CLIN GASTROENTEROL, V39, P699, DOI 10.1097/01.mcg.0000173854.55172.ee
   Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13
   Gasbarrini A, 2001, EUR J GASTROEN HEPAT, V13, P185, DOI 10.1097/00042737-200102000-00015
   Gikas A, 2004, J GASTROEN HEPATOL, V19, P927, DOI 10.1111/j.1440-1746.2004.03404.x
   Gobert AP, 2017, CURR TOP MICROBIOL, V400, P27, DOI 10.1007/978-3-319-50520-6_2
   Hegarty JP, 1999, J APPL MICROBIOL, V87, P697, DOI 10.1046/j.1365-2672.1999.00912.x
   Hunt RH, 2011, J GASTROINTEST LIVER, V20, P299, DOI 10.1097/MCG.0b013e31820fb8f6
   Khan A, 2013, J INFECT DEV COUNTR, V7, P220, DOI 10.3855/jidc.2942
   Khan A, 2012, J INFECT DEV COUNTR, V6, P251, DOI 10.3855/jidc.2312
   Koivisto TT, 2008, SCAND J GASTROENTERO, V43, P1177, DOI 10.1080/00365520802116430
   Konishi K, 2007, APMIS, V115, P1285, DOI 10.1111/j.1600-0643.2007.00594.x
   Malfertheiner P, 1993, Clin Ther, V15 Suppl B, P37
   Malfertheiner P, 1997, EUR J GASTROEN HEPAT, V9, P1
   Matos JI, 2013, EUR J GASTROEN HEPAT, V25, P1431, DOI 10.1097/MEG.0b013e328364b53e
   Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS99, DOI 10.1111/j.1440-1746.2009.06214.x
   Parente JML, 2006, AM J TROP MED HYG, V75, P509, DOI 10.4269/ajtmh.2006.75.509
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731
   Queiroz DM, 2012, HELICOBACTER, V17, P23, DOI 10.1111/j.1523-5378.2011.00894.x
   Reddy KM, 2016, CLIN GASTROENTEROL H, V14, P1420, DOI 10.1016/j.cgh.2016.05.045
   Rodrigues MN, 2004, EUR J GASTROEN HEPAT, V16, P201, DOI 10.1097/00042737-200402000-00013
   Rugge M, 2015, GASTROENTEROL CLIN N, V44, P609, DOI 10.1016/j.gtc.2015.05.009
   Schottker B, 2012, CLIN GASTROENTEROL H, V10, P487, DOI 10.1016/j.cgh.2011.12.036
   Scholte GHA, 1997, DIAGN MOL PATHOL, V6, P238, DOI 10.1097/00019606-199708000-00008
   Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996
   Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832
   Zaterka S, 2007, HELICOBACTER, V12, P82, DOI 10.1111/j.1523-5378.2007.00474.x
NR 30
TC 2
Z9 4
U1 2
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAR-APR
PY 2018
VL 51
IS 2
BP 183
EP 189
DI 10.1590/0037-8682-0412-2016
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG0TA
UT WOS:000432390600010
PM 29768551
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Naouar, IE
   Koles, N
   Mody, R
   Shaw, D
   Bigley, D
   Co, E
   Sherwood, J
   Jeronimo, S
   Aronson, N
AF Naouar, Ines
   Koles, Nancy
   Mody, Rupal
   Shaw, Dutchabong
   Bigley, Daniel
   Co, Edgie
   Sherwood, Jeffrey
   Jeronimo, Selma
   Aronson, Naomi
TI NEW BIOMARKERS FOR HUMAN ASYMPTOMATIC <it>LEISHMANIA INFANTUM</it>
   INFECTION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Naouar, Ines; Koles, Nancy; Shaw, Dutchabong; Aronson, Naomi] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA.
   [Mody, Rupal; Co, Edgie; Sherwood, Jeffrey] William Beaumont Army Med Ctr, El Paso, TX 79920 USA.
   [Bigley, Daniel] DiLorenzo Tricare Hlth Clin, Arlington, VA USA.
   [Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1284
BP 404
EP 405
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603621
DA 2020-11-26
ER

PT J
AU Rodrigues-Neto, JF
   Ferreira, LC
   Jeronimo, SMB
AF Rodrigues-Neto, Joao
   Ferreira, Leonardo
   Bezerra Jeronimo, Selma
TI EXPRESSION OF COSTIMULATORY MOLECULES DURING VISCERAL LEISHMANIASIS AND
   AFTER CLINICAL CURE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Rodrigues-Neto, Joao; Ferreira, Leonardo; Bezerra Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1287
BP 405
EP 406
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386603624
DA 2020-11-26
ER

PT J
AU Neto, JFR
   Monteiro, GR
   Keesen, TSL
   Lacerda, HG
   Carvalho, EM
   Jeronimo, SMB
AF Rodrigues-Neto, Joao F.
   Monteiro, Gloria R.
   Keesen, Tatjana S. L.
   Lacerda, Henio G.
   Carvalho, Edgar M.
   Jeronimo, Selma M. B.
TI CD45RO+T Cells and T Cell Activation in the Long-Lasting Immunity after
   Leishmania infantum Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID HUMAN VISCERAL LEISHMANIASIS; DONOVANI INFECTION; NORTHEAST BRAZIL;
   ASYMPTOMATIC INFECTION; SUBCLINICAL INFECTION; KALA-AZAR; CHAGASI;
   CD4(+); ANTIGEN; MEMORY
AB Manifestations of Leishmania infantum infection range from asymptomatic to symptomatic visceral leishmaniasis (VL). People with symptomatic VL (sVL) have suppressed immune responses against Leishmania antigens that are reversed after clinical cure. The intradermal leishmanin skin test (LST) is negative during sVL, but it becomes positive after treatment. The aim of this study was to compare T cell responses in individuals with sVL, recovered VL (RecVL), and endemic controls. Endemic controls were household contacts of a VL case and they were grouped by their LST results, either positive (LST+) or negative (LST-). Mononuclear cells were studied ex vivo or after stimulation with soluble Leishmania antigens (SLA); cell surface markers and cytokines were determined. T cells, ex vivo, from individuals with sVL and from LST+ individuals presented a higher activation for CD4(+) and CD8(+) cells expressing CD69. However, lymphocytes from sVL stimulated with SLA had lower percentages of CD4(+) and CD8(+) cells expressing CD69 and CD8(+) cells expressing CD25, with no release of interferon-gamma or tumor necrosis factor. sVL subjects had lower percentage of memory cells (CD4(+) CD45RO+), ex vivo, without SLA stimulation than RecVL, LST+, or LST-(P = 0.0022). However, individuals with sVL had fewer regulatory cells after SLA stimulation (CD4(+) CD25(HIGH), P = 0.04 and CD4(+) FOXP3+, P = 0.02) than RecVL. The decrease in specific memory and activated CD4(+) and CD8(+) cells, as in response to Leishmania antigens, could explain, in part, the immune impairment during sVL. Finally, protective T cell responses are long lasting because both RecVL or LST+ individuals maintain a specific protective response to Leishmania years after the primary infection.
C1 [Rodrigues-Neto, Joao F.; Keesen, Tatjana S. L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Rodrigues-Neto, Joao F.; Monteiro, Gloria R.; Lacerda, Henio G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [Carvalho, Edgar M.; Jeronimo, Selma M. B.] Univ Fed Bahia, Natl Inst Sci & Technol Trop Dis INCT DT CNPq, Salvador, BA, Brazil.
   [Carvalho, Edgar M.] Univ Fed Bahia, Serv Immunol, Salvador, BA, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59078970 Natal, RN, Brazil.
EM joao_rneto@yahoo.com.br; gloriag74@hotmail.com; tat.keesen@gmail.com;
   heniolacerda@ufrnet.br; edgar@ufba.br; smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Rodrigues Neto, Joao
   Firmino/0000-0001-8897-4341
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-30639]; CAPESCAPES
FX This work was supported by the National Institutes of Health (AI-30639).
   J.F.R-N. received a fellowship from CAPES.
CR Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004
   Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017
   Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588
   Antonelli LRV, 2004, CLIN EXP IMMUNOL, V136, P341, DOI 10.1111/j.1365-2249.2004.02426.x
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Baeten DLP, 2013, NAT MED, V19, P824, DOI 10.1038/nm.3268
   Banerjee A, 2016, CELL IMMUNOL, V309, P37, DOI 10.1016/j.cellimm.2016.07.004
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Caldas AJM, 2002, T ROY SOC TROP MED H, V96, P21, DOI 10.1016/S0035-9203(02)90227-0
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981
   CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   Chen LM, 2017, HEPATOL INT, V11, P79, DOI 10.1007/s12072-016-9734-5
   Clarencio J, 2009, INT IMMUNOL, V21, P137, DOI 10.1093/intimm/dxn131
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592
   Dieckmann D, 2005, IMMUNOLOGY, V115, P305, DOI 10.1111/j.1365-2567.2005.02144.x
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Fakiola M, 2011, J INFECT DIS, V204, P467, DOI 10.1093/infdis/jir284
   Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749
   Gautam S, 2011, J INFECT DIS, V204, P1134, DOI 10.1093/infdis/jir461
   Gollob KJ, 2005, TRENDS PARASITOL, V21, P347, DOI 10.1016/j.pt.2005.06.007
   Hailu A, 2005, CLIN IMMUNOL, V117, P182, DOI 10.1016/j.clim.2005.06.015
   Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Jordan KA, 2010, EXP PARASITOL, V126, P318, DOI 10.1016/j.exppara.2010.05.008
   Jose F F, 2001, Rev Soc Bras Med Trop, V34, P537, DOI 10.1590/S0037-86822001000600007
   Kaushal H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0653-6
   Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608
   LAINSON R, 1987, T ROY SOC TROP MED H, V81, P517, DOI 10.1016/0035-9203(87)90187-8
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   Maurya R, 2010, PARASITE IMMUNOL, V32, P479, DOI 10.1111/j.1365-3024.2010.01219.x
   Mehrotra S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-71
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141
   Pakpour N, 2008, J IMMUNOL, V180, P8299, DOI 10.4049/jimmunol.180.12.8299
   Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x
   Polley R, 2005, EUR J IMMUNOL, V35, P498, DOI 10.1002/eji.200425436
   Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551
   Saha S, 2007, J IMMUNOL, V179, P5592, DOI 10.4049/jimmunol.179.8.5592
   Scott P, 2005, CELL MICROBIOL, V7, P1707, DOI 10.1111/j.1462-5822.2005.00626.x
   Selvapandiyan A, 2009, J IMMUNOL, V183, P1813, DOI 10.4049/jimmunol.0900276
   Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12
   SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013
   Stassen M, 2004, EUR J IMMUNOL, V34, P1303, DOI 10.1002/eji.200324656
   Taylor JJ, 2006, J IMMUNOL, V176, P5839, DOI 10.4049/jimmunol.176.10.5839
   Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108
NR 57
TC 2
Z9 2
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 3
BP 875
EP 882
DI 10.4269/ajtmh.16-0747
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BW
UT WOS:000430952800044
PM 29280433
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Rodriguez, NE
   Lima, ID
   Dixit, UG
   Turcotte, EA
   Lockard, RD
   Batra-Sharma, H
   Nascimento, EL
   Jeronimo, SMB
   Wilson, ME
AF Rodriguez, Nilda E.
   Lima, Iraci D.
   Dixit, Upasna Gaur
   Turcotte, Elizabeth A.
   Lockard, Ryan D.
   Batra-Sharma, Hemali
   Nascimento, Eliana L.
   Jeronimo, Selma M. B.
   Wilson, Mary E.
TI Epidemiological and Experimental Evidence for Sex-Dependent Differences
   in the Outcome of Leishmania infantum Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VISCERAL LEISHMANIASIS; CHAGASI; BRAZIL; METAANALYSIS; IMMUNITY
AB Leishmania infantum causes visceral leishmaniasis (VL) in Brazil. We previously observed that VL is more common in males than females living in endemic neighborhoods, despite similar exposure. Using a larger sample, we document that VL is more common in males than females, but only after puberty. BALB/c and C57BL/6 mouse models confirmed that there is a biological basis for male susceptibility to symptomatic VL, showing higher parasite burdens in males than females. Female C57BL/6 mice generated more antigen-induced cytokines associated with curative responses (interferon-gamma, interleukin [IL]-1 ss). Males expressed higher levels of IL-10 and tumor necrosis factor, which are linked to exacerbated disease. Different parasite lines entered or survived at a higher rate in macrophages of male-than female-origin. These results suggest that males are inherently more susceptible to L. infantum than females and that mice are a valid model to study this sex-dependent difference.
C1 [Rodriguez, Nilda E.; Turcotte, Elizabeth A.; Lockard, Ryan D.] Univ Northern Iowa, Dept Biol, 85 McCollum Sci Hall, Cedar Falls, IA 50614 USA.
   [Lima, Iraci D.] Fundacao Nacl Saude, Secretaria Saude Estado Rio Grande Norte, Natal, RN, Brazil.
   [Lima, Iraci D.; Nascimento, Eliana L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Sci Post Grad Program, Natal, RN, Brazil.
   [Dixit, Upasna Gaur; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Batra-Sharma, Hemali] Univ Iowa, Carver Coll Med, Iowa City, IA USA.
   [Nascimento, Eliana L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Nascimento, Eliana L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
RP Rodriguez, NE (corresponding author), Univ Northern Iowa, Dept Biol, 85 McCollum Sci Hall, Cedar Falls, IA 50614 USA.
EM nilda.rodriguez@uni.edu; iraciduarte.lima@gmail.com;
   upasnadixit5@gmail.com; turcotte@uni.edu; lockardr@uni.edu;
   hemalibatra@gmail.com; eltomaz@gmail.com; selma.b.jeronimo@gmail.com;
   mary-wilson@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Rodriguez,
   Nilda/0000-0002-5755-3680; Wilson, Mary/0000-0001-8680-7275
FU University of Northern Iowa Graduate College; College of Humanities,
   Arts and Sciences; Dr. Robert and Brenda Good Undergraduate Research
   Assistantship; Department of Veterans AffairsUS Department of Veterans
   Affairs; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI076233]; NIH Tropical Medicine
   Research CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P50 AI-30639];
   National Institute of Science and Technology of Tropical Diseases; VA
   grants [5I01BX001983, 2I01BX000536]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI045540, R01AI045540,
   R01AI045540, R01AI045540, R01AI045540, R01AI045540, R01AI045540,
   R01AI045540, R01AI045540] Funding Source: NIH RePORTER; Veterans
   AffairsUS Department of Veterans Affairs [I01BX001983, I01BX001983,
   I01BX001983, I01BX001983, I01BX001983, I01BX001983] Funding Source: NIH
   RePORTER
FX This work was supported in part by funds from the University of Northern
   Iowa Graduate College (N. E. R., R. D. L.), the College of Humanities,
   Arts and Sciences (N. E. R., E. A. T.), and the Dr. Robert and Brenda
   Good Undergraduate Research Assistantship (E.A.T.). Additional support
   was provided by a Career Developmental Award from the Department of
   Veterans Affairs (N. E. R.), VA grants 5I01BX001983 and 2I01BX000536 (M.
   E. W.) and NIH grants R01 AI076233 (M. E. W.) and NIH Tropical Medicine
   Research Center P50 AI-30639 (M. E. W. and S. M. B. J.), and National
   Institute of Science and Technology of Tropical Diseases.
CR Belo VS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002182
   Das A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005150
   Das VNR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005196
   de Freitas EO, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00153
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   Jansen R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-33
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006
   Mayne BT, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00183
   Mukhopadhyay D, 2016, INT J DERMATOL, V55, pE250, DOI 10.1111/ijd.13048
   Rodriguez NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019000
   Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265
   Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10
   Travi BL, 2002, INFECT IMMUN, V70, P2288, DOI 10.1128/IAI.70.5.2288-2296.2002
   vom Steeg LG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005374
   Weirather JL, 2017, ANN HUM GENET, V81, P41, DOI 10.1111/ahg.12180
   Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 20
TC 7
Z9 8
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 98
IS 1
BP 142
EP 145
DI 10.4269/ajtmh.17-0563
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GE1BD
UT WOS:000430950900027
PM 29165220
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Lima, JG
   Nobrega, LHC
   Lima, NN
   dos Santos, MCF
   Baracho, MDP
   Bandeira, F
   Capistrano, L
   Neto, FPF
   Jeronimo, SMB
AF Lima, Josivan G.
   Nobrega, Lucia Helena C.
   Lima, Natalia N.
   dos Santos, Marcel C. F.
   Baracho, Maria de Fatima P.
   Bandeira, Francisco
   Capistrano, Leonardo
   Freire Neto, Francisco Paulo
   Jeronimo, Selma Maria B.
TI Bone Density in Patients With Berardinelli-Seip Congenital Lipodystrophy
   Is Higher in Trabecular Sites and in Type 2 Patients
SO JOURNAL OF CLINICAL DENSITOMETRY
LA English
DT Article
DE Bone mass; density; insulin; leptin; lipodystrophy
ID GENERALIZED LIPODYSTROPHY; INSULIN-RESISTANCE; MINERAL DENSITY;
   CELL-FUNCTION; LEPTIN; DEFICIENCY; MASS; WOMEN; SKELETON; DISEASES
AB Berardinelli-Seip congenital lipodystrophy (BSCL) is a rare autosomal recessive syndrome characterized by a difficulty storing lipid in adipocytes, low body fat, hypoleptinemia, and hyperinsulinemia. We report here laboratory, bone mineral density (BMD), and bone mineral content findings of 21 patients (24.1 +/- 8.4 yr old, 14 females, 18 diabetics, 5.3% total body fat) with BSCL. The mean leptin was very low (0.91 +/- 0.42 ng/mL), and the mean values of the Z-scores for all studied sites were positive, except for the 33% radius (Z-score -0.5 standard deviation [SD]). Twelve patients (57.1%) had a BMD Z-score higher than +2.5 SD in at least 1 site. There was no significant difference in the Z-scores between males and females. None of type 1 (AGPAT2) patients had Z-scores higher than +2.5 SD, and these patients had a smaller Z-score of BMD total body (0.26 SD vs 1.90 SD, p = 0.022) and of bone mineral content (1.59 SD vs 3.3 SD, p = 0.032) than type 2 (seipin) patients. Insulin, as well as HOMA(IR) (homeostasis model assessment), correlated positively with the BMD of all sites, except for the 33% radius. Z-Scores on this site (33% radius) were the smallest of all. More than half of our patients with BSCL have BMD Z-scores higher than +2.5 SD on at least 1 site, and this increase is more pronounced in the trabecular sites and in type 2 patients.
C1 [Lima, Josivan G.; Nobrega, Lucia Helena C.; Lima, Natalia N.; dos Santos, Marcel C. F.; Baracho, Maria de Fatima P.] HUOL, Dept Med Clin, Rua Joaquim Fabrfcio, BR-233 Natal, RN, Brazil.
   [Lima, Josivan G.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, Hlth Grad Program, Natal, RN, Brazil.
   [Bandeira, Francisco] Univ Pernambuco, Med Sch, Div Endocrinol & Diabet, Recife, PE, Brazil.
   [Capistrano, Leonardo; Freire Neto, Francisco Paulo; Jeronimo, Selma Maria B.] lnst Med Trop Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] Inst Sci & Technol Trop Dis INCT DT, Natal, RN, Brazil.
RP Lima, JG (corresponding author), HUOL, Dept Med Clin, Rua Joaquim Fabrfcio, BR-233 Natal, RN, Brazil.
EM josivanlima@gmail.com
RI Bandeira, Francisco/AAO-1702-2020; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020; Ferreira, Leonardo Capistrano/D-7097-2019
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ferreira, Leonardo
   Capistrano/0000-0001-9268-4881
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-30639]
FX We thank John Donelson, PhD (The University of Iowa), and Dr. Clifford
   Rosen, MD (Maine Medical Center Research Institute), for their helpful
   suggestion. We thank Ione Oliveira de Medeiros for technical
   contributions in densitometry. This work was funded in part by a grant
   from the National Institutes of Health (AI-30639).
CR Bandeira Francisco F, 2007, Endocr Pract, V13, P764
   BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193
   Bishop N, 2008, J CLIN DENSITOM, V11, P29, DOI 10.1016/j.jocd.2007.12.004
   Bonnick SL, 2010, CURR CLIN PRACT, P1, DOI 10.1007/978-1-60327-499-9
   Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011
   Chen XX, 2015, J BONE MINER METAB, V33, P474, DOI 10.1007/s00774-014-0569-7
   Christensen JD, 2014, J CLIN ENDOCR METAB, V99, pE1493, DOI 10.1210/jc.2014-1353
   Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101
   FLECKENSTEIN JL, 1992, SKELETAL RADIOL, V21, P381
   Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jcem.84.9.6103
   Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020
   Gregson CL, 2013, RHEUMATOLOGY, V52, P968, DOI 10.1093/rheumatology/ket007
   Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864
   Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712
   Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Kavanagh K, 2013, OBESITY, V21, P1031, DOI 10.1002/oby.20077
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Kobashi Y, 2007, SKELETAL RADIOL, V36, P999, DOI 10.1007/s00256-007-0332-4
   Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168
   Rajab A, 2003, AM J MED GENET A, V121A, P271, DOI 10.1002/ajmg.a.20245
   Reid IR, 2004, BONE, V34, P369, DOI 10.1016/j.bone.2003.11.007
   SEIP M, 1959, Acta Paediatr, V48, P555
   Shinya Takayoshi, 2007, Radiat Med, V25, P484, DOI 10.1007/s11604-007-0166-y
   Sienkiewicz E, 2011, METABOLISM, V60, P1211, DOI 10.1016/j.metabol.2011.05.016
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Whyte MP, 2005, J CLIN DENSITOM, V8, P1, DOI 10.1385/JCD:8:1:001
NR 32
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1094-6950
EI 1559-0747
J9 J CLIN DENSITOM
JI J. Clin. Densitom.
PD JAN-MAR
PY 2018
VL 21
IS 1
BP 61
EP 67
DI 10.1016/j.jocd.2016.10.002
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FT0KL
UT WOS:000422813900008
PM 27894728
DA 2020-11-26
ER

PT J
AU Nobre, ML
   Amorim, FM
   De Souza, MCF
   De Neves-Manta, FS
   Esquenazi, D
   Moraes, MO
   Sarno, EN
   Jeronimo, SMB
AF Nobre, Mauricio Lisboa
   Amorim, Francianne Medeiros
   Freitas De Souza, Marcia Celia
   De Neves-Manta, Fernanda Saloum
   Esquenazi, Danuza
   Moraes, Milton Ozorio
   Sarno, Euzenir Nunes
   Bezerra Jeronimo, Selma Maria
TI Multibacillary leprosy and the elderly: a field for further research
SO LEPROSY REVIEW
LA English
DT Article
ID DECLINING INCIDENCE RATES; DO-NORTE STATE; PATTERNS; TRENDS;
   TRANSMISSION; STRATEGY; BRAZIL; AGE
AB Introduction: Leprosy is an important public health problem in Brazil where 28,761 new cases were diagnosed in 2015 and 7.3% were among children, indicating active transmission.
   Objectives: This study was designed to analyse leprosy indicators in a Brazilian municipality (Mossoro, RN) and to identify the burden of Mycobacterium leprae infection among elderly residents using ML-Flow assay.
   Results: Leprosy continues to be hyperendemic in Mossoro and does not present signs of decline. However, both the general new case detection rate and the detection of MB cases were higher among 60-79 year olds. The percentage of new cases classified as MB increased progressively by age group and reached 67.7% among those with 60 or more years of age (180/266). A hyperendemic neighbourhood was selected for a diagnostic campaign and a total of 504 elderly individuals were tested with ML Flow test, which was strongly positive in four people (0.8%) and samples from skin biopsy of these subjects were also qPCR positive. Two new MB cases were confirmed, one of which had no cutaneous lesions.
   Conclusions: MB leprosy appears to be more frequent among the elderly regardless of whether the disease is experiencing or not a period of decline. According to our results and literature review we hypothesized that the greatest incidence of leprosy by age apparently is related to the life expectancy of the population. These characteristics suggest that active case finding campaigns for untreated MB leprosy among the elderly may be useful in endemic areas as an innovative complementary strategy to interrupt the transmission of M. leprae.
C1 [Nobre, Mauricio Lisboa] Hosp Giselda Trigueiro, Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa; Amorim, Francianne Medeiros; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa] Fiocruz MS, Inst Oswaldo Cruz, Postgrad Program Trop Med, Rio De Janeiro, RJ, Brazil.
   [Freitas De Souza, Marcia Celia] INSS, Mossoro, RN, Brazil.
   [De Neves-Manta, Fernanda Saloum] Fundacao Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Esquenazi, Danuza; Moraes, Milton Ozorio; Sarno, Euzenir Nunes; Bezerra Jeronimo, Selma Maria] INCT DT, Salvador, BA, Brazil.
RP Nobre, ML (corresponding author), Univ Fed Rio Grande do Norte, IMT RN, Av Sen Salgado Filho 3000, BR-59078900 Natal, RN, Brazil.
EM nobreml@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; Moraes, Milton Ozorio/G-9753-2011
OI Jeronimo, Selma/0000-0002-4784-9904; Moraes, Milton
   Ozorio/0000-0003-2653-0037
CR Amorim FM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004934
   [Anonymous], 2015, PORT SAUD SIT EP DAD
   [Anonymous], 2010, GUIA PROC TECN BAC H, P20
   Barbieri RR, 2014, MEM I OSWALDO CRUZ, V109, P944, DOI 10.1590/0074-0276140212
   Browne S G, 1965, Int J Lepr, V33, P267
   Buhrer-Sekula S, 2003, J CLIN MICROBIOL, V41, P1991, DOI 10.1128/JCM.41.5.1991-1995.2003
   Chou JP, 2013, CURR PHARM DESIGN, V19, P1680
   COCHRANE R. G., 1934, International Journal of Leprosy, V2, P385
   Dias MCFD, 2007, LEPROSY REV, V78, P261
   Doull J, 1942, INT J LEPROSY, V10, P107
   FINE PEM, 1988, INT J LEPROSY, V56, P243
   Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016
   ILEP Technical Bulletin, 2001, USDA TECHNICAL B, P3
   IRGENS L M, 1980, Leprosy Review, V51, P1
   IRGENS LM, 1990, LEPROSY REV, V61, P32
   IRGENS LM, 1985, AM J EPIDEMIOL, V122, P695, DOI 10.1093/oxfordjournals.aje.a114148
   IRGENS LM, 1981, LEPROSY REV, V52, P147
   Lee J, 2015, LEPROSY REV, V86, P316
   Martinez AN, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001354
   Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935
   Ministerio da Saude (BR), 2016, DIR VIG AT EL HANS C
   Nobre ML, 2015, LEPROSY REV, V86, P335
   Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022
   Penna MLF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004703
   Report of the International Leprosy Association Technical Forum, 2002, INT J LEPR OTHER M S, V70, pS1
   Richardus JH, 2007, LEPROSY REV, V78, P330
   Riley JC, 2005, POPUL DEV REV, V31, P537, DOI 10.1111/j.1728-4457.2005.00083.x
   Larrea MR, 2012, LEPROSY REV, V83, P184
   Sansarricq H., 2004, MULTIDRUG THERAPY LE
   Smith CS, 2014, LANCET INFECT DIS, V14, P96, DOI 10.1016/S1473-3099(13)70365-7
NR 30
TC 2
Z9 3
U1 0
U2 1
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD DEC
PY 2017
VL 88
IS 4
BP 510
EP 519
PG 10
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA FV8RT
UT WOS:000424855200007
DA 2020-11-26
ER

PT J
AU Ferreira, LC
   Lopes, TPB
   Guimaraes, TB
   Gomes, CEM
   Jeronimo, SMB
AF Ferreira, L. C.
   Lopes, T. P. B.
   Guimaraes, T. B.
   Gomes, C. E. M.
   Jeronimo, S. M. B.
TI The maternal 14bp Ins/Del polymorphism in HLA-G is not associated with
   preeclampsia risk
SO INTERNATIONAL JOURNAL OF IMMUNOGENETICS
LA English
DT Article
DE Genetic association; HLA-G; Polymorphism; Preeclampsia
ID G GENE; INSERTION/DELETION POLYMORPHISM; G GENOTYPE; PREGNANCY;
   EXPRESSION; BP; DELETION; REGION; ALLELE; CELLS
AB The effect of HLA-G 14bp Ins/Del polymorphism (rs371194629) on the risk of preeclampsia has been assessed in several populations, yet the results are still conflicting. Lack of power due to small sample sizes is a common cause of inconsistencies in genetic association studies. We aimed to test whether the maternal polymorphism is associated with preeclampsia, eclampsia or HELLP syndrome (acronym for Hemolysis, Elevation of Liver enzymes, Low Platelets). To achieve a statistical power greater than 0.90, a total of 741 women (332 controls, 246 preeclampsia, 57 eclampsia and 106 HELLP) were genotyped for the 14-bp Ins/Del polymorphism. The genetic association with disease status was assessed by Fisher's exact test and odds ratio (OR) estimates using logistic regression model adjusted for maternal age and parity status. Allele and genotype distributions were the same between control and case groups (p > .05). The polymorphism was not associated with the risk of developing preeclampsia [OR = 0.93 (0.72-1.19); p = .541], or eclampsia [OR = 0.90 (0.60-1.38); p = .628] nor HELLP syndrome [OR = 0.92 (0.66-1.28); p = .628]. This well-powered study clearly demonstrates that the maternal HLA-G 14-bp Ins/Del polymorphism is not associated with preeclampsia risk. However, as the offspring genotypes were not evaluated here, we could not rule out the effect of the foetal genotype on the preeclampsia pathogenesis.
C1 [Ferreira, L. C.; Lopes, T. P. B.; Guimaraes, T. B.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Ferreira, L. C.; Gomes, C. E. M.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med, Natal, RN, Brazil.
   [Gomes, C. E. M.] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Natal, RN, Brazil.
   [Jeronimo, S. M. B.] Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Inst Trop Med Rio Grande Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Ferreira, Leonardo Capistrano/D-7097-2019
OI Jeronimo, Selma/0000-0002-4784-9904; Ferreira, Leonardo
   Capistrano/0000-0001-9268-4881
FU Fulbright Association [CAPES-Fulbright Fellowship]; Instituto Nacional
   de Ciencia e Tecnologia de Doencas Tropicais; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES [PHD fellowship]
FX Fulbright Association, Grant/Award Number: CAPES-Fulbright Fellowship;
   Instituto Nacional de Ciencia e Tecnologia de Doencas Tropicais;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Grant/Award
   Number: PHD fellowship
CR Alegre E, 2007, HUM IMMUNOL, V68, P661, DOI 10.1016/j.humimm.2007.04.007
   Bermingham J, 2000, BIOCHEM SOC T, V28, P215, DOI 10.1042/bst0280215
   Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74
   Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138
   Dantas EMD, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-159
   Djurisic S, 2015, MOL HUM REPROD, V21, P281, DOI 10.1093/molehr/gau108
   Emmery J, 2017, J REPROD IMMUNOL, V120, P8, DOI 10.1016/j.jri.2017.02.002
   Ferreira LMR, 2016, P NATL ACAD SCI USA, V113, P5364, DOI 10.1073/pnas.1602886113
   GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390
   Hackmon R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.033
   Hsu P, 2014, AM J REPROD IMMUNOL, V71, P217, DOI 10.1111/aji.12195
   Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev
   Hviid TV, 2002, TISSUE ANTIGENS, V60, P122, DOI 10.1034/j.1399-0039.2002.600202.x
   Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z
   Hylenius S, 2004, MOL HUM REPROD, V10, P237, DOI 10.1093/molehr/gah035
   Iversen AC, 2008, J REPROD IMMUNOL, V78, P158, DOI 10.1016/j.jri.2008.03.001
   Jahan P, 2014, PREGNANCY HYPERTENS, V4, P164, DOI 10.1016/j.preghy.2014.03.002
   Lin A, 2006, TISSUE ANTIGENS, V68, P311, DOI 10.1111/j.1399-0039.2006.00667.x
   Loisel DA, 2013, MOL HUM REPROD, V19, P144, DOI 10.1093/molehr/gas041
   Martelli-Palomino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071742
   Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874
   Nilsson LL, 2016, HLA, V88, P172, DOI 10.1111/tan.12871
   Nilsson LL, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00198
   O'Brien M, 2001, CELL MOL LIFE SCI, V58, P1943, DOI 10.1007/PL00000828
   OSUNGBADE KO, 2011, J PREGNANCY, V2011
   Pabalan N, 2015, TISSUE ANTIGENS, V86, P186, DOI 10.1111/tan.12627
   Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520
   Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Tan CY, 2008, MOL HUM REPROD, V14, P317, DOI 10.1093/molehr/gan013
   Vianna P, 2007, HUM IMMUNOL, V68, P668, DOI 10.1016/j.humimm.2007.05.006
   Vianna P, 2016, REPRODUCTION, V152, P741, DOI 10.1530/REP-15-0608
   Zhang Z, 2012, TISSUE ANTIGENS, V80, P158, DOI 10.1111/j.1399-0039.2012.01907.x
NR 35
TC 4
Z9 5
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-3121
EI 1744-313X
J9 INT J IMMUNOGENET
JI Int. J. Immunogenet.
PD DEC
PY 2017
VL 44
IS 6
BP 350
EP 355
DI 10.1111/iji.12344
PG 6
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA FM6VD
UT WOS:000415198000011
PM 29105301
DA 2020-11-26
ER

PT J
AU Jeronimo, SM
   Monteiro, GR
   Nunes, J
   Weirather, JL
   Valverde, JG
   Mohr, EL
   Macedo-Silva, VP
   Queiroz, JW
   Bezerra, FS
   Dupnik, KM
   Pearson, RD
   Wilson, ME
AF Jeronimo, Selma M.
   Monteiro, Gloria R.
   Nunes, Jethe
   Weirather, Jason L.
   Valverde, Joanna G.
   Mohr, Emma L.
   Macedo-Silva, Virginia P.
   Queiroz, Jose W.
   Bezerra, Francisco S.
   Dupnik, Kathryn M.
   Pearson, Richard D.
   Wilson, Mary E.
TI LEISHMANIA INFANTUM PARASITEMIA IN ASYMPTOMATIC BLOOD DONORS IN AN
   ENDEMIC REGION OF NORTHEAST BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Jeronimo, Selma M.; Monteiro, Gloria R.; Nunes, Jethe; Valverde, Joanna G.; Macedo-Silva, Virginia P.; Queiroz, Jose W.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Weirather, Jason L.; Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
   [Mohr, Emma L.] Emory Univ, Atlanta, GA 30322 USA.
   [Bezerra, Francisco S.] Univ Fed Rural Semi Arido, Mossoro, Brazil.
   [Dupnik, Kathryn M.] Cornell Univ, New York, NY 10021 USA.
   [Pearson, Richard D.] Univ Virginia, Charlottesville, VA USA.
RI Mohr, Emma/ABD-2994-2020; Jeronimo, Selma/AAY-4033-2020; Valverde,
   Joanna G/C-1284-2014
OI Mohr, Emma/0000-0003-0742-305X; Jeronimo, Selma/0000-0002-4784-9904;
   Valverde, Joanna G/0000-0001-8064-6255
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 653
BP 205
EP 205
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502176
DA 2020-11-26
ER

PT J
AU Ferreira, LC
   Neto, JF
   Jeronimo, SM
AF Ferreira, Leonardo C.
   Neto, Joao F.
   Jeronimo, Selma M.
TI TRANSCRIPTIONAL PROFILE OF HUMAN WHOLE BLOOD CELLS STIMULATED WITH
   SOLUBLE LEISHMANIA ANTIGENS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Ferreira, Leonardo C.; Neto, Joao F.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1754
BP 549
EP 549
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503308
DA 2020-11-26
ER

PT J
AU Rodrigues-Neto, JF
   Jeronimo, SMB
AF Rodrigues-Neto, Joao Firmino
   Bezerra Jeronimo, Selma Maria
TI CTLA-4 AND ICOS COSTIMULATORS: POSSIBLE ROLE DURING ACTIVE VISCERAL
   LEISHMANIASIS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Rodrigues-Neto, Joao Firmino] Multicampi Sch Med Sci Rio Grande do Norte, Caico, Brazil.
   [Rodrigues-Neto, Joao Firmino] Univ Fed Rio Grande do Norte, Inst Trop Med, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1763
BP 552
EP 552
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851503317
DA 2020-11-26
ER

PT J
AU Lima, ALM
   de Lima, ID
   Coutinho, JFV
   de Sousa, UPST
   Rodrigues, MAG
   Wilson, ME
   Pearson, RD
   Queiroz, JW
   Jeronimo, SMB
AF Lima, Adila L. M.
   de Lima, Iraci D.
   Coutinho, Jose F. V.
   de Sousa, Ursula P. S. T.
   Rodrigues, Marcos A. G.
   Wilson, Mary E.
   Pearson, Richard D.
   Queiroz, Jose W.
   Jeronimo, Selma M. B.
TI Changing epidemiology of visceral leishmaniasis in northeastern Brazil:
   a 25-year follow-up of an urban outbreak
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Brazil; Leishmania infantum; Spatial distribution; Urbanization;
   Visceral leishmaniasis
ID LUTZOMYIA-LONGIPALPIS; INFECTION; CHAGASI; PSYCHODIDAE; DIPTERA; STATE;
   AIDS
AB Background: Visceral leishmaniasis (VL) continues to be a deadly parasitic disease in Brazil but the epidemiology has changed. The objective of this study was to assess the evolution of urban VL in the city of Natal, Brazil, over the past 25 y.
   Methods: A retrospective study of human VL was performed, considering reported cases over the past 25 y in Natal. Analyses considered the spatial distribution of VL cases, human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) co-infection, Leishmania infantum infection in dogs, density of the insect vector (Lutzomyia longipalpis) and socio-economic factors.
   Results: Paralleling migration of the population, VL cases changed from mostly rural to predominantly urban regions. The incidence of human VL was highest during the initial years (1990-1994) of our study. Human VL was positively associated with a high density of L. longipalpis, a high prevalence of canine L. infantum infection and HIV/AIDS co-infection. The average age at diagnosis increased over prior years and males were more frequently affected. The overall fatality rate was 6%. Socio-economic variables indicative of poverty were associated with a greater incidence of VL and clusters of VL.
   Conclusion: VL has become endemic in Natal. The disease is associated with poverty and male gender. Surprisingly, there has been an increase in the age at diagnosis.
C1 [Lima, Adila L. M.; de Lima, Iraci D.; Coutinho, Jose F. V.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Grad Program, Natal, RN, Brazil.
   [Lima, Adila L. M.; Coutinho, Jose F. V.; de Sousa, Ursula P. S. T.; Rodrigues, Marcos A. G.] Hlth Secretariat Natal, Ctr Zoonot Control, Natal, RN, Brazil.
   [Coutinho, Jose F. V.; Queiroz, Jose W.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA.
   [Pearson, Richard D.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI-030639]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639] Funding Source: NIH
   RePORTER
FX The project was funded by the National Institutes of Health (AI-030639).
CR ALVAR J, 1992, LANCET, V339, P1427, DOI 10.1016/0140-6736(92)91255-7
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   Anselin L, 1996, SPATIAL ANAL PERSPEC, P111, DOI DOI 10.1201/9780203739051-8
   ARCAY L, 1985, Revista Latinoamericana de Microbiologia, V27, P195
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Belo VS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002982
   Box G. E. P., 1994, TIME SERIES ANAL FOR
   Brazil RP, 2013, REV SOC BRAS MED TRO, V46, P263, DOI 10.1590/0037-8682-0101-2013
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Instituto Brasileiro de Geografia e Estatistica, 2016, CID RIO GRAND NORT N
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Macedo-Silva VP, 2014, J MED ENTOMOL, V51, P237, DOI 10.1603/ME12131
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   Menezes Júlia Alves, 2016, Rev. bras. epidemiol., V19, P362, DOI 10.1590/1980-5497201600020013
   Minesterio Saude, 2016, SIT EP DAD
   Mukhopadhyay D, 2016, INT J DERMATOL, V55, pE250, DOI 10.1111/ijd.13048
   Nackers F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004187
   PENNA HA, 1934, J BRASILIERO MED, V48, P949
   Singh Om Prakash, 2016, Lancet Infect Dis, V16, pe304, DOI 10.1016/S1473-3099(16)30140-2
   Waller LA, 2004, APPL SPATIAL STAT PU
   Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
NR 30
TC 8
Z9 8
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD OCT
PY 2017
VL 111
IS 10
BP 440
EP 447
DI 10.1093/trstmh/trx080
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FV4JI
UT WOS:000424539000002
PM 29394411
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Lima, JG
   Lima, NN
   Santos, MCF
   Vieira, TC
   Silva, PHD
   Nobrega, LHC
   Baracho, MFP
   Jeronimo, SMB
AF Lima, J. G.
   Lima, N. N.
   Santos, M. C. F.
   Vieira, T. C.
   Silva, P. H. D.
   Nobrega, L. H. C.
   Baracho, M. F. P.
   Jeronimo, S. M. B.
TI Early results of the first Brazilian patients with generalised
   congenital lipodystrophy on treatment with metreleptin
SO DIABETOLOGIA
LA English
DT Meeting Abstract
CT 53rd Annual Meeting of the
   European-Association-for-the-Study-of-Diabetes (EASD)
CY SEP 11-15, 2017
CL Lisbon, PORTUGAL
SP European Assoc Study Diabet
C1 [Lima, J. G.; Lima, N. N.; Santos, M. C. F.; Vieira, T. C.; Silva, P. H. D.; Nobrega, L. H. C.; Baracho, M. F. P.] Hosp Univ Onofre Lopes, Med Clin, Natal, RN, Brazil.
   [Jeronimo, S. M. B.] IMT, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD SEP
PY 2017
VL 60
SU 1
MA 855
BP S396
EP S396
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA FE6JE
UT WOS:000408315002195
DA 2020-11-26
ER

PT J
AU Teixeira, DG
   Monteiro, GRG
   Martins, DRA
   Fernandes, MZ
   Macedo-Silva, V
   Ansaldi, M
   Nascimento, PRP
   Kurtz, MA
   Streit, JA
   Ximenes, MFFM
   Pearson, RD
   Miles, A
   Blackwell, JM
   Wilson, ME
   Kitchen, A
   Donelson, JE
   Lima, JPMS
   Jeronimo, SMB
AF Teixeira, D. G.
   Monteiro, G. R. G.
   Martins, D. R. A.
   Fernandes, M. Z.
   Macedo-Silva, V.
   Ansaldi, M.
   Nascimento, P. R. P.
   Kurtz, M. A.
   Streit, J. A.
   Ximenes, M. F. F. M.
   Pearson, R. D.
   Miles, A.
   Blackwell, J. M.
   Wilson, M. E.
   Kitchen, A.
   Donelson, J. E.
   Lima, J. P. M. S.
   Jeronimo, S. M. B.
TI Comparative analyses of whole genome sequences of Leishmania infantum
   isolates from humans and dogs in northeastern Brazil
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Article
DE Leishmania infantum; Intracellular parasite; Evolution; Parasite
   population structure; Copy number variation; Brazil
ID VISCERAL LEISHMANIASIS; POPULATION-GENETICS; KALA-AZAR; INFECTION;
   DONOVANI; CHAGASI; DNA; EPIDEMIOLOGY; GENERATION; ANEUPLOIDY
AB The genomic sequences of 20 Leishmania infantum isolates collected in northeastern Brazil were compared with each other and with the available genomic sequences of 29 L. infantum/donovani isolates from Nepal and Turkey. The Brazilian isolates were obtained in the early 1990s or since 2009 from patients with visceral or non-ulcerating cutaneous leishmaniasis, asymptomatic humans, or dogs with visceral leishmaniasis. Two isolates were from the blood and bone marrow of the same visceral leishmaniasis patient. All 20 genomic sequences display 99.95% identity with each other and slightly less identity with a reference L. infantum genome from a Spanish isolate. Despite the high identity, analysis of individual differences among the 32 million base pair genomes showed sufficient variation to allow the isolates to be clustered based on the primary sequence. A major source of variation detected was in chromosome somy, with only four of the 36 chromosomes being predominantly disomic in all 49 isolates examined. In contrast, chromosome 31 was predominantly tetrasomic/pentasomic, consistent with its regions of synteny on two different disomic chromosomes of Trypanosoma brucei. In the Brazilian isolates, evidence for recombination was detected in 27 of the 36 chromosomes. Clustering analyses suggested two populations, in which two of the five older isolates from the 1990s clustered with a majority of recent isolates. Overall the analyses do not suggest individual sequence variants account for differences in clinical outcome or adaptation to different hosts. For the first known time, DNA of isolates from asymptomatic subjects were sequenced. Of interest, these displayed lower diversity than isolates from symptomatic subjects, an observation that deserves further investigation with additional isolates from asymptomatic subjects. (C) 2017 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
C1 [Teixeira, D. G.; Martins, D. R. A.; Macedo-Silva, V.; Nascimento, P. R. P.; Lima, J. P. M. S.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, Natal, RN, Brazil.
   [Teixeira, D. G.; Monteiro, G. R. G.; Donelson, J. E.; Lima, J. P. M. S.; Jeronimo, S. M. B.] Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Martins, D. R. A.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Cellular Biol & Genet, Natal, RN, Brazil.
   [Fernandes, M. Z.] Univ Fed Rio Grande do Norte, Dept Internal Med, Natal, RN, Brazil.
   [Ansaldi, M.; Ximenes, M. F. F. M.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Natal, RN, Brazil.
   [Kurtz, M. A.; Streit, J. A.; Wilson, M. E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   [Streit, J. A.; Wilson, M. E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Pearson, R. D.] Univ Virginia, Dept Internal Med, Div Infect Dis, Charlottesville, VA USA.
   [Miles, A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford, England.
   [Blackwell, J. M.] Univ Western Australia, Telethon Inst Child Hlth, Perth, WA, Australia.
   [Wilson, M. E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA.
   [Kitchen, A.] Univ Iowa, Dept Anthropol, Iowa City, IA USA.
   [Donelson, J. E.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.
   [Jeronimo, S. M. B.] Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Dept Biochem, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Miles, Alistair/0000-0001-9018-4680; streit,
   judy/0000-0001-8629-3622; Wilson, Mary/0000-0001-8680-7275
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P50 AI-30639,
   R01 AI076233]; Science Without Borders from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [CNPQ
   401546/2013-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI076233, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER
FX This work was supported in part by grants P50 AI-30639 (SMBJ, MEW, RDP)
   and R01 AI076233 (MEW, JMB) from the US National Institutes of Health.
   The study was performed while JED (CNPQ 401546/2013-6) and DGT were
   supported by Science Without Borders from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. This research
   was supported in part through computational resources provided by the
   University of Iowa, USA, and Universidade Federal do Rio Grande do
   Norte, Natal, RN, Brazil.
CR Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Alger J, 1996, MEM I OSWALDO CRUZ, V91, P589, DOI 10.1590/S0074-02761996000500009
   Almeida AS, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-13
   Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718
   Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Chagas E, 1936, SCIENCE, V84, P397, DOI 10.1126/science.84.2183.397-a
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Costa C.H.N., 1990, EPIDEMIA LEISHMANIOS
   Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795
   Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330
   Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   Denise H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-42
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111
   Eckert AJ, 2010, MOL ECOL RESOUR, V10, P542, DOI 10.1111/j.1755-0998.2009.02768.x
   El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Franke CR, 2002, T ROY SOC TROP MED H, V96, P236, DOI 10.1016/S0035-9203(02)90087-8
   GRADONI L, 1995, B WORLD HEALTH ORGAN, V73, P191
   Hefnawy A., 2016, TRENDS PARASITOL, P1
   Imamura H, 2016, ELIFE, V5, DOI 10.7554/eLife.12613
   Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kaszak Ilona, 2015, Annals of Parasitology, V61, P69
   Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155
   Leblois R, 2011, INFECT GENET EVOL, V11, P1091, DOI 10.1016/j.meegid.2011.04.004
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Mosca E, 2012, EVOL APPL, V5, P762, DOI 10.1111/j.1752-4571.2012.00256.x
   Albuquerque PLMM, 2009, REV PANAM SALUD PUBL, V26, P330, DOI 10.1590/S1020-49892009001000007
   Nei M, 1987, MOL EVOLUTIONARY GEN
   Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696
   Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053
   PEARSON RD, 1980, J IMMUNOL, V125, P2195
   Rai K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005420
   Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267
   Rogers MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004092
   Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111
   Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004
   Rougeron V, 2015, TRENDS PARASITOL, V31, P52, DOI 10.1016/j.pt.2014.12.001
   Salomon O.D., 2009, GAZ MED BAHIA, V79, P3
   Schonian G, 2011, PARASITOLOGY, V138, P405, DOI 10.1017/S0031182010001538
   Segatto M, 2012, MEM I OSWALDO CRUZ, V107, P39, DOI 10.1590/S0074-02762012000100006
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Sterkers Y, 2012, MOL MICROBIOL, V86, P15, DOI 10.1111/j.1365-2958.2012.08185.x
   Sterkers Y, 2011, CELL MICROBIOL, V13, P274, DOI 10.1111/j.1462-5822.2010.01534.x
   TAJIMA F, 1989, GENETICS, V123, P585
   TAJIMA F, 1983, GENETICS, V105, P437
   Walton EL, 2014, MICROBES INFECT, V16, P269, DOI [10.1016/j.micinf.2013.11.008, 10.1016/j.micinf.2014.03.004]
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Zemanova E, 2007, INT J PARASITOL, V37, P149, DOI 10.1016/j.ijpara.2006.08.008
   Zhang WW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004244
   Zhang WW, 2010, MOL MICROBIOL, V77, P505, DOI 10.1111/j.1365-2958.2010.07230.x
   Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200
   Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606
NR 66
TC 10
Z9 10
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-7519
EI 1879-0135
J9 INT J PARASITOL
JI Int. J. Parasit.
PD SEP
PY 2017
VL 47
IS 10-11
BP 655
EP 665
DI 10.1016/j.ijpara.2017.04.004
PG 11
WC Parasitology
SC Parasitology
GA FI2MT
UT WOS:000411773700009
PM 28606698
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Fernandes, U
   Vital, AL
   Ramos, E
   Urbano, JC
   Sena, A
   Fraiman, PHA
   Luz, K
   Queiroz, JW
   Jeronimo, SMB
AF Dourado, M. E.
   Fernandes, U.
   Vital, A. L.
   Ramos, E.
   Urbano, J. C.
   Sena, A.
   Fraiman, P. H. A.
   Luz, K.
   Queiroz, J. W.
   Jeronimo, S. M. B.
TI HIGH INCIDENCE OF GUILLAIN-BARRE SYNDROME AFTER ZIKA VIRUS INFECTION IN
   THE STATE RIO GRANDE DO NORTE, IN NORTHEAST BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Dourado, M. E.; Fernandes, U.; Vital, A. L.; Ramos, E.; Urbano, J. C.; Sena, A.; Fraiman, P. H. A.; Luz, K.; Queiroz, J. W.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 275
EP 276
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500125
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Fernandes, U
   Vital, AL
   Ramos, E
   Urbano, JC
   Sena, A
   Queiroz, JW
   Jeronimo, SMB
AF Dourado, M. E.
   Fernandes, U.
   Vital, A. L.
   Ramos, E.
   Urbano, J. C.
   Sena, A.
   Queiroz, J. W.
   Jeronimo, S. M. B.
TI EGOS DID NOT HAVE A GOOD CAPACITY TO PROGNOSIS IN GBS IN RIO GRANDE DO
   NORTE, BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Peripheral-Nerve-Society Meeting
CY JUL 08-12, 2017
CL Sitges, SPAIN
SP Peripheral Nerve Soc, Alnylam Pharmaceut Inc, CSL Behring, Grifols S A, Kedr S p A, Pfizer Inc Rare Dis, Terumo BCT Inc, Shire Plc, GBS CIDP Fdn Int, Octapharma AG, Acceleron Pharma Inc, Ionis Pharmaceut Inc, LFB Biomedicaments, Mayo Med Labs, Pharnext SA, Hereditary Neuropathy Fdn, Syntimmune Inc, UCB Biosciences Inc
C1 [Dourado, M. E.; Fernandes, U.; Vital, A. L.; Ramos, E.; Urbano, J. C.; Sena, A.; Queiroz, J. W.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2017
VL 22
IS 3
BP 275
EP 275
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FF8CU
UT WOS:000409243500124
DA 2020-11-26
ER

PT J
AU Lima, JG
   Nobrega, LHC
   Lima, NN
   dos Santos, MCF
   Baracho, MDP
   Winzenrieth, R
   Bandeira, F
   Mendes-Aguiar, CD
   Neto, FPF
   Ferreira, LC
   Rosen, CJ
   Jeronimo, SMB
AF Lima, Josivan Gomes
   Nobrega, Lucia Helena C.
   Lima, Natalia Nobrega
   Ferreira dos Santos, Marcel Catao
   Baracho, Maria de Fatima P.
   Winzenrieth, Renaud
   Bandeira, Francisco
   Mendes-Aguiar, Carolina de O.
   Freire Neto, Francisco Paulo
   Ferreira, Leonardo Capistrano
   Rosen, Clifford J.
   Jeronimo, Selma Maria B.
TI Normal bone density and trabecular bone score, but high serum sclerostin
   in congenital generalized lipodystrophy
SO BONE
LA English
DT Article
DE Sclerostin; Lipodystrophy; Bone; Diabetes
ID TYPE-2 DIABETES-MELLITUS; INSULIN-RESISTANCE; CLINICAL-PRACTICE;
   ANOREXIA-NERVOSA; ADOLESCENT GIRLS; MINERAL CONTENT; TURNOVER;
   ASSOCIATION; DEFICIENCY; CATENIN
AB Context: Berardinelli-Seip Congenital Lipodystrophy (BSCL) is a rare autosomal recessive syndrome characterized by a difficulty in storing lipids in adipocytes, low body fat mass, hypoleptinemia, and hyperinsulinemia. Sclerostin is a product of SOST gene that blocks the Wnt/beta-catenin pathway, decreasing bone formation and enhancing adipogenesis. There are no data about sclerostin in people with BSCL.
   Objective: We aimed to evaluate serum sclerostin, bone mineral density (BMD), and L1-L4Trabecular Bone Score (TBS) in BSCL patients, generating new knowledge about potential mechanisms involved in the bone alterations of these patients.
   Design, setting, and patients: In this cross-sectional study, we included 11 diabetic patients with BSCL (age 24.7 8.1 years; 6 females). Sclerostin, leptin, L1-L4 TBS, BMD were measured. Potential pathophysiological mechanisms have been suggested.
   Results: Mean serum sclerostin was elevated (44.7 +/- 13.4 pmol/L) and was higher in men than women (55.3 +/- 9.0 vs. 35.1 +/- 8.4 pmol/L, p = 0.004). Median of serum leptin was low [0.9 ng/mL (0.5-1.9)]. Seven out of 11 patients had normal BMD, while four patients had high bone mass (defined as Z-score > + 2.5SD). Patients on insulin had lower sclerostin (37.3 +/- 9.2 vs. 52.6 +/- 13.4 pmol/L, p = 0.05). The mean TBS was 1.402 +/- 0.106, and it was higher than 1300 in nine patients.
   Conclusions: Patients with lipoatrophic diabetes (BSCL) have high serum concentrations of sclerostin, normal or high BMD, and reasonable trabecular bone mass measured by TBS. This is the first report of high sclerostin and good bone microarchitecture (TBS) in BSCL patients. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Lima, Josivan Gomes; Nobrega, Lucia Helena C.; Lima, Natalia Nobrega; Ferreira dos Santos, Marcel Catao; Baracho, Maria de Fatima P.] HUOL, Dept Clin Med, Hlth Sci Ctr, Natal, RN, Brazil.
   [Lima, Josivan Gomes] Univ Fed Rio Grande do Norte, Hlth Postgrad Program, Natal, RN, Brazil.
   [Winzenrieth, Renaud] Hop Xavier Arnozan, Medimaps, Pessac, France.
   [Bandeira, Francisco] Univ Pernambuco, Med Sch, Div Endocrinol & Diabet, Recife, PE, Brazil.
   [Mendes-Aguiar, Carolina de O.; Freire Neto, Francisco Paulo; Ferreira, Leonardo Capistrano; Jeronimo, Selma Maria B.] Biosci Ctr, Dept Biochem, Natal, RN, Brazil.
   [Mendes-Aguiar, Carolina de O.; Freire Neto, Francisco Paulo; Ferreira, Leonardo Capistrano; Jeronimo, Selma Maria B.] Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.
   [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME USA.
   [Jeronimo, Selma Maria B.] Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
RP Lima, JG (corresponding author), HUOL, Dept Clin Med, Hlth Sci Ctr, Natal, RN, Brazil.; Lima, JG (corresponding author), Univ Fed Rio Grande do Norte, Hlth Postgrad Program, Natal, RN, Brazil.
EM josivanlima@gmail.com
RI Ferreira, Leonardo Capistrano/D-7097-2019; Jeronimo, Selma
   M.B./M-8672-2014; Bandeira, Francisco/AAO-1702-2020; Lima,
   Josivan/I-6362-2013; Jeronimo, Selma/AAY-4033-2020
OI Ferreira, Leonardo Capistrano/0000-0001-9268-4881; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Lima, Josivan/0000-0002-1627-7018; Jeronimo,
   Selma/0000-0002-4784-9904
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P50 AI-30639];
   Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R24DK092759, R24DK092759, R24DK092759,
   R24DK092759, R24DK092759, R24DK092759, R24DK092759, R24DK092759,
   R24DK092759] Funding Source: NIH RePORTER
FX We thank the staff from the Hospital Universitario Onofre Lopes,
   Universidade Federal do Rio Grande do Norte, for their help with subject
   recruitment. This work was supported in part by grants P50 AI-30639
   (SMBJ) from the US National Institutes of Health and Conselho Nacional
   de Pesquisa (CNPq). The funders had no role in designing the study nor
   in the writing of the manuscript.
CR Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152
   Armamento-Villareal R, 2012, J BONE MINER RES, V27, P1215, DOI 10.1002/jbmr.1560
   BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193
   Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475
   Bishop N, 2008, J CLIN DENSITOM, V11, P29, DOI 10.1016/j.jocd.2007.12.004
   Catalano A, 2014, EUR J ENDOCRINOL, V171, P293, DOI 10.1530/EJE-14-0106
   Christensen JD, 2014, J CLIN ENDOCR METAB, V99, pE1493, DOI 10.1210/jc.2014-1353
   Daniele G, 2015, DIABETES CARE, V38, P1509, DOI 10.2337/dc14-2989
   Donaldson AA, 2015, J CLIN ENDOCR METAB, V100, P3436, DOI 10.1210/jc.2015-2002
   Faje AT, 2012, BONE, V51, P474, DOI 10.1016/j.bone.2012.06.006
   Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186
   Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jcem.84.9.6103
   Gaudio A, 2012, J CLIN ENDOCR METAB, V97, P3744, DOI 10.1210/jc.2012-1901
   Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020
   Gennari L, 2012, J CLIN ENDOCR METAB, V97, P1737, DOI 10.1210/jc.2011-2958
   Girard-Mauduit S, 2010, ANN ENDOCRINOL-PARIS, V71, P89, DOI 10.1016/j.ando.2010.02.001
   Hans D, 2011, J CLIN DENSITOM, V14, P302, DOI 10.1016/j.jocd.2011.05.005
   Harvey NC, 2015, BONE, V78, P216, DOI 10.1016/j.bone.2015.05.016
   Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Jahn K, 2012, EUR CELLS MATER, V24, P197
   Jahn K, 2012, EUR CELLS MATER, V24, P209
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002
   Leslie WD, 2012, J BONE MINER RES, V27, P2231, DOI 10.1002/jbmr.1759
   Lima J.G., 2016, J CLIN DENSITOM
   Lima JG, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0140-x
   Lima JG, 2016, MED HYPOTHESES, V97, P94, DOI 10.1016/j.mehy.2016.10.025
   Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Morales-Santana S, 2013, DIABETES CARE, V36, P1667, DOI 10.2337/dc12-1691
   Neumann T, 2016, OSTEOPOROSIS INT, V27, P127, DOI 10.1007/s00198-015-3222-y
   Nuche-Berenguer B, 2010, REGUL PEPTIDES, V159, P61, DOI 10.1016/j.regpep.2009.06.010
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   Pereira M., 2016, OSTEOPOROS INT
   Rajab A, 2003, AM J MED GENET A, V121A, P271, DOI 10.1002/ajmg.a.20245
   Recker RR, 2015, J BONE MINER RES, V30, P216, DOI 10.1002/jbmr.2351
   SEIP M, 1959, Acta Paediatr, V48, P555
   Suzuki K, 2003, BONE, V33, P108, DOI 10.1016/S8756-3282(03)00169-8
   Ukita M, 2016, J CELL BIOCHEM, V117, P1419, DOI 10.1002/jcb.25432
   Whyte MP, 2005, J CLIN DENSITOM, V8, P1, DOI 10.1385/JCD:8:1:001
   Yamamoto M, 2013, J CLIN ENDOCR METAB, V98, P4030, DOI 10.1210/jc.2013-2143
   Yavropoulou Maria P, 2014, Hormones (Athens), V13, P323, DOI 10.14310/horm.2002.1552
NR 43
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD AUG
PY 2017
VL 101
BP 21
EP 25
DI 10.1016/j.bone.2017.03.053
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EY9LE
UT WOS:000404319300004
PM 28390904
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Nobre, ML
   Illarramendi, X
   Dupnik, KM
   Hacker, MD
   Nery, JAD
   Jeronimo, SMB
   Sarno, EN
AF Nobre, Mauricio Lisboa
   Illarramendi, Ximena
   Dupnik, Kathryn Margaret
   Hacker, Mariana de Andrea
   da Costa Nery, Jose Augusto
   Bezerra Jeronimo, Selma Maria
   Sarno, Euzenir Nunes
TI Multibacillary leprosy by population groups in Brazil: Lessons from an
   observational study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DECLINING INCIDENCE RATES; SEX-DIFFERENCES; PATTERNS; TRENDS;
   TRANSMISSION; INFECTION; CONTACTS; SYSTEM; STATE; RISK
AB Background
   Leprosy remains an important public health problem in Brazil where 28,761 new cases were diagnosed in 2015, the second highest number of new cases detected globally. The disease is caused by Mycobacterium leprae, a pathogen spread by patients with multibacillary (MB) leprosy. This study was designed to identify population groups most at risk for MB disease in Brazil, contributing to new ideas for early diagnosis and leprosy control.
   Methods
   A national databank of cases reported in Brazil (2001-2013) was used to evaluate epidemiological characteristics of MB leprosy. Additionally, the databank of a leprosy reference center was used to determine factors associated with higher bacillary loads.
   Results
   A total of 541,090 cases were analyzed. New case detection rates (NCDRs) increased with age, especially for men with MB leprosy, reaching 44.8 new cases/100,000 population in 65-69 year olds. Males and subjects older than 59 years had twice the odds of MB leprosy than females and younger cases (OR = 2.36, CI95% = 2.33-2.38; OR = 1.99, CI95% = 1.96-2.02, respectively). Bacillary load was higher in male and in patients aged 20-39 and 40-59 years compared to females and other age groups. From 2003 to 2013, there was a progressive reduction in annual NCDRs and an increase in the percentage of MB cases and of elderly patients in Brazil. These data suggest reduction of leprosy transmission in the country.
   Conclusion
   Public health policies for leprosy control in endemic areas in Brazil should include activities especially addressed to men and to the elderly in order to further reduce M. leprae transmission.
C1 [Nobre, Mauricio Lisboa] Fiocruz MS, Inst Oswaldo Cruz, Posgrad Med Trop, Rio De Janeiro, RJ, Brazil.
   [Nobre, Mauricio Lisboa] Secretaria Estadual Saude, Hosp Giselda Trigueiro, Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.
   [Illarramendi, Ximena] Fiocruz MS, Ctr Desenvolvimento Tecnol Saude, Rio De Janeiro, RJ, Brazil.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA.
   [Hacker, Mariana de Andrea; da Costa Nery, Jose Augusto; Sarno, Euzenir Nunes] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, RJ, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] INCT DT, Natal, RN, Brazil.
RP Nobre, ML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Posgrad Med Trop, Rio De Janeiro, RJ, Brazil.; Nobre, ML (corresponding author), Secretaria Estadual Saude, Hosp Giselda Trigueiro, Natal, RN, Brazil.; Nobre, ML (corresponding author), Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.
EM nobreml@gmail.com
RI Jeronimo, Selma M.B./M-8672-2014; Illarramendi, Ximena/G-2592-2019;
   Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Illarramendi,
   Ximena/0000-0003-1504-1553; Jeronimo, Selma/0000-0002-4784-9904; Nunes
   Sarno, Euzenir/0000-0003-0129-2159
FU Institute of Science and Technology of Tropical Diseases; Brazilian
   Ministry of Education/SESu/ PROEXT; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [T32-AI007613, R25-TW009337-02]; Burroughs-Welcome
   Fund / American Society for Tropical Medicine and Hygiene; Heiser
   Foundation for Leprosy Research; CAPES (Brazilian Federal Agency for
   Support and Assessment of Post-graduate Education); FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613] Funding Source: NIH RePORTER
FX This study was supported by a grant from the Institute of Science and
   Technology of Tropical Diseases and from the Brazilian Ministry of
   Education/SESu/ PROEXT (SMBJ and MLN). KMD was supported by the National
   Institutes of Health (T32-AI007613 and R25-TW009337-02), by a
   Burroughs-Welcome Fund / American Society for Tropical Medicine and
   Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases, and a
   Heiser Foundation for Leprosy Research grant. MLN was supported by a
   fellowship from CAPES (Brazilian Federal Agency for Support and
   Assessment of Post-graduate Education). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], SIT EP DAD IND EP OP
   [Anonymous], PROJ BRAS SEX ID 200
   [Anonymous], 2001, DEP AT TROL HANS AT
   Brasil, 2016, B EPIDEMIOLOGICO, V47
   Brasil. Ministerio da Saude, 2011, REL GEST CORD GER PR, P21
   Brasil. Portal da Saude, DIR VIG AT HANS COM
   Brasil. Portal da Saude, 2015, SIT EP DAD TAX DET H
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Browne S G, 1965, Int J Lepr, V33, P267
   Buhrer-Sekula S, 2003, J CLIN MICROBIOL, V41, P1991, DOI 10.1128/JCM.41.5.1991-1995.2003
   Butlin CR, 2014, LEPROSY REV, V85, P69
   Chou JP, 2013, CURR PHARM DESIGN, V19, P1680
   de Oliveira MLW, 1998, WHO TECH REP SER, V874, P1
   Penna MLF, 2013, LEPROSY REV, V84, P308
   Penna MLF, 2012, TROP MED INT HEALTH, V17, P244, DOI 10.1111/j.1365-3156.2011.02900.x
   Penna MLF, 2009, LEPROSY REV, V80, P332
   FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245
   Mendes ADG, 2012, CAD SAUDE PUBLICA, V28, P955, DOI 10.1590/S0102-311X2012000500014
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   GUINTO RICARDO S., 1954, INTERNATL JOUR LEPROSY, V22, P409
   Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016
   IRGENS LM, 1990, LEPROSY REV, V61, P32
   IRGENS LM, 1985, AM J EPIDEMIOL, V122, P695, DOI 10.1093/oxfordjournals.aje.a114148
   IRGENS LM, 1981, LEPROSY REV, V52, P147
   Bini EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093831
   James M, 2015, NEW ENGL J MED, V372, P2177, DOI [10. 1056/ NEJMp1501140, DOI 10.1056/NEJMP1501140]
   Koba A, 2009, LEPROSY REV, V80, P432
   Lee J, 2015, LEPROSY REV, V86, P316
   Leiker DL, 1987, GUIA TECNICO BACILOS
   Norwegian Institute of Public Health, LIF EXP NORW FACT SH
   Pinzan CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010757
   Report of the International Leprosy Association Technical Forum, 2002, INT J LEPR OTHER M S, V70, pS1
   Richardus JH, 2007, LEPROSY REV, V78, P330
   Riley JC, 2005, POPUL DEV REV, V31, P537, DOI 10.1111/j.1728-4457.2005.00083.x
   Larrea MR, 2012, LEPROSY REV, V83, P184
   Sales AM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001013
   Galvao PRS, 2008, LEPROSY REV, V79, P171
   Smith CS, 2014, LANCET INFECT DIS, V14, P96, DOI 10.1016/S1473-3099(13)70365-7
   Smith WC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003658
   Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265
   Cardoso LPV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-497
   WHO, 2012, WHO TECH REP SER, V968, P1
   World Bank, WORLD DEV IND LIF EX
   World Health Organization (WHO), 2014, WKLY EPIDEMIOL REC, V36, P389
   World Health Organization (WHO), 2015, WKLY EPIDEMIOL REC, P405
   YAMAMOTO Y, 1990, AM REV RESPIR DIS, V142, P430, DOI 10.1164/ajrccm/142.2.430
   YAMAMOTO Y, 1991, INFECT IMMUN, V59, P4089, DOI 10.1128/IAI.59.11.4089-4096.1991
NR 47
TC 18
Z9 19
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2017
VL 11
IS 2
AR e0005364
DI 10.1371/journal.pntd.0005364
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EO0RW
UT WOS:000396406600011
PM 28192426
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Aronson, N
   Herwaldt, BL
   Libman, M
   Pearson, R
   Lopez-Velez, R
   Weina, P
   Carvalho, E
   Ephros, M
   Jeronimo, S
   Magill, A
AF Aronson, Naomi
   Herwaldt, Barbara L.
   Libman, Michael
   Pearson, Richard
   Lopez-Velez, Rogelio
   Weina, Peter
   Carvalho, Edgar
   Ephros, Moshe
   Jeronimo, Selma
   Magill, Alan
TI Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines
   by the Infectious Diseases Society of America (IDSA) and the American
   Society of Tropical Medicine and Hygiene (ASTMH)
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Guidelines for the clinical management of persons with leishmaniasis were prepared by a Panel of the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). The guidelines are intended for internists, pediatricians, family practitioners, and dermatologists, as well as infectious disease specialists, practicing in the United States and Canada (for simplicity, referred to here as North America). The Panel followed a guideline development process that has been adopted by IDSA, which includes a systematic method of grading both the quality of evidence (very low, low, moderate, or high) and the strength of the recommendation (weak or strong) [1] (Figure 1).
   In these guidelines, we describe our approaches to the diagnosis and management of cases of cutaneous, mucosal, and visceral leishmaniasis, the three main clinical syndromes caused by infection with Leishmania parasites. Less common or rare syndromes that may require specialized expertise are beyond the scope of these guidelines. Whenever possible, our recommendations are based on randomized clinical trials. However, because of the diversity encompassed by leishmaniasis, which includes a spectrum of diseases caused by >20 Leishmania species found in many areas of the world, many of the recommendations are based on observational studies, anecdotal data, or expert opinion. Although there may be disagreement with some of our recommenda- tions and suggestions, the approaches we describe have been both useful and feasible in North America.
   Cutaneous leishmaniasis (CL) is the most common leishmanial syndrome worldwide and the one most likely to be encountered in patients in North America. The skin lesions of CL are usually painless and chronic, often occurring at sites of infected sand fly bites. Slow spontaneous healing as cell mediated immunity develops is the usual natural history, accelerated by antileishmanial therapy. A minority of cutaneous infections caused by Leishmania (Viannia) braziliensis (L. [V.] braziliensis) and related species in the Viannia subgenus, including L (V.) panamensis and L. (V.) guyanensis, are associated with concomitant or late mucosal leishmaniasis (ML), which can cause destructive lesions of the naso-oropharyngeal/ laryngeal mucosa. No universally applicable treatment has been identified for CL; the choice of agent, dose, and duration of therapy should be individualized. Parasite and host factors must be considered, as well as clinical characteristics (Table 1).
   Visceral leishmaniasis (VL), which reflects dissemination of Leishmania parasites throughout the reticuloendothelial system, is potentially life threatening without treatment. VL is an opportunistic infection in persons with HIV/AIDS or other causes of cell-mediated immunosuppression.
   The primary goals of therapy for VL and CUML are to prevent mortality and morbidity, respectively. The only Food and Drug Administration (FDA)-approved medications for the treatment of leishmaniasis are intravenous liposomal amphotericin B (L-AmB) for VL and oral miltefosine for CL, ML, and VL caused by particular species. For prevention of leishmaniasis in travelers, no vaccines or chemoprophylaxis currently are available; personal protective measures to minimize exposure to sand fly bites are recommended.
   Our recommendations for the diagnosis and clinical management of leishmaniasis are listed below. Background information about leishmaniasis, a description of our methods, and the evidence summaries that support our recommendations can be found online in the full text, tables, figures, and appendix of the guidelines.
C1 [Aronson, Naomi] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
   [Herwaldt, Barbara L.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Libman, Michael] McGill Univ, Ctr Hlth, Montreal, PQ, Canada.
   [Pearson, Richard] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Lopez-Velez, Rogelio] Univ Alcala De Henares, Madrid, Spain.
   [Weina, Peter] Walter Reed Army Inst Res, Silver Spring, MD USA.
   [Carvalho, Edgar] Univ Fed Bahia, Salvador, BA, Brazil.
   [Ephros, Moshe] Carmel Hosp, Haifa, Israel.
   [Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Magill, Alan] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Aronson, N (corresponding author), Uniformed Serv Univ Hlth Serv, Div Infect Dis, 4301 Jones Bridge Rd,Room A3060, Bethesda, MD 20814 USA.
EM naomi.aronson@usuhs.edu
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
FU Infectious Diseases Society of America; American Society of Tropical
   Medicine and Hygiene
FX Support for these guidelines was provided by the Infectious Diseases
   Society of America and the American Society of Tropical Medicine and
   Hygiene.
CR Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Laguna F, 2003, J ANTIMICROB CHEMOTH, V52, P464, DOI 10.1093/jac/dkg356
   Magill A., 2015, PRINCIPLES PRACTICE, P3091
   Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971
   WHO, 2010, WHO TECH REP SER, V949, P1
NR 5
TC 74
Z9 77
U1 0
U2 12
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JAN
PY 2017
VL 96
IS 1
BP 24
EP 45
DI 10.4269/ajtmh.16-84256
PG 22
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EQ1IH
UT WOS:000397822900009
PM 27927991
OA Green Published, Other Gold
DA 2020-11-26
ER

PT J
AU Ryken, KO
   Valverde, JG
   Barreto, SM
   Pereira, FV
   Wilson, ME
   Jeronimo, S
AF Ryken, Katherine O.
   Valverde, Joanna G.
   Barreto, Sonia M.
   Pereira, Flavio V.
   Wilson, Mary E.
   Jeronimo, Selma
TI EMOTIONAL PERCEPTIONS DURING PREGNANCY WITH POTENTIAL EXPOSURE TO ZIKA
   VIRUS: A PILOT STUDY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Ryken, Katherine O.; Wilson, Mary E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA.
   [Valverde, Joanna G.; Barreto, Sonia M.; Pereira, Flavio V.; Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
RI Valverde, Joanna G/C-1284-2014; Jeronimo, Selma/AAY-4033-2020
OI Valverde, Joanna G/0000-0001-8064-6255; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 244
BP 76
EP 76
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215202244
DA 2020-11-26
ER

PT J
AU Weirather, JL
   Duggal, P
   Nascimento, EL
   Monteiro, GR
   Martins, DR
   Lacerda, HG
   Fakiola, M
   Blackwell, JM
   Jeronimo, SMB
   Wilson, ME
AF Weirather, Jason L.
   Duggal, Priya
   Nascimento, Eliana L.
   Monteiro, Gloria R.
   Martins, Daniella R.
   Lacerda, Henio G.
   Fakiola, Michaela
   Blackwell, Jenefer M.
   Jeronimo, Selma M. B.
   Wilson, Mary E.
TI Comprehensive candidate gene analysis for symptomatic or asymptomatic
   outcomes of Leishmania infantum infection in Brazil
SO ANNALS OF HUMAN GENETICS
LA English
DT Article
DE visceral leishmaniasis; Leishmania infantum; transforming growth
   factor-beta; candidate gene studies; Fc gamma receptor; asymptomatic
   infection
ID VISCERAL LEISHMANIASIS; TGF-BETA; CUTANEOUS LEISHMANIASIS; NORTHEASTERN
   BRAZIL; CHAGASI INFECTION; SUSCEPTIBILITY; GENOME; LINKAGE; GROWTH; SCAN
AB Genetic risk factors contribute to asymptomatic versus symptomatic visceral leishmaniasis (VL) outcomes following infection with Leishmania infantum. We therefore carried out a family-based (n = 918 post-quality control fully genotyped and phenotyped individuals) candidate gene study for symptomatic VL or asymptomatic delayed-type hypersensitivity (DTH) skin test phenotypes in highly endemic neighborhoods of northeast Brazil. A total of 248 SNPs were genotyped in 42 genes selected as candidates on the basis of prior genetic, immunological, and transcriptional profiling studies. The most significant association with the VL phenotype was with SNP rs6785358 (P = 5.7e-04; p(corrected)=0.026) 3.8 kb upstream of TGFBR2, the gene encoding the type 2 receptor for transforming growth factor beta (TGF beta). A second inhibitory member of the TGB beta superfamily signaling pathway, SMAD7, was associated with the DTH phenotype (SNP rs7238442: P = 0.001; p(corrected)=0.051). The most significant association for the DTH phenotype was with SNP rs10800309 (P = -8.4e-06; p(corrected)=3.9e-04) situated 3.1 kb upstream of FCGR2A, the gene encoding the low-affinity IIa receptor for the Fc fragment of IgG. Overall, our results imply a role for IgG-mediated inflammation in determining DTH associated with asymptomatic infection and contribute to growing evidence that the TGF beta pathway is important in the immunopathogenesis of VL.
C1 [Weirather, Jason L.; Wilson, Mary E.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA USA.
   [Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Nascimento, Eliana L.; Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [Nascimento, Eliana L.; Monteiro, Gloria R.; Martins, Daniella R.; Lacerda, Henio G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.
   [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA.
RP Wilson, ME (corresponding author), Univ Iowa, Internal Med Microbiol, SW34 GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275; Fakiola,
   Michaela/0000-0001-9071-4709
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI076233, AI045540, AI067874, T32
   GM008629, T32 GM082729]; Tropical Medicine Research Center grant [P50
   AI-30639]; Department of Veterans' AffairsUS Department of Veterans
   Affairs [1i01BX001983, 5I01BX000536]; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [R03TW001369,
   R03TW001369, R03TW001369] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, R01AI048822, P50AI030639, R01AI076233,
   R01AI045540, R01AI045540, P50AI030639, P50AI030639, R01AI067874,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI067874, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   R01AI048822, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI067874,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, R01AI067874, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM082729,
   T32GM008629, T32GM082729, T32GM082729, T32GM008629, T32GM008629,
   T32GM008629, T32GM082729, T32GM008629, T32GM008629, T32GM008629,
   T32GM082729, T32GM008629, T32GM008629, T32GM008629] Funding Source: NIH
   RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX000536, I01BX000536, I01BX000536, I01BX000536, I01BX000536,
   I01BX000536, I01BX000536, I01BX000536, I01BX000536] Funding Source: NIH
   RePORTER
FX This work was supported by NIH grant R01 AI076233 (JMB and MEW),
   AI045540 (MEW) and AI067874 (MEW, JMB). Data were collected under the
   Tropical Medicine Research Center grant P50 AI-30639 (SMBJ, MEW, JMB).
   Partial support was received from Merit Review grants from the
   Department of Veterans' Affairs (1i01BX001983 and 5I01BX000536; MEW).
   The work was performed in part during the tenure of J.L.W. on NIH
   training grants T32 GM008629 and T32 GM082729. The authors are grateful
   to Anne Kwitek, Ph.D. and to Jeffrey Murray, M.D. for their helpful
   advice and discussions regarding genetic data analysis.
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   Akhurst RJ, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aad0416
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x
   Blackwell J.M., 2010, IMMUNOLOGY INFECT DI
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927
   Castellucci L, 2011, GENES IMMUN, V12, P589, DOI 10.1038/gene.2011.37
   Castellucci L, 2012, INFECT GENET EVOL, V12, P1102, DOI 10.1016/j.meegid.2012.03.017
   Ejghal R, 2014, ACTA TROP, V140, P130, DOI 10.1016/j.actatropica.2014.08.013
   Ettinger NA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000252
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Fierro-Fernandez M, 2015, EMBO REP, V16, P1358, DOI 10.15252/embr.201540750
   Frade AF, 2011, INFECT GENET EVOL, V11, P912, DOI 10.1016/j.meegid.2011.02.014
   Fu YX, 2014, J CELL PHYSIOL, V229, P772, DOI 10.1002/jcp.24497
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001
   Im YH, 2000, CANCER RES, V60, P1536
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141
   Kumar R, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00251
   Li L, 2012, J CELL BIOCHEM, V113, P1235, DOI 10.1002/jcb.23457
   Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419
   Rodriguez NE, 2004, INFECT IMMUN, V72, P2111, DOI 10.1128/IAI.72.4.2111-2122.2004
   Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933
   Wei W, 2013, HEPATOLOGY, V57, P2491, DOI 10.1002/hep.26252
   Weirather JL, 2016, INFECT GENET EVOL, V43, P1, DOI 10.1016/j.meegid.2016.05.005
   Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864
   Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 40
TC 5
Z9 5
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-4800
EI 1469-1809
J9 ANN HUM GENET
JI Ann. Hum. Genet.
PD JAN
PY 2017
VL 81
IS 1
BP 41
EP 48
DI 10.1111/ahg.12180
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA EI2RE
UT WOS:000392334600006
PM 28054334
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Aronson, N
   Herwaldt, BL
   Libman, M
   Pearson, R
   Lopez-Velez, R
   Weina, P
   Carvalho, EM
   Ephros, M
   Jeronimo, S
   Magill, A
AF Aronson, Naomi
   Herwaldt, Barbara L.
   Libman, Michael
   Pearson, Richard
   Lopez-Velez, Rogelio
   Weina, Peter
   Carvalho, Edgar M.
   Ephros, Moshe
   Jeronimo, Selma
   Magill, Alan
TI Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines
   by the Infectious Diseases Society of America (IDSA) and the American
   Society of Tropical Medicine and Hygiene (ASTMH)
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE cutaneous leishmaniasis; mucosal leishmaniasis; visceral leishmaniasis;
   immunocompromised host; leishmaniasis diagnostic testing
ID VISCERAL LEISHMANIASIS
AB It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The IDSA and ASTMH consider adherence to these guidelines to be voluntary, with the ultimate determinations regarding their application to be made by the physician in the light of each patient's individual circumstances.
C1 [Aronson, Naomi] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
   [Herwaldt, Barbara L.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Libman, Michael] McGill Univ, Ctr Hlth, Montreal, PQ, Canada.
   [Pearson, Richard] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Lopez-Velez, Rogelio] Ramon & Cajal Univ Hosp, Madrid, Spain.
   [Weina, Peter] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA.
   [Carvalho, Edgar M.] Fiocruz MS, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ephros, Moshe] Carmel Hosp, Haifa, Israel.
   [Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Magill, Alan] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Aronson, N (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM naomi.aronson@usuhs.edu
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
CR Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Laguna F, 2003, J ANTIMICROB CHEMOTH, V52, P464, DOI 10.1093/jac/dkg356
   Magill A., 2015, PRINCIPLES PRACTICE, P3091
   Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971
   WHO, 2010, WHO TECH REP SER, V949, P1
NR 5
TC 30
Z9 31
U1 2
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2016
VL 63
IS 12
BP 1539
EP 1557
DI 10.1093/cid/ciw742
PG 19
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WW
UT WOS:000392716100003
PM 27941143
OA Bronze
DA 2020-11-26
ER

PT J
AU Aronson, N
   Herwaldt, BL
   Libman, M
   Pearson, R
   Lopez-Velez, R
   Weina, P
   Carvalho, EM
   Ephros, M
   Jeronimo, S
   Magill, A
AF Aronson, Naomi
   Herwaldt, Barbara L.
   Libman, Michael
   Pearson, Richard
   Lopez-Velez, Rogelio
   Weina, Peter
   Carvalho, Edgar M.
   Ephros, Moshe
   Jeronimo, Selma
   Magill, Alan
TI Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines
   by the Infectious Diseases Society of America (IDSA) and the American
   Society of Tropical Medicine and Hygiene (ASTMH)
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE cutaneous leishmaniasis; mucosal leishmaniasis; visceral leishmaniasis;
   immunocompromised host; leishmaniasis diagnostic testing
ID LIPOSOMAL AMPHOTERICIN-B; HUMAN-IMMUNODEFICIENCY-VIRUS; INDIAN VISCERAL
   LEISHMANIASIS; WORLD CUTANEOUS LEISHMANIASIS; ACTIVE ANTIRETROVIRAL
   THERAPY; AZAR DERMAL LEISHMANIASIS; RECONSTITUTION INFLAMMATORY
   SYNDROME; INTRALESIONAL MEGLUMINE ANTIMONIATE;
   POLYMERASE-CHAIN-REACTION; DIRECT AGGLUTINATION-TEST
AB It is important to realize that leishmaniasis guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The IDSA and ASTMH consider adherence to these guidelines to be voluntary, with the ultimate determinations regarding their application to be made by the physician in the light of each patient's individual circumstances.
C1 [Aronson, Naomi] Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
   [Herwaldt, Barbara L.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Libman, Michael] McGill Univ, Ctr Hlth, Montreal, PQ H3A 2T5, Canada.
   [Pearson, Richard] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA.
   [Lopez-Velez, Rogelio] Ramon & Cajal Univ Hosp, Madrid, Spain.
   [Weina, Peter] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA.
   [Carvalho, Edgar M.] Fiocruz MS, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ephros, Moshe] Carmel Hosp, Haifa, Israel.
   [Jeronimo, Selma] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Magill, Alan] Bill & Melinda Gates Fdn, Seattle, WA USA.
RP Aronson, N (corresponding author), Uniformed Serv Univ Hlth Sci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM naomi.aronson@usuhs.edu
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
CR Adam GK, 2009, INT J GYNECOL OBSTET, V107, P208, DOI 10.1016/j.ijgo.2009.08.002
   Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354
   Adler-Moore Jill, 2003, Curr Opin Investig Drugs, V4, P179
   Ahluwalia S, 2004, BMJ-BRIT MED J, V329, P842, DOI 10.1136/bmj.329.7470.842
   Ait-Oudhia K, 2011, PARASITOL RES, V109, P1225, DOI 10.1007/s00436-011-2555-5
   Akilov OE, 2007, INT J DERMATOL, V46, P132, DOI 10.1111/j.1365-4632.2007.03154.x
   Albrecht H, 1998, AIDS, V12, P2225, DOI 10.1097/00002030-199816000-00019
   Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016
   ALGINDAN Y, 1988, BRIT J DERMATOL, V118, P851, DOI 10.1111/j.1365-2133.1988.tb02605.x
   Aliaga L, 2003, MEDICINE, V82, P147, DOI 10.1097/00005792-200305000-00001
   Alkhawajah AM, 1997, ANN TROP MED PARASIT, V91, P899, DOI 10.1080/00034989760284
   AlMajali O, 1997, INT J DERMATOL, V36, P460, DOI 10.1046/j.1365-4362.1997.00045.x
   Almeida RP, 2005, AM J TROP MED HYG, V73, P79, DOI 10.4269/ajtmh.2005.73.79
   Alrajhi AA, 2002, NEW ENGL J MED, V346, P891, DOI 10.1056/NEJMoa011882
   Alsina-Gibert M, 2006, ARCH DERMATOL, V142, P787, DOI 10.1001/archderm.142.6.787
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   Sampaio MJAD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000877
   Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x
   Amato VS, 2011, AM J TROP MED HYG, V85, P818, DOI 10.4269/ajtmh.2011.11-0287
   Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003
   Amato VS, 2007, AM J TROP MED HYG, V77, P266, DOI 10.4269/ajtmh.2007.77.266
   Amato VS, 2007, CLIN INFECT DIS, V44, P311, DOI 10.1086/510494
   Amato VS, 2000, J ANTIMICROB CHEMOTH, V46, P341, DOI 10.1093/jac/46.2.341
   Amato VS, 2004, ACTA TROP, V92, P127, DOI 10.1016/j.actatropica.2004.06.006
   Andersen EM, 2005, AM J TROP MED HYG, V72, P133, DOI 10.4269/ajtmh.2005.72.133
   Andrade-Narvaez Fernando J., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P191, DOI 10.1590/S0036-46652005000400003
   Andrade-Narvaez FJ, 2001, MEM I OSWALDO CRUZ, V96, P163, DOI 10.1590/S0074-02762001000200005
   [Anonymous], 2013, ANT DRUGS ADV COMM M
   Antinori S, 2007, BRIT J DERMATOL, V157, P1032, DOI 10.1111/j.1365-2133.2007.08157.x
   Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4
   Aoun J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003255
   Ara M, 1998, BRIT J DERMATOL, V139, P114, DOI 10.1046/j.1365-2133.1998.02326.x
   Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546
   Arevalo I, 2001, CLIN INFECT DIS, V33, P1847, DOI 10.1086/324161
   Arevalo I, 2007, CLIN INFECT DIS, V44, P1549, DOI 10.1086/518172
   Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041
   Aronson NE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000628
   Asilian A, 2006, CLIN EXP DERMATOL, V31, P634, DOI 10.1111/j.1365-2230.2006.02182.x
   Asilian A, 2004, INT J DERMATOL, V43, P281, DOI 10.1111/j.1365-4632.2004.02002.x
   Badaro Roberto, 2015, J Int Assoc Provid AIDS Care, V14, P402, DOI 10.1177/2325957414555225
   Bafica A, 2003, INT J DERMATOL, V42, P203, DOI 10.1046/j.1365-4362.2003.01868.x
   Bart A, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.30.20544
   BAUM KF, 1994, CLIN INFECT DIS, V18, P813, DOI 10.1093/clinids/18.5.813
   Bechade D, 1996, REV MED INTERNE, V17, P234, DOI 10.1016/0248-8663(96)81251-3
   Belay AD, 2006, ANN TROP MED PARASIT, V100, P223, DOI 10.1179/136485906X91440
   Ben Salah A, 2013, NEW ENGL J MED, V368, P524, DOI 10.1056/NEJMoa1202657
   Ben Salah A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000432
   Berenguer J, 2000, AIDS, V14, P2946, DOI 10.1097/00002030-200012220-00020
   BERMAN JD, 1989, T ROY SOC TROP MED H, V83, P784, DOI 10.1016/0035-9203(89)90327-1
   Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25
   Berman J, 2015, AM J TROP MED HYG, V92, P471, DOI 10.4269/ajtmh.14-0743
   Bern C, 2000, AM J TROP MED HYG, V63, P153, DOI 10.4269/ajtmh.2000.63.153
   Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530
   Berry A, 2004, SCAND J INFECT DIS, V36, P225, DOI 10.1080/00365540410019426
   Bezuneh A, 2014, AM J TROP MED HYG, V91, P1109, DOI [10.4269/ajtmh.14-0759, 10.4269/ajtmh.13-0759]
   Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657
   Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638
   Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690
   Bittencourt Achiléa, 2002, Braz J Infect Dis, V6, P313, DOI 10.1590/S1413-86702002000600008
   Blanche P, 2002, CLIN INFECT DIS, V34, P1279, DOI 10.1086/338720
   Blum J, 1994, Schweiz Rundsch Med Prax, V83, P1025
   Blum J, 2014, J TRAVEL MED, V21, P116, DOI 10.1111/jtm.12089
   Blum J, 2012, INT HEALTH, V4, P153, DOI 10.1016/j.inhe.2012.06.004
   Boaventura VS, 2006, AM J TROP MED HYG, V75, P267, DOI 10.4269/ajtmh.2006.75.267
   Boaventura VS, 2009, AM J TROP MED HYG, V81, P384, DOI 10.4269/ajtmh.2009.81.384
   Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2
   Boggild AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026395
   Boggild AK, 2011, J CLIN MICROBIOL, V49, P1097, DOI 10.1128/JCM.02457-10
   Boggild AK, 2010, AM J TROP MED HYG, V83, P345, DOI 10.4269/ajtmh.2010.09-0414
   BonfanteGarrido R, 1996, INT J DERMATOL, V35, P561, DOI 10.1111/j.1365-4362.1996.tb03655.x
   Bosch RJ, 2002, INT J DERMATOL, V41, P670, DOI 10.1046/j.1365-4362.2002.01610.x
   Bourgeois N, 2010, HIV MED, V11, P670, DOI 10.1111/j.1468-1293.2010.00846.x
   BOUROS D, 1991, CHEST, V99, P416, DOI 10.1378/chest.99.2.416
   Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Brito G, 2014, AM J TROP MED HYG, V90, P617, DOI 10.4269/ajtmh.12-0729
   Brustoloni YM, 2010, INFECTION, V38, P261, DOI 10.1007/s15010-010-0022-3
   Buonomano R, 2009, SCAND J INFECT DIS, V41, P777, DOI 10.1080/00365540903104127
   Burden-Teh E, 2015, BRIT J DERMATOL, V172, P861, DOI 10.1111/bjd.13496
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Burza S, 2014, PLOS NEGLECT TROP D, V8, P49
   Burza S, 2014, PLOS NEGLECT TROP D, V8, P46
   Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003053
   Caldas AJM, 2006, ACTA TROP, V97, P252, DOI 10.1016/j.actatropica.2005.09.010
   Caldas AJM, 2003, ACTA TROP, V88, P39, DOI 10.1016/S0001-706X(03)00160-8
   Camargo RA, 2010, AM J TROP MED HYG, V83, P515, DOI 10.4269/ajtmh.2010.10-0081
   Camuset G, 2007, MED MALADIES INFECT, V37, P343, DOI 10.1016/j.medmal.2007.03.012
   Carnauba D, 2009, INT J INFECT DIS, V13, pE504, DOI 10.1016/j.ijid.2009.01.022
   Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010
   Cascio A, 2004, J ANTIMICROB CHEMOTH, V54, P217, DOI 10.1093/jac/dkh279
   Cascio A, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e27
   Cascio A, 2000, EUR J CLIN MICROBIOL, V19, P651, DOI 10.1007/s100960000328
   Casero R, 2010, REV ARGENT MICROBIOL, V42, P118, DOI 10.1590/S0325-75412010000200010
   Cassagne C, 2014, CLIN MICROBIOL INFEC, V20, P551, DOI 10.1111/1469-0691.12387
   Catorze G, 2006, ANN DERMATOL VENER, V133, P39, DOI 10.1016/S0151-9638(06)70841-9
   Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C
   Chappuis F, 2011, ANTIMICROB AGENTS CH, V55, P455, DOI 10.1128/AAC.01298-10
   Chien KS, 2013, CLIN INFECT DIS, V56, P308, DOI [10.1093/cid/cis834, 10.1093/cid/cis972]
   Chrusciak-Talhari A, 2011, AM J TROP MED HYG, V84, P255, DOI 10.4269/ajtmh.2011.10-0155
   Chrusciak-Talhari A, 2009, AM J TROP MED HYG, V81, P559, DOI 10.4269/ajtmh.2009.09-0077
   CHULAY JD, 1985, AM J TROP MED HYG, V34, P702, DOI 10.4269/ajtmh.1985.34.702
   Clemente W, 2015, CLIN MICROBIOL INFEC, V21, P89, DOI 10.1016/j.cmi.2014.09.002
   Clemente WT, 2014, AM J TRANSPLANT, V14, P96, DOI 10.1111/ajt.12521
   Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841
   Colebunders R, 1999, J AM ACAD DERMATOL, V41, P847, DOI 10.1016/S0190-9622(99)70342-7
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   Conceicao-Silva F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002472
   Rubiano LC, 2012, J INFECT DIS, V205, P684, DOI 10.1093/infdis/jir816
   Correia D, 1996, Rev Soc Bras Med Trop, V29, P447, DOI 10.1590/S0037-86821996000500007
   Costa J M, 1986, Rev Soc Bras Med Trop, V19, P109, DOI 10.1590/S0037-86821986000200012
   Coster LO, 2013, INFECT DIS CLIN N AM, V27, P395, DOI 10.1016/j.idc.2013.02.008
   Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195
   Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153
   Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665
   Couppie P, 2004, BRIT J DERMATOL, V151, P1165, DOI 10.1111/j.1365-2133.2004.06226.x
   Craig C, 1943, CLIN PARASITOLOGY
   Cruz A, 2007, J INFECT DIS, V195, P602, DOI 10.1086/510860
   Cunha MA, 2015, AM J TROP MED HYG, V93, P1214, DOI 10.4269/ajtmh.15-0033
   D'Oliveira A, 1997, INT J DERMATOL, V36, P938, DOI 10.1046/j.1365-4362.1997.00308.x
   Da Silva MRB, 2005, AM J TROP MED HYG, V72, P811, DOI 10.4269/ajtmh.2005.72.811
   Davidson RN, 1996, CLIN INFECT DIS, V22, P938, DOI 10.1093/clinids/22.6.938
   DAVIDSON RN, 1994, Q J MED, V87, P75
   Davies C R, 2000, Cad Saude Publica, V16, P925, DOI 10.1590/S0102-311X2000000400013
   Vasconcellos ECFE, 2012, AM J TROP MED HYG, V87, P257, DOI 10.4269/ajtmh.2012.11-0612
   de la Rosa R, 2002, J CLIN MICROBIOL, V40, P762, DOI 10.1128/JCM.40.3.762-767.2002
   de la Rosa R, 2001, CLIN INFECT DIS, V32, P633, DOI 10.1086/318708
   de Melo EC, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/319234
   de Oliveira-Neto MP, 2006, REV SOC BRAS MED TRO, V39, P323, DOI 10.1590/S0037-86822006000400001
   de Oliveira-Neto MP, 2000, INT J DERMATOL, V39, P506, DOI 10.1046/j.1365-4362.2000.00969.x
   de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14
   del Giudice P, 2002, J INFECT DIS, V186, P1366, DOI 10.1086/344325
   Delgado J, 1999, AM J TROP MED HYG, V61, P766, DOI 10.4269/ajtmh.1999.61.766
   DIETZE R, 1995, T ROY SOC TROP MED H, V89, P309, DOI 10.1016/0035-9203(95)90557-X
   DIETZE R, 1993, CLIN INFECT DIS, V17, P981, DOI 10.1093/clinids/17.6.981
   diMartino L, 1997, J PEDIATR-US, V131, P271, DOI 10.1016/S0022-3476(97)70165-3
   DIMIERDAVID L, 1993, B SOC PATHOL EXOT, V86, P106
   Diniz DS, 2012, REV SOC BRAS MED TRO, V45, P597, DOI 10.1590/S0037-86822012000500011
   Diro E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004087
   Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869
   Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002875
   Disch J, 2004, ACTA TROP, V92, P279, DOI 10.1016/j.actatropica.2004.08.002
   Dooley KE, 2008, J INFECT DIS, V198, P948, DOI 10.1086/591459
   Dorlo TPC, 2008, ANTIMICROB AGENTS CH, V52, P2855, DOI 10.1128/AAC.00014-08
   Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039
   Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275
   Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P1996, DOI 10.1093/jac/dks164
   Dorlo TPC, 2012, ANTIMICROB AGENTS CH, V56, P3864, DOI 10.1128/AAC.00292-12
   Eichner S, 2013, EUR J DERMATOL, V23, P218, DOI 10.1684/ejd.2013.1934
   ELON J, 1986, J INVEST DERMATOL, V87, P284, DOI 10.1111/1523-1747.ep12696697
   Emad M, 2011, J AM ACAD DERMATOL, V64, P606, DOI 10.1016/j.jaad.2010.04.014
   Enk CD, 2015, BRIT J DERMATOL, V172, P1364, DOI 10.1111/bjd.13490
   Esfandiarpour I, 2012, INT J DERMATOL, V51, P1221, DOI 10.1111/j.1365-4632.2012.05460.x
   Farooq U, 2013, INT J DERMATOL, V52, P1098, DOI 10.1111/ijd.12139
   Faucher B, 2011, J INFECTION, V63, P76, DOI 10.1016/j.jinf.2011.03.012
   FDA, 2013, FDA BRIEF DOC ANT DR
   Pimentel MIF, 2011, REV SOC BRAS MED TRO, V44, P254, DOI 10.1590/S0037-86822011000200026
   Fernandez-Guerrero ML, 2004, ACTA TROP, V90, P11, DOI 10.1016/j.actatropica.2003.09.009
   FERNANDEZGUERRERO ML, 1987, AM J MED, V83, P1098, DOI 10.1016/0002-9343(87)90948-X
   Figueiro EA, 2008, ARCH GYNECOL OBSTET, V278, P13, DOI 10.1007/s00404-007-0532-0
   Figueiro-Filho Ernesto Antonio, 2004, Infect Dis Obstet Gynecol, V12, P31, DOI 10.1080/1064744042000210384
   Figueroa RA, 2009, J INFECT DIS, V200, P638, DOI 10.1086/600109
   Fisa R, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS191, DOI 10.1016/S0035-9203(02)90075-1
   Fletcher K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121418
   Flores-Figueroa J, 2011, CLIN INFECT DIS, V53, P523, DOI 10.1093/cid/cir468
   Silva JSFE, 2013, REV SOC BRAS MED TRO, V46, P669, DOI 10.1590/0037-8682-0104-2013
   Food and Drug Administration, MILT HIGHL PRESCR IN
   Foulet F, 2006, ARCH DERMATOL, V142, P1368, DOI 10.1001/archderm.142.10.1368
   FRANKE ED, 1994, AM J TROP MED HYG, V51, P77, DOI 10.4269/ajtmh.1994.51.77
   FRANKE ED, 1990, ANN INTERN MED, V113, P934, DOI 10.7326/0003-4819-113-12-934
   Frapier JM, 2001, J HEART LUNG TRANSPL, V20, P912, DOI 10.1016/S1053-2498(01)00263-7
   Freire M, 1997, BRAZ J INFECT DIS, V1, P230
   Gaeta GB, 2000, SCAND J INFECT DIS, V32, P675, DOI 10.1080/003655400459612
   Gangneux JP, 2007, EMERG INFECT DIS, V13, P1436, DOI 10.3201/eid1309.061446
   Gangneux JP, 1996, ANTIMICROB AGENTS CH, V40, P1214, DOI 10.1128/AAC.40.5.1214
   Ganguly S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004138
   Bustos MFG, 2014, MEDICINA-BUENOS AIRE, V74, P371
   Gautret P, 2012, EUROSURVEILLANCE, P17
   Ghosh K, 2007, T ROY SOC TROP MED H, V101, P1163, DOI 10.1016/j.trstmh.2007.05.021
   Giavedoni P, 2015, ACTAS DERMO-SIFILOGR, V106, P310, DOI 10.1016/j.ad.2014.12.003
   Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10
   Gilad J, 2001, ISRAEL MED ASSOC J, V3, P451
   Gois L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0774-6
   GOLINO A, 1992, J HEART LUNG TRANSPL, V11, P820
   Gomes CM, 2014, DIAGN MICR INFEC DIS, V79, P413, DOI 10.1016/j.diagmicrobio.2014.05.002
   GONZALEZ U, 2008, COCHRANE DB SYST REV, V4
   Gonzalez U, 2009, COCHRANE DB SYST REV, V15, DOI DOI 10.1002/14651858.CD004834
   Gonzalez U, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000055
   Gonzalez U, 2010, CLIN INFECT DIS, V51, P409, DOI 10.1086/655134
   Gonzalez-Beato MJ, 2000, BRIT J DERMATOL, V143, P1316, DOI 10.1046/j.1365-2133.2000.03909.x
   Goto H, 2010, EXPERT REV ANTI-INFE, V8, P419, DOI [10.1586/eri.10.19, 10.1586/ERI.10.19]
   GRADONI L, 1994, SCAND J INFECT DIS, V26, P627, DOI 10.3109/00365549409011824
   Gradoni L, 1993, J DRUG TARGET, V1, P311, DOI 10.3109/10611869308996089
   Guerra JAO, 2011, AM J TROP MED HYG, V85, P524, DOI 10.4269/ajtmh.2011.11-0075
   Guimaraes LH, 2009, T ROY SOC TROP MED H, V103, P712, DOI 10.1016/j.trstmh.2009.04.019
   Gunduz K, 2000, J EUR ACAD DERMATOL, V14, P11, DOI 10.1046/j.1468-3083.2000.00004.x
   Gurel MS, 2002, INT J DERMATOL, V41, P32, DOI 10.1046/j.0011-9059.2001.01396.x
   GUTIERREZ Y, 1991, AM J TROP MED HYG, V45, P281, DOI 10.4269/ajtmh.1991.45.281
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011
   Hadighi R, 2006, PLOS MED, V3, P659, DOI 10.1371/journal.pmed.0030162
   HARMS G, 1991, T ROY SOC TROP MED H, V85, P214, DOI 10.1016/0035-9203(91)90026-U
   Hartley MA, 2014, TRENDS PARASITOL, V30, P412, DOI 10.1016/j.pt.2014.05.006
   Hartzell JD, 2008, AM J TROP MED HYG, V79, P843, DOI 10.4269/ajtmh.2008.79.843
   Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657
   Herrador Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003594
   Hervas JA, 2012, PEDIATR INFECT DIS J, V31, P97, DOI 10.1097/INF.0b013e31822dfbf7
   HERWALDT BL, 1992, J INFECT DIS, V165, P518, DOI 10.1093/infdis/165.3.518
   HERWALDT BL, 1992, AM J TROP MED HYG, V46, P296, DOI 10.4269/ajtmh.1992.46.296
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Hodiamont CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002832
   Houghton RL, 1998, J INFECT DIS, V177, P1339, DOI 10.1086/515289
   Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x
   Ilett Kenneth F, 2005, Expert Opin Drug Saf, V4, P745, DOI 10.1517/14740338.4.4.745
   JANKNEGT R, 1992, CLIN PHARMACOKINET, V23, P279, DOI 10.2165/00003088-199223040-00004
   Jara M, 2013, J CLIN MICROBIOL, V51, P1826, DOI 10.1128/JCM.00208-13
   Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198
   Jeronimo SMB, 2006, TROPICAL INFECT DIS, P1095
   Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403
   Jimenez-Exposito MJ, 1999, AIDS, V13, P152
   JONES TC, 1987, J INFECT DIS, V156, P73, DOI 10.1093/infdis/156.1.73
   KAGER PA, 1984, TROP GEOGR MED, V36, P21
   KANJ LF, 1993, J AM ACAD DERMATOL, V28, P495, DOI 10.1016/S0190-9622(08)81764-1
   KAR K, 1995, CRIT REV MICROBIOL, V21, P123, DOI 10.3109/10408419509113537
   Keith PJ, 2014, BRIT J DERMATOL, V171, P1307, DOI 10.1111/bjd.13355
   Kerob D, 2006, CLIN INFECT DIS, V43, P664, DOI 10.1086/506572
   Khalil EAG, 2014, PLOS NEGLECT TROP D, V8, P21
   Khamesipour A, 2014, EXPERT OPIN BIOL TH, V14, P1641, DOI 10.1517/14712598.2014.945415
   Kim DH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000381
   KLOTZ OSKAR, 1923, American Journal of Tropical Medicine, V3, P117
   Kopterides P, 2007, T ROY SOC TROP MED H, V101, P1181, DOI 10.1016/j.trstmh.2007.08.003
   Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534
   Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710
   Laguna F, 2003, ANN TROP MED PARASIT, V97, P135, DOI 10.1179/000349803225002606
   Laguna F, 1999, AIDS, V13, P1063, DOI 10.1097/00002030-199906180-00009
   Laguna F, 2003, J ANTIMICROB CHEMOTH, V52, P464, DOI 10.1093/jac/dkg356
   LAGUNA F, 1995, CLIN INFECT DIS, V21, P711, DOI 10.1093/clinids/21.3.711
   Lambertucci JR, 2008, REV SOC BRAS MED TRO, V41, P87, DOI 10.1590/S0037-86822008000100018
   Larocca L, 2007, J HEART LUNG TRANSPL, V26, P1347, DOI 10.1016/j.healun.2007.09.005
   Lawn SD, 2006, T ROY SOC TROP MED H, V100, P264, DOI 10.1016/j.trstmh.2005.03.012
   Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127
   Lawn SD, 2003, T ROY SOC TROP MED H, V97, P443, DOI 10.1016/S0035-9203(03)90084-8
   Lawn SD, 2007, CURR OPIN INFECT DIS, V20, P482, DOI 10.1097/QCO.0b013e3282a6463d
   Layegh P, 2011, AM J TROP MED HYG, V84, P539, DOI 10.4269/ajtmh.2011.10-0002
   Leishmaniasis Magill A., 2013, HUNTERS TROPICAL MED, P739
   Lessa H A, 1994, Rev Soc Bras Med Trop, V27, P103, DOI 10.1590/S0037-86821994000200008
   Lessa HA, 2001, AM J TROP MED HYG, V65, P87, DOI 10.4269/ajtmh.2001.65.87
   Lessa HA, 2012, T ROY SOC TROP MED H, V106, P376, DOI 10.1016/j.trstmh.2012.03.007
   Lindoso JAL, 2009, BRIT J DERMATOL, V160, P311, DOI 10.1111/j.1365-2133.2008.08908.x
   Llanos-Cuentas A, 2008, CLIN INFECT DIS, V46, P223, DOI 10.1086/524042
   Llanos-Cuentas A, 2007, AM J TROP MED HYG, V76, P1128, DOI 10.4269/ajtmh.2007.76.1128
   LlanosCuentas A, 1997, CLIN INFECT DIS, V25, P677, DOI 10.1086/513776
   Lohuis PJFM, 1997, J LARYNGOL OTOL, V111, P973, DOI 10.1017/S0022215100139106
   Lopez L, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-58
   Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436
   Lopez-Velez R, 2004, J ANTIMICROB CHEMOTH, V53, P540, DOI 10.1093/jac/dkh084
   Lopez-Velez R, 2003, ANN TROP MED PARASIT, V97, P143, DOI 10.1179/000349803225002615
   MACHADO ES, 1992, MEM I OSWALDO CRUZ, V87, P487, DOI 10.1590/S0074-02761992000400005
   Machado P, 2002, CLIN INFECT DIS, V34, pE69, DOI 10.1086/340526
   Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912
   Machado PRL, 2007, CLIN INFECT DIS, V44, P788, DOI 10.1086/511643
   Machado PR, 2007, CLIN INFECT DIS, V45, P1
   Madeddu G, 2014, PARASITOL INT, V63, P35, DOI 10.1016/j.parint.2013.10.002
   Magill A., 2015, PRINCIPLES PRACTICE, P3091
   Maguire GP, 1998, PATHOLOGY, V30, P73, DOI 10.1080/00313029800169715
   Mahajan R, 2015, CLIN INFECT DIS, V61, P1255, DOI 10.1093/cid/civ530
   Mandal J, 2008, AM J TROP MED HYG, V79, P76, DOI 10.4269/ajtmh.2008.79.76
   Marovich MA, 2001, CLIN INFECT DIS, V33, P1076, DOI 10.1086/322643
   Marques N, 2008, SCAND J INFECT DIS, V40, P523, DOI 10.1080/00365540701787800
   MARSDEN PD, 1990, BRIT MED J, V301, P656, DOI 10.1136/bmj.301.6753.656
   MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9
   Martin-Davila P, 2008, CLIN MICROBIOL REV, V21, P60, DOI 10.1128/CMR.00021-07
   MARU M, 1979, AM J TROP MED HYG, V28, P15, DOI 10.4269/ajtmh.1979.28.15
   Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004
   Mary C, 2006, AM J TROP MED HYG, V75, P858, DOI 10.4269/ajtmh.2006.75.858
   Mattos M, 1998, J EUR ACAD DERMATOL, V10, P218, DOI 10.1016/S0926-9959(98)00012-9
   Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005
   Mejia R, 2012, CURR OPIN INFECT DIS, V25, P458, DOI 10.1097/QCO.0b013e3283551dbd
   Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135
   Meyerhoff A, 1999, CLIN INFECT DIS, V28, P42, DOI 10.1086/515085
   Meymandi SS, 2011, J EUR ACAD DERMATOL, V25, P587, DOI 10.1111/j.1468-3083.2010.03781.x
   Minodier P, 2005, ARCH PEDIATRIE, V12, P1102, DOI 10.1016/j.arcped.2005.01.009
   MIRALLES ES, 1994, DERMATOLOGY, V189, P275, DOI 10.1159/000246860
   Lessa Marcus Miranda, 2007, Rev. Bras. Otorrinolaringol., V73, P843, DOI 10.1016/S1808-8694(15)31181-2
   MISHRA M, 1994, LANCET, V344, P1599, DOI 10.1016/S0140-6736(94)90406-5
   MISHRA M, 1992, LANCET, V340, P1256, DOI 10.1016/0140-6736(92)92952-C
   Mohammadzadeh M, 2013, J INFECT PUBLIC HEAL, V6, P120, DOI 10.1016/j.jiph.2012.11.003
   Molina I, 2007, J ANTIMICROB CHEMOTH, V60, P837, DOI 10.1093/jac/dkm294
   Molinet FJ, 2013, MEM I O CRUZ, V108, P108
   Monge-Maillo B, 2015, CLIN INFECT DIS, V60, P1398, DOI 10.1093/cid/civ004
   Monge-Maillo B, 2013, DRUGS, V73, P1863, DOI 10.1007/s40265-013-0133-0
   Morales P, 2003, TRANSPLANT P, V35, P2001, DOI 10.1016/S0041-1345(03)00664-X
   Morgan DJ, 2007, CLIN INFECT DIS, V45, P478, DOI 10.1086/520017
   Morizot G, 2007, AM J TROP MED HYG, V76, P48
   Morizot G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004304
   Mota Sasaki M, 1997, BRAZ J INFECT DIS, V1, P142
   Mouri O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002841
   Mueller M, 2006, J ANTIMICROB CHEMOTH, V58, P811, DOI 10.1093/jac/dkl342
   Mueller MC, 2009, AM J TROP MED HYG, V81, P52, DOI 10.4269/ajtmh.2009.81.52
   Mueller Y, 2009, TROP MED INT HEALTH, V14, P910, DOI 10.1111/j.1365-3156.2009.02305.x
   Mueller YK, 2014, AM J TROP MED HYG, V90, P33, DOI 10.4269/ajtmh.13-0150
   Mueller YK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001872
   Murray HW, 2012, AM J TROP MED HYG, V86, P434, DOI 10.4269/ajtmh.2012.11-0682
   Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5
   Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   NAVIN TR, 1990, AM J TROP MED HYG, V42, P36, DOI 10.4269/ajtmh.1990.42.36
   NAVIN TR, 1992, J INFECT DIS, V165, P528, DOI 10.1093/infdis/165.3.528
   NAVIN TR, 1990, AM J TROP MED HYG, V42, P43, DOI 10.4269/ajtmh.1990.42.43
   Ndiaye B, 1996, B SOC PATHOL EXOT, V89, P282
   Negera E, 2012, T ROY SOC TROP MED H, V106, P496, DOI 10.1016/j.trstmh.2012.02.006
   NETTO EM, 1990, T ROY SOC TROP MED H, V84, P367, DOI 10.1016/0035-9203(90)90321-5
   Neumayr ALC, 2013, TRAVEL MED INFECT DI, V11, P412, DOI 10.1016/j.tmaid.2013.05.003
   Neumayr ALC, 2012, J TRAVEL MED, V19, P124, DOI 10.1111/j.1708-8305.2011.00572.x
   Neves LO, 2011, AN BRAS DERMATOL, V86, P1092, DOI 10.1590/S0365-05962011000600005
   Niamba P, 2006, ANN DERMATOL VENER, V133, P537, DOI 10.1016/S0151-9638(06)70958-9
   Niamba P, 2007, AUSTRALAS J DERMATOL, V48, P32, DOI 10.1111/j.1440-0960.2007.00323.x
   NUZUM E, 1995, J INFECT DIS, V171, P751, DOI 10.1093/infdis/171.3.751
   NYAKUNDI PM, 1994, E AFR MED J, V71, P453
   Obonaga R, 2014, ANTIMICROB AGENTS CH, V58, P144, DOI 10.1128/AAC.01023-13
   Odiwuor SOC, 2011, EUR J CLIN MICROBIOL, V30, P209, DOI 10.1007/s10096-010-1071-3
   Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007
   Oliveira-Neto Manoel Paes de, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P321
   Oliveira-Neto MP, 1997, AM J TROP MED HYG, V57, P651, DOI 10.4269/ajtmh.1997.57.651
   OliveiraNeto MP, 1997, INT J DERMATOL, V36, P463, DOI 10.1046/j.1365-4362.1997.00188.x
   Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130
   Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6
   Osorio LE, 1998, AM J TROP MED HYG, V59, P49, DOI 10.4269/ajtmh.1998.59.49
   OSTER CN, 1985, AM J TROP MED HYG, V34, P856, DOI 10.4269/ajtmh.1985.34.856
   Ostyn B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100220
   Pagliano P, 2005, J ANTIMICROB CHEMOTH, V55, P229, DOI 10.1093/jac/dkh538
   Palacios R, 2001, AM J TROP MED HYG, V64, P187, DOI 10.4269/ajtmh.2001.64.187
   Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6
   Patel TA, 2009, TROP MED INT HEALTH, V14, P1064, DOI 10.1111/j.1365-3156.2009.02329.x
   Pattabhi S, 2010, PLOS NEGLECT TROP D, P4
   Paul BC, 2012, ANN OTO RHINOL LARYN, V121, P708, DOI 10.1177/000348941212101102
   Paumgartten FJR, 2001, REPROD TOXICOL, V15, P327, DOI 10.1016/S0890-6238(01)00127-7
   Pavli A, 2010, INT J INFECT DIS, V14, pE1032, DOI 10.1016/j.ijid.2010.06.019
   de Albuquerque LCP, 2014, REV SOC BRAS MED TRO, V47, P38, DOI 10.1590/0037-8682-0180-2013
   Pérez Carlos, 2006, Biomédica, V26, P485
   Perez-Ayala A, 2009, J TRAVEL MED, V16, P395, DOI 10.1111/j.1708-8305.2009.00341.x
   PerezMolina JA, 1996, AIDS, V10, P237, DOI 10.1097/00002030-199602000-00023
   PERRIN C, 1995, AM J DERMATOPATH, V17, P145, DOI 10.1097/00000372-199504000-00006
   Pintado V, 2001, MEDICINE, V80, P54, DOI 10.1097/00005792-200101000-00006
   Pittalis S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-177
   Posada-Vergara MP, 2005, J INFECT DIS, V192, P1819, DOI 10.1086/497338
   Prajapati VK, 2012, AM J TROP MED HYG, V87, P655, DOI 10.4269/ajtmh.2012.12-0022
   Puig L, 2003, ANN TROP MED PARASIT, V97, P107, DOI 10.1179/000349803225002589
   Purkait B, 2015, J ANTIMICROB CHEMOTH, V70, P1343, DOI 10.1093/jac/dku534
   Rahman M, 2011, AM J TROP MED HYG, V85, P66, DOI 10.4269/ajtmh.2011.10-0661
   Ramesh V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2424-8
   Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768
   Ranawaka RR, 2011, J DERMATOL TREAT, V22, P241, DOI 10.3109/09546631003762654
   Ranawaka RR, 2010, J DERMATOL TREAT, V21, P286, DOI 10.3109/09546630903287445
   Reithinger R, 2005, EMERG INFECT DIS, V11, P634, DOI 10.3201/eid1104.040945
   Reithinger R, 2005, CLIN INFECT DIS, V40, P1148, DOI 10.1086/428736
   Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8
   Reithinger R, 2007, J CLIN MICROBIOL, V45, P21, DOI 10.1128/JCM.02029-06
   Ribera E, 1996, AM J MED, V100, P496, DOI 10.1016/S0002-9343(97)89503-4
   Richter J, 2011, PARASITOL RES, V109, P959, DOI 10.1007/s00436-011-2356-x
   Rihl Markus, 2006, J Infect, V53, pe25, DOI 10.1016/j.jinf.2005.09.015
   Rijal S, 2003, T ROY SOC TROP MED H, V97, P350, DOI 10.1016/S0035-9203(03)90167-2
   Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102
   Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217
   Ritmeijer K, 2006, AM J TROP MED HYG, V74, P76, DOI 10.4269/ajtmh.2006.74.76
   Ritmeijer K, 2001, T ROY SOC TROP MED H, V95, P668, DOI 10.1016/S0035-9203(01)90110-5
   Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674
   Robinson Ramirez Jose, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS169
   ROCHA RAA, 1980, J TROP MED HYG, V83, P131
   Rocio C, 2014, T ROY SOC TROP MED H, V108, P176, DOI 10.1093/trstmh/tru011
   Roden MM, 2003, CLIN INFECT DIS, V36, P1213, DOI 10.1086/374553
   Rodrigues AM, 2006, REV SOC BRAS MED TRO, V39, P139, DOI 10.1590/S0037-86822006000200001
   RODRIGUEZ LV, 1995, MEM I OSWALDO CRUZ, V90, P525, DOI 10.1590/S0074-02761995000400020
   Rojas R, 2006, J INFECT DIS, V193, P1375, DOI 10.1086/503371
   Romero G A, 1998, Rev Soc Bras Med Trop, V31, P511, DOI 10.1590/S0037-86821998000600001
   Romero HD, 2009, AM J TROP MED HYG, V81, P27
   Rosbotham JL, 1996, CLIN EXP DERMATOL, V21, P288, DOI 10.1111/j.1365-2230.1996.tb00097.x
   Rosenthal E, 2000, CLIN INFECT DIS, V31, P1093, DOI 10.1086/318135
   Russo R, 1996, J INFECTION, V32, P133, DOI 10.1016/S0163-4453(96)91343-2
   Russo R, 2003, ANN TROP MED PARASIT, V97, P99, DOI 10.1179/000349803225002570
   SACKS DL, 1983, AM J TROP MED HYG, V32, P300, DOI 10.4269/ajtmh.1983.32.300
   Sadeghian G, 2007, CLIN EXP DERMATOL, V32, P371, DOI 10.1111/j.1365-2230.2007.02405.x
   Sadeghian G, 2011, Indian J Dermatol, V56, P37, DOI 10.4103/0019-5154.77549
   SAENZ RE, 1991, AM J TROP MED HYG, V44, P394, DOI 10.4269/ajtmh.1991.44.394
   SAENZ RE, 1990, AM J MED, V89, P147, DOI 10.1016/0002-9343(90)90292-L
   Safi N, 2012, MIL MED, V177, P345, DOI 10.7205/MILMED-D-11-00161
   SAHA AK, 1986, MOL BIOCHEM PARASIT, V19, P195, DOI 10.1016/0166-6851(86)90001-0
   Salam MA, 2012, J CLIN MICROBIOL, V50, P837, DOI 10.1128/JCM.05067-11
   Salih NA, 2014, TROP MED INT HEALTH, V19, P146, DOI 10.1111/tmi.12238
   Salmanpour R, 2006, INT J DERMATOL, V45, P1115, DOI 10.1111/j.1365-4632.2006.02822.x
   Sampaio R N, 1997, Rev Soc Bras Med Trop, V30, P125, DOI 10.1590/S0037-86821997000200007
   Sampaio Raimunda Nonata Ribeiro, 2002, Rev. Soc. Bras. Med. Trop., V35, P651, DOI 10.1590/S0037-86822002000600017
   SAMPAIO S A P, 1971, International Journal of Dermatology, V10, P179, DOI 10.1111/j.1365-4362.1971.tb01694.x
   SANCHEZ JL, 1992, AM J TROP MED HYG, V47, P47, DOI 10.4269/ajtmh.1992.47.47
   SARAVIA NG, 1990, LANCET, V336, P398, DOI 10.1016/0140-6736(90)91945-7
   Sarazin E, 2005, Bull Soc Pathol Exot, V98, P187
   Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013
   Schraner C, 2005, CLIN INFECT DIS, V40, pE120, DOI 10.1086/430444
   Schubach A, 1998, AM J TROP MED HYG, V58, P824, DOI 10.4269/ajtmh.1998.58.824
   Schwartz BS, 2013, AM J TRANSPLANT, V13, P280, DOI 10.1111/ajt.12120
   Schwartz E, 2006, LANCET INFECT DIS, V6, P342, DOI 10.1016/S1473-3099(06)70492-3
   Scope A, 2003, CLIN INFECT DIS, V37, pE83, DOI 10.1086/377045
   Seaman J, 1996, ANN INTERN MED, V124, P664, DOI 10.7326/0003-4819-124-7-199604010-00007
   SEAMAN J, 1995, CLIN INFECT DIS, V21, P188, DOI 10.1093/clinids/21.1.188
   Shafran DM, 2014, CAN MED ASSOC J, V186, P1239, DOI 10.1503/cmaj.131430
   Shani-Adir A, 2005, J AM ACAD DERMATOL, V53, P810, DOI 10.1016/j.jaad.2005.07.026
   Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739
   Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001
   Simon I, 2011, TRANSPL INFECT DIS, V13, P397, DOI 10.1111/j.1399-3062.2011.00598.x
   Sindermann H, 2006, T ROY SOC TROP MED H, V100, pS17, DOI 10.1016/j.trstmh.2006.02.010
   Sindermann H, 2004, CLIN INFECT DIS, V39, P1520, DOI 10.1086/425359
   SINGER C, 1975, AM J MED, V59, P444, DOI 10.1016/0002-9343(75)90405-2
   Singh Utpal Kant, 2006, Indian Journal of Pediatrics, V73, P1077, DOI 10.1007/BF02763048
   Singh UK, 2010, J TROP PEDIATRICS, V56, P321, DOI 10.1093/tropej/fmp132
   Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521
   Sinha S, 2008, INT J DERMATOL, V47, P1263, DOI 10.1111/j.1365-4632.2008.03804.x
   Solomon M, 2011, J EUR ACAD DERMATOL, V25, P973, DOI 10.1111/j.1468-3083.2010.03908.x
   Solomon M, 2014, J AM ACAD DERMATOL, V71, P271, DOI 10.1016/j.jaad.2013.12.047
   Solomon M, 2013, J AM ACAD DERMATOL, V68, P284, DOI 10.1016/j.jaad.2012.06.014
   Sosa N, 2013, AM J TROP MED HYG, V89, P557, DOI 10.4269/ajtmh.12-0736
   Soto J, 2007, CLIN INFECT DIS, V44, P350, DOI 10.1086/510588
   Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321
   SOTO J, 1994, AM J TROP MED HYG, V50, P107, DOI 10.4269/ajtmh.1994.50.107
   Soto J, 2013, CLIN INFECT DIS, V56, P1255, DOI 10.1093/cid/cit049
   Soto J, 2009, AM J TROP MED HYG, V81, P387, DOI 10.4269/ajtmh.2009.81.387
   Soto JM, 2002, AM J TROP MED HYG, V66, P147, DOI 10.4269/ajtmh.2002.66.147
   SOTOMANCIPE J, 1993, CLIN INFECT DIS, V16, P417, DOI 10.1093/clind/16.3.417
   Sousa AQ, 2011, CLIN INFECT DIS, V53, P693, DOI 10.1093/cid/cir496
   Lima MIS, 2010, ARCH TOXICOL, V84, P227, DOI 10.1007/s00204-009-0485-0
   Stark D, 2006, J CLIN MICROBIOL, V44, P1178, DOI 10.1128/JCM.44.3.1178-1180.2006
   Sundar S, 2006, CLIN INFECT DIS, V42, P608, DOI 10.1086/500138
   Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0
   Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002
   Sundar S, 2004, CLIN INFECT DIS, V38, P377, DOI 10.1086/380971
   Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434
   Sundar S, 2002, CLIN INFECT DIS, V35, P581, DOI 10.1086/342057
   Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556
   Sundar S, 1996, LANCET, V348, P614, DOI 10.1016/S0140-6736(05)64828-3
   Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419
   Sundar S, 1997, ANN INTERN MED, V127, P133, DOI 10.7326/0003-4819-127-2-199707150-00007
   Sundar S, 1999, J Assoc Physicians India, V47, P186
   Sundar S, 1998, ANN TROP MED PARASIT, V92, P755, DOI 10.1080/00034989858998
   Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121
   Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972
   Sundar S, 2007, CLIN INFECT DIS, V45, P556, DOI 10.1086/520665
   Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536
   Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474
   Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627
   Syriopoulou V, 2003, CLIN INFECT DIS, V36, P560, DOI 10.1086/367843
   Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023
   Tadesse Abilo, 2009, Ethiop Med J, V47, P77
   Tavares CAP, 2003, EXPERT REV MOL DIAGN, V3, P657, DOI 10.1586/14737159.3.5.657
   ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899
   ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929
   Thakur C. P., 1993, National Medical Journal of India, V6, P263
   THAKUR CP, 1994, B WORLD HEALTH ORGAN, V72, P931
   Thakur CP, 2004, ANN TROP MED PARASIT, V98, P129, DOI 10.1179/000349804225003154
   Thakur CP, 1997, T ROY SOC TROP MED H, V91, P668, DOI 10.1016/S0035-9203(97)90516-2
   THAKUR CP, 1991, AM J TROP MED HYG, V45, P435, DOI 10.4269/ajtmh.1991.45.435
   Thomaidou E, 2015, AM J TROP MED HYG, V93, P770, DOI 10.4269/ajtmh.14-0787
   Topno RK, 2008, ANN TROP MED PARASIT, V102, P267, DOI 10.1179/136485908X278766
   Torres DC, 2013, ACTA TROP, V126, P132, DOI 10.1016/j.actatropica.2013.02.002
   Torrico F, 2009, AM J TROP MED HYG, V81, P555, DOI 10.4269/ajtmh.2009.09-0268
   Tortajada C, 2002, J ACQ IMMUN DEF SYND, V30, P364, DOI 10.1097/00126334-200207010-00015
   Troya J, 2008, SCAND J INFECT DIS, V40, P78, DOI 10.1080/00365540701466215
   Tuon FF, 2008, CLIN IMMUNOL, V128, P442, DOI 10.1016/j.clim.2008.05.007
   Tuon FF, 2007, INT J DERMATOL, V46, P628, DOI 10.1111/j.1365-4632.2006.03096.x
   Turetz ML, 2002, J INFECT DIS, V186, P1829, DOI 10.1086/345772
   Unger A, 2009, AM J TROP MED HYG, V80, P574, DOI 10.4269/ajtmh.2009.80.574
   Utaile M, 2013, EXP PARASITOL, V134, P68, DOI 10.1016/j.exppara.2013.01.022
   Uzun S, 1999, BRIT J DERMATOL, V140, P347, DOI 10.1046/j.1365-2133.1999.02673.x
   Vaish M, 2011, J CLIN MICROBIOL, V49, P2003, DOI 10.1128/JCM.00130-11
   Valencia C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001656
   Valesky Eva Maria, 2007, J Dtsch Dermatol Ges, V5, P770, DOI 10.1111/j.1610-0387.2007.06377.x
   Vallur AC, 2016, J CLIN MICROBIOL, V54, P1025, DOI 10.1128/JCM.02620-15
   van der Auwera G, 2015, CLIN MICROBIOL REV, V28, P265, DOI 10.1128/CMR.00104-14
   van der Meide WF, 2009, INT J DERMATOL, V48, P52, DOI 10.1111/j.1365-4632.2009.03883.x
   van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556
   van Griensven J, 2013, LANCET INFECT DIS, V13, P251, DOI 10.1016/S1473-3099(12)70348-1
   van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005
   van Thiel PPAM, 2010, CLIN INFECT DIS, V50, P80, DOI 10.1086/648726
   VELASCO O, 1989, AM J TROP MED HYG, V41, P280, DOI 10.4269/ajtmh.1989.41.280
   Velez I, 1997, ANN INTERN MED, V126, P232, DOI 10.7326/0003-4819-126-3-199702010-00010
   VELEZ I, 1994, T ROY SOC TROP MED H, V88, P199, DOI 10.1016/0035-9203(94)90294-1
   Veroux M, 2010, TRANSPL INFECT DIS, V12, P387, DOI 10.1111/j.1399-3062.2010.00520.x
   Villanueva JL, 2000, EUR J CLIN MICROBIOL, V19, P798, DOI 10.1007/s100960000364
   Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3
   WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489
   Weina PJ, 2004, CLIN INFECT DIS, V39, P1674, DOI 10.1086/425747
   Welch RJ, 2008, CLIN VACCINE IMMUNOL, V15, P1483, DOI 10.1128/CVI.00174-08
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   WHO, 2010, WHO TECH REP SER, V949, P1
   Wise ES, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001688
   World Health Organization, 2011, WHO DIAGN EV SER, V4
   World Health Organization, 2011, POST KAL DERM LEISHM
   Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583
   Wortmann G, 2007, AM J TROP MED HYG, V76, P906, DOI 10.4269/ajtmh.2007.76.906
   Wortmann G, 2010, AM J TROP MED HYG, V83, P1028, DOI 10.4269/ajtmh.2010.10-0171
   Wortmann GW, 2000, CLIN INFECT DIS, V31, P199, DOI 10.1086/313924
   Zanger P, 2012, CLIN MICROBIOL INFEC, V18, P670, DOI 10.1111/j.1469-0691.2011.03674.x
   Zerpa O, 2007, BRIT J DERMATOL, V156, P1328, DOI 10.1111/j.1365-2133.2007.07872.x
   Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6
   Zijlstra E E, 1992, Trop Geogr Med, V44, P288
NR 502
TC 79
Z9 82
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2016
VL 63
IS 12
BP E202
EP E264
DI 10.1093/cid/ciw670
PG 63
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WW
UT WOS:000392716100001
PM 27941151
OA Bronze
DA 2020-11-26
ER

PT J
AU Lima, JG
   Lima, NN
   Nobrega, LHC
   Jeronimo, SMB
AF Lima, Josivan Gomes
   Lima, Natalia Nobrega
   Nobrega, Lucia Helena C.
   Jeronimo, Selma Maria B.
TI Conversations between insulin and bone: Potential mechanism of high bone
   density in patients with Berardinelli-Seip Congenital Lipodystrophy
SO MEDICAL HYPOTHESES
LA English
DT Article
DE Lipodystrophy; Leptin; Insulin; Bone mass; Density
ID GENERALIZED LIPODYSTROPHY; LEPTIN DEFICIENCY; MINERAL DENSITY;
   METABOLISM; DIFFERENTIATION; OSTEOBLASTS; RESISTANCE; CELLS; WOMEN; MASS
AB Berardinelli-Seip Congenital Lipodystrophy (BSCL) is a rare autosomal recessive syndrome characterized by a difficulty storing lipid in adipocytes, low body fat, hypertriglyceridemia, and fat liver. The serum leptin is usually very low, and serum insulin, as well as HOMA(IR) (homeostasis model assessment), is very high and correlated positively with bone mineral density (BMD). Despite deficiency/insufficiency of vitamin D, low body mass index, low daily calcium intake, physical inactivity, and menarche at a later age, BSCL patients usually have normal or even high BMD. We hypothesize that low leptin and high insulin may play a role in this outcome. Understanding the potential pathophysiological mechanism of these bone abnormalities will help to clarify the effects of extreme insulin resistance in the bone. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Lima, Josivan Gomes; Lima, Natalia Nobrega; Nobrega, Lucia Helena C.] HUOL, Dept Med Clin, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] Inst Med Trop Rio Grande do Norte, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] INCT DT, Inst Sci & Technol Trop Dis, Rio De Janeiro, Brazil.
RP Lima, JG (corresponding author), Rua Joaquim Fabricio 233, BR-59012340 Natal, RN, Brazil.
EM josivanlima@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Bandeira Francisco F, 2007, Endocr Pract, V13, P764
   BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11
   Chen XX, 2015, J BONE MINER METAB, V33, P474, DOI 10.1007/s00774-014-0569-7
   Christensen JD, 2014, J CLIN ENDOCR METAB, V99, pE1493, DOI 10.1210/jc.2014-1353
   Cirmanova V, 2008, PHYSIOL RES, V57, pS143
   Cornish J, 2002, J ENDOCRINOL, V175, P405, DOI 10.1677/joe.0.1750405
   Daniele G, 2015, DIABETES CARE, V38, P1509, DOI 10.2337/dc14-2989
   Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5
   Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101
   Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003
   Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186
   Garg A, 1999, J CLIN ENDOCR METAB, V84, P3390, DOI 10.1210/jcem.84.9.6103
   Gregson CL, 2013, RHEUMATOLOGY, V52, P968, DOI 10.1093/rheumatology/ket007
   Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P3864, DOI 10.1210/jc.81.11.3864
   Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020
   Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660
   Jurimae J, 2015, OSTEOPOROS INT
   Kavanagh K, 2013, OBESITY, V21, P1031, DOI 10.1002/oby.20077
   Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328
   Lima JG, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0140-x
   Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168
   Rajab A, 2003, AM J MED GENET A, V121A, P271, DOI 10.1002/ajmg.a.20245
   Reid IR, 2004, BONE, V34, P369, DOI 10.1016/j.bone.2003.11.007
   Rui XF, 2014, MED SCI MONITOR, V20, P711, DOI 10.12659/MSM.890130
   Savopoulos C, 2011, HIPPOKRATIA, V15, P18
   SEIP M, 1959, Acta Paediatr, V48, P555
   Sellmeyer DE, 2016, DIABETES, V65, P1757, DOI 10.2337/db16-0063
   Shinya Takayoshi, 2007, Radiat Med, V25, P484, DOI 10.1007/s11604-007-0166-y
   Sienkiewicz E, 2011, METABOLISM, V60, P1211, DOI 10.1016/j.metabol.2011.05.016
   Starup-Linde J, 2015, EUR J ENDOCRINOL, V173, pR93, DOI 10.1530/EJE-15-0155
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tarantino U, 2015, J BONE JOINT SURG AM, V97A, P429, DOI 10.2106/JBJS.N.00648
   Thomas DM, 1998, BONE, V23, P181, DOI 10.1016/S8756-3282(98)00095-7
   Wang C, 2016, MED SCI MONITOR, V22, P226, DOI 10.12659/MSM.897044
   Yavropoulou Maria P, 2014, Hormones (Athens), V13, P323, DOI 10.14310/horm.2002.1552
NR 41
TC 3
Z9 3
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD DEC
PY 2016
VL 97
BP 94
EP 97
DI 10.1016/j.mehy.2016.10.025
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA ED9CD
UT WOS:000389166900020
PM 27876139
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Ferreira, LC
   Freire-Neto, FP
   Jeronimo, SMB
AF Dourado Junior, Mario Emilio
   Ferreira, Leonardo Capistrano
   Freire-Neto, Francisco Paulo
   Jeronimo, Selma M. B.
TI No association between FCGR2A and FCGR3A polymorphisms in Guillain-Barre
   Syndrome in a Brazilian population
SO JOURNAL OF NEUROIMMUNOLOGY
LA English
DT Article
DE Guillain-Barre Syndrome; FCGR; Polymorphism; Genetics
ID FC-RECEPTOR POLYMORPHISMS; ZIKA VIRUS OUTBREAK; CAMPYLOBACTER-JEJUNI;
   ANTIGANGLIOSIDE ANTIBODIES; INFECTION; IIA; SUSCEPTIBILITY;
   POLYNEUROPATHY; IMMUNOGLOBULIN; SEVERITY
AB The pathogenesis of Guillain-Barre Syndrome (GBS) is not entirely understood, but includes infection-induced aberrant immune responses. Genetic polymorphisms in Fc gamma receptor genes (FCGR) have been associated with GBS. We assessed whether polymorphisms rs1801274 in FCGR2A and rs396991 in FCGR3A were associated with GBS in a Brazilian population. We genotyped 141 GBS cases and 364 healthy controls from Brazil for both polymorphisms. The FCGR genotypes and alleles frequencies did not differ significantly between GBS and controls. In addition, there was no genetic association with either severity or clinical outcomes. We conclude that these FCGR polymorphisms are not associated with susceptibility to Guillain-Barre Syndrome in this Brazilian population. (C) 2016 Published by Elsevier B.V.
C1 [Dourado Junior, Mario Emilio] Univ Fed Rio Grande do Norte, Dept Integrat Med, Natal, RN, Brazil.
   [Dourado Junior, Mario Emilio; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Postgrad Program, Natal, RN, Brazil.
   [Ferreira, Leonardo Capistrano; Freire-Neto, Francisco Paulo; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Dept Biochem, Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Ferreira, Leonardo Capistrano/D-7097-2019
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ferreira, Leonardo
   Capistrano/0000-0001-9268-4881
FU Brazilian Research Council (CNPq)National Council for Scientific and
   Technological Development (CNPq) [482017/2009-0]
FX We thank John Donelson, PhD (University of Iowa, Iowa City, IA, USA) and
   Cleni M Marzocchi-Machado, PhD (FCFRP-USP, Ribeirao Preto, Brazil) for
   their helpful revision of this manuscript. This study was supported by a
   grant 482017/2009-0 from the Brazilian Research Council (CNPq).
CR Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Vigato-Ferreira ICC, 2014, AUTOIMMUNITY, V47, P451, DOI 10.3109/08916934.2014.921809
   Dalakas MC, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.6_Suppl_5.S2
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Dourado ME, 2003, ACTA NEUROL SCAND, V108, P102, DOI 10.1034/j.1600-0404.2003.00103.x
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254
   Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32
   GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Kuwano ST, 2000, TRANSFUSION, V40, P1388, DOI 10.1046/j.1537-2995.2000.40111388.x
   McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610
   Moriya H, 2014, BIOMED REP, V2, P265, DOI 10.3892/br.2013.210
   Nachamkin I, 2008, J INFECT DIS, V198, P226, DOI 10.1086/589624
   Odaka M, 2001, J NEUROL NEUROSUR PS, V70, P50, DOI 10.1136/jnnp.70.1.50
   Rodrigues F.N., 2016, PLOS CURR, V8
   SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994
   SALMON JE, 1990, J CLIN INVEST, V85, P1287, DOI 10.1172/JCI114566
   Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Siqueira JF, 2011, J ENDODONT, V37, P1345, DOI 10.1016/j.joen.2011.06.025
   Siqueira JF, 2009, J ENDODONT, V35, P1186, DOI 10.1016/j.joen.2009.05.006
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856
   van der Pol WL, 2000, NEUROLOGY, V54, P1661, DOI 10.1212/WNL.54.8.1661
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Sorge NM, 2005, J NEUROIMMUNOL, V162, P157, DOI 10.1016/j.jneuroim.2005.01.016
   van Sorge NM, 2003, ANN NEUROL, V53, P570, DOI 10.1002/ana.10503
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Vedeler CA, 2000, NEUROLOGY, V55, P705, DOI 10.1212/WNL.55.5.705
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zhang G., 2014, PLOS ONE, V11
NR 40
TC 4
Z9 4
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-5728
EI 1872-8421
J9 J NEUROIMMUNOL
JI J. Neuroimmunol.
PD SEP 15
PY 2016
VL 298
BP 160
EP 164
DI 10.1016/j.jneuroim.2016.07.020
PG 5
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA DW8WQ
UT WOS:000383936600023
PM 27609290
DA 2020-11-26
ER

PT J
AU Amorim, FM
   Nobre, ML
   Ferreira, LC
   Nascimento, LS
   Miranda, AM
   Monteiro, GRG
   Dupnik, KM
   Duthie, MS
   Reed, SG
   Jeronimo, SMB
AF Amorim, Francianne M.
   Nobre, Mauricio L.
   Ferreira, Leonardo C.
   Nascimento, Larissa S.
   Miranda, Alesson M.
   Monteiro, Gloria R. G.
   Dupnik, Kathryn M.
   Duthie, Malcolm S.
   Reed, Steven G.
   Jeronimo, Selma M. B.
TI Identifying Leprosy and Those at Risk of Developing Leprosy by Detection
   of Antibodies against LID-1 and LID-NDO
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID HANSENS-DISEASE LEPROSY; MYCOBACTERIUM-LEPRAE; TREATMENT EFFICACY;
   INFECTION; ANTIGENS; CLASSIFICATION; SURVEILLANCE; POPULATION;
   CHALLENGES; HOUSEHOLD
AB Leprosy is caused by Mycobacterium leprae infection and remains a major public health problem in many areas of the world. Challenges to its timely diagnosis result in delay in treatment, which is usually associated with severe disability. Although phenolic glycolipid (PGL)-I has been reported as auxiliary diagnostic tool, currently there is no serological assay routinely used in leprosy diagnosis. The aim of this study was to evaluate the effectiveness of two related reagents, LID-1 and LID-NDO, for the detection of M. leprae infection. Sera from 98 leprosy patients, 365 household contacts (HHC) and 98 endemic controls from Rio Grande do Norte, Brazil, were evaluated. A subgroup of the HHC living in a hyperendemic area was followed for 7-10 years. Antigen-specific antibody responses were highest in multibacillary (MB) at the lepromatous pole (LL/BL) and lowest in paucibacillary (PB) at the tuberculoid pole (TT/BT). A positive correlation for both anti-LID-1 and anti-LID-NDO antibodies was found with bacterial burden (LID-1, r = 0.84, p<0.001; LID-NDO, r = 0.82, p<0.001), with higher sensitivity than bacilloscopy. According to Receiver Operating Curve, LID-1 and LID-NDO performed similarly. The sensitivity for MB cases was 89% for LID-1 and 95% for LID-NDO; the specificity was 96% for LID-1 and 88% for LID-NDO. Of the 332 HHC that were followed, 12 (3.6%) were diagnosed with leprosy in a median time of 31 (3-79) months after recruitment. A linear generalized model using LID-1 or LID-NDO as a predictor estimated that 8.3% and 10.4% of the HHC would become a leprosy case, respectively. Together, our findings support a role for the LID-1 and LID-NDO antigens in diagnosing MB leprosy and identifying people at greater risk of developing clinical disease. These assays have the potential to improve the diagnostic capacity at local health centers and aid development of strategies for the eventual control and elimination of leprosy from endemic areas.
C1 [Amorim, Francianne M.; Nobre, Mauricio L.; Ferreira, Leonardo C.; Nascimento, Larissa S.; Miranda, Alesson M.; Monteiro, Gloria R. G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, Natal, RN, Brazil.
   [Amorim, Francianne M.; Nobre, Mauricio L.; Ferreira, Leonardo C.; Nascimento, Larissa S.; Miranda, Alesson M.; Monteiro, Gloria R. G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Nobre, Mauricio L.] Fiocruz MS, Inst Oswaldo Cruz, Postgrad Program Trop Med, Rio De Janeiro, Brazil.
   [Nobre, Mauricio L.] Hosp Giselda Trigueiro, Rio Grande Norte Hlth Secretariat, Natal, RN, Brazil.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA.
   [Duthie, Malcolm S.; Reed, Steven G.] Infect Dis Res Inst, Seattle, WA USA.
   [Jeronimo, Selma M. B.] INCT DT, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), INCT DT, Salvador, BA, Brazil.
EM smbj@cb.ufrn.br
RI Ferreira, Leonardo Capistrano/D-7097-2019; Jeronimo,
   Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Ferreira, Leonardo Capistrano/0000-0001-9268-4881; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Nobre, Mauricio/0000-0003-4932-3137; Duthie, Malcolm/0000-0002-8515-5516
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto
   Nacional de Ciencia e Tecnologia de Doencas Tropicais); Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [401545/ 2013-6];
   Fundacao de Amparo a Pesquisa do Rio Grande do Norte (FAPERN)
FX This work was supported by a grant from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia
   e Tecnologia de Doencas Tropicais and 401545/ 2013-6). FMA received a
   fellowship from Fundacao de Amparo a Pesquisa do Rio Grande do Norte
   (FAPERN). The funders had no role in the study design, data collection
   and analysis, decision to publish or preparation of the manuscript.
CR Bakker MI, 2006, LEPROSY REV, V77, P48
   BRENNAN PJ, 1980, INT J LEPROSY, V48, P382
   Buhrer-Sekula S, 2008, REV SOC BRAS MED TRO, V41, P81, DOI 10.1590/S0037-86822008000700017
   de Moura RS, 2008, REV SOC BRAS MED TRO, V41, P11, DOI 10.1590/S0037-86822008000700004
   de Oliveira DT, 2012, GEOSPATIAL HEALTH, V6, pS125
   Deps PD, 2006, LEPROSY REV, V77, P34
   Duthie MS, 2011, EUR J CLIN MICROBIOL, V30, P1257, DOI 10.1007/s10096-011-1221-2
   Duthie MS, 2007, CLIN VACCINE IMMUNOL, V14, P1400, DOI 10.1128/CVI.00299-07
   Duthie MS, 2014, J CLIN MICROBIOL, V52, P613, DOI 10.1128/JCM.02085-13
   Duthie MS, 2014, DIAGN MICROBIOL INFE
   Fine PEM, 1997, AM J EPIDEMIOL, V146, P91, DOI 10.1093/oxfordjournals.aje.a009195
   Geluk A, 2005, INFECT IMMUN, V73, P5636, DOI 10.1128/IAI.73.9.5636-5644.2005
   Goulart IMB, 2008, CLIN VACCINE IMMUNOL, V15, P101, DOI 10.1128/CVI.00372-07
   HUNTER SW, 1982, J BIOL CHEM, V257, P5072
   HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981
   Kamath S, 2014, J AM ACAD DERMATOL, V71, P795, DOI 10.1016/j.jaad.2014.03.034
   Cavalcanti AAL, 2012, REV SOC BRAS MED TRO, V45, P616, DOI 10.1590/S0037-86822012000500014
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Moet FJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000198
   Moura MLN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002093
   Nobre ML, 2015, LEPROSY REV, V86, P335
   Norman G, 2004, INT J LEPROSY, V72, P278, DOI 10.1489/0020-7349(2004)72&lt;278:VOTWOC&gt;2.0.CO;2
   Fabri ADOC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0962-4
   Pan QH, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/352689
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Rada E, 2012, MEM I OSWALDO CRUZ, V107, P90, DOI 10.1590/S0074-02762012000900015
   Reed NK, 1997, INT J LEPROSY, V65, P328
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Rodrigues IA, 2016, INT J INFECT DIS, V45, P118, DOI 10.1016/j.ijid.2016.02.018
   Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8
   Sampaio LH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-26
   Saunderson P, 2000, LEPROSY REV, V71, P309
   Scollard DM, 2015, AM J TROP MED HYG, V92, P108, DOI 10.4269/ajtmh.13-0221
   Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006
   Shen JP, 2009, LEPROSY REV, V80, P164
   Spencer JS, 2012, MEM I OSWALDO CRUZ, V107, P79, DOI 10.1590/S0074-02762012000900014
   Cardoso LPV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-497
   Wang HS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-279
NR 38
TC 20
Z9 20
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD SEP
PY 2016
VL 10
IS 9
AR e0004934
DI 10.1371/journal.pntd.0004934
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA DZ1UZ
UT WOS:000385627900017
PM 27658042
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Weirather, JL
   Duggal, P
   Nascimento, EL
   Monteiro, GR
   Martins, DR
   Lacerda, HG
   Fakiola, M
   Blackwell, JM
   Jeronimo, SMB
   Wilson, ME
AF Weirather, Jason L.
   Duggal, Priya
   Nascimento, Eliana L.
   Monteiro, Gloria R.
   Martins, Daniella R.
   Lacerda, Henio G.
   Fakiola, Michaela
   Blackwell, Jenefer M.
   Jeronimo, Selma M. B.
   Wilson, Mary E.
TI Fine mapping under linkage peaks for symptomatic or asymptomatic
   outcomes of Leishmania infantum infection in Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Visceral leishmaniasis; Fine mapping; Linkage regions; Tropical disease;
   Genetic risk factors
ID VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; NORTHEASTERN BRAZIL;
   CHAGASI INFECTION; TGF-BETA; SUSCEPTIBILITY; GENOME; GENES; SCAN;
   VISUALIZATION
AB Infection with the protozoan Leishmania infantum can lead to asymptomatic infection and protective immunity, or to the progressive and potentially fatal disease visceral leishmaniasis (VL). Published studies show host genetic background determines in part whether infected individuals will develop a symptomatic or asymptomatic outcome. The purpose of the current study was to fine map chromosome regions previously linked with risk for symptomatic (chromosome 9) or asymptomatic (chromosomes 15 and 19) manifestations of L. infantum infection. We conducted a family-based genetic study of VL and asymptomatic infection (detected by a DTH skin test) with a final post quality control sample of 961 individuals with full genotype and phenotype information from highly endemic neighborhoods of northeast Brazil. A total of 5485 SNPs under the linkage peaks on chromosomes 9, 15 and 19 were genotyped. No strong SNP associations were observed for the DTH phenotype. The most significant associations with the VL phenotype were with SNP rs1470217 (p= 5.9e-05; p(corrected) = 0.057) on chromosome 9, and with SNP rs8107014 (p= 1.4e-05; p(corrected) = 0.013) on chromosome 19. SNP rs1470217 is situated in a 180 kb intergenic region between TMEM215 (Transmembrane protein 215) and APTX (Aprataxin). SNP rs8107014 lies in the intron between exons 26 and 27 of a 34 exon transcript (ENST00000204005) of LTBP4, (Latent transforming growth factor-beta-binding protein 4a). The latter supports growing evidence that the transforming growth factor-beta pathway is important in the immunopathogenesis of VL. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Weirather, Jason L.; Wilson, Mary E.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA USA.
   [Duggal, Priya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Nascimento, Eliana L.; Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   [Nascimento, Eliana L.; Monteiro, Gloria R.; Martins, Daniella R.; Lacerda, Henio G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, Natal, RN, Brazil.
   [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis, Natal, RN, Brazil.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA USA.
   [Wilson, Mary E.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA.
   [Fakiola, Michaela] Inst Mol Genet, Milan, Italy.
RP Wilson, ME (corresponding author), Univ Iowa, Internal Med Microbiol, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM jason-weirather@uiowa.edu; pduggal@jhsph.edu; eltomaz@gmail.com;
   gloriag74@hotmail.com; daniellamartins@cb.ufrn.br;
   heniolacerda@ufrnet.br; mf300@cam.ac.uk;
   jenefer.blackwell@telethonkids.org.au; smbj@cb.ufrn.br;
   mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275; Weirather,
   Jason/0000-0003-0556-0616; Fakiola, Michaela/0000-0001-9071-4709
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI076233, AI045540, AI067874, T32
   GM008629, T32 GM082729]; Tropical Medicine Research Center [P50
   AI-30639]; Department of Veterans' AffairsUS Department of Veterans
   Affairs [1i01BX001983, 5I01BX000536]; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, R01AI067874, P50AI030639, R01AI048822, R01AI045540,
   R01AI067874, P50AI030639, P50AI030639, R01AI067874, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI067874, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, R01AI045540, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI067874,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM082729, T32GM008629,
   T32GM008629, T32GM082729, T32GM008629, T32GM082729, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM082729, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM082729,
   T32GM008629, T32GM008629, T32GM008629] Funding Source: NIH RePORTER;
   Veterans AffairsUS Department of Veterans Affairs [I01BX000536,
   I01BX001983, I01BX000536, I01BX001983, I01BX000536, I01BX000536,
   I01BX001983, I01BX001983, I01BX000536, I01BX000536, I01BX000536,
   I01BX001983, I01BX000536, I01BX000536, I01BX001983] Funding Source: NIH
   RePORTER
FX This work was supported by NIH grant R01 AI076233 (JMB and MEW),
   AI045540 (MEW) and AI067874 (MEW, JMB). Data were collected under the
   Tropical Medicine Research Center grant P50 AI-30639 (SMBJ, MEW, JMB).
   Partial support was received from Merit Review grants from the
   Department of Veterans' Affairs (1i01BX001983 and 5I01BX000536; MEW).
   The work was performed in part during the tenure of J.L.W. on NIH
   training grants T32 GM008629 and T32 GM082729. The authors are grateful
   to Anne Kwitek, Ph.D. and to Jeffrey Murray, M.D. for their helpful
   advice and discussions regarding genetic data analysis.
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x
   Blackwell JM, 2010, IMMUNOLOGY INFECT DI, P483
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   Castellucci L, 2011, GENES IMMUN, V12, P589, DOI 10.1038/gene.2011.37
   Castellucci L, 2012, INFECT GENET EVOL, V12, P1102, DOI 10.1016/j.meegid.2012.03.017
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277
   Luck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025376
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   Oklo R., 2000, BIOCHEM J, V352, P601
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419
   Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864
   Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529
   Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693
NR 27
TC 3
Z9 3
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD SEP
PY 2016
VL 43
BP 1
EP 5
DI 10.1016/j.meegid.2016.05.005
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA DR1YP
UT WOS:000379701100001
PM 27155051
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Jeronimo, SMB
   Pearson, RD
AF Bezerra Jeronimo, Selma Maria
   Pearson, Richard D.
TI The challenges on developing vaccine against visceral leishmaniasis
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
ID INFECTION; DISEASE
C1 [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] INCT DT, Inst Nacl Ciencias & Tecnol Doencas Tropicais, Salvador, BA, Brazil.
   [Pearson, Richard D.] Univ Virginia, Dept Internal Med, Charlottesville, VA USA.
   [Pearson, Richard D.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Natal, RN, Brazil.; Jeronimo, SMB (corresponding author), INCT DT, Inst Nacl Ciencias & Tecnol Doencas Tropicais, Salvador, BA, Brazil.
EM selma.b.jeronimo@gmail.com
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR ALVAR J, 1989, J INFECT DIS, V160, P560, DOI 10.1093/infdis/160.3.560
   BADARO R, 1986, LANCET, V1, P647
   Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x
   Duarte MC, 2016, MOL IMMUNOL, V76, P70, DOI 10.1016/j.molimm.2016.06.014
   Duarte MC, 2016, REV SOC BRAS MED TRO, V49, P398, DOI 10.1590/0037-8682-0120-2016
   Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Reed SG, 2016, EXPERT REV VACCINES, V15, P81, DOI 10.1586/14760584.2016.1105135
   Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 10
TC 4
Z9 6
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2016
VL 49
IS 4
BP 395
EP 397
DI 10.1590/0037-8682-0343-2016
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DU8IT
UT WOS:000382457200001
PM 27598623
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Schaut, RG
   Lamb, IM
   Toepp, AJ
   Scott, B
   Mendes-Aguiar, CO
   Coutinho, JFV
   Jeronimo, SMB
   Wilson, ME
   Harty, JT
   Waldschmidt, TJ
   Petersen, CA
AF Schaut, Robert G.
   Lamb, Ian M.
   Toepp, Angela J.
   Scott, Benjamin
   Mendes-Aguiar, Carolina O.
   Coutinho, Jose F. V.
   Jeronimo, Selma M. B.
   Wilson, Mary E.
   Harty, John T.
   Waldschmidt, Thomas J.
   Petersen, Christine A.
TI Regulatory IgD(hi) B Cells Suppress T Cell Function via IL-10 and PD-L1
   during Progressive Visceral Leishmaniasis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID EXHAUSTION; INFECTION; INTERLEUKIN-10; EXPRESSION; RESPONSES; BINDING
AB During visceral leishmaniasis (VL), Th1-based inflammation is induced to control intracellular parasites. Inflammation-based pathology was shown to be dampened by IL-10 and eventual programmed death 1-mediated T cell exhaustion. Cell type(s) responsible for the initiation of T cell-produced IL-10 during VL are unknown. CD19(+), CD5(-), CD1d(-), IgD(hi) regulatory B cells from healthy controls produced IL-10 in the absence of infection or stimulation, in contrast to IgD(lo/neg) B cells. IgD(hi) B cells may have a de novo versus induced regulatory program. The population of IgD(hi) B cells increased 3-fold as VL progressed. B cells from VL dogs were necessary and sufficient to suppress Th1 cell effector function. IgD(hi) B cells induced IL-10 production by T cells and IgD(lo) B cells. Blockage of B cell-specific PD-L1 restored Th1 responses. IgD(hi) regulatory B cells represent a novel regulatory B cell that may precipitate T cell exhaustion during VL.
C1 [Schaut, Robert G.; Lamb, Ian M.; Toepp, Angela J.; Scott, Benjamin; Petersen, Christine A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, S429 CHBP,145 N Riverside Dr, Iowa City, IA 52242 USA.
   [Mendes-Aguiar, Carolina O.; Coutinho, Jose F. V.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Hlth Grad Program, Inst Trop Med, BR-59072970 Natal 1655, RN, Brazil.
   [Mendes-Aguiar, Carolina O.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro 4365, Brazil.
   [Coutinho, Jose F. V.] Hlth Secretariat, Ctr Zoonosis, BR-59072970 Natal 1655, RN, Brazil.
   [Wilson, Mary E.; Harty, John T.; Waldschmidt, Thomas J.; Petersen, Christine A.] Univ Iowa, Program Immunol, Carver Coll Med, Iowa City, IA 52242 USA.
RP Petersen, CA (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, S429 CHBP,145 N Riverside Dr, Iowa City, IA 52242 USA.
EM christine-petersen@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Petersen, Christine/M-1881-2014
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Waldschmidt, Thomas/0000-0001-6147-6991;
   Wilson, Mary/0000-0001-8680-7275; Harty, John/0000-0001-7266-2802;
   Schaut, Robert G./0000-0003-2713-9013; Petersen,
   Christine/0000-0002-7285-4254
FU National Cancer Institute, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P30CA086862]; National Center
   for Research Resources, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [1S10 RR027219];
   National Institutes of Health Tropical Medicine Research Center
   [AI030639]; Morris Animal Foundation; start-up funds from the Department
   of Epidemiology, College of Public Health, University of Iowa; Carver
   College of Medicine; Holden Comprehensive Cancer Center; Iowa City
   Veteran's Administration Medical Center; NATIONAL CANCER INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862, P30CA086862, P30CA086862, P30CA086862, P30CA086862,
   P30CA086862] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [S10RR027219] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX001983, I01BX001983, I01BX001983, I01BX001983, I01BX001983,
   I01BX001983] Funding Source: NIH RePORTER
FX This work was supported by the National Cancer Institute, National
   Institutes of Health (Award P30CA086862), the National Center for
   Research Resources, National Institutes of Health (Award 1S10 RR027219),
   the National Institutes of Health Tropical Medicine Research Center
   (Grant AI030639), the Morris Animal Foundation, and start-up funds from
   the Department of Epidemiology, College of Public Health, University of
   Iowa. The flow cytometry facility used in this study is funded through
   user fees and the generous financial support of the Carver College of
   Medicine, the Holden Comprehensive Cancer Center, and the Iowa City
   Veteran's Administration Medical Center.
CR Andreani G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003543
   Ansari NA, 2011, J IMMUNOL, V186, P3977, DOI 10.4049/jimmunol.1003588
   Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238
   Bankoti R, 2012, J IMMUNOL, V188, P3961, DOI 10.4049/jimmunol.1102880
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009
   Bogdan C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00069
   Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09
   Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039
   Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180
   Cabral SM, 2008, IMMUNOLOGY, V123, P555, DOI 10.1111/j.1365-2567.2007.02725.x
   Candando KM, 2014, IMMUNOL REV, V259, P259, DOI 10.1111/imr.12176
   Correale J, 2014, METHODS MOL BIOL, V1190, P257, DOI 10.1007/978-1-4939-1161-5_18
   Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139
   Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274
   Esch KJ, 2015, AM J PATHOL, V185, P2105, DOI 10.1016/j.ajpath.2015.04.017
   Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810
   Fernandez ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104951
   Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401
   Geisberger R, 2006, IMMUNOLOGY, V118, P429, DOI 10.1111/j.1365-2567.2006.02386.x
   Gibson-Corley KN, 2008, CAN VET J, V49, P1005
   Gigley JP, 2012, TRENDS PARASITOL, V28, P377, DOI 10.1016/j.pt.2012.07.001
   Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114
   Hernandez-Ruiz J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000871
   Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249
   Kaye PM, 2011, CLIN MICROBIOL INFEC, V17, P1462, DOI 10.1111/j.1469-0691.2011.03610.x
   Kim J, 2014, YONSEI MED J, V55, P1354, DOI 10.3349/ymj.2014.55.5.1354
   Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679
   Kumar R, 2009, FEMS IMMUNOL MED MIC, V57, P239, DOI 10.1111/j.1574-695X.2009.00607.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003
   Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874
   Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016
   MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994
   Mukherjee S, 2014, J IMMUNOL, V193, P4083, DOI 10.4049/jimmunol.1400710
   Nduati E, 2011, J INFECT DIS, V204, P962, DOI 10.1093/infdis/jir438
   Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141
   Ortiz M, 2015, CLIN NEPHROL, V83, P370, DOI 10.5414/CN108195
   Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x
   Petersen Christine A, 2009, Interdiscip Perspect Infect Dis, V2009, P802712, DOI 10.1155/2009/802712
   Petersen CA, 2009, TOP COMPANION ANIM M, V24, P182, DOI 10.1053/j.tcam.2009.06.006
   Rodrigues V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004096
   Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114
   Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005
   Saussine A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043588
   Shen P, 2015, NAT REV IMMUNOL, V15, P441, DOI 10.1038/nri3857
   Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436
   Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103
   Singh K, 2014, J INFECT DIS, V209, P1418, DOI 10.1093/infdis/jit593
   Smelt SC, 1997, J IMMUNOL, V158, P3813
   Vadasz Z, 2014, INT ARCH ALLERGY IMM, V163, P245, DOI 10.1159/000360477
   van der Vlugt LEPM, 2014, J INFECT DIS, V210, P1207, DOI 10.1093/infdis/jiu257
   Vida B, 2016, VET IMMUNOL IMMUNOP, V169, P34, DOI 10.1016/j.vetimm.2015.11.008
   Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583
   Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501
NR 55
TC 26
Z9 27
U1 0
U2 7
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 15
PY 2016
VL 196
IS 10
BP 4100
EP 4109
DI 10.4049/jimmunol.1502678
PG 10
WC Immunology
SC Immunology
GA DL7OY
UT WOS:000375831200013
PM 27076677
OA Green Accepted, Bronze
DA 2020-11-26
ER

PT J
AU Lima, JG
   Nobrega, LHC
   de Lima, NN
   Santos, MGD
   Baracho, MFP
   Jeronimo, SMB
AF Lima, Josivan G.
   Nobrega, Lucia Helena C.
   de Lima, Natalia Nobrega
   do Nascimento Santos, Maria Goretti
   Baracho, Maria F. P.
   Bezerra Jeronimo, Selma Maria
TI Clinical and laboratory data of a large series of patients with
   congenital generalized lipodystrophy
SO DIABETOLOGY & METABOLIC SYNDROME
LA English
DT Article
DE Lipodystrophy; Diabetes; Insulin resistance; Berardinelli-Seip
ID INSULIN-RESISTANCE; SEIPIN; PATHOGENESIS; AGPAT2; MUTATIONS
AB Background: Berardinelli-Seip congenital lipodystrophy (BSCL) was initially described by Berardinelli in Brazil in 1954 and 5 years later by Seip in Norway. It is an autosomal recessive disease that leads to a generalized deficit of body fat, evolving with diabetes and hypertriglyceridemia. The aim of this study was to describe the clinical and laboratory characteristics of a large series of patients with BSCL.
   Methods: This is a cross-sectional study of patients with BSCL. A total of 54 cases of BSCL were diagnosed, treated and followed for the past 17 years. We report clinical and laboratorial data of 44 of those patients.
   Results: There was a predominance of female patients (27 patients), and the mean age was 21.3 +/- 13.7 years old. The majority of patients (30/44; 68.2 %) were diabetic, and almost half of them (14/30 patients, 46.7 %) were on insulin. The mean body mass index was 19.6 +/- 3.3 and the mean body fat measured by dual-energy X-ray absorptiometry (DEXA) was 5.4 +/- 0.8 %. Acanthosis nigricans, acromegaloid facies, atrophic cheeks, prognathism, phlebomegaly, and muscle hypertrophy were the most common clinical features. Only two patients had triglyceridemia lower than 150 mg/dl without the use of lipid-lowering drugs. Hyperinsulinemia was present in the majority of patients, and leptin values were very low in all patients.
   Conclusions: We report one of the largest series of patients with BSCL treated at a single medical center. Earlier identification of the mutations and a better understanding of the pathophysiology can aid to better treatment and decrease complications, potentially improving life quality and expectacyn.
C1 [Lima, Josivan G.; Nobrega, Lucia Helena C.; de Lima, Natalia Nobrega; Baracho, Maria F. P.] Univ Fed Rio Grande do Norte, HUOL, Dept Med Clin, Ave Nilo Pecanha,620 Petropolis, BR-59012300 Natal, RN, Brazil.
   [Lima, Josivan G.] Hlth Grad Program, Natal, RN, Brazil.
   [do Nascimento Santos, Maria Goretti] Univ Fed Rio Grande do Norte, Dept Anal Clin & Toxicol, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Inst Med Trop Rio Grande Norte, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] INCT DT, Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Lima, JG (corresponding author), Univ Fed Rio Grande do Norte, HUOL, Dept Med Clin, Ave Nilo Pecanha,620 Petropolis, BR-59012300 Natal, RN, Brazil.
EM josivanlima@gmail.com
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Lima,
   Josivan/I-6362-2013
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Lima, Josivan/0000-0002-1627-7018
CR Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880
   Akpinar F, 2012, EUR J DERMATOL, V22, P106, DOI 10.1684/ejd.2011.1572
   Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011
   BERARDINELLI W, 1954, J CLIN ENDOCR METAB, V14, P193, DOI 10.1210/jcem-14-2-193
   BEYLOT M, 1988, DIABETES METAB, V14, P20
   Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106
   Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011
   Chan JL, 2011, ENDOCR PRACT, V17, P922, DOI 10.4158/EP11229.OR
   Cho Y, 2015, ANN LAB MED, V35, P586, DOI 10.3343/alm.2015.35.6.586
   Cortes VA, 2015, J PHYSIOL BIOCHEM, V71, P471, DOI 10.1007/s13105-015-0404-1
   Ebihara C, 2015, HUM MOL GENET, V24, P4238, DOI 10.1093/hmg/ddv156
   Fu M, 2004, J CLIN ENDOCR METAB, V89, P2916, DOI 10.1210/jc.2003-030485
   Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261
   Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020
   Haghighi A, 2016, CLIN GENET, V89, P434, DOI 10.1111/cge.12623
   Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070
   Knebel B, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-119
   Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003
   Lima JG, 2016, J CLIN MOL ENDOCRINO, V1, P1
   Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123
   SEIP M, 1959, Acta Paediatr, V48, P555
   Simha V, 2003, J CLIN ENDOCR METAB, V88, P5433, DOI 10.1210/jc.2003-030835
   Simha V, 2003, DIABETES CARE, V26, P30, DOI 10.2337/diacare.26.1.30
   Temelkova-Kurktschiev T, 2004, EXP CLIN ENDOCR DIAB, V112, P75, DOI 10.1055/s-2004-815753
   Uslusoy HS, 2009, WORLD J GASTROENTERO, V15, P1863, DOI 10.3748/wjg.15.1863
   Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722
   Viana LV, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003336
   Wee K, 2014, BIOSCIENCE REP, V34, P583, DOI 10.1042/BSR20140114
   Wei SH, 2013, J NEUROCHEM, V124, P478, DOI 10.1111/jnc.12099
   Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231
NR 32
TC 20
Z9 21
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1758-5996
J9 DIABETOL METAB SYNDR
JI Diabetol. Metab. Syndr.
PD MAR 15
PY 2016
VL 8
AR 23
DI 10.1186/s13098-016-0140-x
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DG9SE
UT WOS:000372423300001
PM 26985241
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Nobre, ML
   Dupnik, KM
   Nobre, PJL
   De Souza, MCF
   Duppre, NC
   Sarno, EN
   Jeronimo, SMB
AF Nobre, Mauricio Lisboa
   Dupnik, Kathryn Margaret
   Lisboa Nobre, Paulo Jose
   Freitas De Souza, Marcia Celia
   Duppre, Nadia Cristina
   Sarno, Euzenir Nunes
   Bezerra Jeronimo, Selma Maria
TI Human migration, railways and the geographic distribution of leprosy in
   Rio Grande do Norte State - Brazil
SO LEPROSY REVIEW
LA English
DT Article
ID HANSENS-DISEASE LEPROSY
AB Introduction: Leprosy is a public health problem in Brazil where 31,044 new cases were detected in 2013. Rio Grande do Norte is a small Brazilian state with a rate of leprosy lower than other areas in the same region, for unknown reasons.
   Objectives: We present here a review based on the analysis of a database of registered leprosy cases in Rio Grande do Norte state, comparing leprosy's geographic distribution among municipalities with local socio-economic and public health indicators and with historical documents about human migration in this Brazilian region.
   Results: The current distribution of leprosy in Rio Grande do Norte did not show correlation with socio-economic or public health indicators at the municipal level, but it appears related to economically emerging municipalities 100 years ago, with spread facilitated by railroads and train stations. Drought-related migratory movements which occurred from this state to leprosy endemic areas within the same period may be involved in the introduction of leprosy and with its present distribution within Rio Grande do Norte.
   Conclusions: Leprosy may disseminate slowly, over many decades in certain circumstances, such as in small cities with few cases. This is a very unusual situation currently and a unique opportunity for epidemiologic studies of leprosy as an emerging disease.
C1 [Nobre, Mauricio Lisboa] Hosp Giselda Trigueiro, Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa; Dupnik, Kathryn Margaret; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande Norte, BR-59078900 Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa] Fiocruz MS, Inst Oswaldo Cruz, Posgrad Med Trop, BR-21045900 Rio De Janeiro, Brazil.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA.
   [Lisboa Nobre, Paulo Jose] Univ Fed Rio Grande do Norte, Dept Arquitetura, BR-59078900 Natal, RN, Brazil.
   [Freitas De Souza, Marcia Celia] INSS, Mossoro, RN, Brazil.
   [Duppre, Nadia Cristina; Sarno, Euzenir Nunes] Fundacao Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil.
   [Bezerra Jeronimo, Selma Maria] INCT DT, Belo Horizonte, MG, Brazil.
RP Nobre, ML (corresponding author), Univ Fed Rio Grande do Norte, Inst Med Trop RN IMT RN, Ave Sen Salgado Filho 3000, BR-59078900 Natal, RN, Brazil.
EM nobreml@gmail.com
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Nobre,
   Mauricio/0000-0003-4932-3137; Nunes Sarno, Euzenir/0000-0003-0129-2159
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32-AI007613,
   R25-TW009337-02]; Burroughs-Wellcome Fund / American Society for
   Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical
   Infectious Diseases; Heiser Foundation; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613] Funding
   Source: NIH RePORTER
FX The authors are grateful to Gabriel Leopoldino Paulo de Medeiros from
   Federal University of Rio Grande do Norte for authorizing the use and
   adaptation of his illustration of railways and train stations in Rio
   Grande do Norte and to Dr. Gerson Oliveira Penna from University of
   Brasilia for revising the manuscript. KMD was supported by the National
   Institutes of Health (T32-AI007613 and R25-TW009337-02), a
   Burroughs-Wellcome Fund / American Society for Tropical Medicine and
   Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases, and a
   Heiser Foundation for Leprosy Research grant.
CR Brasil. Ministerio da Saticle, 2013, REG AT NUM PERC CAS
   Brasil. Ministerio da Satide. DATASUS, 2012, DATASUS POP RES RIO
   Brasil. Ministerio da Satide. DATASUS, 2012, PROD INT BRUT CAP BR
   Brasil. Ministerio da Saude. DATASUS, DATASUS INF SAUD EP
   Brasil. Ministerio da Saude. DATASUS, DATASUS INF SAUD DEM
   Brasil. Ministerio da Saude. DATASUS, 2010, DATASUS POP RES BRAS
   CASCUDO Luis da Camara, 1955, HIST RIO GRANDE NORT
   Da Silva AF, 2007, REV ELECT GEOGRAFIA
   Dias MCFD, 2007, LEPROSY REV, V78, P261
   Estado do Rio Grande do Norte, PERF RIO GRAND NORT
   Farias HTM, 2008, THESIS U FEDERAL RIO
   Ferreira ALA, 2001, REV ELECT GEOGRAFIA, V94, P96
   FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245
   Global leprosy update, 2013, WKLY EPIDEMIOL REC, V89, P389
   Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002
   Lopes E M., 2005, CIDADE INDESEJADA LE
   Magalhães Maria da Conceição Cavalcanti, 2005, Rev. bras. epidemiol., V8, P342
   Medeiros GLP., 2007, THESIS U FEDERAL RIO
   Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759
   Moura MLN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002093
   Neto MAS, 2011, THESIS U FEDERAL ROR
   Nobre ML, 2005, RELATORIO ENCONTRO E
   Pinheiro Karisa Lorena Carmo Barbosa, 2006, PROC URB CID MOSS PR
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Rede Ferroviaria do Nordeste, EXT DAT AB TRILH
   Ross JLS, 1998, GEOGRAFIA BRASIL
   Santos PP., 2002, EVOLUCAO EC RIO GRAN
   Sousa AQ, 2009, EMERG INFECT DIS, V15, P916, DOI 10.3201/eid1506.071331
   Souza-Araujo H C., 1946, HIST LEPRA BRASIL
   Souza-Araujo HC de, 1933, MEM I O CRUZ, V27, P165
   Suzuki K, 2010, J CLIN MICROBIOL, V48, P3432, DOI 10.1128/JCM.00017-10
   Villa MA, 2001, VIDA MORTE SERTAO HI
NR 32
TC 9
Z9 8
U1 0
U2 1
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD DEC
PY 2015
VL 86
IS 4
BP 335
EP 344
PG 10
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA DC3LK
UT WOS:000369120600006
PM 26964429
DA 2020-11-26
ER

PT J
AU Amorim, FM
   Nascimento, LS
   Miranda, AM
   Neto, FPF
   Monteiro, GR
   Nobre, ML
   Dupnik, KM
   Jeronimo, SM
AF Amorim, Francianne M.
   Nascimento, Larissa S.
   Miranda, Alesson M.
   Freire-Neto, Francisco P.
   Monteiro, Gloria R.
   Nobre, Mauricio L.
   Dupnik, Kathryn M.
   Jeronimo, Selma M.
TI CHANGES IN THE PROFILE OF CIRCULATING B CELLS AND IGG AND COMPLEMENT
   RECEPTORS CAN BE ASSOCIATED WITH THE DEVELOPMENT OF ERYTHEMA NODOSUM
   LEPROSUM
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Amorim, Francianne M.; Nascimento, Larissa S.; Miranda, Alesson M.; Freire-Neto, Francisco P.; Monteiro, Gloria R.; Nobre, Mauricio L.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande Norte, Ctr Biociencias, Lab Imunogenet Doencas Complexas, Natal, RN, Brazil.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2015
VL 93
IS 4
SU S
MA 432
BP 130
EP 131
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA VB0ZJ
UT WOS:000412844102177
DA 2020-11-26
ER

PT J
AU Esch, KJ
   Schaut, RG
   Lamb, IM
   Clay, G
   Lima, ALM
   do Nascimento, PRP
   Whitley, EM
   Jeronimo, SMB
   Sutterwala, FS
   Haynes, JS
   Petersen, CA
AF Esch, Kevin J.
   Schaut, Robert G.
   Lamb, Ian M.
   Clay, Gwendolyn
   Lima, Adila L. Morais
   do Nascimento, Paulo R. P.
   Whitley, Elizabeth M.
   Jeronimo, Selma M. B.
   Sutterwala, Fayyaz S.
   Haynes, Joseph S.
   Petersen, Christine A.
TI Activation of Autophagy and Nucleotide-Binding Cross Mark Domain
   Leucine-Rich Repeat-Containing-Like Receptor Family, Pyrin
   Domain-Containing 3 Inflammasome during Leishmania infantum-Associated
   Glomerulonephritis
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID RENAL BIOPSY SPECIMENS; VISCERAL LEISHMANIASIS; DIABETIC-NEPHROPATHY;
   CANINE LEISHMANIASIS; NALP3 INFLAMMASOME; IMMUNE-COMPLEXES;
   KIDNEY-DISEASE; PODOCYTES; CELLS; NLRP3
AB Chronic kidney disease is a major contributor to human and companion animal morbidity and mortality. Renal complications are sequelae of canine and human visceral Leishmaniasis (VL). Despite the high incidence of infection-mediated glomerulonephritis, Little is known about pathogenesis of VL-associated renal disease. Leishmania infantum infected dogs are a naturally occurring model of VL-associated glomerulonephritis. Membranoproliferative glomerulonephritis type I [24 of 25 (96%)], with interstitial lymphoplasmacytic nephritis [23 of 25 (92%)], and glomerular and interstitial fibrosis [12 of 25 (48%)] were predominant Lesions. An ultrastructural evaluation of glomeruli from animals with VL identified mesangial cell proliferation and interposition. Immunohistochemistry demonstrated significant Leishmania antigen, IgG, and C3b deposition in VL dog glomeruli. Asymptomatic and symptomatic dogs had increased glomerular nucleotide-binding domain leucine-rich repeat containing-Like receptor family, pyrin domain containing 3 and autophagosome-associated microtubule-associated protein 1 Light chain 3 associated with glomerular lesion severity. Transcriptional analyses from symptomatic dogs confirmed induction of autophagy and inflammasome genes within glomeruli and tubules. On the basis of temporal VL staging, glomerulonephritis was initiated by IgG and complement deposition. This deposition preceded presence of nucleotide-binding domain leucine-rich repeat containing-Like receptor family, pyrin domain containing 3 associated inflammasomes and increased Light chain 3 puncta indicative of autophagosomes in glomeruli from dogs with clinical VL and renal failure. These findings indicate potential roles for intlammasome complexes in glomerular damage during VL and autophagy in ensuing cellular responses.
C1 [Esch, Kevin J.; Whitley, Elizabeth M.; Haynes, Joseph S.; Petersen, Christine A.] Iowa State Univ, Dept Vet Pathol, Coll Vet Med, Ames, IA USA.
   [Schaut, Robert G.; Lamb, Ian M.; Petersen, Christine A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA USA.
   [Clay, Gwendolyn; Sutterwala, Fayyaz S.] Univ Iowa, Carver Coll Med, Inflammat Program, Dept Internal Med, Iowa City, IA USA.
   [Lima, Adila L. Morais; do Nascimento, Paulo R. P.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Inst Trop Med, BR-59072970 Natal, RN, Brazil.
RP Petersen, CA (corresponding author), Iowa State Univ, Dept Epidemiol, 145 N Riverside Dr,S429 CPHB, Iowa City, IA 52241 USA.
EM christine-petersen@uiowa.edu
RI Petersen, Christine/M-1881-2014; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020
OI Petersen, Christine/0000-0002-7285-4254; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904; Schaut,
   Robert G./0000-0003-2713-9013
FU National Institutes of Allergy and Infectious Diseases (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [AI088051]; NIB [RO1 AI087630]; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI087630,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R21AI088051, P50AI030639, P50AI030639, R01AI087630,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI087630, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI087630, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R21AI088051, R01AI087630, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Environmental Health Sciences (NIEHS) [P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605, P30ES005605, P30ES005605, P30ES005605,
   P30ES005605, P30ES005605] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337] Funding Source: NIH RePORTER
FX Supported in part by National Institutes of Allergy and Infectious
   Diseases (NIH) grant AI088051 (C.A.P.) and NIB grant RO1 AI087630
   (F.S.S.).
CR Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666
   Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798
   Beltrame A, 2008, J TRAVEL MED, V15, P358, DOI 10.1111/j.1708-8305.2008.00220.x
   BENDERITTER T, 1988, ANN TROP MED PARASIT, V82, P335, DOI 10.1080/00034983.1988.11812255
   Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09
   Boini KM, 2014, BBA-MOL CELL RES, V1843, P836, DOI 10.1016/j.bbamcr.2014.01.033
   Bomback AS, 2012, NAT REV NEPHROL, V8, P634, DOI 10.1038/nrneph.2012.213
   Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009
   Chevrier M, 2010, AUTOPHAGY, V6, P589, DOI 10.4161/auto.6.5.11943
   Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]
   Clay GM, 2014, IMMUNOL RES, V59, P142, DOI 10.1007/s12026-014-8544-x
   Costa FAL, 2003, VET PATHOL, V40, P677, DOI 10.1354/vp.40-6-677
   Costa FAL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-112
   Coussens G, 2012, J EXP BOT, V63, P4263, DOI 10.1093/jxb/ers113
   DEB T, 1975, AM J TROP MED HYG, V24, P9
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   DUTRA M, 1985, AM J KIDNEY DIS, V6, P22, DOI 10.1016/S0272-6386(85)80034-2
   Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363
   Gibson-Corley KN, 2008, CAN VET J, V49, P1005
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749
   Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492
   Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014
   Janczy JR, 2014, J IMMUNOL, V193, P5190, DOI 10.4049/jimmunol.1400628
   Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460
   Liborio AB, 2012, PEDIATR INFECT DIS J, V31, P451, DOI 10.1097/INF.0b013e318247f533
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6
   Ma TA, 2013, EXP CELL RES, V319, P779, DOI 10.1016/j.yexcr.2013.01.018
   Maeda S, 2013, J VET INTERN MED, V27, P47, DOI 10.1111/jvim.12023
   Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108
   Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516
   Munz C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00009
   Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330
   NIETO CG, 1992, VET PARASITOL, V45, P33, DOI 10.1016/0304-4017(92)90025-5
   Oosting M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4090
   POLI A, 1991, NEPHRON, V57, P444, DOI 10.1159/000186348
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Rocha NA, 2011, TURKISH J PEDIATR, V53, P154
   Rodgers MA, 2014, ANTIOXID REDOX SIGN, V20, P495, DOI 10.1089/ars.2013.5347
   Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421
   Sato S, 2009, PATHOBIOLOGY, V76, P221, DOI 10.1159/000228897
   Sato S., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P167
   Sato Shigeru, 2006, Journal of Nippon Medical School, V73, P52, DOI 10.1272/jnms.73.52
   Sayari M, 2008, Pak J Biol Sci, V11, P1630, DOI 10.3923/pjbs.2008.1630.1633
   Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178
   Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271
   Sow Fatoumata B, 2009, Int J Biomed Sci, V5, P105
   Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759
   Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458
   Takenouchi T, 2009, J IMMUNOL, V182, P2051, DOI 10.4049/jimmunol.0802577
   Timoshanko JR, 2004, J AM SOC NEPHROL, V15, P910, DOI 10.1097/01.ASN.0000115704.86897.F4
   Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41, DOI 10.1615/CritRevImmunol.2013008686
   Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143
   Zatelli A, 2003, AM J VET RES, V64, P558, DOI 10.2460/ajvr.2003.64.558
NR 55
TC 18
Z9 18
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD AUG
PY 2015
VL 185
IS 8
BP 2105
EP 2117
DI 10.1016/j.ajpath.2015.04.017
PG 13
WC Pathology
SC Pathology
GA CO3YD
UT WOS:000359096300005
PM 26079813
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Dupnik, KM
   Bair, TB
   Maia, AO
   Amorim, FM
   Costa, MR
   Keesen, TSL
   Valverde, JG
   Queiroz, MDAP
   Medeiros, LL
   de Lucena, NL
   Wilson, ME
   Nobre, ML
   Johnson, WD
   Jeronimo, SMB
AF Dupnik, Kathryn M.
   Bair, Thomas B.
   Maia, Andressa O.
   Amorim, Francianne M.
   Costa, Marcos R.
   Keesen, Tatjana S. L.
   Valverde, Joanna G.
   Queiroz, Maria do Carmo A. P.
   Medeiros, Lucio L.
   de Lucena, Nelly L.
   Wilson, Mary E.
   Nobre, Mauricio L.
   Johnson, Warren D., Jr.
   Jeronimo, Selma M. B.
TI Transcriptional Changes That Characterize the Immune Reactions of
   Leprosy
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE leprosy; reversal reaction; erythema nodosum leprosum; complement
ID ERYTHEMA-NODOSUM LEPROSUM; TYPE-1 REVERSAL REACTIONS; GENE; ASSOCIATION;
   MARKERS; SUSCEPTIBILITY; TUBERCULOSIS; RESPONSES; ANTIGENS; DISEASE
AB Methods.aEuro integral To discover host factors related to immune reactions, global transcriptional profiles of peripheral blood mononuclear cells were compared between 11 RR, 11 ENL, and 19 matched control patients, with confirmation by quantitative polymerase chain reaction. Encoded proteins were investigated in skin biopsy specimens by means of immunohistochemistry.
   Results.aEuro integral There were 275 genes differentially expressed in RR and 517 differentially expressed in ENL on the microarray. Pathway analysis showed immunity-related pathways represented in RR and ENL transcriptional profiles, with the "complement and coagulation" pathway common to both. Interferon gamma was identified as a significant upstream regulator of the expression changes for RR and ENL. Immunohistochemical staining of skin lesions showed increased C1q in both RR and ENL.
   Conclusions.aEuro integral These data suggest a previously underrecognized role for complement in the pathogenesis of both RR and ENL, and we propose new hypotheses for reaction pathogenesis.
C1 [Dupnik, Kathryn M.; Johnson, Warren D., Jr.] Weill Cornell Med Coll, Div Infect Dis, New York, NY 10021 USA.
   [Dupnik, Kathryn M.; Johnson, Warren D., Jr.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY 10021 USA.
   [Bair, Thomas B.] Univ Iowa, Iowa Inst Human Genet, Iowa City, IA USA.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] VA Med Ctr, Iowa City, IA USA.
   [Maia, Andressa O.; Amorim, Francianne M.; Keesen, Tatjana S. L.; Valverde, Joanna G.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Costa, Marcos R.] Univ Fed Rio Grande do Norte, Brain Inst, BR-59072970 Natal, RN, Brazil.
   [Queiroz, Maria do Carmo A. P.] Univ Fed Rio Grande do Norte, Hosp Onofre Lopes, BR-59072970 Natal, RN, Brazil.
   [Nobre, Mauricio L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   [de Lucena, Nelly L.] Hosp Giselda Trigueiro, Lab Luchiari, Natal, RN, Brazil.
   [Nobre, Mauricio L.] Hosp Giselda Trigueiro, Natal, RN, Brazil.
   [Medeiros, Lucio L.] Secretaria Saude, Mossoro, RN, Brazil.
   [Nobre, Mauricio L.] Fiocruz MS, Inst Oswaldo Cruz, Postgrad Pogram Trop Med, BR-21045900 Rio De Janeiro, Brazil.
   [Nobre, Mauricio L.; Jeronimo, Selma M. B.] Natl Inst Sci & Technol Trop Dis, Salvador, BA, Brazil.
RP Dupnik, KM (corresponding author), Weill Cornell Med Coll, Ctr Global Hlth, 402 E 67th St,2nd Floor, New York, NY 10021 USA.
EM kad9040@med.cornell.edu
RI Jeronimo, Selma M.B./M-8672-2014; Costa, Marcos R/F-8071-2012; Valverde,
   Joanna G/C-1284-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Costa, Marcos
   R/0000-0002-4928-2163; Valverde, Joanna G/0000-0001-8064-6255; Jeronimo,
   Selma/0000-0002-4784-9904; Nobre, Mauricio/0000-0003-4932-3137; Wilson,
   Mary/0000-0001-8680-7275
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32-AI007613,
   R25-TW009337-02]; Burroughs-Wellcome FundBurroughs Wellcome Fund;
   American Society of Tropical Medicine and Hygiene; Brazil National
   Institute of Science and Technology [CNPq 573839/2008-15]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32AI007613, T32AI007613, T32AI007613,
   R01AI048822, R01AI048822, R01AI048822, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, R01AI048822,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, R01AI048822,
   T32AI007613, T32AI007613] Funding Source: NIH RePORTER; Veterans
   AffairsUS Department of Veterans Affairs [I01BX001983, I01BX001983,
   I01BX001983, I01BX001983, I01BX001983] Funding Source: NIH RePORTER
FX This work was supported by the National Institutes of Health (grants
   T32-AI007613 and R25-TW009337-02 to K. M. D.), Burroughs-Wellcome Fund
   and the American Society of Tropical Medicine and Hygiene (Postdoctoral
   Fellowship in Tropical Infectious Diseases to K. M. D.), and the Brazil
   National Institute of Science and Technology (tropical diseases grant
   CNPq 573839/2008-15).
CR [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P365
   Balagon M, 2011, LEPROSY REV, V82, P213
   Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785
   Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688
   Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213
   da Silva SA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-134
   Tran HTT, 2014, IMMUNOBIOLOGY, V219, P37, DOI 10.1016/j.imbio.2013.07.004
   Iyer A, 2007, CLIN EXP IMMUNOL, V150, P210, DOI 10.1111/j.1365-2249.2007.03485.x
   Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359
   Kahawita IP, 2008, T ROY SOC TROP MED H, V102, P329, DOI 10.1016/j.trstmh.2008.01.004
   Kraal G, 2000, MICROBES INFECT, V2, P313, DOI 10.1016/S1286-4579(00)00296-3
   Lockwood DNJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001327
   Lockwood DNJ, 2002, AM J TROP MED HYG, V66, P409, DOI 10.4269/ajtmh.2002.66.409
   Lustosa AA, 2011, REV SOC BRAS MED TRO, V44, P621, DOI 10.1590/S0037-86822011000500019
   Orlova M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003624
   Pocaterra L, 2006, AM J TROP MED HYG, V74, P868, DOI 10.4269/ajtmh.2006.74.868
   Ranque B, 2007, CLIN INFECT DIS, V44, P33, DOI 10.1086/509923
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Scollard DM, 2011, CLIN VACCINE IMMUNOL, V18, P947, DOI 10.1128/CVI.00042-11
   Shaw MA, 2001, GENES IMMUN, V2, P196, DOI 10.1038/sj.gene.6363754
   Smith WCS, 2004, BMJ-BRIT MED J, V328, P1459, DOI 10.1136/bmj.38107.645926.AE
   Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006
   Sousa ALM, 2012, J INFECT DIS, V205, P1417, DOI 10.1093/infdis/jis208
   Teles RMB, 2013, SCIENCE, V339, P1448, DOI 10.1126/science.1233665
   Walker SL, 2008, LEPROSY REV, V79, P372
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   World Health Organization, 2012, WHO TECHN REP SER
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
NR 30
TC 17
Z9 17
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAY 15
PY 2015
VL 211
IS 10
BP 1658
EP 1676
DI 10.1093/infdis/jiu612
PG 19
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA CI4MG
UT WOS:000354723000015
PM 25398459
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Franca, ASC
   Lobao-Soares, B
   Muratori, L
   Nascimento, G
   Winne, J
   Pereira, CM
   Jeronimo, SMB
   Ribeiro, S
AF Franca, A. S. C.
   Lobao-Soares, B.
   Muratori, L.
   Nascimento, G.
   Winne, J.
   Pereira, C. M.
   Jeronimo, S. M. B.
   Ribeiro, S.
TI D2 dopamine receptor regulation of learning, sleep and plasticity
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Article
DE REM sleep; CaMKII; Zif-268; BDNF; Haloperidol; Object recognition
ID LONG-TERM POTENTIATION; AMP RESPONSE ELEMENT; PROTEIN-KINASE-II; EARLY
   GENE ZIF268; LATE-LTP; MEMORY CONSOLIDATION; CONDITIONED FEAR; FOS
   EXPRESSION; HIPPOCAMPUS; PHOSPHORYLATION
AB Dopamine and sleep have been independently linked with hippocampus-dependent learning. Since D2 dopaminergic transmission is required for the occurrence of rapid-eye-movement (REM) sleep, it is possible that dopamine affects learning by way of changes in post-acquisition REM sleep. To investigate this hypothesis, we first assessed whether D2 dopaminergic modulation in mice affects novel object preference, a hippocampus-dependent task. Animals trained in the dark period, when sleep is reduced, did not improve significantly in performance when tested 24 h after training. In contrast, animals trained in the sleep-rich light period showed significant learning after 24 h. When injected with the D2 inverse agonist haloperidol immediately after the exploration of novel objects, animals trained in the light period showed reduced novelty preference upon retesting 24 h later. Next we investigated whether haloperidol affected the protein levels of plasticity factors shown to be up-regulated in an experience-dependent manner during REM sleep. Haloperidol decreased post-exploration hippocampal protein levels at 3 h, 6 h and 12 h for phosphorylated Ca2+/calmodulin-dependent protein kinase II, at 6 h for Zif-268; and at 12 h for the brain-derived neurotrophic factor. Electrophysiological and kinematic recordings showed a significant decrease in the amount of REM sleep following haloperidol injection, while slow-wave sleep remained unaltered. Importantly, REM sleep decrease across animals was strongly correlated with deficits in novelty preference (Rho=0.56, p=0.012). Altogether, the results suggest that the dopaminergic regulation of REM sleep affects learning by modulating post-training levels of calcium-dependent plasticity factors. (C)) 2015 Elsevier B.V. and ECNP. All rights reserved.
C1 [Franca, A. S. C.; Muratori, L.; Ribeiro, S.] Fed Univ Rio Grande do Norte UFRN, Brain Inst, BR-59056450 Natal, RN, Brazil.
   [Lobao-Soares, B.] Fed Univ Rio Grande do Norte UFRN, Dept Biophys & Pharmacol, Natal, RN, Brazil.
   [Muratori, L.; Jeronimo, S. M. B.] Fed Univ Rio Grande do Norte UFRN, Dept Biochem, Natal, RN, Brazil.
   [Nascimento, G.] Fed Univ Rio Grande do Norte UFRN, Dept Biomed Engn, Natal, RN, Brazil.
   [Nascimento, G.; Winne, J.; Pereira, C. M.] Edmond & Lily Safra Int Inst Neurosci Natal ELS I, Natal, RN, Brazil.
RP Lobao-Soares, B (corresponding author), Fed Univ Rio Grande do Norte UFRN, Dept Biophys & Pharmacol, Natal, RN, Brazil.
EM brunolobaosoares@gmail.com; sidartaribeiro@neuro.ufrn.br
RI Soares, Bruno L/N-1142-2018; Franca, Arthur S. C./J-1576-2015; Jeronimo,
   Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Franca,
   Arthur/F-2667-2014; Ribeiro, Sidarta/C-5794-2016
OI Soares, Bruno L/0000-0003-4564-2288; Franca, Arthur S.
   C./0000-0002-5836-1672; Jeronimo, Selma/0000-0002-4784-9904; Jeronimo,
   Selma M.B./0000-0002-4784-9904; Ribeiro, Sidarta/0000-0001-9325-9545
FU Pew Latin American Fellows Program in the Biomedical Sciences;
   Financiadora de Estudos e Projetos (FINEP)Ciencia Tecnologia e Inovacao
   (FINEP) [01.06.1092.00]; Ministerio da Ciencia, Tecnologia e Inovacao
   (MCTI), CNPq [481351/2011-6, PQ 306604/2012-4]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES;
   FAPERN/CNPqNational Council for Scientific and Technological Development
   (CNPq) [003/2011]; Capes SticAmSud; FAPESP Center for Neuromathematics
   (Sao Paulo Research Foundation)Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [2013/07699-0]; Associacao Alberto Santos Dumont
   para Apoio a Pesquisa (AASDAP); NIMBIOS working group "Multi-scale
   analysis of cortical networks."; Div Of Biological
   InfrastructureNational Science Foundation (NSF)NSF - Directorate for
   Biological Sciences (BIO) [1300426] Funding Source: National Science
   Foundation
FX Support was obtained from the Pew Latin American Fellows Program in the
   Biomedical Sciences, Financiadora de Estudos e Projetos (FINEP) Grant
   01.06.1092.00, Ministerio da Ciencia, Tecnologia e Inovacao (MCTI), CNPq
   Universal 481351/2011-6, PQ 306604/2012-4, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), FAPERN/CNPq Pronem
   003/2011, Capes SticAmSud, FAPESP Center for Neuromathematics (Grant no.
   2013/07699-0, Sao Paulo Research Foundation), Associacao Alberto Santos
   Dumont para Apoio a Pesquisa (AASDAP), and NIMBIOS working group
   "Multi-scale analysis of cortical networks." We thank V. Arboes for
   veterinary care, A. Ragoni and A. Karla for administrative help, G.L.
   Borba Filho for electrode manufacture, and D. Koshiyama for library
   support.
CR Ahmed T, 2005, NEUROPHARMACOLOGY, V49, P477, DOI 10.1016/j.neuropharm.2005.04.018
   Barbosa FF, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00112
   Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025
   Bekinschtein R, 2014, BDNF REGULATION SY C, V76, P677
   Binder S, 2012, NEUROBIOL LEARN MEM, V97, P213, DOI 10.1016/j.nlm.2011.12.004
   Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940
   Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3
   Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.00254.x
   Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006
   Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174
   Franca ASC, 2014, EUR J NEUROSCI, V40, P3693, DOI 10.1111/ejn.12739
   Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004
   Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010
   Hakansson K, 2006, J NEUROCHEM, V96, P482, DOI 10.1111/j.1471-4159.2005.03558.x
   Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106
   Hernandez PJ, 2011, SLEEP MED CLIN, V6, P71, DOI 10.1016/j.jsmc.2010.12.004
   Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004
   Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381
   Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138
   Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001
   Kang JH, 2007, AM J PHYSIOL-ENDOC M, V292, pE215, DOI 10.1152/ajpendo.00181.2006
   Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107
   KONRADI C, 1995, NEUROSCIENCE, V65, P1051, DOI 10.1016/0306-4522(94)00546-H
   Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006
   Lima MMS, 2008, BEHAV BRAIN RES, V188, P406, DOI 10.1016/j.bbr.2007.11.025
   Lima MMS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000513
   Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753
   Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002
   Manahan-Vaughan D, 2003, CEREB CORTEX, V13, P123, DOI 10.1093/cercor/13.2.123
   de Lima MNM, 2011, NEUROBIOL LEARN MEM, V95, P305, DOI 10.1016/j.nlm.2010.12.007
   Medina JH, 2008, BEHAV BRAIN RES, V192, P61, DOI 10.1016/j.bbr.2008.02.006
   Monti JM, 2007, SLEEP MED REV, V11, P113, DOI 10.1016/j.smrv.2006.08.003
   Morice E, 2007, NEUROPSYCHOPHARMACOL, V32, P2108, DOI 10.1038/sj.npp.1301354
   Nader K, 1999, BEHAV NEUROSCI, V113, P891, DOI 10.1037/0735-7044.113.5.891
   Ouyang Y, 1997, J NEUROSCI, V17, P5416
   Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024
   Piterkin P, 2008, LEARN MEMORY, V15, P785, DOI 10.1101/lm.1035508
   Ponnusamy R, 2005, LEARN MEMORY, V12, P399, DOI 10.1101/lm.96605
   Proenca MB, 2014, NEUROPHARMACOLOGY, V76, P118, DOI 10.1016/j.neuropharm.2013.08.024
   Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500
   Ribeiro S, 2004, LEARN MEMORY, V11, P686, DOI 10.1101/lm.75604
   Ribeiro S, 2002, J NEUROSCI, V22, P10914, DOI 10.1523/jneurosci.22-24-10914.2002
   Ribeiro S, 2007, FRONT NEUROSCI-SWITZ, V1, P43, DOI 10.3389/neuro.01.1.1.003.2007
   Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545
   Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011
   Ulloor J, 2005, J NEUROCHEM, V95, P418, DOI 10.1111/j.1471-4159.2005.03378.x
   Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001
   Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488
   Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134
   Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647
NR 50
TC 11
Z9 11
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD APR
PY 2015
VL 25
IS 4
BP 493
EP 504
DI 10.1016/j.euroneuro.2015.01.011
PG 12
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA CH6JY
UT WOS:000354144100006
PM 25778861
OA Other Gold, Green Published
DA 2020-11-26
ER

PT J
AU Ferreira, LC
   Gomes, CEM
   Araujo, ACP
   Bezerra, PF
   Duggal, P
   Jeronimo, SMB
AF Ferreira, L. C.
   Gomes, C. E. M.
   Araujo, A. C. P.
   Bezerra, P. F.
   Duggal, P.
   Jeronimo, S. M. B.
TI Association between ACVR2A and early-onset preeclampsia: Replication
   study in a Northeastern Brazilian population
SO PLACENTA
LA English
DT Article
DE Activin; ACVR2A; Genetic association; Preeclampsia; SNP
ID MATERNAL SUSCEPTIBILITY LOCUS; GENOME-WIDE SCAN; ACTIVIN-A;
   GENE-EXPRESSION; PREGNANCY; POLYMORPHISMS; HYPERTENSION; REVEALS;
   LINKAGE; RISK
AB Introduction: Preeclampsia is a complex and heterogeneous disease with increased risk of maternal mortality, especially for earlier gestational onset. There is a great inconsistency regarding the genetics of preeclampsia across the literature. The gene Activin A receptor, type IIA (ACVR2A), was reported as associated to preeclampsia in Australian/New Zealand and Norwegian populations. The goal of this study was to validate this genetic association in a Brazilian population.
   Methods: We performed a case-control study using 693 controls and 613 cases (443 preeclampsia, 64 eclampsia and 106 HELLP syndrome), from a Northeastern Brazilian population. Five single nucleotide polymorphisms (SNPs) in ACVR2A were tested for association through multiple logistic regression models.
   Results: There was no statistical association with preeclampsia (per se), eclampsia or HELLP. However, by grouping preeclampsia in accordance to the gestational age at delivery, SNPs rs1424954 (OR = 1.86; 95% Cl, 1.25-2.78; p = 0.002) and rs1014064 (OR = 1.77; 95% CI, 1.21-2.60; p = 0.004) were significantly associated with early onset preeclampsia (gestational age <= 34 weeks). The risk haplotype had a frequency of 0.468 in early preeclampsia compared to 0.316 in controls (p = 0.0008 and permuted p = 0.002).
   Discussion: Activin A receptors are important in decidualization, trophoblast invasion and placentation processes during pregnancy. The gene ACVR2A was associated with the more severe early onset preeclampsia. This finding supports the hypothesis of different pathogenic mechanisms contributing to the early- and late-onset preeclampsia. 2014 Elsevier Ltd. All rights reserved.
C1 [Ferreira, L. C.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Ferreira, L. C.; Gomes, C. E. M.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   [Gomes, C. E. M.] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, BR-59072970 Natal, RN, Brazil.
   [Araujo, A. C. P.] Univ Fed Rio Grande do Norte, Dept Obstet & Gynecol, BR-59072970 Natal, RN, Brazil.
   [Bezerra, P. F.] Univ Fed Rio Grande do Norte, Maternidade Escola Januario Cicco, BR-59072970 Natal, RN, Brazil.
   [Duggal, P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Ave Senador Salgado Filho 3000, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Ferreira, Leonardo Capistrano/D-7097-2019
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ferreira, Leonardo
   Capistrano/0000-0001-9268-4881
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES;
   CAPES-FulbrightCAPES
FX This work was funded in part by a grant from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico and CAPES. LCF received a
   fellowship from CAPES-Fulbright.
CR Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Bezerra PCFM, 2010, ACTA OBSTET GYN SCAN, V89, P612, DOI 10.3109/00016341003623720
   CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303
   Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257
   Fitzpatrick E, 2009, MOL HUM REPROD, V15, P195, DOI 10.1093/molehr/gap001
   Florio P, 2010, REPROD SCI, V17, P320, DOI 10.1177/1933719109353205
   Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8
   Harrison GA, 1997, AM J HUM GENET, V60, P1158
   Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666
   Junus K, 2012, MOL HUM REPROD, V18, P146, DOI 10.1093/molehr/gar067
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706
   Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311
   Lins TCL, 2007, GENET MOL RES, V6, P316
   Lins TC, 2010, AM J HUM BIOL, V22, P187, DOI 10.1002/ajhb.20976
   Lokki A Inkeri, 2011, BMC Res Notes, V4, P545, DOI 10.1186/1756-0500-4-545
   MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0
   Manuelpillai U, 2001, J ENDOCRINOL, V171, P57, DOI 10.1677/joe.0.1710057
   Mbah AK, 2010, BJOG-INT J OBSTET GY, V117, P997, DOI 10.1111/j.1471-0528.2010.02593.x
   Moses EK, 2006, MOL HUM REPROD, V12, P505, DOI 10.1093/molehr/gal056
   Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888
   Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004
   Muttukrishna S, 1997, LANCET, V349, P1285, DOI 10.1016/S0140-6736(96)09264-1
   Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095
   PETRAGLIA F, 1995, PLACENTA, V16, P447, DOI 10.1016/0143-4004(95)90102-7
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Quinn KH, 2011, J REPROD IMMUNOL, V91, P76, DOI 10.1016/j.jri.2011.05.006
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Ros HS, 2000, AM J MED GENET, V91, P256
   Roten LT, 2009, EUR J HUM GENET, V17, P250, DOI 10.1038/ejhg.2008.158
   Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282
   von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060
   Yong HEJ, 2014, PLACENTA, V35, P117, DOI 10.1016/j.placenta.2013.11.008
   Yu L, 2012, J CLIN ENDOCR METAB, V97, pE1370, DOI 10.1210/jc.2011-2729
   Zhao LL, 2013, ANN HUM GENET, V77, P277, DOI 10.1111/ahg.12021
NR 39
TC 12
Z9 13
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0143-4004
EI 1532-3102
J9 PLACENTA
JI Placenta
PD FEB
PY 2015
VL 36
IS 2
BP 186
EP 190
DI 10.1016/j.placenta.2014.11.007
PG 5
WC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
SC Developmental Biology; Obstetrics & Gynecology; Reproductive Biology
GA CB4FH
UT WOS:000349583100012
PM 25499008
DA 2020-11-26
ER

PT J
AU Maciel, BLL
   Valverde, JG
   Rodrigues-Neto, JF
   Freire-Neto, F
   Keesen, TSL
   Jeronimo, SMB
AF Lima Maciel, Bruna L.
   Valverde, Joanna Gardel
   Rodrigues-Neto, Joao Firmino
   Freire-Neto, Francisco
   Keesen, Tatjana S. L.
   Bezerra Jeronimo, Selma Maria
TI Dual Immune Modulatory Effect of Vitamin A in Human Visceral
   Leishmaniasis
SO PLOS ONE
LA English
DT Article
ID REGULATORY T-CELLS; TRANS-RETINOIC ACID; INDIAN KALA-AZAR; TGF-BETA;
   INTERFERON-GAMMA; SUBCLINICAL INFECTION; DONOVANI INFECTION; NORTHEAST
   BRAZIL; TH17 CELLS; CYTOKINE
AB Vitamin A supplementation has shown to prevent mortality by diarrheal and respiratory diseases in several countries. Nevertheless, there are few studies investigating the effect of vitamin A in visceral leishmaniasis (VL), although there are reports of its deficiency in children with symptomatic VL in Brazil and Bangladesh. This study analyzed the effect of vitamin A on a subset of Treg cells and monocytes isolated from symptomatic VL and from healthy children residing in an endemic area for VL in Northeast Brazil. Serum retinol concentrations correlated inversely with IL-10 and TGF-beta productions in CD4(+)CD25(high)Foxp3(+) T cells isolated from children with VL stimulated with leishmanial antigens. All-trans retinoic acid in vitro induced IL-10 in CD4(+)CD25(high)Foxp(3+) T cells; IL-10 and TGF-beta production in CD4(+)CD25(-)Foxp(3-) T cells, and IL-10 in monocytes isolated from healthy children. However, the use of all-trans retinoic acid together with leishmanial antigens in vitro prevented increases in IL-10 production in Treg cells and monocytes isolated from VL children. Strikingly, those results show a potential dual role of vitamin A in the immune system: improvement of a regulatory profile in cells from healthy children after leishmanial stimulation and down modulation of IL-10 in Treg cells and monocytes during symptomatic VL. Therefore, the use of vitamin A concomitant to VL therapy might be useful in improving recovery from disease status caused by Leishmania infantum infection and warrants additional study.
C1 [Lima Maciel, Bruna L.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Dept Nutr, BR-59072970 Natal, RN, Brazil.
   [Lima Maciel, Bruna L.; Valverde, Joanna Gardel; Rodrigues-Neto, Joao Firmino; Freire-Neto, Francisco; Keesen, Tatjana S. L.; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Lima Maciel, Bruna L.; Freire-Neto, Francisco; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Natl Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Valverde, Joanna G/C-1284-2014; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020
OI Valverde, Joanna G/0000-0001-8064-6255; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904; Rodrigues
   Neto, Joao Firmino/0000-0001-8897-4341
FU National Institutes of Health, USAUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI-30639];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq,
   BrazilNational Council for Scientific and Technological Development
   (CNPq); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER
FX This work has been supported by the National Institutes of Health, USA
   (AI-30639) and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPq, Brazil. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adalid-Peralta L, 2011, INT J BIOL SCI, V7, P1412, DOI 10.7150/ijbs.7.1412
   ADINOLFI LE, 1985, INFECT IMMUN, V48, P409, DOI 10.1128/IAI.48.2.409-416.1985
   Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001
   Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092
   Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719
   Bern C, 2007, AM J TROP MED HYG, V76, P909
   Bottrel RLA, 2001, INFECT IMMUN, V69, P3232, DOI 10.1128/IAI.69.5.3232-3239.2001
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113
   Cantorna MT, 1996, J IMMUNOL, V156, P2674
   Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   Cippitelli M, 1996, J BIOL CHEM, V271, P26783, DOI 10.1074/jbc.271.43.26783
   Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680
   Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27
   Di Caro V, 2013, CLIN EXP IMMUNOL, V174, P302, DOI 10.1111/cei.12177
   DOENHOFF MJ, 1991, PARASITOL TODAY, V7, P16, DOI 10.1016/0169-4758(91)90079-4
   Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Ganguly S, 2010, J INVEST DERMATOL, V130, P1013, DOI 10.1038/jid.2009.393
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Garg R, 2004, PARASITOLOGY, V129, P685, DOI 10.1017/S0031182004006055
   Gautam S, 2014, J INFECT DIS, V209, P290, DOI 10.1093/infdis/jit401
   GLASZIOU PP, 1993, BMJ-BRIT MED J, V306, P366, DOI 10.1136/bmj.306.6874.366
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   HAIDARIS CG, 1983, AM J TROP MED HYG, V32, P286, DOI 10.4269/ajtmh.1983.32.286
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Joshi T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000431
   Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kenney RT, 1998, J INFECT DIS, V177, P815, DOI 10.1086/517817
   Liu LM, 2006, PARASITOL RES, V99, P189, DOI 10.1007/s00436-006-0168-1
   Ma J, 2013, J LEUKOC BIOL
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Maggini S, 2007, BRIT J NUTR, V98, pS29, DOI 10.1017/S0007114507832971
   Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950
   Mayne ST, 1998, AM J CLIN NUTR, V68, P642
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Montenegro J, 1926, ARCH DERMATOL SYPH, V13, P187, DOI 10.1001/archderm.1926.02370140053003
   Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697
   Murray HW, 2005, INFECT IMMUN, V73, P3903, DOI 10.1128/IAI.73.7.3903-3911.2005
   Murray HW, 2003, J INFECT DIS, V188, P458, DOI 10.1086/376510
   Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639
   Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141
   Nylen S, 2010, J GLOB INFECT DIS, V2, P135, DOI 10.4103/0974-777X.62876
   PASATIEMPO AMG, 1990, FASEB J, V4, P2518
   Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813
   Qiao Z, 1999, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V17, P21
   Rai AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031551
   Rodrigues OR, 2009, IMMUNOBIOLOGY, V214, P101, DOI 10.1016/j.imbio.2008.07.001
   SACKS DL, 1987, J IMMUNOL, V138, P908
   Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785
   Sankaranarayanan S, 2007, J NUTR, V137, P1229
   Singh OP, 2012, CLIN VACCINE IMMUNOL, V19, P961, DOI 10.1128/CVI.00143-12
   SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013
   Stephensen CB, 2004, J NUTR, V134, P2660
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660
   WHO UNICEF IVACG Task Force, 1997, VIT SUPPL GUID THEIR
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277
   Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725
   Yin G, 1998, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V16, P251
   Ziegler SF, 2009, MICROBES INFECT, V11, P594, DOI 10.1016/j.micinf.2009.04.002
NR 71
TC 7
Z9 7
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 30
PY 2014
VL 9
IS 9
AR e107564
DI 10.1371/journal.pone.0107564
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR6CW
UT WOS:000343671700040
PM 25268355
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Moura, RS
   Buhrer-Sekula, S
   Jeronimo, SMB
   Stefani, MMA
AF Moura, Rodrigo Scaliante
   Buehrer-Sekula, Samira
   Bezerra Jeronimo, Selma Maria
   Araujo Stefani, Mariane Martins
TI Phenolic Glycolipid-I Does Not Cross-react With Visceral Leishmaniasis
   Sera in a Brazilian Subset
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
ID HANSENS-DISEASE LEPROSY
C1 [Moura, Rodrigo Scaliante; Buehrer-Sekula, Samira; Araujo Stefani, Mariane Martins] Univ Goias, Inst Trop Med & Publ Hlth, Goiania, Go, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Rio Grande Norte, Biosci Ctr, Natal, RN, Brazil.
RP Buhrer-Sekula, S (corresponding author), Inst Patol Trop & Saude Publ, Alameda Acacias,QD37,LT01, Goiania, Go, Brazil.
EM samira@buhrer.net
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Buhrer-Sekula, Samira/H-5115-2012
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Buhrer-Sekula, Samira/0000-0002-5984-7770
CR BRETT SJ, 1983, CLIN EXP IMMUNOL, V52, P271
   Buhrer-Sekula S, 2000, INT J LEPROSY, V68, P456
   de Moura RS, 2008, REV SOC BRAS MED TRO, V41, P11, DOI 10.1590/S0037-86822008000700004
   Ministerio da Saude, 2013, SINAN SIST INF AGR N
   Moura MLN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002093
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Sinha R, 2010, CLIN INFECT DIS, V50, P937, DOI 10.1086/650541
NR 7
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL 15
PY 2014
VL 59
IS 2
DI 10.1093/cid/ciu277
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AM2FR
UT WOS:000339665700029
PM 24759833
OA Bronze
DA 2020-11-26
ER

PT J
AU Eu-ahsunthornwattana, J
   Miller, EN
   Fakiola, M
   Jeronimo, SMB
   Blackwell, JM
   Cordell, HJ
AF Eu-ahsunthornwattana, Jakris
   Miller, E. Nancy
   Fakiola, Michaela
   Jeronimo, Selma M. B.
   Blackwell, Jenefer M.
   Cordell, Heather J.
CA Wellcome Trust Case Control
TI Comparison of Methods to Account for Relatedness in Genome-Wide
   Association Studies with Family-Based Data
SO PLOS GENETICS
LA English
DT Article
ID MISSING GENOTYPE DATA; LINEAR MIXED MODELS; POPULATION-STRUCTURE;
   CRYPTIC RELATEDNESS; UNIFIED APPROACH; INDIVIDUALS; TESTS; LINKAGE;
   TRAIT; INFORMATION
AB Approaches based on linear mixed models (LMMs) have recently gained popularity for modelling population substructure and relatedness in genome-wide association studies. In the last few years, a bewildering variety of different LMM methods/software packages have been developed, but it is not always clear how (or indeed whether) any newly-proposed method differs from previously-proposed implementations. Here we compare the performance of several LMM approaches (and software implementations, including EMMAX, GenABEL, FaST-LMM, Mendel, GEMMA and MMM) via their application to a genome-wide association study of visceral leishmaniasis in 348 Brazilian families comprising 3626 individuals (1972 genotyped). The implementations differ in precise details of methodology implemented and through various user-chosen options such as the method and number of SNPs used to estimate the kinship (relatedness) matrix. We investigate sensitivity to these choices and the success (or otherwise) of the approaches in controlling the overall genome-wide error-rate for both real and simulated phenotypes. We compare the LMM results to those obtained using traditional family-based association tests (based on transmission of alleles within pedigrees) and to alternative approaches implemented in the software packages MQLS, ROADTRIPS and MASTOR. We find strong concordance between the results from different LMM approaches, and all are successful in controlling the genome-wide error rate (except for some approaches when applied naively to longitudinal data with many repeated measures). We also find high correlation between LMMs and alternative approaches (apart from transmission-based approaches when applied to SNPs with small or non-existent effects). We conclude that LMM approaches perform well in comparison to competing approaches. Given their strong concordance, in most applications, the choice of precise LMM implementation cannot be based on power/type I error considerations but must instead be based on considerations such as speed and ease-of-use.
C1 [Eu-ahsunthornwattana, Jakris; Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Eu-ahsunthornwattana, Jakris; Wellcome Trust Case Control] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Med Genet,Dept Internal Med, Bangkok 10400, Thailand.
   [Miller, E. Nancy; Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Ctr Biosci, BR-59072970 Natal, RN, Brazil.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia.
RP Eu-ahsunthornwattana, J (corresponding author), Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM heather.cordell@newcastle.ac.uk
RI Eu-ahsunthornwattana, Jakris/AAL-1435-2020; Jeronimo,
   Selma/AAY-4033-2020; Blackwell, Jenefer M/H-3015-2015; Jeronimo, Selma
   M.B./M-8672-2014
OI Eu-ahsunthornwattana, Jakris/0000-0002-8060-9566; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Fakiola, Michaela/0000-0001-9071-4709
FU Wellcome TrustWellcome Trust [087436, 085475]; Faculty of Medicine
   Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
FX This work was supported by the Wellcome Trust (Grant Reference 087436).
   This study makes use of data generated by the Wellcome Trust funded
   WTCCC2 project (Grant Reference 085475). JEa receives scholarship and
   funding from Faculty of Medicine Ramathibodi Hospital, Mahidol
   University, Bangkok, Thailand. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705
   Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109
   Almasy L, 2014, GENET EPIDE IN PRESS
   Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274
   Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307
   Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x
   Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580
   Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x
   Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108
   Dudbridge F, 2011, ANN HUM GENET, V75, P428, DOI 10.1111/j.1469-1809.2010.00636.x
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   Eu-Ahsunthornwattana Jakris, 2014, BMC Proc, V8, pS79, DOI 10.1186/1753-6561-8-S1-S79
   Fakiola M, 2013, NAT GENET, V45, P208, DOI 10.1038/ng.2518
   Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52
   Furlotte NA, 2012, GENET EPIDEMIOL, V36, P463, DOI 10.1002/gepi.21640
   HENDERSON CR, 1953, BIOMETRICS, V9, P226, DOI 10.2307/3001853
   Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625
   Jakobsdottir J, 2013, AM J HUM GENET, V92, P652, DOI 10.1016/j.ajhg.2013.03.014
   Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101
   Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548
   Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D
   Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895
   Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563
   Lange K, 2013, BIOINFORMATICS, V29, P1568, DOI 10.1093/bioinformatics/btt187
   Lippert C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01815
   Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]
   Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037
   Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559
   Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088
   Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957
   Pirinen M, 2013, ANN APPL STAT, V7, P369, DOI 10.1214/12-AOAS586
   Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865
   Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795
   Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918
   Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251
   Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010
   SPIELMAN RS, 1993, AM J HUM GENET, V52, P506
   Svishcheva GR, 2012, NAT GENET, V44, P1166, DOI 10.1038/ng.2410
   Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001
   Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497
   Wang K, 2013, HUM HERED, V76, P1, DOI 10.1159/000353345
   Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011
   Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702
   Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546
   Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310
NR 48
TC 54
Z9 54
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD JUL
PY 2014
VL 10
IS 7
AR e1004445
DI 10.1371/journal.pgen.1004445
PG 20
WC Genetics & Heredity
SC Genetics & Heredity
GA AM5ME
UT WOS:000339902600008
PM 25033443
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Araujo, SRF
   Jamieson, SE
   Dupnik, KM
   Monteiro, GR
   Nobre, ML
   Dias, MS
   Neto, PBT
   Queiroz, MDP
   Gomes, CEM
   Blackwell, JM
   Jeronimo, SMB
AF Fernandes Araujo, Sergio Ricardo
   Jamieson, Sarra Elisabeth
   Dupnik, Kathryn Margaret
   Monteiro, Gloria Regina
   Nobre, Mauricio Lisboa
   Dias, Marcia Sousa
   Trindade Neto, Pedro Bezerra
   Palmeira Queiroz, Maria do Carmo
   Maia Gomes, Carlos Eduardo
   Blackwell, Jenefer Mary
   Bezerra Jeronimo, Selma Maria
TI Examining ERBB2 as a candidate gene for susceptibility to leprosy
   (Hansen's disease) in Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE leprosy; genetic susceptibility; ErbB2 receptor; Brazil
ID TUBERCULOSIS; RISK; ASSOCIATION; GENOTYPE; GENOME; CANCER
AB Leprosy remains prevalent in Brazil. ErbB2 is a receptor for leprosy bacilli entering Schwann cells, which mediates Mycobacterium leprae-induced demyelination and the ERBB2 gene lies within a leprosy susceptibility locus on chromosome 17q11-q21. To determine whether polymorphisms at the ERBB2 locus contribute to this linkage peak, three haplotype tagging single nucleotide polymorphisms (tag-SNPs) (rs2517956, rs2952156, rs1058808) were genotyped in 72 families (208 cases; 372 individuals) from the state of Para (PA). All three tag-SNPs were associated with leprosy per se [best SNP rs2517959 odds ratio (OR) = 2.22; 95% confidence interval (CI) 1.37-3.59; p = 0.001]. Lepromatous (LL) (OR = 3.25; 95% CI 1.37-7.70; p = 0.007) and tuberculoid (TT) (OR = 1.79; 95% CI 1.04-3.05; p = 0.034) leprosy both contributed to the association, which is consistent with the previous linkage to chromosome 17q11-q21 in the population from PA and supports the functional role of ErbB2 in disease pathogenesis. To attempt to replicate these findings, six SNPs (rs2517955, rs2517956, rs1810132, rs2952156, rs1801200, rs1058808) were genotyped in a population-based sample of 570 leprosy cases and 370 controls from the state of Rio Grande do Norte (RN) and the results were analysed using logistic regression analysis. However, none of the associations were replicated in the RN sample, whether analysed for leprosy per se, LL leprosy, TT leprosy, erythema nodosum leprosum or reversal reaction conditions. The role of polymorphisms at ERBB2 in controlling susceptibility to leprosy in Brazil therefore remains unclear.
C1 [Fernandes Araujo, Sergio Ricardo; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biocencias, BR-59072970 Natal, RN, Brazil.
   [Monteiro, Gloria Regina; Nobre, Mauricio Lisboa; Maia Gomes, Carlos Eduardo; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Med Trop Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Trindade Neto, Pedro Bezerra] Univ Fed Rio Grande do Norte, Dept Clin Med, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil.
   [Palmeira Queiroz, Maria do Carmo] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, BR-59072970 Natal, RN, Brazil.
   [Maia Gomes, Carlos Eduardo] Univ Fed Rio Grande do Norte, Dept Biofis & Farmacol, BR-59072970 Natal, RN, Brazil.
   [Jamieson, Sarra Elisabeth; Blackwell, Jenefer Mary] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Nobre, Mauricio Lisboa] Hosp Giselda Trigueiro, Secretaria Saude Estado Rio Grande do Norte, Natal, RN, Brazil.
   [Dias, Marcia Sousa] Univ Estado Rio Grande do Norte, Fac Med, Mossoro, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Inst Nacl Ciencia & Tecnol Doencas Trop, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biocencias, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Blackwell, Jenefer M/H-3015-2015; Jeronimo, Selma/AAY-4033-2020;
   Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Nobre, Mauricio/0000-0003-4932-3137
FU Wellcome TrustWellcome Trust; INCT-DT; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613] Funding
   Source: NIH RePORTER
FX The Wellcome Trust (to JMB) and INCT-DT SRFA and SEJ contributed equally
   to this work. JMB and SMBJ contributed equally to supervision of the
   work.
CR Beck-Bleumink M, 1992, INT J LEPROSY, V60, P173
   Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x
   Trindade MAB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000921
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   CARTEL JL, 1992, LEPROSY REV, V63, P223
   Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851
   Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307
   Fernando SL, 2006, IMMUNOL CELL BIOL, V84, P125, DOI 10.1111/j.1440-1711.2006.01420.x
   FINE PEM, 1983, INT J LEPROSY, V51, P553
   Frank B, 2005, CARCINOGENESIS, V26, P643, DOI 10.1093/carcin/bgh342
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029
   Manglani P R, 2006, J Indian Med Assoc, V104, P686
   Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Moura MLN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002093
   O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Sreenivasan P, 1998, IMMUNOLOGY, V95, P529, DOI 10.1046/j.1365-2567.1998.00634.x
   Subramanian M, 2003, Indian J Lepr, V75, P335
   Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433
   Tong SY, 2009, BJOG-INT J OBSTET GY, V116, P1046, DOI 10.1111/j.1471-0528.2009.02186.x
   Walker SL, 2006, BRIT MED BULL, V77-78, P103, DOI 10.1093/bmb/ldl010
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
NR 25
TC 2
Z9 2
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD APR
PY 2014
VL 109
IS 2
BP 182
EP 188
DI 10.1590/0074-0276130344
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AJ7VQ
UT WOS:000337908500008
PM 24676663
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Fraga, DBM
   da Silva, ED
   Pacheco, LV
   Borja, LS
   de Oliveira, IQ
   Coura-Vital, W
   Monteiro, GR
   Oliveira, GGD
   Jeronimo, SMB
   Reis, AB
   Veras, PST
AF Mothe Fraga, Deborah Bittencourt
   da Silva, Edimilson Domingos
   Pacheco, Luciano Vasconcellos
   Borja, Lairton Souza
   de Oliveira, Isaac Queiroz
   Coura-Vital, Wendel
   Monteiro, Gloria Regina
   de Sa Oliveira, Geraldo Gileno
   Bezerra Jeronimo, Selma Maria
   Reis, Alexandre Barbosa
   Tavares Veras, Patricia Sampaio
TI A multicentric evaluation of the recombinant Leishmania infantum
   antigen-based immunochromatographic assay for the serodiagnosis of
   canine visceral leishmaniasis
SO PARASITES & VECTORS
LA English
DT Article
DE Canine visceral leishmaniasis; Serological diagnosis; Recombinant
   antigen; Rapid test; Multicentric study
ID TUBERCULOSIS; IMMUNOASSAY
AB Background: Visceral leishmaniasis (VL) is a serious public health challenge in Brazil and dogs are considered to be the main urban reservoir of the causative agent. The culling of animals to control VL in some countries makes the accurate diagnosis of canine VL (CVL) essential. Recombinant antigens rLci1A and rLci2B were selected from a cDNA library of Leishmania infantum amastigotes due to their strong potential as candidates in diagnostic testing for CVL. The present multicentric study aimed to evaluate the sensitivity of a prototype test using these antigens (DPP rLci1A/ rLci2B) against 154 sera obtained from symptomatic dogs within three endemic areas of VL in Brazil. The specificity was evaluated using 40 serum samples from negative dogs and dogs infected with other pathogens. Sensitivity and specificity rates of DPP rLci1A/rLci2B prototype were compared to rates from other diagnostic tests currently in use by the Brazilian Ministry of Health, including DPP (R) LVC, EIE (R) LVC.
   Findings: DPP rLci1A/rLci2B prototype offered similar performance to that offered by DPP (R) LVC rapid test, as follows: sensitivity of 87% (CI 81-91) and 88% (CI 82-93) and specificity of 100% (CI 91-100) and 97% (CI 87-100), respectively for DPP rLci1A/rLci2B and DPP (R) LVC. When results of these two tests were considered concomitantly, sensitivity increased to 93.5% (CI 89-96).
   Conclusions: The recombinant antigens rLci1A and rLci2B represent promising candidates for use in a multi-antigen rapid test for CVL. The inclusion of novel antigens to the DPP rLci1A/rLci2B prototype model could offer additionally enhanced sensitivity to detect animals infected by L. infantum.
C1 [Mothe Fraga, Deborah Bittencourt; Pacheco, Luciano Vasconcellos; Borja, Lairton Souza; de Oliveira, Isaac Queiroz; de Sa Oliveira, Geraldo Gileno; Tavares Veras, Patricia Sampaio] Fiocruz MS, Lab Patol & Biointervencao, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
   [Mothe Fraga, Deborah Bittencourt] Univ Fed Bahia, Escola Med Vet & Zootecnia, Dept Med Vet Prevent & Prod Anim, Salvador, BA, Brazil.
   [Mothe Fraga, Deborah Bittencourt; Coura-Vital, Wendel; Monteiro, Gloria Regina; de Sa Oliveira, Geraldo Gileno; Bezerra Jeronimo, Selma Maria; Reis, Alexandre Barbosa; Tavares Veras, Patricia Sampaio] INCT DT, Inst Ciencia & Tecnol Doencas Tropicais, Salvador, BA, Brazil.
   [da Silva, Edimilson Domingos] Fiocruz MS, Lab Tecnol Diagnost, Inst Tecnol Imunobiol, Biomanguinhos, BR-21045900 Rio De Janeiro, Brazil.
   [Coura-Vital, Wendel] Univ Fed Minas Gerais, Fac Med, Belo Horizonte, MG, Brazil.
   [Coura-Vital, Wendel; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.
   [Monteiro, Gloria Regina; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
RP Veras, PST (corresponding author), Fiocruz MS, Lab Patol & Biointervencao, Ctr Pesquisa Goncalo Moniz, Salvador, BA, Brazil.
EM pveras@bahia.fiocruz.com
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Veras,
   Patricia S T Sampaio Tavares/I-9632-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Veras, Patricia S T Sampaio
   Tavares/0000-0001-8308-9263; Gileno de Sa Oliveira,
   Geraldo/0000-0001-6065-6480; /0000-0002-1434-7676
FU INCT
FX This study received funding from INCT. The authors would like to thank
   Andris K. Walter for providing English revision and consulting services.
   Additionally, the authors acknowledge Dr. Edgar M. Carvalho for help in
   the study design.
CR Almeida MAO, 2005, VET PARASITOL, V127, P227, DOI 10.1016/j.vetpar.2004.10.010
   [Anonymous], 2006, MAN VIG CONTR LEISHM
   Costa MM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001622
   De Souza CM, 2012, PARASITE IMMUNOL, V34, P1, DOI 10.1111/j.1365-3024.2011.01334.x
   Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
   Ireton GC, 2010, CLIN VACCINE IMMUNOL, V17, P1539, DOI 10.1128/CVI.00198-10
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lyashchenko KP, 2007, CLIN VACCINE IMMUNOL, V14, P1158, DOI 10.1128/CVI.00230-07
   Lyashchenko KP, 2000, J IMMUNOL METHODS, V242, P91, DOI 10.1016/S0022-1759(00)00241-6
   Nunes V L, 2001, Rev Soc Bras Med Trop, V34, P299, DOI 10.1590/S0037-86822001000300014
   Oliveira GGS, 2011, AM J TROP MED HYG, V85, P1025, DOI 10.4269/ajtmh.2011.11-0102
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86
   Teixeira MCA, 2007, BIOLOGICALS, V35, P51, DOI 10.1016/j.biologicals.2006.01.005
   WHO, 2010, WHO TECH REP SER, V949, P1
NR 15
TC 8
Z9 8
U1 0
U2 9
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 31
PY 2014
VL 7
AR 136
DI 10.1186/1756-3305-7-136
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA AG3TN
UT WOS:000335342700002
PM 24684857
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU da Silva, MDC
   Galvao, ACAD
   de Souza, NL
   de Azevedo, GD
   Jeronimo, SMB
   de Araujo, ACPF
AF Costa da Silva, Maria de Lourdes
   Araujo de Andrade Galvao, Ana Cristina
   de Souza, Nilba Lima
   de Azevedo, George Dantas
   Bezerra Jeronimo, Selma Maria
   Pinheiro Fernandes de Araujo, Ana Cristina
TI Women with cardiovascular risk after preeclampsia: is there follow-up
   within the Unified Health System in Brazil?
SO REVISTA LATINO-AMERICANA DE ENFERMAGEM
LA English
DT Article
DE Lost to Follow-Up; Pre-Eclampsia; Risk Management; Cardiovascular
   Diseases
ID DISEASE RISK; HYPERTENSION; PREGNANCY
AB Objectives: to identify women with cardiovascular risk, five years after a preeclampsic episode (PE), and identify the follow-up of these women within the Unified Health System (Sistema Unico de Saude-SUS), in the city of Natal/RN. Methods: a quantitative and exploratory study conducted at the Januario Cicco University Maternity Ward/RN. The sample consisted of 130 women, 65 with a PE episode and 65 who were normotensive. Results: we found statistical significance with regard to body mass index, weight, family history of cardiovascular disease (CVD) and cardiovascular complications when comparing women with previous PE to normotensive women. The groups were unaware of their cardiovascular risk factors and, in addition, they reported difficulties in accessing primary health care (PHC) services. Conclusions: women with a PE history are at increased risk of developing CVD, unaware of late PE complications, and lacked customized care when compared to normotensive patients.
C1 [Costa da Silva, Maria de Lourdes; Araujo de Andrade Galvao, Ana Cristina; de Souza, Nilba Lima] Univ Fed Rio Grande do Norte, Dept Enfermagem, Ctr Ciencias Saude, BR-59078970 Natal, RN, Brazil.
   [Araujo de Andrade Galvao, Ana Cristina] Univ Fed Rio Grande do Norte, Escola Enfermagem, BR-59078970 Natal, RN, Brazil.
   [de Azevedo, George Dantas; Bezerra Jeronimo, Selma Maria; Pinheiro Fernandes de Araujo, Ana Cristina] Univ Fed Rio Grande do Norte, Ctr Biociencias, BR-59078970 Natal, RN, Brazil.
RP da Silva, MDC (corresponding author), Univ Fed Rio Grande do Norte, Dept Enfermagem, Ctr Ciencias Saude, Av Senador Salgado Filho S-N,Campus Univ, BR-59078970 Natal, RN, Brazil.
EM lurdinhafoc@hotmail.com
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR [Anonymous], 2002, OBSTET GYNECOL, V99, P159
   Cassidy-Bushrow AE, 2009, J WOMENS HEALTH, V18, P1709, DOI 10.1089/jwh.2008.1285
   Cesarino CB, 2008, ARQ BRAS CARDIOL, V91, P29
   de Padua KS, 2010, REV SAUDE PUBL, V44, P70, DOI 10.1590/S0034-89102010000100008
   FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1
   Firoz T, 2011, BEST PRACT RES CL OB, V25, P549, DOI 10.1016/j.bpobgyn.2011.03.003
   Forest JC, 2005, OBSTET GYNECOL, V105, P1373, DOI 10.1097/01.AOG.0000163252.02227.f8
   Lu J, 2011, CHINESE MED J-PEKING, V124, P775, DOI 10.3760/cma.j.issn.0366-6999.2011.05.026
   MacDonald SE, 2007, J OBSTET GYNAECOL CA, V29, P705, DOI 10.1016/S1701-2163(16)32601-9
   Mangos GJ, 2012, J HYPERTENS, V30, P351, DOI 10.1097/HJH.0b013e32834e5ac7
   Mansur AP, 2011, ARQ BRAS CARDIOL, V99, P755
   McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042
   Ministerio da Saude (BR). Conselho Nacional de Secretaries de Saude, 2011, AT PRIM PROM SAUD
   Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330
   Nauderer TM, 2008, REV LAT-AM ENFERM, V16, P889, DOI 10.1590/S0104-11692008000500015
   de Melo BCP, 2009, REV ASSOC MED BRAS, V55, P175, DOI 10.1590/S0104-42302009000200022
   Carolino IDR, 2008, REV LAT-AM ENFERM, V16, P238, DOI 10.1590/S0104-11692008000200011
   Smith GN, 2012, J OBSTET GYNAECOL CA, V34, P830, DOI 10.1016/S1701-2163(16)35381-6
   Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190
   Valdiviezo C, 2012, CLIN CARDIOL, V35, P160, DOI 10.1002/clc.21965
NR 20
TC 1
Z9 1
U1 0
U2 6
PU UNIV SAO PAULO, ESCOLA DE ENFERMAGEM DE RIBEIRAO PRETO
PI RIBEIRAO PRETO
PA AV BANDEIRANTES, 3900, RIBEIRAO PRETO, SP 14040-902  A, BRAZIL
SN 1518-8345
J9 REV LAT-AM ENFERM
JI Rev. Latino-Am. Enfermagem
PD JAN-FEB
PY 2014
VL 22
IS 1
BP 93
EP 99
DI 10.1590/0104-1169.3197.2389
PG 7
WC Nursing
SC Nursing
GA AA8LC
UT WOS:000331346000013
PM 24553708
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Macedo-Silva, VP
   Martins, DRA
   De Queiroz, PVS
   Pinheiro, MPG
   Freire, CCM
   Queiroz, JW
   Dupnik, KM
   Pearson, RD
   Wilson, ME
   Jeronimo, SMB
   Ximenes, MDFF
AF Macedo-Silva, Virginia P.
   Martins, Daniella R. A.
   Souza De Queiroz, Paula Vivianne
   Pinheiro, Marcos Paulo G.
   Freire, Caio C. M.
   Queiroz, Jose W.
   Dupnik, Kathryn M.
   Pearson, Richard D.
   Wilson, Mary E.
   Jeronimo, Selma M. B.
   Ximenes, Maria De Fatima F. M.
TI Feeding Preferences of Lutzomyia longipalpis (Diptera: Psychodidae), the
   Sand Fly Vector, for Leishmania infantum (Kinetoplastida:
   Trypanosomatidae)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Leishmania infantum; Lutzomyia longipalpis; opossum; host preference;
   sand fly
ID AMERICAN VISCERAL LEISHMANIASIS; GRANDE-DO-NORTE; NEW-WORLD;
   DIDELPHIS-MARSUPIALIS; PHLEBOTOMUS-PAPATASI; CHAGASI; BRAZIL; STATE;
   URBAN; INFECTION
AB Leishmania infantum, the causative agent of visceral leishmaniasis (VL) in Brazil, is spread mostly by the bite of the sand fly Lutzomyia longipalpis (Lutz& Neiva). Wetrapped sand flies in endemic neighborhoods near Natal, Brazil, where cases of human and dog VL were documented. Amplification of species-specific cytochrome b (Cyt b) genes by polymerase chain reaction revealed that sand flies from rural and periurban areas harbored blood from different sources. The most common source of bloodmeal was human, but blood from dog, chicken, and armadillo was also present. We tested the preference for a source of bloodmeal experimentally by feeding L. longipalpis F 1 with blood from different animals. There were significant differences between the proportion of flies engorged and number of eggs laid among flies fed on different sources, varying from 8.4 to 19 (P < 0.0001). Blood from guinea pig or horse was best to support sand fly oviposition, but human blood also supported sand fly oviposition well. No sand flies fed on cats, and sand flies feeding on the opossum Monodelphis domestica Wagner produced no eggs. These data support the hypothesis that L. longipalpis is an eclectic feeder, and humans are an important source of blood for this sand fly species in periurban areas of Brazil.
C1 [Macedo-Silva, Virginia P.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59078 Natal, RN, Brazil.
   [Martins, Daniella R. A.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biol & Genet, BR-59078 Natal, RN, Brazil.
   [Souza De Queiroz, Paula Vivianne] Coll Med, State Mossoro, RN, Brazil.
   [Pinheiro, Marcos Paulo G.; Freire, Caio C. M.; Ximenes, Maria De Fatima F. M.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Microbiol & Parasitol, BR-59078 Natal, RN, Brazil.
   [Queiroz, Jose W.] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59078 Natal, RN, Brazil.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Ctr Global Hlth, Div Infect Dis, New York, NY 10065 USA.
   [Pearson, Richard D.] Univ Virginia, Dept Med, Ctr Global Hlth, Div Infect Dis, Charlottesville, VA 22908 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Inst Trop Med Rio Grande Norte, Dept Biochem, BR-59078 Natal, RN, Brazil.
RP Ximenes, MDFF (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Microbiol & Parasitol, Av Sen Salgado Filho 3000, BR-59078 Natal, RN, Brazil.
EM ximenes@cb.ufrn.br
RI Freire, Caio/C-8248-2014; Jeronimo, Selma M.B./M-8672-2014; Jeronimo,
   Selma/AAY-4033-2020
OI Freire, Caio/0000-0002-7723-4230; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904; Wilson,
   Mary/0000-0001-8680-7275
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P50 AI-30639];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI076233]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); CAPESCAPES; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T-32]; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs
   [I01BX001983, I01BX001983, I01BX001983, I01BX001983, I01BX001983]
   Funding Source: NIH RePORTER
FX These studies were funded by grant P50 AI-30639 from the US National
   Institutes of Health (MEW, SMBJ), grant R01 AI076233 from the NIH (MEW),
   and by a grant from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (MFFMX and SMBJ). VPM received a fellowship from CAPES. KD
   received a fellowship from National Institutes of Health (T-32).
CR Bezerra HSD, 2001, MEM I OSWALDO CRUZ, V96, P349
   Carneiro DDMT, 2007, GEOSPATIAL HEALTH, V2, P113, DOI 10.4081/gh.2007.260
   Chelbi I, 2007, J MED ENTOMOL, V44, P597, DOI 10.1603/0022-2585(2007)44[597:BOPPDP]2.0.CO;2
   CORREDOR A, 1989, T ROY SOC TROP MED H, V83, P195, DOI 10.1016/0035-9203(89)90640-8
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Costa PL, 2013, ACTA TROP, V126, P99, DOI 10.1016/j.actatropica.2013.01.011
   Cross ER, 1996, ENVIRON HEALTH PERSP, V104, P724, DOI 10.2307/3433217
   Salomon OD, 2009, MEDICINA-BUENOS AIRE, V69, P625
   Afonso MMD, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/858657
   Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990
   Hemmer CJ, 2007, DEUT MED WOCHENSCHR, V132, P2583, DOI 10.1055/s-2007-993101
   Humberg RMP, 2012, AM J TROP MED HYG, V87, P470, DOI 10.4269/ajtmh.2012.11-0534
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   LAINSON R, 1977, NATURE, V266, P628, DOI 10.1038/266628a0
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   LAINSON R, 1972, BRIT MED BULL, V28, P44, DOI 10.1093/oxfordjournals.bmb.a070892
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Maia C, 2011, TRENDS PARASITOL, V27, P341, DOI 10.1016/j.pt.2011.03.008
   Malaviya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014751
   Marty P, 2007, ANN TROP MED PARASIT, V101, P563, DOI 10.1179/136485907X229121
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   MICHALSKY Érika M., 2002, Rev. Inst. Med. trop. S. Paulo, V44, P255, DOI 10.1590/S0036-46652002000500004
   Albuquerque PLMM, 2009, REV PANAM SALUD PUBL, V26, P330, DOI 10.1590/S1020-49892009001000007
   Nascimento M do D, 1996, Rev Soc Bras Med Trop, V29, P233
   Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8
   Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014
   QUINNELL RJ, 1992, MED VET ENTOMOL, V6, P195, DOI 10.1111/j.1365-2915.1992.tb00606.x
   Rotureau B, 2006, MED HYPOTHESES, V67, P1235, DOI 10.1016/j.mehy.2006.02.056
   Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018
   Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003
   Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004
   Travi BL, 1998, EXP PARASITOL, V88, P73, DOI 10.1006/expr.1998.4214
   Vides JP, 2011, VET PARASITOL, V178, P22, DOI 10.1016/j.vetpar.2010.12.042
   WIJEYARATNE PM, 1994, ACTA TROP, V56, P349, DOI 10.1016/0001-706X(94)90106-6
   Ximenes MDFFDM, 2007, NEOTROP ENTOMOL, V36, P128, DOI 10.1590/S1519-566X2007000100016
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Ximenes MDFFD, 2001, MEM I OSWALDO CRUZ, V96, P883
   Yoshida E L, 1979, Rev Inst Med Trop Sao Paulo, V21, P110
   Young DG, 1994, MEM AM ENTOMOL I, V54, DOI DOI 10.21236/ADA285737
NR 40
TC 16
Z9 16
U1 3
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2014
VL 51
IS 1
BP 237
EP 244
DI 10.1603/ME12131
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 291CF
UT WOS:000329804600027
PM 24605474
OA Green Accepted
DA 2020-11-26
ER

PT J
AU do Nascimento, PRP
   Martins, DRA
   Monteiro, GRG
   Queiroz, PV
   Freire-Neto, FP
   Queiroz, JW
   Lima, ALM
   Jeronimo, SMB
AF Porfirio do Nascimento, Paulo Ricardo
   Arantes Martins, Daniella Regina
   Gois Monteiro, Gloria Regina
   Queiroz, Paula Vivianne
   Freire-Neto, Francisco Paulo
   Queiroz, Jose Wilton
   Morais Lima, Adila Lorena
   Bezerra Jeronimo, Selma Maria
TI Association of Pro-Inflammatory Cytokines and Iron Regulatory Protein 2
   (IRP2) with Leishmania Burden in Canine Visceral Leishmaniasis
SO PLOS ONE
LA English
DT Article
ID IFN-GAMMA; INFECTION; DISEASE; BRAZIL; STEROIDOGENESIS; EPIDEMIOLOGY;
   REPLICATION; SUPPRESSION; INFANTUM; CHAGASI
AB Leishmania infantum infection in humans and dogs can evolve with a wide range of clinical presentations, varying from asymptomatic infections to visceral leishmaniasis. We hypothesized that the immune response elicited by L. infantum infection could modulate whether the host will remain asymptomatic or progress to disease. A total of 44 dogs naturally infected with L. infantum were studied. Leishmania burden was estimated in the blood and spleen by qPCR. The expression of IFN-gamma, TNF-alpha, IL-10 and Iron Regulatory Protein 2 (IRP2) were determined in the spleen by quantitative PCR. Sera cytokines were evaluated by ELISA. Dogs were grouped in quartiles according parasite burden. Increased expression of IFN-gamma and TNF-alpha was associated with reduced Leishmania burden, whereas increased IL-10 and IRP2 expressions were associated with higher Leishmania load. Increased plasma albumin and IFN-gamma expression explained 22.8% of the decrease in parasite burden in the spleen. These data confirm that lower IFN-gamma response and higher IL-10 correlated with increased parasite load and severity of the visceral leishmaniasis in dogs. The balance between the branches of immune response and the intracellular iron availability could determine, in part, the course of Leishmania infection.
C1 [Porfirio do Nascimento, Paulo Ricardo; Freire-Neto, Francisco Paulo; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Porfirio do Nascimento, Paulo Ricardo; Arantes Martins, Daniella Regina; Gois Monteiro, Gloria Regina; Freire-Neto, Francisco Paulo; Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   [Arantes Martins, Daniella Regina] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biol & Genet, BR-59072970 Natal, RN, Brazil.
   [Gois Monteiro, Gloria Regina; Morais Lima, Adila Lorena; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   [Queiroz, Paula Vivianne] State Univ Rio Grande Norte, Coll Med, Mossoro, RN, Brazil.
   [Queiroz, Jose Wilton; Bezerra Jeronimo, Selma Maria] Inst Sci & Technol Trop Dis INCT DT, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI030639-20];
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER
FX The study was funded in part with a grant from the National Institutes
   of Health (AI030639-20) and by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879
   Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020
   Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Baneth G, 2008, VET J, V175, P14, DOI 10.1016/j.tvjl.2006.11.011
   Bern C, 2007, AM J TROP MED HYG, V76, P909
   Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Coura-Vital W, 2011, Vet J, V190, pe43, DOI 10.1016/j.tvjl.2011.04.005
   EVANS TG, 1990, J PARASITOL, V76, P212, DOI 10.2307/3283018
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Figueroa F, 2012, LIFE SCI, V90, P733, DOI 10.1016/j.lfs.2012.03.019
   Gorski S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000705
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5
   Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Manna L, 2009, VET J, V182, P441, DOI 10.1016/j.tvjl.2008.08.009
   MARZOCHI MCA, 1994, PARASITOL TODAY, V10, P37, DOI 10.1016/0169-4758(94)90358-1
   Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004
   Olakanmi O, 2002, J BIOL CHEM, V277, P49727, DOI 10.1074/jbc.M209768200
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707
   Qian G, 1999, Pac Symp Biocomput, P314
   Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057
   Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807
   Salomon OD, 2009, MEM I OSWALDO CRUZ, V104, P801, DOI 10.1590/S0074-02762009000500024
   Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107
   Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Neto RGT, 2010, VET PARASITOL, V169, P248, DOI 10.1016/j.vetpar.2010.01.023
   Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Wilson ME, 1996, J IMMUNOL, V156, P2231
NR 38
TC 16
Z9 16
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 11
PY 2013
VL 8
IS 10
AR e73873
DI 10.1371/journal.pone.0073873
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 236SL
UT WOS:000325819400002
PM 24146743
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Dupnik, KM
   Cardoso, FJR
   de Macedo, ALBB
   de Sousa, ILC
   Leite, RCB
   Jeronimo, SMB
   Nobre, ML
AF Dupnik, Kathryn Margaret
   Ramos Cardoso, Fernando Jose
   Braga Brito de Macedo, Ana Luiza
   Cardoso de Sousa, Igor Leonardo
   Barros Leite, Renata Cristina
   Bezerra Jeronimo, Selma Maria
   Nobre, Mauricio Lisboa
TI Intolerance to Leprosy Multi-Drug Therapy: More Common in Women?
SO LEPROSY REVIEW
LA English
DT Article
ID DAPSONE; ANEMIA; CLOFAZIMINE; PATIENT
AB Objectives: The objective was to characterise and identify potential risk factors for intolerance to multi-drug leprosy therapy (MDT) which prompted a medication change in a leprosy referral centre in northeastern Brazil.
   Design: A retrospective chart review of leprosy patients treated at a state referral centre for leprosy in Natal, Rio Grande do Norte, Brazil was completed. Chart review focus was on adverse effects necessitating modification of MDT regimen.
   Results: Six hundred and twelve records were reviewed with detection of 91 (14.8%) adverse effects with associated change in MDT regimen. The most common recorded causes of medication intolerance were anemia (8.7%), headache (4.2%), cyanosis (1.8%), and gastrointestinal symptoms (1.6%). Both female gender (OR = 2.63) and age less than 42 years old (OR = 2.7) remained risk factors for MDT intolerance in a multivariate model including gender, age, and WHO regimen type. With intolerance due to anemia as the outcome, female gender (OR = 2.36) and age less than 42 years (OR -= 1.86) were associated.
   Conclusions: In this study, female gender and younger age were associated with greater risk of medication intolerance and medication intolerance related to anemia. These findings have important operational implications for drug intolerance monitoring during therapy for leprosy.
C1 [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA.
   [Ramos Cardoso, Fernando Jose; Nobre, Mauricio Lisboa] Giselda Trigueiro Hosp, Natal, RN, Brazil.
   [Braga Brito de Macedo, Ana Luiza; Cardoso de Sousa, Igor Leonardo; Barros Leite, Renata Cristina; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria; Nobre, Mauricio Lisboa] Natl Inst Sci & Technol INCT DT, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria; Nobre, Mauricio Lisboa] Univ Fed Rio Grande do Norte, Inst Trop Med Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   [Nobre, Mauricio Lisboa] Fiocruz MS, Inst Oswaldo Cruz, Postgrad Program Trop Med, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Nobre, ML (corresponding author), Hosp Giselda Trigueiro, Rua Conego Monte 110, BR-59037170 Natal, RN, Brazil.
EM nobreml@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Nobre, Mauricio/0000-0003-4932-3137
FU KMD [5T32-AI007613-12]; Burroughs Wellcome Fund/American Society of
   Tropical MedicineBurroughs Wellcome Fund; Tropical Infectious Diseases;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613,
   T32AI007613, T32AI007613, T32AI007613, T32AI007613, T32AI007613] Funding
   Source: NIH RePORTER
FX We would like to thank the staff of the Hansen's disease treatment team
   at Hospital Giselda Trigueiro for their care and Dr. Warren Johnson for
   helpful suggestions for the manuscript. KMD was supported by
   5T32-AI007613-12 and a Burroughs Wellcome Fund/American Society of
   Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical
   Infectious Diseases. The funders had no role in study design.
CR Armed Forces Health Surveillance Center (AFHSC), 2012, MSMR, V19, P17
   Brasil MTLRD, 1996, INT J LEPROSY, V64, P97
   BYRD SR, 1991, LEPROSY REV, V62, P171
   De D, 2007, LEPROSY REV, V78, P401
   de Sena L L, 1986, AMB Rev Assoc Med Bras, V32, P17
   Deps PD, 2007, LEPROSY REV, V78, P216
   Vieira JLF, 2010, BRAZ J INFECT DIS, V14, P319, DOI 10.1590/S1413-86702010000300022
   FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245
   Goncalves HD, 2012, MEM I OSWALDO CRUZ, V107, P74, DOI 10.1590/S0074-02762012000900013
   Goulart IMB, 2005, LEPROSY REV, V76, P167
   Goulart Isabela Maria Bernades, 2002, Rev. Soc. Bras. Med. Trop., V35, P453, DOI 10.1590/S0037-86822002000500005
   Kaluarachchi S I, 2001, Indian J Lepr, V73, P121
   Kannan G, 2009, INDIAN J PHARM SCI, V71, P456, DOI 10.4103/0250-474X.57301
   Kosseifi SG, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-9
   Lopez-Gomez M, 2011, NEUROL SCI, V32, P1063, DOI 10.1007/s10072-011-0612-6
   Mirakian R, 2009, CLIN EXP ALLERGY, V39, P43, DOI 10.1111/j.1365-2222.2008.03155.x
   PUAVILAI S, 1984, J MED ASSOC THAILAND, V67, P404
   Queiroz R H, 1997, Pharm Acta Helv, V72, P209, DOI 10.1016/S0031-6865(97)00016-2
   Queiroz RHC, 2002, PHARMACOL RES, V46, P191, DOI 10.1016/S1043-6618(02)00086-5
   Queiroz RHC, 1997, LEPROSY REV, V68, P212
   Ranawaka RR, 2008, LEPROSY REV, V79, P436
   Sapkota BR, 2008, LEPROSY REV, V79, P425
   Singh H, 2011, LEPROSY REV, V82, P17
   Tsankov N, 2004, DM-DIS MON, V50, P369, DOI 10.1016/j.disamonth.2004.05.008
   Varkevisser CM, 2009, LEPROSY REV, V80, P65
   Warrington Richard, 2011, Allergy Asthma Clin Immunol, V7 Suppl 1, pS10, DOI 10.1186/1710-1492-7-S1-S10
   *WHO, 2012, 8 WHO EXP COMM LEPR
   WHO, 2012, WKLY EPIDEMIOL REC, V87, P317
   Wolf R, 2000, CLIN DERMATOL, V18, P37, DOI 10.1016/S0738-081X(99)00093-0
NR 29
TC 6
Z9 6
U1 0
U2 5
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD SEP
PY 2013
VL 84
IS 3
BP 209
EP 218
PG 10
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA 280AB
UT WOS:000328999900006
PM 24428115
DA 2020-11-26
ER

PT J
AU Dantas, EMD
   Pereira, FVM
   Queiroz, JW
   Dantas, DLD
   Monteiro, GRG
   Duggal, P
   Azevedo, MD
   Jeronimo, SMB
   Araujo, ACPF
AF de Melo Dantas, Edailna Maria
   Marinho Pereira, Flavio Venicio
   Queiroz, Jose Wilton
   de Melo Dantas, Diogo Luis
   Gois Monteiro, Gloria Regina
   Duggal, Priya
   Azevedo, Maria de Fatima
   Bezerra Jeronimo, Selma Maria
   Pinheiro Fernandes Araujo, Ana Cristina
TI Preeclampsia is associated with increased maternal body weight in a
   northeastern Brazilian population
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Preeclampsia; BMI; Obesity; Hypertension; Pregnancy
ID GESTATIONAL HYPERTENSION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE;
   METABOLIC SYNDROME; CESAREAN DELIVERY; UNITED-STATES; MORTALITY;
   PREGNANCY; HEALTH; WOMEN
AB Background: Preeclampsia is a disease with great variability in incidence across the world. The mortality is higher in lower income countries, where it is the leading cause of maternal mortality. This study aimed to determine the frequency of and risk factors for preeclampsia in a low income population from an urban area of Brazil.
   Methods: A prospective case control study of 242 women of which 30 developed preeclampsia, 4 had gestational hypertension, 2 had superimposed hypertension, 11 had spontaneous abortion, 13 were lost to follow up and 192 had normal pregnancy. This latter group was considered the normotensive controls. The rate of preeclampsia and the risk of cardiovascular disease, after onset of preeclampsia, were determined.
   Results: Of the 218 women who completed the study, the frequency of hypertensive disorder of pregnancy was 16.5% (36 of 218) and of preeclampsia was 13.8% (30 of 218). Women with preeclampsia had a higher body mass index (BMI), mean of 25.3 +/- 4.8 compared to 23.5 +/- 3.7 for the normotensive controls, p = 0.02. The risk of preeclampsia increased with BMI [Odds ratio (OR) 1.12, 95% Confidence Interval (CI = 1.02; 1.24, p-value = 0.023)]. Women with preeclampsia developed chronic hypertension more often than normotensive controls (p = 0.043) and their systolic and ambulatory blood pressure monitoring was elevated (p = 0.034). Women with preeclampsia had higher BMI even 5 years post-pregnancy (p = 0.008).
   Conclusions: Women who are overweight or older have an increased risk of preeclampsia. Previous history of preeclampsia increases the risk of early onset of chronic hypertension. Therefore, effective preventive measures are needed, particularly women at lower social economic stratum who have less access to proper medical care and adequate nutrition.
C1 [de Melo Dantas, Edailna Maria; Marinho Pereira, Flavio Venicio; Queiroz, Jose Wilton; Gois Monteiro, Gloria Regina; Bezerra Jeronimo, Selma Maria; Pinheiro Fernandes Araujo, Ana Cristina] Hlth Sci Postgrad Program, Natal, RN, Brazil.
   [Queiroz, Jose Wilton; Gois Monteiro, Gloria Regina; Bezerra Jeronimo, Selma Maria] Inst Trop Med Rio Grande do Norte, Natal, RN, Brazil.
   [de Melo Dantas, Diogo Luis; Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Gois Monteiro, Gloria Regina; Bezerra Jeronimo, Selma Maria] Inst Sci & Technol Trop Dis INCT DT, Natal, RN, Brazil.
   [Duggal, Priya] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   [Azevedo, Maria de Fatima] Univ Fed Rio Grande do Norte, Dept Internal Med, Hlth Sci Ctr, Natal, RN, Brazil.
   [Pinheiro Fernandes Araujo, Ana Cristina] Univ Fed Rio Grande do Norte, Dept Obstet & Gynecol, Hlth Sci Ctr, Natal, RN, Brazil.
RP Araujo, ACPF (corresponding author), Hlth Sci Postgrad Program, Natal, RN, Brazil.
EM crysaraujo@uol.com.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
FU Fundacao de Apoio a Pesquisa no Rio Grande do Norte (FAPERN); Bom Pastor
   Health Post Center
FX We are thankful to the Bom Pastor Health Post Center and to the Health
   Agents for the support and help with participant's recruitment. We are
   also thankful to the participants and to the Fundacao de Apoio a
   Pesquisa no Rio Grande do Norte (FAPERN) for the financial support.
CR Abramovici D, 1999, AM J OBSTET GYNECOL, V180, P221, DOI 10.1016/S0002-9378(99)70178-X
   Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56
   Belghiti J, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.062
   Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE
   Belogolovkin V, 2007, J MATERN-FETAL NEO M, V20, P509, DOI 10.1080/14767050701420027
   Bezerra PCFM, 2010, ACTA OBSTET GYN SCAN, V89, P612, DOI 10.3109/00016341003623720
   Bodnar LM, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.028
   Brink Andries, 2002, Cardiovasc J S Afr, V13, P68
   Chu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044484
   Conde-Agudelo A, 2000, ACTA OBSTET GYN SCAN, V79, P371, DOI 10.1034/j.1600-0412.2000.079005371.x
   Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040
   Cripe SM, 2012, J IMMIGR MINOR HEALT, V14, P747, DOI 10.1007/s10903-011-9537-7
   Delahaije DHJ, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-60
   Fortner RT, 2011, MED SCI SPORT EXER, V43, P639, DOI 10.1249/MSS.0b013e3181f58d3e
   Fortner RT, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.021
   Freitas PF, 2005, REV SAUDE PUBL, V39, P761, DOI 10.1590/S0034-89102005000500010
   Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Habli M, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.059
   HSU CD, 1995, INT J GYNECOL OBSTET, V49, P271, DOI 10.1016/0020-7292(95)02373-K
   Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213
   Strufaldi MWL, 2008, DIABETES VASC DIS RE, V5, P291, DOI 10.3132/dvdr.2008.042
   Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5
   Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968
   McDonald SD, 2013, DIABETIC MED, V30, pE1, DOI 10.1111/dme.12033
   Menzies J, 2007, HYPERTENS PREGNANCY, V26, P447, DOI 10.1080/10641950701521742
   Moreira MD, 2012, J PEDIAT-BRAZIL, V88, P347, DOI 10.2223/JPED.2203
   O'Brien E, 2000, Expert Opin Pharmacother, V1, P675, DOI 10.1517/14656566.1.4.675
   O'Connor HD, 2012, AM J PERINATOL
   Okafor UV, 2010, J POSTGRAD MED, V56, P21, DOI 10.4103/0022-3859.62431
   Payne B, 2011, J OBSTET GYNAECOL CA, V33, P588, DOI 10.1016/S1701-2163(16)34907-6
   Pickering Thomas G, 2005, J Clin Hypertens (Greenwich), V7, P102, DOI 10.1111/j.1524-6175.2005.04377.x
   Ramos AV, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-101
   Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4
   Rudra CL, 2005, GYNECOL ENDOCRINOL, V21, P200, DOI 10.1080/09513590500168431
   Saadat Mandana, 2007, Taiwan J Obstet Gynecol, V46, P255, DOI 10.1016/S1028-4559(08)60029-7
   SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D
   Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002
   SIBAI BM, 1983, OBSTET GYNECOL, V61, P571
   Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008
   SIBAI BM, 1984, OBSTET GYNECOL, V64, P319
   SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3
   Siqueira FM, 2008, J PERIODONTOL, V79, P207, DOI [10.1902/jop.2008.070174, 10.1902/jop.2008.070174 ]
   Skjaerven R, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7677
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Strufaldi MWL, 2009, ACTA PAEDIATR, V98, P1646, DOI 10.1111/j.1651-2227.2009.01411.x
   Valerio EG, 2011, HYPERTENS PREGNANCY, V30, P302, DOI 10.3109/10641950903214609
   Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7
   Virk J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000826
   Vitolo MR, 2011, REV BRAS GINECOL OBS, V33, P58, DOI 10.1590/S0100-72032011000100009
   von Dadelszen P, 2008, CURR OPIN OBSTET GYN, V20, P110, DOI 10.1097/GCO.0b013e3282f733a2
   Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20
   Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003
   Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x
   Wikstrom AK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.003
NR 55
TC 10
Z9 12
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 8
PY 2013
VL 13
AR 159
DI 10.1186/1471-2393-13-159
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 283KD
UT WOS:000329244100001
PM 23927768
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Santos-Oliveira, JR
   Regis, EG
   Giacoia-Gripp, CBW
   Valverde, JG
   Alexandrino-de-Oliveira, P
   Lindoso, JAL
   Goto, H
   Oliveira-Neto, MP
   Guerra, JO
   Grinsztejn, B
   Jeronimo, SB
   Morgado, MG
   Da-Cruz, AM
AF Santos-Oliveira, Joanna R.
   Regis, Eduardo G.
   Giacoia-Gripp, Carmem B. W.
   Valverde, Joanna G.
   Alexandrino-de-Oliveira, Priscilla
   Lindoso, Jose Angelo L.
   Goto, Hiro
   Oliveira-Neto, Manoel P.
   Guerra, Jorge O.
   Grinsztejn, Beatriz
   Jeronimo, Selma B.
   Morgado, Mariza G.
   Da-Cruz, Alda M.
TI Microbial Translocation Induces an Intense Proinflammatory Response in
   PatientsWith Visceral Leishmaniasis and HIV Type 1 Coinfection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE visceral leishmaniasis-HIV/AIDS coinfection; microbial translocation;
   inflammatory cytokines
ID T-CELLS; IMMUNE ACTIVATION; INFECTED PATIENTS; DISEASE; VIRUS;
   CYTOKINES; REPLICATION; MACROPHAGES; EXPRESSION; DEPLETION
AB Background. Leishmania infection is a cofactor in the heightened cellular activation observed in patients with American visceral leishmaniasis and human immunodeficiency virus type 1 (HIV) infection, with or without progression to AIDS (AVL/HIV). Thus, the persistence of a high parasite load despite antileishmanial therapy could be responsible for the continued immune stimulation.
   Methods. CD8(+) T cells expressing CD38, parasite load, lipopolysaccharide (LPS), soluble CD14, macrophage migration inhibitory factor (MIF), intestinal fatty acid-binding protein (IFABP), and proinflammatory cytokines (interleukin 1 beta, interleukin 6, interleukin 8, interleukin 17, interferon gamma, and tumor necrosis factor) were measured in 17 patients with AVL/HIV, 16 with HIV, and 14 healthy subjects (HS).
   Results. Lower Leishmania parasitemia was observed after antileishmanial and antiretroviral therapies. However, higher levels of CD38(+) on CD8(+) T cells were observed in both clinical phases of leishmaniasis, compared with HIV cases. AVL/HIV and HIV patients showed higher levels of LPS and IFABP than HS. Proinflammatory cytokine levels were significantly augmented in patients with active coinfection, as well as those with remission of Leishmania infection. LPS levels and Leishmania infection were positively correlated with CD38 expression on CD8(+) T cells and with IL-6 and IL-8 levels.
   Conclusions. LPS levels along with the immune consequences of Leishmania infection were associated with elevated cellular activation in coinfected patients. As a consequence, secondary chemoprophylaxis for leishmaniasis or even the use of antiinflammatory drugs or antibiotics may be considered for improving the prognosis of AVL/HIV.
C1 [Santos-Oliveira, Joanna R.; Da-Cruz, Alda M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Regis, Eduardo G.] Fiocruz MS, Inst Oswaldo Cruz, Lab Pesquisa Timo, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Giacoia-Gripp, Carmem B. W.; Morgado, Mariza G.] Fiocruz MS, Inst Oswaldo Cruz, Lab Aids & Imunol Mol, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Oliveira-Neto, Manoel P.; Grinsztejn, Beatriz] Fiocruz MS, IPEC, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Da-Cruz, Alda M.] Univ Estado Rio de Janeiro, Fac Ciencias Med, Disciplina Parasitol, Rio De Janeiro, Brazil.
   [Valverde, Joanna G.; Jeronimo, Selma B.] Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Alexandrino-de-Oliveira, Priscilla] Univ Fed Mato Grosso do Sul, Univ Hosp, Hosp Dia Profa Esterina Corsini, Campo Grande, Brazil.
   [Lindoso, Jose Angelo L.; Goto, Hiro] Univ Sao Paulo, Inst Med Trop Sao Paulo, BR-05508 Sao Paulo, Brazil.
   [Guerra, Jorge O.] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
RP Da-Cruz, AM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM alda@ioc.fiocruz.br
RI Valverde, Joanna G/C-1284-2014; Jeronimo, Selma/AAY-4033-2020; Goto,
   Hiro/B-5745-2009; Lindoso, Jose Angelo Lauletta/E-9339-2012; Da-Cruz,
   Alda Maria/J-2152-2012
OI Valverde, Joanna G/0000-0001-8064-6255; Jeronimo,
   Selma/0000-0002-4784-9904; Goto, Hiro/0000-0001-7048-562X; Lindoso, Jose
   Angelo Lauletta/0000-0002-4405-4401; 
FU Programa Nacional de DST/AIDS, Ministerio da Saude [ED00095/2007];
   Instituto Oswaldo Cruz; FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [FAPERJ nota
   10]; CNPqNational Council for Scientific and Technological Development
   (CNPq)
FX This work was supported by the Programa Nacional de DST/AIDS, Ministerio
   da Saude (grant ED00095/2007) and Instituto Oswaldo Cruz (internal
   funds). J. R. S. O. received a fellowship from FAPERJ (FAPERJ nota 10).
   A. M. C. is a researcher fellowship from CNPq and FAPERJ.
CR Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   [Anonymous], 2006, MAN VIG CONTR LEISHM
   Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167
   Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276
   Baba Chalamalasetty Sreenivasa, 2006, Indian J Gastroenterol, V25, P309
   Balkhair A, 2008, INT J INFECT DIS, V12, P111, DOI 10.1016/j.ijid.2007.04.009
   Barreto-De-Souza V, 2006, J INFECT DIS, V194, P846, DOI 10.1086/506618
   Bernier R, 1998, J IMMUNOL, V160, P2881
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001
   Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874
   Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200
   Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101
   Casado JL, 2001, EUR J CLIN MICROBIOL, V20, P202, DOI 10.1007/s10096-001-8082-z
   Connolly NC, 2005, AIDS REV, V7, P168
   Cooke KR, 2002, J ENDOTOXIN RES, V8, P441, DOI 10.1179/096805102125001046
   Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153
   de Sousa-Gomes ML, 2011, EPIDEMIOL SERV SAUDE, V20, P519, DOI 10.5123/S1679-49742011000400011
   Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410
   Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549
   Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052
   Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660
   Senent SG, 2009, GASTROENTEROL HEPATO, V32, P176, DOI 10.1016/j.gastrohep.2008.09.021
   Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09
   Goto H, 2009, REV I MED TROP, V51, P241, DOI 10.1590/S0036-46652009000500002
   Hicks L, 2009, EUR J GASTROEN HEPAT, V21, P117, DOI 10.1097/MEG.0b013e32830e6fdb
   Lee PI, 2009, J INFECT DIS, V199, P1664, DOI 10.1086/598953
   Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9
   Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003
   McCoy JJ, 1998, MOL BIOCHEM PARASIT, V95, P251, DOI 10.1016/S0166-6851(98)00112-1
   Medrano FJ, 1998, CLIN EXP IMMUNOL, V114, P403
   Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   Ministerio da Saude [Ministry of Health], PROT CLIN DIR TER AD
   Mock DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002635
   Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852
   Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141
   Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x
   Rabello A, 2003, ANN TROP MED PARASIT, V97, P17, DOI 10.1179/000349803225002507
   Rodrigues Denise do Socorro S., 2003, Braz J Infect Dis, V7, P161, DOI 10.1590/S1413-86702003000200010
   Saha S, 2006, INDIAN J MED RES, V123, P245
   Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063
   Santos-Oliveira JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001198
   Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358
   Sinha PK, 2006, INDIAN J MED RES, V123, P197
   Weirather JL, 2011, J CLIN MICROBIOL, V49, P3892, DOI 10.1128/JCM.r00764-11
   Wolday D, 1998, SCAND J INFECT DIS, V30, P29, DOI 10.1080/003655498750002268
   Zhao CQ, 2004, CLIN IMMUNOL, V113, P81, DOI 10.1016/j.clim.2004.06.003
NR 49
TC 22
Z9 22
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 1
PY 2013
VL 208
IS 1
BP 57
EP 66
DI 10.1093/infdis/jit135
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 156NX
UT WOS:000319830300010
PM 23539743
OA Bronze
DA 2020-11-26
ER

PT J
AU Amaral, CT
   Pontes, NN
   Maciel, BLL
   Bezerra, HSM
   Triesta, ANAB
   Jeronimo, SMB
   McGowan, SE
   Dantas, VM
AF Amaral, Cleia T.
   Pontes, Nubia N.
   Maciel, Bruna L. L.
   Bezerra, Hugo S. M.
   Triesta, Ana Nataly A. B.
   Jeronimo, Selma M. B.
   McGowan, Stephen E.
   Dantas, Vera M.
TI Vitamin A deficiency alters airway resistance in children with acute
   upper respiratory infection
SO PEDIATRIC PULMONOLOGY
LA English
DT Article
DE Asthma; modified relative dose response test; forced oscillation;
   wheezing; respiratory virus
ID RETINOL-BINDING-PROTEIN; DOSE-RESPONSE TEST; PRESCHOOL-CHILDREN;
   PULMONARY-FUNCTION; PLASMA RETINOL; LUNG-FUNCTION; SUPPLEMENTATION;
   INFLAMMATION; CHILDHOOD; QUESTIONNAIRE
AB Objective To assess whether vitamin A deficiency alters the recovery of total respiratory resistance (TRR) following acute upper respiratory tract infection (URI). Methods This is a case control study of children, age 46 years and grouped as: URI, (n=74), URI and wheezing, (URI-wheezing, n=52), and healthy controls (n=51). Vitamin A and total respiratory resistance (TRR) were assessed using the modified relative dose response (MRDR) and forced oscillometry, respectively. Results Children with URI and URI-wheezing had lower retinol, 32.4 +/- 13.12 and 18.3 +/- 6.83 mu g/dl respectively, compared to controls, 56.9 +/- 29.82 mu g/dl (ANOVA, P<0.001). The MRDR was elevated in children in the URI or URI-wheezing groups 0.066 +/- 0.045 and 0.021 +/- 0.021, respectively, compared to controls 0.007 +/- 0.006 (ANOVA, P<0.0001). The TRR in the URI and URI-wheezing groups differed from controls. During convalescence, the TRR failed to decline in the URI-group only when the MRDR was >0.06. In the URI-wheezing group, TRR declined independently of retinol and MRDR. Conclusion Vitamin A contributes to preservation of airway function during and in recovery after upper respiratory infection in children. Pediatr Pulmonol. 2013; 48:481489. (c) 2012 Wiley Periodicals, Inc.
C1 [Amaral, Cleia T.; Pontes, Nubia N.; Dantas, Vera M.] Univ Fed Rio Grande do Norte, Heriberto Bezerra Pediat Hosp, BR-59072970 Natal, RN, Brazil.
   [Amaral, Cleia T.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Post Grad Program, BR-59072970 Natal, RN, Brazil.
   [Maciel, Bruna L. L.; Bezerra, Hugo S. M.; Triesta, Ana Nataly A. B.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Maciel, Bruna L. L.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Dept Nutr, BR-59072970 Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] INCT DT CNPq, Inst Nacl Ciencia & Tecnol Doencas Tropicais, Campinas, SP, Brazil.
   [McGowan, Stephen E.] Univ Iowa Hosp & Clin, Dept Internal Med, Div Pulm Crit Care & Occupat Med, Iowa City, IA 52246 USA.
   [McGowan, Stephen E.] Dept Vet Affairs Res Serv, Iowa City, IA USA.
RP McGowan, SE (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, Div Pulm Crit Care & Occupat Med, C33B GH,201 Hawkins Dr, Iowa City, IA 52246 USA.
EM stephen-mcgowan@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; McGowan, Stephen/0000-0003-3084-1962
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R03TW01297]; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001297, R03TW001297, R03TW001297]
   Funding Source: NIH RePORTER
FX National Institutes of Health Fogarty International Collaboration Award,
   Number: R03TW01297, CNPq.
CR Ahmad SM, 2009, J NUTR, V139, P377, DOI 10.3945/jn.108.100198
   Al Senaidy AM, 2009, J ASTHMA, V46, P699, DOI 10.1080/02770900903056195
   Al-Mekhlafi HM, 2010, AM J TROP MED HYG, V83, P523, DOI 10.4269/ajtmh.2010.09-0371
   Allen S, 2009, THORAX, V64, P610, DOI 10.1136/thx.2008.101469
   Arora P, 2002, PEDIATR ALLERGY IMMU, V13, P223, DOI 10.1034/j.1399-3038.2002.00010.x
   Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST
   Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911
   Checkley W, 2010, NEW ENGL J MED, V310, P1684
   CHYTIL F, 1992, AM J PHYSIOL, V262, pL517
   Silva Rosangela da, 2005, J. Pediatr. (Rio J.), V81, P162, DOI 10.1590/S0021-75572005000300013
   Delacourt C, 2000, AM J RESP CRIT CARE, V161, P730, DOI 10.1164/ajrccm.161.3.9904081
   Duttsman PK, 1995, NUTR RES, V15, P1263
   Espe K, 2007, PEDIATR RES, V62, P741, DOI 10.1203/PDR.0b013e318158787e
   Folkerts G, 1998, AM J RESP CRIT CARE, V157, P1708, DOI 10.1164/ajrccm.157.6.9707163
   Fryer AD, 1998, AM J RESP CRIT CARE, V158, pS154, DOI 10.1164/ajrccm.158.supplement_2.13tac120
   Fumagalli F, 2008, NUTRITION, V24, P427, DOI 10.1016/j.nut.2008.01.008
   Gern JE, 1997, AM J RESP CRIT CARE, V155, P1159, DOI 10.1164/ajrccm.155.3.9117003
   Gilliland FD, 2003, AM J EPIDEMIOL, V158, P576, DOI 10.1093/aje/kwg181
   Goldman MD, 2002, PEDIATR PULM, V34, P312, DOI 10.1002/ppul.10168
   Grotto I, 2003, J PEDIATR-US, V142, P297, DOI 10.1067/mpd.2003.116
   Haque R, 2010, J HEALTH POPUL NUTR, V28, P230
   Hellinckx J, 1998, EUR RESPIR J, V12, P438, DOI 10.1183/09031936.98.12020438
   Kassaye T, 2001, INT J EPIDEMIOL, V30, P457, DOI 10.1093/ije/30.3.457
   Kelly FJ, 2005, P NUTR SOC, V64, P510, DOI 10.1079/PNS2005457
   Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107
   Kohlhaufl M, 2002, EUR J MED RES, V7, P72
   Luo ZX, 2010, WORLD J PEDIATR, V6, P81, DOI 10.1007/s12519-010-0012-7
   Maqsood M, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-21
   McGowan SE, 2002, AM J PHYSIOL-LUNG C, V282, pL1031, DOI 10.1152/ajplung.00319.2001
   Mizuno Y, 2011, PEDIATR INT, V48, P261
   Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513
   REDLINE S, 1989, AM REV RESPIR DIS, V140, P179, DOI 10.1164/ajrccm/140.1.179
   Rosales FJ, 1998, J NUTR, V128, P1681
   Rosales FJ, 1996, J LIPID RES, V37, P962
   Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834
   Sole D, 1998, J INVEST ALLERG CLIN, V8, P376
   STEPHENSEN CB, 1993, J NUTR, V123, P823
   Stephensen CB, 2002, AM J CLIN NUTR, V76, P1351
   Tanumihardjo SA, 2004, J NUTR, V134, p290S
   Tanumihardjo SA, 1996, AM J CLIN NUTR, V64, P966
   Teran R, 2011, CLIN IMMUNOL, V138, P299, DOI 10.1016/j.clim.2010.12.011
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   Trigg CJ, 1996, CLIN EXP ALLERGY, V26, P665, DOI 10.1111/j.1365-2222.1996.tb00593.x
NR 43
TC 4
Z9 8
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8755-6863
EI 1099-0496
J9 PEDIATR PULM
JI Pediatr. Pulmonol.
PD MAY
PY 2013
VL 48
IS 5
BP 481
EP 489
DI 10.1002/ppul.22621
PG 9
WC Pediatrics; Respiratory System
SC Pediatrics; Respiratory System
GA 130PN
UT WOS:000317930800007
PM 22833544
OA Green Published
DA 2020-11-26
ER

PT J
AU Aslan, H
   Dey, R
   Meneses, C
   Castrovinci, P
   Jeronimo, SMB
   Oliva, G
   Fischer, L
   Duncan, RC
   Nakhasi, HL
   Valenzuela, JG
   Kamhawi, S
AF Aslan, Hamide
   Dey, Ranadhir
   Meneses, Claudio
   Castrovinci, Philip
   Jeronimo, Selma Maria Bezerra
   Oliva, Gaetano
   Fischer, Laurent
   Duncan, Robert C.
   Nakhasi, Hira L.
   Valenzuela, Jesus G.
   Kamhawi, Shaden
TI A New Model of Progressive Visceral Leishmaniasis in Hamsters by Natural
   Transmission via Bites of Vector Sand Flies
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE visceral leishmaniasis; Leishmania; Lutzomyia longipalpis; sand fly;
   vector; transmission; bite; intracardiac
ID CUTANEOUS LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; PROTECTS HAMSTERS;
   SALIVARY PROTEIN; IN-VIVO; DONOVANI; IMMUNITY; INFANTUM;
   IMMUNOSUPPRESSION; INFECTION
AB Background. Visceral leishmaniasis (VL) is transmitted by sand flies. Protection of needle-challenged vaccinated mice was abrogated in vector-initiated cutaneous leishmaniasis, highlighting the importance of developing natural transmission models for VL.
   Methods. We used Lutzomyia longipalpis to transmit Leishmania infantum or Leishmania donovani to hamsters. Vector-initiated infections were monitored and compared with intracardiac infections. Body weights were recorded weekly. Organ parasite loads and parasite pick-up by flies were assessed in sick hamsters.
   Results. Vector-transmitted L. infantum and L. donovani caused >= 5-fold increase in spleen weight compared with uninfected organs and had geometric mean parasite loads (GMPL) comparable to intracardiac inoculation of 10(7)-10(8) parasites, although vector-initiated disease progression was slower and weight loss was greater. Only vector-initiated L. infantum infections caused cutaneous lesions at transmission and distal sites. Importantly, 45.6%, 50.0%, and 33.3% of sand flies feeding on ear, mouth, and testicular lesions, respectively, were parasite-positive. Successful transmission was associated with a high mean percent of metacyclics (66%-82%) rather than total GMPL (2.0 x 10(4)-8.0 x 10(4)) per midgut.
   Conclusions. This model provides an improved platform to study initial immune events at the bite site, parasite tropism, and pathogenesis and to test drugs and vaccines against naturally acquired VL.
C1 [Aslan, Hamide; Meneses, Claudio; Castrovinci, Philip; Valenzuela, Jesus G.; Kamhawi, Shaden] NIAID, VMBS, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
   [Dey, Ranadhir; Duncan, Robert C.; Nakhasi, Hira L.] US FDA, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.
   [Jeronimo, Selma Maria Bezerra] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Oliva, Gaetano] Univ Naples Federico II, Dept Vet Clin Sci, Naples, Italy.
   [Fischer, Laurent] MERIAL, Lyon, France.
RP Kamhawi, S (corresponding author), NIAID, VMBS, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 2E-22, Rockville, MD 20852 USA.
EM skamhawi@niaid.nih.gov
RI SUAU, Hamide ASLAN/AAD-7710-2019; Jeronimo, Selma M.B./M-8672-2014;
   Duncan, Robert/I-8168-2015; Jeronimo, Selma/AAY-4033-2020
OI SUAU, Hamide ASLAN/0000-0002-8528-0202; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Duncan, Robert/0000-0001-8409-2501; Jeronimo,
   Selma/0000-0002-4784-9904
FU Intramural Research Program of the Division of Intramural Research,
   National Institute of Allergy and Infectious Diseases, National
   Institutes of Health; Intramural Research Program of the Office of Blood
   Research and Review, Center for Biologics Research and Review, US Food
   and Drug Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [ZIAAI000932, ZIAAI000932, ZIAAI000932,
   ZIAAI000932, ZIAAI000932, ZIAAI000932, ZIAAI000932, ZIAAI000932,
   ZIAAI000932, ZIAAI000932] Funding Source: NIH RePORTER
FX The study was funded by the Intramural Research Program of the Division
   of Intramural Research, National Institute of Allergy and Infectious
   Diseases, National Institutes of Health and by the Intramural Research
   Program of the Office of Blood Research and Review, Center for Biologics
   Research and Review, US Food and Drug Administration. Because R. D., R.
   C. D., H. L. N., J. G. V., and S. K. are government employees and this
   is government work, the work is in the public domain in the United
   States. Notwithstanding any other agreements, the NIH reserves the right
   to provide the work to PubMed Central for display and use by the public,
   and PubMed Central may tag or modify the work consistent with its
   customary practices. You can establish rights outside of the U. S.
   subject to a government use license.
CR Banerjee S, 2009, INFECT IMMUN, V77, P2330, DOI 10.1128/IAI.00057-09
   Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941
   Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969
   Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313
   Bethony JM, 2011, IMMUNOL REV, V239, P237, DOI 10.1111/j.1600-065X.2010.00976.x
   da Silva RAA, 2011, ACTA TROP, V120, P185, DOI 10.1016/j.actatropica.2011.08.007
   Garg R, 2006, INDIAN J MED RES, V123, P439
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610
   Goto H, 2004, BRAZ J MED BIOL RES, V37, P615, DOI 10.1590/S0100-879X2004000400020
   Jamjoom MB, 2004, PARASITOLOGY, V129, P399, DOI 10.1017/S0031182004005955
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012
   Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105
   Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081
   Maia C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001181
   Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
   Mookerjee A, 2003, INFECT IMMUN, V71, P2439, DOI 10.1128/IAI.71.5.2439-2446.2003
   Nieto A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-39
   Osorio EY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002417
   Peters N, 2006, IMMUNOL REV, V213, P159, DOI 10.1111/j.1600-065X.2006.00432.x
   Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194
   Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484
   Prajapati VK, 2011, J ANTIMICROB CHEMOTH, V66, P874, DOI 10.1093/jac/dkr002
   Ready PD, 2010, EUROSURVEILLANCE, V15, P29
   Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002
   Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091
   Rogers ME, 2006, J INFECT DIS, V194, P512, DOI 10.1086/505584
   Rogers ME, 2004, NATURE, V430, P463, DOI 10.1038/nature02675
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265
   Secundino NFC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-20
   Selvapandiyan A, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/631460
   Selvapandiyan A, 2009, J IMMUNOL, V183, P1813, DOI 10.4049/jimmunol.0900276
   TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x
   World Health Organization, 9492010 WHO TRS
NR 36
TC 38
Z9 37
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 15
PY 2013
VL 207
IS 8
BP 1328
EP 1338
DI 10.1093/infdis/jis932
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 113WT
UT WOS:000316700800018
PM 23288926
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Moura, MLN
   Dupnik, KM
   Sampaio, GAA
   Nobrega, PFC
   Jeronimo, AK
   do Nascimento, JM
   Dantas, RLM
   Queiroz, JW
   Barbosa, JD
   Dias, G
   Jeronimo, SMB
   Souza, MCF
   Nobre, ML
AF Moura, Maria L. N.
   Dupnik, Kathryn M.
   Sampaio, Gabriel A. A.
   Nobrega, Priscilla F. C.
   Jeronimo, Ana K.
   do Nascimento-Filho, Jose M.
   Miranda Dantas, Roberta L.
   Queiroz, Jose W.
   Barbosa, James D.
   Dias, Gutemberg
   Jeronimo, Selma M. B.
   Souza, Marcia C. F.
   Nobre, Mauricio L.
TI Active Surveillance of Hansen's Disease (Leprosy): Importance for Case
   Finding among Extra-domiciliary Contacts
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID NEGLECTED TROPICAL DISEASES; INCUBATION PERIOD; ENDEMIC AREA;
   RISK-FACTORS; GIS; SUSCEPTIBILITY; HOUSEHOLD; INFECTION; DISTANCE
AB Hansen's disease (leprosy) remains an important health problem in Brazil, where 34,894 new cases were diagnosed in 2010, corresponding to 15.3% of the world's new cases detected in that year. The purpose of this study was to use home visits as a tool for surveillance of Hansen's disease in a hyperendemic area in Brazil. A total of 258 residences were visited with 719 individuals examined. Of these, 82 individuals had had a previous history of Hansen's disease, 209 were their household contacts and 428 lived in neighboring residences. Fifteen new Hansen's disease cases were confirmed, yielding a detection rate of 2.0% of people examined. There was no difference in the detection rate between household and neighbor contacts (p = 0.615). The two groups had the same background in relation to education (p = 0.510), household income (p = 0.582), and the number of people living in the residence (p = 0.188). Spatial analysis showed clustering of newly diagnosed cases and association with residential coordinates of previously diagnosed multibacillary cases. Active case finding is an important tool for Hansen's disease control in hyperendemic areas, enabling earlier diagnosis, treatment, decrease in disability from Hansen's disease and potentially less spread of Mycobacterium leprae.
C1 [Moura, Maria L. N.; Sampaio, Gabriel A. A.; Nobrega, Priscilla F. C.; Jeronimo, Ana K.; do Nascimento-Filho, Jose M.; Miranda Dantas, Roberta L.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Dupnik, Kathryn M.; Queiroz, Jose W.; Jeronimo, Selma M. B.] Inst Sci & Technol Trop Dis INCT DT, Natal, RN, Brazil.
   [Queiroz, Jose W.; Barbosa, James D.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Postgrad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   [Dias, Gutemberg] State Univ Rio Grande Norte, Mossoro, RN, Brazil.
   [Souza, Marcia C. F.] INSS, Mossoro, RN, Brazil.
   [Nobre, Mauricio L.] Fiocruz MS, Postgrad Grad Program Trop Med, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Nobre, Mauricio L.] Hosp Giselda Trigueiro, Natal, RN, Brazil.
RP Moura, MLN (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Moura,
   Maria Luisa/N-5654-2015; Dias, Gutemberg H/D-7510-2018
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Moura, Maria Luisa/0000-0003-1013-8233; Dias,
   Gutemberg H/0000-0003-2147-8647; Nobre, Mauricio/0000-0003-4932-3137
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Instituto Nacional de Ciencia e Tecnologia de Doencas Tropicas
   (INCT-DT); FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337] Funding Source: NIH RePORTER
FX This work was funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) and by the Instituto Nacional de Ciencia
   e Tecnologia de Doencas Tropicas (INCT-DT), http://inctdt.cebio.org/.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bakker MI, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-40
   Bakker MI, 2006, LEPROSY REV, V77, P48
   Bakker MI, 2009, LEPROSY REV, V80, P327
   Bechelli L M, 1973, Int J Lepr Other Mycobact Dis, V41, P285
   Blackwell JM, 2001, LEPROSY REV, V72, P352
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Dias MCFD, 2007, LEPROSY REV, V78, P261
   Deps PD, 2006, LEPROSY REV, V77, P34
   DOULL J A, 1947, Int J Lepr, V15, P369
   Features of the Ridley-Jopling classification, 1979, INT J LEPR OTHER MYC, V47, P611
   Penna MLF, 2009, LEPROSY REV, V80, P332
   GODAL T, 1973, BRIT MED J, V3, P557, DOI 10.1136/bmj.3.5880.557
   Goulart L, 2009, ARCH DERMATOL RES, V301, P123, DOI 10.1007/s00403-008-0917-3
   GUINTO R S, 1951, Int J Lepr, V19, P117
   Hoeven TA, 2008, EPIDEMIOL INFECT, V136, P1624, DOI 10.1017/S0950268808000381
   Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   JESUDASAN K, 1984, LEPROSY REV, V55, P353
   Kai M, 2004, INT J LEPROSY, V72, P50, DOI 10.1489/1544-581X(2004)072&lt;0050:ASOLCI&gt;2.0.CO;2
   Katoch K, 2008, Indian J Lepr, V80, P331
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Liu H, 2012, AM J HUM GENET, V91, P935, DOI 10.1016/j.ajhg.2012.09.010
   Lockwood DNJ, 2000, J MED MICROBIOL, V49, P301, DOI 10.1099/0022-1317-49-4-301
   Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326
   Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278
   Murthy P Krishna, 2004, J Indian Med Assoc, V102, P678
   Netea MG, 2010, NEW ENGL J MED, V362, P1447
   Pearce V, 2008, AUSTRALAS J DERMATOL, V49, P226, DOI 10.1111/j.1440-0960.2008.00475.x
   PRASAD KVN, 1967, INDIAN J MED RES, V55, P29
   Queiroz JW, 2010, AM J TROP MED HYG, V82, P306, DOI 10.4269/ajtmh.2010.08-0675
   Richardus JH, 2007, LEPROSY REV, V78, P330
   Richardus JH, 2005, INT J LEPROSY, V73, P249
   RIDLEY D. S., 1962, LEPROSY REV, V33, P119
   Sharma V K, 1968, Int J Lepr Other Mycobact Dis, V36, P1
   Shen Jian-ping, 2005, Chinese Medical Sciences Journal, V20, P77
   Shen JP, 2009, INDIAN J DERMATOL VE, V75, P152, DOI 10.4103/0378-6323.48660
   SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930
   Suzuki K, 2010, J CLIN MICROBIOL, V48, P3432, DOI 10.1128/JCM.00017-10
   van Beers SM, 1999, INT J LEPROSY, V67, P119
   van Veen NHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004548
   Wheeler E, 2006, ANN HUM GENET, V70, P78, DOI 10.1111/j.1529-8817.2005.00223.x
   World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P337
NR 42
TC 33
Z9 33
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2013
VL 7
IS 3
AR e2093
DI 10.1371/journal.pntd.0002093
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 117HI
UT WOS:000316943800013
PM 23516645
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Fakiola, M
   Strange, A
   Cordell, HJ
   Miller, EN
   Pirinen, M
   Su, Z
   Mishra, A
   Mehrotra, S
   Monteiro, GR
   Band, G
   Bellenguez, C
   Dronov, S
   Edkins, S
   Freeman, C
   Giannoulatou, E
   Gray, E
   Hunt, SE
   Lacerda, HG
   Langford, C
   Pearson, R
   Pontes, NN
   Rai, M
   Singh, SP
   Smith, L
   Sousa, O
   Vukcevic, D
   Bramon, E
   Brown, MA
   Casas, JP
   Corvin, A
   Duncanson, A
   Jankowski, J
   Markus, HS
   Mathew, CG
   Palmer, CNA
   Plomin, R
   Rautanen, A
   Sawcer, SJ
   Trembath, RC
   Viswanathan, AC
   Wood, NW
   Wilson, ME
   Deloukas, P
   Peltonen, L
   Christiansen, F
   Witt, C
   Jeronimo, SMB
   Sundar, S
   Spencer, CCA
   Blackwell, JM
   Donnelly, P
AF Fakiola, Michaela
   Strange, Amy
   Cordell, Heather J.
   Miller, E. Nancy
   Pirinen, Matti
   Su, Zhan
   Mishra, Anshuman
   Mehrotra, Sanjana
   Monteiro, Gloria R.
   Band, Gavin
   Bellenguez, Celine
   Dronov, Serge
   Edkins, Sarah
   Freeman, Colin
   Giannoulatou, Eleni
   Gray, Emma
   Hunt, Sarah E.
   Lacerda, Henio G.
   Langford, Cordelia
   Pearson, Richard
   Pontes, Nubia N.
   Rai, Madhukar
   Singh, Shri P.
   Smith, Linda
   Sousa, Olivia
   Vukcevic, Damjan
   Bramon, Elvira
   Brown, Matthew A.
   Casas, Juan P.
   Corvin, Aiden
   Duncanson, Audrey
   Jankowski, Janusz
   Markus, Hugh S.
   Mathew, Christopher G.
   Palmer, Colin N. A.
   Plomin, Robert
   Rautanen, Anna
   Sawcer, Stephen J.
   Trembath, Richard C.
   Viswanathan, Ananth C.
   Wood, Nicholas W.
   Wilson, Mary E.
   Deloukas, Panos
   Peltonen, Leena
   Christiansen, Frank
   Witt, Campbell
   Jeronimo, Selma M. B.
   Sundar, Shyam
   Spencer, Chris C. A.
   Blackwell, Jenefer M.
   Donnelly, Peter
CA LeishGEN Consortium
   Wellcome Trust Case Control
TI Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are
   associated with susceptibility to visceral leishmaniasis
SO NATURE GENETICS
LA English
DT Article
ID GENOME-WIDE ASSOCIATION; INFECTION; POLYMORPHISM; CHAGASI; GENES; MODEL
AB To identify susceptibility loci for visceral leishmaniasis, we undertook genome-wide association studies in two populations: 989 cases and 1,089 controls from India and 357 cases in 308 Brazilian families (1,970 individuals). The HLA-DRB1-HLA-DQA1 locus was the only region to show strong evidence of association in both populations. Replication at this region was undertaken in a second Indian population comprising 941 cases and 990 controls, and combined analysis across the three cohorts for rs9271858 at this locus showed P-combined = 2.76 x 10(-17) and odds ratio (OR) = 1.41, 95% confidence interval (Cl) = 1.30-1.52. A conditional analysis provided evidence for multiple associations within the HLA-DRB1-HLA-DQA1 region, and a model in which risk differed between three groups of haplotypes better explained the signal and was significant in the Indian discovery and replication cohorts. In conclusion, the HLA-DRB1-HLA-DQA1 HLA class II region contributes to visceral leishmaniasis susceptibility in India and Brazil, suggesting shared genetic risk factors for visceral leishmaniasis that cross the epidemiological divides of geography and parasite species.
C1 [Fakiola, Michaela; Miller, E. Nancy; Blackwell, Jenefer M.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Sch Clin Med, Cambridge CB2 2QQ, England.
   [Pirinen, Matti; Su, Zhan; Band, Gavin; Bellenguez, Celine; Freeman, Colin; Giannoulatou, Eleni; Pearson, Richard; Vukcevic, Damjan; Rautanen, Anna; Spencer, Chris C. A.; Donnelly, Peter; LeishGEN Consortium] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Cordell, Heather J.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Mishra, Anshuman; Mehrotra, Sanjana; Rai, Madhukar; Singh, Shri P.; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.
   [Monteiro, Gloria R.; Pontes, Nubia N.; Sousa, Olivia; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Ctr Biosci, BR-59072970 Natal, RN, Brazil.
   [Dronov, Serge; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Langford, Cordelia; Deloukas, Panos; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England.
   [Lacerda, Henio G.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   [Smith, Linda; Christiansen, Frank; Witt, Campbell] Royal Perth Hosp, Dept Clin Immunol, Perth, WA 6001, Australia.
   [Bramon, Elvira] S London & Maudsley Natl Hlth Serv NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr Mental Hlt, London, England.
   [Bramon, Elvira] Kings Coll London, Inst Psychiat, London WC2R 2LS, England.
   [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia.
   [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.
   [Corvin, Aiden] Trinity Coll Dublin, Neuropsychiat Genet Res Grp, Inst Mol Med, Dublin, Ireland.
   [Duncanson, Audrey] Wellcome Trust Res Labs, London, England.
   [Jankowski, Janusz] Univ Oxford, Dept Oncol, Oxford, England.
   [Markus, Hugh S.] St Georges Univ London, Stroke & Dementia Res Grp, London, England.
   [Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, London WC2R 2LS, England.
   [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland.
   [Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England.
   [Sawcer, Stephen J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England.
   [Trembath, Richard C.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab ICDEM, Oxford OX3 7LJ, England.
   [Viswanathan, Ananth C.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Ctr Ophthalmol, London, England.
   [Viswanathan, Ananth C.] UCL, Inst Ophthalmol, London, England.
   [Wood, Nicholas W.] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Vet Affairs VA Med Ctr, Iowa City, IA USA.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia.
   [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England.
RP Donnelly, P (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
EM jblackwell@ichr.uwa.edu.au; donnelly@well.ox.ac.uk
RI Mathew, Christopher G/G-3434-2015; Jeronimo, Selma/AAY-4033-2020;
   Belllenguez, Celine/Y-3183-2018; Blackwell, Jenefer M/H-3015-2015;
   Brown, Matthew A/E-5749-2010; Bellenguez, Celine/X-4004-2019; Wood,
   Nicholas W/C-2505-2009; Deloukas, Panos/B-2922-2013; Palmer, Colin
   NA/C-7053-2008; Jankowski, Janusz/H-2706-2012; Jeronimo, Selma
   M.B./M-8672-2014
OI Mathew, Christopher G/0000-0003-4178-1838; Jeronimo,
   Selma/0000-0002-4784-9904; Belllenguez, Celine/0000-0002-1240-7874;
   Brown, Matthew A/0000-0003-0538-8211; Bellenguez,
   Celine/0000-0002-1240-7874; Wood, Nicholas W/0000-0002-9500-3348;
   Deloukas, Panos/0000-0001-9251-070X; Palmer, Colin
   NA/0000-0002-6415-6560; Jankowski, Janusz/0000-0003-2130-9181; Jeronimo,
   Selma M.B./0000-0002-4784-9904; Vukcevic, Damjan/0000-0001-7780-9586;
   Corvin, Aiden/0000-0001-6717-4089; Mishra, Anshuman/0000-0002-9390-9971;
   Wilson, Mary/0000-0001-8680-7275; Plomin, Robert/0000-0002-0756-3629;
   Hunt, Sarah/0000-0002-8350-1235; Fakiola, Michaela/0000-0001-9071-4709;
   Pirinen, Matti/0000-0002-1664-1350; Trembath,
   Richard/0000-0003-0550-3400; Giannoulatou, Eleni/0000-0002-7084-6736;
   Walters, James/0000-0002-6980-4053
FU Wellcome Trust, WTCCC2 project [085475/B/08/Z, 085475/Z/08/Z]; Wellcome
   Senior Fellowship in Basic Biomedical Science [087436/Z/10/Z]; Royal
   Society Wolfson Merit AwardRoyal Society of London; Wellcome Trust
   Centre for Human Genetics core grants [090532/Z/09/Z, 075491/Z/04/B];
   Wellcome TrustWellcome Trust [085475/Z/08/Z, 074196/Z/04/Z]; US National
   Institutes of Health (Tropical Medicine Research Center) in Brazil
   [P50AI074321, P50 AI-30639, 1201 AI076233, R01 AI048822]; Medical
   Research CouncilMedical Research Council UK (MRC) [G9817803B,
   MC_G1000735] Funding Source: researchfish; National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [NF-SI-0507-10379]
   Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI074321, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   R01AI048822, P50AI074321, P50AI074321, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, R01AI048822, P50AI030639,
   P50AI074321, R01AI048822, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, R01AI076233, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI074321, P50AI030639, R01AI076233,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, R01AI048822, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI074321, R01AI076233, P50AI030639, P50AI074321, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH
   RePORTER
FX The principal funding for this study was provided by the Wellcome Trust,
   as part of the WTCCC2 project (085475/B/08/Z and 085475/Z/08/Z). We
   thank S. Bertrand, J. Bryant, S.L. Clark, J.S. Conquer, T. Dibling, J.C.
   Eldred, S. Gamble, C. Hind, M.L. Perez, C.R. Stribling, S. Taylor and A.
   Wilk of the Wellcome Trust Sanger Institute's Sample and Genotyping
   Facilities for technical assistance. We thank D. Davison for making
   available his Shellfish program for calculating principal components in
   large genetic data sets. C.C.A.S. is supported by a Wellcome Trust
   Fellowship (097364/Z/11/Z). H.J.C. is supported by a Wellcome Senior
   Fellowship in Basic Biomedical Science (087436/Z/10/Z). P. Donnelly is
   supported in part by a Royal Society Wolfson Merit Award, and work was
   supported in part by Wellcome Trust Centre for Human Genetics core
   grants 090532/Z/09/Z and 075491/Z/04/B. Collection of samples and
   epidemiological data, sample preparation and sequence-based HLA typing
   were supported by grants from the Wellcome Trust (074196/Z/04/Z and
   085475/Z/08/Z to J.M.B., S.S., S.M.B.J. and M.E.W.) and the US National
   Institutes of Health (Tropical Medicine Research Center award
   P50AI074321 to S.S. in India; Tropical Medicine Research Center award
   P50 AI-30639 to E.M. Carvalho and S.M.B.J. in Brazil; and 1201 AI076233
   to M.E.W. and J.M.B.; R01 AI048822 to MEW, S.M.B.J. and J.M.B.). We give
   special thanks to all subjects who contributed samples and to clinicians
   and field staff in India and Brazil who helped with the recruitment of
   study subjects.
CR Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274
   Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307
   Bellenguez C, 2012, BIOINFORMATICS, V28, P134, DOI 10.1093/bioinformatics/btr599
   Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x
   Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08
   Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355
   Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8
   Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204
   de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   Fakiola M, 2011, J INFECT DIS, V204, P467, DOI 10.1093/infdis/jir284
   HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5
   Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548
   Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960
   Kuhls K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001155
   Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/NMETH.1681, 10.1038/nmeth.1681]
   Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3
   Mehrotra S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-162
   Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089
   Olivo-Diaz A, 2004, HUM IMMUNOL, V65, P255, DOI 10.1016/j.humimm.2003.12.008
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q
   SACKS DL, 1987, J IMMUNOL, V138, P908
   Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251
   Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522
   Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639
   Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753
   Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546
NR 36
TC 67
Z9 68
U1 0
U2 32
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD FEB
PY 2013
VL 45
IS 2
BP 208
EP 213
DI 10.1038/ng.2518
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 081PB
UT WOS:000314333000018
PM 23291585
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Dupnik, KM
   Martins, MMC
   Souza, ATD
   Jeronimo, SMB
   Nobre, ML
AF Dupnik, Kathryn Margaret
   Costa Martins, Milena Maria
   Da Silva Souza, Ana Teresa
   Bezerra Jeronimo, Selma Maria
   Nobre, Mauricio Lisboa
TI Nodular secondary syphilis simulating lepromatous leprosy
SO LEPROSY REVIEW
LA English
DT Article
AB There are diverse skin manifestations of both leprosy and syphilis. These diseases can appear similar to many other dermatologic conditions as well as to systemic diseases with dermatologic signs. Nodular syphilis is an uncommon type of secondary syphilis. We present here a person from a leprosy-endemic area with diffuse nodular skin lesions of secondary syphilis who was initially suspected of having lepromatous leprosy.
C1 [Dupnik, Kathryn Margaret] Weill Cornell Med Coll, Div Infect Dis, New York, NY USA.
   [Costa Martins, Milena Maria; Nobre, Mauricio Lisboa] Hosp Giselda Trigueiro, BR-59037170 Natal, RN, Brazil.
   [Da Silva Souza, Ana Teresa] Secretaria Municipal Saude, Programa Saude Familia, Natal, RN, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
RP Nobre, ML (corresponding author), Hosp Giselda Trigueiro, Rua Conego Monte 110, BR-59037170 Natal, RN, Brazil.
EM nobreml@gmail.com
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Nobre, Mauricio/0000-0003-4932-3137
CR Baughn RE, 2005, CLIN MICROBIOL REV, V18, P205, DOI 10.1128/CMR.18.1.205-216.2005
   BAUM EW, 1983, JAMA-J AM MED ASSOC, V249, P3069, DOI 10.1001/jama.249.22.3069
   Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7
   Fonseca E, 1999, J CUTAN PATHOL, V26, P51, DOI 10.1111/j.1600-0560.1999.tb01791.x
   JOB CK, 1994, INT J LEPROSY, V62, P433
   MATTHEWS LJ, 1965, LANCET, V2, P915
   NSIBAMBI JK, 1981, LEPROSY REV, V52, P171
   Pandhi D, 2005, J EUR ACAD DERMATOL, V19, P256, DOI 10.1111/j.1468-3083.2005.00972.x
   Papini M, 1998, BRIT J DERMATOL, V138, P704
   Rosmaninho A, 2011, EUR J DERMATOL, V21, P136, DOI 10.1684/ejd.2010.1200
   RUGE H, 1955, Bull World Health Organ, V13, P861
   SAPRA S, 1989, ARCH DERMATOL, V125, P1666, DOI 10.1001/archderm.125.12.1666
   SCOTTI AT, 1970, ARCH DERMATOL, V101, P328, DOI 10.1001/archderm.101.3.328
   Sehgal Virendra N., 1993, Journal of Dermatology (Tokyo), V20, P102, DOI 10.1111/j.1346-8138.1993.tb03839.x
NR 14
TC 1
Z9 1
U1 0
U2 1
PU LEPRA
PI COLCHESTER
PA 28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND
SN 0305-7518
EI 2162-8807
J9 LEPROSY REV
JI Lepr. Rev.
PD DEC
PY 2012
VL 83
IS 4
BP 389
EP 393
PG 5
WC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
SC Dermatology; Infectious Diseases; Pathology; Tropical Medicine
GA 114WB
UT WOS:000316772600011
PM 23614258
DA 2020-11-26
ER

PT J
AU Esch, KJ
   Pontes, NN
   Arruda, P
   O'Connor, A
   Morais, L
   Jeronimo, SMB
   Petersen, CA
AF Esch, Kevin J.
   Pontes, Nubia N.
   Arruda, Paulo
   O'Connor, Annette
   Morais, Lorena
   Jeronimo, Selma M. B.
   Petersen, Christine A.
TI Preventing Zoonotic Canine Leishmaniasis in Northeastern Brazil: Pet
   Attachment and Adoption of Community Leishmania Prevention
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VISCERAL LEISHMANIASIS; ENDEMIC AREA; PHLEBOTOMUS-PERNICIOSUS; INFANTUM
   INFECTION; RISK-FACTORS; DOGS; PERMETHRIN; COMBINATION; HEALTH; URBAN
AB Visceral leishmaniasis (VL), caused by Leishmania infantum chagasi (L.i. chagasi syn. infantum) in north-eastern Brazil, was responsible for 51,000 new VL cases from 1980 to 2003. Household presence of L. infantum-infected dogs is a major risk factor for human infection. Despite culling of dogs based on seropositivity, canine L. infantum seroprevalence remains near 20%, suggesting that dog culling is ineffective for preventing VL spread. We administered a cross-sectional survey to 224 households within 300 m of the homes of VL human patients diagnosed within the last year. The goal was to develop a model for voluntary preventative use based on characteristics and motivations of dog owners. We identified that owner knowledge deficiencies regarding canine transmission of L. infantum associated with increased risk of dog infection (odds ratio [OR] = 3.681, confidence interval [CI] = 1.223, 11.08). Higher owner education was associated with decreased levels of dog seropositivity (OR = 0.40, CI = 0.20, 0.81). Pet attachment (P = 0.036) and perception of risk/disease knowledge (P = 0.040) were significantly associated with willingness to voluntarily purchase canine VL prevention. These results highlight the importance of owner attachment to their pet in implementing reservoir-targeted zoonotic VL prevention.
C1 Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Morais, Lorena] Ctr Zoonoses, Dept Publ Hlth, Natal, RN, Brazil.
   Iowa State Univ Sci & Technol, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.
RP Esch, KJ (corresponding author), 2714 Vet Med, Ames, IA 50011 USA.
EM kjesch@iastate.edu; np12@ufrn.br; paulohea@iastate.edu;
   oconnor@iastate.edu; morrais.lorena@cz.rn.bz; smbj@ufrn.br;
   kalicat@iastate.edu
RI Jeronimo, Selma/AAY-4033-2020; Petersen, Christine/M-1881-2014;
   Jeronimo, Selma M.B./M-8672-2014; O'Connor, A/E-5591-2010
OI Jeronimo, Selma/0000-0002-4784-9904; Petersen,
   Christine/0000-0002-7285-4254; Jeronimo, Selma M.B./0000-0002-4784-9904;
   O'Connor, A/0000-0003-0604-7822
FU Pfizer Animal Health/Morris Animal Foundation Veterinary Fellowship for
   Advanced Degrees; NEWAID Foundation Fellowship for Research in Neglected
   Tropical Disease; National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA [1
   R21 AI088051-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21AI088051, R21AI088051] Funding Source:
   NIH RePORTER
FX This project was funded through the Pfizer Animal Health/Morris Animal
   Foundation Veterinary Fellowship for Advanced Degrees, the NEWAID
   Foundation Fellowship for Research in Neglected Tropical Disease, and
   National Institutes of Health Grant 1 R21 AI088051-01.
CR Alexander B, 2009, TROP MED INT HEALTH, V14, P1272, DOI 10.1111/j.1365-3156.2009.02371.x
   Borges BKA, 2008, CAD SAUDE PUBLICA, V24, P777, DOI 10.1590/S0102-311X2008000400007
   Baneth G, 2008, TRENDS PARASITOL, V24, P324, DOI 10.1016/j.pt.2008.04.001
   Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X
   Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   Chompook P, 2006, INT J INFECT DIS, V10, P425, DOI 10.1016/j.ijid.2006.05.011
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291
   Day MJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-49
   de Almeida AS, 2011, AM J TROP MED HYG, V84, P681, DOI 10.4269/ajtmh.2011.10-0325
   Oliveira TMFD, 2008, REV BRAS PARASITOL V, V17, P7, DOI 10.1590/S1984-29612008000100002
   Ferroglio E, 2008, ZOONOSES PUBLIC HLTH, V55, P145, DOI 10.1111/j.1863-2378.2007.01092.x
   Giffoni Juliana Haddad, 2002, Vet Ther, V3, P485
   Goldman D, 2011, SOC SCI MED, V72, P1728, DOI 10.1016/j.socscimed.2011.02.047
   Gorter AC, 1998, INT J EPIDEMIOL, V27, P1090, DOI 10.1093/ije/27.6.1090
   Gouvea MV, 2007, ACTA TROP, V104, P99, DOI 10.1016/j.actatropica.2007.07.010
   Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P489, DOI 10.1046/j.1365-3156.2002.00889.x
   JOHNSON TP, 1992, ANTHROZOOS, V5, P160, DOI 10.2752/089279392787011395
   Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492
   Mencke N, 2003, PARASITOL RES, V90, pS108, DOI 10.1007/s00436-003-0905-7
   Mercier P, 2003, VET THER, V4, P309
   Miro G, 2007, VET PARASITOL, V143, P375, DOI 10.1016/j.vetpar.2006.09.014
   Molina R, 2006, VET REC, V159, P206, DOI 10.1136/vr.159.7.206
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044
   Otranto D, 2007, VET PARASITOL, V144, P270, DOI 10.1016/j.vetpar.2006.09.012
   Paz GF, 2010, PREV VET MED, V97, P131, DOI 10.1016/j.prevetmed.2010.08.006
   Pedrosa FDA, 2009, AM J TROP MED HYG, V81, P195
   Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014
   Raina P, 1999, J AM GERIATR SOC, V47, P323, DOI 10.1111/j.1532-5415.1999.tb02996.x
   Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006
   Romero GAS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000584
   Tasca KI, 2009, REV BRAS PARASITOL V, V18, P27, DOI 10.4322/rbpv.01801005
   Vulpiani MP, 2009, VET PARASITOL, V160, P190, DOI 10.1016/j.vetpar.2008.11.014
   WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355
   Werneck GL, 2008, CAD SAUDE PUBLICA, V24, P2937, DOI 10.1590/S0102-311X2008001200023
NR 38
TC 17
Z9 17
U1 0
U2 10
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2012
VL 87
IS 5
BP 822
EP 831
DI 10.4269/ajtmh.2012.12-0251
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 036VI
UT WOS:000311060000008
PM 22987654
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Eu-Ahsunthornwattana, J
   Miller, N
   Pirinen, M
   Fakiola, M
   Jeronimo, SMB
   Blackwell, JM
   Cordell, HJ
AF Eu-Ahsunthornwattana, Jakris
   Miller, Nancy
   Pirinen, Matti
   Fakiola, Michaela
   Jeronimo, Selma M. B.
   Blackwell, Jenefer M.
   Cordell, Heather J.
CA WTCCC2
TI Accounting for Relatedness in Genomewide Association Studies: An
   Empirical Methods Comparison
SO GENETIC EPIDEMIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the International-Genetic-Epidemiology-Society (IGES)
CY OCT 18-20, 2012
CL Stevenson, WA
SP Int Genet Epidemiol Soc (IGES)
C1 [Eu-Ahsunthornwattana, Jakris; Cordell, Heather J.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Miller, Nancy; Fakiola, Michaela] Univ Cambridge, Cambridge CB2 1TN, England.
   [Pirinen, Matti] Univ Oxford, Oxford OX1 2JD, England.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Blackwell, Jenefer M.] Univ Western Australia, Nedlands, WA 6009, Australia.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Eu-ahsunthornwattana, Jakris/AAL-1435-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Eu-ahsunthornwattana,
   Jakris/0000-0002-8060-9566
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0741-0395
J9 GENET EPIDEMIOL
JI Genet. Epidemiol.
PD NOV
PY 2012
VL 36
IS 7
MA 184
BP 772
EP 773
PG 2
WC Genetics & Heredity; Mathematical & Computational Biology
SC Genetics & Heredity; Mathematical & Computational Biology
GA 021VJ
UT WOS:000309913200189
DA 2020-11-26
ER

PT J
AU Stober, CB
   Jeronimo, SMB
   Pontes, NN
   Miller, EN
   Blackwell, JM
AF Stober, Carmel B.
   Jeronimo, Selma M. B.
   Pontes, Nubia N.
   Miller, E. Nancy
   Blackwell, Jenefer M.
TI Cytokine Responses to Novel Antigens in a Pen-Urban Population in Brazil
   Exposed to Leishmania infantum chagasi
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID AMERICAN VISCERAL LEISHMANIASIS; PRIME-BOOST VACCINATION; CUTANEOUS
   LEISHMANIASIS; CONTROLLED-TRIAL; MAJOR INFECTION; DOUBLE-BLIND; PLUS
   BCG; MURINE; PREVENTION; PROTECTION
AB Visceral leishmaniasis (VL) is fatal if untreated, and there are no vaccines for this disease. High levels of CD4-derived interferon-gamma (IFN-gamma) in the presence of low levels of interleukin-10 (IL-10) predicts vaccine success. Tumor necrosis factor-alpha (TNF-alpha) is also important in this process. We characterized human immune responses in three groups exposed to Leishmania infantum chagasi in Brazil: 1) drug-cured VL patients (recovered VL); 2) asymptomatic persons with positive Leishmania-specific delayed-type hypersensitivity skin reactions (DTH+); and 3) DTH-negative household contacts. Magnitude of DTH correlated with crude Leishmania antigen driven IFN-gamma, TNF-alpha, and IL-5, but not IL-10. DTH+ persons showed equivalent levels of IFN-gamma, but higher levels of IL-10, to tryparedoxin peroxidase and Leishmania homolog of receptor for activated C kinase compared with recovered VL patients. The IFN-gamma:IL-10 and TNF-alpha:IL-10 ratios were higher in recovered VL patients than in DTH+ persons. Seven of 11 novel candidates (R71, L37, N52, L302.06, M18, J41, and M22) elicited cytokine responses (36-71% of responders) in recovered VL patients and DTH+ persons. This result confirmed their putative status as cross-species vaccine/immunotherapeutic candidates.
C1 [Stober, Carmel B.] Univ Cambridge, Dept Med, Sch Clin Med, Cambridge CB2 2QQ, England.
   [Jeronimo, Selma M. B.; Pontes, Nubia N.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Jeronimo, Selma M. B.; Pontes, Nubia N.] Inst Ciencia & Tecnol Doencas Trop, Natal, RN, Brazil.
   [Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA 6008, Australia.
RP Blackwell, JM (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, POB 855, Subiaco, WA 6872, Australia.
EM c.stober@doctors.org.uk; smbj@cb.ufrn.br; nnatalir@yahoo.com.br;
   jblackwell@ichr.uwa.edu.au
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014;
   Blackwell, Jenefer M/H-3015-2015
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; 
FU University of Cambridge School of Clinical Medicine; National Institutes
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI067874-01, P50 AI-30639];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, P50AI030639, R01AI067874, P50AI074321,
   R01AI076233, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI074321,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI074321, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI074321, R01AI076233, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI074321,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI074321, R01AI067874,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, R01AI076233, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, R01AI067874, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321] Funding Source: NIH RePORTER; National Institute for Health
   ResearchNational Institute for Health Research (NIHR) [ACF-2011-14-005]
   Funding Source: researchfish
FX The study was undertaken as part of a partially self-funded elective
   project by University of Cambridge School of Clinical Medicine. We thank
   the study participants for their cooperation and Manoel Gomes Fernandes
   (Brazilian National Health Foundation) for assistance during field
   work.; This study was supported by grants from the National Institutes
   of Health to Jenefer M. Blackwell (R01AI067874-01) and Selma M. B.
   Jeronimo (P50 AI-30639).
CR ANTUNES CM, 1986, INT J EPIDEMIOL, V15, P572, DOI 10.1093/ije/15.4.572
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   BARRALNETTO M, 1991, J INFECT DIS, V163, P853, DOI 10.1093/infdis/163.4.853
   Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001
   Chakravarty J, 2011, VACCINE, V29, P3531, DOI 10.1016/j.vaccine.2011.02.096
   Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005
   Follador I, 2002, CLIN INFECT DIS, V34, pE54, DOI 10.1086/340261
   Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001042
   Goto Y, 2011, CLIN VACCINE IMMUNOL, V18, P1118, DOI 10.1128/CVI.05024-11
   GREENBLATT CL, 1988, PARASITOL TODAY, V4, P53, DOI 10.1016/0169-4758(88)90067-1
   Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000
   Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529
   Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680
   Jayakumar A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001204
   Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7
   Levick MP, 1998, MOL BIOCHEM PARASIT, V96, P125, DOI 10.1016/S0166-6851(98)00122-4
   Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x
   Mauel J., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P201, DOI 10.2174/1568008023340631
   MAYRINK W, 1979, T ROY SOC TROP MED H, V73, P385, DOI 10.1016/0035-9203(79)90159-7
   Modabber F, 2010, INT J ANTIMICROB AG, V36, pS58, DOI 10.1016/j.ijantimicag.2010.06.024
   Momeni AZ, 1999, VACCINE, V17, P466, DOI 10.1016/S0264-410X(98)00220-5
   MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103
   Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000943, 10.1371/journal.pntd.0000965]
   Novoa R, 2011, PARASITE IMMUNOL, V33, P132, DOI 10.1111/j.1365-3024.2010.01256.x
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   SACKS DL, 1987, J IMMUNOL, V138, P908
   Sharifi I, 1998, LANCET, V351, P1540, DOI 10.1016/S0140-6736(98)09552-X
   Stober CB, 2007, INFECT IMMUN, V75, P852, DOI 10.1128/IAI.01490-06
   Stober CB, 2006, VACCINE, V24, P2602, DOI 10.1016/j.vaccine.2005.12.012
   Stober CB, 2005, J IMMUNOL, V175, P2517, DOI 10.4049/jimmunol.175.4.2517
NR 38
TC 11
Z9 11
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2012
VL 87
IS 4
BP 663
EP 670
DI 10.4269/ajtmh.2012.12-0180
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 020FS
UT WOS:000309795000013
PM 22826477
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Miranda, RHF
   Jeronimo, SM
AF Dourado, M. E.
   Felix Miranda, R. H.
   Jeronimo, S. M.
TI Response: serial nerve conduction studies in Guillain-Barre syndrome
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Letter
C1 [Dourado, M. E.; Felix Miranda, R. H.; Jeronimo, S. M.] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, BR-59072970 Natal, RN, Brazil.
RP Dourado, ME (corresponding author), Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, BR-59072970 Natal, RN, Brazil.
EM medourado@ufrnet.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260
   Nagasawa K, 2006, MUSCLE NERVE, V33, P766, DOI 10.1002/mus.20520
   Sladky JT, 2007, NEUROLOGY, V69, P1647, DOI 10.1212/01.wnl.0000280583.84253.05
NR 5
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0001-6314
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD APR
PY 2012
VL 125
IS 4
BP e23
EP e23
DI 10.1111/j.1600-0404.2011.01565.x
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 904UJ
UT WOS:000301223100002
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Felix, RH
   da Silva, WKA
   Queiroz, JW
   Jeronimo, SMB
AF Dourado, M. E.
   Felix, R. H.
   da Silva, W. K. A.
   Queiroz, J. W.
   Jeronimo, S. M. B.
TI Clinical characteristics of Guillain-Barre syndrome in a tropical
   country: a Brazilian experience
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE Guillain-Barre syndrome; electromyography; critical care;
   neuroimmunology; neuropathy; peripheral neuropathy
ID CAMPYLOBACTER-JEJUNI; GANGLIOSIDE MIMICRY; ANTIBODIES; FEATURES;
   PREDICTORS; NEUROPATHY; PROGNOSIS; PATTERNS; CRITERIA
AB Objective - To analyze the clinical variants, outcomes, and prognosis of Guillain-Barre syndrome (GBS) in a Brazilian population. Materials and methods - Clinical and laboratory data of 149 cases of GBS diagnosed from 1994 to 2007 were analyzed. Results - Acute inflammatory demyelinating polyneuropathy (AIDP) was the most frequent variant (81.8%) of GBS, followed by acute motor axonal neuropathy (AMAN) (14.7%) and acute motor and sensory axonal neuropathy (AMSAN) (3.3%). The incidence of GBS was 0.3/100,000 for the state of Rio Grande do Norte and cases occurred at a younger age. GBS was preceded by infections, with the axonal variant associated with episodes of diarrheas (P = 0.025). Proximal weakness was more frequent in AIDP, and distal weakness predominant in the axonal variant. Compared to 42.4% of cases with AIDP (P < 0.0001), 84.6% of cases with the axonal variant had nadir in < 10 days. Individuals with the axonal variant took longer to recover deambulation (P < 0.0001). The mortality of GBS was 5.3%. Conclusion - A predominance of the AIDP variant was seen, and the incidence of the disease decreased with age. As expected, the distribution of weakness correlated with the clinical variants, and individuals with the axonal variant had a poorer prognosis.
C1 [Dourado, M. E.] Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, BR-59072970 Natal, RN, Brazil.
   [Dourado, M. E.; Felix, R. H.; Queiroz, J. W.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Post Grad Program, BR-59072970 Natal, RN, Brazil.
   [da Silva, W. K. A.; Queiroz, J. W.; Jeronimo, S. M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Jeronimo, S. M. B.] CNPq, MCT, INCT DT, Campinas, SP, Brazil.
RP Dourado, ME (corresponding author), Univ Fed Rio Grande do Norte, Hosp Univ Onofre Lopes, CP 1624, BR-59072970 Natal, RN, Brazil.
EM medourado@ufrnet.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
FU Brazilian Research Council (Conselho Nacional de Pesquisa e
   Desenvolvimento, CNPq-Universal) [14/2009]; Instituto Nacional de
   Ciencia e Tecnologia de Doencas Tropicais (INCT-DT)
FX We thank the staff of the Hospital Walfredo Gurgel, Hospital
   Universitario Onofre Lopes and Hospital Infantil Varella Santiago in
   Natal for the referral of the patients with Guillain-Barre syndrome and
   Kate Dupnik, MD (New York Presbyterian Hospital/Weil Cornell Medical
   College) for her helpful suggestions. This work was supported by the
   Brazilian Research Council (Conselho Nacional de Pesquisa e
   Desenvolvimento, CNPq-Universal 14/2009) and by the Instituto Nacional
   de Ciencia e Tecnologia de Doencas Tropicais (INCT-DT).
CR Andrade IG, 2009, T ROY SOC TROP MED H, V103, P506, DOI 10.1016/j.trstmh.2008.12.017
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   DEARRUDA E, 1991, J INFECT DIS, V164, P252, DOI 10.1093/infdis/164.2.252
   Dias-Tosta E, 2002, ARQ NEURO-PSIQUIAT, V60, P367, DOI 10.1590/S0004-282X2002000300005
   Dourado ME, 2003, ACTA NEUROL SCAND, V108, P102, DOI 10.1034/j.1600-0404.2003.00103.x
   Durand MC, 2006, LANCET NEUROL, V5, P1021, DOI 10.1016/S1474-4422(06)70603-2
   Franca MC, 2005, ARQ NEURO-PSIQUIAT, V63, P772, DOI 10.1590/S0004-282X2005000500010
   Funakoshi K, 2009, J NEUROL NEUROSUR PS, V80, P60, DOI 10.1136/jnnp.2008.154351
   GRIFFIN JW, 1995, BRAIN, V118, P577, DOI 10.1093/brain/118.3.577
   Hao Q, 1998, J NEUROIMMUNOL, V81, P116, DOI 10.1016/S0165-5728(97)00166-5
   Hao Q, 1999, ANN NEUROL, V45, P758
   Hauck LJ, 2008, J NEUROL NEUROSUR PS, V79, P318, DOI 10.1136/jnnp.2007.118810
   Hiraga A, 2005, NEUROLOGY, V64, P856, DOI 10.1212/01.WNL.0000153071.71335.E9
   Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1997, LANCET, V349, P225
   Hui ACF, 2005, J CLIN NEUROSCI, V12, P134, DOI 10.1016/j.jocn.2003.10.018
   Kushnir M, 2008, ACTA NEUROL SCAND, V117, P347, DOI 10.1111/j.1600-0404.2007.00949.x
   Lawn ND, 1999, MUSCLE NERVE, V22, P1058
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   MEULSTEE J, 1995, J NEUROL NEUROSUR PS, V59, P482, DOI 10.1136/jnnp.59.5.482
   Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104
   Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd
   Nagasawa K, 2006, MUSCLE NERVE, V33, P766, DOI 10.1002/mus.20520
   Paradiso G, 1999, ANN NEUROL, V46, P701, DOI 10.1002/1531-8249(199911)46:5<701::AID-ANA4>3.0.CO;2-7
   REES JH, 1995, ANN NEUROL, V38, P809, DOI 10.1002/ana.410380516
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P511, DOI 10.1001/archneur.1984.04050170057018
   Soares CN, 2008, ARQ NEURO-PSIQUIAT, V66, P234, DOI 10.1590/S0004-282X2008000200018
   Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Koningsveld R, 2001, NEUROLOGY, V56, P1467, DOI 10.1212/WNL.56.11.1467
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   VISSER LH, 1995, BRAIN, V118, P841, DOI 10.1093/brain/118.4.841
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Yuki N, 2005, CURR OPIN NEUROL, V18, P557, DOI 10.1097/01.wco.0000174604.42272.2d
   Yuki N, 2007, MUSCLE NERVE, V35, P691, DOI 10.1002/mus.20762
NR 38
TC 23
Z9 24
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD JAN
PY 2012
VL 125
IS 1
BP 47
EP 53
DI 10.1111/j.1600-0404.2011.01503.x
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 867TN
UT WOS:000298477600010
PM 21428966
DA 2020-11-26
ER

PT J
AU Lima, ID
   Queiroz, JW
   Lacerda, HG
   Queiroz, PVS
   Pontes, NN
   Barbosa, JDA
   Martins, DR
   Weirather, JL
   Pearson, RD
   Wilson, ME
   Jeronimo, SMB
AF Lima, Iraci D.
   Queiroz, Jose W.
   Lacerda, Henio G.
   Queiroz, Paula V. S.
   Pontes, Nubia N.
   Barbosa, James D. A.
   Martins, Daniella R.
   Weirather, Jason L.
   Pearson, Richard D.
   Wilson, Mary E.
   Jeronimo, Selma M. B.
TI Leishmania infantum chagasi in Northeastern Brazil: Asymptomatic
   Infection at the Urban Perimeter
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CANINE VISCERAL LEISHMANIASIS; KALA-AZAR; LUTZOMYIA-LONGIPALPIS;
   NATURAL-HISTORY; UNITED-STATES; ENDEMIC AREA; BLOOD-DONORS; FOLLOW-UP;
   TRANSMISSION; SENSITIVITY
AB Visceral leishmaniasis (VL) is endemic in large cities in Brazil, including Natal. We determined the prevalence of asymptomatic human infection with Leishmania infantum chagasi and associated environmental risks around Natal. Infection was detected by Leishmania skin test (LST) and anti-leishmanial antibodies in humans and anti-leishmanial antibodies in dogs. Amongst 345 humans, 24.6% were seropositive, and 38.6% were LST-positive. Prevalence of positive serology was similar in both sexes and across all ages. However, positive LST responses increased with age, suggesting that LST is long-lasting and cumulative. Multinomial logistic analysis showed that LST response varied with location (P = 0.007) and that males were more frequently LST-positive (P = 0.027). Indicators of lower socioeconomic status associated significantly with human infection. Furthermore, there was geographic coincidence of seropositive humans and dogs (r = 0.7926, P = 0.011). These data suggest that dog and human L. i. chagasi infection are intimately interrelated in environmental conditions associated with low income.
C1 Univ Fed Rio Grande do Norte, Hlth Postgrad Program, Dept Infect Dis, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Martins, Daniella R.] Univ Fed Rio Grande do Norte, Dept Biol & Genet, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Lima, Iraci D.] Fdn Nacl Saude, Natal, RN, Brazil.
   [Pearson, Richard D.] Univ Virginia, Dept Med, Ctr Global Hlth, Div Infect Dis & Int Hlth,Sch Med, Charlottesville, VA USA.
   [Pearson, Richard D.] Univ Virginia, Dept Pathol, Ctr Global Hlth, Div Infect Dis & Int Hlth,Sch Med, Charlottesville, VA 22903 USA.
   Univ Iowa, Dept Internal Med, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA.
   [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   [Jeronimo, Selma M. B.] Fed Rio Grande Norte, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Jeronimo, Selma M. B.] Fed Rio Grande Norte, Hlth Postgrad Program, BR-59078970 Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Fed Rio Grande Norte, Dept Biochem, Av Sen Salgado Filho SN,CP 1624, BR-59078970 Natal, RN, Brazil.
EM iraci.duarte@ig.com.br; jwq@supercabo.com.br; heniolacerda@ufrnet.br;
   paulavivianne@hotmail.com; nnatalir@yahoo.com.br; jamesdary@oi.com.br;
   danillamartins@cb.ufrn.br; jason-weirather@uiowa.edu;
   rdp9g@virginia.edu; mary-wilson@uiowa.edu; smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIHP50 AI-030639, R01
   AI045540, R01 AI067874, R01 AI076233]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq); Department of Veterans'
   AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI067874, R01AI076233,
   P50AI030639, R01AI067874, P50AI030639, R01AI048822, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, R01AI067874, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI067874, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629] Funding Source: NIH RePORTER
FX This work was supported in part by funds from National Institutes of
   Health Grant NIHP50 AI-030639 and the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). Studies were also
   supported by grants from the Department of Veterans' Affairs (to J.L.W.
   and M.E.W.) and National Institutes of Health Grants R01 AI045540 (to
   M.E.W.), R01 AI067874 (to M.E.W.). and R01 AI076233 (to M.E.W.).
CR ABRAMSON MA, 1995, CLIN INFECT DIS, V20, P1292, DOI 10.1093/clinids/20.5.1292
   AKUFFO H, 1995, AM J TROP MED HYG, V53, P16, DOI 10.4269/ajtmh.1995.53.16
   ALI A, 1994, ANN TROP MED PARASIT, V88, P289, DOI 10.1080/00034983.1994.11812869
   ALI A, 1993, ANN TROP MED PARASIT, V87, P163, DOI 10.1080/00034983.1993.11812750
   Andrade IG, 2009, T ROY SOC TROP MED H, V103, P506, DOI 10.1016/j.trstmh.2008.12.017
   Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   BRAY R S, 1982, Ecology of Disease, V1, P257
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   CUMMINS D, 1995, ARCH DIS CHILD, V72, P235, DOI 10.1136/adc.72.3.235
   Daher EF, 2009, J PARASITOL, V95, P652, DOI 10.1645/GE-1678.1
   David JR, 2001, MEM I OSWALDO CRUZ, V96, P839, DOI 10.1590/S0074-02762001000600018
   Marzochi MCD, 2009, REV SOC BRAS MED TRO, V42, P570, DOI 10.1590/S0037-86822009000500017
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   Duprey ZH, 2006, EMERG INFECT DIS, V12, P440, DOI 10.3201/eid1203.050811
   DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118
   FERNANDEZGUERRERO ML, 1987, AM J MED, V83, P1098, DOI 10.1016/0002-9343(87)90948-X
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Gibson L J, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS71, DOI 10.1016/S0035-9203(02)90054-4
   Gouvea MV, 2007, ACTA TROP, V104, P99, DOI 10.1016/j.actatropica.2007.07.010
   Iversson L B, 1979, Rev Saude Publica, V13, P159, DOI 10.1590/S0034-89101979000200012
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kirchhoff LV, 2006, TRANSFUSION, V46, P298, DOI 10.1111/j.1537-2995.2006.00715.x
   LAINSON R, 1977, NATURE, V266, P628, DOI 10.1038/266628a0
   LAINSON R, 1969, T ROY SOC TROP MED H, V63, P741, DOI 10.1016/0035-9203(69)90118-7
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999
   LE PF, 1989, MEM I O CRUZ, V84, P417
   Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004
   Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710
   Melo M N, 1977, Rev Inst Med Trop Sao Paulo, V19, P161
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   MONTALBAN C, 1990, J INFECTION, V21, P261, DOI 10.1016/0163-4453(90)93933-J
   Moral L, 2002, T ROY SOC TROP MED H, V96, P129, DOI 10.1016/S0035-9203(02)90278-6
   MOTT KE, 1990, B WORLD HEALTH ORGAN, V68, P691
   MOTT KE, 1995, B WORLD HEALTH ORGAN, V73, P247
   Albuquerque PLMM, 2009, REV PANAM SALUD PUBL, V26, P330, DOI 10.1590/S1020-49892009001000007
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   Oliveira RA, 2008, TRANSPL INFECT DIS, V10, P364, DOI 10.1111/j.1399-3062.2008.00320.x
   Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014
   Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156
   Rebelo JMM, 2008, CAD SAUDE PUBLICA, V24, P1713, DOI 10.1590/S0102-311X2008000700026
   Riera C, 2008, TRANSFUSION, V48, P1383, DOI 10.1111/j.1537-2995.2008.01708.x
   Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018
   Salomon OD, 2009, MEM I OSWALDO CRUZ, V104, P801, DOI 10.1590/S0074-02762009000500024
   SARAN R, 1991, Journal of Communicable Diseases, V23, P135
   Schantz PM, 2005, JAVMA-J AM VET MED A, V226, P1316, DOI 10.2460/javma.2005.226.1316
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Singh R, 2008, ACTA TROP, V107, P117, DOI 10.1016/j.actatropica.2008.04.025
   Singh S, 1996, TRANSFUSION, V36, P848, DOI 10.1046/j.1537-2995.1996.36996420769.x
   SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013
   SUNDAR S, 2003, TROP MED INT HEALTH, V13, P2
   Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008
   WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123
   Ximenes MDFFDM, 2007, NEOTROP ENTOMOL, V36, P128, DOI 10.1590/S1519-566X2007000100016
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   ZIJLSTRA EE, 1993, T ROY SOC TROP MED H, V87, P425, DOI 10.1016/0035-9203(93)90024-K
NR 67
TC 30
Z9 30
U1 0
U2 7
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JAN
PY 2012
VL 86
IS 1
BP 99
EP 107
DI 10.4269/ajtmh.2012.10-0492
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 875WF
UT WOS:000299065200021
PM 22232458
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Weirather, JL
   Jeronimo, SMB
   Gautam, S
   Sundar, S
   Kang, M
   Kurtz, MA
   Haque, R
   Schriefer, A
   Talhari, S
   Carvalho, EM
   Donelson, JE
   Wilson, ME
AF Weirather, Jason L.
   Jeronimo, Selma M. B.
   Gautam, Shalini
   Sundar, Shyam
   Kang, Mitchell
   Kurtz, Melissa A.
   Haque, Rashidul
   Schriefer, Albert
   Talhari, Sinesio
   Carvalho, Edgar M.
   Donelson, John E.
   Wilson, Mary E.
TI Serial Quantitative PCR Assay for Detection, Species Discrimination, and
   Quantification of Leishmania spp. in Human Samples
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; KINETOPLAST DNA; VISCERAL
   LEISHMANIASIS; KALA-AZAR; RAPID IDENTIFICATION; PERIPHERAL-BLOOD;
   INFANTUM DNA; DIAGNOSIS; INFECTION
AB The Leishmania species cause a variety of human disease syndromes. Methods for diagnosis and species differentiation are insensitive and many require invasive sampling. Although quantitative PCR (qPCR) methods are reported for leishmania detection, no systematic method to quantify parasites and determine the species in clinical specimens is established. We developed a serial qPCR strategy to identify and rapidly differentiate Leishmania species and quantify parasites in clinical or environmental specimens. SYBR green qPCR is mainly employed, with corresponding TaqMan assays for validation. The screening primers recognize kinetoplast minicircle DNA of all Leishmania species. Species identification employs further qPCR set(s) individualized for geographic regions, combining species-discriminating probes with melt curve analysis. The assay was sufficient to detect Leishmania parasites, make species determinations, and quantify Leishmania spp. in sera, cutaneous biopsy specimens, or cultured isolates from subjects from Bangladesh or Brazil with different forms of leishmaniasis. The multicopy kinetoplast DNA (kDNA) probes were the most sensitive and useful for quantification based on promastigote standard curves. To test their validity for quantification, kDNA copy numbers were compared between Leishmania species, isolates, and life stages using qPCR. Maxicircle and minicircle copy numbers differed up to 6-fold between Leishmania species, but the differences were smaller between strains of the same species. Amastigote and promastigote leishmania life stages retained similar numbers of kDNA maxi-or minicircles. Thus, serial qPCR is useful for leishmania detection and species determination and for absolute quantification when compared to a standard curve from the same Leishmania species.
C1 [Weirather, Jason L.; Wilson, Mary E.] Univ Iowa, Iowa City VA Med Ctr, Iowa City, IA 52242 USA.
   [Weirather, Jason L.; Kang, Mitchell; Kurtz, Melissa A.; Donelson, John E.; Wilson, Mary E.] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA 52242 USA.
   [Weirather, Jason L.; Kang, Mitchell; Kurtz, Melissa A.; Donelson, John E.; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Weirather, Jason L.; Kang, Mitchell; Kurtz, Melissa A.; Donelson, John E.; Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Weirather, Jason L.; Kang, Mitchell; Kurtz, Melissa A.; Donelson, John E.; Wilson, Mary E.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.
   [Weirather, Jason L.; Kang, Mitchell; Kurtz, Melissa A.; Donelson, John E.; Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Gautam, Shalini; Sundar, Shyam] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India.
   [Haque, Rashidul] ICDDR B, Dhaka, Bangladesh.
   [Schriefer, Albert; Carvalho, Edgar M.] Univ Fed Bahia, Serv Immunol, Salvador, BA, Brazil.
   [Talhari, Sinesio] Trop Med Fdn Amazon, Manaus, Amazonas, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Iowa City VA Med Ctr, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Schriefer, Albert/AAP-2765-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Schriefer, Albert/0000-0002-5496-6789;
   Wilson, Mary/0000-0001-8680-7275
FU Merit Review grant; Persian Gulf program; Department of Veterans'
   AffairsUS Department of Veterans Affairs; Tropical Diseases Medicine
   Center [P50 AI-074321, P50 AI-30639]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [NIAID
   R01 AI045540, R01AI067874, R01 AI076233, R01 AI059451, T32 GM008629, T32
   GM082729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, R01AI067874, P50AI030639, R01AI048822,
   P50AI074321, P50AI030639, P50AI030639, P50AI074321, R01AI048822,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, R01AI076233, P50AI074321, R01AI045540, P50AI030639,
   P50AI030639, R01AI067874, R01AI076233, R01AI059451, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, R01AI045540, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, R01AI059451, R01AI045540, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   R01AI067874, P50AI074321, P50AI074321, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, R01AI067874,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, R01AI045540, P50AI074321, P50AI074321, P50AI030639,
   R01AI045540, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI074321, R01AI059451, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, R01AI048822, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI074321,
   R01AI067874, R01AI045540, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, R01AI048822, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, R01AI059451, R01AI059451, R01AI045540,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI074321, P50AI074321, P50AI030639, R01AI045540, P50AI074321,
   P50AI030639, P50AI074321, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, R01AI076233, P50AI074321, R01AI076233, P50AI074321,
   P50AI030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM082729, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM008629, T32GM008629, T32GM008629, T32GM082729,
   T32GM082729, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM082729, T32GM008629, T32GM008629, T32GM008629, T32GM008629,
   T32GM008629, T32GM082729] Funding Source: NIH RePORTER; Veterans
   AffairsUS Department of Veterans Affairs [I01BX001983, I01BX001983,
   I01BX001983, I01BX001983, I01BX001983] Funding Source: NIH RePORTER
FX This work was supported in part by a Merit Review grant, a Persian Gulf
   program grant, and an OEF-OIF program grant from the Department of
   Veterans' Affairs. It was supported in part by Tropical Diseases
   Medicine Center grants P50 AI-074321 (S. S., S. G., and M. E. W.) and
   P50 AI-30639 (S. M. B.J., A. S., E. M. C., and M. E. W.) and by NIH
   grants NIAID R01 AI045540 (M. E. W.), R01AI067874 (M. E. W.), R01
   AI076233 (M. E. W.), and R01 AI059451 (J.E.D. and M. E. W.). It was
   performed in part during the tenure of J.L.W. on NIH training grants T32
   GM008629 and T32 GM082729.
CR Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003
   Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298
   Aoun O, 2009, VET PARASITOL, V166, P27, DOI 10.1016/j.vetpar.2009.08.006
   BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536
   BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142
   Berman J, 2005, EXPERT OPIN INV DRUG, V14, P1337, DOI 10.1517/13543784.14.11.1337
   Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003
   Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001
   Bryceson A. D. M, 1970, P ROY SOC MED, V63, P40
   Cardo LJ, 2006, TRANSFUSION, V46, P1641, DOI 10.1111/j.1537-2995.2006.00941.x
   Centers for Disease Control (CDC), 1992, MMWR Morb Mortal Wkly Rep, V41, P131
   Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748
   CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4
   Costa JM, 1996, J CLIN MICROBIOL, V34, P1831, DOI 10.1128/JCM.34.7.1831-1833.1996
   Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI [10.1128/CMR.19.1.111-126.2006, 10.4103/0974-777X.62887]
   Davies CR, 1997, CLIN INFECT DIS, V25, P302, DOI 10.1086/514535
   de Almeida ME, 2011, J CLIN MICROBIOL, V49, P3143, DOI 10.1128/JCM.01177-11
   DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J
   Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0
   FILLOLA G, 1992, J CLIN MICROBIOL, V30, P3284, DOI 10.1128/JCM.30.12.3284-3285.1992
   Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011
   Gardener P J, 1977, Trop Dis Bull, V74, P1069
   GRAMICCIA M, 1992, PARASITOLOGY, V105, P29, DOI 10.1017/S0031182000073650
   GUEVARA P, 1993, LANCET, V341, P1341, DOI 10.1016/0140-6736(93)90845-8
   HAJDUK SL, 1993, FASEB J, V7, P54
   Hanafi R, 2001, EXP PARASITOL, V98, P90, DOI 10.1006/expr.2001.4617
   Heger A, 2005, NUCLEIC ACIDS RES, V33, pD188
   HENDERSON DM, 1992, MOL BIOCHEM PARASIT, V53, P169, DOI 10.1016/0166-6851(92)90019-G
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Johnson K. E, 2004, MSMR, V10, P2
   LASKAY T, 1991, T ROY SOC TROP MED H, V85, P599, DOI 10.1016/0035-9203(91)90360-B
   le Fichoux Y, 1999, J CLIN MICROBIOL, V37, P1953, DOI 10.1128/JCM.37.6.1953-1957.1999
   LEE ST, 1995, J INFECT DIS, V172, P891, DOI 10.1093/infdis/172.3.891
   LOPEZ M, 1993, AM J TROP MED HYG, V49, P348, DOI 10.4269/ajtmh.1993.49.348
   MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904
   Martin-Sanchez J, 2004, AM J TROP MED HYG, V70, P545, DOI 10.4269/ajtmh.2004.70.545
   MARTINEZ P, 1993, AIDS, V7, P227, DOI 10.1097/00002030-199302000-00011
   Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004
   MASSAMBA NN, 1992, ACTA TROP, V52, P1, DOI 10.1016/0001-706X(92)90002-F
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   Maurya R, 2010, J CLIN MICROBIOL, V48, P1932, DOI 10.1128/JCM.01733-09
   McCoy JJ, 1998, MOL BIOCHEM PARASIT, V95, P251, DOI 10.1016/S0166-6851(98)00112-1
   Myjak P, 2009, POL J MICROBIOL, V58, P219
   Nicolas L, 2002, J CLIN MICROBIOL, V40, P1666, DOI 10.1128/JCM.40.5.1666-1669.2002
   NUZUM E, 1995, J INFECT DIS, V171, P751, DOI 10.1093/infdis/171.3.751
   Otero ACS, 2000, AM J TROP MED HYG, V62, P128, DOI 10.4269/ajtmh.2000.62.128
   Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0
   Petersen CA, 2009, TOP COMPANION ANIM M, V24, P182, DOI 10.1053/j.tcam.2009.06.006
   PIARROUX R, 1993, AM J TROP MED HYG, V49, P364, DOI 10.4269/ajtmh.1993.49.364
   Quispe-Tintaya KW, 2005, J INFECT DIS, V192, P685, DOI 10.1086/432077
   Ramos A, 1996, EXP PARASITOL, V82, P242, DOI 10.1006/expr.1996.0031
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sanders JW, 2005, AM J TROP MED HYG, V73, P713, DOI 10.4269/ajtmh.2005.73.713
   Schriefer A, 2009, EMERG INFECT DIS, V15, P871, DOI 10.3201/eid1506.080406
   SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096
   Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009
   van der Meide W, 2008, J CLIN MICROBIOL, V46, P73, DOI 10.1128/JCM.01416-07
   Vitale F, 2004, ANN NY ACAD SCI, V1026, P139, DOI 10.1196/annals.1307.018
   WHO, 2011, LEISHM VECT
   WHO, 1990, WHO TECHN REP SER, V793
   WIRTH DF, 1982, P NATL ACAD SCI-BIOL, V79, P6999, DOI 10.1073/pnas.79.22.6999
   Wortmann G, 2005, AM J TROP MED HYG, V73, P999, DOI 10.4269/ajtmh.2005.73.999
   ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R
NR 67
TC 95
Z9 98
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD NOV
PY 2011
VL 49
IS 11
BP 3892
EP 3904
DI 10.1128/JCM.r00764-11
PG 13
WC Microbiology
SC Microbiology
GA 842RM
UT WOS:000296617300027
PM 22042830
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Dupnik, KM
   Nascimento, EL
   Rodrigues-Neto, JF
   Keesen, T
   Fernandes, MZ
   Duarte, I
   Jeronimo, SMB
AF Dupnik, Kathryn M.
   Nascimento, Eliana L.
   Rodrigues-Neto, Joao F.
   Keesen, Tatjana
   Fernandes, Maria Zelia
   Duarte, Iraci
   Jeronimo, Selma M. B.
TI New Challenges in the Epidemiology and Treatment of Visceral
   Leishmaniasis in Periurban Areas
SO DRUG DEVELOPMENT RESEARCH
LA English
DT Article
DE visceral leishmaniasis; urbanization; HIV; cancer
ID LIPOSOMAL AMPHOTERICIN-B; KALA-AZAR; RISK-FACTORS; SODIUM
   STIBOGLUCONATE; RHEUMATOID-ARTHRITIS; ENDEMIC AREA; IMMUNOCOMPROMISED
   PATIENTS; OPPORTUNISTIC INFECTION; ANTIRETROVIRAL THERAPY; TRANSPLANT
   RECIPIENTS
AB Visceral leishmaniasis (VL) represents a major public health problem in many areas of the world. This review focuses on the impact of periurbanization on the epidemiology and treatment of VL, using Brazil as an example. VL continues to be primarily a disease of poverty with impact on families. However, the disease has expanded in Latin America, with foci reported as far south as Argentina. There is an increasing overlap of Leishmania infantum chagasi and human immune deficiency virus (HIV) infections and other immunosuppressive conditions, resulting in the emergence of VL as an opportunistic infection. This new setting poses new challenges for VL disease control and patient management. Drug Dev Res 72:451-462, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Dupnik, Kathryn M.] Weill Cornell Med Coll, Div Infect Dis, New York, NY 10065 USA.
   [Nascimento, Eliana L.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   [Fernandes, Maria Zelia; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Postgrad Program, BR-59072970 Natal, RN, Brazil.
   [Fernandes, Maria Zelia] Univ Fed Rio Grande do Norte, Dept Internal Med, BR-59072970 Natal, RN, Brazil.
   [Duarte, Iraci] Fundacao Nacl Saude, Secretaria Saude Estado Rio Grande Norte, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Rodrigues Neto, Joao
   Firmino/0000-0001-8897-4341
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH P50 AI-030639,
   5T32 AI 000763-12]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq); FOGARTY INTERNATIONAL CENTERUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337, R25TW009337, R25TW009337, R25TW009337, R25TW009337,
   R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
FX Grant sponsor: National Institutes of Health; Grant numbers: NIH P50
   AI-030639; 5T32 AI 000763-12 (KMD); Grant sponsor: Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Adam GK, 2009, INT J GYNECOL OBSTET, V107, P208, DOI 10.1016/j.ijgo.2009.08.002
   Aleixo JA, 2006, T ROY SOC TROP MED H, V100, P79, DOI 10.1016/j.trstmh.2005.06.025
   Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016
   Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07
   Andrade IG, 2009, T ROY SOC TROP MED H, V103, P506, DOI 10.1016/j.trstmh.2008.12.017
   Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4
   Araujo SA, 2010, AM J TROP MED HYG, V83, P209, DOI 10.4269/ajtmh.2010.09-0430
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   Atta AM, 2007, J AUTOIMMUN, V28, P55, DOI 10.1016/j.jaut.2006.12.001
   Auyeung P, 2010, J MICROBIOL IMMUNOL, V43, P74, DOI 10.1016/S1684-1182(10)60011-4
   Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515
   BACELLAR O, 1991, BRAZ J MED BIOL RES, V24, P791
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Bagalas V, 2007, CLIN RHEUMATOL, V26, P1344, DOI 10.1007/s10067-006-0356-5
   BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536
   Berman J, 2006, T ROY SOC TROP MED H, V100, pS41, DOI 10.1016/j.trstmh.2006.02.009
   Berman J, 2003, CURR OPIN INFECT DIS, V16, P397, DOI 10.1097/00001432-200310000-00005
   Berman Jonathan, 2005, Curr Infect Dis Rep, V7, P33, DOI 10.1007/s11908-005-0021-1
   Boelaert M, 2009, TROP MED INT HEALTH, V14, P639, DOI 10.1111/j.1365-3156.2009.02279.x
   Bourgeois N, 2010, HIV MED, V11, P670, DOI 10.1111/j.1468-1293.2010.00846.x
   Bourgeois N, 2008, JAIDS-J ACQ IMM DEF, V48, P13, DOI 10.1097/QAI.0b013e318166af5d
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BROECKAERTVANORSHOVEN A, 1979, LANCET, V2, P740
   Camargo-Neves V L, 2001, Cad Saude Publica, V17, P1263
   Campos-Varela I, 2008, LIVER TRANSPLANT, V14, P1816, DOI 10.1002/lt.21538
   Carvalho E M, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P368, DOI 10.1590/S0074-02761988000500026
   CARVALHO EM, 1988, BRAZ J MED BIOL RES, V21, P85
   CARVALHO EM, 1983, AM J TROP MED HYG, V32, P61, DOI 10.4269/ajtmh.1983.32.61
   CARVALHO EM, 1981, INFECT IMMUN, V33, P498, DOI 10.1128/IAI.33.2.498-500.1981
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   Choudhury K, 2008, INT J PARASITOL, V38, P1411, DOI 10.1016/j.ijpara.2008.03.005
   Collin S, 2004, CLIN INFECT DIS, V38, P612, DOI 10.1086/381203
   Colomba C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-199
   Daher EF, 2009, J PARASITOL, V95, P652, DOI 10.1645/GE-1678.1
   Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   del Giudice P, 2002, J INFECT DIS, V186, P1366, DOI 10.1086/344325
   Desjeux P, 1995, Afr Health, V18, P20
   Desjeux P, 2001, MED MICROBIOL IMMUN, V190, P77, DOI 10.1007/s004300100085
   Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8
   Dettwiler S, 2010, AM J TRANSPLANT, V10, P1486, DOI 10.1111/j.1600-6143.2010.03125.x
   Domingues M, 2009, J CLIN ONCOL, V27, pE184, DOI 10.1200/JCO.2009.22.7835
   Duprey ZH, 2006, EMERG INFECT DIS, V12, P440, DOI 10.3201/eid1203.050811
   El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181
   EVANS T, 1985, WESTERN J MED, V142, P777
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118
   Fabre S, 2005, CLIN EXP RHEUMATOL, V23, P891
   Fakhar M, 2008, PARASITOL RES, V103, P473, DOI 10.1007/s00436-008-0999-z
   Fernandez-Guerrero ML, 2004, ACTA TROP, V90, P11, DOI 10.1016/j.actatropica.2003.09.009
   Figueiro EA, 2008, ARCH GYNECOL OBSTET, V278, P13, DOI 10.1007/s00404-007-0532-0
   Fitzpatrick MA, 2010, TRANSPL INFECT DIS, V12, P336, DOI 10.1111/j.1399-3062.2010.00517.x
   Garcia-Vidal C, 2009, EUR J CLIN MICROBIOL, V28, P331, DOI 10.1007/s10096-008-0628-x
   Golgher D, 2011, DRUG DEVELOP RES, V72, P463, DOI 10.1002/ddr.20453
   Gontijo CMF, 2002, MEM I OSWALDO CRUZ, V97, P751, DOI 10.1590/S0074-02762002000500029
   Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709
   Herrera-Najera C, 2009, PROTEOMICS, V9, P1293, DOI 10.1002/pmic.200800533
   HERWALDT BL, 1992, J INFECT DIS, V165, P968, DOI 10.1093/infdis/165.5.968
   HOLADAY BJ, 1993, J INFECT DIS, V167, P411, DOI 10.1093/infdis/167.2.411
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403
   Berman J, 2008, EXPERT OPIN DRUG MET, V4, P1209, DOI 10.1517/17425255.4.9.1209
   Kopterides P, 2007, T ROY SOC TROP MED H, V101, P1181, DOI 10.1016/j.trstmh.2007.08.003
   Kotton CN, 2009, AM J TRANSPLANT, V9, pS234, DOI 10.1111/j.1600-6143.2009.02915.x
   Kubar J, 1998, AIDS, V12, P2147, DOI 10.1097/00002030-199816000-00009
   Kumar R, 1999, B WORLD HEALTH ORGAN, V77, P371
   Lachaud L, 2009, CLIN INFECT DIS, V48, pE16, DOI 10.1086/595710
   Larocca L, 2007, J HEART LUNG TRANSPL, V26, P1347, DOI 10.1016/j.healun.2007.09.005
   Lopez-Velez R, 2004, J ANTIMICROB CHEMOTH, V53, P540, DOI 10.1093/jac/dkh084
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   Mauricio IL, 1999, PARASITOLOGY, V119, P237, DOI 10.1017/S0031182099004710
   MAYRINK W, 1989, REV INST MED TROP SP, V31, P256, DOI 10.1590/S0036-46651989000400008
   Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x
   Meheus F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000818
   Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Molina I, 2007, J ANTIMICROB CHEMOTH, V60, P837, DOI 10.1093/jac/dkm294
   MONTALBAN C, 1989, REV INFECT DIS, V11, P655
   Morales P, 2003, TRANSPLANT P, V35, P2001, DOI 10.1016/S0041-1345(03)00664-X
   Albuquerque PLMM, 2009, REV PANAM SALUD PUBL, V26, P330, DOI 10.1590/S1020-49892009001000007
   Mueller M, 2006, J ANTIMICROB CHEMOTH, V58, P811, DOI 10.1093/jac/dkl342
   Mukhopadhyay J, 1998, AM J TROP MED HYG, V59, P893, DOI 10.4269/ajtmh.1998.59.893
   Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5
   Musa AM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000855
   Nascimento ET, 2011, T ROY SOC TROP MED H, V105, P298, DOI 10.1016/j.trstmh.2011.01.006
   Nascimento ELT, 2008, CAD SAUDE PUBLICA, V24, P2964, DOI 10.1590/S0102-311X2008001200028
   Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027
   Oliveira CMC, 2008, TRANSPL P, V40, P755, DOI 10.1016/j.transproceed.2008.02.039
   Oliveira RA, 2008, TRANSPL INFECT DIS, V10, P364, DOI 10.1111/j.1399-3062.2008.00320.x
   Pasquau F, 2005, EUR J CLIN MICROBIOL, V24, P411, DOI 10.1007/s10096-005-1342-6
   Pearson, 1999, Curr Infect Dis Rep, V1, P415, DOI 10.1007/s11908-999-0052-0
   Pearson, 1999, Curr Infect Dis Rep, V1, P448, DOI 10.1007/s11908-999-0057-8
   PEARSON RD, 1986, ANN TROP MED PARASIT, V80, P465, DOI 10.1080/00034983.1986.11812050
   Pittalis S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-177
   Queiroz PVS, 2009, RES VET SCI, V86, P267, DOI 10.1016/j.rvsc.2008.07.014
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217
   Rosenthal E, 2000, CLIN INFECT DIS, V31, P1093, DOI 10.1086/318135
   Salomon OD, 2008, MEM I OSWALDO CRUZ, V103, P109, DOI 10.1590/S0074-02762008000100018
   Salomon OD, 2009, MEM I OSWALDO CRUZ, V104, P801, DOI 10.1590/S0074-02762009000500024
   Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006
   Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862
   Shaw JJ, 2006, MEM I OSWALDO CRUZ, V101, P577, DOI 10.1590/S0074-02762006000500017
   Sirvent-von Bueltzingsloewen A, 2004, BONE MARROW TRANSPL, V33, P667, DOI 10.1038/sj.bmt.1704396
   Souza RM, 2009, T ROY SOC TROP MED H, V103, P749, DOI 10.1016/j.trstmh.2009.01.003
   Sundar S, 1998, LANCET, V352, P1821, DOI 10.1016/S0140-6736(98)04367-0
   Sundar S, 2001, MED MICROBIOL IMMUN, V190, P89, DOI 10.1007/s004300100088
   Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972
   Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536
   Sundar Shyam, 2003, J Assoc Physicians India, V51, P753
   Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8
   Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627
   ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899
   Thakur CP, 2003, JAIDS-J ACQ IMM DEF, V32, P572, DOI 10.1097/00126334-200304150-00017
   THAKUR CP, 1990, INDIAN J MED RES-A, V91, P144
   THAKUR CP, 1984, T ROY SOC TROP MED H, V78, P391, DOI 10.1016/0035-9203(84)90131-7
   Thornton SJ, 2010, DRUG DEV IND PHARM, V36, P1312, DOI 10.3109/03639041003796648
   Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345
   TORREGROSA JV, 1993, NEPHRON, V65, P318, DOI 10.1159/000187498
   Veroux M, 2010, TRANSPL INFECT DIS, V12, P387, DOI 10.1111/j.1399-3062.2010.00520.x
   WALLIS PJW, 1983, ANN RHEUM DIS, V42, P201, DOI 10.1136/ard.42.2.201
   Weisser M, 2007, CLIN MICROBIOL INFEC, V13, P751, DOI 10.1111/j.1469-0691.2007.01755.x
   Werneck GL, 2003, INFECTION, V31, P174, DOI 10.1007/s15010-003-3139-9
   *WHO, 2007, REP 5 CONS M LEISHM
   Wolday D, 2001, MED MICROBIOL IMMUN, V190, P65, DOI 10.1007/s004300100082
NR 130
TC 3
Z9 3
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4391
EI 1098-2299
J9 DRUG DEVELOP RES
JI Drug Dev. Res.
PD SEP
PY 2011
VL 72
IS 6
SI SI
BP 451
EP 462
DI 10.1002/ddr.20452
PG 12
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 824CU
UT WOS:000295180100005
PM 25821334
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Fakiola, M
   Miller, EN
   Fadl, M
   Mohamed, HS
   Jamieson, SE
   Francis, RW
   Cordell, HJ
   Peacock, CS
   Raju, M
   Khalil, EA
   Elhassan, A
   Musa, AM
   Silveira, F
   Shaw, JJ
   Sundar, S
   Jeronimo, SMB
   Ibrahim, ME
   Blackwell, JM
AF Fakiola, Michaela
   Miller, E. Nancy
   Fadl, Manal
   Mohamed, Hiba S.
   Jamieson, Sarra E.
   Francis, Richard W.
   Cordell, Heather J.
   Peacock, Christopher S.
   Raju, Madhuri
   Khalil, Eltahir A.
   Elhassan, Ahmed
   Musa, Ahmed M.
   Silveira, Fernando
   Shaw, Jeffrey J.
   Sundar, Shyam
   Jeronimo, Selma M. B.
   Ibrahim, Muntaser E.
   Blackwell, Jenefer M.
TI Genetic and Functional Evidence Implicating DLL1 as the Gene That
   Influences Susceptibility to Visceral Leishmaniasis at Chromosome 6q27
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID REGULATORY ELEMENTS; TGF-BETA; CASE/PSEUDOCONTROL ANALYSIS; DONOVANI
   INFECTION; MULTIPLE ALIGNMENT; NOTCH LIGANDS; KALA-AZAR; SEQUENCE;
   ASSOCIATION; IDENTIFICATION
AB Background. Visceral leishmaniasis (VL) is caused by Leishmania donovani and Leishmania infantum chagasi. Genome-wide linkage studies from Sudan and Brazil identified a putative susceptibility locus on chromosome 6q27.
   Methods. Twenty-two single-nucleotide polymorphisms (SNPs) at genes PHF10, C6orf70, DLL1, FAM120B, PSMB1, and TBP were genotyped in 193 VL cases from 85 Sudanese families, and 8 SNPs at genes PHF10, C6orf70, DLL1, PSMB1, and TBP were genotyped in 194 VL cases from 80 Brazilian families. Family-based association, haplotype, and linkage disequilibrium analyses were performed. Multispecies comparative sequence analysis was used to identify conserved noncoding sequences carrying putative regulatory elements. Quantitative reverse-transcription polymerase chain reaction measured expression of candidate genes in splenic aspirates from Indian patients with VL compared with that in the control spleen sample.
   Results. Positive associations were observed at PHF10, C6orf70, DLL1, PSMB1, and TBP in Sudan, but only at DLL1 in Brazil (combined P = 3 x 10(-4) at DLL1 across Sudan and Brazil). No functional coding region variants were observed in resequencing of 22 Sudanese VL cases. DLL1 expression was significantly (P = 2 x 10(-7)) reduced (mean fold change, 3.5 [SEM, 0.7]) in splenic aspirates from patients with VL, whereas other 6q27 genes showed higher levels (1.27 x 10(-6) < P < .01) than did the control spleen sample. A cluster of conserved noncoding sequences with putative regulatory variants was identified in the distal promoter of DLL1.
   Conclusions. DLL1, which encodes Delta-like 1, the ligand for Notch3, is strongly implicated as the chromosome 6q27 VL susceptibility gene.
C1 [Jamieson, Sarra E.; Francis, Richard W.; Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA 6008, Australia.
   [Fakiola, Michaela; Miller, E. Nancy; Francis, Richard W.; Cordell, Heather J.; Raju, Madhuri; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 1TN, England.
   [Fakiola, Michaela; Miller, E. Nancy; Francis, Richard W.; Cordell, Heather J.; Raju, Madhuri; Blackwell, Jenefer M.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge CB2 1TN, England.
   [Fadl, Manal; Mohamed, Hiba S.; Khalil, Eltahir A.; Elhassan, Ahmed; Musa, Ahmed M.; Ibrahim, Muntaser E.] Univ Khartoum, Dept Mol Biol, Inst Endem Dis, Khartoum, Sudan.
   [Cordell, Heather J.] Newcastle Univ, Int Ctr Life, Inst Med Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Peacock, Christopher S.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Discipline Microbiol & Immunol, Nedlands, WA 6009, Australia.
   [Silveira, Fernando] Inst Evandro Chagas, Dept Parasitol, Belem, Para, Brazil.
   [Shaw, Jeffrey J.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, BR-05508 Sao Paulo, Brazil.
   [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
RP Blackwell, JM (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, 100 Roberts Rd, Subiaco, WA 6008, Australia.
EM jblackwell@ichr.uwa.edu.au
RI Shaw, Jeffrey/D-2941-2012; Jeronimo, Selma/AAY-4033-2020; Blackwell,
   Jenefer M/H-3015-2015; Peacock, Christopher/A-4052-2012; Francis,
   Richard/K-2812-2019; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Francis,
   Richard/0000-0003-1580-7934; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Fakiola, Michaela/0000-0001-9071-4709; Khalil,
   Eltahir/0000-0002-5165-6902
FU Wellcome TrustWellcome Trust [074196/Z/04/Z]
FX This work was supported by the Wellcome Trust (grants 074196/Z/04/Z to
   J. M. B.).
CR Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1
   Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x
   Brudno M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-66
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577
   Cordell HJ, 2004, GENET EPIDEMIOL, V26, P186, DOI 10.1002/gepi.10306
   Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307
   Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651
   Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556
   Dermitzakis ET, 2002, NATURE, V420, P578, DOI 10.1038/nature01251
   DURET L, 1993, NUCLEIC ACIDS RES, V21, P2315, DOI 10.1093/nar/21.10.2315
   Ettinger NA, 2009, ANN HUM GENET, V73, P304, DOI 10.1111/j.1469-1809.2009.00510.x
   Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168
   Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001
   Grabe Niels, 2002, In Silico Biology, V2, pS1
   Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751
   Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959
   HOLMANS P, 1995, AM J HUM GENET, V57, P1221
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Khalil EAG, 2002, TROP MED INT HEALTH, V7, P35, DOI 10.1046/j.1365-3156.2002.00832.x
   Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334
   LOCKSLEY RM, 1991, IMMUNOL TODAY, V12, P58
   Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904
   Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823
   Payne F, 2005, BIOCHEM BIOPH RES CO, V331, P435, DOI 10.1016/j.bbrc.2005.03.203
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341
   Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878
   Rozen S, 2000, Methods Mol Biol, V132, P365
   SCOTT P, 1989, IMMUNOL REV, V112, P161, DOI 10.1111/j.1600-065X.1989.tb00557.x
   Sekine C, 2009, INT IMMUNOL, V21, P295, DOI 10.1093/intimm/dxn148
   Staden R, 2000, Methods Mol Biol, V132, P115
   Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522
   Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x
   Wilson ME, 2002, EUR J IMMUNOL, V32, P3556, DOI 10.1002/1521-4141(200212)32:12&lt;3556::AID-IMMU3556&gt;3.0.CO;2-Q
   Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3
   ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826
   Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4
NR 50
TC 12
Z9 13
U1 0
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 1
PY 2011
VL 204
IS 3
BP 467
EP 477
DI 10.1093/infdis/jir284
PG 11
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 790BA
UT WOS:000292562300022
PM 21742847
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Miguel, DC
   Zauli-Nascimento, RC
   Yokoyama-Yasunaka, JKU
   Pereira, LIA
   Jeronimo, SMB
   Ribeiro-Dias, F
   Dorta, ML
   Uliana, SRB
AF Miguel, Danilo C.
   Zauli-Nascimento, Rogeria C.
   Yokoyama-Yasunaka, Jenicer K. U.
   Pereira, Ledice I. A.
   Jeronimo, Selma M. B.
   Ribeiro-Dias, Fatima
   Dorta, Miriam L.
   Uliana, Silvia R. B.
TI Clinical isolates of New World Leishmania from cutaneous and visceral
   leishmaniasis patients are uniformly sensitive to tamoxifen
SO INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
LA English
DT Letter
ID BRAZILIENSIS; INFECTIONS
C1 [Miguel, Danilo C.; Zauli-Nascimento, Rogeria C.; Yokoyama-Yasunaka, Jenicer K. U.; Uliana, Silvia R. B.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Pereira, Ledice I. A.; Ribeiro-Dias, Fatima; Dorta, Miriam L.] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RP Uliana, SRB (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.
EM srbulian@icb.usp.br
RI Uliana, Silvia R. B./I-8257-2014; Jeronimo, Selma M.B./M-8672-2014;
   Miguel, Danilo C/C-1484-2012; Jeronimo, Selma/AAY-4033-2020
OI Uliana, Silvia R. B./0000-0002-8070-3704; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Miguel, Danilo C/0000-0003-0522-6562;
   Jeronimo, Selma/0000-0002-4784-9904
CR Dweik A, 2007, ANN TROP MED PARASIT, V101, P399, DOI 10.1179/136485907X176436
   Miguel DC, 2007, J ANTIMICROB CHEMOTH, V60, P526, DOI 10.1093/jac/dkm219
   Miguel DC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000249
   Miguel DC, 2009, J ANTIMICROB CHEMOTH, V63, P365, DOI 10.1093/jac/dkn509
   Zauli-Nascimento RC, 2010, TROP MED INT HEALTH, V15, P68, DOI 10.1111/j.1365-3156.2009.02414.x
NR 5
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0924-8579
J9 INT J ANTIMICROB AG
JI Int. J. Antimicrob. Agents
PD JUL
PY 2011
VL 38
IS 1
BP 93
EP 94
DI 10.1016/j.ijantimicag.2011.03.012
PG 2
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 772AU
UT WOS:000291202600019
PM 21555208
DA 2020-11-26
ER

PT J
AU Nascimento, ET
   Moura, MLN
   Queiroz, JW
   Barroso, AW
   Araujo, AF
   Rego, EF
   Wilson, ME
   Pearson, RD
   Jeronimo, SM
AF Nascimento, E. T.
   Moura, M. L. N.
   Queiroz, J. W.
   Barroso, A. W.
   Araujo, A. F.
   Rego, E. F.
   Wilson, M. E.
   Pearson, R. D.
   Jeronimo, S. M.
TI The emergence of concurrent HIV-1/AIDS and visceral leishmaniasis in
   Northeast Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Visceral leishmaniasis; HIV; AIDS; Leishmania chagasi; Co-infection;
   Brazil
ID HIV COINFECTION; ENDEMIC AREA; INFECTION; CHAGASI
AB HIV has become increasingly prevalent in the Northeast region of Brazil where Leishmania infantum chagasi is endemic, and concurrent AIDS and visceral leishmaniasis (VL) has emerged. In this study, persons with HIV/AIDS and VL (n = 17) had a mean age of 37.3 years (range 29-53 years) compared with 12.5 years (1-80 years) for persons with VL alone (n = 2836). Males accounted for 88% of cases with concurrent VL and AIDS and 65% of those with VL alone. The mean CD4 count and antileishmanial antibody titre were lower and recurrence of VL and death were more likely with co-infection. Considering the prevalences of L.i. chagasi and HIV in the region, this may herald the emergence of an important public health problem. (C) 2011 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Moura, M. L. N.; Barroso, A. W.; Jeronimo, S. M.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   [Nascimento, E. T.] Univ Fed Rio Grande do Norte, Dept Infect Dis, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   [Nascimento, E. T.; Queiroz, J. W.; Jeronimo, S. M.] Univ Fed Rio Grande do Norte, Hlth Postgrad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   [Araujo, A. F.; Rego, E. F.] Hosp Giselda Trigueiro, Secretaria Estadual Saude, Natal, RN, Brazil.
   [Wilson, M. E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Wilson, M. E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] VA Med Ctr, Iowa City, IA USA.
   [Pearson, R. D.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [Pearson, R. D.] Univ Virginia, Dept Pathol, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   [Jeronimo, S. M.] Inst Nacl Ciencia & Tecnol Doencas Trop, Natal, RN, Brazil.
RP Jeronimo, SM (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, CP 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Moura, Maria Luisa/N-5654-2015; Jeronimo,
   Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Moura, Maria
   Luisa/0000-0003-1013-8233; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Wilson, Mary/0000-0001-8680-7275
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI030639];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER
FX This work was funded in part by grants from the US National Institutes
   of Health (AI030639) to SMJ and MEW, and by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Alexandrino-de-Oliveira P, 2010, MEM I OSWALDO CRUZ, V105, P692, DOI 10.1590/S0074-02762010000500016
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Daher EF, 2009, J PARASITOL, V95, P652, DOI 10.1645/GE-1678.1
   Desjeux P, 1999, CLIN DERMATOL, V17, P317, DOI 10.1016/S0738-081X(99)00050-4
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   MONTALBAN C, 1989, REV INFECT DIS, V11, P655
NR 10
TC 28
Z9 29
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2011
VL 105
IS 5
BP 298
EP 300
DI 10.1016/j.trstmh.2011.01.006
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 773DF
UT WOS:000291286500009
PM 21474157
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Stober, CB
   Jeronimo, SMB
   Miller, EN
   Pontes, NN
   Blackwell, JM
AF Stober, C. B.
   Jeronimo, S. M. B.
   Miller, E. N.
   Pontes, N. N.
   Blackwell, J. M.
TI Characterisation of cytokine responses to novel Leishmania antigens in a
   peri-urban population in Natal, Brazil exposed to Leishmania chagasi
SO IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Congress of the British-Society-for-Immunology
CY DEC 06-10, 2010
CL Liverpool, ENGLAND
SP British Soc Immunol
C1 [Stober, C. B.; Miller, E. N.; Blackwell, J. M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England.
   [Jeronimo, S. M. B.; Pontes, N. N.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0019-2805
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2010
VL 131
SU 1
BP 80
EP 80
PG 1
WC Immunology
SC Immunology
GA 689XL
UT WOS:000284964100236
DA 2020-11-26
ER

PT J
AU DebRoy, S
   Keenan, AB
   Ueno, N
   Jeronimo, SMB
   Donelson, JE
   Wilson, ME
AF DebRoy, Sruti
   Keenan, Alexandra B.
   Ueno, Norikiyo
   Jeronimo, Selma M. B.
   Donelson, John E.
   Wilson, Mary E.
TI Leishmania infantum chagasi: A genome-based approach to identification
   of excreted/secreted proteins
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Leishmania; Genome; Secretory pathway; Excreted/secreted proteins;
   Trypanosomatid
ID SERINE-PROTEASE INHIBITORS; TRYPANOSOMA-BRUCEI;
   SUBCELLULAR-LOCALIZATION; INTRACELLULAR INFECTION; DISULFIDE-ISOMERASE;
   MAJOR PROMASTIGOTES; IMMUNE-RESPONSE; SURFACE PROTEIN; HUMAN PATHOGEN;
   PARASITE
AB The parasitic protozoan, Leishmania, survives in harsh environments within its mammalian and sand fly hosts. Secreted proteins likely play critical roles in the parasite's interactions with its environment. As a preliminary identification of the spectrum of potential excreted/secreted (ES) proteins of Leishmania infantum chagasi (Lic), a causative agent of visceral leishmaniasis, we used standard algorithms to screen the annotated L infantum genome for genes whose predicted protein products have an N-terminal signal peptide and lack transmembrane domains and membrane anchors. A suite of 181 candidate ES proteins were identified. These included several that were documented in the literature to be released by other Leishmania spp. Six candidate ES proteins were selected for further validation of their expression and release by different parasite stages. We found both amastigote-specific and promastigote-specific released proteins. The ES proteins of Lic are candidates for future studies of parasite virulence determinants and host protective immunity. Published by Elsevier Inc.
C1 [DebRoy, Sruti; Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Ueno, Norikiyo; Wilson, Mary E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   [Keenan, Alexandra B.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.
   [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Donelson, John E.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Filho,
   Fernando C/Q-8021-2018; Donelson, John E/F-5795-2010
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [T32 HL 0712, AI045540, AI067874,
   AI076233, AI048822, AI-30639]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI059451]; Department of Veterans' AffairsUS
   Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121,
   T32HL007121, T32HL007121, T32HL007121, T32HL007121, T32HL007121] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, R01AI048822, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, R01AI059451, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI059451, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, R01AI048822, R01AI045540, R01AI067874, P50AI030639,
   P50AI030639, P50AI030639, R01AI076233, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI059451, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI059451,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, R01AI059451, P50AI030639,
   P50AI030639, P50AI030639, R01AI067874, P50AI030639, P50AI030639,
   P50AI030639, R01AI067874, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI067874, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER
FX The authors thank Jian Shao for help with confocal microscopy. This work
   was performed during the tenure of SD on NIH Training grant T32 HL 0712,
   and during the support of AK by the Iowa Center for Research by
   Undergraduates. The work was funded in part by the following research
   grants: R01 AI059451 from the National Institutes of Health (J.E.D. and
   M.E.W.), NIH grants AI045540, AI067874, AI076233 and AI048822 (M.E.W.),
   NIH grant AI-30639 (S.J. and M.W.) and a Merit Review grant (MEW.) from
   the Department of Veterans' Affairs.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anantharaman V, 2007, INT REV CYTOL, V262, P1, DOI 10.1016/S0074-7696(07)62001-4
   BANGS JD, 1993, J CELL SCI, V105, P1101
   Bell A, 2006, INT J PARASITOL, V36, P261, DOI 10.1016/j.ijpara.2005.11.003
   Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142
   Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013
   Chang HK, 2007, INFECT IMMUN, V75, P1017, DOI 10.1128/IAI.00914-06
   Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081
   Chenik M, 2006, PARASITOLOGY, V132, P493, DOI 10.1017/S0031182005009546
   CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989
   CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188
   Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358
   Cuvillier A, 2000, J CELL SCI, V113, P2065
   da Silva-Lopez RE, 2005, PARASITOLOGY, V131, P85, DOI 10.1017/S0031182004006675
   Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069
   Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903
   Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299
   FLINN HM, 1994, MOL BIOCHEM PARASIT, V65, P259, DOI 10.1016/0166-6851(94)90077-9
   FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8
   Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7
   HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Horne SM, 1997, INFECT IMMUN, V65, P806, DOI 10.1128/IAI.65.2.806-810.1997
   Hsiao CHC, 2008, MOL BIOCHEM PARASIT, V157, P148, DOI 10.1016/j.molbiopara.2007.10.008
   Hung CH, 2004, EUKARYOT CELL, V3, P1004, DOI 10.1128/EC.3.4.1004-1014.2004
   Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680
   Joshi MB, 2007, J BIOL CHEM, V282, P10079, DOI 10.1074/jbc.M610770200
   Joshi MB, 2004, J EUKARYOT MICROBIOL, V51, P108, DOI 10.1111/j.1550-7408.2004.tb00171.x
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061
   Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200
   Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200
   Moczon T, 1996, PARASITOL RES, V82, P72, DOI 10.1007/s004360050071
   Momen Hooman, 1993, Biological Research, V26, P249
   Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06
   Overath P, 2004, MOL MICROBIOL, V53, P735, DOI 10.1111/j.1365-2958.2004.04224.x
   Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   ROBERTS SC, 1995, J BIOL CHEM, V270, P8884, DOI 10.1074/jbc.270.15.8884
   Roggwiller E, 1996, MOL BIOCHEM PARASIT, V82, P13, DOI 10.1016/0166-6851(96)02714-4
   Rosa R, 2005, EXP PARASITOL, V109, P106, DOI 10.1016/j.exppara.2004.11.008
   Rosa R, 2007, VACCINE, V25, P4525, DOI 10.1016/j.vaccine.2007.04.003
   SACKS DL, 1987, J IMMUNOL, V139, P3099
   SACKS DL, 1989, EXP PARASITOL, V69, P100, DOI 10.1016/0014-4894(89)90176-8
   Salter JP, 2000, J BIOL CHEM, V275, P38667, DOI 10.1074/jbc.M006997200
   Sambrook J, 1989, MOL CLONING LAB MANU
   Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129
   Saveria T, 2007, EUKARYOT CELL, V6, P1439, DOI 10.1128/EC.00084-07
   Shakarian AM, 2000, EXP PARASITOL, V95, P79, DOI 10.1006/expr.2000.4511
   Shakarian AM, 2000, EXP PARASITOL, V94, P238, DOI 10.1006/expr.2000.4493
   Silva-Lopez RE, 2007, PARASITOL RES, V101, P1627, DOI 10.1007/s00436-007-0706-5
   Sinha PK, 2006, J INFECTION, V53, P60, DOI 10.1016/j.jinf.2005.09.011
   Sinha PK, 2005, INDIAN J MED RES, V121, P407
   SOMMER JM, 1993, FEBS LETT, V316, P53, DOI 10.1016/0014-5793(93)81735-I
   Stavrinides J, 2008, CELL MICROBIOL, V10, P285, DOI 10.1111/j.1462-5822.2007.01078.x
   Yao CQ, 2008, EXP PARASITOL, V118, P129, DOI 10.1016/j.exppara.2007.06.012
   Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0
NR 61
TC 13
Z9 13
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
EI 1090-2449
J9 EXP PARASITOL
JI Exp. Parasitol.
PD DEC
PY 2010
VL 126
IS 4
BP 582
EP 591
DI 10.1016/j.exppara.2010.06.011
PG 10
WC Parasitology
SC Parasitology
GA 654IJ
UT WOS:000282161400023
PM 20542033
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Monteiro, GR
   Nascimento, ET
   Neto, JF
   Pontes, NN
   Pearson, RD
   Gaur, U
   Wilson, ME
   Salha, DR
   Jeronimo, SMB
AF Monteiro, Gloria R.
   Nascimento, Eliana T.
   Firmino Neto, Joao
   Pontes, Nubia N.
   Pearson, Richard D.
   Gaur, Upasna
   Wilson, Mary E.
   Salha, Daniella R.
   Jeronimo, Selma M. B.
TI THE EFFECT OF VISCERAL LEISHMANIASIS ON GENE EXPRESSION IN HUMAN
   MONONUCLEAR CELLS: GLOBAL PROFILING OF CELLS FROM PATIENTS DURING
   DISEASE AND AFTER SUCCESSFUL TREATMENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Monteiro, Gloria R.; Nascimento, Eliana T.; Firmino Neto, Joao; Pontes, Nubia N.; Salha, Daniella R.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Pearson, Richard D.] Univ Virginia, Charlottesville, VA USA.
   [Gaur, Upasna; Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 898
BP 269
EP 269
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701266
DA 2020-11-26
ER

PT J
AU Esch, KJ
   Arruda, P
   O'Connor, A
   Wilson, ME
   Jeronimo, SM
   Petersen, CA
AF Esch, Kevin J.
   Arruda, Paulo
   O'Connor, Annette
   Wilson, Mary E.
   Jeronimo, Selma M.
   Petersen, Christine A.
TI DOGS AND THE SOCIAL EPIDEMIOLOGY OF VISCERAL LEISHMANIASIS: KNOWLEDGE,
   PERCEPTION AND PUBLIC HEALTH POLICY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Esch, Kevin J.; Arruda, Paulo; O'Connor, Annette; Petersen, Christine A.] Iowa State Univ, Ames, IA USA.
   [Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
   [Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
RI Petersen, Christine/M-1881-2014; Jeronimo, Selma/AAY-4033-2020;
   Jeronimo, Selma M.B./M-8672-2014
OI Petersen, Christine/0000-0002-7285-4254; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 925
BP 276
EP 277
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701293
DA 2020-11-26
ER

PT J
AU Araujo, SR
   Dupnik, K
   Nobre, ML
   Barbosa, AF
   Monteiro, GM
   Dias, MS
   Trindade, PB
   Gomes, CM
   Jamieson, S
   Blackwell, J
   Jeronimo, SM
AF Araujo, Sergio R.
   Dupnik, Kate
   Nobre, Mauricio L.
   Barbosa, Adriana F.
   Monteiro, Gloria M.
   Dias, Marcia S.
   Trindade, Pedro B.
   Gomes, Carlos M.
   Jamieson, Sarra
   Blackwell, Jenefer
   Jeronimo, Selma M.
TI POLYMORPHISMS ILE655VAL IN ERBB2/HER-2/NEU RECEPTOR IS ASSOCIATED WITH
   HANSEN'S DISEASE (LEPROSY) IN A BRAZILIAN POPULATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Araujo, Sergio R.; Barbosa, Adriana F.; Monteiro, Gloria M.; Dias, Marcia S.; Trindade, Pedro B.; Gomes, Carlos M.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Dupnik, Kate] Weill Cornell Med Coll, New York, NY USA.
   [Nobre, Mauricio L.] Secretaria Saude Governo Rio Grande Norte, Natal, RN, Brazil.
   [Jamieson, Sarra; Blackwell, Jenefer] Univ Western Australia, Perth, WA 6009, Australia.
   [Jeronimo, Selma M.] INCT Doencas Trop, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 1325
BP 395
EP 395
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701692
DA 2020-11-26
ER

PT J
AU Bezerra, PCFM
   Leao, MD
   Queiroz, JW
   Melo, EMD
   Pereira, FVM
   Nobrega, MH
   Jeronimo, AK
   Ferreira, LC
   Jeronimo, SMB
   de Araujo, ACPF
AF Bezerra, Patricia C. F. M.
   Leao, Marcos D.
   Queiroz, Jose W.
   Melo, Edailna M. D.
   Pereira, Flavio V. M.
   Nobrega, Maria Hebe
   Jeronimo, Ana K.
   Ferreira, Leonardo C.
   Jeronimo, Selma M. B.
   de Araujo, Ana Cristina P. F.
TI Family history of hypertension as an important risk factor for the
   development of severe preeclampsia
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE Preeclampsia; HELLP syndrome; eclampsia; Brazil
ID MATERNAL SUSCEPTIBILITY LOCUS; CARDIOVASCULAR RISK; PREGNANCY;
   DISORDERS; PATERNITY; MORTALITY; ECLAMPSIA; SCAN; LIFE
AB Objective. To determine the risk of preeclampsia in a population with respect to maternal and sister histories of chronic hypertension, preeclampsia and eclampsia. Design. A case-control study of severe preeclampsia. Setting. Maternity hospital in Natal, Brazil. Participants. A total of 412 subjects were enrolled, 148 cases and 264 controls. Main outcome measures. Personal and familial histories of hypertensive disorders. Odds ratio estimates of preeclampsia with respect to family history of hypertensive diseases. Results. Women with a history of hypertensive disorders were more frequent in the case group (p = 0.001). Women whose mothers had a history of hypertension (p = 0.003), preeclampsia (p = 0.007) or eclampsia (p = 0.038) were at increased risk of severe preeclampsia. The risk of preeclampsia was greater when the woman had a sister with a history of hypertension (OR 2.60, 95% CI 1.60-4.21, p < 0.001), preeclampsia (OR 2.33, 95% CI 1.58-3.45, p < 0.001), or eclampsia (OR 2.57, 95% CI 1.28-5.16, p = 0.008). The risk of preeclampsia was also higher for women who had both a mother and sister with a history of hypertension (OR 3.65, 95% CI 1.65-8.09, p = 0.001). Conclusions. A family history of hypertensive disorders increased the risk of eclampsia and hemolysis elevated liver enzymes and low platelet (HELLP) syndrome in a Brazilian population.
C1 [Bezerra, Patricia C. F. M.; de Araujo, Ana Cristina P. F.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, BR-59078970 Natal, RN, Brazil.
   [Bezerra, Patricia C. F. M.; Leao, Marcos D.; Queiroz, Jose W.; Melo, Edailna M. D.; Pereira, Flavio V. M.; Nobrega, Maria Hebe; Jeronimo, Selma M. B.; de Araujo, Ana Cristina P. F.] Univ Fed Rio Grande do Norte, Hlth Grad Program, BR-59078970 Natal, RN, Brazil.
   [Jeronimo, Ana K.; Ferreira, Leonardo C.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59078970 Natal, RN, Brazil.
RP de Araujo, ACPF (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, CP 1624, BR-59078970 Natal, RN, Brazil.
EM crysaraujo@uol.com.br
RI Ferreira, Leonardo Capistrano/D-7097-2019; Jeronimo,
   Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Ferreira, Leonardo Capistrano/0000-0001-9268-4881; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904
FU Fundacao de Apoio a Pesquisa no Rio Grande do Norte (FAPERN).; Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq)
FX We thank Priya Duggal from Johns Hopkins University (Baltimore, MD) and
   Emma Rodewald, BS, for helpful suggestions and the staff of Maternidade
   Escola Januario Cicco, where this study was conducted. This work was
   funded in part by a grant from Fundacao de Apoio a Pesquisa no Rio
   Grande do Norte (FAPERN). LCF and AKJ received fellowship from Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The views
   expressed in this paper are those of the authors and do not necessarily
   reflect the views of the funding institutions.
CR Anderson CM, 2007, JOGNN-J OBST GYN NEO, V36, P3, DOI [10.1111/j.1552-6909.2006.00115.x, 10.1111/J.1552-6909.2006.00115.x]
   Araujo ACPF, 2006, AM J OBSTET GYNECOL, V195, P129, DOI 10.1016/j.ajog.2006.01.016
   Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799
   Asbee SM, 2009, OBSTET GYNECOL, V113, P305, DOI 10.1097/AOG.0b013e318195baef
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Diehl CL, 2008, AM J OBSTET GYNECOL, V198, pE11, DOI 10.1016/j.ajog.2007.09.038
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Fitzpatrick E, 2004, HUM BIOL, V76, P849, DOI 10.1353/hub.2005.0017
   Gaio DS, 2001, HYPERTENS PREGNANCY, V20, P269, DOI 10.1081/PRG-100107829
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Laivuori H, 2007, FRONT BIOSCI-LANDMRK, V12, P2372, DOI 10.2741/2239
   MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0
   Moses EK, 2000, AM J HUM GENET, V67, P1581, DOI 10.1086/316888
   Mostello D, 2002, AM J OBSTET GYNECOL, V187, P425, DOI 10.1067/mob.2002.123608
   Nilsson E, 2004, BJOG-INT J OBSTET GY, V111, P200, DOI 10.1111/j.1471-0528.2004.00042x.x
   Rigo J, 2006, EUR J OBSTET GYN R B, V128, P148, DOI 10.1016/j.ejogrb.2006.02.019
   Rodrigues AN, 2009, J PEDIAT-BRAZIL, V85, P55, DOI [10.2223/JPED.1867, 10.1590/S0021-75572009000100010]
   Saftlas AF, 2003, AM J EPIDEMIOL, V157, P1108, DOI 10.1093/aje/kwg101
   SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D
   SALONEN RH, 2000, AM J MED GENET, V91, P256
   Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5
   Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057
   Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F
   Small MJ, 2005, J MATERN-FETAL NEO M, V18, P343, DOI 10.1080/14767050500312433
   Tubbergen P, 1999, J REPROD IMMUNOL, V45, P81, DOI 10.1016/S0165-0378(99)00040-6
   Vega CEP, 2007, CLINICS, V62, P679, DOI 10.1590/S1807-59322007000600004
   VENTURA SJ, 1998, NATL VITAL STAT REPO, V47, P1
   Ward K, 2008, Minerva Ginecol, V60, P399
   Zhang J, 2007, PAEDIATR PERINAT EP, V21, P46, DOI 10.1111/j.1365-3016.2007.00837.x
NR 29
TC 24
Z9 26
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD MAY
PY 2010
VL 89
IS 5
BP 612
EP 617
DI 10.3109/00016341003623720
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 588QJ
UT WOS:000277087900003
PM 20423274
DA 2020-11-26
ER

PT J
AU Queiroz, JW
   Dias, GH
   Nobre, ML
   Dias, MCDS
   Araujo, SF
   Barbosa, JD
   da Trindade-Neto, PB
   Blackwell, JM
   Jeronimo, SMB
AF Queiroz, Jose Wilton
   Dias, Gutemberg H.
   Nobre, Mauricio Lisboa
   De Sousa Dias, Marcia C.
   Araujo, Sergio F.
   Barbosa, James D.
   da Trindade-Neto, Pedro Bezerra
   Blackwell, Jenefer M.
   Jeronimo, Selma M. B.
TI Geographic Information Systems and Applied Spatial Statistics Are
   Efficient Tools to Study Hansen's Disease (Leprosy) and to Determine
   Areas of Greater Risk of Disease
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID POTENTIAL DISTRIBUTION; NORTHEAST BRAZIL; SCAN STATISTICS; CONTROL
   PROGRAM; AMAZON REGION; ENDEMIC AREA; KALA-AZAR; ELIMINATION; STATE;
   CONTACTS
AB Applied Spatial Statistics used in Conjunction with geographic information systems (GIS) provide ail efficient tool for the surveillance of diseases. Here. using these tools we analyzed the spatial distribution of Hansen's disease in an endemic area in Brazil. A sample of 808 selected from a Universe of 1,293 cases was geocoded in Mossoro, Rio Grande do Norte, Brazil. Hansen's disease cases were not distributed randomly within the neighborhoods, with higher detection rates found in more populated districts. Cluster analysis identified two areas of high risk, one with a relative risk of 5.9 (P = 0.001) and the other 6.5 (P = 0.001). A significant relationship between the geographic distribution of disease and the social economic variables indicative of poverty was observed. Our study shows that the combination of G IS and spatial analysis can identify clustering of transmissible disease, such as Hansen's disease, pointing to areas where intervention efforts can be targeted to control disease.
C1 [Queiroz, Jose Wilton; Araujo, Sergio F.; Barbosa, James D.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Dias, Gutemberg H.; De Sousa Dias, Marcia C.] Univ Estado Rio Grande do Norte, Mossoro, RN, Brazil.
   [Nobre, Mauricio Lisboa] Secretaria Saude Estado Rio Grande Norte, Hosp Giselda Trigueiro, Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Internal Med, Div Dermatol, Hlth Postgrad Program,Hlth Sci Ctr, BR-59078970 Natal, RN, Brazil.
   [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA, Australia.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, POB 1624, BR-59078970 Natal, RN, Brazil.
EM jwq@supercabo.com.bn; gutemberg@progel.com.br; nobreml@gmail.com;
   mceres@terra.com.br; srfernandesaraujo@gmail.com; jamesdary@oi.com.br;
   ptrindade@uol.com.br; jblackwell@ichn.uwa.edu.au; smbj@cb.ufrn.br
RI Dias, Gutemberg H/D-7510-2018; Jeronimo, Selma M.B./M-8672-2014; Araujo,
   Ademir SF/N-1377-2016; Blackwell, Jenefer M/H-3015-2015; Jeronimo,
   Selma/AAY-4033-2020
OI Dias, Gutemberg H/0000-0003-2147-8647; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Araujo, Ademir SF/0000-0002-3212-3852;
   Jeronimo, Selma/0000-0002-4784-9904; Nobre, Mauricio/0000-0003-4932-3137
FU Conselho Nacional de Desenvolvimento Tecnologico [CNPq]National Council
   for Scientific and Technological Development (CNPq) [401200/2005-1]
FX Conselho Nacional de Desenvolvimento Tecnologico [CNPq 401200/2005-1].
CR Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006
   Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000
   Anselin L, 2006, AM J PREV MED, V30, pS3, DOI 10.1016/j.amepre.2005.09.015
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Anselin L, 1996, REG SCI URBAN ECON, V26, P77, DOI 10.1016/0166-0462(95)02111-6
   Argaw AT, 2006, GEOSPATIAL HEALTH, V1, P105, DOI 10.4081/gh.2006.285
   Aseffa A, 2005, LEPROSY REV, V76, P147
   Bakker MI, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-40
   Bakker MI, 2006, LEPROSY REV, V77, P48
   Beyers N, 1996, S AFR MED J, V86, P40
   Brianti E, 2007, VET RES COMMUN, V31, P213, DOI 10.1007/s11259-007-0008-5
   da Cunha MD, 2007, CAD SAUDE PUBLICA, V23, P1187, DOI 10.1590/S0102-311X2007000500020
   De Oliveira CR, 2003, LEPROSY REV, V74, P337
   Dias MCFD, 2007, LEPROSY REV, V78, P261
   Deps PD, 2007, LEPROSY REV, V78, P216
   Deps PD, 2006, LEPROSY REV, V77, P34
   Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6
   Fine PEM, 2008, LEPROSY REV, V79, P235
   Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-125
   Gebre-Michael T, 2004, ACTA TROP, V90, P73, DOI 10.1016/j.actatropica.2003.09.021
   Gujarati D., 2006, BASIC ECONOMETRICS
   Hoeven TA, 2008, EPIDEMIOL INFECT, V136, P1624, DOI 10.1017/S0950268808000381
   Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x
   Jung IY, 2009, STAT MED, V28, P1131, DOI 10.1002/sim.3535
   Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809
   Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818
   Lockwood DNJ, 2005, B WORLD HEALTH ORGAN, V83, P230
   Mardia K., 1980, MULTIVARIATE ANAL
   Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114
   *MILEP2 STUD GROUP, 2000, LEPR REV S, V71, pS26
   Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326
   Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278
   Moet FJ, 2004, LEPROSY REV, V75, P376
   Moet FJ, 2004, LEPROSY REV, V75, P310
   Molyneux DH, 2001, T ROY SOC TROP MED H, V95, P233, DOI 10.1016/S0035-9203(01)90220-2
   Montenegro ACD, 2004, MEM I OSWALDO CRUZ, V99, P683, DOI 10.1590/S0074-02762004000700003
   Penna MLF, 2009, EMERG INFECT DIS, V15, P650, DOI 10.3201/eid1504.081378
   Pereira ED, 2000, LEPROSY REV, V71, P77
   Revankar CR, 1999, LEPROSY REV, V70, P73
   Richardus JH, 2007, LEPROSY REV, V78, P330
   Richardus JH, 2005, INT J LEPROSY, V73, P249
   Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255
   Galvao PRS, 2008, LEPROSY REV, V79, P171
   Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5
   Sterne JAC, 1995, INT J EPIDEMIOL, V24, P1211, DOI 10.1093/ije/24.6.1211
   Talbot TO, 2008, J PUBLIC HEALTH MAN, V14, P526, DOI 10.1097/01.PHH.0000338364.20962.3b
   Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I
   Talhari S, 1982, Med Cutan Ibero Lat Am, V10, P309
   Tanser FC, 2002, TROP MED INT HEALTH, V7, P80, DOI 10.1046/j.1365-3156.2002.00825.x
   Thomson MC, 1999, TROP MED INT HEALTH, V4, P105, DOI 10.1046/j.1365-3156.1999.00368.x
   Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33
   TOBLER W, 1977, J ENVIRON SYST, V6, P271
   van Veen NHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004548
   WALLER LA, 1995, APPL SPATIAL STAT PU
NR 56
TC 33
Z9 35
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD FEB
PY 2010
VL 82
IS 2
BP 306
EP 314
DI 10.4269/ajtmh.2010.08-0675
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 552CC
UT WOS:000274263300022
PM 20134009
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Simons, AP
   Monteiro, GR
   Pontes, NN
   Feitosa, TM
   Gaur, U
   Pearson, RD
   Wilson, ME
   Jeronimo, SM
AF Simons, Adam P.
   Monteiro, Gloria R.
   Pontes, Nubia N.
   Feitosa, Taysa M.
   Gaur, Upasna
   Pearson, Richard D.
   Wilson, Mary E.
   Jeronimo, Selma M.
TI SERUM LIPID PROFILE, APOLIPOPROTEIN E GENOTYPE AND VISCERAL
   LEISHMANIASIS INFECTION IN A NORTHEASTERN BRAZILIAN POPULATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Simons, Adam P.] Univ Calif Davis, Sacramento, CA 95817 USA.
   [Monteiro, Gloria R.; Pontes, Nubia N.; Feitosa, Taysa M.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Gaur, Upasna; Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
   [Pearson, Richard D.] Univ Virginia, Charlottesville, VA USA.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 39
BP 11
EP 12
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956700040
DA 2020-11-26
ER

PT J
AU Medeiros, AS
   Marcondes, CB
   De Azevedo, PRM
   Jeronimo, SMB
   Silva, VPME
   Ximenes, MDFD
AF Medeiros, Arlinete S.
   Marcondes, Carlos B.
   De Azevedo, Paulo R. M.
   Jeronimo, Selma M. B.
   Macedo E Silva, Virginia P.
   Freire De Melo Ximenes, Maria De Fatima
TI Seasonal Variation of Potential Flavivirus Vectors in an Urban
   Biological Reserve in Northeastern Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; Aedes aegypti; Haemagogus leucocelaenus; yellow fever;
   Atlantic Forest
ID YELLOW-FEVER VIRUS; HAEMAGOGUS-LEUCOCELAENUS; AEDES-SCAPULARIS;
   CULICIDAE; DIPTERA; EPIDEMIC; TRANSMISSION; ARBOVIRUSES; CHIKUNGUNYA;
   INFECTION
AB Although yellow fever (YF) has not been reported on the eastern coast of Brazil since 1942, there was a reemergence of dengue fever in Brazil in 1987 due to the reintroduction of Aedes aegypti (L.). To assess areas of potential risk for transmission of vector-borne diseases, a surveillance system was placed in a large Atlantic Forest reserve in Natal, Rio Grande do Norte, Brazil, where in 2004 unexplained epizootics were reported among marmosets. The etiologic agent causing the mortality in marmosets has not been identified. Wyeomyia bourrouli Lutz, Haemagogus leucocelaenus Dyar & Shannon, Ae. aegypti, Aedes albopictus (Skuse), Ochlerotatus scapularis Rondani, Ochlerotatus serratus Theobald, Ochlerotatus taeniorhynchus Wiedemann, Culex quinquefasciatus Say, and Limatus durhami Theobald were collected in the park and in the proximity of the households adjacent to the park. Seasonal abundance fluctuation was significant for Ae. aegypti, Ae. albopictus, Ochlerotatus scapularis (Rondani), and Hg. leucocelaenus. Eggs of Ae. aegypti, Ae. albopictus, and Hg. leucocelaenus were more frequently found at the conclusion of the rainy season. A significant negative correlation between the number of Ae. albopictus collected and temperature was observed (r = -0.50), i.e., for each IT increase in temperature, the number of specimens collected decreased eight-fold. The findings reported herein reinforce the need for a sustainable arboviral surveillance program in this area to decrease the potential risk of emergence of vector borne diseases as YF.
C1 [Medeiros, Arlinete S.; Jeronimo, Selma M. B.; Macedo E Silva, Virginia P.; Freire De Melo Ximenes, Maria De Fatima] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   [Medeiros, Arlinete S.] Secretaria Saude Publ Estado Rio Grande Norte, BR-59025600 Natal, RN, Brazil.
   [Marcondes, Carlos B.] Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Ctr Ciencias Biol, BR-88036670 Santa Catarina, Brazil.
   [De Azevedo, Paulo R. M.] Univ Fed Rio Grande do Norte, Dept Estatist, Ctr Ciencias Exatas & Terra, BR-59072970 Natal, RN, Brazil.
   [Freire De Melo Ximenes, Maria De Fatima] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
RP Ximenes, MDFD (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
EM ximenes@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR Alencar J, 2008, J MED ENTOMOL, V45, P873, DOI 10.1603/0022-2585(2008)45[873:FPOHCA]2.0.CO;2
   ARNELL J H, 1976, Contributions of the American Entomological Institute, V13, P1
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Consoli RAGB, 1994, PRINCIPAIS MOSQUITOS
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   Degallier N, 2003, REV SAUDE PUBL, V37, P386, DOI 10.1590/s0034-89102003000300019
   Degallier Nicolas, 1992, Ciencia e Cultura (Sao Paulo), V44, P136
   DIGOUTTE JP, 1995, EXOTIC VIRAL INFECT, P67
   FAY R. W., 1966, MOSQUITO NEWS, V26, P531
   Forattini O., 2002, CULICIDOLOGIA MED, V2, P860
   FORATTINI OP, 1995, REV SAUDE PUBL, V29, P199, DOI 10.1590/S0034-89101995000300007
   Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990
   Freire M.S.B., 1990, ACTA BOT BRAS, V4, P41, DOI DOI 10.1590/S0102-33061990000300006
   GOMES AC, 1999, INFORM EPIDEMIOLOGIC, V2, P79
   Gomes de AC, 1998, INF EPIDEMIOL SUS, V7, P49, DOI DOI 10.5123/S0104-16731998000300006
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   KARABATSOS N, 1978, AM J TROP MED HYG, V27, P372
   KUMM HW, 1951, B ENTOMOL RES, V42, P169, DOI 10.1017/S0007485300025256
   Labarthe N, 2005, VET PARASITOL, V133, P149, DOI 10.1016/j.vetpar.2005.04.006
   Lopes J, 1997, REV SAUDE PUBL, V31, P370, DOI 10.1590/S0034-89101997000400006
   MARINHO AD, 2006, B EPIDEMIOLOGICO SEC, V1, P1
   Marti GA, 2007, J AM MOSQUITO CONTR, V23, P252, DOI 10.2987/8756-971X(2007)23[252:SAAOTM]2.0.CO;2
   MARZOCHI KBF, 1994, MEM I OSWALDO CRUZ, V89, P235, DOI 10.1590/S0074-02761994000200023
   MITCHELL CJ, 1984, J MED ENTOMOL, V21, P34, DOI 10.1093/jmedent/21.1.34
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   MORETTIN PA, 2004, ANAL SERIES TEMPORAI, V564
   MORI A, 1979, Tropical Medicine, V21, P85
   NOBRE A, 1994, REV SOC BRAS MED TRO, V2, P59
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Reinert JF, 2000, J AM MOSQUITO CONTR, V16, P175
   REINERT JF, 1975, MOSQ SYST, V7, P105
   Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422
   Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002
   TAUIL PL, 1985, REV SOCIEDADE BRASIL, V18, P5
   Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199
   TRAVASSOS APA, 1998, BELEM I EVANDRO CHAG, V99, P72
   Vasconcelos PFC, 2003, T ROY SOC TROP MED H, V97, P60, DOI 10.1016/S0035-9203(03)90023-X
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   WADDELL MB, 1949, AM J TROP MED, V29, P567
   *WHO, 2008, WKLY EPIDEMIOL REC, V83, P61
NR 40
TC 9
Z9 9
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2009
VL 46
IS 6
BP 1450
EP 1457
DI 10.1603/033.046.0630
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 517CW
UT WOS:000271591800030
PM 19960696
OA Bronze
DA 2020-11-26
ER

PT J
AU Ettinger, NA
   Duggal, P
   Braz, RFS
   Nascimento, ET
   Beaty, TH
   Jeronimo, SMB
   Pearson, RD
   Blackwell, JM
   Moreno, L
   Wilson, ME
AF Ettinger, Nicholas A.
   Duggal, Priya
   Braz, Regina F. S.
   Nascimento, Eliana T.
   Beaty, Terri H.
   Jeronimo, Selma M. B.
   Pearson, Richard D.
   Blackwell, Jenefer M.
   Moreno, Lina
   Wilson, Mary E.
TI Genetic Admixture in Brazilians Exposed to Infection with Leishmania
   chagasi
SO ANNALS OF HUMAN GENETICS
LA English
DT Article
DE Leishmaniasis; Brazil; admixture; STRUCTURE; susceptibility; variation
ID CELL-LINE PANEL; VISCERAL LEISHMANIASIS; NORTHEASTERN BRAZIL; RACIAL
   ADMIXTURE; SUSCEPTIBILITY; POPULATIONS; LOCUS; SCAN; ASSOCIATION; SUDAN
AB Visceral leishmaniasis (VL) in northeast Brazil is a disease caused by infection with the protozoan Leishmania chagasi. Infection leads to variable clinical outcomes ranging from asymptomatic infection to potentially fatal disease. Prior studies suggest the genetic background of the host contributes to the development of different outcomes after infection, although it is not known if ancestral background itself influences outcomes. VL is endemic in peri-urban areas around the city of Natal in northeast Brazil. The population of northeast Brazil is a mixture of distinct racial and ethnic groups. We hypothesized that some sub-populations may be more susceptible than others to develop different clinical outcomes after L. chagasi infection. Using microsatellite markers, we examined whether admixture of the population as a whole, or markers likely inherited from a distinct ethnic background, differed between individuals with VL, individuals with an asymptomatic infection, or individuals with no infection. There was no apparent significant difference in overall population admixture proportions among the three clinical phenotype groups. However, one marker on Chr. 22 displayed evidence of excess ancestry from putative ancestral populations among different clinical phenotypes, suggesting this region may contain genes determining the course of L. chagasi infection.
C1 [Duggal, Priya; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Braz, Regina F. S.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Parasitol, BR-59078970 Natal, RN, Brazil.
   [Nascimento, Eliana T.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Wilson, Mary E.] VA Med Ctr, Iowa City, IA 52246 USA.
   [Ettinger, Nicholas A.; Wilson, Mary E.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bi, Iowa City, IA 52242 USA.
   [Ettinger, Nicholas A.; Wilson, Mary E.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA.
   [Moreno, Lina] Univ Iowa, Dept Orthodont, Iowa City, IA 52242 USA.
   [Wilson, Mary E.] Univ Iowa, Dept Microbiol & Epidemiol, Iowa City, IA 52242 USA.
   [Braz, Regina F. S.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Microbiol, BR-59078970 Natal, RN, Brazil.
   [Jeronimo, Selma M. B.; Pearson, Richard D.] Univ Virginia, Sch Med, Dept Internal Med, Charlottesville, VA 22903 USA.
   [Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM pduggal@jhsph.edu; lina-moreno@uiowa.edu; mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Blackwell, Jenefer M/H-3015-2015;
   Jeronimo, Selma/AAY-4033-2020; Ettinger, Nicholas Andreas/P-3366-2019
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ettinger, Nicholas
   Andreas/0000-0002-0388-7693; Wilson, Mary/0000-0001-8680-7275
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI048822, AI067874, AI045540];
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, T32AI007511, R01AI067874, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, R01AI048822, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, T32AI007511, P50AI030639,
   T32AI007511, R01AI045540, T32AI007511, R01AI045540, P50AI030639,
   R01AI048822, P50AI030639, R01AI045540, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, R01AI045540, P50AI030639, P50AI030639, T32AI007511,
   R01AI076233, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, R01AI067874,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   T32AI007511, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI067874, P50AI030639, R01AI067874,
   P50AI030639, T32AI007511, P50AI030639, T32AI007511, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, T32AI007511, T32AI007511,
   P50AI030639, R01AI076233, T32AI007511, R01AI067874, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337] Funding Source: NIH RePORTER
FX This work was supported in part by NIH R01 grants AI048822, AI067874,
   and AI045540 from the National Institutes of Health (MEW), Merit Review
   and Gulf War RFA grants from the Department of Veterans' Affairs (MEW),
   NIH TMRC grant P50 AI-30639 (RFSB, ETN, SMBJ, RDP) and in part by the
   Intramural Research Program of the National Human Genome Research
   Institute, National Institutes of Health. The work of NAE was supported
   by NIH T32 AI07511.
CR Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   Callegari-Jacques Sidia M., 1999, Ciencia e Cultura (Sao Paulo), V51, P166
   Cann HM, 2002, SCIENCE, V296, P261
   DASILVA MIA, 1981, STUD PHYS ANTHR, V7, P3
   Falush D, 2003, GENETICS, V164, P1567
   FRANCO MHLP, 1982, AM J PHYS ANTHROPOL, V58, P127, DOI 10.1002/ajpa.1330580204
   Griffiths A.J.F., 1999, MODERN GENETIC ANAL
   Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628
   *IBGE, 2007, 500 AN POV HOM IBGE
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x
   Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238
   Melo M N, 1977, Rev Inst Med Trop Sao Paulo, V19, P161
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089
   Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977
   PRITCHARD JK, 2003, STRUCTURE
   Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311
   Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x
   Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194
   Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865
   Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733
   Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510
NR 34
TC 16
Z9 17
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0003-4800
EI 1469-1809
J9 ANN HUM GENET
JI Ann. Hum. Genet.
PD MAY
PY 2009
VL 73
BP 304
EP 313
DI 10.1111/j.1469-1809.2009.00510.x
PN 3
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 440NI
UT WOS:000265706600006
PM 19397557
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Blackwell, JM
   Fakiola, M
   Ibrahim, ME
   Jamieson, SE
   Jeronimo, SB
   Miller, EN
   Mishra, A
   Mohamed, HS
   Peacock, CS
   Raju, M
   Sundar, S
   Wilson, ME
AF Blackwell, J. M.
   Fakiola, M.
   Ibrahim, M. E.
   Jamieson, S. E.
   Jeronimo, S. B.
   Miller, E. N.
   Mishra, A.
   Mohamed, H. S.
   Peacock, C. S.
   Raju, M.
   Sundar, S.
   Wilson, M. E.
TI Genetics and visceral leishmaniasis: of mice and man
SO PARASITE IMMUNOLOGY
LA English
DT Review
DE leishmaniasis; candidate genes; genome scans
ID GENOME-WIDE ASSOCIATION; SLC11A1 FORMERLY NRAMP1; TYPE-1 DIABETES
   SUSCEPTIBILITY; INTERFERON-GAMMA PRODUCTION; AZAR DERMAL LEISHMANIASIS;
   ANTIGEN-PRESENTING CELLS; CORONARY-ARTERY-DISEASE; INDIAN KALA-AZAR; HLA
   CLASS-I; NORTHEASTERN BRAZIL
AB Ninety per cent of the 500 000 annual new cases of visceral leishmaniasis (VL) occur in India/Bangladesh/Nepal, Sudan and Brazil. Importantly, 80-90% of human infections are sub-clinical or asymptomatic, usually associated with strong cell-mediated immunity. Understanding the environmental and genetic risk factors that determine why two people with the same exposure to infection differ in susceptibility could provide important leads for improved therapies. Recent research using candidate gene association analysis and genome-wide linkage studies (GWLS) in collections of families from Sudan, Brazil and India have identified a number of genes/regions related both to environmental risk factors (e.g. iron), as well as genes that determine type 1 vs. type 2 cellular immune responses. However, until now all of the allelic association studies carried out have been underpowered to find genes of small effect sizes (odds ratios or OR < 2), and GWLS using multicase pedigrees have only been powered to find single major genes, or at best oligogenic control. The accumulation of large DNA banks from India and Brazil now makes it possible to undertake genome-wide association studies (GWAS), which are ongoing as part of phase 2 of the Wellcome Trust Case Control Consortium. Data from this analysis should seed research into novel genes and mechanisms that influence susceptibility to VL.
C1 [Ibrahim, M. E.; Mohamed, H. S.] Univ Khartoum, Inst Endem Dis, Khartoum, Sudan.
   [Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.
   [Jeronimo, S. B.; Mishra, A.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Wilson, M. E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Blackwell, J. M.; Jamieson, S. E.; Peacock, C. S.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia.
   [Blackwell, J. M.; Fakiola, M.; Miller, E. N.; Raju, M.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England.
   [Blackwell, J. M.; Fakiola, M.; Miller, E. N.; Raju, M.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England.
   [Wilson, M. E.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA.
   [Wilson, M. E.] VA Med Ctr, Iowa City, IA USA.
RP Blackwell, JM (corresponding author), Telethon Inst Child Hlth Res, POB 855, Perth, WA 6872, Australia.
EM jblackwell@ichr.uwa.edu.au
RI Peacock, Christopher/A-4052-2012; Jeronimo, Selma/AAY-4033-2020;
   Blackwell, Jenefer M/H-3015-2015; trivedi, kruti/H-5242-2011
OI Jeronimo, Selma/0000-0002-4784-9904; Mishra,
   Anshuman/0000-0002-9390-9971; Fakiola, Michaela/0000-0001-9071-4709;
   Wilson, Mary/0000-0001-8680-7275
FU Wellcome TrustWellcome Trust; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI074321, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI074321,
   P50AI030639, P50AI030639, P50AI074321, P50AI074321, P50AI030639,
   P50AI074321, P50AI030639, P50AI074321, P50AI074321, P50AI074321,
   P50AI074321, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, R01AI076233, P50AI030639, P50AI074321,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI074321,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI074321, R01AI076233, P50AI030639, P50AI030639, P50AI074321,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI074321, P50AI074321, P50AI074321,
   P50AI074321, P50AI030639, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI074321, P50AI074321, R01AI076233, P50AI030639,
   P50AI030639, P50AI074321, P50AI030639, P50AI074321, P50AI030639,
   P50AI030639, P50AI074321, R01AI076233, P50AI074321, P50AI030639,
   P50AI074321, P50AI074321, P50AI074321, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER
FX We acknowledge the many members of our laboratories who have contributed
   to research reviewed here. We thank the communities in Sudan, Brazil and
   India who have participated in our studies. Our research is funded by
   The Wellcome Trust and the NIH.
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   AMOS CI, 1994, AM J HUM GENET, V54, P535
   Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Anderson AC, 2001, CURR OPIN GENET DEV, V11, P554, DOI 10.1016/S0959-437X(00)00232-X
   Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Baker M, 2008, NATURE, V451, P516, DOI 10.1038/451516a
   Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289
   BECKLY JB, 2008, INFLAMM BOWEL DIS
   Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002
   BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0
   Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678
   Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x
   BRADLEY DJ, 1977, CLIN EXP IMMUNOL, V30, P130
   BRADLEY DJ, 1974, NATURE, V250, P353, DOI 10.1038/250353a0
   Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101
   Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927
   Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8
   Burgner D, 2006, LANCET INFECT DIS, V6, P653, DOI 10.1016/S1473-3099(06)70601-6
   Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71
   Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7
   Cordero JF, 2002, AM J HUM GENET, V70, P1
   Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651
   CRONIN S, 2007, HUM MOL GENET
   Cruz KK, 2008, PARASITE IMMUNOL, V30, P171, DOI 10.1111/j.1365-3024.2007.01014.x
   Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1
   DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0
   Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250
   Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887
   Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6
   ETTINGER NA, 2008, PLOS NEGLEC IN PRESS
   FAGHIRI Z, 1995, HUM HERED, V45, P258, DOI 10.1159/000154309
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451
   Goppelt A, 1996, EMBO J, V15, P3105, DOI 10.1002/j.1460-2075.1996.tb00673.x
   Goswami T, 2001, BIOCHEM J, V354, P511, DOI 10.1042/0264-6021:3540511
   Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999
   Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954
   HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5
   Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625
   Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477
   Hovatta I, 1998, MOL PSYCHIATR, V3, P452, DOI 10.1038/sj.mp.4000443
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   INOUYE C, 1994, DNA CELL BIOL, V13, P731, DOI 10.1089/dna.1994.13.731
   Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029
   Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17
   KURTZHALS JAL, 1995, SCAND J IMMUNOL, V41, P343, DOI 10.1111/j.1365-3083.1995.tb03577.x
   LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241
   Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209
   Li Hong-tao, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P428
   Li HT, 2006, INT J TUBERC LUNG D, V10, P3
   LOCKSLEY RM, 1991, IMMUNOPARASITOL TOD, pA58, DOI 10.1016/S0167-5699(05)80017-9
   Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X
   Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324
   Marquet S, 1999, J INFECT DIS, V180, P1521, DOI 10.1086/315091
   Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089
   Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977
   Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406
   Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17
   Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5
   Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061
   Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27
   Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104
   Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590
   ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x
   Roberts R, 2007, CAN J CARDIOL, V23, p7A, DOI 10.1016/S0828-282X(07)71000-0
   Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528
   SACKS DL, 1987, J IMMUNOL, V138, P908
   Salih MA, 2007, GENES IMMUN, V8, P75, DOI 10.1038/sj.gene.6364353
   Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366
   Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464
   Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394
   Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115
   Searle S, 1999, J MED GENET, V36, P295
   Searle S, 1998, J CELL SCI, V111, P2855
   SHAW MA, 1995, AM J HUM GENET, V57, P1159
   Singh N, 1997, TROP MED INT HEALTH, V2, P468, DOI 10.1046/j.1365-3156.1997.d01-290.x
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   SPIELMAN RS, 1993, AM J HUM GENET, V52, P506
   STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6
   Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13
   Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522
   Techau ME, 2007, J BIOL CHEM, V282, P35646, DOI 10.1074/jbc.M707057200
   Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32
   Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068
   Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085
   Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262
   Vallance P, 2007, CLIN PHARMACOL THER, V82, P363, DOI 10.1038/sj.clpt.6100333
   VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D
   WEEKS DE, 1995, TRENDS GENET, V11, P513, DOI 10.1016/S0168-9525(00)89163-5
   Yamaguchi E, 2002, IMMUNOL LETT, V81, P59, DOI 10.1016/S0165-2478(01)00326-1
   Zaahl MG, 2004, BLOOD CELL MOL DIS, V33, P45, DOI 10.1016/j.bcmd.2004.04.003
   Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089
   Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364
   Zhu JF, 2006, P NATL ACAD SCI USA, V103, P18214, DOI 10.1073/pnas.0608981103
   ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826
   ZWINGENBERGER K, 1990, CLIN IMMUNOL IMMUNOP, V57, P242, DOI 10.1016/0090-1229(90)90038-R
NR 114
TC 65
Z9 69
U1 0
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-9838
EI 1365-3024
J9 PARASITE IMMUNOL
JI Parasite Immunol.
PD MAY
PY 2009
VL 31
IS 5
BP 254
EP 266
DI 10.1111/j.1365-3024.2009.01102.x
PG 13
WC Immunology; Parasitology
SC Immunology; Parasitology
GA 431CA
UT WOS:000265037700004
PM 19388946
OA Green Accepted
DA 2020-11-26
ER

PT J
AU Andrade, IG
   Queiroz, JW
   Cabral, AP
   Lieberman, JA
   Jeronimo, SMB
AF Andrade, Ion G.
   Queiroz, Jose W.
   Cabral, Angela P.
   Lieberman, Joshua A.
   Jeronimo, Selma M. B.
TI Improved sanitation and income are associated with decreased rates of
   hospitalization for diarrhoea in Brazilian infants
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Diarrhoea; Infant mortality; Sanitation; Poverty; Hospitalization;
   Brazil
ID EARLY-CHILDHOOD DIARRHEA; CHILDREN; DISEASE; HEALTH; STRATEGY; HYGIENE;
   FOOD
AB Diarrhoeal diseases remain a major cause of morbidity and mortality in Brazilian children. However, from 1992 to 2001 there was a significant decline in hospitalizations for acute diarrhoea in children below 1 year of age in Brazil. A significant improvement in child health was also observed in the state of Rio Grande do Norte (RN), with a decrease in child mortality from 70 to 40 deaths per 1000. Using distributed tag analysis we analysed a number of factors possibly connected with decreased hospitalization in RN and found that hospitalization was correlated up to tag 3 with poverty (P < 0.001) and inflation (P < 0.001). Improvements in public health infrastructure such as better waste collection, presence of city water supply and increased sanitation, socio-economic variables such as education and literacy, and increased investment in health services were all important in reducing severe early childhood diarrhoeas and thus directly associated with the decrease in hospitalization. We also observed a positive seasonal correlation between rainfall and hospitalizations with an increased in rainfall impacting positively on hospitalization in all tags. The data suggests that increased buying power and reductions in poverty played a crucial rote in reducing hospitalizations for acute diarrhoea in infants in RN. (C) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All. rights reserved.
C1 [Andrade, Ion G.; Queiroz, Jose W.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
   [Cabral, Angela P.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Lieberman, Joshua A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
FU Howard Hughes Medical Institute Undergraduate Research FellowshipHoward
   Hughes Medical Institute
FX JAL was supported by a Howard Hughes Medical Institute Undergraduate
   Research Fellowship. SMBJ is a Conselho Nacional de Desenvolvimento
   Tecnologico (CNPq) Researcher.
CR Albrechtsen HJ, 2002, WATER SCI TECHNOL, V46, P311
   Barros FC, 2001, PAEDIATR PERINAT EP, V15, P4, DOI 10.1046/j.1365-3016.2001.00320.x
   BOX GEP, 1976, TIME SERIES ANAL FOR, P371
   Bryce J, 2006, LANCET, V368, P817, DOI 10.1016/S0140-6736(06)69299-4
   Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194
   Fayer R, 2002, PARASITOL RES, V88, P998, DOI 10.1007/s00436-002-0697-1
   Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707
   Guerrant RL, 2002, TRENDS PARASITOL, V18, P191, DOI 10.1016/S1471-4922(02)02253-5
   Hartigan J.A., 1975, CLUSTERING ALGORITHM
   Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1
   Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002
   Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197
   Lanata CF, 2003, INT J ENVIRON HEAL R, V13, pS175, DOI 10.1080/0960312031000102921
   LAURSEN E, 1994, J EPIDEMIOL COMMUN H, V48, P453, DOI 10.1136/jech.48.5.453
   Leao BD, 2001, ST HEAL T, V84, P38
   LLOYDEVANS N, 1984, T ROY SOC TROP MED H, V78, P209, DOI 10.1016/0035-9203(84)90279-7
   MIOSSEC L, 2000, REV EPIDEMIOL SAN S2, V48
   MORRISON DF, 2008, MULTIVARIATE STAT ME
   Mygind O, 1995, Ugeskr Laeger, V157, P4676
   Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590
   PANKRATZ A, 1991, FORECASTING DYNAMIC
   Rowland M G, 1986, Dialogue Diarrhoea, P3
   Thapar N, 2004, LANCET, V363, P641, DOI 10.1016/S0140-6736(04)15599-2
   Tukey JW, 1977, EXPLORATORY DATA ANA
   VICTORA CG, 1986, B WORLD HEALTH ORGAN, V64, P299
   Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0
NR 26
TC 12
Z9 13
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY
PY 2009
VL 103
IS 5
BP 506
EP 511
DI 10.1016/j.trstmh.2008.12.017
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 442EI
UT WOS:000265822400014
PM 19215948
DA 2020-11-26
ER

PT J
AU Queiroz, PVS
   Monteiro, GRG
   Macedo, VPS
   Rocha, MAC
   Batista, LMM
   Queiroz, JW
   Jeronimo, SMB
   Ximenes, MFFM
AF Queiroz, Paula V. S.
   Monteiro, Gloria R. G.
   Macedo, Virginia P. S.
   Rocha, Maria A. C.
   Batista, Leopoldina M. M.
   Queiroz, Jose W.
   Jeronimo, Selma M. B.
   Ximenes, Maria F. F. M.
TI Canine visceral leishmaniasis in urban and rural areas of Northeast
   Brazil
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Canine visceral leishmaniasis; Leishmania chagasi; Lutzomyia
   longipalpis; Lutzomyia intermedia
ID RECOMBINANT K-39 ANTIGEN; SAND FLIES DIPTERA; GRANDE-DO-NORTE; CUTANEOUS
   LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; MINAS-GERAIS; INFANTUM; STATE;
   EPIDEMIOLOGY; SERODIAGNOSIS
AB The purpose of this study was to determine the clinical and laboratory profiles of canine leishmaniasis in two distinct areas. Dogs from urban and rural areas were examined. The population studied in the metropolitan area included 54 dogs. Of these, 20 (37%) animals did not present with any signs suggestive of visceral leishmaniasis (VL). Among these, only eight were confirmed negative by ELISA (rK39 and CE) and 12 dogs, clinically negative for leishmaniasis, were seropositive by ELISA (rK39 and CE). Thinness, conjunctivitis and onychogryphosis were the most frequent clinical signs in the urban areas, followed by crusty lesions, alopecia, ulcerated lesions, hyperkeratosis and exfoliation. In the metropolitan area human VL cases occurred mainly in 1991, 1992, 1999 and 2000. In the rural areas the ELISA rK39 test detected a seroprevalence of 11.3% and ELISA CE (Leishmania crude extract) of 20.6%. Thirty-nine dogs were examined 6 months after the first visit. Serological exams using rK39 antigen showed seroconversion of only one dog, whereas Leishmania CE showed seroconversion of 13 (33.4%) dogs. In this rural environment 83.3% of the positive dogs were asymptomatic. Lutzomyia intermedia and Lu. longipalpis were the most predominant sandfly vector species. Amastigotes were identified in spleen and liver fragments of symptomatic necropsied animals. PCR amplification of DNA isolated from promastigote culture indicated that the species was Leishmania chagasi. This finding suggests that delayed diagnosis and euthanasia of potentially infectious animals may occur with an increased transmission risk to sandflies and subsequently to humans. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Macedo, Virginia P. S.; Ximenes, Maria F. F. M.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   [Queiroz, Paula V. S.; Monteiro, Gloria R. G.; Macedo, Virginia P. S.; Jeronimo, Selma M. B.; Ximenes, Maria F. F. M.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   [Rocha, Maria A. C.] Univ Fed Rio Grande do Norte, Dept Pathol, BR-59072970 Natal, RN, Brazil.
   [Queiroz, Jose W.] Univ Fed Rio Grande do Norte, Dept Stat, BR-59072970 Natal, RN, Brazil.
RP Ximenes, MFFM (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
EM mffmx@digizap.com.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159
   Adler S, 1932, P R SOC LOND B-CONTA, V110, P402, DOI 10.1098/rspb.1932.0035
   ALENCAR JE, 1959, IMPRENSA OFICIAL CAL, P342
   ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879
   Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53
   BARBOSA GMS, 1999, BRASIL CAD SAUDE PUB, V3, P641
   BETTINI S, 1986, INSECT SCI APPL, V7, P241, DOI 10.1017/S1742758400009024
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   Camargo-Neves V L, 2001, Cad Saude Publica, V17, P1263
   Cortada VMCL, 2004, VET RES COMMUN, V28, P365, DOI 10.1023/B:VERC.0000035014.80785.b7
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   FERRER LM, 1999, P INT CAN LEISHM FOR, V6, P10
   Franca-Silva JC, 2003, VET PARASITOL, V111, P161, DOI 10.1016/S0304-4017(02)00351-5
   Gontijo CMF, 2002, ACTA TROP, V81, P143, DOI 10.1016/S0001-706X(01)00205-4
   Gravino A. E., 2004, Parassitologia (Rome), V46, P227
   Hamilton J. G. C., 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene, V86, P341
   *IBGE, CENS DEM 2000, P520
   JARVIS EK, 1992, J MED ENTOMOL, V29, P171, DOI 10.1093/jmedent/29.2.171
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kelly DW, 1997, ANIM BEHAV, V53, P721, DOI 10.1006/anbe.1996.0309
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020
   Madeira Maria de Fátima, 2004, Braz J Infect Dis, V8, P440, DOI 10.1590/S1413-86702004000600008
   MANCIANTI F, 1988, AM J VET RES, V49, P1409
   MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988
   MOLINA R, 1994, T ROY SOC TROP MED H, V88, P491, DOI 10.1016/0035-9203(94)90446-4
   *MS, 1999, DOENC INF PAR ASP CL, P121
   OLIVEIRA GGS, 1993, MEM I OSWALDO CRUZ, V88, P243, DOI 10.1590/S0074-02761993000200011
   ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39
   QU JQ, 1994, T ROY SOC TROP MED H, V88, P543, DOI 10.1016/0035-9203(94)90154-6
   Rangel E F, 1984, Mem Inst Oswaldo Cruz, V79, P395, DOI 10.1590/S0074-02761984000300020
   Reithinger R, 2002, J CLIN MICROBIOL, V40, P2352, DOI 10.1128/JCM.40.7.2352-2356.2002
   Reithinger R, 1999, AM J TROP MED HYG, V61, P530, DOI 10.4269/ajtmh.1999.61.530
   Rhalem A, 1999, VET PARASITOL, V81, P173, DOI 10.1016/S0304-4017(98)00240-4
   Rosypal AC, 2007, VET PARASITOL, V149, P172, DOI 10.1016/j.vetpar.2007.08.004
   Rosypal AC, 2005, J VET INTERN MED, V19, P802, DOI 10.1892/0891-6640(2005)19[802:UODTUI]2.0.CO;2
   Scalone A, 2002, VET PARASITOL, V104, P275, DOI 10.1016/S0304-4017(01)00643-4
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   *SINAN, 2004, SIST INF AGR NOT
   SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096
   *SSP RN, 1997, DOENC NOT COMP, P126
   Teodoro U, 1997, REV SAUDE PUBL, V31, P512, DOI 10.1590/S0034-89101997000600011
   UCHOA CMA, 2001, BRASIL REV SOC BRAS, V34, P563
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
   XIMENES MFF, 2006, NE BRAZIL J MED ENTO, V43
   Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1
   Zaffaroni E, 1999, VET PARASITOL, V81, P11, DOI 10.1016/S0304-4017(98)00237-4
NR 50
TC 29
Z9 29
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD APR
PY 2009
VL 86
IS 2
BP 267
EP 273
DI 10.1016/j.rvsc.2008.07.014
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 419UI
UT WOS:000264244800015
PM 18804826
DA 2020-11-26
ER

PT J
AU Ximenes, MDFM
   Pinheiro, MPG
   Cavalcante, KB
   Silva, VPM
   Pontes, NN
   Queiroz, PV
   Martins, DR
   Gomes, C
   Duarte, I
   Araujo, PSF
   Jeronimo, SMB
AF Ximenes, Maria de Fatima F. M.
   Pinheiro, Marcos P. G.
   Cavalcante, Katrine B.
   Silva, Virginia P. M.
   Pontes, Nubia N.
   Queiroz, Paula V.
   Martins, Daniela R.
   Gomes, Carlos
   Duarte, Iraci
   Araujo, Paulo S. F.
   Jeronimo, Selma M. B.
TI Urbanization of visceral leishmaniasis in Rio Grande do Norte, Brazil:
   biotic and abiotic interactions
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Visceral leishmaniasis; Lutzomyia longipalpis; Leishmania chagasi
ID LUTZOMYIA-LONGIPALPIS DIPTERA; SAND FLIES DIPTERA; NORTHEASTERN BRAZIL;
   PSYCHODIDAE; CHAGASI; STATE; PHLEBOTOMINAE; INFECTION; AREA
AB Leishmaniases, whose parasites develop on vertebrate and invertebrate hosts in natural ecotopes, were originally considered zoonotic diseases occurring exclusively in the wild. Even though the measures adopted to control visceral leishmaniasis seem adequate, the disease is spreading rapidly throughout the country. In Rio Grande do Norte, two important epidemic outbreaks were reported, approximately 10 years apart, with cases of the diseases mainly occurring in metropolitan Natal, the capital of the state. However, in the last three years has seen the urbanization of the disease in the second most populous city of the state, in a region of transition between the Caatinga and the coast. The socio-environmental aspects seem to be relevant in this expansion. Over the last twenty years studies have been conducted to understand the different parameters related to the disease in the state. An analysis of biotic and abiotic interactions related to epidemiological chains is presented, focusing on the biology of Lutzomyia longipalpis, its relationship with animal hosts; the influence of environmental degradation in the relationships that are established between the vector and vertebrate hosts; hematophagic aspects and the rate of infection by Leishmania chagasi in rural and pen-urban areas.
C1 [Ximenes, Maria de Fatima F. M.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Ctr Biociencias, BR-59078970 Natal, RN, Brazil.
   [Queiroz, Paula V.] Univ Estado Rio Grande do Norte, Caico, RN, Brazil.
RP Ximenes, MDFM (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, Ctr Biociencias, BR-59078970 Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Amóra Sthenia Santos Albano, 2006, Cienc. Rural, V36, P1854, DOI 10.1590/S0103-84782006000600029
   ALBUQUERQUE PLM, 2009, PAN AM J PUBLIC HLTH, V26
   Ambroise-Thomas P, 2000, INT J PARASITOL, V30, P1361, DOI 10.1016/S0020-7519(00)00131-4
   Barbosa PBBM, 2008, MEM I OSWALDO CRUZ, V103, P545, DOI 10.1590/S0074-02762008000600006
   Bern C, 2008, NEGL TROP DIS, V313, P1
   BLACKWELL JM, 1992, PARASITOLOGY, V104, pS19, DOI 10.1017/S0031182000075223
   Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004
   Cortez AM, 2007, J VECTOR ECOL, V32, P336, DOI 10.3376/1081-1710(2007)32[336:VSADAO]2.0.CO;2
   Costa CHN, 2005, ANN TROP MED PARASIT, V99, P229, DOI 10.1179/136485905X28018
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990
   Gama SR, 2007, CAD SAUDE PUBLICA, V23, P2239, DOI 10.1590/S0102-311X2007000900032
   *IBGE, PARN RN EST POP 2009
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   Mendes Wellington da Silva, 2002, Rev. Soc. Bras. Med. Trop., V35, P227, DOI 10.1590/S0037-86822002000300005
   Montoya-Lerma J, 2003, ACTA TROP, V85, P19, DOI 10.1016/S0001-706X(02)00189-4
   Patz JA, 2000, INT J PARASITOL, V30, P1395, DOI 10.1016/S0020-7519(00)00141-7
   Pedrosa Célia Maria Silva, 2004, Rev. Soc. Bras. Med. Trop., V37, P300, DOI 10.1590/S0037-86822004000400003
   Rabello A, 2003, ANN TROP MED PARASIT, V97, P17, DOI 10.1179/000349803225002507
   Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025
   Rohousova I, 2005, PARASITOLOGY, V130, P493, DOI 10.1017/S003118200400681X
   Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024
   Santos Soraya Oliveira Dos, 1998, Medical and Veterinary Entomology, V12, P315
   SHERLOCK I A, 1988, Memorias do Instituto Oswaldo Cruz, V83, P141, DOI 10.1590/S0074-02761988000100019
   SOARES RPP, 2003, ANAIS ACAD BRASILEIR, P301
   Souza GD, 2009, MEM I OSWALDO CRUZ, V104, P1181, DOI 10.1590/S0074-02762009000800017
   Stober C, 2002, PHILOS T ROY SOC B, V357, P5, DOI 10.1098/rstb.2001.0985
   TRAVI BL, 1994, AM J TROP MED HYG, V50, P557, DOI 10.4269/ajtmh.1994.50.557
   Volf P, 2008, PARASITE, V15, P237, DOI 10.1051/parasite/2008153237
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
NR 34
TC 1
Z9 1
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2009
VL 42
SU 2
BP 138
EP 140
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 684QA
UT WOS:000284563200029
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Maciel, BL
   Lima, ID
   Lacerda, HG
   Duarte, PV
   Queiroz, JW
   Pontes, NN
   Araujo, SR
   Nascimento, ET
   Monteiro, GR
   Pearson, RD
   Wilson, ME
   McGowan, SE
   Jeronimo, SM
AF Maciel, Bruna L.
   Lima, Iraci D.
   Lacerda, Henio G.
   Duarte, Paula V.
   Queiroz, Jose W.
   Pontes, Nubia N.
   Araujo, Sergio R.
   Nascimento, Eliana T.
   Monteiro, Gloria R.
   Pearson, Richard D.
   Wilson, Mary E.
   McGowan, Stephen E.
   Jeronimo, Selma M.
TI THE EPIDEMIOLOGY OF LEISHMANIA CHAGASI INFECTION IN RIO GRANDE DO NORTE,
   NORTHEAST BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Maciel, Bruna L.; Lima, Iraci D.; Lacerda, Henio G.; Duarte, Paula V.; Queiroz, Jose W.; Pontes, Nubia N.; Araujo, Sergio R.; Nascimento, Eliana T.; Monteiro, Gloria R.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Pearson, Richard D.] Univ Virginia, Charlottesville, VA USA.
   [Wilson, Mary E.; McGowan, Stephen E.] Univ Iowa, Wisconsin, IA USA.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 421
BP 125
EP 125
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644600421
DA 2020-11-26
ER

PT J
AU Queiroz, JW
   Dias, GH
   Nobre, ML
   Dias, MCDS
   Araujo, SF
   Sousa, JD
   Blackwell, JM
   Jeronimo, SM
AF Queiroz, Jose W.
   Dias, Gutemberg H.
   Nobre, Mauricio L.
   Dias, Marcia C. De Sousa
   Araujo, Sergio F.
   Sousa, James D.
   Blackwell, Jenefer M.
   Jeronimo, Selma M.
TI CLUSTERING OF HANSEN'S DISEASE (LEPROSY) IN A POPULATION IN NORTHEAST
   BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Queiroz, Jose W.; Dias, Gutemberg H.; Nobre, Mauricio L.; Araujo, Sergio F.; Sousa, James D.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Dias, Marcia C. De Sousa] Univ Estado Rio Grande do Norte, Mossoro, Brazil.
   [Blackwell, Jenefer M.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA, Australia.
RI Dias, Gutemberg H/D-7510-2018; Jeronimo, Selma/AAY-4033-2020; Jeronimo,
   Selma M.B./M-8672-2014
OI Dias, Gutemberg H/0000-0003-2147-8647; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 872
BP 257
EP 257
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644601237
DA 2020-11-26
ER

PT J
AU Nascimento, ELT
   Martins, DR
   Monteiro, GR
   Barbosa, JD
   Ximenes, MFFM
   Maciel, BL
   Duarte, I
   Jeronimo, SMB
AF Nascimento, Eliana L. T.
   Martins, Daniella R.
   Monteiro, Gloria R.
   Barbosa, James D.
   Ximenes, Maria F. F. M.
   Maciel, Bruna L.
   Duarte, Iraci
   Jeronimo, Selma M. B.
TI Forum: geographic spread and urbanization of visceral leishmaniasis in
   Brazil. Postscript: new challenges in the epidemiology of Leishmania
   chagasi infection
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Editorial Material
ID LUTZOMYIA-LONGIPALPIS DIPTERA; STATE; PSYCHODIDAE; AREA; POPULATION
C1 [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   [Nascimento, Eliana L. T.] Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil.
   [Duarte, Iraci] Minist Saude, Fundacao Nacl Saude, Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, CP 1524, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR Andrade AM, 2008, CAD SAUDE PUBLICA, V24, P927, DOI 10.1590/S0102-311X2008000400024
   Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4
   Barao SC, 2007, AM J TROP MED HYG, V77, P1051, DOI 10.4269/ajtmh.2007.77.1051
   BIRLEY MH, 1993, ANN TROP MED PARASIT, V87, P319, DOI 10.1080/00034983.1993.11812776
   Cordoba-Lanus E, 2006, ACTA TROP, V98, P1, DOI 10.1016/j.actatropica.2005.11.010
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Cruz I, 2006, INDIAN J MED RES, V123, P357
   DUARTE I, EMERG INFECT D UNPUB
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Ximenes MDFD, 2006, J MED ENTOMOL, V43, P990
   Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X
   JERONIMO SM, 2004, CECIL TXB MED, P2082
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x
   Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001
   Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024
   Mannocci A, 2007, J Prev Med Hyg, V48, P27
   Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393
   Costa CHN, 2008, CAD SAUDE PUBLICA, V24, P2959, DOI 10.1590/S0102-311X2008001200027
   Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005
   Oliveira CDL, 2008, CAD SAUDE PUBLICA, V24, P2953, DOI 10.1590/S0102-311X2008001200026
   Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025
   Salomon OD, 2005, MEM I OSWALDO CRUZ, V100, P475, DOI 10.1590/S0074-02762005000500005
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Weisser M, 2007, CLIN MICROBIOL INFEC, V13, P751, DOI 10.1111/j.1469-0691.2007.01755.x
   Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881
   Werneck GL, 2002, EPIDEMIOLOGY, V13, P364, DOI 10.1097/00001648-200205000-00020
   Ximenes MDFFDM, 2007, NEOTROP ENTOMOL, V36, P128, DOI 10.1590/S1519-566X2007000100016
NR 30
TC 19
Z9 19
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD DEC
PY 2008
VL 24
IS 12
BP 2964
EP 2967
DI 10.1590/S0102-311X2008001200028
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 402EB
UT WOS:000262995900028
PM 19082290
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Lacerda, HG
   Monteiro, GR
   Oliveira, CCG
   Suassuna, FB
   Queiroz, JW
   Barbosa, JDA
   Martins, DR
   Reis, MG
   Ko, AI
   Jeronimo, SMB
AF Lacerda, Henio G.
   Monteiro, Gloria R.
   Oliveira, Carlos C. G.
   Suassuna, Fernando B.
   Queiroz, Jose W.
   Barbosa, James D. A.
   Martins, Daniella R.
   Reis, Mitemayer G.
   Ko, Albert I.
   Jeronimo, Selma M. B.
TI Leptospirosis in a subsistence farming community in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Leptospirosis; Disease outbreaks; Surveillance; Prevalence; Rural
   population; Brazil
ID RISK-FACTORS; URBAN EPIDEMIC; BARBADOS; INFECTION; SERODIAGNOSIS;
   ANTIBODIES; OUTBREAK; ILLNESS; SEROVAR; AMAZON
AB Leptospirosis has been reported in rural areas of Brazil. However, there is limited information about the exposure risk or the risk of Leptospira infection for rural-based populations. A cross-sectional study was carried out in order to determine the prevalence and risk factors for prior Leptospira infection in a rural subsistence farming region of the state of Rio Grande do Norte, an area in which outbreaks of leptospirosis have occurred. Among 290 individuals enrolled, 44 (15.2%) had anti-Leptospira IgM antibodies as determined by IgM ELISA. Infection tended to occur with activities related to the rice fields (P=0.08). Our findings indicate that Leptospira infection occurs even in years of tow rainfall, and may have an important impact among poor rural-based subsistence farmers in Brazil. Additional studies are needed to characterize the mode of transmission in this region. (c) 2008 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Monteiro, Gloria R.; Queiroz, Jose W.; Barbosa, James D. A.; Martins, Daniella R.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, BR-59078970 Natal, RN, Brazil.
   [Lacerda, Henio G.; Suassuna, Fernando B.] Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59078970 Natal, RN, Brazil.
   [Oliveira, Carlos C. G.; Reis, Mitemayer G.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59078970 Natal, RN, Brazil.
   [Ko, Albert I.] Oswoldo Cruz Fdn Brazilian Minister Hlth, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Ko, Albert I.] Cornell Univ, Weil Med Coll, Div Int Med & Infect Dis, New York, NY 10021 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, CP 1624, BR-59078970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Ko,
   Albert Icksang/P-2343-2015
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Ko, Albert Icksang/0000-0001-9023-2339
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [A1052473, FIC D43 TWO0919]; Consetho
   Nacionat de Desenvolvimento Cientifico e Tecnologico (CNPq)National
   Council for Scientific and Technological Development (CNPq); FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919, D43TW000919, D43TW000919,
   D43TW000919, D43TW000919, D43TW000919] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473, R01AI052473, R01AI052473, R01AI052473, R01AI052473,
   R01AI052473] Funding Source: NIH RePORTER
FX This work was funded in part by NIH grants (NIAID R01 A1052473 and FIC
   D43 TWO0919) and Consetho Nacionat de Desenvolvimento Cientifico e
   Tecnologico (CNPq), SMBJ and MGR are CNPq researchers.
CR Aguiar DM, 2007, BRAZ J MICROBIOL, V38, P93, DOI 10.1590/S1517-83822007000100019
   Ashford DA, 2000, AM J TROP MED HYG, V63, P249, DOI 10.4269/ajtmh.2000.63.249
   AZEVEDO E, 1968, REV I ADOLFO LUTZ SA, V28, P85
   Bruce MG, 2005, ACTA TROP, V96, P36, DOI 10.1016/j.actatropica.2005.07.001
   Bunnell JE, 2000, AM J TROP MED HYG, V63, P255, DOI 10.4269/ajtmh.2000.63.255
   CALDAS E. M., 1977, Revista de Medicina, Bahia, V23, P90
   CALDAS E. M., 1979, Revista do Instituto Adolfo Lutz, V39, P85
   Cumberland P, 2001, EUR J EPIDEMIOL, V17, P601, DOI 10.1023/A:1015509105668
   EVERARD COR, 1992, J TROP MED HYG, V95, P13
   EVERARD COR, 1989, EPIDEMIOL INFECT, V103, P143, DOI 10.1017/S0950268800030442
   Everard J. D., 1993, Reviews in Medical Microbiology, V4, P114
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Flannery B, 2001, AM J TROP MED HYG, V65, P657, DOI 10.4269/ajtmh.2001.65.657
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Hartskeerl RA, 1996, VET QUART, V18, pS149
   Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Kuriakose M, 1997, EUR J EPIDEMIOL, V13, P691, DOI 10.1023/A:1007300729615
   Levett PN, 2000, AM J TROP MED HYG, V62, P112, DOI 10.4269/ajtmh.2000.62.112
   Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208
   LIMA CCC, 1996, REV SOC BRAS MED TRO, V29, P95
   LUPIDI R, 1991, J CLIN MICROBIOL, V29, P805, DOI 10.1128/JCM.29.4.805-809.1991
   MARTINEZ SR, 1993, REV CUBANA MED TROP, V45, P32
   McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c
   McBride AJA, 2007, ACTA TROP, V102, P206, DOI 10.1016/j.actatropica.2007.05.002
   Ministerio da Saude, 1995, MAN LEPT
   Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760
   Phraisuwan P, 2002, EMERG INFECT DIS, V8, P1455, DOI 10.3201/eid0812.020180
   Russell KL, 2003, AM J TROP MED HYG, V69, P53, DOI 10.4269/ajtmh.2003.69.53
   Sarkar U, 2002, AM J TROP MED HYG, V66, P605
   *SECR EST SAUD RIO, 1997, REL VIG EP LEPT
   SUASSUNA F, 1985, REV SOC BRAS MED TRO, V19, P116
   Tangkanakul W, 2000, AM J TROP MED HYG, V63, P204, DOI 10.4269/ajtmh.2000.63.204
   World Health Organization, 2003, HUM LEPT GUID DIAGN
NR 34
TC 12
Z9 13
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD DEC
PY 2008
VL 102
IS 12
BP 1233
EP 1238
DI 10.1016/j.trstmh.2008.05.010
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 377XK
UT WOS:000261285500011
PM 18599101
OA Green Accepted, Green Published
DA 2020-11-26
ER

PT J
AU Maciel, BLL
   Lacerda, HG
   Queiroz, JW
   Galvao, J
   Pontes, NN
   Dimenstein, R
   McGowan, SE
   Pedrosa, LFC
   Jeronimo, SMB
AF Maciel, Bruna L. Lima
   Lacerda, Henio G.
   Queiroz, Jose W.
   Galvao, Juliana
   Pontes, Nubia N.
   Dimenstein, Roberto
   McGowan, Stephen E.
   Pedrosa, Lucia F. C.
   Jeronimo, Selma M. B.
TI Association of nutritional status with the response to infection with
   Leishmania chagasi
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID RETINOL-BINDING-PROTEIN; VITAMIN-A STATUS; VISCERAL LEISHMANIASIS;
   SUBCLINICAL INFECTION; PARASITIC DISEASE; NORTHEAST BRAZIL;
   RANDOMIZED-TRIAL; BIRTH-WEIGHT; CHILDREN; MALNUTRITION
AB Outcomes of infection with Leishmania chagasi range from self-resolving infection to visceral leishmaniasis (VL). Risk factors determining development of disease are not totally understood, but probably include environmental influences and host genetics. We assessed whether nutrition influenced the outcome of Leishmania infection by comparing relatives of children with VL with either self-resolving Leishmania spp. infection or apparently uninfected households. We observed a decrease in body mass index (P < 0.0005) and mid-upper arm circumference for age (P = 0.022) z-scores for children with VL. Levels of vitamin A were lower in active children with VL as measured by serum retinol (P = 0.035) and the modified-relative-dose-response test (P = 0.009). Higher birth weight (P = 0.047) and albumin concentrations (P = 0.040) protected against disease. Increased breastfeeding time (P = 0.036) was associated with asymptomatic infection. The results indicate that modifiable nutritional aspects are associated with the outcome of Leishmania spp. infection in humans.
C1 [Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Hlth Sci Postgrad Program, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Infect Dis, Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil.
   Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Biosci Ctr, CP 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Pedrosa, Lucia Fatima Campos/N-7343-2019
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Pedrosa, Lucia Fatima
   Campos/0000-0002-5436-5115; McGowan, Stephen/0000-0003-3084-1962
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI030639-1551];
   Coordenaqao de Aperfeiqoamento de Pessoal de Nivel SuperiorCAPES;
   FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001297, R03TW001297, R03TW001297]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
FX This study was supported by grant AI030639-1551. from the National
   Institutes of Health. Selma M. B. Jeronimo is a researcher of the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnoldgico. Bruna L.
   Lima Maciel was supported by a fellowship from Coordenaqao de
   Aperfeiqoamento de Pessoal de Nivel Superior.
CR Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Ballew C, 2001, AM J CLIN NUTR, V73, P586
   BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A
   Bern C, 2007, AM J TROP MED HYG, V76, P909
   Bhaskaram P, 2002, NUTR REV, V60, pS40, DOI 10.1301/00296640260130722
   Biesalski HK, 1999, AM J CLIN NUTR, V69, P931
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Cantorna MT, 1996, J IMMUNOL, V156, P2674
   CANTORNA MT, 1995, EUR J IMMUNOL, V25, P1673, DOI 10.1002/eji.1830250629
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   Davies CR, 1999, PARASITOLOGY, V119, P247, DOI 10.1017/S0031182099004680
   DYE C, 1993, P ROY SOC B-BIOL SCI, V254, P33, DOI 10.1098/rspb.1993.0123
   ELLESTADSAYED J, 1979, CAN MED ASSOC J, V120, P295
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Filteau SM, 2000, BRIT J NUTR, V83, P513
   Filteau SM, 1998, BRIT J NUTR, V80, P75, DOI 10.1017/S0007114598001792
   Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698
   Garg R, 2004, PARASITOLOGY, V129, P685, DOI 10.1017/S0031182004006055
   Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Ho JJ, 2001, PEDIATR INFECT DIS J, V20, P557, DOI 10.1097/00006454-200106000-00002
   HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jason J, 2002, CLIN DIAGN LAB IMMUN, V9, P616, DOI 10.1128/CDLI.9.3.616-621.2002
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244
   Kolsteren PWV, 1997, ANN TROP PAEDIATR, V17, P201, DOI 10.1080/02724936.1997.11747887
   Lima Marilia de Carvalho, 2004, Sao Paulo Med. J., V122, P117, DOI 10.1590/S1516-31802004000300008
   LIZANA J, 1974, CLIN CHEM, V20, P1181
   LopezAlarcon M, 1997, J NUTR, V127, P436
   Mitra AK, 1998, AM J CLIN NUTR, V68, P1095
   Mitra AK, 1998, LANCET, V351, P1033, DOI 10.1016/S0140-6736(05)79000-0
   Mitra AK, 2002, J HEALTH POPUL NUTR, V20, P12
   Montenegro J, 1926, ARCH DERMATOL SYPH, V13, P187, DOI 10.1001/archderm.1926.02370140053003
   Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590
   Organization WH, 1996, IND ASS VIT DEF THEI
   PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443
   PILCH SM, 1987, J NUTR, V117, P636
   Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254
   SCHORLING JB, 1990, INT J EPIDEMIOL, V19, P728, DOI 10.1093/ije/19.3.728
   Semba RD, 1999, J NUTR, V129, P783
   Semba RD, 1999, P NUTR SOC, V58, P719, DOI 10.1017/S0029665199000944
   Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2
   SHANKAR AH, 1995, AM J CLIN NUTR, V62, P842
   SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013
   Surles RL, 2006, J NUTR, V136, P939
   Tanumihardjo SA, 1996, AM J CLIN NUTR, V64, P966
   Taylor CE, 2000, J INFECT DIS, V182, pS1, DOI 10.1086/315904
   Tchum SK, 2006, AM J CLIN NUTR, V84, P1344
   Thielman NM, 1996, J MED MICROBIOL, V44, P155, DOI 10.1099/00222615-44-3-155
   Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4
   VICTORA CG, 1988, PEDIATRICS, V81, P807
   WAITS RP, 1995, CLIN CHEM, V41, P1288
NR 56
TC 37
Z9 37
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2008
VL 79
IS 4
BP 591
EP 598
DI 10.4269/ajtmh.2008.79.591
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 357PG
UT WOS:000259858000020
PM 18840750
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Barbosa, PBBM
   de Queiroz, PVS
   Jeronimo, SMB
   Ximenes, MDFD
AF Barra Medeiros Barbosa, Patricia Batista
   Sousa de Queiroz, Paula Viviane
   Jeronimo, Selma Maria B.
   Freire de Melo Ximenes, Maria de Fatima
TI Experimental infection parameters in Galea spixii (Rodentia: Caviidae)
   with Leishmania infantum chagasi
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Galea spixii; Leishmania infantum chagasi; animal hosts
ID AMERICAN VISCERAL LEISHMANIASIS; BRAZIL
AB In order to better understand the epidemiological transmission network of leishmaniasis, an endemic disease in Northeast Brazil, we investigated the susceptibility of Spix yellow-toothed cavies (Galea spixii) to the Leishmania infantum chagasi parasite. Nine cavies were experimentally infected, separated into three groups and monitored at 30, 90 and 180 days, respectively. Amastigotes were identified in the spleen slides of two cavies killed 180 days after infection. Antibodies against the L. i. chagasi were identified in one of the cavies. This demonstrates that G. spixii is in fact capable of maintaining a stable infection by L. i. chagasi without alterations in biochemical and hematological parameters of the host and without perceivable micro and macroscopic lesions.
C1 [Freire de Melo Ximenes, Maria de Fatima] Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   [Barra Medeiros Barbosa, Patricia Batista; Sousa de Queiroz, Paula Viviane] Univ Estado Rio Grande do Norte, Fac Ciencias Saude, Natal, RN, Brazil.
   [Jeronimo, Selma Maria B.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RP Ximenes, MDFD (corresponding author), Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
EM ximenes@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX Financial support: CNPq, CAPES
CR BLACKWELL JM, 1996, PARASITOLOGY, V112, P67
   ECCO R, 2000, CIENCIA RURAL, V30, P225
   LACHER TE, 1981, B CARNEGIE MUS NAT H, V17, P1
   Lainson R, 2002, T ROY SOC TROP MED H, V96, P630, DOI 10.1016/S0035-9203(02)90333-0
   MACHADO MI, 1994, PARASITOLOGY, V109, P135, DOI 10.1017/S0031182000076241
   MEDINA HSG, 1946, ARG BIOL TECNOL, V1, P29
   MUNIZ J, 1948, Hospital (Rio J), V33, P7
   Oliveira FS, 2005, VET PARASITOL, V129, P219, DOI 10.1016/j.vetpar.2005.01.005
   PINHEIRO MJP, 1989, CAATINGA, V6, P28
   QU JQ, 1994, T ROY SOC TROP MED H, V88, P543, DOI 10.1016/0035-9203(94)90154-6
   SMYTH AJ, 1992, PARASITOLOGY, V105, P173
   Travi BL, 1998, T ROY SOC TROP MED H, V92, P275, DOI 10.1016/S0035-9203(98)91009-4
   Zulueta AM, 1999, AM J TROP MED HYG, V61, P945, DOI 10.4269/ajtmh.1999.61.945
NR 13
TC 4
Z9 5
U1 0
U2 3
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD SEP
PY 2008
VL 103
IS 6
BP 545
EP 548
DI 10.1590/S0074-02762008000600006
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 365DL
UT WOS:000260386000006
PM 18949323
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Romero, GAS
   Fernandes, AP
   da Cruz, AM
   Rabello, A
   Elkhoury, ANSM
   Fernandes, AP
   Fux, B
   Nunes, CM
   Costa, CHN
   Furtado, E
   Noronha, E
   Grimaldi, G
   Goto, H
   da Silva, JCF
   Lindoso, JAL
   Brazuna, JCM
   Garcez, L
   Teixeira, LAS
   Pereira, LA
   Hueb, M
   Arruda, M
   Souza, RCC
   Jeronimo, SMB
   de Mendonca, SCF
   de Carvalho, SFG
   Amato, VS
   de Camargo-Neves, VLF
   Alves, WA
   Profeta, Z
   Costa, DL
AF Sierra Romero, Gustavo Adolfo
   Fernandes, Ana Paula
   da Cruz, Alda Maria
   Rabello, Ana
   Silveira Maia Elkhoury, Ana Nilce
   Fernandes, Ana Paula
   Fux, Blima
   Nunes, Caris Maroni
   Nery Costa, Carlos Henrique
   Furtado, Eliana
   Noronha, Elza
   Grimaldi, Gabriel
   Goto, Hiro
   Franca da Silva, Joao Carlos
   Lindoso, Jose Angelo L.
   Macksoud Brazuna, Julia Cristina
   Garcez, Lourdes
   Silva Teixeira, Luciana Almeida
   Pereira, Luiz Alberto
   Hueb, Marcia
   Arruda, Mauro
   Souza, Renata C. C.
   Bezerra Jeronimo, Selma Maria
   Furtado de Mendonca, Sergio Coutinho
   Guimaraes de Carvalho, Silvio Fernando
   Amato, Valdir Sabbaga
   Fonseca de Camargo-Neves, Vera Lucia
   Alves, Waneska Alexandra
   Profeta, Zelia
   Costa, Dorcas Lamounier
TI Review of workshops on Leishmania 2002-2007: availability of
   recommendations, implementation analysis and proposal effects
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Editorial Material
C1 [Fernandes, Ana Paula; Fux, Blima; Franca da Silva, Joao Carlos; Souza, Renata C. C.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Nunes, Caris Maroni] Univ Estadual Paulista, Sao Paulo, Brazil.
   [Goto, Hiro; Amato, Valdir Sabbaga] Univ Sao Paulo, Sao Paulo, Brazil.
   [Bezerra Jeronimo, Selma Maria] Univ Fed Rio Grande do Norte, Natal, RN, Brazil.
   [Guimaraes de Carvalho, Silvio Fernando] Univ Estadual Montes Claros, Montes Claros, MG, Brazil.
   [Fonseca de Camargo-Neves, Vera Lucia] SES SP, Sao Paulo, Brazil.
RI Fux, Blima/AAO-2941-2020; Lindoso, Jose Angelo Lauletta/E-9339-2012;
   Jeronimo, Selma/AAY-4033-2020; Da-Cruz, Alda Maria/J-2152-2012;
   Jeronimo, Selma M.B./M-8672-2014; Romero, Gustavo A.S./F-7214-2012
OI Lindoso, Jose Angelo Lauletta/0000-0002-4405-4401; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Romero, Gustavo A.S./0000-0003-1425-926X
NR 0
TC 0
Z9 0
U1 1
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2008
VL 41
BP 123
EP 125
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 521TD
UT WOS:000271946100031
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Duarte, I
   Maciel, BL
   Monteiro, GR
   Queiroz, JW
   Nascimento, ELT
   Lacerda, HG
   Braz, RFS
   Sousa, ON
   Ximenes, MFFM
   Sampaio, GA
   Gomes, CEM
   Pontes, NN
   Martins, DR
   Blackwell, JM
   Wilson, ME
   Pearson, RD
   Jeronimo, SMB
AF Duarte, Iraci
   Maciel, Bruna L.
   Monteiro, Gloria R.
   Queiroz, Jose W.
   Nascimento, Eliana L. T.
   Lacerda, Henio G.
   Braz, Regina. F. S.
   Sousa, Olivia N.
   Ximenes, Maria F. F. M.
   Sampaio, Gabriel A.
   Gomes, Carlos E. M.
   Pontes, Nubia N.
   Martins, Daniella R.
   Blackwell, Jenefer M.
   Wilson, Mary E.
   Pearson, Richard D.
   Jeronimo, Selma M. B.
TI Risk factors associated with Leishmania infection and the development of
   visceral leishmaniasis: the example of the state of Rio Grande do Norte,
   Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article; Proceedings Paper
CT 24th Annual Conference on Applied Research on Chagas Disease/12th Annual
   Conference on Applied Research in Leishmaniasis
CY OCT 23-25, 2008
CL Uberaba, BRAZIL
ID HUMAN IMMUNODEFICIENCY VIRUS; KALA-AZAR; CUTANEOUS LEISHMANIASIS; GENE
   POLYMORPHISMS; CHAGASI INFECTION; NORTHEAST BRAZIL; MINAS-GERAIS;
   SUSCEPTIBILITY; DISEASE; ALPHA
AB Leishmania chagasi is a protozoa pathogen which causes disease with a wide clinical spectrum varying from asymptomatic to symptomatic disease, visceral leishmaniasis (VL) or kala-azar, which is fatal in 5-10% of the cases even with proper treatment. VL became a disease predominantly of periurban sites in Brazil in the last 20 years and the newly endemic areas have expanded to southeast and central regions of the country. The factors determining the risk of exposure to Leishmania include important social-economic variables related to location, type of house material and presence of animals, whereas the factors leading to disease are also complex and include host genetic factors, exposure to sandflies, co-infections and nutritional status. In this review we will discuss the urbanization of A in the state of Rio Grande do Norte, Brazil, as well as the factors involved in infection and development of diseased caused by L. chagasi.
C1 [Duarte, Iraci] Fdn Nacl Saude, Natal, RN, Brazil.
   [Braz, Regina. F. S.; Sousa, Olivia N.; Ximenes, Maria F. F. M.] Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   [Ximenes, Maria F. F. M.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Programa Posgrad Bioquim, BR-59072970 Natal, RN, Brazil.
   [Sampaio, Gabriel A.; Gomes, Carlos E. M.; Pontes, Nubia N.; Martins, Daniella R.; Jeronimo, Selma M. B.] Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   [Blackwell, Jenefer M.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia.
   [Wilson, Mary E.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   [Pearson, Richard D.] Univ Virginia, Dept Internal Med, Charlottesville, VA USA.
   Univ Fed Rio Grande do Norte, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil.
RP Duarte, I (corresponding author), Fdn Nacl Saude, Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Aeberli D, 2002, SWISS MED WKLY, V132, P414
   Alencar J E, 1974, Rev Bras Malariol Doencas Trop, V26-27, P27
   Almeida RP, 2005, AM J TROP MED HYG, V73, P79, DOI 10.4269/ajtmh.2005.73.79
   ALVAR J, 1989, J INFECT DIS, V160, P560, DOI 10.1093/infdis/160.3.560
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497
   Blackwell JM, 2004, TRENDS PARASITOL, V20, P268, DOI 10.1016/j.pt.2004.04.003
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   BLACKWELL JM, 1992, PARASITOLOGY, V104, pS19, DOI 10.1017/S0031182000075223
   Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   Camargo-Neves V L, 2001, Cad Saude Publica, V17, P1263
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   Craven NM, 2001, BRIT J DERMATOL, V144, P849, DOI 10.1046/j.1365-2133.2001.04143.x
   Davies MK, 2000, ARCH DIS CHILD, V82, P340, DOI 10.1136/adc.82.5.340
   DE AJ, 1961, REV INST MED TROP SP, V3, P175
   DEANE L M, 1955, Rev Bras Malariol Doencas Trop, V7, P131
   EVANS T, 1985, WESTERN J MED, V142, P777
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Jeronimo SMB, 2007, J INFECT DIS, V196, P1261, DOI 10.1086/521682
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Maciel BLL, 2008, AM J TROP MED HYG, V79, P591, DOI 10.4269/ajtmh.2008.79.591
   MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0
   Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   MONTALBAN C, 1989, REV INFECT DIS, V11, P655
   Moreno EC, 2005, REV SOC BRAS MED TRO, V38, P456, DOI 10.1590/S0037-86822005000600002
   RANGEL E F, 1985, Memorias do Instituto Oswaldo Cruz, V80, P373, DOI 10.1590/S0074-02761985000300017
   Santos AR, 2000, INT J LEPROSY, V68, P325
   Silva ES, 2001, MEM I OSWALDO CRUZ, V96, P285, DOI 10.1590/S0074-02762001000300002
   Stober C, 2002, PHILOS T ROY SOC B, V357, P5, DOI 10.1098/rstb.2001.0985
   WILSON AG, 1995, J INFLAMM, V45, P1
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Wollheim FA, 2002, EXPERT OPIN INV DRUG, V11, P947, DOI 10.1517/13543784.11.7.947
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
NR 44
TC 0
Z9 0
U1 0
U2 4
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PY 2008
VL 41
SU 3
BP 168
EP 171
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 521TD
UT WOS:000271946100043
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Martins, ANN
   de Figueiredo, MM
   Rocha, OD
   Fernandes, MAF
   Jeronimo, SMB
   Dourado, ME
AF Martins, Antonio N. N., Jr.
   de Figueiredo, Marcelo M.
   Rocha, Orlandil D.
   Fernandes, Maria A. F.
   Jeronimo, Selma M. B.
   Dourado, Mario E., Jr.
TI Frequency of stroke types at an emergency hospital in Natal, Brazil
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE stroke; Brazil; hypertension
ID CASE-FATALITY; BLOOD-PRESSURE; EPIDEMIOLOGY; PREVALENCE; POPULATION;
   MORTALITY
AB We performed a cross-sectional study of stroke type frequency at a local emergency hospital, in Natal, Brazil. The sample consisted of all patients who were admitted to an emergency hospital with a presumptive diagnosis of stroke. Of the 416 patients, 328 were studied, 88 were excluded for not meeting inclusion criteria, 74.7% (n= 245) had ischemic stroke 17.7% (n=58) had intracerebral hemorrhage, 7.6% (n=25) had subarachnoid hemorrhage; 173 were men (52.7%). Mean age was 64.1 years. The intrahospital mortality rate was 10.2%, 17.2% and 36% for ischemic stroke, intracerebral hemorrhage and subarachnoid hemorrhage, respectively. The most prevalent modifiable risk factor was hypertension for ischemic stroke (67.6%) and hemorrhage stroke (57.8%). Logistic regression analysis identified diabetes (OR=3.70; CI=1.76-7.77) as independent risk factor for ischemic stroke. The ischemic stroke was most common type of stroke. Hypertension and diabetes were important risk factors for stroke.
C1 [Martins, Antonio N. N., Jr.; de Figueiredo, Marcelo M.; Rocha, Orlandil D.; Fernandes, Maria A. F.; Jeronimo, Selma M. B.; Dourado, Mario E., Jr.] Monsenhor Walfredo Gurgel Hosp, Natal, RN, Brazil.
   [Martins, Antonio N. N., Jr.; de Figueiredo, Marcelo M.; Rocha, Orlandil D.; Jeronimo, Selma M. B.; Dourado, Mario E., Jr.] Ctr Biosci, Dept Biochem, Natal, RN, Brazil.
   [Fernandes, Maria A. F.] Hlth Sci Ctr, Hlth Grad Program, Dept Dent, Natal, RN, Brazil.
   [Dourado, Mario E., Jr.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
RP Dourado, ME (corresponding author), Rua Marcilio Furtado, BR-59063360 Natal, RN, Brazil.
EM medourado@digi.com.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35
   Ala L, 2004, J HUM HYPERTENS, V18, P775, DOI 10.1038/sj.jhh.1001750
   Andre C, 2006, STROKE, V37, P2784, DOI 10.1161/01.STR.0000244768.46566.73
   Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D
   BONITA R, 1990, STROKE, V21, P989, DOI 10.1161/01.STR.21.7.989
   BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U
   Cabral NL, 1997, ARQ NEURO-PSIQUIAT, V55, P357, DOI 10.1590/S0004-282X1997000300002
   COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892
   Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9
   Donnan GA, 2003, J HYPERTENS, V21, pS25, DOI 10.1097/00004872-200306005-00006
   Donnan GA, 2003, CURR OPIN NEUROL, V16, P81, DOI 10.1097/00019052-200302000-00011
   Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4
   Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7
   Lavados PM, 2005, LANCET, V365, P2206, DOI 10.1016/S0140-6736(05)66779-7
   Lotufo Paulo Andrade, 2005, Sao Paulo Med. J., V123, P3, DOI 10.1590/S1516-31802005000100001
   MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5
   *MIN SAUD, 2001, AN EST SAUD BRAS
   Neal B, 2000, LANCET, V356, P1955
   Radanovic M, 2000, ARQ NEURO-PSIQUIAT, V58, P99, DOI 10.1590/S0004-282X2000000100015
   Sagui E, 2005, STROKE, V36, P1844, DOI 10.1161/01.STR.0000177864.08516.47
   Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB
   Saposnik G, 2001, ACTA NEUROL SCAND, V104, P130, DOI 10.1034/j.1600-0404.2001.00039.x
   SICHIERI R, 1994, AM J PUBLIC HEALTH, V84, P793, DOI 10.2105/AJPH.84.5.793
   Smadja D, 2001, STROKE, V32, P2741, DOI 10.1161/hs1201.099385
   Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x
NR 25
TC 8
Z9 10
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 2007
VL 65
IS 4B
BP 1139
EP 1143
DI 10.1590/S0004-282X2007000700009
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 245UI
UT WOS:000251963900009
PM 18345418
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Lima, JR
   Queiroz, JW
   Leung, D
   Lacerda, HG
   Nascimento, EL
   Martins, DR
   Pearson, RD
   Wilson, ME
   Stapleton, JT
   Jeronimo, SM
AF Lima, Josane R.
   Queiroz, Jose Wilton
   Leung, Daniel
   Lacerda, Henio G.
   Nascimento, Eliana L.
   Martins, Daniella R.
   Pearson, Richard D.
   Wilson, Mary E.
   Stapleton, Jack T.
   Jeronimo, Selma M.
TI GBV-C viremia influence DTH response to Leishmania
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Lima, Josane R.; Queiroz, Jose Wilton; Lacerda, Henio G.; Nascimento, Eliana L.; Martins, Daniella R.; Jeronimo, Selma M.] Univ Fed Rio de Janeiro, Natal, RN, Brazil.
   [Leung, Daniel; Wilson, Mary E.; Stapleton, Jack T.] Univ Iowa, Iowa City, IA USA.
   [Pearson, Richard D.] Univ Virginia, Charlottesville, VA USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 313
BP 89
EP 89
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758200312
DA 2020-11-26
ER

PT J
AU Jeronimo, SMB
   Duggal, P
   Ettinger, NA
   Nascimento, ET
   Monteiro, GR
   Cabral, AP
   Pontes, NN
   Lacerda, HG
   Queiroz, PV
   Gomes, CEM
   Pearson, RD
   Blackwell, JM
   Beaty, TH
   Wilson, ME
AF Jeronimo, Selma M. B.
   Duggal, Priya
   Ettinger, Nicholas A.
   Nascimento, Eliana T.
   Monteiro, Gloria R.
   Cabral, Angela P.
   Pontes, Nubia N.
   Lacerda, Henio G.
   Queiroz, Paula V.
   Gomes, Carlos E. M.
   Pearson, Richard D.
   Blackwell, Jenefer M.
   Beaty, Terri H.
   Wilson, Mary E.
TI Genetic predisposition to self-curing infection with the protozoan
   Leishmania chagasi: A genomewide scan
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID VISCERAL LEISHMANIASIS; NATURAL-HISTORY; URBAN OUTBREAK; LINKAGE;
   CHROMOSOME; ANTIGEN; BRAZIL; LOCUS
AB The protozoan Leishmania chagasi can cause disseminated, fatal visceral leishmaniasis (VL) or asymptomatic infection in humans. We hypothesized that host genetic factors contribute to this variable response to infection. A family study was performed in neighborhoods of endemicity for L. chagasi near Natal in northeastern Brazil. Study subjects were assessed for the presence of VL or asymptomatic infection, which was defined by a positive delayed-type hypersensitivity (DTH) skin test response to Leishmania antigen without disease symptoms. A genomewide panel of 385 autosomal microsatellite markers in 1254 subjects from 191 families was analyzed to identify regions of linkage. Regions with potential linkage to the DTH response on chromosomes 15 and 19, as well as a novel region on chromosome 9 with potential linkage to VL, were identified. Understanding the genetic factors that determine whether an individual will develop symptomatic or asymptomatic infection with L. chagasi may identify proteins essential for immune protection against this parasitic disease and reveal strategies for immunotherapy or prevention.
C1 Univ Iowa, Dept Internal Med, Mol & Cellular Biol Program, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol & Epidemiol, Iowa City, IA 52242 USA.
   Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.
   Univ Virginia, Sch Med, Dept Internal Med & Pathol, Charlottesville, VA USA.
   Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
   NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA.
   Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Hlth Postgrad Program, BR-59072970 Natal, RN, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, Mol & Cellular Biol Program, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Blackwell, Jenefer M/H-3015-2015; Jeronimo, Selma/AAY-4033-2020;
   Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R03 TW001369] Funding Source: Medline; Intramural NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA Funding Source: Medline; NIAID NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [P50
   AI030639, AI30639, R01 AI048822, AI048822, R01 AI045540, AI45540]
   Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [T32 GM007337] Funding
   Source: Medline; Wellcome TrustWellcome Trust [074196] Funding Source:
   Medline; FOGARTY INTERNATIONAL CENTERUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Human Genome Research
   Institute (NHGRI) [Z01HG200327, Z01HG200327, Z01HG200327, Z01HG200327]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   R01AI045540, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [R03DK052550, R03DK052550] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337] Funding Source: NIH
   RePORTER
CR Abe-Sandes K, 2004, HUM BIOL, V76, P77, DOI 10.1353/hub.2004.0014
   Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   ALI A, 1993, ANN TROP MED PARASIT, V87, P163, DOI 10.1080/00034983.1993.11812750
   AMOS CI, 1994, AM J HUM GENET, V54, P535
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Broman KW, 1998, AM J HUM GENET, V63, P1563, DOI 10.1086/302112
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Jamieson SE, 2007, GENES IMMUN, V8, P84, DOI 10.1038/sj.gene.6364357
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Jose F F, 2001, Rev Soc Bras Med Trop, V34, P537, DOI 10.1590/S0037-86822001000600007
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Kaye PM, 2002, WORLD CL PARASITES, V4, P137
   Kohlrausch FB, 2005, AM J PHYS ANTHROPOL, V126, P463, DOI 10.1002/ajpa.20042
   Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592
   LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Miller EN, 2007, PLOS GENET, V3, P679, DOI 10.1371/journal.pgen.0030071
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Sawcer S, 1997, GENET EPIDEMIOL, V14, P223, DOI 10.1002/(SICI)1098-2272(1997)14:3<223::AID-GEPI1>3.0.CO;2-6
   Werneck GL, 2002, ACTA TROP, V83, P13, DOI 10.1016/S0001-706X(02)00058-X
   WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
NR 29
TC 44
Z9 45
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT 15
PY 2007
VL 196
IS 8
BP 1261
EP 1269
DI 10.1086/521682
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 212KR
UT WOS:000249595700020
PM 17955446
OA Green Accepted, Bronze
DA 2020-11-26
ER

PT J
AU Jeronimo, SMB
   Holst, AKB
   Jamieson, SE
   Francis, R
   Martins, DRA
   Bezerra, FL
   Ettinger, NA
   Nascimento, ET
   Monteiro, GR
   Lacerda, HG
   Miller, EN
   Cordell, HJ
   Duggal, P
   Beaty, TH
   Blackwell, JM
   Wilson, ME
AF Jeronimo, S. M. B.
   Holst, A. K. B.
   Jamieson, S. E.
   Francis, R.
   Martins, D. R. A.
   Bezerra, F. L.
   Ettinger, N. A.
   Nascimento, E. T.
   Monteiro, G. R.
   Lacerda, H. G.
   Miller, E. N.
   Cordell, H. J.
   Duggal, P.
   Beaty, T. H.
   Blackwell, J. M.
   Wilson, M. E.
TI Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity
   responses associated with Leishmania chagasi infection
SO GENES AND IMMUNITY
LA English
DT Article
DE delayed type hypersensitivity; visceral leishmaniasis; genetic control;
   chromosome 5q31.1
ID HLA CLASS-I; VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; IMMUNE-RESPONSE;
   KALA-AZAR; PLUS BCG; MYCOBACTERIUM-TUBERCULOSIS; CUTANEOUS
   LEISHMANIASIS; DISEQUILIBRIUM MEASURES; NORTHEASTERN BRAZIL
AB Visceral leishmaniasis (VL) caused by Leishmania chagasi is endemic to northeast Brazil. A positive delayed-type hypersensitivity skin test response (DTH+) is a marker for acquired resistance to disease, clusters in families and may be genetically controlled. Twenty-three single nucleotide polymorphisms (SNPs) were genotyped in the cytokine 5q23.3-q31.1 region IRF1-IL5-IL13-IL4-IL9-LECT2-TGFBI in 102 families (323 DTH+; 190 DTH+; 123 VL individuals) from a VL endemic region in northeast Brazil. Data from 20 SNPs were analyzed for association with DTH+/- status and VL using family-based, stepwise conditional logistic regression analysis. Independent associations were observed between the DTH+ phenotype and markers in separate linkage disequilibrium blocks in LECT2 (OR 2.25; P = 0.005; 95% CI = 1.28-3.97) and TGFBI (OR 1.94; P = 0.003; 95% CI = 1.24-3.03). VL child/parent trios gave no evidence of association, but the DTH- phenotype was associated with SNP rs2070874 at IL4 (OR 3.14; P = 0.006; 95% CI = 1.38-7.14), and SNP rs30740 between LECT2 and TGFBI (OR 3.00; P = 0.042; 95% CI = 1.04-8.65). These results indicate several genes in the immune response gene cluster at 5q23.3-q31.1 influence outcomes of L. chagasi infection in this region of Brazil.
C1 Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, Natal, RN, Brazil.
   Univ Iowa, VA Med Ctr, Dept Internal Med, Iowa City, IA USA.
   Univ Iowa, VA Med Ctr, Dept Microbiol, Iowa City, IA USA.
   Univ Iowa, VA Med Ctr, Dept Epidemiol, Iowa City, IA USA.
   Univ Iowa, VA Med Ctr, Dept Mol Biol Program, Iowa City, IA USA.
   Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England.
   Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   NIH, Natl Human Genome Res Inst, Inherited Dis Res Branch, Bethesda, MD USA.
   Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Francis, Richard/K-2812-2019; Beaty, Terri/A-6032-2008; Jeronimo,
   Selma/AAY-4033-2020; Blackwell, Jenefer M/H-3015-2015; Jeronimo, Selma
   M.B./M-8672-2014
OI Francis, Richard/0000-0003-1580-7934; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Wilson, Mary/0000-0001-8680-7275
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01 AI048822, P50 AI030639,
   AI30639, R01 AI045540, R01 AI076233, AI048822, AI45540] Funding Source:
   Medline; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [T32 GM007337] Funding Source:
   Medline; Wellcome TrustWellcome Trust [074196] Funding Source: Medline;
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [Z01HG200327,
   Z01HG200327, Z01HG200327, Z01HG200327] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, R01AI045540,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI076233,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337,
   T32GM007337, T32GM007337, T32GM007337, T32GM007337, T32GM007337] Funding
   Source: NIH RePORTER
CR AMENDOIERA R, 1988, MEM I O CRUZ, V83, P119
   ANTUNES CM, 1986, INT J EPIDEMIOL, V15, P572, DOI 10.1093/ije/15.4.572
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Biedermann T, 2001, NAT IMMUNOL, V2, P1054, DOI 10.1038/ni725
   Black GF, 2001, INT J TUBERC LUNG D, V5, P664
   BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0
   BRADLEY DJ, 1974, NATURE, V250, P353, DOI 10.1038/250353a0
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927
   Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   CASTES M, 1994, VACCINE, V12, P1041, DOI 10.1016/0264-410X(94)90342-5
   Cordell HJ, 2004, GENET EPIDEMIOL, V26, P186, DOI 10.1002/gepi.10306
   Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007
   Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334
   DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003
   Dey A, 2007, INFECT GENET EVOL, V7, P219, DOI 10.1016/j.meegid.2006.09.001
   El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2
   El-Safi S, 2006, CR BIOL, V329, P863, DOI 10.1016/j.crvi.2006.07.007
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   FAGHIRI Z, 1995, HUM HERED, V45, P258, DOI 10.1159/000154309
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   HEDRICK PW, 1987, GENETICS, V117, P331
   HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5
   HOLMANS P, 1995, AM J HUM GENET, V57, P1221
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   JERONIMO SM, 2007, IN PRESS J INFECT DI
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820
   Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Khalil EAG, 2000, LANCET, V356, P1565, DOI 10.1016/S0140-6736(00)03128-7
   Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334
   Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274
   Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8
   Leclercq V, 1996, J IMMUNOL, V157, P4537
   Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181
   MAYRINK W, 1979, T ROY SOC TROP MED H, V73, P385, DOI 10.1016/0035-9203(79)90159-7
   MAYRINK W, 1989, REV INST MED TROP SP, V31, P256, DOI 10.1590/S0036-46651989000400008
   Meddeb-Garnaoui A, 2001, HUM IMMUNOL, V62, P509, DOI 10.1016/S0198-8859(01)00237-3
   Mohamed HS, 2004, EUR J HUM GENET, V12, P66, DOI 10.1038/sj.ejhg.5201089
   Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977
   Momeni AZ, 1999, VACCINE, V17, P466, DOI 10.1016/S0264-410X(98)00220-5
   Nagai H, 1998, PATHOL INT, V48, P882, DOI 10.1111/j.1440-1827.1998.tb03855.x
   O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904
   Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x
   Sharifi I, 1998, LANCET, V351, P1540, DOI 10.1016/S0140-6736(98)09552-X
   Singh N, 1997, TROP MED INT HEALTH, V2, P468, DOI 10.1046/j.1365-3156.1997.d01-290.x
   Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484
   SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571
   Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522
   SUNDAR S, 1994, J INFECT DIS, V170, P659, DOI 10.1093/infdis/170.3.659
   Weir RE, 2003, CLIN EXP IMMUNOL, V134, P285, DOI 10.1046/j.1365-2249.2003.02272
   WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   Yamagoe S, 1998, BBA-GENE STRUCT EXPR, V1396, P105, DOI 10.1016/S0167-4781(97)00181-4
   Yamagoe S, 1998, GENOMICS, V48, P324, DOI 10.1006/geno.1997.5198
   Zijlstra EE, 1998, CLIN DIAGN LAB IMMUN, V5, P717, DOI 10.1128/CDLI.5.5.717-720.1998
   ZWINGENBERGER K, 1990, CLIN IMMUNOL IMMUNOP, V57, P242, DOI 10.1016/0090-1229(90)90038-R
NR 66
TC 33
Z9 35
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
EI 1476-5470
J9 GENES IMMUN
JI Genes Immun.
PD OCT
PY 2007
VL 8
IS 7
BP 539
EP 551
DI 10.1038/sj.gene.6364422
PG 13
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 223OV
UT WOS:000250382200003
PM 17713557
OA Bronze, Green Accepted
DA 2020-11-26
ER

PT J
AU de Souza, NL
   Araujo, ACPF
   de Azevedo, GD
   Jeronimo, SMB
   Barbosa, LDM
   de Sousa, NML
AF de Souza, Nilba Lima
   Pinheiro Fernandes Araujo, Ana Cristina
   de Azevedo, George Dantas
   Bezerra Jeronimo, Selma Maria
   Barbosa, Lara de Melo
   Lima de Sousa, Nubia Maria
TI Maternal perception of premature birth and the experience of
   pre-eclampsia pregnancy
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE pre-eclampsia, psychology; obstetric labor, premature, psychology;
   obstetric labor complications, psychology; health knowledge, attitudes,
   practice; qualitative research
ID RANDOMIZED CONTROLLED-TRIAL; ANTENATAL CARE; VISITS
AB OBJECTIVE: To analyze maternal experiences of pre-eclampsia pregnancy with premature birth at a neonatal intensive care unit.
   METHODS: A qualitative study using the focus group technique was conducted with 28 women in a facility specialized in high-risk pregnancies in the state of Rio Grande do Norte, Northeastern Brazil, in 2004. Mothers included had had pre-eclampsia during pregnancy and a preterm delivery with consequent hospitalization of their baby at a neonatal intensive care unit. The data were analyzed using thematic content analysis of three thematic nuclei subjects: information about preeclampsia during prenatal care; experiences with the preterm newborn, and their perception of neonatal intensive care unit professionals' attitudes.
   RESULTS: Maternal reports showed subjects' lack of knowledge with regard topre-eclampsia and its association with prematurity. Difficulties inherent to the maternal role of caring for the child in the neonatal intensive care unit were identified, accentuated by communication flaws between health professionals and users.
   CONCLUSIONS: Some difficulties experienced by the mothers, in the context of pre-eclampsia and prematurity, were aggravated by lack or inadequacy of information provided to the users.
C1 Univ Fed Rio Grande do Norte, Dept Enfermagem, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Programa Posgrad, Ctr Ciencias Saude, Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Estat, Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Maternidade Escola Januario Cicco, Natal, RN, Brazil.
RP de Souza, NL (corresponding author), R Av Senador Salgado Filho S-N,Campus Univ Lagoa, BR-59072970 Natal, RN, Brazil.
EM nilbalima@uol.com.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR ACOG, 2002, OBSTET GYNECOL, V99, P869
   BARDIN L, 1995, ANAL CONTEUDO, V70
   BECKMANN CRB, 1998, OBSTET GYNECOL, P237
   CarliniCotrim B, 1996, REV SAUDE PUBL, V30, P285, DOI 10.1590/S0034-89101996000300013
   Coimbra LC, 2003, REV SAUDE PUBL, V37, P456, DOI [10.1590/S0034-89102003000400010, 10.1590/s0034-89102003000400010]
   ENKIN M, 2005, GUIA PARA ATENCAO EF, P11
   Harrison MJ, 2003, BIRTH-ISS PERINAT C, V30, P109, DOI 10.1046/j.1523-536X.2003.00229.x
   Holditch-Davis D, 2003, JOGNN, V32, P161, DOI 10.1177/0884217503252035
   KRUERGER RA, 1988, FOCUS GROUPS PRACTIC
   Leichtentritt RD, 2005, HEALTH SOC WORK, V30, P39, DOI 10.1093/hsw/30.1.39
   Munjanja SP, 1996, LANCET, V348, P364, DOI 10.1016/S0140-6736(96)01250-0
   Oliveira Cristiane Alves de, 2006, Rev. Bras. Saude Mater. Infant., V6, P93, DOI 10.1590/S1519-38292006000100011
   Rades Érica, 2004, Rev. Bras. Ginecol. Obstet., V26, p655, DOI 10.1590/S0100-72032004000800010
   Scochi Carmen Gracinda Silvan, 2004, Rev. Latino-Am. Enfermagem, V12, P727, DOI 10.1590/S0104-11692004000500005
   Serruya Suzanne Jacob, 2004, Rev. Bras. Ginecol. Obstet., V26, P517, DOI 10.1590/S0100-72032004000700003
   Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7
   Sikorski J, 1996, BRIT MED J, V312, P546, DOI 10.1136/bmj.312.7030.546
   Sittner Barbara J, 2005, MCN Am J Matern Child Nurs, V30, P121, DOI 10.1097/00005721-200503000-00010
   Smith R A, 2005, Minerva Ginecol, V57, P379
NR 19
TC 11
Z9 21
U1 0
U2 5
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD OCT
PY 2007
VL 41
IS 5
BP 704
EP 710
DI 10.1590/S0034-89102007000500003
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 218HB
UT WOS:000250005500003
PM 17923890
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Pinto, FEL
   Brandt, CT
   Medeiros, ADC
   de Oliveira, AJF
   Jeronimo, SM
   de Britol, HMF
AF Edilson Leite Pinto, Francisco, Jr.
   Teixeira Brandt, Carlos
   da Cunha Medeiros, Aldo
   Jose Freitas de Oliveira, Ariano
   Maria Jeronimo, Selma
   Marques Fonseca de Britol, Helena
TI Bacterial translocation in rats nonfunctioning diverted distal colon
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Bacterial Translocation; colitis; rats, Wistar
ID SURGICAL-PATIENTS; BARRIER FUNCTION; GUT; ENDOTOXIN; FLORA; MUCUS
AB Purpose: To investigate whether the alterations of the diverted colon segment mucosa, evidenced in fecal colitis, would be able to alter Bacterial Translocation (BT). Methods: Sixty-two Wistar male rats ranging from 220 to 320 grams of weight, were divided in two groups: A (Colostomy) and B (Control), with 31 animals each one. In group A, all animals underwent end colostomy, one stoma, in ascending colon; and in the 70(th) POD was injected in five rats, by rectal route diverted segment - 2ml of a 0.9% saline solution in animals (A1 subgroup); in eight it was inoculated, by rectal route, 2ml of a solution containing Escherichia coli ATCC 25922 (American Type Culture Collection), in a concentration of 10(8) Colony Forming Unit for milliliters (CFU/ml) - A2 Subgroup; in ten animals the same solution of E. coli was inoculated, in a concentration of 10(11) CFU/ml (A3 Subgroup); and in eight it was collected part of the mucus found in the diverted distal colonic segment for neutral sugars and total proteins dosage (A4 subgroup). The animals from the group B underwent the same procedures of group A, but with differences in the colostomy confection. In rats from subgroups A 1, A2, A3, B1, B2, and B3 2ml of blood were aspirated from the heart, and fragments from mesenteric lymphatic nodule, liver, spleen, lung and kidney taken for microbiological analysis, after their death. This analysis consisted of evidencing the presence of E. coli ATCC 25922 CFU. Mann-Whitney and ANOVA Tests were applied as analytic techniques for association of variables. Results: The occurrence of BT was evidenced only in those animals in which inoculated concentration of E. coli ATCC 25922, reached levels of 10(11)CFU/ml, i.e. in Subgroups A3 and B3, although, being significantly greater (80%) in those animals without colostomy (subgroup B3) when compared to the ones with colostomy (20%) from the subgroup A3 (P <0.05). Lung, liver and mesenteric lymphatic nodules were the tissues with larger percentile of bacterial recovery, so much in subgroup A3, as in B3. Blood culture was considered positive in 60% of the animals from subgroup B3 and in 10% of those from subgroup A3 (p <0.05). There was greater concentration of neutral sugars, in subgroup A4 - mean 27.3mg/ml -, than in subgroup B4 - mean 8.4mg/ml - (P <0.05). Conclusion: The modifications in the architecture of intestinal mucosa in colitis following fecal diversion can cause alterations in the intestinal barrier, but it does not necessarily lead to an increased frequency of BT.
C1 [Edilson Leite Pinto, Francisco, Jr.; da Cunha Medeiros, Aldo; Jose Freitas de Oliveira, Ariano; Maria Jeronimo, Selma] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
RP Pinto, FEL (corresponding author), Rua Pinto Martins 1044-302, BR-59014060 Natal, RN, Brazil.
EM edilsonpinto@uol.com.br
RI Jeronimo, Selma M.B./M-8672-2014; Oliveira, Ariano/D-3815-2017;
   Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR Alencar SSS, 2001, ACTA CIR BRAS S1, V17, P35
   ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012
   BAILEY ME, 1976, BRIT J SURG, V63, P774, DOI 10.1002/bjs.1800631011
   CASTRO LS, 1999, THESIS RIO DE JANEIR
   CRUZ N, 1994, J TRAUMA, V36, P612, DOI 10.1097/00005373-199405000-00002
   Deitch EA, 2002, SURGERY, V131, P241, DOI 10.1067/msy.2002.116408
   DEITCH EA, 1992, ANN SURG, V216, P127
   DEITCH EA, 1998, AM J GASTROENTEROL, V93, P277
   Fink M P, 1994, Semin Respir Infect, V9, P256
   Florey HW, 1933, J PATHOL BACTERIOL, V37, P283, DOI 10.1002/path.1700370210
   Kane TD, 1998, ANN SURG, V227, P1, DOI 10.1097/00000658-199801000-00001
   Katayama M, 1997, ANN SURG, V225, P317, DOI 10.1097/00000658-199703000-00012
   Koh IHJ, 1996, TRANSPLANT P, V28, P2661
   KUDSK KA, 1983, ANN SURG, V23, P503
   MacFie J, 1997, ANN ROY COLL SURG, V79, P183
   MacFie J, 2000, NUTRITION, V16, P606, DOI 10.1016/S0899-9007(00)00249-5
   Medeiros Aldo da Cunha, 2003, Acta Cir. Bras., V18, P15, DOI 10.1590/S0102-86502003000700003
   NEUT C, 1989, GUT, V30, P1094, DOI 10.1136/gut.30.8.1094
   Nieuwenhuijzen G A, 1999, Curr Opin Clin Nutr Metab Care, V2, P399, DOI 10.1097/00075197-199909000-00008
   O'Boyle CJ, 1998, NUTRITION, V14, P358, DOI 10.1016/S0899-9007(97)00488-7
   PINTO FEL, 1999, REV COL BRAS CIR, V26, P327, DOI DOI 10.1590/S0100-69911999000600003
   PINTO FEL, 1999, REV COL BRAS CIR, V26, P185
   ROCHA SI, 1999, THESIS PARANA
   SCOTT LD, 1982, GASTROENTEROLOGY, V82, P737
   SEDMAN PC, 1994, GASTROENTEROLOGY, V107, P643, DOI 10.1016/0016-5085(94)90110-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tamayo FG, 1996, ARCH MED RES, V27, P115
   YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508
NR 28
TC 12
Z9 12
U1 0
U2 3
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD MAY-JUN
PY 2007
VL 22
IS 3
BP 195
EP 201
DI 10.1590/S0102-86502007000300007
PG 7
WC Surgery
SC Surgery
GA 339JE
UT WOS:000258573100007
PM 17546292
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Leao, MD
   Jeronimo, SMB
   Araujo, ACPF
AF Leao, Marcos D.
   Jeronimo, Selma M. B.
   Araujo, Ana C. P. F.
TI Hepatic rupture caused by HELLP syndrome?
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, Hlth Graduating Program, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, Dept Biochem,Biosci Ctr, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, Dept Gynecol & Obstet, BR-59078970 Natal, RN, Brazil.
RP Leao, MD (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Maternidade Escola Januario Cicco, Hlth Graduating Program, CP 1624, BR-59078970 Natal, RN, Brazil.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR Araujo ACPF, 2006, AM J OBSTET GYNECOL, V195, P129, DOI 10.1016/j.ajog.2006.01.016
   Barton JR, 1996, AM J OBSTET GYNECOL, V174, P1820, DOI 10.1016/S0002-9378(96)70216-8
   Sheikh RA, 1999, J CLIN GASTROENTEROL, V28, P323, DOI 10.1097/00004836-199906000-00008
NR 3
TC 1
Z9 1
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD APR
PY 2007
VL 196
IS 4
AR e16
DI 10.1016/j.ajog.2006.11.009
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 157UT
UT WOS:000245747600071
DA 2020-11-26
ER

PT J
AU Teixeira, MCA
   Oliveira, GGS
   Silvany, MA
   Alcantara-Neves, NM
   Soares, MBP
   Ribeiro-dos-Santos, R
   Jeronimo, SMB
   Costa, CH
   dos-Santos, WLC
   Eichinger, D
   Pontes-De-Carvalho, L
AF Teixeira, Marcia C. A.
   Oliveira, Geraldo G. S.
   Silvany, Marco A.
   Alcantara-Neves, Neuza M.
   Soares, Milena B. P.
   Ribeiro-dos-Santos, Ricardo
   Jeronimo, Selma M. B.
   Costa, Carlos H.
   dos-Santos, Washington L. C.
   Eichinger, Daniel
   Pontes-de-Carvalho, Lain
TI A strategy for identifying serodiagnostically relevant antigens of
   Leishmania or other pathogens in genetic libraries
SO BIOLOGICALS
LA English
DT Article
DE recombinant antigen; cDNA library; serodiagnosis; immunoassay
   sensitivity; Leishmania infantum; visceral leishmaniasis
ID RECOMBINANT; DIAGNOSIS; PROTEINS
AB Different individuals, when infected with the same parasite, rarely produce antibodies against the same set of antigens. Indeed, unless a particular antigen happens to be recognized by antibodies in all individuals, the use of a single antigen in the serodiagnosis of parasitic diseases leads, invariably, to false-negative results. A straightforward method for pin-pointing, in genetic libraries, the precise antigens that would increase serodiagnostic assay sensitivities is presented. The method is based on the utilization of sera that produced false-negative results against previously available antigens. Employing this false-negative serum-selection methodology for the identification of new Leishmania infantum recombinant antigens (rAgs), the sensitivity of a dipstick assay for anti-Leishmania antibodies in a panel of sera from patients with visceral leishmaniasis was increased from 83.3% to 98.1%, without affecting its specificity, by the inclusion of a fifth and a sixth L. infantum rAg. (c) 2006 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
C1 Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, BR-40295001 Salvador, BA, Brazil.
   Fac Ciencias & Tecnol, Salvador, BA, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
   Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   Univ Fed Piaui, Teresina, Brazil.
   NYU, Med Ctr, New York, NY 10016 USA.
RP Pontes-De-Carvalho, L (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Rua Valdemar Falcao 121, BR-40295001 Salvador, BA, Brazil.
EM lain@cpqgm.fiocruz.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014;
   Teixeira, Marcia/AAP-3628-2020; dos-Santos, Washington LC/B-4173-2009
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Teixeira, Marcia/0000-0003-0477-5092; Gileno
   de Sa Oliveira, Geraldo/0000-0001-6065-6480; Soares,
   Milena/0000-0001-7549-2992; dos-Santos, Washington
   LC/0000-0003-1445-2318
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI44893] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI044893, R01AI044893, R01AI044893, R01AI044893, R01AI044893,
   R01AI044893, R01AI044893, R01AI044893, R01AI044893] Funding Source: NIH
   RePORTER
CR CHANG KP, 1980, SCIENCE, V209, P1240, DOI 10.1126/science.7403880
   CHU NM, 1989, J HISTOCHEM CYTOCHEM, V37, P257, DOI 10.1177/37.2.2536057
   da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9
   EPERON S, 1989, J PROTOZOOL, V36, P502, DOI 10.1111/j.1550-7408.1989.tb01086.x
   Fenech FF, 1997, ANN TROP MED PARASIT, V91, P747, DOI 10.1080/00034989760491
   Flannery B, 2001, J CLIN MICROBIOL, V39, P3303, DOI 10.1128/JCM.39.9.3303-3310.2001
   Jiang J, 2003, AM J TROP MED HYG, V69, P60, DOI 10.4269/ajtmh.2003.69.60
   LAINSON R, 1983, T ROY SOC TROP MED H, V77, P569, DOI 10.1016/0035-9203(83)90185-2
   ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39
   Roitt IM, 2001, ESSENTIAL IMMUNOLOGY
   SCHENKMAN S, 1992, J EXP MED, V175, P567, DOI 10.1084/jem.175.2.567
   Suh IB, 2003, ANN TROP MED PARASIT, V97, P481, DOI 10.1179/000349803235002498
NR 12
TC 7
Z9 7
U1 0
U2 1
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1045-1056
J9 BIOLOGICALS
JI Biologicals
PD MAR
PY 2007
VL 35
IS 1
BP 51
EP 54
DI 10.1016/j.biologicals.2006.01.005
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA 146TC
UT WOS:000244956600009
PM 16580229
OA Green Published
DA 2020-11-26
ER

PT J
AU Atta, AM
   Carvalho, EM
   Jeronimo, SMB
   Atta, MLBS
AF Atta, A. M.
   Carvalho, E. M.
   Jeronimo, S. M. B.
   Atta, M. L. B. Sousa
TI Serum markers of rheumatoid arthritis in visceral leishmaniasis:
   Rheumatoid factor and anti-cyclic citrullinated peptide antibody
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE autoimmunity; CCP-Ab; RF-IgA; RF-IgM; visceral leishmaniasis
ID CIRCULATING IMMUNE-COMPLEXES; MANIFESTATIONS; AUTOIMMUNITY; INFECTION;
   DISEASE
AB Rheumatoid factor (RF) has been described in visceral leishmaniasis (VL). However, there is no report of RF-isotype or other rheumatoid arthritis (RA) autoantibody in VL. This work investigated RF and anti-cyclic citrullinated peptide antibody (CCP-Ab) in sera from 35 inhabitants from a VL area: 15 from healthy persons (HIEA); 10 from VL patients (VL), and 10 from subjects cured of VL (CVL). The controls were represented by sera from 15 healthy individuals (HI) and from 10 RA patients from a VL free area. IgM-RF was investigated by immunoturbidimetry, while IgA-RF and CCP-Ab by enzyme-linked immunosorbent assay (ELISA). Increased RF-IgM production was found in 9 out of 10 sera from both VL and RA groups (median level 100 and 182 IU/ml respectively); in three out of CVL-sera (level 94 IU), and in only one HIEA-serum (level 58 IU). IgA-RF was only detected in RA-sera (5110, 50%), while CCP-Ab was found in three VL and in four RA sera (median level 36.5 U and 161.5 U respectively). A strong correlation was observed between RF-IgM and VL in endemic area (P < 0.0001). We concluded that an increased IgM-RF production associated with sporadic and moderate CCP-Ab synthesis is an autoimmune characteristic of VL. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, BR-40170115 Salvador, BA, Brazil.
   Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
   Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
RP Atta, AM (corresponding author), Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Rua Barao Geremoabo S-No, BR-40170115 Salvador, BA, Brazil.
EM ajatta@ig.com.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR ARGOV S, 1989, CLIN EXP IMMUNOL, V76, P190
   ARNETT FC, 1988, ARTHRITIS RHEUM, V21, P315
   BADARO R, 1983, AM J TROP MED HYG, V32, P480, DOI 10.4269/ajtmh.1983.32.480
   BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72
   CARSON DA, 1991, J CLIN INVEST, V87, P379, DOI 10.1172/JCI115007
   CARVALHO EM, 1983, AM J TROP MED HYG, V32, P61, DOI 10.4269/ajtmh.1983.32.61
   Dorner T, 2004, CURR OPIN RHEUMATOL, V16, P246
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Galanakis E, 1997, LANCET, V350, P368, DOI 10.1016/S0140-6736(05)63428-9
   GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
   Jonsson T, 1995, SCAND J RHEUMATOL, V24, P372, DOI 10.3109/03009749509095183
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Newkirk MM, 2002, CLIN IMMUNOL, V104, P1, DOI 10.1006/clim.2002.5210
   Pai S, 1998, SCAND J RHEUMATOL, V27, P252
   Peng SL, 2002, SEMIN ARTHRITIS RHEU, V31, P228, DOI 10.1053/sarh.2002.30441
   Posnett DN, 1997, J EXP MED, V185, P1721, DOI 10.1084/jem.185.10.1721
   ROOSNEK E, 1991, J EXP MED, V173, P487, DOI 10.1084/jem.173.2.487
   Sutton B, 2000, IMMUNOL TODAY, V21, P177, DOI 10.1016/S0167-5699(00)01589-9
   WALLBRACHT I, 2005, AUTOIMMUN REV, V4, P389
   WATANABE K, 1991, CLIN RHEUMATOL, V10, P31, DOI 10.1007/BF02208030
   Westwood OMR, 2006, RHEUMATOLOGY, V45, P379, DOI 10.1093/rheumatology/kei228
   Zendman AJW, 2006, RHEUMATOLOGY, V45, P20, DOI 10.1093/rheumatology/kei111
NR 22
TC 26
Z9 27
U1 1
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
J9 J AUTOIMMUN
JI J. Autoimmun.
PD FEB
PY 2007
VL 28
IS 1
BP 55
EP 58
DI 10.1016/j.jaut.2006.12.001
PG 4
WC Immunology
SC Immunology
GA 146TY
UT WOS:000244958800008
PM 17257811
DA 2020-11-26
ER

PT J
AU Jamieson, SE
   Miller, EN
   Peacock, CS
   Fakiola, M
   Wilson, ME
   Bales-Holst, A
   Shaw, MA
   Silveira, F
   Shaw, JJ
   Jeronimo, SM
   Blackwell, JM
AF Jamieson, S. E.
   Miller, E. N.
   Peacock, C. S.
   Fakiola, M.
   Wilson, M. E.
   Bales-Holst, A.
   Shaw, M-A
   Silveira, F.
   Shaw, J. J.
   Jeronimo, S. M.
   Blackwell, J. M.
TI Genome-wide scan for visceral leishmaniasis susceptibility genes in
   Brazil
SO GENES AND IMMUNITY
LA English
DT Article
DE visceral leishmaniasis; genome scan; linkage analysis; allelic
   association; chromosome 17q11-q21; chromosome 6q27
ID KALA-AZAR; NORTHEASTERN BRAZIL; CHAGASI INFECTION; SUBCLINICAL
   INFECTION; INTERFERON-GAMMA; HUMAN MONOCYTES; LINKAGE; ASSOCIATION;
   ACTIVATION; LOCUS
AB A genome-wide scan was conducted for visceral leishmaniasis (VL) in Brazil. Initially, 405 markers were typed in 22 multicase pedigrees ( 28 nuclear families; 174 individuals; 66 affected). Non-parametric multipoint analysis detected nine chromosomal regions with provisional evidence (logarithm of the odds (LOD) scores 0.95-1.66; 0.003 < P < 0.018) for linkage. To confirm linkage, 132 individuals (43 affected) from 19 independently ascertained families were genotyped across these regions. Three regions (6q27, 7q11.22 and 17q11.2-q21.3) retained evidence (LOD scores 1.08, 1.34, 1.14; P = 0.013, 0.007, 0.011) for linkage. To determine which genes contribute to linkage at 17q11.2-q21.3, 80 single nucleotide polymorphisms were genotyped in 98 nuclear families with 183 affected individuals. Family-based association test analysis indicated associations at two chemokine genes, CCL1 and CCL16, that lie 1.6Mb apart, show some extended linkage disequilibrium with each other, but each lie within different clusters of candidate CCL genes. Multiple genes may therefore contribute to the linkage peak for VL at 17q12.
C1 Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England.
   Dept Internal Med, Div Infect Dis, Iowa City, IA USA.
   Univ Leeds, Dept Biol, Leeds, W Yorkshire, England.
   Inst Evandro Chagas, Belem, Para, Brazil.
   Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil.
   Univ Fed Rio Grande Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
RP Blackwell, JM (corresponding author), Univ Cambridge, Sch Clin Med, Addenbrookes Hosp, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.
EM jennie.blackwell@cimr.cam.ac.uk
RI Peacock, Christopher/A-4052-2012; Jeronimo, Selma M.B./M-8672-2014;
   trivedi, kruti/H-5242-2011; Jeronimo, Selma/AAY-4033-2020; Blackwell,
   Jenefer M/H-3015-2015; Shaw, Jeffrey/D-2941-2012
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Silveira, Fernando/0000-0002-0412-6060;
   Fakiola, Michaela/0000-0001-9071-4709; Wilson, Mary/0000-0001-8680-7275
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, R01AI076233, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI076233, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI076233, P50AI030639] Funding Source: NIH RePORTER; FIC
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R03 TW001369] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI076233, R01 AI048822, P50 AI030639, AI30639] Funding Source:
   Medline; Wellcome TrustWellcome Trust [074196] Funding Source: Medline
CR Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   DAVIES CR, 1995, EPIDEMIOL INFECT, V114, P297, DOI 10.1017/S0950268800057964
   DEBEER P, 1990, LANCET, V335, P224, DOI 10.1016/0140-6736(90)90313-T
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514
   HEDRICK PW, 1987, GENETICS, V117, P331
   HO M, 1982, T ROY SOC TROP MED H, V76, P741, DOI 10.1016/0035-9203(82)90095-5
   HOLMANS P, 1995, AM J HUM GENET, V57, P1221
   Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Kemp K, 1999, CLIN EXP IMMUNOL, V116, P500
   Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334
   Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592
   Milano S, 2002, CLIN EXP IMMUNOL, V127, P360, DOI 10.1046/j.1365-2249.2002.01749.x
   Miller EN, 2004, GENES IMMUN, V5, P63, DOI 10.1038/sj.gene.6364031
   MILLER EN, 2006, UNPUB Y CHROMOSOME L
   Murray HW, 2000, INFECT IMMUN, V68, P288, DOI 10.1128/IAI.68.1.288-293.2000
   Musso T, 2005, INT J IMMUNOPATH PH, V18, P339, DOI 10.1177/039463200501800216
   Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   PEREA WA, 1989, LANCET, V2, P1222, DOI 10.1016/S0140-6736(89)91834-5
   Rodriguez NE, 2004, INFECT IMMUN, V72, P2111, DOI 10.1128/IAI.72.4.2111-2122.2004
   SACKS DL, 1987, J IMMUNOL, V138, P908
   Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2
   Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586
   SPIELMAN RS, 1993, AM J HUM GENET, V52, P506
   ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826
NR 36
TC 35
Z9 36
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1466-4879
J9 GENES IMMUN
JI Genes Immun.
PD JAN
PY 2007
VL 8
IS 1
BP 84
EP 90
DI 10.1038/sj.gene.6364357
PG 7
WC Genetics & Heredity; Immunology
SC Genetics & Heredity; Immunology
GA 130EX
UT WOS:000243783500012
PM 17122780
OA Green Accepted, Bronze
DA 2020-11-26
ER

PT J
AU Martins, DRA
   Jeronimo, SMB
   Donelson, JE
   Wilson, ME
AF Martins, Daniella R. A.
   Jeronimo, Selma M. B.
   Donelson, John E.
   Wilson, Mary E.
TI Leishmania chagasi T-cell antigens identified through a double library
   screen
SO INFECTION AND IMMUNITY
LA English
DT Article
ID AMERICAN VISCERAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; MOLECULAR
   CHARACTERIZATION; RECOMBINANT ANTIGENS; PROTECTIVE IMMUNITY; NORTHEAST
   BRAZIL; DRUG-RESISTANCE; DNA VACCINATION; DONOVANI; INFECTION
AB Control of human visceral leishmaniasis in regions where it is endemic is hampered in part by limited accessibility to medical care and emerging drug resistance. There is no available protective vaccine. Leishmania spp. protozoa express multiple antigens recognized by the vertebrate immune system. Since there is not one immunodominant epitope recognized by most hosts, strategies must be developed to optimize selection of antigens for prevention and immunodiagnosis. For this reason, we generated a cDNA library from the intracellular amastigote form of Leishmania chagasi, the cause of South American visceral leishmaniasis. We employed a two-step expression screen of the library to systematically identify T-cell antigens and T-dependent B-cell antigens. The first step was aimed at identifying the largest possible number of clones producing an epitope-containing polypeptide by screening with a pool of sera from Brazilians with documented visceral leishmaniasis. After removal of clones encoding heat shock proteins, positive clones underwent a second-step screen for their ability to cause proliferation and gamma interferon responses in T cells from immune mice. Six unique clones were selected from the second screen for further analysis. The corresponding antigens were derived from glutamine synthetase, a transitional endoplasmic reticulum ATPase, elongation factor 1 gamma, kinesin K39, repetitive protein A2, and a hypothetical conserved protein. Humans naturally infected with L. chagasi mounted both cellular and antibody responses to these proteins. Preparations containing multiple antigens may be optimal for immunodiagnosis and protective vaccines.
C1 Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   Vet Adm Med Ctr, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.
   Fed Univ Rio Grande Norte, Dept Biochem, Natal, RN, Brazil.
   Fed Univ Rio Grande Norte, Hlth Grad Program, Natal, RN, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Donelson, John E/F-5795-2010; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R03 TW001369, TW 00007, TW 01369] Funding Source: Medline; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI032135, R01 AI067874, AI 067874, R01
   AI045540, P50 AI030639, R01 AI032135, AI 045540, R01 AI048822, AI 32135,
   R01 AI059451, AI 048822, AI 059451] Funding Source: Medline; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   R01AI067874, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   R21AI032135, P50AI030639, P50AI030639, R01AI045540, R01AI045540,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, R01AI032135,
   R01AI045540, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   R01AI059451, P50AI030639, R01AI048822, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI059451, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   R01AI059451, R01AI032135, R01AI067874, R01AI067874, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, R01AI059451, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, R01AI059451, R01AI067874, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, R01AI067874,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
CR Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002
   Ausubel F. A., 2006, CURRENT PROTOCOLS MO
   Beetham JK, 1997, J BIOL CHEM, V272, P17360, DOI 10.1074/jbc.272.28.17360
   BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   CAMPBELL K, 2003, INFECT IMMUN, V71, P6270
   Campbell M, 2004, INFECT IMMUN, V72, P2194, DOI 10.1128/IAI.72.4.2194-2202.2004
   Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001
   CAMPOSNETO A, 1995, J EXP MED, V182, P1423, DOI 10.1084/jem.182.5.1423
   Canavate Carmen, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS41, DOI 10.1016/S0035-9203(02)90050-7
   CHAMPSI J, 1988, INFECT IMMUN, V56, P3272, DOI 10.1128/IAI.56.12.3272-3279.1988
   Charest H, 1996, J BIOL CHEM, V271, P17081, DOI 10.1074/jbc.271.29.17081
   CHAREST H, 1994, MOL CELL BIOL, V14, P2975, DOI 10.1128/MCB.14.5.2975
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Coligan J., 1991, CURRENT PROTOCOLS IM
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   COULSON RMR, 1990, MOL BIOCHEM PARASIT, V40, P63, DOI 10.1016/0166-6851(90)90080-6
   Davies CR, 2003, BRIT MED J, V326, P377, DOI 10.1136/bmj.326.7385.377
   de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5
   DEANDRADE CR, 1992, J CLIN MICROBIOL, V30, P330, DOI 10.1128/JCM.30.2.330-335.1992
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
   Ghedin E, 1997, CLIN DIAGN LAB IMMUN, V4, P530, DOI 10.1128/CDLI.4.5.530-535.1997
   Ghosh A, 2001, VACCINE, V19, P3169, DOI 10.1016/S0264-410X(01)00023-8
   Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X
   Ghosh M, 2003, MOL CELL BIOCHEM, V253, P199, DOI 10.1023/A:1026047429604
   Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7
   Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137
   Handman E, 2000, VACCINE, V18, P3011, DOI 10.1016/S0264-410X(00)00109-2
   Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Kaye PM, 2002, WORLD CL PARASITES, V4, P137
   MACBEATH JRE, 2001, DNA SEQUENCING PROTO, V167, P119
   Mauel J., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P201, DOI 10.2174/1568008023340631
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x
   Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X
   Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001
   Momen Hooman, 1993, Biological Research, V26, P249
   MUSTAFA AS, 1988, J IMMUNOL, V141, P2729
   Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   RACHAMIN N, 1999, J IMMUNOL, V150, P2322
   Rafati S, 2000, CLIN EXP IMMUNOL, V120, P134, DOI 10.1046/j.1365-2249.2000.01160.x
   Reed SG, 2003, CURR OPIN IMMUNOL, V15, P456, DOI 10.1016/S0952-7915(03)00069-4
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Singh N, 2003, J INFECT DIS, V188, P600, DOI 10.1086/377133
   Skeiky YAW, 1998, J IMMUNOL, V161, P6171
   SOONG L, 1995, INFECT IMMUN, V63, P3559, DOI 10.1128/IAI.63.9.3559-3566.1995
   Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064
   Streit JA, 2001, J IMMUNOL, V166, P1921, DOI 10.4049/jimmunol.166.3.1921
   Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x
   Vogel SN, 1999, J IMMUNOL, V162, P5666
   Walker PS, 1998, HUM GENE THER, V9, P1899, DOI 10.1089/hum.1998.9.13-1899
   WILSON ME, 1994, INFECT IMMUN, V62, P5133, DOI 10.1128/IAI.62.11.5133-5141.1994
   Wilson ME, 2005, MICROB PATHOGENESIS, V38, P147, DOI 10.1016/j.micpath.2004.11.002
   WILSON ME, 1986, J IMMUNOL, V136, P4681
   WILSON ME, 1995, INFECT IMMUN, V63, P2062, DOI 10.1128/IAI.63.5.2062-2069.1995
   WILSON ME, 1989, J IMMUNOL, V143, P678
   Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6
NR 61
TC 25
Z9 27
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2006
VL 74
IS 12
BP 6940
EP 6948
DI 10.1128/IAI.02032-05
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 109KX
UT WOS:000242308100045
PM 17000724
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Martins, DR
   Jeronimo, SM
   Donelson, JE
   Wilson, ME
AF Martins, Daniella R.
   Jeronimo, Selma M.
   Donelson, John E.
   Wilson, Mary E.
TI Leishmania chagasi T cell antigens identified through a double library
   screen
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Univ Fed Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   Univ Iowa, Iowa City, IA USA.
   Univ Iowa, Vet Affairs Med Ctr, Iowa City, IA USA.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 685
BP 198
EP 198
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343901120
DA 2020-11-26
ER

PT J
AU Nobre, ML
   Dias, MC
   Dias, GH
   Queiroz, JW
   Silva, AK
   Sampaio, GA
   Medeiros, J
   Dupnik, KM
   Moura, ML
   Nobrega, PF
   Lacerda, RM
   Araujo, SF
   Nascimento, EL
   Monteiro, GR
   Gomes, CE
   Blackwell, JM
   Jeronimo, SM
AF Nobre, Mauricio L.
   Dias, Marcia C.
   Dias, Gutemberg H.
   Queiroz, Jose W.
   Silva, Ana K.
   Sampaio, Gabriel A.
   Medeiros, Jose Filho
   Dupnik, Kathyrin M.
   Moura, Maria L.
   Nobrega, Priscilla F.
   Lacerda, Roberta M.
   Araujo, Sergio F.
   Nascimento, Eliana L.
   Monteiro, Gloria R.
   Gomes, Carlos E.
   Blackwell, Jenefer M.
   Jeronimo, Selma M.
TI Increased detection rate of leprosy (Hansen's disease) and strategy for
   disease control in Rio Grande do Norte, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Univ Fed Rio Grande Norte, BR-59072970 Natal, RN, Brazil.
   Univ Fed Sao Paulo, Sao Paulo, Brazil.
   Univ Virginia, Charlottesville, VA USA.
   Univ Cambridge, Cambridge, England.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Dias,
   Gutemberg H/D-7510-2018; Moura, Maria Luisa/N-5654-2015
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Dias, Gutemberg H/0000-0003-2147-8647; Moura,
   Maria Luisa/0000-0003-1013-8233
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 1061
BP 306
EP 306
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343901496
DA 2020-11-26
ER

PT J
AU Ximenes, MDFD
   Castellon, EG
   De Souza, MD
   Menezes, AAL
   Queiroz, JW
   Silva, VPME
   Jeronimo, SMB
AF Freire de Melo Ximenes, Maria De Fatima
   Castellon, Eloy G.
   De Souza, Maria De Fatima
   Lara Menezes, Alexandre A.
   Queiroz, Jose Wilton
   Macedo E Silva, Virgnia Penellope
   Jeronimo, Selma M. B.
TI Effect of abiotic factors on seasonal population dynamics of Lutzomyia
   longipalpis (Diptera : Psychodidae) in northeastern Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Lutzomyia longipalpis; seasonality; climate; visceral leishmaniasis;
   Brazil
ID SAND FLIES DIPTERA; GRANDE-DO-NORTE; VISCERAL LEISHMANIASIS;
   PHLEBOTOMINE SANDFLIES; ENDEMIC FOCUS; COLOMBIA; CHAGASI; STATE;
   INFECTION
AB The resurgence of visceral leishmaniasis in Brazil increases the need for studies to elucidate the spatial and temporal dynamics of Lutzomyia longipalpis (Lutz & Neiva) (Diptera: Psychodidae), the vector of Leishmania infantum, the causative agent of visceral leishmaniasis in Brazil. Sand flies were captured in peridomestic habitats biweekly for 3 yr. Cross-correlation tests and spectral analysis were used to analyze the simultaneous and lag-time correlations between Lu. longipalpis population densities and abiotic factors of temperature, relative humidity, wind velocity, and rainfall. Distinct seasonal patterns were observed for males and females, with intervals of 6 mo between population peaks for males and 12 mo for females. Peak female population densities lagged 3 mo behind the maximum annual temperature. Female population density was negatively correlated with relative humidity. An increase in average wind velocity was followed by a decrease in the number of females for 2 wk. Understanding the relationship between the seasonal population dynamics of Lu. longipalpis and abiotic factors will contribute to the design of better control measures to decrease transmission of L. infantum and consequently the incidence of leishmaniasis.
C1 Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   Inst Nacl de Pesquisas da Amazonia, BR-69011970 Manaus, Amazonas, Brazil.
   Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Fisiol, BR-59072970 Natal, RN, Brazil.
RP Ximenes, MDFD (corresponding author), Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-30639] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER
CR Alexander B, 2000, MED VET ENTOMOL, V14, P109, DOI 10.1046/j.1365-2915.2000.00237.x
   Alexander B, 2003, MED VET ENTOMOL, V17, P1, DOI 10.1046/j.1365-2915.2003.00420.x
   Arias JR, 1996, EMERG INFECT DIS, V2, P145, DOI 10.3201/eid0202.960213
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P167, DOI 10.1590/S0074-02761987000200003
   FERRO C, 1995, J MED ENTOMOL, V32, P618, DOI 10.1093/jmedent/32.5.618
   Franke CR, 2002, EMERG INFECT DIS, V8, P914, DOI 10.3201/eid0809.010523
   Hamilton J. G. C., 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene, V86, P341
   JARVIS EK, 1992, J MED ENTOMOL, V29, P171, DOI 10.1093/jmedent/29.2.171
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   Kelly DW, 1997, ANIM BEHAV, V53, P721, DOI 10.1006/anbe.1996.0309
   KILLICKKENDRICK R, 1986, T ROY SOC TROP MED H, V80, P138, DOI 10.1016/0035-9203(86)90213-0
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   Momen H, 1998, EMERG INFECT DIS, V4, P1, DOI 10.3201/eid0401.980101
   MORRISON AC, 1995, J MED ENTOMOL, V32, P538, DOI 10.1093/jmedent/32.4.538
   MORRISON AC, 1995, J MED ENTOMOL, V32, P605, DOI 10.1093/jmedent/32.5.605
   NELSON W, 1979, CHRONOBIOLOGIA, V6, P305
   PLATT T, 1975, ANNU REV ECOL SYST, V6, P189, DOI 10.1146/annurev.es.06.110175.001201
   QUINNELL RJ, 1994, B ENTOMOL RES, V84, P379, DOI 10.1017/S0007485300032508
   RUTLEDGE LC, 1975, ENVIRON ENTOMOL, V4, P78, DOI 10.1093/ee/4.1.78
   Sherlock I A, 1969, Rev Bras Malariol Doencas Trop, V21, P715
   Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003
   Tauber M. J., 1986, SEASONAL ADAPTATIONS
   Travi BL, 1996, J MED ENTOMOL, V33, P278, DOI 10.1093/jmedent/33.3.278
   WARD RD, 1993, B ENTOMOL RES, V83, P437, DOI 10.1017/S0007485300029357
   WARD RD, 1990, MEM I OSWALDO CRUZ, V85, P445, DOI 10.1590/S0074-02761990000400009
   WARD RD, 1988, LUTZOMYIA LONGIPALPI
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
   Ximenes MDFFD, 2001, MEM I OSWALDO CRUZ, V96, P883
   Young D.G., 1991, PHLEBOTOMINE SANDFLI
   Young DG, 1994, MEM AM ENTOMOL I, V54, DOI DOI 10.21236/ADA285737
   Zeledon R., 1984, Memorias do Instituto Oswaldo Cruz, V79, P455, DOI 10.1590/S0074-02761984000400010
NR 33
TC 32
Z9 35
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD SEP
PY 2006
VL 43
IS 5
BP 990
EP 995
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 085LI
UT WOS:000240605200031
PM 17017238
DA 2020-11-26
ER

PT J
AU Castellucci, L
   Menezes, E
   Oliveira, J
   Magalhaes, A
   Guimaraes, LH
   Lessa, M
   Ribeiro, S
   Reale, J
   Noronha, EF
   Wilson, ME
   Duggal, P
   Beaty, TH
   Jeronimo, S
   Jamieson, SE
   Bales, A
   Blackwell, JM
   de Jesus, AR
   Carvalho, EM
AF Castellucci, Lea
   Menezes, Eliane
   Oliveira, Joyce
   Magalhaes, Andrea
   Guimaraes, Luiz Henrique
   Lessa, Marcus
   Ribeiro, Silvana
   Reale, Jeancarlo
   Noronha, Elza Ferreira
   Wilson, Mary E.
   Duggal, Priya
   Beaty, Terri H.
   Jeronimo, Selma
   Jamieson, Sarra E.
   Bales, Ashlee
   Blackwell, Jenefer M.
   Ribeiro de Jesus, Amelia
   Carvalho, Edgar M.
TI IL6-174 G/C promoter polymorphism influences susceptibility to mucosal
   but not localized cutaneous leishmaniasis in Brazil
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID REGULATORY T-CELLS; TRES-BRACOS; IL-6; GENOTYPE; DIFFERENTIATION;
   IDENTIFICATION; ASSOCIATION; DISEASE; ALPHA; BAHIA
AB Background. Mucosal leishmaniasis (ML) is associated with exaggerated tumor necrosis factor-alpha and interferon-gamma responses and tissue destruction. ML follows localized cutaneous leishmaniasis (CL) caused by Leishmania braziliensis infection. Interleukin (IL)-6 down-regulates T helper (Th) cell type 1 differentiation and drives Th2 cell differentiation. The IL6 -174 G/C polymorphism is associated with proinflammatory diseases and IL-6 regulation.
   Methods. The -174 G/C polymorphism was genotyped in population samples and families with CL and ML from Brazil. Genotype frequencies were compared among patients with ML, patients with CL, and 2 control groups by logistic regression and family-based association test (FBAT) analysis. IL-6 levels were measured in macrophages.
   Results. The C allele was more common in patients with ML than in patients with CL (odds ratio [OR], 2.55 [95% confidence interval {CI}, 1.32-4.91]; P = .005), than in patients who were leishmanin skin-test positive (OR, 2.23 [95% CI, 1.23-4.05]; P = .009), and than in neighborhood control subjects (OR, 2.47 [95% CI, 1.24-4.90]; P = .01). FBAT analysis confirmed an association between allele C and ML under both additive (P = .000017) and dominant (z = 4.325; P = .000015) models. Significantly lower levels of IL-6 were measured in unstimulated macrophages from CC individuals than from GG individuals (P = .003) as well as after stimulation with soluble leishmania antigen (P = .009).
   Conclusions. IL-6 may regulate type 1 proinflammatory responses, putting individuals with low macrophage IL-6 levels at increased risk for ML.
C1 Univ Fed Bahia, HUPES, Serv Imunol, Salvador, BA, Brazil.
   Univ Fed Rio Grande do Norte, Dept Bioquim, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   Univ Brasilia, BR-70910900 Brasilia, DF, Brazil.
   Univ Iowa, Iowa City, IA 52242 USA.
   Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA.
   Johns Hopkins Sch Publ Hlth, Baltimore, MD USA.
   Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge CB2 1TN, England.
RP de Jesus, AR (corresponding author), Univ Fed Bahia, HUPES, Serv Imunol, 5o Andar,Rua Joao Botas S-N, Salvador, BA, Brazil.
EM imuno@ufba.br
RI Blackwell, Jenefer M/H-3015-2015; Jeronimo, Selma/AAY-4033-2020;
   Henrique, Luiz/ABA-2621-2020
OI Jeronimo, Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [1 D43 TW007127-01] Funding Source: Medline; Intramural NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI-48822, AI-30639, R01 AI048822] Funding Source: Medline; Wellcome
   TrustWellcome Trust Funding Source: Medline; FOGARTY INTERNATIONAL
   CENTERUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [D43TW007127, D43TW007127, D43TW007127, D43TW007127, D43TW007127,
   D43TW007127] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME
   RESEARCH INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Human
   Genome Research Institute (NHGRI) [Z01HG200327, Z01HG200327,
   Z01HG200327, Z01HG200327] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER
CR Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   BERMUDEZ LE, 1992, INFECT IMMUN, V60, P4245, DOI 10.1128/IAI.60.10.4245-4252.1992
   Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645
   Bittar MN, 2005, HEART SURG FORUM, V8, pE140, DOI 10.1532/HSF98.20041120
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   CARVALHO EM, 1985, J IMMUNOL, V135, P4144
   Carvalho LP, 2005, SCAND J IMMUNOL, V61, P337, DOI 10.1111/j.1365-3083.2005.01581.x
   Castellucci LA, 2005, AM J TROP MED HYG, V73, P69, DOI 10.4269/ajtmh.2005.73.69
   CASTES M, 1984, CLIN EXP IMMUNOL, V57, P279
   Castes M, 1993, Biol Res, V26, P233
   CUBA CAC, 1984, T ROY SOC TROP MED H, V78, P708, DOI 10.1016/0035-9203(84)90256-6
   de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128
   Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026
   Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9
   Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9
   Fife MS, 2005, GENES IMMUN, V6, P367, DOI 10.1038/sj.gene.6364186
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Grady WM, 2005, CLIN CANCER RES, V11, P3151, DOI 10.1158/1078-0432.CCR-05-0414
   HATZIGEORGIOU DE, 1993, J IMMUNOL, V151, P3682
   Herbert A, 2005, DIABETOLOGIA, V48, P1492, DOI 10.1007/s00125-005-1830-3
   Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625
   Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D
   Lessa HA, 2001, AM J TROP MED HYG, V65, P87, DOI 10.4269/ajtmh.2001.65.87
   Marsden PD, 1998, AM J TROP MED HYG, V59, P543, DOI 10.4269/ajtmh.1998.59.543
   Mendez S, 2004, J EXP MED, V200, P201, DOI 10.1084/jem.20040298
   O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904
   Pawlik A, 2005, SCAND J RHEUMATOL, V34, P109, DOI 10.1080/03009740510026373
   REIN T, 1995, J BIOL CHEM, V270, P19643, DOI 10.1074/jbc.270.33.19643
   Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461
   ROSA AC, 1988, T ROY SOC TROP MED H, V82, P409, DOI 10.1016/0035-9203(88)90138-1
   SAMBROOK J, 1989, MOL CLONING LAB MAN, V2
   Sawczenko A, 2005, P NATL ACAD SCI USA, V102, P13260, DOI 10.1073/pnas.0503589102
   Soares MBP, 1998, J IMMUNOL, V160, P1811
   Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200
   Testa R, 2006, DIABETES RES CLIN PR, V71, P299, DOI 10.1016/j.diabres.2005.07.007
   VAN SJ, 1990, ANNU REV IMMUNOL, V8, P253
   Zauberman A, 2001, J BIOL CHEM, V276, P24719, DOI 10.1074/jbc.M005813200
NR 38
TC 70
Z9 71
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD AUG 15
PY 2006
VL 194
IS 4
BP 519
EP 527
DI 10.1086/505504
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 064WO
UT WOS:000239121000016
PM 16845637
DA 2020-11-26
ER

PT J
AU Araujo, ACPF
   Leao, MD
   Nobrega, MH
   Bezerra, PFM
   Pereira, FVM
   Dantas, EMM
   Azevedo, GD
   Jeronimo, SMB
AF Araujo, Ana C. P. F.
   Leao, Marcos D.
   Nobrega, Maria H.
   Bezerra, Patricia F. M.
   Pereira, Flavio V. M.
   Dantas, Edailna M. M.
   Azevedo, George D.
   Jeronimo, Selma M. B.
TI Characteristics and treatment of hepatic rupture caused by HELLP
   syndrome
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE hepatic rupture; HELLP (hemolysis, elevated liver enzymes, and low
   platelet count) syndrome; preeclampsia; hepatic artery ligation
ID ELEVATED LIVER-ENZYMES; LOW PLATELETS; PREGNANCY; HEMOLYSIS; MANAGEMENT;
   HEMATOMA
AB Objective: The purpose of this study was to review the management of hepatic rupture caused by HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome and to assess maternal and perinatal outcomes of these cases.
   Study design: A retrospective study of HELLP syndrome cases that were complicated by hepatic rupture was conducted.
   Results: Ten cases of hepatic rupture were identified. The median maternal age was 42.5 +/- 5.9 years (median +/- SD), and the median gestational age at delivery was 35.5 +/- 4.9 weeks. The most frequent signs and symptoms of hepatic rupture were the sudden onset of abdominal pain, acute anemia, and hypotension. Laboratory findings included low platelet count and increased hepatic enzymes. Surgery was performed in 9 cases. One case was treated nonsurgically. The maternal mortality rate was 10%, and the perinatal mortality rate was 80%.
   Conclusion: A combination of surgical treatment with hepatic artery ligation and omental patching with supportive measures was effective in decreasing the mortality rate in hepatic rupture caused by HELLP syndrome. (c) 2006 Mosby, Inc. All rights reserved.
C1 Univ Fed Rio Grande Norte, Dept Biochem, Biosci Ctr, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Morphol, Biosci Ctr, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Hlth Grad Program, Hlth Sci Ctr, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Gynecol & Obstet, Hlth Sci Ctr, BR-59078970 Natal, RN, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande Norte, Dept Biochem, Biosci Ctr, CP 1624, BR-59078970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Audibert F, 1996, AM J OBSTET GYNECOL, V175, P460, DOI 10.1016/S0002-9378(96)70162-X
   BARTON JR, 1992, GASTROENTEROL CLIN N, V21, P937
   Bis K A, 1976, Obstet Gynecol Surv, V31, P763, DOI 10.1097/00006254-197611000-00001
   Carlson KL, 2004, AM J OBSTET GYNECOL, V190, P558, DOI 10.1016/S0002-9378(03)00759-2
   Gonzalez A L, 2000, Ginecol Obstet Mex, V68, P353
   GONZALEZ GD, 1984, SOUTHERN MED J, V77, P242, DOI 10.1097/00007611-198402000-00028
   Haddad B, 2000, AM J OBSTET GYNECOL, V183, P444, DOI 10.1067/mob.2000.105915
   Nelson D B, 1989, J Obstet Gynecol Neonatal Nurs, V18, P106, DOI 10.1111/j.1552-6909.1989.tb00473.x
   Reck T, 2001, EUR J OBSTET GYN R B, V99, P57, DOI 10.1016/S0301-2115(01)00358-X
   Rinehart B K, 1999, Obstet Gynecol Surv, V54, P196, DOI 10.1097/00006254-199903000-00024
   Risseeuw J J, 1999, J Matern Fetal Med, V8, P32
   Sheikh RA, 1999, J CLIN GASTROENTEROL, V28, P323, DOI 10.1097/00004836-199906000-00008
   SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I
   SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I
   SMITH LG, 1991, OBSTET GYNECOL, V77, P171, DOI 10.1097/00006250-199102000-00001
   Wicke C, 2004, AM J OBSTET GYNECOL, V190, P106, DOI 10.1016/j.ajog.2003.08.029
NR 16
TC 61
Z9 72
U1 1
U2 5
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUL
PY 2006
VL 195
IS 1
BP 129
EP 133
DI 10.1016/j.ajog.2006.01.016
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 062EF
UT WOS:000238926700020
PM 16579935
DA 2020-11-26
ER

PT J
AU Aleixo, JA
   Nascimento, ET
   Monteiro, GR
   Fernandes, MZ
   Ramos, AMO
   Wilson, ME
   Pearson, RD
   Jeronimo, SMB
AF Aleixo, JA
   Nascimento, ET
   Monteiro, GR
   Fernandes, MZ
   Ramos, AMO
   Wilson, ME
   Pearson, RD
   Jeronimo, SMB
TI Atypical American visceral leishmaniasis caused by disseminated
   Leishmania amazonensis infection presenting with hepatitis and
   adenopathy
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE visceral leishmaniasis; hepatitis; adenomegaly; Leishmania amazonensis;
   Brazil
ID BRAZIL; CHAGASI
AB Leishmania amazonensis is widely recognised as a cause of cutaneous leishmaniasis in Latin America, but it can also disseminate to produce atypical visceral Leishmaniasis with hepatitis and lymphadenopathy. The patient, an 8-year-old Brazilian boy, presented with a febrile illness and hepatosplenomegaly, elevated liver enzymes and generalised adenopathy. Serological tests using antigens of L. chagasi, the typical cause of visceral leishmaniasis in Latin America, were inconclusive. Leishmania amazonensis was eventually isolated in a culture of a lymph node. The patient recovered fully after treatment with meglumine antimoniate. As this case illustrates, L. amazonensis produces a spectrum of disease that includes atypical American visceral leishmaniasis with evidence of hepatocellular injury and generalised lymphadenopathy. (c) 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Pediat, BR-59072970 Natal, RN, Brazil.
   Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Virginia, Sch Med, Dept Internal Med, Charlottesville, VA 22908 USA.
   Univ Virginia, Sch Med, Dept Pathol, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande Norte, Dept Biochem, CP 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, R01AI032135, R01AI045540, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, R01AI032135,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, R01AI032135,
   R01AI045540, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI032135, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540] Funding Source: NIH RePORTER; FIC NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R03 TW01369] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI032135, R01 AI45540, R01 AI48822, U11 AI-30639] Funding Source:
   Medline
CR BARRAL A, 1995, AM J TROP MED HYG, V53, P256, DOI 10.4269/ajtmh.1995.53.256
   BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   ELHAG IA, 1994, J CLIN PATHOL, V47, P547, DOI 10.1136/jcp.47.6.547
   Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Jeronimo SMB, 2005, PRINCIPLES PRACTICE, P3145
   PICHETH G, 2002, J BRAS PATOL MED LAB, V38, P2
   Sacher T, 2002, EUR J IMMUNOL, V32, P3628, DOI 10.1002/1521-4141(200212)32:12<3628::AID-IMMU3628>3.0.CO;2-E
   Singh Utpal Kant, 1995, Indian Journal of Pediatrics, V62, P571, DOI 10.1007/BF02761879
   Sousa Ade Q, 1995, AM J TROP MED HYG, V53, P380
   Tsuchiya N, 2004, J GASTROENTEROL, V39, P859, DOI 10.1007/s00535-004-1402-1
   VASCONCELOS IAB, 1988, ANN TROP MED PARASIT, V82, P547, DOI 10.1080/00034983.1988.11812290
   Wang JY, 1999, WORLD J GASTROENTERO, V5, P38
NR 14
TC 29
Z9 32
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN
PY 2006
VL 100
IS 1
BP 79
EP 82
DI 10.1016/j.trstmh.2005.06.025
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 990ST
UT WOS:000233764200016
PM 16198385
DA 2020-11-26
ER

PT J
AU Lovell, AM
   Rodriguez, NE
   Monteiro, GR
   Nascimento, ET
   Jeronimo, SM
   Wilson, ME
AF Lovell, Alyssa M.
   Rodriguez, Nilda E.
   Monteiro, Gloria R.
   Nascimento, Eliana T.
   Jeronimo, Selma M.
   Wilson, Mary E.
TI Male susceptibility to Leishmania chagasi infection: The
   immunocompromising effect of testosterone
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Lovell, Alyssa M.; Rodriguez, Nilda E.; Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
   [Monteiro, Gloria R.; Nascimento, Eliana T.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2005
VL 73
IS 6
SU S
MA 112
BP 38
EP 38
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA V44GA
UT WOS:000202990000113
DA 2020-11-26
ER

PT J
AU Martins, DR
   Jeronimo, SM
   Wilson, ME
AF Martins, Daniella R.
   Jeronimo, Selma M.
   Wilson, Mary E.
TI T cell antigens of the parasitic protozoan Leishmania chagasi
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 [Martins, Daniella R.; Jeronimo, Selma M.] Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
   [Wilson, Mary E.] Univ Iowa, Iowa City, IA USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2005
VL 73
IS 6
SU S
MA 784
BP 258
EP 258
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA V44GA
UT WOS:000202990001207
DA 2020-11-26
ER

PT J
AU Passos, S
   Carvalho, LP
   Orge, G
   Jeronimo, SM
   Bezerra, G
   Soto, M
   Alonso, C
   Carvalho, EM
AF Passos, S
   Carvalho, LP
   Orge, G
   Jeronimo, SM
   Bezerra, G
   Soto, M
   Alonso, C
   Carvalho, EM
TI Recombinant Leishmania antigens for serodiagnosis of visceral
   leishmaniasis
SO CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
LA English
DT Article
ID INFECTION; DIAGNOSIS; CHAGASI
AB Serological tests with crude or recombinant Leishmania antigens are important tools for the diagnosis of leishmania infection. However, these tests are not markers of active visceral leishmaniasis (VL), since antibodies to these markers are often observed in individuals with subclinical L. chagasi infection and they do not fall shortly after therapy. In this study, levels of immunoglobulin G (IgG) against three recombinant Leishmania antigens (rH2A, KMP11, and the "Q" protein) were evaluated in sera from individuals with subclinical L. chagasi infection and in patients with VL pre- and posttherapy. The sensitivity of the serological test for diagnosis of VL was 100% with all three antigens. The titers of IgG fell significantly after therapy. While most of the individuals with subclinical L. chagasi infection had antibodies to rH2A and the "Q" protein, only I out of 15 individuals had antibodies to KMP11. These data indicate that KMP11 may be used to discriminate L. chagasi infection from active VL and may serve as a marker of response to therapy.
C1 Univ Fed Bahia, Serv Immunol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   Univ Fed Rio Grande Norte, Lab Imunobioquim, Natal, RN, Brazil.
   Univ Fed Maranhao, Ctr Ciencias Biol & Saude, Maranhao, Brazil.
   Univ Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, Madrid, Spain.
RP Carvalho, EM (corresponding author), Univ Fed Bahia, Serv Immunol, Hosp Univ Prof Edgard Santos, 5 Andar,Rua Joao Botas,S-N Canela, BR-40110160 Salvador, BA, Brazil.
EM edgar@ufba.br
RI Carvalho, Lucas/J-6734-2012; Jeronimo, Selma/AAY-4033-2020; Carvalho,
   Lucas/AAP-1844-2020; Jeronimo, Selma M.B./M-8672-2014; Alvarez, Manuel
   Soto/Q-5234-2018
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Alvarez, Manuel Soto/0000-0001-6825-841X
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI-30639, P50
   AI030639] Funding Source: Medline
CR [Anonymous], 1990, World Health Organ Tech Rep Ser, V793, P1
   Boelaert M, 2000, T ROY SOC TROP MED H, V94, P465, DOI 10.1016/S0035-9203(00)90055-5
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   Fuertes MA, 2001, J BIOL INORG CHEM, V6, P107, DOI 10.1007/s007750000175
   Miles SA, 2005, J EXP MED, V201, P747, DOI 10.1084/jem.20041470
   Reed SG, 1996, CLIN DERMATOL, V14, P471, DOI 10.1016/0738-081X(96)00038-7
   Soto M, 1998, J CLIN MICROBIOL, V36, P58, DOI 10.1128/JCM.36.1.58-63.1998
   *WHO, 2002, STRAT DIR LEISHM
   Zijlstra E E, 1992, Trop Geogr Med, V44, P288
NR 13
TC 23
Z9 26
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1071-412X
J9 CLIN DIAGN LAB IMMUN
JI Clin. Diagn. Lab. Immunol.
PD OCT
PY 2005
VL 12
IS 10
BP 1164
EP 1167
DI 10.1128/CDLI.12.10.1164-1167.2005
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 974CU
UT WOS:000232569700005
PM 16210478
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Pereira, WO
   Paiva, AS
   Queiroz, JW
   Toma, L
   Dietrich, CP
   Nader, HB
   Jeronimo, SMB
AF Pereira, WO
   Paiva, AS
   Queiroz, JW
   Toma, L
   Dietrich, CP
   Nader, HB
   Jeronimo, SMB
TI Genetic polymorphism in the sulfotransferase SULT1A1 gene in cancer
SO CANCER GENETICS AND CYTOGENETICS
LA English
DT Article
ID HUMAN PHENOL SULFOTRANSFERASE; CHONDROITIN SULFATE; PROSTATE-CANCER;
   LUNG-CANCER; ASSOCIATION; PHARMACOGENETICS; DIAGNOSIS; GENOTYPE; RISK;
   CARCINOGENESIS
AB Cytosolic sulfotransferases are enzymes that catalyze the conjugation of sulfate groups to a variety of xenobiotic and endogenous substrates. A mutation in the SULT1A1 gene has been associated with decreased sulfotransferase activity. We studied 125 cancer patients and 100 healthy controls from Brazil matched by age and gender. The objective of this study was to assess the impact of the SULT1A1 polymorphism on sulfotransferase activity in a population of cancer patients. Both heterozygous and homozygous individuals for the mutant allele had significantly decreased sulfotransferase enzymatic activity. This decrease was more significant in cancer patients. The frequency of the SULT1A1*2 allele was increased in the myeloma group (odds ratio = 0.53). These data suggest a functional role for the SULT1A1 gene polymorphism in cancer. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio Grande Norte, Ctr Ciencias Saude, Ctr Biociencias, Dept Bioquim, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Ctr Ciencias Saude, Ctr Biociencias, Programa Posgrad Saude, BR-59078970 Natal, RN, Brazil.
   Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande Norte, Ctr Ciencias Saude, Ctr Biociencias, Dept Bioquim, CP 1624,Campus Univ,Lagoa Nova, BR-59078970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Nader,
   Helena B/D-9253-2012
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR Bamber DE, 2001, PHARMACOGENETICS, V11, P679, DOI 10.1097/00008571-200111000-00006
   Coughtrie MWH, 1999, BIOCHEM J, V337, P45, DOI 10.1042/0264-6021:3370045
   Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8
   DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5
   DIETRICH CP, 1993, LAB INVEST, V68, P439
   Dooley TP, 1996, BIOCHEM BIOPH RES CO, V228, P134, DOI 10.1006/bbrc.1996.1628
   DOOLEY TP, 1993, GENOMICS, V18, P440, DOI 10.1006/geno.1993.1494
   Engelke CEH, 2000, PHARMACOGENETICS, V10, P163, DOI 10.1097/00008571-200003000-00008
   FALANY CN, 1991, TRENDS PHARMACOL SCI, V12, P255, DOI 10.1016/0165-6147(91)90566-B
   Glatt H, 2000, TOXICOL LETT, V112, P341, DOI 10.1016/S0378-4274(99)00214-3
   Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0
   Her CT, 1996, GENOMICS, V33, P409, DOI 10.1006/geno.1996.0216
   Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020
   JERONIMO SMB, 1994, BRAZ J MED BIOL RES, V27, P2253
   KATO R, 1994, CHEM-BIOL INTERACT, V92, P111
   Liang G, 2004, CARCINOGENESIS, V25, P773, DOI 10.1093/carcin/bgh053
   Martins JRM, 2000, OTOLARYNG HEAD NECK, V122, P115, DOI 10.1016/S0194-5998(00)70158-6
   MILLER JA, 1994, CHEM-BIOL INTERACT, V92, P329, DOI 10.1016/0009-2797(94)90074-4
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   MULDER GJ, 1977, BIOCHEM PHARMACOL, V26, P189, DOI 10.1016/0006-2952(77)90301-X
   Nowell S, 2004, CANCER EPIDEM BIOMAR, V13, P270, DOI 10.1158/1055-9965.EPI-03-0047
   Ozawa S, 1999, J BIOCHEM-TOKYO, V126, P271, DOI 10.1093/oxfordjournals.jbchem.a022445
   Peng CT, 2003, INT J MOL MED, V11, P85
   Raftogianis RB, 1999, BIOCHEM PHARMACOL, V58, P605, DOI 10.1016/S0006-2952(99)00145-8
   Raftogianis RB, 1997, BIOCHEM BIOPH RES CO, V239, P298, DOI 10.1006/bbrc.1997.7466
   Steiner M, 2000, ARCH TOXICOL, V74, P222, DOI 10.1007/s002040000118
   Wang YF, 2002, LUNG CANCER, V35, P137, DOI 10.1016/S0169-5002(01)00406-8
   WEINSHILBOUM R, 1990, PHARMACOL THERAPEUT, V45, P93, DOI 10.1016/0163-7258(90)90010-Y
   WEINSHILBOUM R, 1994, CHEM-BIOL INTERACT, V92, P233, DOI 10.1016/0009-2797(94)90066-3
   Weinshilboum RM, 1997, FASEB J, V11, P3
   Williams JA, 2001, CARCINOGENESIS, V22, P209, DOI 10.1093/carcin/22.2.209
NR 31
TC 15
Z9 16
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0165-4608
J9 CANCER GENET CYTOGEN
JI Cancer Genet. Cytogenet.
PD JUL 1
PY 2005
VL 160
IS 1
BP 55
EP 60
DI 10.1016/j.cancergencyto.2004.12.005
PG 6
WC Oncology; Genetics & Heredity
SC Oncology; Genetics & Heredity
GA 941NI
UT WOS:000230221100008
PM 15949571
DA 2020-11-26
ER

PT J
AU Wilson, ME
   Jeronimo, SMB
   Pearson, RD
AF Wilson, ME
   Jeronimo, SMB
   Pearson, RD
TI Immunopathogenesis of infection with the visceralizing Leishmania
   species
SO MICROBIAL PATHOGENESIS
LA English
DT Review
ID INNATE IMMUNE-RESPONSE; NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR-BETA; HUMAN
   CUTANEOUS LEISHMANIASIS; PROTEINASE-DEFICIENT MUTANTS;
   NECROSIS-FACTOR-ALPHA; TGF-BETA; T-CELL; MAJOR INFECTION; IFN-GAMMA
AB Human leishmaniasis is a spectral disease that includes asymptomatic self-resolving infection, localized skin lesions, and progressive visceral leishmaniasis. With some overlap, visceral and cutaneous leishmaniasis are usually caused by different species of Leishmania.
   This review focuses on host responses to infection with the species that cause visceral leishmaniasis, as they contrast with species causing localized cutaneous leishmaniasis. Data from experimental models document significant differences between host responses to organisms causing these diverse syndromes. The visceralizing Leishmania spp. cause localized organ-specific immune responses that are important determinants of disease outcome. Both the Leishmania species causing cutaneous and those causing visceral leishmaniasis require a Type 1 immune response to undergo cure in mouse models. However, during progressive murine infection with the visceralizing Leishmania sp., the Type 1 response is suppressed at least in part by TGF-beta and IL-10 without type 2 cytokine production. This contrasts with the cutaneous species L. major, in which a Type 2 response suppresses type 1 cytokines and leads to murine disease progression. Population and family studies are beginning to elucidate human genetic determinants predisposing to different outcomes of Leishmania infection. These studies should eventually result in a better understanding of the immunopathogenesis and the spectrum of human leishmaniasis. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Iowa, Dept Microbiol & Epidemiol, VA Med Ctr, Iowa City, IA 52242 USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   Univ Virginia, Dept Internal Med, Charlottesville, VA USA.
   Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, VA Med Ctr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; LUKASZEWICZ, EWA T./B-4114-2017;
   Kowalczyk, Artur/B-5721-2017; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; LUKASZEWICZ, EWA
   T./0000-0002-9505-0056; Kowalczyk, Artur/0000-0001-7446-0147; Jeronimo,
   Selma M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P50 AI-30639, R01 AI32135, R01 AI45540,
   R01-AI48822] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, R01AI045540,
   R01AI045540, R01AI048822, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, R01AI045540,
   P50AI030639, R01AI045540, R01AI045540, R01AI048822, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   P50AI030639, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI032135, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER
CR Ahmed S, 2003, INFECT IMMUN, V71, P401, DOI 10.1128/IAI.71.1.401-410.2003
   Alcais A, 1997, AM J HUM GENET, V61, P968, DOI 10.1086/514882
   Alexander J, 1998, J IMMUNOL, V161, P6794
   ALEXANDER J, 1988, PARASITOLOGY, V96, P297, DOI 10.1017/S0031182000058303
   ALVAR J, 1994, PARASITOL TODAY, V10, P160, DOI 10.1016/0169-4758(94)90270-4
   ANDRADE TM, 1990, J INFECT DIS, V162, P1354, DOI 10.1093/infdis/162.6.1354
   Anstead GM, 2001, INFECT IMMUN, V69, P4709, DOI 10.1128/IAI.69.8.4709-4718.2001
   ANURADHA, 1990, INDIAN J EXP BIOL, V28, P876
   Atta AM, 1998, AM J TROP MED HYG, V59, P426, DOI 10.4269/ajtmh.1998.59.426
   Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   BARBIER D, 1987, TISSUE ANTIGENS, V30, P63, DOI 10.1111/j.1399-0039.1987.tb01598.x
   BARBOSA AA, 1987, BRAZ J MED BIOL RES, V20, P63
   BARRAL A, 1991, AM J TROP MED HYG, V44, P536, DOI 10.4269/ajtmh.1991.44.536
   BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442
   BARRALNETTO M, 1991, J IMMUNOL, V147, P281
   BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092
   Bart G, 1997, MOL BIOCHEM PARASIT, V88, P53, DOI 10.1016/S0166-6851(97)00072-8
   Beebe AM, 1997, IMMUNITY, V6, P551, DOI 10.1016/S1074-7613(00)80343-X
   Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969
   BLACKWELL J, 1980, NATURE, V283, P72, DOI 10.1038/283072a0
   Blackwell JM, 1998, INT J PARASITOL, V28, P21, DOI 10.1016/S0020-7519(97)00175-6
   Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678
   Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x
   BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102
   Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084
   Bucheton B, 2003, GENES IMMUN, V4, P104, DOI 10.1038/sj.gene.6363927
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969
   CARVALHO EM, 1994, J IMMUNOL, V152, P5949
   Corradin S, 1999, J BIOL CHEM, V274, P25411, DOI 10.1074/jbc.274.36.25411
   Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418
   Das L, 2001, J IMMUNOL, V166, P4020, DOI 10.4049/jimmunol.166.6.4020
   Demant P, 1996, SCIENCE, V274, P1392, DOI 10.1126/science.274.5291.1392
   Descoteaux A, 1998, PARASITOL TODAY, V14, P220, DOI 10.1016/S0169-4758(98)01241-1
   Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659
   Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951
   Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4
   ELHASSAN AM, 1995, TROP GEOGR MED, V47, P151
   Engwerda CR, 2000, IMMUNOL TODAY, V21, P73, DOI 10.1016/S0167-5699(99)01549-2
   Engwerda CR, 1998, EUR J IMMUNOL, V28, P669, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;669::AID-IMMU669&gt;3.0.CO;2-N
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J
   Frame MJ, 2000, PARASITOLOGY, V121, P367, DOI 10.1017/S0031182099006435
   Gantt KR, 2003, J IMMUNOL, V170, P2613, DOI 10.4049/jimmunol.170.5.2613
   Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893
   GHALIB HW, 1995, J IMMUNOL, V154, P4623
   GHALIB HW, 1993, J CLIN INVEST, V92, P324, DOI 10.1172/JCI116570
   GHOSH AK, 1987, INDIAN J MED RES, V86, P14
   Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001
   Gomes NA, 2001, TRENDS PARASITOL, V17, P487, DOI 10.1016/S1471-4922(01)02038-4
   Gorak PMA, 1998, EUR J IMMUNOL, V28, P687, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;687::AID-IMMU687&gt;3.0.CO;2-N
   GORCZYNSKI RM, 1982, DEV COMP IMMUNOL, V6, P199, DOI 10.1016/S0145-305X(82)80003-7
   Gorelik L, 2000, J IMMUNOL, V165, P4773, DOI 10.4049/jimmunol.165.9.4773
   Gorham JD, 1998, J IMMUNOL, V161, P1664
   Gorham JD, 1996, P NATL ACAD SCI USA, V93, P12467, DOI 10.1073/pnas.93.22.12467
   GREEN SJ, 1991, J LEUKOCYTE BIOL, V50, P93
   Guler ML, 1996, SCIENCE, V271, P984, DOI 10.1126/science.271.5251.984
   Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   HEINZEL FP, 1991, P NATL ACAD SCI USA, V88, P7011, DOI 10.1073/pnas.88.16.7011
   HEY AS, 1994, J IMMUNOL, V152, P4542
   Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926
   HO M, 1983, CLIN EXP IMMUNOL, V51, P207
   Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941
   Ilg T, 2000, PARASITOL TODAY, V16, P489, DOI 10.1016/S0169-4758(00)01791-9
   Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777
   Janeway Jr C.A., 2001, IMMUNOBIOLOGY
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, IN PRESS SCAND J INF
   Ji HX, 2003, INFECT IMMUN, V71, P4278, DOI 10.1128/IAI.71.8.4278-4288.2003
   Jones D, 1998, INFECT IMMUN, V66, P3818, DOI 10.1128/IAI.66.8.3818-3824.1998
   Jones DE, 2000, J IMMUNOL, V165, P364, DOI 10.4049/jimmunol.165.1.364
   Julia V, 1996, SCIENCE, V274, P421, DOI 10.1126/science.274.5286.421
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   Karplus TM, 2002, INFECT IMMUN, V70, P6919, DOI 10.1128/IAI.70.12.6919-6925.2002
   Kaye PM, 2002, WORLD CL PARASITES, V4, P137
   KAYE PM, 1991, J IMMUNOL, V146, P2763
   Kemp K, 1999, CLIN EXP IMMUNOL, V116, P500
   Koay MA, 2001, INFECT IMMUN, V69, P5991, DOI 10.1128/IAI.69.10.5991-5996.2001
   LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J
   Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8
   Launois P, 1999, MICROBES INFECT, V1, P59, DOI 10.1016/S1286-4579(99)80015-X
   Lehmann J, 2000, J INTERF CYTOK RES, V20, P63, DOI 10.1089/107999000312748
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Li J, 1999, J IMMUNOL, V162, P974
   LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216
   Liew FY, 1997, PHILOS T R SOC B, V352, P1311, DOI 10.1098/rstb.1997.0115
   Lipoldova M, 2000, GENES IMMUN, V1, P200, DOI 10.1038/sj.gene.6363660
   Maekawa Y, 1998, J IMMUNOL, V161, P2120
   MAUEL J, 1991, RES IMMUNOL, V142, P577, DOI 10.1016/0923-2494(91)90106-S
   Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9
   MCELRATH MJ, 1988, J EXP MED, V167, P1927, DOI 10.1084/jem.167.6.1927
   MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0
   MEBRAHTU YB, 1993, T ROY SOC TROP MED H, V87, P598, DOI 10.1016/0035-9203(93)90101-U
   Melby PC, 2001, EXP PARASITOL, V99, P17, DOI 10.1006/expr.2001.4640
   Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
   MIRALLES GD, 1994, INFECT IMMUN, V62, P1058, DOI 10.1128/IAI.62.3.1058-1063.1994
   MOCK BA, 1985, INFECT IMMUN, V50, P588, DOI 10.1128/IAI.50.2.588-591.1985
   MOCK BA, 1988, INFECT IMMUN, V56, P3316, DOI 10.1128/IAI.56.12.3316-3319.1988
   Mohamed HS, 2003, GENES IMMUN, V4, P351, DOI 10.1038/sj.gene.6363977
   MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   MULLER I, 1992, EUR J IMMUNOL, V22, P3063, DOI 10.1002/eji.1830221206
   Murphy ML, 1998, J IMMUNOL, V161, P4153
   MURRAY HW, 1992, J IMMUNOL, V148, P1858
   MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513
   Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741
   MURRAY HW, 1999, INFLAMMATION BASIC P, P977
   NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995
   Nandan D, 1999, INFECT IMMUN, V67, P4055, DOI 10.1128/IAI.67.8.4055-4063.1999
   Noyes H, 1997, EXP PARASITOL, V85, P264, DOI 10.1006/expr.1996.4133
   PANARO MA, 1995, IMMUNOPHARM IMMUNOT, V17, P595, DOI 10.3109/08923979509016390
   Park AY, 2002, J IMMUNOL, V168, P5771, DOI 10.4049/jimmunol.168.11.5771
   Peacock C, 2002, GENES IMMUN, V3, P350, DOI 10.1038/sj.gene.6363852
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   Pearson RD, 1995, PRINCIPLES PRACTICE, P2428
   PETZLERLER ML, 1991, HUM IMMUNOL, V32, P254, DOI 10.1016/0198-8859(91)90088-Q
   PONCE C, 1991, LANCET, V337, P67, DOI 10.1016/0140-6736(91)90734-7
   Roberts LJ, 1997, J EXP MED, V185, P1705, DOI 10.1084/jem.185.9.1705
   Roberts LJ, 1999, EUR J IMMUNOL, V29, P3047, DOI 10.1002/(SICI)1521-4141(199909)29:09&lt;3047::AID-IMMU3047&gt;3.0.CO;2-L
   ROBERTS M, 1993, EUR J IMMUNOGENET, V20, P349, DOI 10.1111/j.1744-313X.1993.tb00154.x
   Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200
   Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998
   Sang DK, 1999, J INFECT DIS, V179, P743, DOI 10.1086/314635
   SARTORI A, 1992, CLIN EXP IMMUNOL, V87, P386, DOI 10.1111/j.1365-2249.1992.tb03007.x
   Sato N, 2000, J EXP MED, V192, P205, DOI 10.1084/jem.192.2.205
   SATOSKAR A, 1995, INFECT IMMUN, V63, P4894, DOI 10.1128/IAI.63.12.4894-4899.1995
   SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675
   SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337
   SHAW MA, 1995, AM J HUM GENET, V57, P1159
   Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7
   Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200
   SQUIRES KE, 1990, INFECT IMMUN, V58, P3893, DOI 10.1128/IAI.58.12.3893-3898.1990
   SQUIRES KE, 1989, J IMMUNOL, V143, P4244
   STERN JJ, 1988, J IMMUNOL, V140, P3971
   Travi BL, 2002, INFECT IMMUN, V70, P2288, DOI 10.1128/IAI.70.5.2288-2296.2002
   TUMANG MCT, 1994, J IMMUNOL, V153, P768
   TURCO SJ, 1992, ANNU REV MICROBIOL, V46, P65, DOI 10.1146/annurev.micro.46.1.65
   VANDERPOLL T, 1995, CLIN IMMUNOL IMMUNOP, V77, P111, DOI 10.1016/0090-1229(95)90144-2
   Verweij CL, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.2008.i20
   VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D
   VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   WILSON ME, 1987, J PARASITOL, V73, P55, DOI 10.2307/3282344
   Wilson ME, 2002, EUR J IMMUNOL, V32, P3556, DOI 10.1002/1521-4141(200212)32:12&lt;3556::AID-IMMU3556&gt;3.0.CO;2-Q
   Wilson ME, 1998, J IMMUNOL, V161, P6148
   Wilson ME, 1996, J IMMUNOL, V156, P2231
NR 155
TC 188
Z9 190
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD APR
PY 2005
VL 38
IS 4
BP 147
EP 160
DI 10.1016/j.micpath.2004.11.002
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA 918CH
UT WOS:000228515700002
PM 15797810
DA 2020-11-26
ER

PT J
AU Miles, SA
   Conrad, SM
   Aves, RG
   Jeronimo, SMB
   Mosser, DM
AF Miles, SA
   Conrad, SM
   Aves, RG
   Jeronimo, SMB
   Mosser, DM
TI A role for IgG immune complexes during infection with the intracellular
   pathogen Leishmania
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID EXPERIMENTAL CUTANEOUS LEISHMANIASIS; AMERICAN VISCERAL LEISHMANIASIS;
   MACROPHAGE ACTIVATION; DENDRITIC CELLS; IL-10 RECEPTOR; NITRIC-OXIDE;
   T-CELLS; AMASTIGOTES; RESPONSES; ANTIGEN
AB We examined the role of immunoglobulin (Ig)G antibodies in mediating host defense to the intracellular parasite, Leishmania. We show that IgG not only fails to provide protection against this intracellular pathogen, but it actually contributes to disease progression. The J(H) strain of BALB/c mice, which lack IgG because they have a targeted deletion in the Ig heavy chain (J) locus, were more resistant to infection with Leishmania major than were normal BALB/c mice. However, the passive administration of anti-Leishmania 196 caused J mice to develop large lesions containing high numbers of parasites. Antibody administration correlated with an increase in interleukin (IL) 10 production in lesions, and blocking the murine IL-10 receptor prevented antibody-mediated disease exacerbation. In human patients with active visceral leishmaniasis, high IgG levels are predictive of disease. Patients with ongoing disease had high IgG antibody titers and no delayed-type hypersensitivity (DTH) responses to Leishmania antigens. This pattern was reversed upon disease resolution after treatment; resulting in a decrease in total IgG, which was accompanied by a progressive increase in DTH responsiveness. We conclude that IgG can cause a novel form of immune enhancement due to its ability to induce IL-10 production from macrophages.
C1 Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59078970 Natal, RN, Brazil.
RP Mosser, DM (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
EM dmosser@umd.edu
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Mosser,
   David M/I-6697-2016
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Mosser, David M/0000-0002-9503-4187
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI12345, R21 AI055576, R01 AI055576,
   AI055576] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI055576, R01AI055576,
   R01AI055576, R21AI055576, R01AI055576, R01AI055576] Funding Source: NIH
   RePORTER
CR Anderson CF, 2004, J IMMUNOL, V173, P955, DOI 10.4049/jimmunol.173.2.955
   Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697
   ANDRADE ZA, 1984, AM J PATHOL, V114, P137
   Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152
   Berman J, 2003, CURR OPIN INFECT DIS, V16, P397, DOI 10.1097/00001432-200310000-00005
   Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   CARVALHO EM, 1983, AM J TROP MED HYG, V32, P61, DOI 10.4269/ajtmh.1983.32.61
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58
   Hailu A, 2001, J INFECT DIS, V184, P112, DOI 10.1086/320994
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HOWARD JG, 1980, PARASITE IMMUNOL, V2, P303, DOI 10.1111/j.1365-3024.1980.tb00061.x
   HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338
   Ji HX, 2003, INFECT IMMUN, V71, P4278, DOI 10.1128/IAI.71.8.4278-4288.2003
   JUNQUEIRA PM, 2003, DIAGN MICROBIOL INFE, V47, P477
   Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   Kima PE, 2000, J EXP MED, V191, P1063, DOI 10.1084/jem.191.6.1063
   Lang R, 2002, J IMMUNOL, V168, P3402, DOI 10.4049/jimmunol.168.7.3402
   Liu Y, 1997, J IMMUNOL, V158, P604
   LOCKSLEY RM, 1991, IMMUNOL TODAY, V12, P58
   LOVE DC, 1993, J CELL BIOL, V123, P759, DOI 10.1083/jcb.123.3.759
   Melby PC, 2002, CURR OPIN INFECT DIS, V15, P485, DOI 10.1097/00001432-200210000-00005
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Murray HW, 2002, INFECT IMMUN, V70, P6284, DOI 10.1128/IAI.70.11.6284-6293.2002
   Noben-Trauth N, 2003, J IMMUNOL, V170, P5152, DOI 10.4049/jimmunol.170.10.5152
   O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006
   PEARSON RD, 1983, J INFECT DIS, V147, P1102, DOI 10.1093/infdis/147.6.1102
   Quinnell RJ, 2003, VET IMMUNOL IMMUNOP, V91, P161, DOI 10.1016/S0165-2427(02)00311-2
   REED SG, 1990, AM J TROP MED HYG, V43, P632, DOI 10.4269/ajtmh.1990.43.632
   Rivera J, 2002, J IMMUNOL, V168, P3419, DOI 10.4049/jimmunol.168.7.3419
   SACKS DL, 1984, J IMMUNOL, V132, P2072
   Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501
   Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217
   Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977
   Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688
   Teixeira MCA, 2002, PARASITOL RES, V88, P963, DOI 10.1007/s00436-002-0695-3
   von Stebut E, 1998, J EXP MED, V188, P1547, DOI 10.1084/jem.188.8.1547
NR 39
TC 192
Z9 194
U1 0
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD MAR 7
PY 2005
VL 201
IS 5
BP 747
EP 754
DI 10.1084/jem.20041470
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 906XY
UT WOS:000227679500012
PM 15753208
OA Bronze, Green Accepted, Green Published
DA 2020-11-26
ER

PT J
AU Atta, AM
   Colossi, R
   Sousa-Atta, MLB
   Jeronimo, S
   Nascimento, MDSB
   Bezerra, GF
   Orge, G
   Carvalho, E
AF Atta, AM
   Colossi, R
   Sousa-Atta, MLB
   Jeronimo, S
   Nascimento, MDSB
   Bezerra, GF
   Orge, G
   Carvalho, E
TI Antileishmanial IgG and IgE antibodies recognize predominantly
   carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE visceral leishmaniasis; anti-carbohydrate antibodies; IgG; IgE
ID MAJOR SURFACE GLYCOPROTEIN; DIAGNOSIS; MOIETIES; BINDING
AB The specificity of human antileishmanial IgG and IgE antibodies to glycosylated antigens of Leishmania chagasi was evaluated. An ELISA was performed with soluble leishmanial antigen (SLA) and a panel of 95 sera including samples from patients with subclinical infection (SC) and visceral leishmaniasis (VL), subjects cured of visceral leishmaniasis (CVL), and from healthy individuals from endemic areas (HIEA). Antileishmanial IgG were verified for 18 (40%) of 45 SC subjects (mean absorbance of 0.49 +/- 0.17). All nine sera from VL patients had such antibody (0.99 +/- 0.21), while 11 (65%) of 17 CVL individuals were seropositive (0.46 +/- 0.05). Only three (12%) of 24 HIEA controls reacted in IgG-ELISA. Antileishmanial IgE was detected in 26 (58%) of 45 SC patients (0.35 +/- 0.14), and in all VL patients (0.65 +/- 0.29). These antibodies were also detected in 13(76%) of 17 CVL subjects (0.42 +/- 0.14) while all HIEA controls were seronegative. There was no correlation between antileishmanial IgG and IgE antibody absorbances. Mild periodate oxidation at acid pH of SLA carbohydrates drastically diminished its antigenicity in both IgG and IgE-ELISA, affecting mainly the antigens of 125, 102, 94, and 63 kDa as demonstrated by western immunoblotting.
C1 Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Lab Pesquisa Imunol, BR-40171970 Salvador, BA, Brazil.
   Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   Univ Fed Maranhao, Dept Patol, Sao Luis, MA, Brazil.
   Univ Fed Bahia, Hosp Uinv Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
RP Atta, AM (corresponding author), Univ Fed Bahia, Fac Farm, Dept Anal Clin & Toxicol, Lab Pesquisa Imunol, Rua Barao Geremoabo S-N,Campus Ondina, BR-40171970 Salvador, BA, Brazil.
EM ajatta@ig.com.br
RI Bezerra, Geusa Felipa/X-5620-2019; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020; Nascimento, Maria do Desterro Soares
   Brandao/S-7024-2019
OI Bezerra, Geusa Felipa/0000-0002-9472-6317; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904;
   Nascimento, Maria do Desterro Soares Brandao/0000-0003-2783-362X
CR Afferni C, 1999, CLIN EXP ALLERGY, V29, P1087, DOI 10.1046/j.1365-2222.1999.00590.x
   Anam K, 1999, INFECT IMMUN, V67, P6663
   Andrade AFB, 1999, PARASITOL RES, V85, P576, DOI 10.1007/s004360050597
   Atta AM, 1998, AM J TROP MED HYG, V59, P426, DOI 10.4269/ajtmh.1998.59.426
   AVILA JL, 1991, J CLIN MICROBIOL, V29, P2305, DOI 10.1128/JCM.29.10.2305-2312.1991
   BADARO R, 2001, DIAGNOSTICO LAB PRIN, P255
   BADARO R, 1997, TRATADO INFECTOLOGIA, P1234
   BOUVIER J, 1987, MOL BIOCHEM PARASIT, V24, P73, DOI 10.1016/0166-6851(87)90117-4
   de Noya BA, 2000, EXP PARASITOL, V95, P106, DOI 10.1006/expr.2000.4515
   Fotisch K, 2001, GLYCOCONJUGATE J, V18, P373, DOI 10.1023/A:1014860030380
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   GHOSH AK, 1995, CLIN DIAGN LAB IMMUN, V2, P291, DOI 10.1128/CDLI.2.3.291-296.1995
   Kumar P, 2002, CLIN DIAGN LAB IMMUN, V9, P1119, DOI 10.1128/CDLI.9.5.1119-1123.2002
   KUTNER S, 1991, J CLIN MICROBIOL, V29, P595, DOI 10.1128/JCM.29.3.595-599.1991
   Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5
   PALATNIKDESOUSA CB, 1993, ACTA TROP, V53, P59, DOI 10.1016/0001-706X(93)90006-W
   Petersen A, 2001, J CHROMATOGR B, V756, P141, DOI 10.1016/S0378-4347(01)00099-8
   Shiddo SA, 1996, IMMUNOL LETT, V50, P87, DOI 10.1016/0165-2478(96)02529-1
   SHREFFLER WG, 1993, J INFECT DIS, V167, P426, DOI 10.1093/infdis/167.2.426
   Souza-Atta MLB, 1999, BRAZ J MED BIOL RES, V32, P1101, DOI 10.1590/S0100-879X1999000900008
   van der Kleij D, 1999, INFECT IMMUN, V67, P5946, DOI 10.1128/IAI.67.11.5946-5950.1999
   van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770
   WOODWARD MP, 1985, J IMMUNOL METHODS, V78, P143, DOI 10.1016/0022-1759(85)90337-0
NR 23
TC 7
Z9 8
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2004
VL 99
IS 5
BP 525
EP 530
DI 10.1590/S0074-02762004000500012
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 853HA
UT WOS:000223816700012
PM 15543418
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Jeronimo, SMB
   Duggal, P
   Braz, RFS
   Cheng, C
   Monteiro, GRG
   Nascimento, ET
   Martins, DRA
   Karplus, TM
   Ximenes, MFFM
   Oliveira, CCG
   Pinheiro, VG
   Pereira, W
   Peralta, JM
   Sousa, JMA
   Medeiros, IM
   Pearson, RD
   Burns, TL
   Pugh, EW
   Wilson, ME
AF Jeronimo, SMB
   Duggal, P
   Braz, RFS
   Cheng, C
   Monteiro, GRG
   Nascimento, ET
   Martins, DRA
   Karplus, TM
   Ximenes, MFFM
   Oliveira, CCG
   Pinheiro, VG
   Pereira, W
   Peralta, JM
   Sousa, JMA
   Medeiros, IM
   Pearson, RD
   Burns, TL
   Pugh, EW
   Wilson, ME
TI An emerging peri-urban pattern of infection with Leishmania chagasi, the
   protozoan causing visceral leishmaniasis in northeast Brazil
SO SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID CUTANEOUS LEISHMANIASIS; SUBCLINICAL INFECTION; NATURAL-HISTORY;
   FOLLOW-UP; ANTIGEN; SUSCEPTIBILITY; TRANSMISSION; EPIDEMIC; SUDAN
AB Peri-urban visceral leishmaniasis (VL) caused by Leishmania chagasi is emerging in a new epidemiologic pattern in Brazilian cities. We studied peri-urban VL in endemic neighborhoods surrounding Natal, Brazil, identified through hospitalized individuals with VL. Clinical and environmental information obtained for 1106 members of 216 families living in endemic neighborhoods enabled us to identify 4 groups: VL: individuals with current or prior symptomatic visceral leishmaniasis (n = 135); DTH +: individuals with positive delayed-type hypersensitivity response with no history of VL (n = 390); Ab +: individuals with negative DTH response and seropositive (n = 21); DTH-: individuals with negative DTH and seronegative (n = 560). The mean+/-SD age of VL was 9.3+/-12.3 y. The gender distribution was nearly equal below age 5, but skewed toward males at higher ages. Acutely infected VL subjects had significantly lower hematocrits, neutrophils, and eosinophils than other categories. AB+ subjects also had lower eosinophil counts than others, a possible immune marker of early infection. VL was not associated with ownership of dogs or other animals, raising the question whether the reservoir differs in peri-urban settings. This new pattern of L. chagasi infection enables us to identify epidemiological and host factors underlying this emerging infectious disease.
C1 Univ Fed Rio Grande Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   NHGRI, Inherited Dis Res Branch, NIH, Baltimore, MD USA.
   Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil.
   Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   VA Med Ctr, Iowa City, IA USA.
   Univ Virginia, Dept Internal Med, Charlottesville, VA USA.
   Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.
   Ctr Inherited Dis Res, Baltimore, MD USA.
   Johns Hopkins Univ, Baltimore, MD USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande Norte, Dept Bioquim, CP 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, R01AI048822, P50AI030639, P50AI030639, T32AI007511,
   T32AI007511, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, R01AI045540,
   P50AI030639, R01AI045540, P50AI030639, R01AI045540, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, R01AI045540,
   T32AI007511, T32AI007511, P50AI030639, P50AI030639, T32AI007511,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, T32AI007511, P50AI030639, P50AI030639, T32AI007511,
   P50AI030639, T32AI007511, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, R01AI045540, T32AI007511, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   R01AI045540, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   P50AI030639, P50AI030639, R01AI048822, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI045540, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [K08DK002550, K08DK002550, K08DK002550, K08DK002550,
   K08DK002550] Funding Source: NIH RePORTER; FIC NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC) [TW01369] Funding Source:
   Medline; NIAID NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [T32 AI07511, AI-30639,
   AI48822, AI45540] Funding Source: Medline; NIDDK NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [DK/AI2550] Funding Source: Medline
CR ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159
   AEBISCHER T, 1994, PARASITOL TODAY, V10, P25, DOI 10.1016/0169-4758(94)90353-0
   Alencar J.E., 1961, REV INST MED TROP, V3, P175
   ANURADHA PR, 1990, INDIAN J EXP BIOL, V27, P876
   ASHFORD RW, 1992, T ROY SOC TROP MED H, V86, P379, DOI 10.1016/0035-9203(92)90229-6
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   Bebo BF, 1999, J IMMUNOL, V162, P35
   Blackwell JM, 1998, INT J PARASITOL, V28, P21, DOI 10.1016/S0020-7519(97)00175-6
   Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678
   Braz RFS, 2002, AM J TROP MED HYG, V67, P344, DOI 10.4269/ajtmh.2002.67.344
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   CHAGAS E, SCIENCE, V84, P397
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DEANE LM, ESTUDOS RESERVATORIO
   Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   ESTERRE P, 1992, VIRCHOWS ARCH A, V421, P239, DOI 10.1007/BF01611181
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   EVANS TG, 1989, MEM I OSWALDO CRUZ, V84, P157, DOI 10.1590/S0074-02761989000200003
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056
   Travi BL, 2002, INFECT IMMUN, V70, P2288, DOI 10.1128/IAI.70.5.2288-2296.2002
   ZIJLSTRA EE, 1994, AM J TROP MED HYG, V51, P826, DOI 10.4269/ajtmh.1994.51.826
NR 30
TC 61
Z9 61
U1 0
U2 5
PU TAYLOR & FRANCIS AS
PI OSLO
PA CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY
SN 0036-5548
J9 SCAND J INFECT DIS
JI Scand. J. Infect. Dis.
PD JUL
PY 2004
VL 36
IS 6-7
BP 443
EP 449
DI 10.1080/00365540410020451
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA 833PS
UT WOS:000222351100008
PM 15307565
DA 2020-11-26
ER

PT J
AU Oliveira, CCG
   Lacerda, HG
   Martins, DRM
   Barbosa, JDA
   Monteiro, GR
   Queiroz, JW
   Sousa, JMA
   Ximenes, MFFM
   Jeronimo, SMB
AF Oliveira, CCG
   Lacerda, HG
   Martins, DRM
   Barbosa, JDA
   Monteiro, GR
   Queiroz, JW
   Sousa, JMA
   Ximenes, MFFM
   Jeronimo, SMB
TI Changing epidemiology of American cutaneous leishmaniasis (ACL) in
   Brazil: A disease of the urban-rural interface
SO ACTA TROPICA
LA English
DT Article
DE cutaneous leishmaniasis; sandflies; Montenegro response; Brazil
ID SAND FLIES DIPTERA; GRANDE-DO-NORTE; VISCERAL LEISHMANIASIS; CEARA
   STATE; PSYCHODIDAE; BAHIA; AREA
AB American cutaneous leishmaniasis (ACL) was first reported from the south-western region of the state of Rio Grande do Norte in 1987. S (a) over tildeo Miguel municipality and adjacent areas have accounted for 90% of the American cutaneous leishmaniasis cases in the region since then. A population survey conducted in S (a) over tildeo Miguel and adjacent areas was undertaken to identify individuals with a history of ACL. The incidence of ACL, distribution by age and gender, clinical characteristics, family clustering, relationship to animals. association with skin test responses, and development of mucosal lesions were determined. Males and females were equally likely to be infected by Leishmania. Thirty-eight percent of the individuals tested were found to be Montenegro skin test positive. No difference in the Montenegro skin test was observed with gender, but the response increased with age. Among the 140 ACL cases treated in a 4-year period in S (a) over tildeo Miguel, five (3.6%) developed mucosal involvement. Sandflies capable of transmitting Leishmania were captured inside households and in the areas surrounding them. The high density of sandfly species potentially able to transmit Leishmania species and the age distribution of cases of cutaneous leishmaniasis suggest that transmission of the parasite occurred inside or in close proximity to houses. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Fed Rio Grande do Norte, Dept Biochem, RN, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Microbiol, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Parasitol, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Grad Program Hlth Sci, BR-59072970 Natal, RN, Brazil.
   Univ Fed Bahia, Grad Program Immunol, Salvador, BA, Brazil.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, RN, CP 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR ADLER S., 1927, ANN TROP MED & PARASITOL, V21, P89
   Alcais A, 1997, AM J HUM GENET, V61, P968, DOI 10.1086/514882
   Blackwell JM, 1999, PARASITOL TODAY, V15, P73, DOI 10.1016/S0169-4758(98)01355-6
   Brandao SP, 1999, T ROY SOC TROP MED H, V93, P488, DOI 10.1016/S0035-9203(99)90346-2
   Broutet N, 1994, Sante, V4, P87
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004
   CARVALHO EM, 1985, J IMMUNOL, V135, P4144
   DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J
   DEQUEIROZ RG, 1994, AM J TROP MED HYG, V50, P693, DOI 10.4269/ajtmh.1994.50.693
   DOURADO MIC, 1989, REV SAUDE PUBL, V23, P2, DOI 10.1590/S0034-89101989000100002
   Follador I, 2002, CLIN INFECT DIS, V34, pE54, DOI 10.1086/340261
   *IBGE, 2000, AN EST BRAS
   *IBGE, 1991, CENS DEM 1991 MUN SA
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Jorquera A, 1998, AM J TROP MED HYG, V58, P589, DOI 10.4269/ajtmh.1998.58.589
   LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036
   LAGO L, 1990, T ROY SOC TROP MED H, V84, P241, DOI 10.1016/0035-9203(90)90271-F
   LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0
   Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4
   PEARSON RD, 1999, PRINCIPLES PRACTICE, V2, P2831
   SILVA NS, 1999, REV SAUDE PUBL, V33, P554, DOI DOI 10.1590/S0034-89101999000600006
   Teodoro U, 1997, REV SAUDE PUBL, V31, P512, DOI 10.1590/S0034-89101997000600011
   VASCONCELOS IAB, 1988, ANN TROP MED PARASIT, V82, P547, DOI 10.1080/00034983.1988.11812290
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
   Young DG, 1994, MEM AM ENTOMOL I, V54, DOI DOI 10.21236/ADA285737
NR 27
TC 37
Z9 40
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD APR
PY 2004
VL 90
IS 2
BP 155
EP 162
DI 10.1016/j.actatropica.2003.11.011
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 805JC
UT WOS:000220361600003
PM 15177141
DA 2020-11-26
ER

PT J
AU Nascimento, ALTO
   Ko, AI
   Martins, EAL
   Monteiro-Vitorello, CB
   Ho, PL
   Haake, DA
   Verjovski-Almeida, S
   Hartskeerl, RA
   Marques, MV
   Oliveira, MC
   Menck, CFM
   Leite, LCC
   Carrer, H
   Coutinho, LL
   Degrave, WM
   Dellagostin, OA
   El-Dorry, H
   Ferro, ES
   Ferro, MIT
   Furlan, LR
   Gamberini, M
   Giglioti, EA
   Goes-Neto, A
   Goldman, GH
   Goldman, MHS
   Harakava, R
   Jeronimo, SMB
   Junqueira-de-Azevedo, ILM
   Kimura, ET
   Kuramae, EE
   Lemos, EGM
   Lemos, MVF
   Marino, CL
   Nunes, LR
   de Oliveira, RC
   Pereira, GG
   Reis, MS
   Schriefer, A
   Siqueira, WJ
   Sommer, P
   Tsai, SM
   Simpson, AJG
   Ferro, JA
   Camargo, LEA
   Kitajima, JP
   Setubal, JC
   Van Sluys, MA
AF Nascimento, ALTO
   Ko, AI
   Martins, EAL
   Monteiro-Vitorello, CB
   Ho, PL
   Haake, DA
   Verjovski-Almeida, S
   Hartskeerl, RA
   Marques, MV
   Oliveira, MC
   Menck, CFM
   Leite, LCC
   Carrer, H
   Coutinho, LL
   Degrave, WM
   Dellagostin, OA
   El-Dorry, H
   Ferro, ES
   Ferro, MIT
   Furlan, LR
   Gamberini, M
   Giglioti, EA
   Goes-Neto, A
   Goldman, GH
   Goldman, MHS
   Harakava, R
   Jeronimo, SMB
   Junqueira-de-Azevedo, ILM
   Kimura, ET
   Kuramae, EE
   Lemos, EGM
   Lemos, MVF
   Marino, CL
   Nunes, LR
   de Oliveira, RC
   Pereira, GG
   Reis, MS
   Schriefer, A
   Siqueira, WJ
   Sommer, P
   Tsai, SM
   Simpson, AJG
   Ferro, JA
   Camargo, LEA
   Kitajima, JP
   Setubal, JC
   Van Sluys, MA
TI Comparative genomics of two Leptospira interrogans serovars reveals
   novel insights into physiology and pathogenesis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; NUCLEOTIDE-SEQUENCE; TREPONEMA-PALLIDUM;
   PROTEIN; IDENTIFICATION; GENE; BORGPETERSENII; BIOSYNTHESIS;
   LOCALIZATION; TRANSDUCTION
AB Leptospira species colonize a significant proportion of rodent populations worldwide and produce life-threatening infections in accidental hosts, including humans. Complete genome sequencing of Leptospira interrogans serovar Copenhageni and comparative analysis with the available Leptospira interrogans serovar Lai genome reveal that despite overall genetic similarity there are significant structural differences, including a large chromosomal inversion and extensive variation in the number and distribution of insertion sequence elements. Genome sequence analysis elucidates many of the novel aspects of leptospiral physiology relating to energy metabolism, oxygen tolerance, two-component signal transduction systems, and mechanisms of pathogenesis. A broad array of transcriptional regulation proteins and two new families of afimbrial adhesins which contribute to host tissue colonization in the early steps of infection were identified. Differences in genes involved in the biosynthesis of lipopolysaccharide 0 side chains between the Copenhageni and Lai serovars were identified, offering an important starting point for the elucidation of the organism's complex polysaccharide surface antigens. Differences in adhesins and in lipopolysaccharide might be associated with the adaptation of serovars Copenhageni and Lai to different animal hosts. Hundreds of genes encoding surface-exposed lipoproteins and transmembrane outer membrane proteins were identified as candidates for development of vaccines for the prevention of leptospirosis.
C1 Univ Sao Paulo, Ctr Biotechnol, Inst Butantan, BR-05503900 Sao Paulo, SP, Brazil.
   Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Ciencias Biomed, BR-05508 Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Biol, Sao Paulo, Brazil.
   Univ Sao Paulo, Piracicaba, Brazil.
   Univ Estadual Paulista, Fac Ciencias Agrarias & Vet, Jaboticabal, Brazil.
   Univ Fed Sao Carlos, Ctr Ciencias Agrarias, Araras, Brazil.
   Fac Ciencias Farmaceut, Ribeirao Preto, Brazil.
   Fac Filosofia Ciencias & Letras, Ribeirao Preto, Brazil.
   Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
   Univ Mogi das Cruzes, Fac Ciencias Agron, Mogi Das Cruzes, Brazil.
   Univ Mogi das Cruzes, Inst Biociencias, Mogi Das Cruzes, Brazil.
   Univ Estadual Paulista, Botucatu, SP, Brazil.
   Univ Mogi das Cruzes, Nucleo Integrado Biotecnol, Mogi Das Cruzes, Brazil.
   Univ Estadual Paulista, Dept Genet & Evolucao, Campinas, SP, Brazil.
   Univ Estadual Paulista, Inst Computacao, Campinas, SP, Brazil.
   Univ Estadual Paulista, Inst Agron Campinas, Campinas, SP, Brazil.
   Univ Estadual Paulista, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil.
   Univ Fed Bahia, Serv Immunol, BR-41170290 Salvador, BA, Brazil.
   Univ Estadual Feira de Santana, LAPEM, Dept Ciencias Biol, Feira de Santana, BA, Brazil.
   Inst Oswaldo Cruz, Dept Bioquim & Biol Mol, BR-20001 Rio De Janeiro, Brazil.
   Univ Fed Pelotas, Ctr Biotechnol, Pelotas, Brazil.
   Univ Fed Rio Grande do Norte, Ctr Biociencias, BR-59072970 Natal, RN, Brazil.
   Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, New York, NY USA.
   Ludwig Inst Canc Res, New York, NY USA.
   Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA.
   Vet Affairs Greater Los Angeles Healthcare Syst, Div Infect Dis, Los Angeles, CA USA.
   Koninklin Inst Tropen, Royal Trop Inst, KIT Biomed Res, Amsterdam, Netherlands.
RP Nascimento, ALTO (corresponding author), Univ Sao Paulo, Ctr Biotechnol, Inst Butantan, Avenida Vital Brazil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM tabet@usp.br
RI Harakava, Ricardo/C-4471-2012; Coutinho, Luiz L/C-8455-2012; Goldman,
   Gustavo Henrique/F-1848-2013; Jeronimo, Selma M.B./M-8672-2014;
   Jeronimo, Selma/AAY-4033-2020; Kimura, Edna/D-7334-2012; FERRO, MARIA
   INES/D-3634-2012; Verjovski-Almeida, Sergio/AAI-2728-2020; Ko, Albert
   Icksang/P-2343-2015; Kuramae, Eiko Eurya/F-4738-2012; Marino,
   celso/AAH-2836-2020; Ho, Paulo/P-8267-2015; Schriefer,
   Albert/AAP-2765-2020; Tsai, Siu Mui/C-2793-2012; Marino,
   Celso/L-2448-2013; Camargo, Luis Eduardo Aranha/Y-9954-2019; LEMOS,
   ELIANA GM/A-3604-2008; Nascimento, Ana Lucia/E-8488-2012; Nunes, Luiz
   R/M-4804-2013; Monteiro-Vitorello, Claudia B/F-2436-2012; Goldman, Maria
   Helena S./D-1424-2012; Camargo, Luis Eduardo A/C-2735-2012; Leite,
   Luciana/D-1353-2012; Ferro, Jesus Aparecido/C-8251-2013; Coutinho,
   Luiz/P-5233-2019; Van Sluys, Marie-Anne/A-8483-2012; Marques, Marilis
   V/C-3085-2013; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Degrave,
   Wim/B-4162-2009; Verjovski-Almeida, Sergio/E-4082-2012; Pereira, Goncalo
   A. G./B-7944-2012; Carrer, Helaine/C-3159-2012; de Oliveira, Mariana
   Cabral/G-2512-2012; Reis, Marcelo S./K-4075-2012; Nascimento, Ana L. T.
   O./M-8663-2019; Setubal, Joao C/C-7305-2012; Ferro, Emer S/D-3908-2012;
   Costa de Oliveira, Regina/A-4571-2017; Goes-Neto,
   Aristoteles/A-6955-2013; Martins, Elizabeth AL/B-7135-2015; Menck,
   Carlos FM/G-6321-2011; Junqueira-de-Azevedo, Inacio L. M./H-5239-2011;
   Dellagostin, Odir/C-2331-2009
OI Harakava, Ricardo/0000-0003-1431-2665; Coutinho, Luiz
   L/0000-0002-7266-8881; Goldman, Gustavo Henrique/0000-0002-2986-350X;
   Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Kimura, Edna/0000-0001-8403-4459;
   Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ko, Albert
   Icksang/0000-0001-9023-2339; Kuramae, Eiko Eurya/0000-0001-6701-8668;
   Ho, Paulo/0000-0003-3652-241X; Schriefer, Albert/0000-0002-5496-6789;
   Tsai, Siu Mui/0000-0002-3733-6312; Camargo, Luis Eduardo
   Aranha/0000-0002-5650-5695; LEMOS, ELIANA GM/0000-0002-1119-7748;
   Nascimento, Ana Lucia/0000-0003-4851-0870; Nunes, Luiz
   R/0000-0001-9619-269X; Monteiro-Vitorello, Claudia
   B/0000-0002-1238-9354; Goldman, Maria Helena S./0000-0002-6786-9320;
   Camargo, Luis Eduardo A/0000-0002-5650-5695; Leite,
   Luciana/0000-0003-0156-1312; Ferro, Jesus Aparecido/0000-0002-3966-1303;
   Coutinho, Luiz/0000-0002-7266-8881; Van Sluys,
   Marie-Anne/0000-0002-6506-2734; de Macedo Lemos, Eliana
   Gertrudes/0000-0002-1119-7748; Verjovski-Almeida,
   Sergio/0000-0002-6356-2401; Carrer, Helaine/0000-0002-9329-1841; de
   Oliveira, Mariana Cabral/0000-0001-8495-2962; Reis, Marcelo
   S./0000-0002-3754-9115; Nascimento, Ana L. T. O./0000-0003-4851-0870;
   Setubal, Joao C/0000-0001-9174-2816; Ferro, Emer S/0000-0003-1651-9192;
   Costa de Oliveira, Regina/0000-0002-2446-5510; Goes-Neto,
   Aristoteles/0000-0002-7692-6243; Martins, Elizabeth
   AL/0000-0002-2333-9379; Menck, Carlos FM/0000-0003-1941-0694;
   Junqueira-de-Azevedo, Inacio L. M./0000-0003-4491-0180; Dellagostin,
   Odir/0000-0003-2803-4088; Tiraboschi Ferro, Maria
   Ines/0000-0003-3389-9131
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431, R01AI034431, R01AI034431,
   R01AI034431, R01AI034431, R01AI034431] Funding Source: NIH RePORTER;
   NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI034431-07, R01 AI034431] Funding
   Source: Medline
CR Barocchi MA, 2002, INFECT IMMUN, V70, P6926, DOI 10.1128/IAI.70.12.6926-6932.2002
   Barocchi MA, 2001, J CLIN MICROBIOL, V39, P191, DOI 10.1128/JCM.39.1.191-195.2001
   BOURSAUXEUDE C, 1995, MICROBIOL-UK, V141, P2165, DOI 10.1099/13500872-141-9-2165
   Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359
   Chen CW, 2002, TRENDS GENET, V18, P522, DOI 10.1016/S0168-9525(02)02752-X
   COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9
   de la Pena-Moctezuma A, 1999, FEMS MICROBIOL LETT, V177, P319, DOI 10.1111/j.1574-6968.1999.tb13749.x
   Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369
   Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924
   DOLATA MM, 1993, J BIOL CHEM, V268, P14426
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   Durbin R., 1998, BIOL SEQUENCE ANAL P
   Eisen JA, 2000, GENOME BIOL, V1
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1
   Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002
   Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551
   Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375
   FUKUNAGA M, 1989, J BACTERIOL, V171, P5763, DOI 10.1128/jb.171.11.5763-5767.1989
   FULOP V, 1995, STRUCTURE, V3, P1225, DOI 10.1016/S0969-2126(01)00258-1
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Gilges D, 2000, BIOCHEM J, V352, P49, DOI 10.1042/0264-6021:3520049
   Godfroid F, 1998, INFECT IMMUN, V66, P5485, DOI 10.1128/IAI.66.11.5485-5493.1998
   Haake DA, 2000, MICROBIOL-SGM, V146, P1491, DOI 10.1099/00221287-146-7-1491
   HAAKE DA, 1993, J BACTERIOL, V175, P4225, DOI 10.1128/JB.175.13.4225-4234.1993
   HENNEBERRY RC, 1970, CAN J MICROBIOL, V16, P41, DOI 10.1139/m70-007
   Howell ML, 2000, J BACTERIOL, V182, P4545, DOI 10.1128/JB.182.16.4545-4556.2000
   Hunnicutt DW, 2002, J BACTERIOL, V184, P2370, DOI 10.1128/JB.184.9.2370-2378.2002
   Jovanovic T, 2000, J BIOL CHEM, V275, P28439, DOI 10.1074/jbc.M003314200
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Lamothe GT, 2002, ARCH MICROBIOL, V178, P218, DOI 10.1007/s00203-002-0447-x
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Lombard M, 2000, J BIOL CHEM, V275, P27021
   Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x
   Meidanis J, 2002, MICROBIOL MOL BIOL R, V66, P272, DOI 10.1128/MMBR.66.2.272-299.2002
   Missiakas D, 1998, MOL MICROBIOL, V28, P1059, DOI 10.1046/j.1365-2958.1998.00865.x
   Palaniappan RUM, 2002, INFECT IMMUN, V70, P5924, DOI 10.1128/IAI.70.11.5924-5930.2002
   Paton AW, 1999, INFECT IMMUN, V67, P5930, DOI 10.1128/IAI.67.11.5930-5937.1999
   Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5
   Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597
   Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x
   Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65
   Tang YXP, 1999, MOL MICROBIOL, V32, P139, DOI 10.1046/j.1365-2958.1999.01337.x
   Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003
   Vujaskovic Z, 2002, FREE RADICAL BIO MED, V33, P857, DOI 10.1016/S0891-5849(02)00980-2
   Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354
   Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x
   Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001
   Zuerner RL, 2002, FEMS MICROBIOL LETT, V215, P175, DOI 10.1111/j.1574-6968.2002.tb11388.x
   ZUERNER RL, 1994, PLASMID, V31, P1, DOI 10.1006/plas.1994.1001
NR 52
TC 302
Z9 692
U1 1
U2 54
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD APR
PY 2004
VL 186
IS 7
BP 2164
EP 2172
DI 10.1128/JB.186.7.2164-2172.2004
PG 9
WC Microbiology
SC Microbiology
GA 805JS
UT WOS:000220363200029
PM 15028702
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Bezerra, MM
   Brain, SD
   Greenacre, S
   Jeronimo, SMB
   de Melo, LB
   Keeble, J
   da Rocha, FAC
AF Bezerra, MM
   Brain, SD
   Greenacre, S
   Jeronimo, SMB
   de Melo, LB
   Keeble, J
   da Rocha, FAC
TI Reactive nitrogen species scavenging, rather than nitric oxide
   inhibition, protects from articular cartilage damage in rat
   zymosan-induced arthritis
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE inflammation; rheumatoid arthritis; nitric oxide; cartilage;
   peroxynitrite; arthritis; zymosan; uric acid; antioxidants
ID URIC-ACID; MULTIPLE-SCLEROSIS; TYROSINE NITRATION; ADJUVANT ARTHRITIS;
   URATE OXIDASE; PEROXYNITRITE SCAVENGER; CHRONIC INFLAMMATION; OXIDATIVE
   DAMAGE; SYNOVIAL-FLUID; TISSUE-DAMAGE
AB 1 The contribution of nitric oxide (NO) and peroxynitrite (PN) to inflammation in a zymosan-induced (1 mg, intra-articular, i.art.) rat model of arthritis was assessed by histopathology and by measuring the glycosaminoglycan (GAG) content of the articular cartilage.
   2 Progression of the chronic synovitis in zymosan-induced arthritis (ZYA) was associated with increased nitrite and nitrotyrosine (3-NT) levels in the joint exudates that paralleled a progressive loss of the GAG content. An increase in 3-NT was also observed after i.art. PN.
   3 The nonselective nitric oxide synthase (NOS) inhibitor L-N-G-nitroarginine methyl ester (25-75 mg kg(-1) day(-1)) or the selective inducible NOS inhibitor aminoguanidine (50-100 mg kg(-1) day(-1)) given I It before (prophylactic) or 3 days after (therapeutic) injection of the zymosan ameliorated the synovitis, but worsened the GAG loss, as measured at the end of the experiment (day 7).
   4 The PN scavenger uric acid (100-250 mg kg(-1) i.p. four times daily) given prophylactically until the end of the experiment (day 14), in a dose compatible with its PN scavenging activity, significantly decreased both the synovitis and the GAG loss.
   5 In conclusion, PN formation is associated with cartilage damage in addition to proinflammatory activity in ZYA. NOS inhibitors and a PN scavenger were able to reduce the cellular infiltration, while displaying opposite effects on cartilage homeostasis either by enhancing or ameliorating the damage, respectively.
C1 Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   Kings Coll London, Ctr Cardiovasc Biol & Med, London SE1 1UL, England.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
RP da Rocha, FAC (corresponding author), Univ Fed Ceara, Fac Med, Dept Fisiol & Farmacol, Rua Cel Nunes Melo 1127, BR-60430270 Fortaleza, Ceara, Brazil.
EM arocha@ufc.br
RI Brain, Susan/L-3681-2013; rocha, francisco ac/O-1988-2018; Jeronimo,
   Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI rocha, francisco ac/0000-0003-4370-3294; Jeronimo,
   Selma/0000-0002-4784-9904; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Keeble, Julie/0000-0002-8891-1129; Brain, Susan/0000-0002-9684-8342
CR Beckman JS, 1996, CHEM RES TOXICOL, V9, P836, DOI 10.1021/tx9501445
   BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81
   BENSOUYAD A, 1990, ANN RHEUM DIS, V49, P301, DOI 10.1136/ard.49.5.301
   Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200
   CLANCY PM, 1988, ARTHRITIS RHEUM, V41, P1141
   Da Rocha FAC, 2002, J BONE MINER RES, V17, P434, DOI 10.1359/jbmr.2002.17.3.434
   Del Carlo M, 2002, ARTHRITIS RHEUM, V46, P394, DOI 10.1002/art.10056
   DIETRICH CP, 1972, ANAL BIOCHEM, V46, P209, DOI 10.1016/0003-2697(72)90413-7
   Dowling P, 1997, J NEUROL SCI, V149, P1, DOI 10.1016/S0022-510X(97)05213-1
   Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923
   Fletcher DS, 1998, J PHARMACOL EXP THER, V284, P714
   Galinanes M, 2002, BIOCHEM J, V367, P467, DOI 10.1042/BJ20020825
   GEGOUT P, 1994, LIFE SCI, V55, P321
   GREENACRE SA, 2002, BRIT J PHARMACOL, V36, P985
   GREENACRE SA, 2001, J PHYSL, V531, pS222
   Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471
   HARRIS JR, 1993, TXB RHEUMATOLOGY, P833
   Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675
   Hooper DC, 2000, FASEB J, V14, P691
   IALENTI A, 1993, BRIT J PHARMACOL, V110, P701, DOI 10.1111/j.1476-5381.1993.tb13868.x
   Ishimaru JI, 2001, OSTEOARTHR CARTILAGE, V9, P365, DOI 10.1053/joca.2000.0397
   JACQUES LB, 1968, CAN J PHYSL PHARM, V46, P351
   JERONIMO SMB, 1994, BRAZ J MED BIOL RES, V27, P2253
   KAUR H, 1994, FEBS LETT, V350, P9, DOI 10.1016/0014-5793(94)00722-5
   KEILIN J, 1959, BIOL REV, V34, P265, DOI 10.1111/j.1469-185X.1959.tb01447.x
   Kelley WN, 1993, TXB RHEUMATOLOGY, V2, P1291
   KEYSTONE EC, 1977, ARTHRITIS RHEUM, V20, P1396, DOI 10.1002/art.1780200714
   Khan J, 1998, BIOCHEM J, V330, P795, DOI 10.1042/bj3300795
   KOCK R, 1993, EUR J CLIN CHEM CLIN, V31, P303
   MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853
   McCartney-Francis NL, 2001, J IMMUNOL, V166, P2734, DOI 10.4049/jimmunol.166.4.2734
   MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749
   Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496
   MONCADA S, 1991, PHARMACOL REV, V43, P1109
   PRYOR WA, 1995, AM J PHYSIOL, V268, P699
   Ridger VC, 1997, BRIT J PHARMACOL, V122, P1083, DOI 10.1038/sj.bjp.0701498
   Rocha FAC, 1999, INFLAMM RES, V48, P485, DOI 10.1007/s000110050491
   Rocha JCD, 2002, BRIT J PHARMACOL, V136, P588, DOI 10.1038/sj.bjp.0704755
   Sharif M, 1996, BRIT J RHEUMATOL, V35, P951
   Skinner KA, 1998, J BIOL CHEM, V273, P24491, DOI 10.1074/jbc.273.38.24491
   SLEDGE CB, 1993, TXB RHEUMATOLOGY, V1, P1
   Spitsin SV, 2000, NEUROSCI LETT, V292, P137, DOI 10.1016/S0304-3940(00)01446-4
   STEFANOVICRACIC M, 1995, J RHEUMATOL, V22, P1922
   STEFANOVICRACIC M, 1994, ARTHRITIS RHEUM, V37, P1062, DOI 10.1002/art.1780370712
   TONUSSI CR, 1992, PAIN, V48, P421, DOI 10.1016/0304-3959(92)90095-S
   Tsukada K, 2000, SURGERY, V127, P439, DOI 10.1067/msy.2000.104486
   USUDA N, 1988, LAB INVEST, V58, P100
   vanderVliet A, 1996, METHOD ENZYMOL, V269, P175
   Veihelmann A, 2001, ARTHRITIS RHEUM-US, V44, P1420, DOI 10.1002/1529-0131(200106)44:6<1420::AID-ART237>3.0.CO;2-K
   Wangsiripaisan A, 1999, KIDNEY INT, V55, P2281, DOI 10.1046/j.1523-1755.1999.00484.x
   Whiteman M, 2003, J BIOL CHEM, V278, P8380, DOI 10.1074/jbc.M211086200
   Whiteman M, 2002, ANN NY ACAD SCI, V962, P242, DOI 10.1111/j.1749-6632.2002.tb04072.x
   WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854
   YELDANDI AV, 1991, GENE, V109, P281, DOI 10.1016/0378-1119(91)90622-I
NR 54
TC 41
Z9 42
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-1188
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD JAN
PY 2004
VL 141
IS 1
BP 172
EP 182
DI 10.1038/sj.bjp.0705600
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 773LY
UT WOS:000188926300020
PM 14662723
OA Bronze, Green Published
DA 2020-11-26
ER

PT J
AU Miles, SA
   Jeronimo, SMB
   Mosser, DM
AF Miles, SA
   Jeronimo, SMB
   Mosser, DM
TI A role for IgG during infection with intracellular pathogens
SO JOURNAL OF LEUKOCYTE BIOLOGY
LA English
DT Meeting Abstract
CT 37th Annual Meeting of the Society-for-Leukocyte-Biology
CY OCT 21-23, 2004
CL Toronto, CANADA
SP Soc Leukocyte Biol
C1 Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59078 Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Mosser,
   David M/I-6697-2016
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Mosser, David M/0000-0002-9503-4187
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0741-5400
J9 J LEUKOCYTE BIOL
JI J. Leukoc. Biol.
PY 2004
SU S
BP 41
EP 41
PG 1
WC Cell Biology; Hematology; Immunology
SC Cell Biology; Hematology; Immunology
GA 851KD
UT WOS:000223683100086
DA 2020-11-26
ER

PT J
AU De Sousa, JMA
   Lareau, SM
   Pearson, RD
   Carvalho, EM
   Mann, BJ
   Jeronimo, SMB
AF De Sousa, JMA
   Lareau, SM
   Pearson, RD
   Carvalho, EM
   Mann, BJ
   Jeronimo, SMB
TI Characterization of Leishmania chagasi DNA topoisomerase II: A potential
   chemotherapeutic target
SO SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID MINICIRCLES; RESISTANCE; CLEAVAGE
AB DNA topoisomerase II (topo II), an enzyme essential for cellular replication, is an eminent target for antimicrobial therapy against Leishmania chagasi , the major cause of visceral leishmaniasis in Latin America. The complete L. chagasi (Lch) TOP2 gene, encoding L. chagasi topo II, was isolated from genomic DNA using the polymerase chain reaction. The LchTOP2 gene revealed an open reading frame (ORF) of 3,711 base pairs predicting a protein with 1,236 amino acids and an estimated molecular weight of 140 kDA. The L. chagasi topo II sequence had high identity with the L. donovani topo II (98.8%) and L. infantum topo II (98.7%), followed by Crithidia fasciculata topo II (84.4%), Trypanosoma cruzi topo II (67.6%) and Trypanosoma brucei topo II (66.6%). Lch topo II had low identity with the human homologs htopo II alpha (26.3%) and htopo II beta (26.4%). Differences between L. chagasi TOP2 and human TOP2 genes suggest that leishmanial topo II is a potential target for the development of new antileishmanial agents.
C1 Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, 59072970 Natal, RN, Brazil.
   Univ Fed Bahia, Serv Imunol, Salvador, BA, Brazil.
   Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA.
   Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, CP 1624, 59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [5 D43 TW00909] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [2
   P50 AI30639] Funding Source: Medline; FOGARTY INTERNATIONAL CENTERUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW000909,
   D43TW000909, D43TW000909, D43TW000909, D43TW000909, D43TW000909,
   D43TW000909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER
CR Bodley AL, 2003, P NATL ACAD SCI USA, V100, P7539, DOI 10.1073/pnas.1330762100
   Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5
   Das A, 2001, NUCLEIC ACIDS RES, V29, P1844, DOI 10.1093/nar/29.9.1844
   Gamage SA, 1997, J MED CHEM, V40, P2634, DOI 10.1021/jm970232h
   GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311
   HOOPER DC, 1987, AM J MED, V82, P12
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kelly J M, 1993, Methods Mol Biol, V21, P123
   Pearson, 1999, Curr Infect Dis Rep, V1, P448, DOI 10.1007/s11908-999-0057-8
   SHAPIRO TA, 1990, P NATL ACAD SCI USA, V87, P950, DOI 10.1073/pnas.87.3.950
   SHAPIRO TA, 1989, J BIOL CHEM, V264, P4173
   SHEN LL, 1989, J BIOL CHEM, V264, P2973
   Slunt KM, 1996, ANTIMICROB AGENTS CH, V40, P706, DOI 10.1128/AAC.40.3.706
   Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   WERBOVETZ KA, 1992, ANTIMICROB AGENTS CH, V36, P495, DOI 10.1128/AAC.36.2.495
   WERBOVETZ KA, 1994, MOL BIOCHEM PARASIT, V65, P1, DOI 10.1016/0166-6851(94)90110-4
NR 17
TC 6
Z9 6
U1 0
U2 2
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0036-5548
EI 1651-1980
J9 SCAND J INFECT DIS
JI Scand. J. Infect. Dis.
PD DEC
PY 2003
VL 35
IS 11-12
BP 826
EP 829
DI 10.1080/00365540310017023
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA 749NX
UT WOS:000186927800009
PM 14723357
DA 2020-11-26
ER

PT J
AU Dourado, ME
   Duarte, RC
   Ferreira, LC
   Queiroz, JW
   Illa, I
   Perez-Perez, G
   Guerrant, RL
   Jeronimo, SMB
AF Dourado, ME
   Duarte, RC
   Ferreira, LC
   Queiroz, JW
   Illa, I
   Perez-Perez, G
   Guerrant, RL
   Jeronimo, SMB
TI Anti-ganglioside antibodies and clinical outcome of patients with
   Guillain-Barre Syndrome in northeast Brazil
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Article
DE Guillain-Barre Syndrome; gangliosides; Campylobacter jejuni;
   anti-ganglioside antibodies
ID CAMPYLOBACTER-JEJUNI INFECTION; MOTOR AXONAL NEUROPATHY; ANTI-GM1
   ANTIBODIES; GM1 GANGLIOSIDE; MOLECULAR MIMICRY; PERIPHERAL-NERVE; IGG
   ANTIBODIES; POLYNEUROPATHY; CONDUCTION; CHINA
AB Objectives - The goal of this study was to investigate the frequency of GM1 antibodies and to assess whether exposure to Campylobacter jejuni was associated with a distinct clinical variant of Guillain-Barre Syndrome (GBS) or disease outcome in Rio Grande do Norte, Brazil. Material and methods - Forty-one patients with a presumed diagnosis of GBS were enrolled and prospectively studied between June 1994 and November 1999. Results - Anti-GM1 was present in 51.2% (n = 21) of patients. The presence of anti-GM1 was significantly associated with acute axonal motor neuropathy when compared to acute inflammatory demyelinating polyneuropathy (P = 0.01). Patients with anti-GM1 antibodies presented distal muscle involvement and fewer sensory deficits. Age, time to nadir and ventilatory assistance were not associated with anti-GM1 antibodies. Eight out of 21 patients (32%) presented with anti-C. jejuni antibodies. Clinical features were similar for patients with GBS with positive and negative C. jejuni antibodies. Anti-GM1 antibodies were associated with C. jejuni infection (P = 0.0005). Presence of anti-GM1 and C. jejuni antibodies did not indicate a worse prognosis. Conclusion - Patients with GBS and anti-GM1 antibodies had more distal muscle weakness, fewer sensory deficits, more axonal degeneration and C. jejuni infection, but these findings were not associated with a worse prognosis.
C1 Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, BR-69072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Unidade Neurol, BR-69072970 Natal, RN, Brazil.
   Univ Barcelona, Dept Neurol, Barcelona, Spain.
   NYU, Sch Med, Dept Med & Microbiol, New York, NY USA.
   Univ Virginia, Dept Med, Charlottesville, VA USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bioquim, CP 1624, BR-69072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; ILLA, Isabel/AAD-1816-2019; Perez,
   Guillermo Perez/AAJ-3761-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Ang CW, 1999, NEUROLOGY, V53, P2122, DOI 10.1212/WNL.53.9.2122
   ARASAKI K, 1993, MUSCLE NERVE, V16, P587, DOI 10.1002/mus.880160603
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ENDERS U, 1993, ANN NEUROL, V34, P136, DOI 10.1002/ana.410340208
   Gallardo E, 2001, NEUROLOGIA, V16, P293
   GREGSON NA, 1993, Q J MED, V86, P111
   GRIFFIN JW, 1995, BRAIN, V118, P577, DOI 10.1093/brain/118.3.577
   GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986
   Hadden RDM, 2001, J APPL MICROBIOL, V90, p145S, DOI 10.1046/j.1365-2672.2001.01363.x
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   Hao Q, 1999, ANN NEUROL, V45, P758
   HARTUNG HP, 1995, MUSCLE NERVE, V18, P137, DOI 10.1002/mus.880180202
   HARVEY GK, 1995, MUSCLE NERVE, V18, P388, DOI 10.1002/mus.880180404
   Hirota N, 1997, BRAIN, V120, P2159, DOI 10.1093/brain/120.12.2159
   Ho TW, 1997, NEUROLOGY, V48, P717, DOI 10.1212/WNL.48.3.717
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   HUGHES RAC, 1997, J INFECT DIS S2, V179, P92
   ILLA I, 1995, ANN NEUROL, V38, P218, DOI 10.1002/ana.410380214
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209
   Kaida K, 2000, BRAIN, V123, P116, DOI 10.1093/brain/123.1.116
   Koga M, 2001, J NEUROL NEUROSUR PS, V71, P123, DOI 10.1136/jnnp.71.1.123
   Kusunoki S, 1997, MUSCLE NERVE, V20, P840
   Kuwabara S, 1998, NEUROLOGY, V51, P1656, DOI 10.1212/WNL.51.6.1656
   Ma JJ, 1998, NEUROLOGY, V51, P379, DOI 10.1212/WNL.51.2.379
   MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P
   Miyazaki T, 2001, NEUROLOGY, V56, P1227, DOI 10.1212/WNL.56.9.1227
   Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786
   Nishimura M, 1997, J NEUROL SCI, V153, P91, DOI 10.1016/S0022-510X(97)00170-6
   NOBILEORAZIO E, 1992, J NEUROL SCI, V109, P200, DOI 10.1016/0022-510X(92)90169-L
   O'Hanlon GM, 1998, ACTA NEUROPATHOL, V95, P605, DOI 10.1007/s004010050847
   OOMES PG, 1995, ANN NEUROL, V38, P170, DOI 10.1002/ana.410380208
   PEREZPEREZ GI, 1989, J INFECT DIS, V160, P460, DOI 10.1093/infdis/160.3.460
   PESTRONK A, 1988, ANN NEUROL, V24, P73, DOI 10.1002/ana.410240113
   REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102
   REES JH, 1995, ANN NEUROL, V38, P809, DOI 10.1002/ana.410380516
   ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706
   Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371
   TAKIGAWA T, 1995, ANN NEUROL, V37, P436, DOI 10.1002/ana.410370405
   VANDENBERG LH, J NEUROL NEUROSURG P, V55, P8
   VISSER LH, 1995, BRAIN, V118, P841, DOI 10.1093/brain/118.4.841
   VRIESENDORP FJ, 1993, ANN NEUROL, V34, P130, DOI 10.1002/ana.410340206
   Willison HJ, 1997, J INFECT DIS, V176, pS144, DOI 10.1086/513799
   Yoshino H, 2000, J NEUROIMMUNOL, V105, P195, DOI 10.1016/S0165-5728(99)00280-5
   Yuki N, 1998, J NEUROL SCI, V154, P14, DOI 10.1016/S0022-510X(97)00174-3
   YUKI N, 1993, NEUROLOGY, V43, P414, DOI 10.1212/WNL.43.2.414
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   YUKI N, 1991, NEUROLOGY, V41, P1561, DOI 10.1212/WNL.41.10.1561
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
NR 52
TC 11
Z9 11
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD AUG
PY 2003
VL 108
IS 2
BP 102
EP 108
DI 10.1034/j.1600-0404.2003.00103.x
PG 7
WC Clinical Neurology
SC Neurosciences & Neurology
GA 702AB
UT WOS:000184201000005
PM 12859286
DA 2020-11-26
ER

PT J
AU Gantt, KR
   Schultz-Cherry, S
   Rodriguez, N
   Jeronimo, SMB
   Nascimento, ET
   Goldman, TL
   Recker, TJ
   Miller, MA
   Wilson, ME
AF Gantt, KR
   Schultz-Cherry, S
   Rodriguez, N
   Jeronimo, SMB
   Nascimento, ET
   Goldman, TL
   Recker, TJ
   Miller, MA
   Wilson, ME
TI Activation of TGF-beta by Leishmania chagasi: Importance for parasite
   survival in macrophages
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID GROWTH-FACTOR-BETA; PROTEINASE-DEFICIENT MUTANTS; CATHEPSIN-B;
   NITRIC-OXIDE; VISCERAL LEISHMANIASIS; MEMBRANE GLYCOPROTEIN; CYSTEINE
   PROTEINASES; MEXICANA; SUPPRESSION; INHIBITION
AB TGF-beta is a potent regulatory cytokine that suppresses expression of inducible NO synthase and IFN-gamma, and suppresses Th1 and Th2 cell development. We examined whether functionally active TGF-beta is present in the local environment surrounding the invading protozoan Leishmania chagasi. Our prior data showed that TGF-beta levels are significantly increased in L. chagasi-infected mice. In the current study, we found TGF-beta was also abundant in bone marrows of humans with acute visceral leishmaniasis but not in those of uninfected controls. Furthermore, L. chagasi infection caused an increase in biologically active TGF-beta in human macrophage cultures without changing the total TGF-beta. Therefore, we investigated the means through which leishmania could augment activated but not total TGF-beta. Incubation of latent TGF-beta with Leishmania sp. promastigotes caused active TGF-beta to be released from the latent complex. In contrast, the nonpathogenic protozoan Crithidia fasciculata could not activate TGF-beta. TGF-beta activation by leishmania was prevented by inhibitors of cysteine proteases and by the specific cathepsin B inhibitor CA074. Physiologic concentrations of TGF-beta inhibited killing of intracellular L. chagasi in macrophages, although the phagocytosis-induced respiratory burst remained intact. In contrast, supraphysiologic concentrations of TGF-beta had no effect on parasite survival. We hypothesize that the combined effect of abundant TGF-beta stores at extracellular sites during infection, and the ability of the parasite to activate TGF-beta in its local environment, leads to high levels of active TGF-beta in the vicinity of the infected macrophage. Locally activated TGF-beta could, in turn, enhance parasite survival through its effects on innate and adaptive immune responses.
C1 Univ Iowa, Dept Internal Med, Interdisciplinary Immunol PhD Program, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Vet Affairs Med Ctr, Iowa City, IA 52240 USA.
   Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.
   Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, Interdisciplinary Immunol PhD Program, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020;
   Schultz-Cherry, Stacey/N-2506-2018
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275; Rodriguez,
   Nilda/0000-0002-5755-3680
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [TW01369] Funding Source: Medline; NIAID NIH HHSUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [T32
   AI07511, AI30639, AI45540, AI48822] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, R01AI045540, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI045540, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, R01AI045540, R01AI045540, T32AI007511,
   T32AI007511, T32AI007511, T32AI007511, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI048822, P50AI030639,
   R01AI048822, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, T32AI007511, R01AI045540, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI048822,
   R01AI045540, P50AI030639, P50AI030639, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI045540, P50AI030639, R01AI045540,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI048822, P50AI030639, P50AI030639, P50AI030639,
   R01AI048822, T32AI007511] Funding Source: NIH RePORTER
CR ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042
   Adam PJ, 2000, CYTOKINE, V12, P348, DOI 10.1006/cyto.1999.0559
   ADAMS DH, 1991, J IMMUNOL, V147, P609
   Alexander J, 1998, J IMMUNOL, V161, P6794
   BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442
   BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092
   Bart G, 1997, MOL BIOCHEM PARASIT, V88, P53, DOI 10.1016/S0166-6851(97)00072-8
   BART G, 1995, MOL BIOCHEM PARASIT, V73, P271, DOI 10.1016/0166-6851(95)00113-F
   BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x
   Bottinger EP, 1997, KIDNEY INT, V51, P1355, DOI 10.1038/ki.1997.185
   BOUTARD V, 1995, J IMMUNOL, V155, P2077
   BRANDES ME, 1991, J IMMUNOL, V147, P1600
   BUTTLE DJ, 1992, ARCH BIOCHEM BIOPHYS, V299, P377, DOI 10.1016/0003-9861(92)90290-D
   Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113
   CHANG CS, 1986, MOL BIOCHEM PARASIT, V18, P197, DOI 10.1016/0166-6851(86)90038-1
   CHAO CC, 1991, J PHARMACOL EXP THER, V256, P255
   CHAUDHURI G, 1988, MOL BIOCHEM PARASIT, V27, P43, DOI 10.1016/0166-6851(88)90023-0
   CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483
   CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094
   Dahl KE, 1996, INFECT IMMUN, V64, P399, DOI 10.1128/IAI.64.2.399-405.1996
   Das L, 2001, J IMMUNOL, V166, P4020, DOI 10.4049/jimmunol.166.6.4020
   Descoteaux A, 1998, PARASITOL TODAY, V14, P220, DOI 10.1016/S0169-4758(98)01241-1
   ETGES R, 1986, J BIOL CHEM, V261, P9098
   Frame MJ, 2000, PARASITOLOGY, V121, P367, DOI 10.1017/S0031182099006435
   Gantt KR, 2001, J IMMUNOL, V167, P893, DOI 10.4049/jimmunol.167.2.893
   Gomes NA, 1998, J INFECT DIS, V178, P1847, DOI 10.1086/314520
   Gomes NA, 2000, J IMMUNOL, V164, P2001, DOI 10.4049/jimmunol.164.4.2001
   Gomes NA, 2001, TRENDS PARASITOL, V17, P487, DOI 10.1016/S1471-4922(01)02038-4
   Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076
   Guo M, 2002, J BIOL CHEM, V277, P14829, DOI 10.1074/jbc.M108180200
   Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926
   Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777
   Johnson I, 1998, HISTOCHEM J, V30, P123, DOI 10.1023/A:1003287101868
   Jones Douglas E., 1998, Frontiers in Bioscience, V3, pD1171
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Li J, 1999, J IMMUNOL, V162, P974
   Maekawa Y, 1998, J IMMUNOL, V161, P2120
   MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401
   Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912
   Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200
   MOORE KJ, 1994, J IMMUNOL, V152, P2930
   Mundodi V, 2002, GENE, V282, P257, DOI 10.1016/S0378-1119(01)00851-4
   Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188
   NUNES I, 1995, J IMMUNOL, V155, P1450
   Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8
   OURSLER MJ, 1993, ENDOCRINOLOGY, V133, P2187, DOI 10.1210/en.133.5.2187
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   REIBMAN J, 1991, P NATL ACAD SCI USA, V88, P6805, DOI 10.1073/pnas.88.15.6805
   ROBERTSON CD, 1993, MOL BIOCHEM PARASIT, V62, P271, DOI 10.1016/0166-6851(93)90116-F
   Rodrigues V, 1998, INFECT IMMUN, V66, P1233, DOI 10.1128/IAI.66.3.1233-1236.1998
   SchultzCherry S, 1996, J VIROL, V70, P8624, DOI 10.1128/JVI.70.12.8624-8629.1996
   Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200
   SOSROSENO W, 1995, BRIT J BIOMED SCI, V52, P142
   TSUNAWAKI S, 1989, J IMMUNOL, V142, P3462
   VODOVOTZ Y, 1993, J EXP MED, V178, P605, DOI 10.1084/jem.178.2.605
   WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788
   WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587
   WILSON ME, 1986, J IMMUNOL, V136, P4681
   Wilson ME, 1998, J IMMUNOL, V161, P6148
   Yamamoto A, 2000, J BIOCHEM-TOKYO, V127, P635, DOI 10.1093/oxfordjournals.jbchem.a022651
NR 60
TC 119
Z9 122
U1 0
U2 8
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 1
PY 2003
VL 170
IS 5
BP 2613
EP 2620
DI 10.4049/jimmunol.170.5.2613
PG 8
WC Immunology
SC Immunology
GA 648JD
UT WOS:000181146800046
PM 12594289
OA Bronze
DA 2020-11-26
ER

PT J
AU de Carvalho, LP
   Soto, M
   Jeronimo, S
   Dondji, B
   Bacellar, O
   Luz, V
   Orge, GO
   Alonso, C
   Jesus, AR
   Carvalho, EM
AF de Carvalho, LP
   Soto, M
   Jeronimo, S
   Dondji, B
   Bacellar, O
   Luz, V
   Orge, GO
   Alonso, C
   Jesus, AR
   Carvalho, EM
TI Characterization of the immune response to Leishmania infantum
   recombinant antigens
SO MICROBES AND INFECTION
LA English
DT Article
DE leishmaniasis; immuneregulation; IFN-gamma; KMP11
ID AMERICAN VISCERAL LEISHMANIASIS; INHIBITS CYTOKINE PRODUCTION; MUCOSAL
   LEISHMANIASIS; CELL; INTERLEUKIN-10; DONOVANI; IL-10; INTERFERON;
   SELECTION; INFECTION
AB Leishmaniases have a high prevalence in tropical countries. In order to improve existing diagnostic systems based on total Leishmania proteins, and to identify antigen candidates for vaccine development, an intensive search for the identification of antigens was performed using molecular biology techniques. In this study, the immune response to three L. infantum recombinant antigens was evaluated. Upon stimulation with KMP11, mononuclear cells from leishmaniasis patients produced high levels of IL-10, while a predominant IFN-gamma production could be observed in cultures stimulated with H2A and soluble Leishmania antigen. All the recombinant antigens induced very little IL-5. KMP11 decreased IFN-gamma production by 48% in cultures of peripheral blood mononuclear cells from cutaneous leishmaniasis patients who had been stimulated with soluble Leishmania antigen. Furthermore, antibodies to KMP11 were detected in the sera from all patients with visceral leishmaniasis and in the majority of the sera from patients with cutaneous leishmaniasis or individuals with asymptomatic L. chagasi infection. Thus, KMP11 is recognized by cells and sera of patients with different clinical forms of leishmaniasis, and KMP11, through IL-10 production, proved to be a potent antigen in modulating type 1 immune response. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
C1 Univ Fed Bahia, SErv Imunol, Hosp Univ Prof Edgard Santos, BR-40110160 Salvador, BA, Brazil.
   UAM, CSIC, Ctr Biol Mol, Madrid, Spain.
   Univ Fed Rio Grande Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   Univ Ngaoundere, Fac Sci, Dept Biol Sci, Ngaoundere, Cameroon.
RP Carvalho, EM (corresponding author), Univ Fed Bahia, SErv Imunol, Hosp Univ Prof Edgard Santos, 5o Andar,Rua Joao Botas S-N, BR-40110160 Salvador, BA, Brazil.
RI Alvarez, Manuel Soto/Q-5234-2018; Jeronimo, Selma/AAY-4033-2020
OI Alvarez, Manuel Soto/0000-0001-6825-841X; Jeronimo,
   Selma/0000-0002-4784-9904
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-30639] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER
CR Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694
   BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72
   BOMTIM G, 1996, EXP PARASITOL, V84, P188
   BURNS JM, 1991, J IMMUNOL, V146, P742
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CARVALHO EM, 1989, J CLIN INVEST, V83, P860, DOI 10.1172/JCI113969
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   CARVALHO EM, 1985, J IMMUNOL, V135, P4144
   Castes M, 1993, Biol Res, V26, P233
   Cook JW, 2001, AM SURGEON, V67, P237
   DE WMR, 1991, J EXP MED, V174, P1209
   Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0
   FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081
   FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   Lessa HA, 2001, AM J TROP MED HYG, V65, P87, DOI 10.4269/ajtmh.2001.65.87
   MARSDEN PD, 1985, AM J TROP MED HYG, V34, P710, DOI 10.4269/ajtmh.1985.34.710
   MURRAY HW, 1983, J CLIN INVEST, V72, P1506, DOI 10.1172/JCI111107
   Pauza ME, 1999, DIABETES, V48, P1948, DOI 10.2337/diabetes.48.10.1948
   PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341
   REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79
   Rezende SA, 1997, SCAND J IMMUNOL, V46, P96, DOI 10.1046/j.1365-3083.1997.d01-92.x
   Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020
   RUSSO DM, 1991, J IMMUNOL, V147, P3575
   SACKS DL, 1987, J IMMUNOL, V138, P908
   SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675
   Skeiky YAW, 1998, J IMMUNOL, V161, P6171
   SOTO M, 1992, EUR J BIOCHEM, V205, P211, DOI 10.1111/j.1432-1033.1992.tb16770.x
   SOTO M, 1994, BBA-GENE STRUCT EXPR, V1219, P533, DOI 10.1016/0167-4781(94)90082-5
   Thomas MC, 2001, CLIN EXP IMMUNOL, V123, P465, DOI 10.1046/j.1365-2249.2001.01478.x
   Yang JS, 2000, IMMUNOLOGY, V101, P397, DOI 10.1046/j.1365-2567.2000.00115.x
NR 31
TC 34
Z9 35
U1 0
U2 4
PU EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS CEDEX 15
PA 23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE
SN 1286-4579
J9 MICROBES INFECT
JI Microbes Infect.
PD JAN
PY 2003
VL 5
IS 1
BP 7
EP 12
AR PII S1286-4579(02)00051-5
DI 10.1016/S1286-4579(02)00051-5
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 677LJ
UT WOS:000182808900002
PM 12593967
DA 2020-11-26
ER

PT J
AU Karplus, TM
   Jeronimo, SMB
   Chang, H
   Helms, BK
   Burns, TL
   Murray, JC
   Mitchell, AA
   Pugh, EW
   Braz, RFS
   Bezerra, FL
   Wilson, ME
AF Karplus, TM
   Jeronimo, SMB
   Chang, H
   Helms, BK
   Burns, TL
   Murray, JC
   Mitchell, AA
   Pugh, EW
   Braz, RFS
   Bezerra, FL
   Wilson, ME
TI Association between the tumor necrosis factor locus and the clinical
   outcome of Leishmania chagasi infection
SO INFECTION AND IMMUNITY
LA English
DT Article
ID TNF-ALPHA PROMOTER; MAJOR HISTOCOMPATIBILITY COMPLEX; BACILLE
   CALMETTE-GUERIN; VISCERAL LEISHMANIASIS; NORTHEASTERN BRAZIL;
   MULTIPLE-SCLEROSIS; GENE POLYMORPHISM; RECEPTOR DEFICIENCY;
   LYMPHOTOXIN-ALPHA; CEREBRAL MALARIA
AB A periurban outbreak of visceral leishmaniasis (VL) caused by the protozoan Leishmania chagasi is ongoing outside Natal, northeast Brazil. Manifestations range from asymptomatic infection to disseminated visceral disease. Literature reports suggest that both genetic and environmental factors influence the outcome of infection. Due to the association of the tumor necrosis factor (TNF) locus with other infectious diseases, we examined whether polymorphic alleles at this locus are associated with the outcome of L. chagasi infection. Neighborhoods with ongoing transmission were identified through patients admitted to local hospitals. Altogether, 1,024 individuals from 183 families were classified with the following disease phenotypes: (i) symptomatic VL, (ii) asymptomatic infection (positive delayed-type hypersensitivity [DTH+]), or (iii) no evidence of infection (DTH-). Genotypes were determined at a microsatellite marker (MSM) upstream of the TNFB gene encoding TNF-beta and at a restriction fragment length polymorphism (RFLP) at position -307 in the promoter of the TNFA gene encoding TNF-alpha. Analyses showed that the distribution of TNFA RFLP alleles (TNF1 and TNF2) and the TNF MSM alleles (TNFa1 to TNFa15) differed between individuals with VL and those with DTH+ phenotypes. TNF1 was transmitted more frequently than expected from heterozygous parents to DTH+ offspring (P = 0.0006), and haplotypes containing TNF2 were associated with symptomatic VL (P = 0.0265, transmission disequilibrium test). Resting serum TNF-a levels were higher in TNF1/2 heterozygotes than in TNF1/1 homozygotes (P < 0.05). These data led us to hypothesize that an individual's genotype at the TNF locus may be associated with whether he or she develops asymptomatic or symptomatic disease after L. chagasi infection. The results preliminarily suggest that this may be the case, and follow-up with larger populations is needed for verification.
C1 Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   Vet Affairs Med Ctr, Iowa City, IA 52242 USA.
   Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21218 USA.
   Univ Fed Rio Grande do Norte, Dept Biochem, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Microbiol, BR-59072970 Natal, RN, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, SW34-GH, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FIC NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)
   [R03 TW001369, TW01369-01] Funding Source: Medline; NHGRI NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)
   [N01HG65403] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 AI032135, P50 AI030639, AI32135, AI-30639-08, R21 AI032135, T32
   AI007511, T32AI07511] Funding Source: Medline; NIDDK NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [DK/AI2550] Funding Source: Medline; FOGARTY
   INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Human Genome Research
   Institute (NHGRI) [N01HG065403, N01HG065403, N01HG065403, N01HG065403,
   N01HG065403, N01HG065403] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, T32AI007511, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, T32AI007511, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   T32AI007511, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R21AI032135, T32AI007511, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, T32AI007511,
   P50AI030639, P50AI030639, T32AI007511, P50AI030639, P50AI030639,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, T32AI007511, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI032135, R01AI032135, P50AI030639, T32AI007511,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, T32AI007511, T32AI007511, P50AI030639, T32AI007511,
   T32AI007511, P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [K08DK002550, K08DK002550,
   K08DK002550, K08DK002550, K08DK002550] Funding Source: NIH RePORTER
CR Alcais A, 1997, AM J HUM GENET, V61, P968, DOI 10.1086/514882
   Allen RD, 1999, MOL IMMUNOL, V36, P1017, DOI 10.1016/S0161-5890(99)00127-3
   Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950
   Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   BARRALNETTO M, 1991, J INFECT DIS, V163, P853, DOI 10.1093/infdis/163.4.853
   Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002
   Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614
   Beutler BA, 1999, J RHEUMATOL, V26, P16
   Blackwell JM, 1998, INT J PARASITOL, V28, P21, DOI 10.1016/S0020-7519(97)00175-6
   Blackwell JM, 1997, PHILOS T R SOC B, V352, P1331, DOI 10.1098/rstb.1997.0118
   Blackwell JM, 1999, MICROBES INFECT, V1, P95, DOI 10.1016/S1286-4579(99)80020-3
   Blackwell JM, 1996, PARASITOLOGY, V112, pS67, DOI 10.1017/S0031182000076678
   BLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543
   Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x
   Braun N, 1996, NEUROSCI LETT, V215, P75, DOI 10.1016/0304-3940(96)12920-7
   BRAZ RFS, IN PRESS AM J TROP M
   Brinkman BMN, 1996, J INFLAMM, V46, P32
   CABELLO PH, 1995, AM J TROP MED HYG, V52, P364, DOI 10.4269/ajtmh.1995.52.364
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   CHIOFALO MS, 1992, MICROB PATHOGENESIS, V12, P9, DOI 10.1016/0882-4010(92)90061-R
   Corral LG, 1999, ANN RHEUM DIS, V58, P107, DOI 10.1136/ard.58.2008.i107
   DANIS VA, 1995, DIS MARKERS, V12, P127, DOI 10.1155/1994/756247
   de Jong R, 1998, SCIENCE, V280, P1435
   EVANS TG, 1989, MEM I OSWALDO CRUZ, V84, P157, DOI 10.1590/S0074-02761989000200003
   EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118
   Feitosa MF, 1999, GENET MOL BIOL, V22, P1
   Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084
   Hajeer AH, 2000, MICROSC RES TECHNIQ, V50, P216, DOI 10.1002/1097-0029(20000801)50:3<216::AID-JEMT5>3.0.CO;2-Q
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   Huizinga TWJ, 1997, J NEUROIMMUNOL, V72, P149, DOI 10.1016/S0165-5728(96)00182-8
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   JONGENEEL CV, 1991, P NATL ACAD SCI USA, V88, P9717, DOI 10.1073/pnas.88.21.9717
   Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604
   KREMSNER PG, 1991, J INFECT DIS, V164, P605, DOI 10.1093/infdis/164.3.605
   Kroeger KR, 1996, BIOCHEM MOL BIOL INT, V40, P43
   Louis E, 1998, CLIN EXP IMMUNOL, V113, P401
   MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0
   Mycko M, 1998, J NEUROIMMUNOL, V84, P198, DOI 10.1016/S0165-5728(97)00255-5
   NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053
   Peacock CS, 2001, GENET EPIDEMIOL, V20, P383, DOI 10.1002/gepi.8
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   PISA P, 1990, J INFECT DIS, V161, P988, DOI 10.1093/infdis/161.5.988
   POCIOT F, 1993, EUR J IMMUNOL, V23, P224, DOI 10.1002/eji.1830230135
   POCIOT F, 2000, EUR J IMMUNOL, V23, P3043
   Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536
   Ruuls SR, 1999, AM J HUM GENET, V65, P294, DOI 10.1086/302517
   SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x
   SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x
   Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056
   Stuber F, 1996, J INFLAMM, V46, P42
   TUMANG MCT, 1994, J IMMUNOL, V153, P768
   Uglialoro AM, 1998, TISSUE ANTIGENS, V52, P359, DOI 10.1111/j.1399-0039.1998.tb03056.x
   Verweij CL, 1999, ANN RHEUM DIS, V58, P20, DOI 10.1136/ard.58.2008.i20
   Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863
   Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   WILSON AG, 1995, J INFLAMM, V45, P1
   Wilson AG, 1999, J HEPATOL, V30, P331, DOI 10.1016/S0168-8278(99)80082-8
   Wilson M, 1993, Violence Vict, V8, P3
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
   Zanelli E, 2001, HUM IMMUNOL, V62, P75, DOI 10.1016/S0198-8859(00)00227-5
NR 64
TC 76
Z9 80
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD DEC
PY 2002
VL 70
IS 12
BP 6919
EP 6925
DI 10.1128/IAI.70.12.6919-6925.2002
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 617TU
UT WOS:000179377600052
PM 12438370
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Braz, RFS
   Nascimento, ET
   Martins, DRA
   Wilson, ME
   Pearson, RD
   Reed, SG
   Jeronimo, SMB
AF Braz, RFS
   Nascimento, ET
   Martins, DRA
   Wilson, ME
   Pearson, RD
   Reed, SG
   Jeronimo, SMB
TI The sensitivity and specificity of Leishmania chagasi recombinant K39
   antigen in the diagnosis of American visceral leishmaniasis and in
   differentiating active from subclinical infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID HUMAN-IMMUNODEFICIENCY-VIRUS; LINKED-IMMUNOSORBENT-ASSAY;
   NATURAL-HISTORY; CLONED ANTIGEN; FOLLOW-UP; BRAZIL; SERODIAGNOSIS;
   ANTIBODY; DONOVANI; KINESIN
AB The sensitivity and specificity of a Leishmania chagasi recombinant K39 (rK39)-based enzyme-linked immunosorbent assay (ELISA) for visceral leishmaniasis (VL) was assessed in Natal, Brazil. Anti-rK39 antibodies were detected in 93.3% of patients with parasitologically confirmed VL (n = 120) and in 33 others with clinically diagnosed disease. Anti-rK39 antibodies decreased significantly following treatment. The presence of antibodies was inversely correlated with development of a positive leishmanin skin test result. Anti-rK39 antibodies were detected in only 2.9% of asymptomatic subjects with a positive skin test result (n = 168). They were not detected in healthy controls (n = 30) or in persons with Chagas' disease (n = 13) or active tuberculosis (n = 31). Antibodies were found in only one of 13 patients with cutaneous leishmaniasis. In contrast, an ELISA using total L. chagasi promastigote antigen was sensitive, but not specific. The results indicate that the rK39-based ELISA is a sensitive and specific diagnostic test for symptomatic VL and can differentiate progressive from self-resolving infection.
C1 Univ Fed Rio Grande do Norte, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Infect Dis, BR-59072970 Natal, RN, Brazil.
   Univ Iowa, Dept Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA.
   Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.
   Infect Dis Res Inst, Seattle, WA 98104 USA.
   Univ Iowa, Dept Epidemiol, Iowa City, IA 52242 USA.
RP Jeronimo, SMB (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Caixa Postal 1624, BR-59072970 Natal, RN, Brazil.
EM smbj@cb.ufrn.br
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC) [R03TW001369, R03TW001369, R03TW001369]
   Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [R03 TW01369] Funding Source: Medline
CR BADARO R, 1983, AM J TROP MED HYG, V32, P480, DOI 10.4269/ajtmh.1983.32.480
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   Badaro R, 1996, J INFECT DIS, V173, P758, DOI 10.1093/infdis/173.3.758
   BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72
   BURNS JM, 1993, P NATL ACAD SCI USA, V90, P775, DOI 10.1073/pnas.90.2.775
   CHOUDHRY A, 1990, T ROY SOC TROP MED H, V84, P363, DOI 10.1016/0035-9203(90)90319-A
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DEROSSELL RA, 1987, PARASITE IMMUNOL, V9, P105, DOI 10.1111/j.1365-3024.1987.tb00492.x
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   HAILU A, 1990, T ROY SOC TROP MED H, V84, P673, DOI 10.1016/0035-9203(90)90141-Z
   HARITH AE, 1986, T ROY SOC TROP MED H, V80, P583, DOI 10.1016/0035-9203(86)90149-5
   Houghton RL, 1998, J INFECT DIS, V177, P1339, DOI 10.1086/515289
   JAFFE CL, 1988, J INFECT DIS, V157, P1212, DOI 10.1093/infdis/157.6.1212
   Jeronimo SMB, 2000, CLIN INFECT DIS, V30, P608, DOI 10.1086/313697
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   KHER V, 1991, NEPHROL DIAL TRANSPL, V6, P736, DOI 10.1093/ndt/6.10.736
   MONTALBAN C, 1990, J INFECTION, V21, P261, DOI 10.1016/0163-4453(90)93933-J
   PALATNIKDESOUSA CB, 1995, T ROY SOC TROP MED H, V89, P390, DOI 10.1016/0035-9203(95)90022-5
   PEARSON RD, 2000, PRINCIPLES PRACTICE, P2831
   QU JQ, 1994, T ROY SOC TROP MED H, V88, P543, DOI 10.1016/0035-9203(94)90154-6
   REED SG, 1990, AM J TROP MED HYG, V43, P632, DOI 10.4269/ajtmh.1990.43.632
   SCOTT JM, 1991, AM J TROP MED HYG, V44, P272, DOI 10.4269/ajtmh.1991.44.272
   SMYTH AJ, 1992, PARASITOLOGY, V105, P183, DOI 10.1017/S0031182000074096
   Sundar S, 1998, LANCET, V351, P563, DOI 10.1016/S0140-6736(97)04350-X
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
NR 27
TC 75
Z9 81
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2002
VL 67
IS 4
BP 344
EP 348
DI 10.4269/ajtmh.2002.67.344
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 613EP
UT WOS:000179119400004
PM 12452487
OA Green Published, Bronze
DA 2020-11-26
ER

PT J
AU Ximenes, MDFFD
   Maciel, JC
   Jeronimo, SMB
AF Ximenes, MDFFD
   Maciel, JC
   Jeronimo, SMB
TI Characteristics of the biological cycle of Lutzomyia evandroi Costa Lima
   & Antunes, 1936 (Diptera : Psychodidae) under experimental conditions
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Lutzomyia evandroi; oviposition; biological cycle
ID SAND FLIES DIPTERA; GRANDE-DO-NORTE; VISCERAL LEISHMANIASIS; BRAZIL;
   STATE; AREA
AB Lutzomyia evandroi Costa Lima and Antunes, 1936 is found in Rio Grande do Norte, northeastern Brazil, in areas of visceral and mucocutaneous leishmaniasis and follows the same geographic distribution of L. longipalpis. The biological cycle, oviposition, morphological and behavioral characteristics of the species were studied under experimental conditions. The average number of eggs per wild caught female varied from 21 to 50 eggs along the year, with apeak occurring between January and March and another in August, with oviposition lasting for 4 to 12 days. The mean larval phase was 24 days. Ovipositing rates were influenced by rainfall and temperature indexes, with an increase of eggs per oviposition at the beginning and at the end of the rainy season, and a decrease at the peak of the rainy season.
C1 Univ Fed Rio Grande Norte, Dept Microbiol & Parasitol, BR-59078970 Natal, RN, Brazil.
   Univ Fed Rio Grande Norte, Dept Bioquim, Ctr Biociencias, BR-59078970 Natal, RN, Brazil.
RP Ximenes, MDFFD (corresponding author), Univ Fed Rio Grande Norte, Dept Microbiol & Parasitol, Av Sen Salgado Filho S-N, BR-59078970 Natal, RN, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
CR Brazil R P, 1984, Mem Inst Oswaldo Cruz, V79, P375, DOI 10.1590/S0074-02761984000300013
   DEANE L. M., 1957, REV BRASIL MALARIOL E DOENCAS TROP, V9, P225
   DIAELDIN, 1991, MED VET ENTOMOL, V5, P87
   DIAELDIN, 1992, J MED ENT, V29, P5
   Ferro C, 1998, MEM I OSWALDO CRUZ, V93, P195, DOI 10.1590/S0074-02761998000200011
   FORATTINI O. P., 1953, Arch. Fac. Hig. Saude Publ. Univ. S. Paulo, V7, P157
   KILLICKKENDRICK R, 1977, J MED ENTOMOL, V13, P429, DOI 10.1093/jmedent/13.4-5.429
   Lawyer P.G., 1991, Parassitologia (Rome), V33, P361
   MARTINS AV, 1978, AM SAND FLIES
   MCCALL PJ, 1995, PARASITOL TODAY, V11, P352, DOI 10.1016/0169-4758(95)80192-8
   QUEIROZ RG, 1991, PARASITOLOGIA S1, V33, P157
   RANGEL E F, 1986, Memorias do Instituto Oswaldo Cruz, V81, P431, DOI 10.1590/S0074-02761986000400010
   Rowton E.D., 1991, Parassitologia (Rome), V33, P33
   SCORZA JV, 1994, REV SAUDE PUBL, V28, P400, DOI 10.1590/S0034-89101994000600002
   Sherlock IA, 1996, MEM I OSWALDO CRUZ, V91, P671, DOI 10.1590/S0074-02761996000600003
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Ximenes MDFD, 2000, J MED ENTOMOL, V37, P162, DOI 10.1603/0022-2585-37.1.162
   Young DG, 1994, MEMOIRS AM ENTOMOLOG, V54
NR 18
TC 9
Z9 11
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD AUG
PY 2001
VL 96
IS 6
BP 883
EP 886
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 461JT
UT WOS:000170361700025
PM 11562720
OA DOAJ Gold
DA 2020-11-26
ER

PT J
AU Gantt, KR
   Goldman, TL
   McCormick, ML
   Miller, MA
   Jeronimo, SMB
   Nascimento, ET
   Britigan, BE
   Wilson, ME
AF Gantt, KR
   Goldman, TL
   McCormick, ML
   Miller, MA
   Jeronimo, SMB
   Nascimento, ET
   Britigan, BE
   Wilson, ME
TI Oxidative responses of human and murine macrophages during phagocytosis
   of Leishmania chagasi
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID NITRIC-OXIDE-SYNTHASE; PROTEIN-KINASE-C; NECROSIS-FACTOR-ALPHA; IN-VIVO;
   MONONUCLEAR PHAGOCYTES; ACTIVATED MACROPHAGES; HYDROGEN-PEROXIDE;
   REACTIVE NITROGEN; IMMUNE-RESPONSE; IFN-GAMMA
AB Leishmania chagasi, the cause of South American visceral leishmaniasis, must survive antimicrobial responses of host macrophages to establish infection. Macrophage oxidative responses have been shown to diminish in the presence of intracellular leishmania. However, using electron spin resonance we demonstrated that murine and human macrophages produce O-2 during phagocytosis of opsonized promastigotes. Addition of the O-2(-) scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl to cultures resulted in increased infection, suggesting that O-2(-) enhances macrophage leishmanicidal activity. The importance of NO. produced by inducible NO synthase (iNOS) in controlling murine leishmaniasis is established, but its role in human macrophages has been debated. We detected NO. in supernatants from murine, but not human, macrophages infected with L. chagasi. Nonetheless, the iNOS inhibitor N-G-monomethyl-L-arginine inhibited IFN-gamma-mediated intracellular killing by both murine and human macrophages. According to RNase protection assay and immunohistochemistry, iNOS mRNA and protein were expressed at higher levels in bone marrow of patients with visceral leishmaniasis than in controls. The iNOS protein also increased upon infection of human macrophages with L. chagasi promastigotes in vitro in the presence of IFN-gamma. These data suggest that O-2(-) and NO. each contribute to intracellular killing of L. chagasi inhuman and murine macrophages.
C1 Univ Iowa, Dept Internal Med, Program Immunol, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Iowa, Program Free Radical & Radiat Biol, Iowa City, IA 52242 USA.
   Univ Fed Rio Grande do Norte, BR-59072970 Natal, RN, Brazil.
RP Wilson, ME (corresponding author), Univ Iowa, Dept Internal Med, Program Immunol, SW34-GH,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM mary-wilson@uiowa.edu
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 32135, AI 34954, AI 30639-08] Funding
   Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK/AI 52550] Funding
   Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P50AI030639, P50AI030639, P50AI030639,
   R01AI034954, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI034954, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI034954, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, R01AI034954, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R21AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, R01AI034954, P50AI030639, R01AI034954, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI034954, P50AI030639, P50AI030639, R01AI032135, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, R01AI034954, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI034954, P50AI030639,
   R01AI032135, R01AI034954, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R03DK052550, R03DK052550] Funding Source: NIH
   RePORTER
CR ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328
   Aubry JP, 1997, J IMMUNOL, V159, P614
   BERENS RL, 1976, J PARASITOL, V62, P360, DOI 10.2307/3279142
   BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324
   Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S
   BRITIGAN BE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P213, DOI 10.1016/0304-4165(91)90269-M
   CHAN J, 1989, P NATL ACAD SCI USA, V86, P2453, DOI 10.1073/pnas.86.7.2453
   CHANNON JY, 1984, IMMUNOLOGY, V53, P345
   CUNHA FQ, 1993, EUR J IMMUNOL, V23, P1385, DOI 10.1002/eji.1830230631
   DESCOTEAUX A, 1991, J IMMUNOL, V146, P2747
   DESCOTEAUX A, 1992, J IMMUNOL, V149, P3008
   Diefenbach A, 1999, SCIENCE, V284, P951, DOI 10.1126/science.284.5416.951
   Diefenbach A, 1998, IMMUNITY, V8, P77, DOI 10.1016/S1074-7613(00)80460-4
   EVANS TG, 1993, J IMMUNOL, V151, P907
   Facchetti F, 1999, AM J PATHOL, V154, P145, DOI 10.1016/S0002-9440(10)65261-3
   FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501, DOI 10.1099/00221287-139-3-501
   Gariboldi MB, 1998, FREE RADICAL BIO MED, V24, P913, DOI 10.1016/S0891-5849(97)00372-9
   GREEN SJ, 1991, J LEUKOCYTE BIOL, V50, P93
   GREEN SJ, 1990, J IMMUNOL, V144, P278
   KAYE PM, 1994, EUR J IMMUNOL, V24, P2850, DOI 10.1002/eji.1830241140
   Knapp LT, 2000, J BIOL CHEM, V275, P24136, DOI 10.1074/jbc.M002043200
   KWAN WC, 1992, INFECT IMMUN, V60, P2115, DOI 10.1128/IAI.60.5.2115-2120.1992
   LIEW FY, 1990, J IMMUNOL, V145, P4306
   LIEW FY, 1990, J IMMUNOL, V144, P4794
   LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216
   Lopez-Ongil S, 2000, J BIOL CHEM, V275, P26423, DOI 10.1074/jbc.M000767200
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   METCALF JA, LAB MANUAL NEUTROPHI
   Miller MA, 2000, J BIOL CHEM, V275, P33883, DOI 10.1074/jbc.M003671200
   MOODY SF, 1993, J BIOL CHEM, V268, P18457
   MOORE KJ, 1994, J LEUKOCYTE BIOL, V55, P91
   MURRAY HW, 1992, J INFECT DIS, V165, P513, DOI 10.1093/infdis/165.3.513
   Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741
   MURRAY HW, 1982, J IMMUNOL, V129, P351
   NACY CA, 1991, PATHOBIOLOGY, V59, P182, DOI 10.1159/000163640
   NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995
   NAUSEEF WM, 1991, J BIOL CHEM, V266, P5911
   Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293
   NOBEN NN, 1994, INT IMMUNOL, V6, P935, DOI 10.1093/intimm/6.7.935
   Olivier M, 1998, J BIOL CHEM, V273, P13944, DOI 10.1074/jbc.273.22.13944
   OLIVIER M, 1992, P NATL ACAD SCI USA, V89, P7481, DOI 10.1073/pnas.89.16.7481
   OLIVIER M, 1992, J IMMUNOL, V148, P1188
   PEARSON RD, 1982, J IMMUNOL, V129, P1282
   Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1
   REINER NE, 1987, J IMMUNOL, V138, P1926
   Spink J, 1997, J BIOL CHEM, V272, P24417, DOI 10.1074/jbc.272.39.24417
   VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804
   WILSON ME, 1994, INFECT IMMUN, V62, P5133, DOI 10.1128/IAI.62.11.5133-5141.1994
   WILSON ME, 1986, J IMMUNOL, V136, P4681
   WILSON ME, 1988, INFECT IMMUN, V56, P363, DOI 10.1128/IAI.56.2.363-369.1988
   ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461
NR 51
TC 208
Z9 211
U1 0
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUL 15
PY 2001
VL 167
IS 2
BP 893
EP 901
DI 10.4049/jimmunol.167.2.893
PG 9
WC Immunology
SC Immunology
GA 471VL
UT WOS:000170949300036
PM 11441096
OA Bronze
DA 2020-11-26
ER

PT J
AU Bacellar, O
   D'Oliveira, A
   Jeronimo, S
   Carvalho, EM
AF Bacellar, O
   D'Oliveira, A
   Jeronimo, S
   Carvalho, EM
TI IL-10 and IL-12 are the main regulatory cytokines in visceral
   leishmaniasis
SO CYTOKINE
LA English
DT Article
DE cytokines; interleukin 10; interleukin 12; leishmaniasis; visceral
   leishmaniasis
ID INTERFERON-GAMMA; MAJOR INFECTION; T-CELLS; INTERLEUKIN-12; DONOVANI;
   RESPONSES; MICE; SUSCEPTIBILITY; PROLIFERATION; MACROPHAGES
AB Visceral leishmaniasis (VL) is characterized by the absence of cytokines such as IFN-gamma and IL-12, Cure of VL is associated with a restoration of the ability to make these cytokines, The aim of the present study was to evaluate the role of IL-12 in the recovery of the ability to produce IFN-gamma and to test whether or not IL-4 IL-10 and/or TGF-beta could suppress IFN-gamma production by PBMC from treated VL patients. High stimulation index (SI) of proliferation was observed in PBMC from subjects stimulated with Leishmania chagasi antigen (181 +/- 83), Neutralizing IL-12 inhibited lymphoproliferation [stimulation index (SI) of 210 +/- 114 to 1 +/- 0.6 (P<0.01)] and/or the production of IFN-gamma [2792 +/- 402 pg/ml to 407 +/- 449 pg/ml (P<0.01)]. Recombinant IL-10 abrogated the lymphoproliferation (SI=2 +/- 3) while recombinant IL-4 or TGF-beta had no effect on this response (147 +/- 22 and 194 +/- 12 respectively), IFN-gamma was high when PBMCs mere stimulated with L. chagasi (873 +/- 400 pg/ml) and this was abrogated by the addition of IL-10 (5 +/- 2 pg/ml), In contrast neither IL-4 or TGF-beta suppressed IFN-gamma production (837 +/- 244 pg/ml and 759 +/- 523 pg/ml), These results indicate that IL-12 plays an important role in the ability of treated VL patients to make IFN-g and that IL-10 but not IL-4 or TGF-beta inhibits this response. (C) 2000 Academic Press.
C1 UFBA, Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil.
   Univ Fed Rio Grande Norte, Inst Ciencias Biol, BR-59072970 Natal, RN, Brazil.
RP Carvalho, EM (corresponding author), UFBA, Hosp Univ Prof Edgard Santos, Serv Imunol, Rua Joao Botas S-N,Canela 40-110-160,3 Andar, Salvador, BA, Brazil.
RI Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma/0000-0002-4784-9904
CR AFONSO LCC, 1994, SCIENCE, V263, P235, DOI 10.1126/science.7904381
   ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328
   Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515
   BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092
   CARVALHO EM, 1988, BRAZ J MED BIOL RES, V21, P85
   CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   CARVALHO EM, 1994, J IMMUNOL, V152, P5949
   CARVALHO EM, 1981, INFECT IMMUN, V22, P649
   DING L, 1993, J IMMUNOL, V151, P1224
   FARRELL JP, 1989, J IMMUNOL, V142, P2052
   GHALIB HW, 1995, J IMMUNOL, V154, P4623
   HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59
   KEMP M, 1993, INFECT IMMUN, V61, P1069, DOI 10.1128/IAI.61.3.1069-1073.1993
   KUBIN M, 1994, J EXP MED, V180, P211, DOI 10.1084/jem.180.1.211
   MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199
   MURRAY HW, 1995, J EXP MED, V181, P387, DOI 10.1084/jem.181.1.387
   MURRAY HW, 1983, J CLIN INVEST, V72, P1506, DOI 10.1172/JCI111107
   NABORS GS, 1995, P NATL ACAD SCI USA, V92, P3142, DOI 10.1073/pnas.92.8.3142
   NobenTrauth N, 1996, SCIENCE, V271, P987, DOI 10.1126/science.271.5251.987
   SAHA B, 1995, EUR J IMMUNOL, V25, P2494
   Scott P, 1996, EXP PARASITOL, V84, P178, DOI 10.1006/expr.1996.0103
   Wilson ME, 1998, J IMMUNOL, V161, P6148
   ZWINGENBERGER K, 1990, CLIN IMMUNOL IMMUNOP, V57, P242, DOI 10.1016/0090-1229(90)90038-R
NR 24
TC 91
Z9 96
U1 0
U2 1
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 1043-4666
J9 CYTOKINE
JI Cytokine
PD AUG
PY 2000
VL 12
IS 8
BP 1228
EP 1231
DI 10.1006/cyto.2000.0694
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 344DA
UT WOS:000088741300010
PM 10930301
DA 2020-11-26
ER

PT J
AU Jeronimo, SMB
   Teixeira, MJ
   Sousa, AD
   Thielking, P
   Pearson, RD
   Evans, TG
AF Jeronimo, SMB
   Teixeira, MJ
   Sousa, AD
   Thielking, P
   Pearson, RD
   Evans, TG
TI Natural history of Leishmania (Leishmania) chagasi infection in
   northeastern Brazil: Long-term follow-up
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
ID VISCERAL LEISHMANIASIS
C1 Univ Virginia, Sch Med, Dept Med, Div Geog & Int Med, Charlottesville, VA 22908 USA.
   Univ Virginia, Sch Med, Dept Pathol, Div Geog & Int Med, Charlottesville, VA 22908 USA.
   Univ Rochester, Sch Med & Dent, Dept Med, Infect Dis Unit, Rochester, NY USA.
RP Pearson, RD (corresponding author), Univ Virginia, Hlth Syst, Div Geog & Internal Med, Box 801374, Charlottesville, VA 22908 USA.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [AI30639] Funding
   Source: Medline
CR BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   EVANS TG, 1995, AM J TROP MED HYG, V53, P360, DOI 10.4269/ajtmh.1995.53.360
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   EVANS TG, 1989, MEM I OSWALDO CRUZ, V84, P157, DOI 10.1590/S0074-02761989000200003
   EVANS TG, 1996, EDGE DEV HLTH CRISIS, P225
   FERNANDEZGUERRERO ML, 1987, AM J MED, V83, P1098, DOI 10.1016/0002-9343(87)90948-X
NR 8
TC 64
Z9 66
U1 0
U2 2
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 1058-4838
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAR
PY 2000
VL 30
IS 3
BP 608
EP 609
DI 10.1086/313697
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 302BR
UT WOS:000086345500043
PM 10722458
OA Bronze
DA 2020-11-26
ER

PT J
AU Ximenes, MDFD
   Castellon, EG
   de Souza, MD
   Freitas, RA
   Pearson, RD
   Wilson, ME
   Jeronimo, SMB
AF Ximenes, MDFD
   Castellon, EG
   de Souza, MD
   Freitas, RA
   Pearson, RD
   Wilson, ME
   Jeronimo, SMB
TI Distribution of phlebotomine sand flies (Diptera : Psychodidae) in the
   state of Rio Grande do Norte, Brazil
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Lutzomyia spp.; sand flies; leishmaniasis; Rio Grande do Norte
ID VISCERAL LEISHMANIASIS; LUTZOMYIA-LONGIPALPIS; CUTANEOUS LEISHMANIASIS;
   ENDEMIC AREA; EPIDEMIOLOGY; IDENTIFICATION; POPULATIONS; ECOLOGY; FOCUS
AB Visceral and cutaneous leishmaniasis are major endemic diseases in northeast: Brazil. The objective of the current study was to determine the species and geographic distribution of potential sand fly vectors of Leishmania in the state of Rio Grande do Norte. Sand flies were captured using CDC light traps in 30 municipalities distributed throughout the 8 geographic zones of the state. Twelve Lutzomyia species were identified. Lutzomyia longipalpis Lutz & Neiva was the most prevalent and accounted for 85.59% of the sand fly captured. The remaining species were distributed as follows: L. evandroi Costa Lima & Antunes (10.83%), L. oswaldoi Mangabeira (0.99%), L. sallesi Galvao & Coutinho (0.58%), L. intermedia Lutz & Neiva (0.53%), L. lenti Mangabeira (0.53%), L. migonei Franca (0.49%), L. walkeri Newstead (0.24%), L. goiana Martins, Falcao & Silva (0.15%), L. samueli Deane (0.04%), and L. capixaba Dias, Falcao, Silva & Martins (0.03%), and L. peresi Mangabeira (0.01%). L. longipalpis, which is known to be a vector of Leishmania chagasi Cunha & Chagas (L. donovani chagasi), was captured in 93% of municipalities distributed across all geographical areas of the state and its distribution was independent of obvious climatic and, topographic parameters. It was identified in all municipalities where human visceral leishmaniasis had been reported. In contrast, climate and topography appeared to be important for other Lutzomyia species. For example, L. intermedia and L. migonei, which are known to transmit Leishmania braziliensis Viana, were geographically restricted. They were captured in municipalities where cases of cutaneous and mucosal leishmaniasis had been reported. The widespread distribution of L. longipalpis, its adaptation to peridomicillary settings, and its ability to transmit L. (d.) chagasi suggest that a large number of persons may be at risk of acquiring visceral leishmaniasis in the state of Rio Grande do Norte, Brazil.
C1 Univ Fed Rio Grande Norte, Ctr Biociencias, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
   Inst Nacl Pesquisa Amazonia, BR-69011970 Manaus, Amazonas, Brazil.
   Univ Virginia, Sch Med, Dept Med, Div Geog & Int Med, Charlottesville, VA 22908 USA.
   Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.
   Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.
   Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.
   Univ Fed Rio Grande Norte, Ctr Biociencias, Dept Biochem, BR-59072970 Natal, RN, Brazil.
RP Ximenes, MDFD (corresponding author), Univ Fed Rio Grande Norte, Ctr Biociencias, Dept Microbiol & Parasitol, BR-59072970 Natal, RN, Brazil.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Wilson, Mary/0000-0001-8680-7275
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, R01AI032135,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, R01AI032135, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R21AI032135, R01AI032135,
   P50AI030639, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, R01AI032135, P50AI030639, P50AI030639, P50AI030639,
   R01AI032135, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, R01AI032135, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639, P50AI030639, P50AI030639, P50AI030639, P50AI030639,
   P50AI030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [K08DK002550, K08DK002550, K08DK002550, K08DK002550, K08DK002550]
   Funding Source: NIH RePORTER; NIAID NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [AI-30639-08, AI32135] Funding Source: Medline; NIDDK NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [DK/AI2550] Funding Source: Medline
CR ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098
   AZEVEDO ACR, 1991, MEM I OSWALDO CRUZ, V86, P405, DOI 10.1590/S0074-02761991000400005
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BRANDAO SP, 1994, MEM I O CRUZ, V89, P427
   Castellon E. G., 1991, Acta Amazonica, V21, P51
   Castellon Eloy G., 1994, Acta Amazonica, V24, P91
   Dawkins R, 1976, SELFISH GENE
   DEANE L. M., 1957, REV BRASIL MALARIOL E DOENCAS TROP, V9, P225
   DEANE LEONIDaS M., 1962, REV INST MED TROP SAO PAULO, V4, P198
   DIAS E S, 1986, Memorias do Instituto Oswaldo Cruz, V81, P215, DOI 10.1590/S0074-02761986000200011
   Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
   DYE C, 1991, ANIM BEHAV, V42, P183, DOI 10.1016/S0003-3472(05)80549-4
   EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P119, DOI 10.1590/S0074-02761987000100019
   FORATTINI O. P., 1953, Arch. Fac. Hig. Saude Publ. Univ. S. Paulo, V7, P157
   FRYAUFF DJ, 1993, AM J TROP MED HYG, V49, P598, DOI 10.4269/ajtmh.1993.49.598
   GOMES AD, 1994, MEM I OSWALDO CRUZ, V89, P457, DOI 10.1590/S0074-02761994000300030
   *I DES EC MEIO AMB, 1994, PERF EST RIO GRAND N
   *I DES EC MEIO AMB, 1997, AN EST RIO GRAND NOR
   JERONIMO SMB, 1995, J INFECT DIS, V172, P1055, DOI 10.1093/infdis/172.4.1055
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   Kaul S.M., 1992, Journal of Communicable Diseases, V23, P257
   Kelly DW, 1997, ANIM BEHAV, V53, P721, DOI 10.1006/anbe.1996.0309
   LACERDA MM, 1994, MEM I OSWALDO CRUZ, V89, P489, DOI 10.1590/S0074-02761994000300036
   LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027
   LAINSON R, 1978, NATURE, V273, P595, DOI 10.1038/273595a0
   LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839
   *MIN SAUD FUND NAC, 1994, GUIA VIG EP
   PENNA HA, 1934, J BRASILIERO MED, V48, P949
   QUINNELL RJ, 1994, B ENTOMOL RES, V84, P379, DOI 10.1017/S0007485300032508
   Ryan L., 1986, FLEBOTOMOS ESTADO PA
   *SECR SAUD PUBL RI, 1997, DOENC NOT COMP
   SHERLOCK I, 1966, MEM I O CRUZ, V91, P671
   TEODORO U, 1993, REV SAUDE PUBL, V27, P242, DOI 10.1590/S0034-89101993000400003
   TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287
   WARD RD, 1993, B ENTOMOL RES, V83, P437, DOI 10.1017/S0007485300029357
   Ximenes MDFD, 1999, MEM I OSWALDO CRUZ, V94, P427
   Young D.G., 1994, MEM AM ENTOMOL I, V54, P88
   Young D.G., 1991, PHLEBOTOMINE SANDFLI
NR 40
TC 29
Z9 30
U1 0
U2 1
PU ENTOMOL SOC AMER
PI LANHAM
PA 9301 ANNAPOLIS RD, LANHAM, MD 20706 USA
SN 0022-2585
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JAN
PY 2000
VL 37
IS 1
BP 162
EP 169
DI 10.1603/0022-2585-37.1.162
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 359RB
UT WOS:000089624900024
PM 15218921
DA 2020-11-26
ER

PT J
AU Nader, HB
   Chavante, SF
   dos-Santos, EA
   Oliveira, FW
   de-Paiva, JF
   Jeronimo, SMB
   Medeiros, GF
   de-Abreu, LRD
   Leite, EL
   de-Sousa, JF
   Castro, RAB
   Toma, T
   Tersariol, ILS
   Porcionatto, MA
   Dietrich, CP
AF Nader, HB
   Chavante, SF
   dos-Santos, EA
   Oliveira, FW
   de-Paiva, JF
   Jeronimo, SMB
   Medeiros, GF
   de-Abreu, LRD
   Leite, EL
   de-Sousa, JF
   Castro, RAB
   Toma, T
   Tersariol, ILS
   Porcionatto, MA
   Dietrich, CP
TI Heparan sulfates and heparins: similar compounds performing the same
   functions in vertebrates and invertebrates?
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 5th Brazilian Symposium on Extracellular Matrix (SIMEC 98)
CY SEP 07-10, 1998
CL ANGRA DOS REIS, BRAZIL
DE heparin, occurrence and function; heparan sulfate, occurrence and
   function; heparin, invertebrates; heparan sulfate, invertebrates;
   heparin and heparan sulfate, structure
ID ANOMALOCARDIA-BRASILIANA; FLAVOBACTERIUM-HEPARINUM; DIFFERENT ORIGINS;
   DEGRADATION; MUCOPOLYSACCHARIDES; GLYCOSAMINOGLYCANS; IDENTIFICATION;
   PROTEOGLYCAN; MAINTENANCE; EVOLUTION
AB The distribution and structure of heparan sulfate and heparin are briefly reviewed. Heparan sulfate is a ubiquitous compound of animal cells whose structure has been maintained throughout evolution, showing an enormous variability regarding the relative amounts of its disaccharide units. Heparin, on the other hand, is present only in a few tissues and species of the animal kingdom and in the form of granules inside organelles in the cytoplasm of special cells. Thus, the distribution as well as the main structural features of the molecule, including its main disaccharide unit, have been maintained through evolution. These and other studies led to the proposal that heparan sulfate may be involved in the cell-cell recognition phenomena and control of cell growth, whereas heparin may be involved in defense mechanisms against bacteria and other foreign materials. All indications obtained thus far suggest that these molecules perform the same functions in vertebrates and invertebrates.
C1 Univ Fed Sao Paulo, Dept Bioquim, Escola Paulista Med, BR-04044020 Sao Paulo, Brazil.
   Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil.
   Univ Fed Rio Grande do Norte, Dept Oceanog, BR-59072970 Natal, RN, Brazil.
   Univ Mogi das Cruzes, Ctr Ciencias Biomed, Mogi Das Cruzes, SP, Brazil.
RP Nader, HB (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Escola Paulista Med, Rua 3 Maio 100,4 Andar, BR-04044020 Sao Paulo, Brazil.
RI Jeronimo, Selma/AAY-4033-2020; Nader, Helena B/D-9253-2012; Tersariol,
   Ivarne Luiz Dos Santos/G-4042-2012; Jeronimo, Selma M.B./M-8672-2014;
   Porcionatto, Marimelia/C-3322-2012
OI Jeronimo, Selma/0000-0002-4784-9904; Tersariol, Ivarne Luiz Dos
   Santos/0000-0002-8399-4535; Jeronimo, Selma M.B./0000-0002-4784-9904;
   Porcionatto, Marimelia/0000-0001-6287-916X; NADER,
   HELENA/0000-0002-7569-2166; Santos, Elizeu/0000-0003-4372-2161
CR BIANCHINI P, 1985, THROMB RES, V40, P49, DOI 10.1016/0049-3848(85)90349-4
   BURSON SL, 1956, J AM CHEM SOC, V78, P5874, DOI 10.1021/ja01603a045
   CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   CHAVANTE SF, 1997, 15 ANN M SOC BRAS BI, P101
   DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5
   DIETRICH CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P1, DOI 10.1016/0304-4165(85)90041-8
   DIETRICH CP, 1983, COMP BIOCHEM PHYS B, V76, P695, DOI 10.1016/0305-0491(83)90379-6
   Dietrich CP, 1998, CELL MOL BIOL, V44, P417
   DIETRICH CP, 1989, INT J BIOL MACROMOL, V11, P361, DOI 10.1016/0141-8130(89)90008-1
   DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7
   DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2
   FERREIRA TMPC, 1993, INT J BIOCHEM, V25, P1219, DOI 10.1016/0020-711X(93)90070-U
   GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7
   HOGLUND L, 1976, COMP BIOCHEM PHYS B, V53, P9, DOI 10.1016/0305-0491(76)90087-0
   HOVINGH P, 1982, J BIOL CHEM, V257, P9840
   KATZMAN RL, 1969, SCIENCE, V166, P758, DOI 10.1126/science.166.3906.758
   LINDAHL U, 1984, J BIOL CHEM, V259, P2368
   LINKER A, 1977, FED PROC, V36, P43
   LINKER A, 1979, BIOCHEM J, V183, P711, DOI 10.1042/bj1830711
   LINKER A, 1975, BIOCHIM BIOPHYS ACTA, V385, P324, DOI 10.1016/0304-4165(75)90360-8
   LINKER A, 1975, CONNECT TISSUE RES, V3, P33, DOI 10.3109/03008207509152339
   LYON M, 1994, J BIOL CHEM, V269, P11208
   Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804
   NADER HB, 1983, COMP BIOCHEM PHYS B, V76, P433, DOI 10.1016/0305-0491(83)90271-7
   NADER HB, 1988, CARBOHYD RES, V184, P292, DOI 10.1016/0008-6215(88)80034-X
   NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565
   NADER HB, 1984, J BIOL CHEM, V259, P1431
   NADER HB, 1989, HEPARIN CHEM BIOL PR
   PAIVA JF, 1995, COMP BIOCHEM PHYS A, V111, P495, DOI 10.1016/0300-9629(94)00021-K
   PEJLER G, 1987, J BIOL CHEM, V262, P11413
   PERSON P, 1967, BIOL BULL, V132, P244, DOI 10.2307/1539892
   Porcionatto MA, 1998, J CELL BIOCHEM, V70, P563, DOI 10.1002/(SICI)1097-4644(19980915)70:4<563::AID-JCB12>3.0.CO;2-I
   PORCIONATTO MA, 1994, BRAZ J MED BIOL RES, V27, P2185
   RAHEMTULLA F, 1975, COMP BIOCHEM PHYS B, V50, P631, DOI 10.1016/0305-0491(75)90102-9
   RAHEMTULLA F, 1975, COMP BIOCHEM PHYS B, V50, P627, DOI 10.1016/0305-0491(75)90101-7
   RAHEMTULLA F, 1974, COMP BIOCHEM PHYSIOL, V49, P631, DOI 10.1016/0305-0491(74)90249-1
   RAHEMTULLA F, 1976, COMP BIOCHEM PHYS B, V53, P295, DOI 10.1016/0305-0491(76)90329-1
   RAHEMTULLA F, 1974, COMP BIOCHEM PHYSIOL, V49, P639, DOI 10.1016/0305-0491(74)90250-8
   RAHEMTULLA F, 1976, COMP BIOCHEM PHYS B, V53, P15, DOI 10.1016/0305-0491(76)90088-2
   ROSENBERG RD, 1979, P NATL ACAD SCI USA, V76, P1218, DOI 10.1073/pnas.76.3.1218
   SANTOS EA, 1997, THESIS UNIFESP SAO P
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   SILVA ME, 1974, BIOCHEM BIOPH RES CO, V56, P965, DOI 10.1016/S0006-291X(74)80283-4
   TERSARIOL ILS, 1994, BRAZ J MED BIOL RES, V27, P2097
   TORNA L, 1996, LAB INVEST, V75, P771
NR 45
TC 58
Z9 59
U1 0
U2 4
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAY
PY 1999
VL 32
IS 5
BP 529
EP 538
DI 10.1590/S0100-879X1999000500005
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 199NY
UT WOS:000080489600005
PM 10412563
OA DOAJ Gold, Green Published
DA 2020-11-26
ER

PT J
AU Nader, HB
   Oliveira, FW
   Jeronimo, SMB
   Chavante, SF
   Sampaio, LO
   Dietrich, CP
AF Nader, HB
   Oliveira, FW
   Jeronimo, SMB
   Chavante, SF
   Sampaio, LO
   Dietrich, CP
TI Synchronized order of appearance of hyaluronic acid (or acidic
   galactan)->chondroitin C-6 sulfate->chondroitin C-4/C-6 sulfate, heparan
   sulfate, dermatan sulfate->heparin during morphogenesis, differentiation
   and development
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 4th Brazilian Symposium on Extracellular Matrix
CY SEP 08-11, 1996
CL ANGRA DOS REIS, BRAZIL
DE embryonic development; acidic polysaccharides; fetal development;
   glycosaminoglycans; acidic galactan; mollusc embryogenesis; mammalian
   fetal development; chondroitin 6-sulfate
ID MOLLUSK POMACEA SP; ANOMALOCARDIA-BRASILIANA; CHONDROITIN SULFATES; CELL
   RECOGNITION; MUCOPOLYSACCHARIDES; GLYCOSAMINOGLYCANS; TISSUES; GROWTH
AB The synthesis of glycosaminoglycans and acidic polysaccharides during embryonic and fetal development in mammals and molluscs is briefly reviewed. A sequential order of appearance of each of the acidic polysaccharides was observed, coinciding with the major processes of the ontogeny. In mammals, hyaluronic acid is the first glycosaminoglycan synthesized at the beginning of morphogenesis. This glycosaminoglycan is then replaced by chondroitin 6-sulfate during the migration of the mesenchymal cells. Heparan sulfate, dermatan sulfate and chondroitin 4-sulfate are synthesized only during cell differentiation. The synthesis of heparin, on the other hand, is confined to mast cells in a few tissues and is a late event in the differentiation process. The same general pattern is also observed in molluscs except that hyaluronic acid is replaced by an acidic galactan in the morphogenetic process. The activity of the degrading enzymes responsible for the disappearance of hyaluronic acid, chondroitin sulfate and the acidic galactan in each phase of embryonic development is also reviewed.
C1 UNIV FED RIO GRANDE NORTE,DEPT BIOQUIM,BR-59072970 NATAL,RN,BRAZIL.
RP Nader, HB (corresponding author), UNIV FED SAO PAULO,ESCOLA PAULISTA MED,DEPT BIOQUIM,RUA 3 MAIO,4 ANDAR,BR-04044020 SAO PAULO,BRAZIL.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Nader,
   Helena B/D-9253-2012
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   DIETRICH CP, 1977, BIOCHEM BIOPH RES CO, V75, P329, DOI 10.1016/0006-291X(77)91046-4
   DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5
   DIETRICH CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P1, DOI 10.1016/0304-4165(85)90041-8
   DIETRICH CP, 1983, COMP BIOCHEM PHYS B, V76, P695, DOI 10.1016/0305-0491(83)90379-6
   DIETRICH CP, 1978, BIOCHEM BIOPH RES CO, V84, P794, DOI 10.1016/0006-291X(78)90774-X
   DIETRICH CP, 1978, CANCER RES, V39, P3969
   DIETRICH CP, 1980, MECHANISM SACCHARIDE, P317
   GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7
   JERONIMO SM, 1987, COMP BIOCH PHYSL, V93, P899
   Nader H. B., 1989, HEPARIN CHEM BIOL PR, P81
   NADER HB, 1985, BIOCHIM BIOPHYS ACTA, V840, P187, DOI 10.1016/0304-4165(85)90118-7
   NADER HB, 1984, J BIOL CHEM, V259, P1431
   OLIVEIRA FW, 1994, BBA-GEN SUBJECTS, V1200, P241, DOI 10.1016/0304-4165(94)90163-5
   PEJLER G, 1987, J BIOL CHEM, V262, P11413
   PORCIONATTO MA, 1994, BRAZ J MED BIOL RES, V27, P2185
   SAMPAIO LO, 1981, J BIOL CHEM, V256, P9205
   SAMPAIO LO, 1977, BIOCHIM BIOPHYS ACTA, V498, P123, DOI 10.1016/0304-4165(77)90093-9
   TOLEDO OMS, 1977, BIOCHIM BIOPHYS ACTA, V498, P114, DOI 10.1016/0304-4165(77)90092-7
   Toole BP, 1981, CELL BIOL EXTRACELLU, P259
NR 20
TC 8
Z9 9
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD SEP
PY 1996
VL 29
IS 9
BP 1221
EP 1226
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA VF231
UT WOS:A1996VF23100017
PM 9181066
DA 2020-11-26
ER

PT J
AU JERONIMO, SMB
   HIGGS, E
   VEDVICK, T
   MANN, BJ
   JERNIGAN, J
   PETRI, WA
   PEARSON, RD
AF JERONIMO, SMB
   HIGGS, E
   VEDVICK, T
   MANN, BJ
   JERNIGAN, J
   PETRI, WA
   PEARSON, RD
TI IDENTIFICATION OF LEISHMANIA-CHAGASI ANTIGENS RECOGNIZED BY
   HUMAN-LYMPHOCYTES
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID KALA-AZAR; T-CELL; RESPONSES; PROTEINS; DONOVANI; INVITRO; DISEASE;
   RESISTANCE; MECHANISM; SEQUENCE
AB Preparative SDS-PAGE followed by electroelution was used to separate proteins of Leishmania chagasi promastigotes into 67 fractions. These fractions were tested for the ability to stimulate proliferation of peripheral blood mononuclear cells from healthy immune donors who were treated previously for visceral leishmaniasis and from nonimmune controls. The proliferative responses elicited by these proteins varied among individuals. The 69-kDa protein fraction contained a fragment with sequence similarity to the 70-kDa heat-shock protein. Fragments of the 46- and 41-kDa fractions had sequences not present in the National Biological Research Foundation data bank. These data suggest that a successful subunit vaccine may require multiple parasite antigens. The identification of antigens that elicit human T cell responses is an important step toward understanding the immunology of L. chagasi infection and ultimately in the development of a vaccine.
C1 UNIV VIRGINIA,SCH MED,DEPT MED,CHARLOTTESVILLE,VA 22908.
   UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,DIV GEOG & INT MED,CHARLOTTESVILLE,VA 22908.
   UNIV VIRGINIA,SCH MED,DEPT PATHOL,CHARLOTTESVILLE,VA 22908.
   UNIV FED RIO GRANDE NORTE,DEPT BIOQUIM,NATAL,BRAZIL.
   SALK INST TECHNOL IND ASSOCIATES INC,LA JOLLA,CA.
RI Petri, William A./D-3639-2019; Petri, William/AAL-3642-2020; Jeronimo,
   Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Petri, William/0000-0002-7268-1218; Jeronimo, Selma
   M.B./0000-0002-4784-9904; Jeronimo, Selma/0000-0002-4784-9904
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-26512] Funding Source: Medline
CR ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341
   BADARO R, 1986, LANCET, V1, P647
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   CARVALHO EM, 1994, J IMMUNOL, V152, P5949
   EVANS TG, 1992, J INFECT DIS, V116, P1124
   GREENBLATT CL, 1980, PROG CLIN BIOL RES, V427, P259
   HOLADAY BJ, 1993, J CLIN INVEST, V92, P2626, DOI 10.1172/JCI116878
   HUNKAPILLER MW, 1983, SCIENCE, V219, P650, DOI 10.1126/science.6687410
   JERONIMO SMB, 1994, T ROY SOC TROP MED H, V88, P386, DOI 10.1016/0035-9203(94)90393-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEE MGS, 1988, NUCLEIC ACIDS RES, V16, P9567, DOI 10.1093/nar/16.20.9567
   LOCKSLEY RM, 1992, CURR OPIN IMMUNOL, V4, P413, DOI 10.1016/S0952-7915(06)80032-4
   MACFARLANE J, 1990, EUR J BIOCHEM, V190, P377, DOI 10.1111/j.1432-1033.1990.tb15586.x
   MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
   MELBY PC, 1989, J CLIN INVEST, V83, P1868, DOI 10.1172/JCI114093
   PAMPIGLIONE S, 1975, T ROY SOC TROP MED H, V69, P60, DOI 10.1016/0035-9203(75)90012-7
   PEARSON RD, 1980, J IMMUNOL, V125, P2195
   PLANT JE, 1982, NATURE, V297, P510, DOI 10.1038/297510a0
   REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O
   REED SG, 1990, J CLIN INVEST, V85, P690, DOI 10.1172/JCI114493
   REINER SL, 1993, J CELL BIOCHEM, V53, P323, DOI 10.1002/jcb.240530409
   RUSSO DM, 1992, J IMMUNOL, V148, P202
   RUSSO DM, 1991, J IMMUNOL, V147, P3575
   SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111
   SCOTT P, 1988, J EXP MED, V168, P1675, DOI 10.1084/jem.168.5.1675
   SHAW MA, 1993, ANN HUM GENET, V57, P251, DOI 10.1111/j.1469-1809.1993.tb00899.x
   SKAMENE E, 1991, CURR OPIN IMMUNOL, V3, P511, DOI 10.1016/0952-7915(91)90013-Q
   SOUTHGAT.BA, 1967, J TROP MED HYG, V70, P29
   SYPEK JP, 1991, CELL IMMUNOL, V133, P178, DOI 10.1016/0008-8749(91)90189-I
   VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D
   WYLER DJ, 1979, J INFECT DIS, V140, P215, DOI 10.1093/infdis/140.2.215
   ZIJLSTRA EE, 1991, T ROY SOC TROP MED H, V85, P365, DOI 10.1016/0035-9203(91)90293-8
NR 32
TC 9
Z9 9
U1 0
U2 1
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 S WOODLAWN AVE, CHICAGO, IL 60637
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD OCT
PY 1995
VL 172
IS 4
BP 1055
EP 1060
DI 10.1093/infdis/172.4.1055
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA RW062
UT WOS:A1995RW06200021
PM 7561180
DA 2020-11-26
ER

PT J
AU JERONIMO, SMB
   SALES, AO
   FERNANDES, MZ
   MELO, FP
   SAMPAIO, LO
   DIETRICH, CP
   NADER, HB
AF JERONIMO, SMB
   SALES, AO
   FERNANDES, MZ
   MELO, FP
   SAMPAIO, LO
   DIETRICH, CP
   NADER, HB
TI GLYCOSAMINOGLYCAN STRUCTURE AND CONTENT DIFFER ACCORDING TO THE ORIGINS
   OF HUMAN TUMORS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 3rd Brazilian Symposium on Extracellular Matrix (SIMEC 94)
CY SEP 11-14, 1994
CL ANGRA DES REIS, BRAZIL
DE HEPARAN SULFATE; CHONDROITIN SULFATE; HYALURONIC ACID; TUMORS; URINE;
   WILMS TUMOR; HYPERNEPHROMA
ID MUCOPOLYSACCHARIDES
AB The glycosaminoglycans of the tumor mass and from the urine of patients with a nephroblastoma of embryonic origin (Wilms' tumor) and hypernephroma were analyzed. The urine of patients with Wilms' tumors prior to treatment, and two patients with metastasis contained high levels of hyaluronic acid (2-5 mg/l of urine) when compared to patients after surgery or chemotherapy where the content of hyaluronic acid was less than 0.1 mg/l. Urine of patients with hypernephroma and normal individuals contained even smaller amounts of hyaluronic acid. Normal kidneys contain mainly dermatan sulfate and heparan sulfate, while the hypernephroma and Wilms' tumor contain substantial amounts of chondroitin sulfate. The amount of glycosaminoglycans isolated from Wilms' tumor and hypernephroma were 10 times and 3 times, respectively, greater than normal kidneys. The amounts of hyaluronic acid in Wilms' tumor varied from 56 to 73% whereas normal kidneys contained about 13%. Chondroitin sulfate was also increased in Wilms' tumor and hypernephroma. It corresponded to 11% and 42%, respectively, of the total glycosaminoglycans. These and other findings indicate that the glycosaminoglycans of Wilms' tumors resemble those present during embryonic development of normal tissues whereas those in hypernephroma are typical of other carcinomas of different origins.
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-04044020 SAO PAULO,BRAZIL.
   UNIV FED RIO GRANDE NORTE,DEPT BIOQUIM,BR-59072970 NATAL,RN,BRAZIL.
   UNIV FED RIO GRANDE NORTE,DEPT PATOL,BR-59072970 NATAL,RN,BRAZIL.
   UNIV FED RIO GRANDE NORTE,DEPT CLIN MED,BR-59072970 NATAL,RN,BRAZIL.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014; Nader,
   Helena B/D-9253-2012
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR BECKWITH JB, 1978, CANCER, V41, P1937
   DIETRICH CP, 1984, BRAZ J MED BIOL RES, V17, P5
   DIETRICH CP, 1977, J CHROMATOGR, V130, P299, DOI 10.1016/S0021-9673(00)89809-X
   DIETRICH CP, 1993, LAB INVEST, V68, P439
   HOPWOOD JJ, 1978, PEDIATR RES, V12, P52, DOI 10.1203/00006450-197801000-00013
   IOZZO RV, 1988, CANCER METAST REV, V7, P39, DOI 10.1007/BF00048277
   LONGAKER MT, 1990, J NATL CANCER I, V82, P135, DOI 10.1093/jnci/82.2.135
   MORSE BS, 1967, AM J MED, V42, P996, DOI 10.1016/0002-9343(67)90080-0
   NADER HB, 1984, J BIOL CHEM, V259, P1431
   SAMPAIO LO, 1981, J BIOL CHEM, V256, P9205
   SAMPAIO LO, 1977, BIOCHIM BIOPHYS ACTA, V498, P123, DOI 10.1016/0304-4165(77)90093-9
   STOFFYN PJ, 1954, ARCH BIOCHEM BIOPHYS, V52, P373, DOI 10.1016/0003-9861(54)90137-X
NR 12
TC 10
Z9 13
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD SEP
PY 1994
VL 27
IS 9
BP 2253
EP 2258
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA PG039
UT WOS:A1994PG03900019
PM 7787809
DA 2020-11-26
ER

PT J
AU JERONIMO, SMB
   OLIVEIRA, RM
   MACKAY, S
   COSTA, RM
   SWEET, J
   NASCIMENTO, ET
   LUZ, KG
   FERNANDES, MZ
   JERNIGAN, J
   PEARSON, RD
AF JERONIMO, SMB
   OLIVEIRA, RM
   MACKAY, S
   COSTA, RM
   SWEET, J
   NASCIMENTO, ET
   LUZ, KG
   FERNANDES, MZ
   JERNIGAN, J
   PEARSON, RD
TI AN URBAN OUTBREAK OF VISCERAL LEISHMANIASIS IN NATAL, BRAZIL
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID KALA-AZAR; INFECTION
AB The epidemiological pattern of visceral leishmaniasis in north-eastern Brazil is changing. The disease was typically seen in rural, endemic areas, but is now occurring as an epidemic in the city of Natal where 316 cases have been reported since 1989; 49% mere in children less than 5 years of age. The principle clinical and laboratory findings were weight loss, fever, hepato-splenomegaly, anaemia, leucopenia and hypergammaglobulinaemia. Elevated transaminases and hyperbilirubinaemia were also observed. The diagnosis was confirmed in 87% of cases by identifying amastigotes in aspirates from bone marrow or spleen. Five isolates were identified as Leishmania (L.) chagasi by isoenzyme analysis. The mortality rate was 9%; all deaths occurred during the first week in hospital. One person had concurrent human immunodeficiency virus infection. Among 210 household contacts and neighbours of patients from the endemic area examined for evidence of L. (L.) chagasi infection, 6 additional cases of visceral leishmaniasis were diagnosed. Thirty-eight percent of house-mates and neighbours gave a positive Montenegro skin test reaction, indicating prior subclinical infection.
C1 UNIV VIRGINIA, SCH MED, CTR HLTH SCI 485, DEPT MED, DIV GEOG MED, CHARLOTTESVILLE, VA 22903 USA.
   UNIV FED RIO GRANDE NORTE, DEPT BIOCHEM, RIO GRANDE NORTE, BRAZIL.
   FDN NACL SAUDE, NATAL, RN, BRAZIL.
   HOSP GIZELDA TRIGUEIRO, NATAL, RN, BRAZIL.
   UNIV VIRGINIA, SCH MED, DEPT PATHOL, CHARLOTTESVILLE, VA 22908 USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [P01-AI-26512] Funding Source: Medline;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, P01AI026512,
   P01AI026512] Funding Source: NIH RePORTER
CR ALENCAR JE, 1962, REV INST MED TROP SP, V3, P175
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   COSTA CHN, 1990, REV SAUDE PUBL, V24, P361, DOI 10.1590/S0034-89101990000500003
   DEANE L. M., 1955, REV BRASIL BIOL, V15, P83
   Deane LM, 1955, HOSPITAL-RIO DE JAN, V48, P61
   EVANS T, 1985, WESTERN J MED, V142, P777
   EVANS TG, 1992, J INFECT DIS, V166, P1124, DOI 10.1093/infdis/166.5.1124
   EVANS TG, 1989, MEM I OSWALDO CRUZ, V84, P157, DOI 10.1590/S0074-02761989000200003
   HALIM MA, 1993, CLIN INFECT DIS, V16, P397, DOI 10.1093/clind/16.3.397
   KHALDI F, 1990, ARCH FR PEDIATR, V47, P257
   MEDRANO FJ, 1992, AIDS, V6, P1499, DOI 10.1097/00002030-199212000-00013
   MONTALBAN C, 1990, J INFECTION, V21, P261, DOI 10.1016/0163-4453(90)93933-J
   PENNA HA, 1934, J BRASILIERO MED, V48, P949
   PETERS BS, 1990, Q J MED, V77, P1101, DOI 10.1093/qjmed/77.2.1101
   VIEIRA JB, 1990, PARASITOL TODAY, V6, P339, DOI 10.1016/0169-4758(90)90180-C
NR 15
TC 96
Z9 105
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JUL-AUG
PY 1994
VL 88
IS 4
BP 386
EP 388
DI 10.1016/0035-9203(94)90393-X
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA PE901
UT WOS:A1994PE90100006
PM 7570812
DA 2020-11-26
ER

PT J
AU JERONIMO, SM
   JERNIGAN, J
   VEDVICK, T
   HIGGS, E
   SWEET, J
   MANN, BJ
   PETRI, WA
   PEARSON, RD
AF JERONIMO, SM
   JERNIGAN, J
   VEDVICK, T
   HIGGS, E
   SWEET, J
   MANN, BJ
   PETRI, WA
   PEARSON, RD
TI CHARACTERIZATION OF LEISHMANIA-CHAGASI ANTIGENS RECOGNIZED BY HUMAN
   IMMUNE PERIPHERAL-BLOOD MONONUCLEAR-CELLS
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV FED RIO GRANDE NORTE,DEPT BIOCHEM,NATAL,BRAZIL.
   UNIV VIRGINIA,DEPT MED,CHARLOTTESVILLE,VA 22903.
   SIBIA,LA JOLLA,CA.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020; Petri,
   William A./D-3639-2019; Petri, William/AAL-3642-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; Petri, William/0000-0002-7268-1218
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PD APR
PY 1993
VL 41
IS 2
BP A173
EP A173
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KW761
UT WOS:A1993KW76100344
DA 2020-11-26
ER

PT J
AU WERBOVETZ, KA
   JERONIMO, SMB
   MACDONALD, TL
   PEARSON, RD
AF WERBOVETZ, KA
   JERONIMO, SMB
   MACDONALD, TL
   PEARSON, RD
TI TREATMENT OF LEISHMANIASIS AND TRYPANOSOMIASIS
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Article
AB The Leishmania and Trypanosoma genera, members of the family Trypanosomidae, have species that are pathogenic for humans and other mammals. These organisms are spread by arthropod vectors, have a series of developmental forms, and have a specialized mitochondrial structure at the base of their flagellum known as the kinetoplast. They produce very different clinical syndromes: leishmaniasis, African sleeping sickness, and Chagas' disease. Chemotherapy is available for the treatment of these diseases, although in the case of East African sleeping sickness, which is caused by Trypanosoma brucei rhodesiense, and Chagas' disease, which is caused by Trypanosoma cruzi, therapy is toxic and marginally effective. Recent advances in understanding the biochemistry and molecular biology of the organisms, as well as insights into the immunology of the diseases, have helped to facilitate the development of new approaches to chemotherapy.
RP WERBOVETZ, KA (corresponding author), UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22901, USA.
RI Werbovetz, Karl/E-4290-2011; Jeronimo, Selma M.B./M-8672-2014; Jeronimo,
   Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 5
Z9 5
U1 0
U2 4
PU RAPID SCIENCE PUBLISHERS
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH
SN 0951-7375
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD DEC
PY 1992
VL 5
IS 6
BP 840
EP 848
DI 10.1097/00001432-199212000-00015
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA KA228
UT WOS:A1992KA22800015
DA 2020-11-26
ER

PT J
AU PEARSON, RD
   COX, G
   JERONIMO, SMB
   CASTRACANE, J
   DREW, JS
   EVANS, T
   DEALENCAR, JE
AF PEARSON, RD
   COX, G
   JERONIMO, SMB
   CASTRACANE, J
   DREW, JS
   EVANS, T
   DEALENCAR, JE
TI VISCERAL LEISHMANIASIS - A MODEL FOR INFECTION-INDUCED CACHEXIA
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TUMOR-NECROSIS-FACTOR; PROTEIN-CALORIE MALNUTRITION; FACTOR CACHECTIN;
   INTERLEUKIN-1; RESPONSES; IMMUNITY; UNDERNUTRITION; INTERFERON;
   CHILDREN; DONOVANI
AB Parasitic infections and malnutrition coexist in many tropical and subtropical areas. Studies of Leishmania donovani and of experimentally infected Syrian hamsters have provided important insights into the complex interrelationships between malnutrition and this parasitic disease. Malnutrition, which adversely affects cell-mediated immunity, is associated with the development of visceral leishmaniasis (kala-azar) in children living in endemic areas. In tum, L. donovani can cause wasting as well as hepatosplenomegaly, fever, and anemia. Syrian hamsters infected with L. donovani develop a disease that is comparable to that of humans with kala-azar. Weight loss in infected hamsters is associated with splenic macrophage secretion of potentially catabolic cytokines as measured by the D10.G4.1 assay for interleukin-1 and the L929 cytotoxicity assay for tumor necrosis factor/cachectin. Although decreased food intake contributes to wasting in infected hamsters, studies of skeletal muscle function indicate that it is not the sole factor. Leishmania donovani-infected hamsters have also been used to study drugs with the potential to prevent or reverse cachexia.
C1 UNIV VIRGINIA,HLTH SCI CTR,DEPT PATHOL,CHARLOTTESVILLE,VA 22908.
   UNIV FED RIO GRANDE DO NORTE,NATAL,RN,BRAZIL.
   ENDOGEN,BOSTON,MA.
   UNIV FED CEARA,BR-60000 FORTALEZA,CEARA,BRAZIL.
RP PEARSON, RD (corresponding author), UNIV VIRGINIA,HLTH SCI CTR,DEPT MED,DIV GEOG MED,BOX 485,CHARLOTTESVILLE,VA 22908, USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32AI007046, T32AI007046, T32AI007046, T32AI007046, T32AI007046,
   P01AI026512, T32AI007046, P01AI026512, T32AI007046, P01AI026512,
   P01AI026512, P01AI026512, T32AI007046, P01AI026512, T32AI007046,
   T32AI007046, P01AI026512, P01AI026512, P01AI026512, T32AI007046,
   T32AI007046, T32AI007046, T32AI007046, T32AI007046, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, T32AI007046, P01AI026512,
   P01AI026512, P01AI026512, P01AI026512, T32AI007046, P01AI026512,
   T32AI007046, P01AI026512, P01AI026512, T32AI007046, T32AI007046,
   P01AI026512, T32AI007046, T32AI007046, P01AI026512, T32AI007046,
   P01AI026512, P01AI026512, P01AI026512, T32AI007046, T32AI007046,
   P01AI026512, P01AI026512, P01AI026512, P01AI026512, T32AI007046,
   P01AI026512, P01AI026512, T32AI007046, T32AI007046, P01AI026512,
   T32AI007046, T32AI007046, T32AI007046, T32AI007046, T32AI007046,
   P01AI026512, P01AI026512, T32AI007046, T32AI007046, P01AI026512,
   P01AI026512] Funding Source: NIH RePORTER; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [T32 AI-07046, P01-AI-26512] Funding Source: Medline
CR ACTOR PAUL, 1960, EXPTL PARASITOL, V10, P1, DOI 10.1016/0014-4894(60)90078-3
   ALENCAR JE, 1982, DOENCAS INFECCIOSAS, P712
   BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639
   BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003
   BEUTLER B, 1988, BIOCHEMISTRY-US, V27, P7575, DOI 10.1021/bi00420a001
   CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209
   CERF BJ, 1987, J INFECT DIS, V156, P1030, DOI 10.1093/infdis/156.6.1030
   CHANDRA RK, 1975, ARCH DIS CHILD, V50, P225, DOI 10.1136/adc.50.3.225
   CHANDRA RK, 1980, FED PROC, V39, P3086
   CHANDRA RK, 1977, MALNUTRITION IMMUNE, P155
   CRAWFORD GD, 1985, J INFECT DIS, V152, P315, DOI 10.1093/infdis/152.2.315
   DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433
   DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3
   DOUGLAS SD, 1977, MALNUTRITION IMMUNE, P231
   DOWD PS, 1984, CLIN SCI, V66, P241, DOI 10.1042/cs0660241
   DREW JS, 1988, J APPL PHYSIOL, V64, P460
   EDELMAN R, 1977, MALNUTRITION IMMUNE, P47
   EVANS T, 1985, WESTERN J MED, V142, P777
   EVANS TG, 1989, MEM I OSWALDO CRUZ, V84, P157, DOI 10.1590/S0074-02761989000200003
   HARRISON LH, 1986, REV INFECT DIS, V8, P447
   KEUSCH GT, 1977, MALNUTRITION IMMUNE, P245
   KULAPONGS P, 1977, AM J CLIN NUTR, V30, P367
   Leitzmann C, 1977, MALNUTRITION IMMUNE, P253
   NEUMANN CG, 1975, AM J CLIN NUTR, V28, P89
   Pearson R. D., 1990, Principles and practice of infectious diseases., P2066
   Pearson R. D., 1989, Parasitic infections in the compromised host., P31
   PEARSON RD, 1983, J INFECT DIS, V147, P1102, DOI 10.1093/infdis/147.6.1102
   PEARSON RD, 1990, AM J TROP MED HYG, V43, P640, DOI 10.4269/ajtmh.1990.43.640
   PEREZ H, 1979, CLIN EXP IMMUNOL, V38, P453
   REINER NE, 1990, J CLIN INVEST, V85, P1914, DOI 10.1172/JCI114654
   REINER NE, 1987, J IMMUNOL, V138, P1919
   SALIMONU LS, 1982, CLIN IMMUNOL IMMUNOP, V24, P1, DOI 10.1016/0090-1229(82)90082-4
   SCHLESINGER L, 1974, AM J CLIN NUTR, V27, P615
   SCRIMSHAW NS, 1968, WHO MONOGR SER, V57, P3
   SCUDERI P, 1986, LANCET, V2, P1364
   SMYTHE PM, 1971, LANCET, V2, P939
   TRACEY KJ, 1992, IN PRESS AM J TROP M
NR 37
TC 26
Z9 28
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DRIVE SUITE 130, MCLEAN, VA 22101
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUL
PY 1992
VL 47
IS 1
SU S
BP 8
EP 15
DI 10.4269/ajtmh.1992.47.8
PG 8
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA JG071
UT WOS:A1992JG07100003
PM 1632476
DA 2020-11-26
ER

PT J
AU KELSALL, BL
   JERONIMO, SMB
   PEARSON, RD
AF KELSALL, BL
   JERONIMO, SMB
   PEARSON, RD
TI DEVELOPMENTS IN ANTIPARASITIC CHEMOTHERAPY
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Article
AB The treatment of parasitic infections has undergone dramatic changes.  Isolates of Plasmodium falciparum are now resistant to chloroquine and other antimalarials in many areas of Asia, Africa, and South America.  Mefloquine has emerged as the prophylaxis of choice for most travelers to areas with chloroquine-resistant P. falciparum.  The quest continues for better approaches to the treatment of toxoplasmosis, Chagas' disease, leishmaniasis, and African trypanosomiasis.  Immunotherapy with interferon-gamma appears very promising for the treatment of visceral leishmaniasis.  Eflornithine has produced miraculous cures in some persons with Gambian sleeping sickness, and for the helminths, praziquantel is active against all Schistosoma species and other trematodes except Fasciola hepatica.  Ivermectin has emerged as the treatment of choice for onchocerciasis.  Both praziquantel and albendazole are effective for neurocysticercosis, but corticosteroids are usually administered concomitantly to prevent or reduce cerebral edema.
RP KELSALL, BL (corresponding author), UNIV VIRGINIA,HLTH SCI CTR,CHARLOTTESVILLE,VA 22908, USA.
RI Jeronimo, Selma/AAY-4033-2020; Jeronimo, Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CURRENT SCIENCE
PI PHILADELPHIA
PA 400 MARKET STREET,SUITE 750 ATTN:SARAH WHEALEN/SUB MGR, PHILADELPHIA, PA
   19106
SN 0951-7375
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD JUN
PY 1991
VL 4
IS 3
BP 314
EP 322
DI 10.1097/00001432-199106000-00009
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA FT871
UT WOS:A1991FT87100009
DA 2020-11-26
ER

PT J
AU JERONIMO, SM
   EVANS, TG
   PEARSON, RD
AF JERONIMO, SM
   EVANS, TG
   PEARSON, RD
TI CHARACTERIZATION OF LEISHMANIAL ANTIGENS
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV UTAH,SALT LAKE CITY,UT 84112.
   UNIV VIRGINIA,DEPT MED,CHARLOTTESVILLE,VA 22903.
   UNIV VIRGINIA,DEPT PATHOL,CHARLOTTESVILLE,VA 22903.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PD APR
PY 1990
VL 38
IS 2
BP A391
EP A391
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CZ244
UT WOS:A1990CZ24400952
DA 2020-11-26
ER

PT J
AU PEARSON, RD
   BORLAND, MK
   JERONIMO, SM
   HEWLETT, EL
AF PEARSON, RD
   BORLAND, MK
   JERONIMO, SM
   HEWLETT, EL
TI INTOXICATION OF HUMAN-LEUKOCYTES BY THE ADENYLATE-CYCLASE TOXIN OF
   VIABLE BORDETELLA-PERTUSSIS
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV VIRGINIA,CHARLOTTESVILLE,VA 22903.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PD APR
PY 1990
VL 38
IS 2
BP A270
EP A270
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA CZ244
UT WOS:A1990CZ24400258
DA 2020-11-26
ER

PT J
AU JERONIMO, SMB
   PEARSON, RD
AF JERONIMO, SMB
   PEARSON, RD
TI LEISHMANIASIS - AN UPDATE
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Article
RP JERONIMO, SMB (corresponding author), UNIV FED RIO GRANDE NORTE NATAL,RIO GRAND DO NORTE,BRAZIL.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
NR 0
TC 1
Z9 1
U1 0
U2 0
PU RAPID SCIENCE PUBLISHERS
PI LONDON
PA 2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH
SN 0951-7375
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 1989
VL 2
IS 5
BP 631
EP 638
DI 10.1097/00001432-198910000-00004
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA AX700
UT WOS:A1989AX70000004
DA 2020-11-26
ER

PT J
AU JERONIMO, SMB
   DIETRICH, CP
   NADER, HB
AF JERONIMO, SMB
   DIETRICH, CP
   NADER, HB
TI STRUCTURE OF SULFATED GLYCOSAMINOGLYCANS SYNTHESIZED DURING THE ONTOGENY
   OF THE MOLLUSK POMACEA SP
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED SCH,DEPT BIOQUIM,BR-04034 SAO PAULO,SP,BRAZIL.
RP JERONIMO, SMB (corresponding author), UNIV FED RIO GRANDE NORTE,CTR BIOCIENCIAS,DEPT BIOQUIM,CP 1545,BR-59072 NATAL,RN,BRAZIL.
RI Nader, Helena B/D-9253-2012; Jeronimo, Selma/AAY-4033-2020; Jeronimo,
   Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR CHIARUGI VP, 1977, EXP CELL BIOL, V44, P131
   DIETRICH CP, 1977, BIOCHEM BIOPH RES CO, V75, P329, DOI 10.1016/0006-291X(77)91046-4
   DIETRICH CP, 1983, COMP BIOCHEM PHYS B, V76, P695, DOI 10.1016/0305-0491(83)90379-6
   DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7
   DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2
   DIETRICH CP, 1978, BIOCHEM BIOPH RES CO, V84, P794, DOI 10.1016/0006-291X(78)90774-X
   DIETRICH CP, 1980, MECHANISMS SACCHARID
   DISCHE Z, 1947, J BIOL CHEM, V167, P312
   JERONIMO SMB, 1988, ARQ BIOL TECNOL, V31, P96
   MARCUM JA, 1985, BIOCHEM BIOPH RES CO, V126, P365, DOI 10.1016/0006-291X(85)90615-1
   NADER HB, 1985, BIOCHIM BIOPHYS ACTA, V840, P187, DOI 10.1016/0304-4165(85)90118-7
   NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565
   NADER HB, 1984, J BIOL CHEM, V259, P1431
   NADER HB, 1977, ANAL BIOCHEM, V78, P112, DOI 10.1016/0003-2697(77)90014-8
   RONDLE CJM, 1955, BIOCHEM J, V61, P586, DOI 10.1042/bj0610586
   SAMPAIO LO, 1981, J BIOL CHEM, V256, P9205
   SAMPAIO LO, 1977, BIOCHIM BIOPHYS ACTA, V448, P123
   SENO K, 1981, GLYCOCONJUGATES, P413
   TOOLE BP, 1973, AM ZOOL, V13, P1061
   TOOLE BP, 1982, CONNECT TISSUE RES, V10, P93, DOI 10.3109/03008208209034409
NR 20
TC 4
Z9 5
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PY 1989
VL 93
IS 4
BP 899
EP 903
DI 10.1016/0305-0491(89)90064-3
PG 5
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA AQ570
UT WOS:A1989AQ57000027
DA 2020-11-26
ER

PT J
AU NADER, HB
   JERONIMO, SMB
   PORCIONATTO, MA
   DIETRICH, CP
AF NADER, HB
   JERONIMO, SMB
   PORCIONATTO, MA
   DIETRICH, CP
TI BIOSYNTHESIS OF AN ACIDIC GALACTAN AND SULFATED GLYCOSAMINOGLYCANS
   DURING EMBRYONIC-DEVELOPMENT OF THE MOLLUSK POMACEA SP
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,CP 20372,BR-04023 SAO PAULO,SP,BRAZIL.
   UNIV FED RIO GRANDE NORTE,DEPT BIOQUIM,NATAL,RN,BRAZIL.
RI Jeronimo, Selma M.B./M-8672-2014; Porcionatto, Marimelia/C-3322-2012;
   Nader, Helena B/D-9253-2012; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Porcionatto,
   Marimelia/0000-0001-6287-916X; Jeronimo, Selma/0000-0002-4784-9904;
   NADER, HELENA/0000-0002-7569-2166
CR CZOK R, 1974, METHODEN ENZYMATISCH, P1491
   DIETRICH CP, 1983, COMP BIOCHEM PHYS B, V76, P695, DOI 10.1016/0305-0491(83)90379-6
   DIFERRANTE N, 1971, P NATL ACAD SCI USA, V68, P303
   GORIN PAJ, 1981, CARBOHYD RES, V92, pC1, DOI 10.1016/S0008-6215(00)85996-0
   GORIN PAJ, 1982, CARBOHYD RES, V100, P1, DOI 10.1016/S0008-6215(00)81021-6
   JERONIMO SMB, 1983, ARQ BIOL TECNOL, V26, P199
   JOURDIAN GW, 1971, J BIOL CHEM, V246, P430
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NADER HB, 1984, J BIOL CHEM, V259, P1431
   NADER HB, 1977, ANAL BIOCHEM, V78, P112, DOI 10.1016/0003-2697(77)90014-8
   ROE JH, 1955, J BIOL CHEM, V212, P335
   RONDLE CJM, 1955, BIOCHEM J, V61, P586, DOI 10.1042/bj0610586
   SAMPAIO LO, 1981, J BIOL CHEM, V256, P9205
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   TOOLE BP, 1972, DEV BIOL, V29, P321, DOI 10.1016/0012-1606(72)90071-1
NR 15
TC 7
Z9 8
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PY 1985
VL 840
IS 2
BP 187
EP 192
DI 10.1016/0304-4165(85)90118-7
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ALC34
UT WOS:A1985ALC3400006
DA 2020-11-26
ER

PT J
AU NADER, HB
   FERREIRA, TMPC
   PAIVA, JF
   MEDEIROS, MGL
   JERONIMO, SMB
   PAIVA, VMP
   DIETRICH, CP
AF NADER, HB
   FERREIRA, TMPC
   PAIVA, JF
   MEDEIROS, MGL
   JERONIMO, SMB
   PAIVA, VMP
   DIETRICH, CP
TI ISOLATION AND STRUCTURAL STUDIES OF HEPARAN SULFATES AND CHONDROITIN
   SULFATES FROM 3 SPECIES OF MOLLUSKS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 UNIV FED RIO GRANDE NORTE,DEPT CIENCIAS FISIOL,DISCIPLINA BIOQUIM,NATAL,BRAZIL.
RP NADER, HB (corresponding author), ESCOLA PAULISTA MED,DEPT BIOQUIM,CP 20372,BR-01000 SAO PAULO,SP,BRAZIL.
RI Nader, Helena B/D-9253-2012; Jeronimo, Selma/AAY-4033-2020; Jeronimo,
   Selma M.B./M-8672-2014
OI Jeronimo, Selma/0000-0002-4784-9904; Jeronimo, Selma
   M.B./0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR BIANCHINI P, 1980, J CHROMATOGR, V196, P455, DOI 10.1016/S0021-9673(00)84747-0
   CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   DIETRICH CP, 1977, BIOCHEM BIOPH RES CO, V75, P329, DOI 10.1016/0006-291X(77)91046-4
   DIETRICH CP, 1970, P SOC EXP BIOL MED, V134, P955
   DIETRICH CP, 1983, BIOCHEM BIOPH RES CO, V111, P865, DOI 10.1016/0006-291X(83)91379-7
   DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2
   DIFERRANTE N, 1971, P NATL ACAD SCI USA, V68, P303
   FERREIRA TMP, 1982, ARQ BIOL TECHNOL CUR, V25, P54
   GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7
   HOVINGH P, 1982, J BIOL CHEM, V257, P9840
   KRAEMER PM, 1971, BIOCHEMISTRY-US, V10, P1437, DOI 10.1021/bi00784a026
   LINKER A, 1977, FED PROC, V36, P43
   LINKER A, 1975, BIOCHIM BIOPHYS ACTA, V385, P324, DOI 10.1016/0304-4165(75)90360-8
   MICHELACCI YM, 1976, BIOCHIM BIOPHYS ACTA, V451, P436, DOI 10.1016/0304-4165(76)90138-0
   MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121
   NADER HB, 1977, ANAL BIOCHEM, V78, P112, DOI 10.1016/0003-2697(77)90014-8
   RONDLE CJM, 1955, BIOCHEM J, V61, P586, DOI 10.1042/bj0610586
   SAMPAIO LO, 1981, J BIOL CHEM, V256, P9205
   SILVA ME, 1976, BIOCHIM BIOPHYS ACTA, V437, P129, DOI 10.1016/0304-4165(76)90354-8
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   SILVA ME, 1974, BIOCHEM BIOPH RES CO, V56, P965, DOI 10.1016/S0006-291X(74)80283-4
   SUZUKI S, 1968, J BIOL CHEM, V243, P1543
   TOLEDO OMS, 1977, BIOCHIM BIOPHYS ACTA, V498, P114, DOI 10.1016/0304-4165(77)90092-7
NR 23
TC 95
Z9 97
U1 1
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1984
VL 259
IS 3
BP 1431
EP 1435
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA SD500
UT WOS:A1984SD50000014
PM 6229536
DA 2020-11-26
ER

PT J
AU NADER, HB
   MEDEIROS, MGL
   PAIVA, JF
   PAIVA, VMP
   JERONIMO, SMB
   FERREIRA, TMPC
   DIETRICH, CP
AF NADER, HB
   MEDEIROS, MGL
   PAIVA, JF
   PAIVA, VMP
   JERONIMO, SMB
   FERREIRA, TMPC
   DIETRICH, CP
TI A CORRELATION BETWEEN THE SULFATED GLYCOSAMINOGLYCAN CONCENTRATION AND
   DEGREE OF SALINITY OF THE HABITAT IN 15 SPECIES OF THE CLASSES
   CRUSTACEA, PELECYPODA AND GASTROPODA
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-0100 SAO PAULO,SP,BRAZIL.
RP NADER, HB (corresponding author), UNIV FED RIO GRANDE NORTE,DEPT CIENCIAS FISIOL,DISCIPLINA BIOQUIM,NATAL,RN,BRAZIL.
RI Nader, Helena B/D-9253-2012; Jeronimo, Selma M.B./M-8672-2014; Jeronimo,
   Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   DIETRICH CP, 1970, P SOC EXP BIOL MED, V134, P955
   DIETRICH CP, 1983, COMP BIOCH PHYSL
   GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7
   MEDEIROS MGL, 1982, ARQ BIOL TECHNOL, V25, P53
   TOLEDO OMS, 1977, BIOCHIM BIOPHYS ACTA, V498, P114, DOI 10.1016/0304-4165(77)90092-7
NR 6
TC 17
Z9 17
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PY 1983
VL 76
IS 3
BP 433
EP 436
DI 10.1016/0305-0491(83)90271-7
PG 4
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA RR938
UT WOS:A1983RR93800007
DA 2020-11-26
ER

PT J
AU DIETRICH, CP
   PAIVA, VMP
   JERONIMO, SMB
   FERREIRA, TMOC
   MEDEIROS, MGL
   PAIVA, JF
   NADER, HB
AF DIETRICH, CP
   PAIVA, VMP
   JERONIMO, SMB
   FERREIRA, TMOC
   MEDEIROS, MGL
   PAIVA, JF
   NADER, HB
TI CHARACTERISTIC DISTRIBUTION OF HEPARAN SULFATES AND CHONDROITIN SULFATES
   IN TISSUES AND ORGANS OF THE AMPULARIDAE-POMACEA SP
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-01000 SAO PAULO,SP,BRAZIL.
RP DIETRICH, CP (corresponding author), UNIV FED RIO GRANDE NORTE,DEPT CIENCIAS FISIOL,DISCIPLINA BIOQUIM,NATAL,RN,BRAZIL.
RI Nader, Helena B/D-9253-2012; Jeronimo, Selma M.B./M-8672-2014; Jeronimo,
   Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904; NADER, HELENA/0000-0002-7569-2166
CR BIANCHINI P, 1980, J CHROMATOGR, V196, P455, DOI 10.1016/S0021-9673(00)84747-0
   CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2
   DIETRICH CP, 1977, BIOCH BIOPHYS RES CO, V71, P1
   GOMES PB, 1982, COMP BIOCHEM PHYS B, V73, P857, DOI 10.1016/0305-0491(82)90329-7
   HUNT S, 1970, POLYSACCHARIDE PROTE
   Mathews M B, 1975, CONNECTIVE TISSUE MA
   PAIVA VMP, 1982, ARQ BIOL TECNOL, V25, P55
   PERSON P, 1967, BIOL BULL, V132, P244, DOI 10.2307/1539892
   SENO N, 1981, GLYCOCONJUGATES, V6, P413
   SUZUKI S, 1968, J BIOL CHEM, V243, P1543
   TOLEDO OMS, 1977, BIOCHIM BIOPHYS ACTA, V498, P114, DOI 10.1016/0304-4165(77)90092-7
NR 12
TC 14
Z9 14
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PY 1983
VL 76
IS 4
BP 695
EP 698
DI 10.1016/0305-0491(83)90379-6
PG 4
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA RW747
UT WOS:A1983RW74700005
DA 2020-11-26
ER

PT J
AU NADER, HB
   FERREIRA, TMC
   JERONIMO, SMB
   MEDEIROS, MGL
   DEPAIVA, JF
   DEPAIVA, VMP
   DIETRICH, CP
AF NADER, HB
   FERREIRA, TMC
   JERONIMO, SMB
   MEDEIROS, MGL
   DEPAIVA, JF
   DEPAIVA, VMP
   DIETRICH, CP
TI SULFATED GLYCOSAMINOGLYCANS OF INVERTEBRATES - TISSUE DISTRIBUTION,
   STRUCTURAL CHARACTERIZATION AND CHANGE OF CONCENTRATION WITH THE
   SALINITY OF THE HABITAT
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RP NADER, HB (corresponding author), UNIV FED RIO GRANDE NORTE,CB,DEPT FISIOL,DIV BIOQUIM,BR-59000 NATAL,RN,BRAZIL.
RI Jeronimo, Selma M.B./M-8672-2014; Jeronimo, Selma/AAY-4033-2020
OI Jeronimo, Selma M.B./0000-0002-4784-9904; Jeronimo,
   Selma/0000-0002-4784-9904
CR 1980, AN ACAD BRASIL CIENC, V52, P179
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1982
VL 54
IS 4
BP 764
EP 765
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QB738
UT WOS:A1982QB73800051
DA 2020-11-26
ER

EF